data_2osg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2osg _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.819 0.342 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.28 157.48 21.47 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.402 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.35 134.03 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.708 0.29 . . . . 0.0 111.288 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 mp -103.13 115.02 29.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.508 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 tp -104.98 126.28 51.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.709 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.16 161.41 13.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.743 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.983 -179.806 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.744 0.307 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -58.24 -23.15 54.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.346 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.93 27.53 68.6 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.432 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.06 120.84 41.39 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.631 0.253 . . . . 0.0 110.782 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.48 113.36 25.35 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.1 mp -105.99 124.95 50.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 111.215 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.19 178.31 19.49 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.637 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.6 OUTLIER -139.99 142.92 36.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.152 0.476 . . . . 0.0 111.205 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' B' ' 104' ' ' SER . 11.0 pt20 -129.31 154.42 46.88 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.673 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.513 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 3.2 mt -90.32 120.77 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.378 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.406 ' CE1' ' CG ' ' B' ' 105' ' ' GLN . 39.9 p90 -118.31 173.02 7.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.558 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.426 HG22 HD21 ' A' ' 40' ' ' LEU . 21.5 t -79.16 94.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.102 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -48.94 71.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -167.01 153.74 8.54 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.907 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.37 161.47 34.43 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.834 0.35 . . . . 0.0 111.063 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -70.55 135.66 48.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.002 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -68.91 144.75 54.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.707 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 58.06 31.02 20.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.337 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.78 -174.35 29.37 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.165 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.22 -31.06 71.17 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.15 -39.06 60.7 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.568 0.223 . . . . 0.0 111.452 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -33.71 44.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.167 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -63.28 -37.06 85.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.382 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -100.3 -30.91 11.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.684 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.25 47.14 24.25 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.341 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -63.07 -48.33 79.12 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.46 0.171 . . . . 0.0 111.319 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.426 HD21 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -134.06 144.29 48.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.723 0.296 . . . . 0.0 111.21 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 148.24 22.35 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.629 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -59.01 110.91 1.13 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 111.234 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.75 -16.4 21.15 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.191 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -60.39 134.71 57.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.244 0.522 . . . . 0.0 110.704 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.8 pt -79.86 119.86 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.961 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.434 ' HB ' HG22 ' A' ' 54' ' ' THR . 38.0 mt -88.97 137.54 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.961 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.82 -41.82 8.27 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.329 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.68 147.67 34.62 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.744 0.306 . . . . 0.0 111.069 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.42 ' CG1' HG21 ' A' ' 46' ' ' ILE . 14.7 mt -136.65 117.94 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.676 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 52.25 44.54 29.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 111.224 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.17 17.86 76.15 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.042 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.3 m -120.74 139.39 53.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.759 0.28 . . . . 0.0 110.374 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.8 145.86 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.149 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.513 ' CG2' ' HB ' ' A' ' 23' ' ' ILE . 2.5 m -120.69 20.89 11.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.686 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -119.33 129.65 54.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 70.66 -7.67 1.02 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.57 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 10.5 ttt -66.07 150.66 48.36 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.808 0.337 . . . . 0.0 110.622 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.9 t -71.8 143.47 49.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.079 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.73 -46.19 84.78 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -40.43 82.37 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.055 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -64.08 -47.64 79.31 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.006 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.25 -41.55 89.02 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.003 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -37.96 81.74 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.635 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -38.68 83.18 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.733 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.87 -43.32 94.79 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.923 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 14.3 mt -68.18 -37.84 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.546 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -66.83 -49.56 65.38 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.781 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -68.77 -22.22 64.3 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.437 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.9 t -74.87 73.15 2.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.034 0.445 . . . . 0.0 110.704 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.26 105.84 16.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.474 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.1 -91.19 0.21 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.239 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -129.34 134.11 47.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.735 0.302 . . . . 0.0 110.652 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 pp -123.47 143.96 49.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -112.22 140.48 46.88 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.867 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.42 128.64 31.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.861 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.0 t -109.74 138.84 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.939 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.2 t -121.13 154.31 24.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.288 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 N--CA 1.463 0.197 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.511 179.335 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.481 HG21 HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.876 0.369 . . . . 0.0 111.007 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.02 157.69 15.55 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.791 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 t -131.58 135.31 59.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.769 0.318 . . . . 0.0 111.313 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 mp -104.47 114.94 29.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.62 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 tp -102.16 133.36 47.13 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.978 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 5.7 ttm -105.06 164.47 11.78 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.036 0.446 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 3.7 pttm . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.908 179.8 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 120.713 0.292 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -77.0 -32.12 56.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.394 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.73 26.83 55.57 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.394 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 6.2 mp -104.83 123.12 47.13 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.03 113.68 25.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.245 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 mp -98.26 124.69 43.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.983 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.88 166.21 12.14 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.918 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 1.6 p -121.07 150.71 40.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.028 0.414 . . . . 0.0 111.244 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -137.49 145.38 42.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.459 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.505 ' HB ' ' CG2' ' B' ' 137' ' ' THR . 2.6 mt -88.86 121.14 38.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.175 0.512 . . . . 0.0 111.324 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -118.78 174.54 6.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.568 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' B' ' 123' ' ' LEU . 39.0 t -83.37 95.57 3.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.135 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -63.32 -56.33 17.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 110.573 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -163.99 146.26 9.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -133.37 156.02 48.4 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.804 0.335 . . . . 0.0 111.349 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.26 132.49 49.2 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -67.57 147.82 52.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.929 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 5.2 m 61.85 33.78 17.45 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.243 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.38 -170.31 28.08 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.146 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 7.4 mt -72.84 -30.06 63.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.676 0.238 . . . . 0.0 111.477 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.18 -36.73 61.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.173 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.79 -33.86 52.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -61.57 -38.43 87.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.217 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.88 -28.29 13.18 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.763 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.55 39.07 50.67 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.266 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -59.51 -42.4 92.12 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . 0.428 ' HB3' ' CG2' ' B' ' 108' ' ' VAL . 1.1 mt -133.05 143.87 49.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.766 0.317 . . . . 0.0 111.171 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.04 141.39 28.59 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.56 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -58.19 109.71 0.81 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.104 0.478 . . . . 0.0 110.789 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 108' ' ' VAL . . . 104.99 -15.75 47.47 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.592 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -62.54 141.97 58.19 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.172 0.511 . . . . 0.0 111.459 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 29.6 pt -79.8 127.96 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.898 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 26.8 mt -94.91 143.79 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.425 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.46 -36.63 10.28 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.629 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -154.81 152.43 29.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.627 0.251 . . . . 0.0 111.28 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.4 117.5 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.324 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . 0.413 ' HB2' HD13 ' B' ' 148' ' ' LEU . 2.4 m120 51.16 34.7 11.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.373 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.63 85.7 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.178 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 58.6 m -102.47 132.48 48.48 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.955 0.377 . . . . 0.0 110.201 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.4 t -54.19 145.32 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.075 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.505 ' CG2' ' HB ' ' B' ' 106' ' ' ILE . 27.8 m -113.59 20.19 16.18 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.662 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.44 127.7 53.33 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 70.56 -5.55 1.39 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.755 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.25 169.75 5.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.858 0.361 . . . . 0.0 111.131 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.38 146.77 23.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.481 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -42.22 98.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.004 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 44.2 p -64.12 -39.44 94.04 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.982 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -63.74 -47.92 79.11 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.931 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.37 90.26 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -69.33 -38.86 78.39 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.546 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -67.43 -38.06 83.97 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.631 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . 0.413 HD13 ' HB2' ' B' ' 133' ' ' ASN . 0.2 OUTLIER -60.04 -44.57 94.58 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.63 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 37.9 mt -68.4 -37.57 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.928 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -69.48 -49.22 56.85 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.787 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -24.92 66.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.628 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 99.6 p -83.53 61.17 6.08 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.053 0.454 . . . . 0.0 110.746 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -69.65 110.96 5.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.568 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.62 -84.08 0.3 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -132.24 135.14 46.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.657 0.265 . . . . 0.0 110.792 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.47 ' HG ' ' CD2' ' B' ' 158' ' ' LEU . 0.9 OUTLIER -128.64 143.49 50.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.939 0.4 . . . . 0.0 111.11 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -105.61 142.76 34.79 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.213 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.47 ' CD2' ' HG ' ' B' ' 156' ' ' LEU . 3.6 mm? -134.98 146.84 49.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.314 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 6.2 t -120.67 128.93 76.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.299 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.31 146.63 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.617 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.524 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.729 0.299 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.96 159.93 23.43 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.654 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 t -123.56 131.76 72.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.696 0.284 . . . . 0.0 110.977 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 tt -100.28 108.57 20.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.706 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp -95.88 136.58 36.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.718 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.4 ttm -110.75 165.09 12.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.013 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.7 pttp . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.977 -179.889 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 N--CA 1.47 0.565 0 CA-C-O 121.352 0.596 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.411 ' HB3' ' CD1' ' A' ' 17' ' ' LEU . 64.9 m-85 -88.26 -32.24 18.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.312 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.13 23.32 35.18 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.733 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.411 ' CD1' ' HB3' ' A' ' 15' ' ' TYR . 3.4 mp -104.98 115.46 30.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.786 0.293 . . . . 0.0 110.794 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.99 113.53 22.83 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mp -102.02 124.8 48.26 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.596 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -114.82 -167.51 15.57 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.77 147.92 31.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.241 0.521 . . . . 0.0 111.136 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -133.47 140.57 47.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.414 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.48 ' CD1' HG21 ' A' ' 54' ' ' THR . 27.5 mt -88.22 120.55 37.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.41 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.402 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 40.1 p90 -122.26 173.95 7.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.01 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.1 t -80.16 94.12 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.778 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -65.12 -56.25 14.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.039 -179.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -147.53 151.18 35.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.416 ' HG3' ' HG ' ' B' ' 100' ' ' LEU . 3.2 tmm? -138.26 142.72 39.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.82 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.76 120.06 12.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.623 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 153.68 23.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.083 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.98 22.46 12.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.327 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.87 -168.77 36.55 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.568 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.34 -30.8 66.62 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.97 -33.39 61.88 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.14 -34.7 43.05 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.176 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -36.88 85.12 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.21 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -98.39 -37.56 9.57 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.424 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.35 45.7 9.67 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.789 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -71.93 -49.45 37.48 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -129.82 132.01 46.35 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.661 0.267 . . . . 0.0 111.107 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.25 145.95 24.06 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.651 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -58.05 111.84 1.32 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.077 0.465 . . . . 0.0 111.075 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.68 -19.4 12.55 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.856 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -62.9 134.27 55.95 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.105 0.452 . . . . 0.0 110.587 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 pt -78.65 130.25 36.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.058 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.1 mt -96.07 138.06 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.503 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 tp -98.93 -40.61 7.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.984 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.49 148.21 27.14 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.832 0.349 . . . . 0.0 111.409 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mt -138.74 118.83 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.66 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 53.23 44.64 29.93 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 111.182 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.47 15.37 72.88 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.172 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 m -120.84 135.45 55.17 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.855 0.328 . . . . 0.0 110.389 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 t -62.67 146.98 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.927 0.394 . . . . 0.0 111.266 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.48 HG21 ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -126.71 16.32 7.5 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.334 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.7 131.61 55.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 71.46 -6.18 1.44 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.281 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.85 175.03 6.9 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.9 m -90.14 143.81 26.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 tt -58.41 -40.48 82.57 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.788 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 m -63.17 -42.06 99.34 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.88 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -63.99 -48.05 77.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.768 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.47 -40.57 91.7 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.169 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -63.62 -41.03 98.33 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.949 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -38.27 86.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.711 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 tp -60.75 -43.4 98.03 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.6 mt -67.21 -38.01 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.681 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -67.65 -49.51 62.56 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -64.31 -23.28 67.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.257 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 t -75.7 73.03 2.67 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.123 0.487 . . . . 0.0 110.821 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.15 100.63 13.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.552 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.08 -95.33 0.19 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.943 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.18 135.84 49.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.591 0.234 . . . . 0.0 110.439 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.12 141.83 51.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.093 0.473 . . . . 0.0 111.309 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -101.87 128.36 48.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.112 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 mp -126.53 129.18 48.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.664 0.269 . . . . 0.0 111.383 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.3 m -119.57 114.8 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.685 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -107.9 157.57 8.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.541 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.831 179.779 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.728 0.299 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.43 155.87 16.83 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.632 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 17.4 t -131.49 135.11 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.725 0.297 . . . . 0.0 111.118 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 4.7 tt -103.65 107.12 17.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.612 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 21.3 tp -99.88 129.27 45.95 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.332 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.4 ttt -109.37 164.64 12.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.984 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.991 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 . . . . . 0 N--CA 1.471 0.581 0 CA-C-O 121.314 0.578 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -71.49 -32.03 67.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.417 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.01 26.74 47.94 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.467 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . 0.416 ' HG ' ' HG3' ' A' ' 28' ' ' MET . 4.2 mp -104.73 116.64 32.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.665 0.269 . . . . 0.0 110.846 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -92.74 113.52 25.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.231 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 5.0 mp -94.79 125.01 39.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.288 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -110.27 178.36 20.02 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.581 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.12 146.45 46.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.094 0.447 . . . . 0.0 111.017 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -134.1 141.79 47.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.43 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 20' ' ' GLY . 5.6 mt -88.14 122.05 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.597 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -122.25 171.47 9.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.047 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 38.8 t -83.78 93.59 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.059 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . 0.418 ' HG3' ' HA3' ' A' ' 20' ' ' GLY . 7.1 mtpt -61.94 -51.55 67.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.64 121.44 3.72 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.102 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -116.92 143.89 45.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.025 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 36.1 p -65.65 137.17 57.15 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.628 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.07 162.87 25.58 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.997 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.4 m 59.73 23.07 11.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.286 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.6 -154.99 27.36 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.095 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 2.2 mt -82.86 -33.38 27.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.529 0.204 . . . . 0.0 111.374 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.43 66.53 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.165 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 1.3 p -78.63 -33.88 46.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.277 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -60.83 -38.35 85.15 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.311 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -100.19 -36.05 9.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.42 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.06 44.03 7.28 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.907 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -55.38 -54.1 47.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.383 0.135 . . . . 0.0 111.261 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.4 156.66 45.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 111.296 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.81 150.8 20.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.591 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -59.83 109.44 0.94 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.092 0.472 . . . . 0.0 110.874 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 111.04 0.08 28.49 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.98 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -78.42 138.66 38.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 117.347 0.573 . . . . 0.0 110.719 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -76.1 124.38 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.327 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 19.8 mt -91.99 144.05 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.173 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 tp -98.39 -41.89 7.61 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.356 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -145.83 148.06 32.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 111.195 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 32.2 mt -138.35 118.42 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.809 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . 0.42 ' HB3' HD12 ' B' ' 148' ' ' LEU . 2.3 t-20 53.87 48.09 22.09 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.317 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 65.58 18.02 65.3 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.993 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.21 144.8 47.54 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 t -63.52 146.88 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.503 ' CG2' ' HB ' ' B' ' 106' ' ' ILE . 18.2 m -115.32 1.42 13.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.865 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . 0.402 ' HG2' ' HE2' ' A' ' 26' ' ' LYS . 1.5 tt0 -100.39 131.63 46.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.67 0.271 . . . . 0.0 110.357 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 71.85 -7.65 1.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.435 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 36.7 ttm -65.51 155.42 35.69 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.012 0.434 . . . . 0.0 111.377 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 28.6 t -79.58 149.56 31.33 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.387 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 tt -60.8 -48.13 83.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.893 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 39.1 p -58.47 -38.22 77.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.882 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.21 -43.21 95.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.841 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' B' ' 106' ' ' ILE . . . -59.71 -42.88 94.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.173 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -67.67 -38.3 83.57 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.654 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -67.63 -38.35 83.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.485 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . 0.42 HD12 ' HB3' ' B' ' 133' ' ' ASN . 0.1 OUTLIER -60.3 -44.09 95.71 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.844 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 15.7 mt -68.13 -37.7 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.915 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -69.16 -48.39 62.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.773 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -71.22 -23.62 62.05 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.992 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 80.1 p -77.25 66.97 3.12 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.147 0.498 . . . . 0.0 110.628 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -74.51 127.94 34.31 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.564 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 109.39 -91.64 0.66 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.274 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -124.17 138.36 54.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.71 135.19 48.19 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.035 0.445 . . . . 0.0 111.14 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -97.86 136.93 37.46 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.643 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.03 128.77 35.0 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.803 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.1 t -113.69 136.6 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.84 149.67 33.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.266 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 N--CA 1.462 0.142 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.548 179.603 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.5 tt . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.781 0.324 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.12 156.1 15.74 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.669 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.47 133.03 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.377 . . . . 0.0 111.058 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.35 114.81 29.14 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 1.1 mp -98.42 144.53 27.69 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.8 ttm -113.24 164.05 14.02 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.893 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.109 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.952 0.406 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.466 ' CZ ' HD21 ' B' ' 156' ' ' LEU . 57.2 m-85 -71.82 -22.25 61.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.817 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.48 20.38 38.12 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.704 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.9 mp -102.48 115.95 31.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.821 0.31 . . . . 0.0 110.786 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.99 114.58 24.74 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mp -97.9 124.81 42.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 111.776 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -114.73 174.93 15.71 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 p -130.17 151.04 51.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.608 0.704 . . . . 0.0 111.84 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -136.75 135.83 38.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.176 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.559 HD12 HG22 ' A' ' 54' ' ' THR . 21.5 mt -88.14 121.47 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.931 0.396 . . . . 0.0 110.125 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.401 ' CE2' ' HG2' ' A' ' 26' ' ' LYS . 41.7 p90 -125.42 172.92 9.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.314 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 40' ' ' LEU . 40.8 t -82.29 97.53 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.745 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.401 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -67.65 -57.01 7.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.282 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.39 141.33 17.17 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.953 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -126.66 144.31 50.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.17 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.5 m -73.73 127.83 33.87 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.583 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -63.29 168.25 4.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.73 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.63 29.8 15.03 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.445 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.87 -174.09 17.58 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.194 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.39 -28.19 61.88 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.38 -36.49 63.55 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.502 0.191 . . . . 0.0 111.203 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.9 -34.05 45.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.062 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -62.77 -37.14 85.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.339 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.62 -33.41 10.31 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.493 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.48 44.74 32.26 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.165 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.409 ' HB2' ' CG2' ' B' ' 87' ' ' VAL . 10.4 p-10 -81.65 -49.04 10.95 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.453 HD13 ' CD2' ' A' ' 75' ' ' LEU . 13.2 mt -95.64 113.18 24.8 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.904 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.47 130.29 34.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.552 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -54.39 111.62 0.83 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.125 0.488 . . . . 0.0 110.868 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.95 -14.1 37.66 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.865 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.33 138.64 58.6 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.038 0.447 . . . . 0.0 111.31 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.403 ' O ' HG13 ' A' ' 45' ' ' ILE . 24.3 pt -79.96 119.49 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.674 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.419 HG21 ' CD1' ' A' ' 49' ' ' ILE . 7.8 mt -83.33 144.11 10.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.343 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 tt -105.23 -42.56 5.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.438 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -152.38 147.97 26.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.68 0.276 . . . . 0.0 111.368 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.459 HG23 HD12 ' A' ' 49' ' ' ILE . 27.8 mm -137.47 118.97 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.431 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.91 40.14 31.85 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.217 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.27 14.58 80.59 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.32 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 m -120.23 139.64 52.38 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.028 0.414 . . . . 0.0 110.51 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.69 145.63 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.203 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.559 HG22 HD12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -124.18 20.13 9.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.433 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.79 132.13 56.77 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 71.1 -7.57 1.11 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.65 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.403 ' HB3' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -68.38 172.13 6.41 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 111.125 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.81 146.16 24.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.308 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.9 -38.62 86.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.27 -46.94 84.47 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -44.2 93.94 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.796 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.96 93.61 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.951 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -39.66 88.57 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.695 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.97 -38.39 86.01 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 tp -60.32 -43.35 96.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.026 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 24.5 mt -68.33 -37.48 78.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.78 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.0 -49.44 57.75 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.078 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -64.89 -30.5 71.5 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.212 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 m -81.95 62.01 5.52 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.201 0.524 . . . . 0.0 110.791 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 147.26 41.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.785 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.0 -86.59 0.59 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.224 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -134.95 126.87 29.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.663 0.268 . . . . 0.0 110.568 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.462 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 2.3 pp -125.87 143.84 50.91 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.45 141.46 34.29 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.462 ' HG ' ' CD1' ' A' ' 73' ' ' LEU . 0.8 OUTLIER -133.4 128.08 34.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.965 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 t -107.97 134.62 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.248 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.98 164.58 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.518 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tp . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.594 179.658 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.89 166.96 20.34 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.924 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.409 ' CG2' ' HB2' ' A' ' 39' ' ' ASN . 21.4 t -129.69 134.86 62.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.641 0.258 . . . . 0.0 111.086 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tt -96.99 121.91 39.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.516 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 7.6 tp -115.3 144.62 43.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.581 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.7 ttt -107.1 163.61 12.85 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.144 0.497 . . . . 0.0 110.922 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . 0.401 ' HE3' ' HA ' ' B' ' 97' ' ' GLU . 4.1 tttt . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.914 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . 0.401 ' HA ' ' HE3' ' B' ' 91' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.827 0.346 . . . . 0.0 110.818 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . 0.408 ' CE2' ' CD2' ' A' ' 73' ' ' LEU . 47.0 m-85 -49.74 -31.14 10.72 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.685 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.25 15.36 74.52 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.521 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 mp -101.3 119.82 39.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.659 0.266 . . . . 0.0 110.668 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -96.13 113.43 25.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.211 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.41 124.78 41.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.625 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.44 177.13 17.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.978 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.37 145.76 50.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.847 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -130.05 140.16 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.413 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.432 ' HB ' HG23 ' B' ' 137' ' ' THR . 9.1 mt -88.37 120.46 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.176 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -119.68 170.48 9.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.714 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' B' ' 126' ' ' GLY . 41.2 t -81.07 89.5 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.038 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -53.77 -42.46 68.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.816 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.03 132.17 0.51 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -114.24 146.31 40.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.079 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 25.2 p -77.13 126.57 31.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.704 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.78 165.87 12.04 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.289 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.3 m 64.95 22.85 12.52 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.183 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -105.19 -171.7 24.11 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.172 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.15 -30.81 66.93 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.25 -35.03 63.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.489 0.185 . . . . 0.0 110.941 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 2.1 p -78.95 -34.1 44.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.184 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -59.15 -38.85 80.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.424 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.58 -29.9 10.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.539 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.16 58.44 5.59 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.2 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.95 -32.68 12.49 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 39.4 mt -131.34 133.02 44.91 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.641 0.258 . . . . 0.0 111.195 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.79 161.86 13.4 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' B' ' 125' ' ' GLU . 2.1 pt-20 -73.64 120.55 19.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.518 0.675 . . . . 0.0 110.178 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 108' ' ' VAL . . . 106.89 -15.77 40.25 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.587 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -63.97 135.31 56.37 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 111.082 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 13.7 pt -78.25 121.32 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.825 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 mt -91.2 143.7 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.149 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.77 -35.47 6.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.902 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.83 148.04 31.47 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.541 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 45.4 mt -140.93 118.68 9.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.616 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 55.7 44.14 26.84 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.931 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.83 17.43 73.29 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.051 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.84 137.71 54.42 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 116.948 0.374 . . . . 0.0 110.478 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.87 145.04 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.838 0.351 . . . . 0.0 110.872 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.432 HG23 ' HB ' ' B' ' 106' ' ' ILE . 1.8 m -119.03 9.9 11.98 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.788 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.28 131.13 49.06 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 70.85 -4.33 1.75 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.65 169.52 6.2 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 111.285 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.69 141.72 28.28 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.168 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.14 -44.38 87.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.555 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 7.2 t -61.46 -39.29 90.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.693 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -64.81 -46.73 80.77 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.54 -42.56 88.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -65.72 -40.27 92.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.502 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -66.39 -38.63 87.93 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.886 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 5.3 tt -59.94 -44.78 94.16 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.713 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.5 -37.35 77.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.773 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.85 -47.57 65.63 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.055 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -66.33 -27.77 68.16 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 3.6 m -79.24 63.23 3.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.006 0.431 . . . . 0.0 110.747 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 18.2 mmm-85 -83.93 74.78 10.18 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.422 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 167.54 -73.32 0.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.251 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.41 127.49 27.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.712 0.291 . . . . 0.0 110.875 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.466 HD21 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -129.84 139.51 51.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 4.4 tt0 -103.57 141.01 36.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.195 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.72 128.13 32.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 111.001 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.24 135.27 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.47 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 16.9 m -128.46 152.82 37.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.854 0.359 . . . . 0.0 111.711 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 15.0 tp . . . . . 0 C--O 1.232 0.173 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 -179.844 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.1 pt . . . . . 0 C--O 1.235 0.307 0 CA-C-O 120.625 0.25 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.74 158.6 22.64 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.865 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.0 t -130.01 132.73 65.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.758 0.313 . . . . 0.0 110.94 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.88 113.68 25.25 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.023 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.416 ' HB3' ' CE1' ' A' ' 15' ' ' TYR . 8.0 mp -91.23 131.56 36.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.656 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.0 ttt -107.62 162.21 14.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.228 0.537 . . . . 0.0 111.143 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.738 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.711 0.291 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.416 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 50.6 m-85 -61.56 -29.76 70.23 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.95 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.48 27.25 57.71 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.196 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mp -113.75 117.86 32.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.71 0.29 . . . . 0.0 110.66 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.38 113.33 25.27 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 mp -98.01 124.86 42.69 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.193 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -105.27 -167.46 23.88 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.8 OUTLIER -146.02 149.24 33.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.258 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' B' ' 104' ' ' SER . 1.9 pt20 -132.1 133.47 44.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.964 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' B' ' 103' ' ' GLY . 68.8 mt -87.75 120.23 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.115 0.483 . . . . 0.0 110.29 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -122.86 172.92 8.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.297 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.1 t -82.54 99.78 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.767 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -58.69 3.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.216 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -156.42 147.56 22.22 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.631 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.32 163.15 30.65 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.894 0.378 . . . . 0.0 111.428 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.8 m -65.38 139.89 58.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -76.51 156.92 32.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.977 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 50.35 30.9 4.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.918 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.17 -170.55 30.84 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.152 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.37 -31.09 68.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.02 -36.94 61.9 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.236 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -33.85 45.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.175 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -60.86 -39.21 88.29 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.149 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.14 -30.83 11.71 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.789 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.38 47.92 20.64 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.226 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -65.24 -47.34 77.13 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.44 136.57 50.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.812 0.339 . . . . 0.0 111.386 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.96 148.48 22.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.489 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -59.53 109.49 0.91 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.27 0.557 . . . . 0.0 111.08 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.23 -13.6 16.27 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.286 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -62.86 135.43 57.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.232 0.516 . . . . 0.0 110.391 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.55 112.43 18.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.085 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.9 mt -77.49 130.43 36.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.176 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.2 tp -92.21 -40.96 10.7 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.322 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -151.36 148.66 28.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.852 0.358 . . . . 0.0 111.833 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.7 mt -138.33 119.66 17.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.344 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.5 m120 55.23 39.99 31.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.124 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.77 11.65 84.41 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.424 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 m -119.82 135.3 54.92 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 117.113 0.456 . . . . 0.0 110.203 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 t -61.69 147.79 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.843 0.354 . . . . 0.0 111.146 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.424 HG21 ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -118.42 6.55 11.81 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.751 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.01 135.73 33.55 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 p30 52.59 11.79 0.21 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.649 0.593 . . . . 0.0 112.198 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -73.32 171.92 12.16 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.003 0.43 . . . . 0.0 111.357 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.6 130.66 35.22 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.883 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.97 -35.69 59.27 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.9 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.9 -46.75 80.44 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.063 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.67 -46.06 89.92 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.684 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.12 84.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -70.31 -37.46 74.75 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.466 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -67.85 -38.17 82.81 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.568 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.1 tt -59.69 -44.77 93.51 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.706 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.5 mt -68.22 -37.66 78.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.763 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.03 -49.61 56.05 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.791 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -65.19 -27.24 68.55 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.207 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.5 t -80.55 63.13 4.89 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.002 0.43 . . . . 0.0 110.557 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -77.76 94.83 4.54 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.537 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.06 -84.1 0.18 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.521 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.6 131.08 46.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.641 0.257 . . . . 0.0 110.761 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.83 140.71 50.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 111.323 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -106.37 140.64 38.98 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.553 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 mp -136.11 134.64 38.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.102 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.4 t -118.87 140.69 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.93 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.17 134.97 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.321 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 tt . . . . . 0 CA--C 1.53 0.182 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.774 179.461 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.912 0.387 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.49 157.03 15.59 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.409 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 13.8 t -131.09 134.28 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.895 0.378 . . . . 0.0 111.328 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 7.9 tt -106.19 108.1 19.44 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.573 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.8 tp -99.04 144.69 27.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.831 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 9.2 ttm -117.81 163.13 16.99 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.133 0.492 . . . . 0.0 111.051 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.102 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 121.006 0.432 . . . . 0.0 111.386 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -79.33 -26.26 42.18 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.377 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.39 28.57 43.53 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.395 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mp -105.07 123.49 47.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.722 0.296 . . . . 0.0 110.702 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.47 113.65 27.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.371 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -109.3 124.86 51.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.459 . . . . 0.0 111.453 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -106.8 -170.2 22.55 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.258 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.6 OUTLIER -134.71 147.54 50.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.882 0.373 . . . . 0.0 111.375 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 21' ' ' SER . 3.3 pt20 -125.34 139.04 54.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.225 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' B' ' 137' ' ' THR . 33.7 mt -88.15 120.42 37.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.963 0.411 . . . . 0.0 111.034 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -124.2 171.58 9.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.083 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 39.3 t -80.27 95.22 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.92 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -53.18 50.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.112 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -156.21 141.35 17.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.688 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.12 151.04 49.38 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.867 0.365 . . . . 0.0 111.463 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -65.73 143.34 57.59 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.165 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -73.15 148.71 43.62 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.148 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 54.85 32.84 18.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.61 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' B' ' 119' ' ' LYS . . . -96.47 -164.98 33.34 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.323 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.36 -37.12 84.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.1 -33.73 61.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.273 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -33.72 44.47 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.286 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' B' ' 115' ' ' GLY . 12.1 ttmt -64.17 -37.07 86.14 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 111.266 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.99 -30.8 12.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.467 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.82 45.69 63.55 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.2 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -81.83 -53.4 6.21 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 10.2 mp -118.5 119.41 34.47 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.68 0.276 . . . . 0.0 110.944 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.17 152.84 22.5 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.619 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -60.5 110.65 1.32 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.169 0.509 . . . . 0.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.55 -15.16 24.69 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.894 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -62.85 135.75 57.49 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 117.245 0.522 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -81.05 108.86 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.103 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 29.3 mt -76.41 152.49 5.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.322 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 13.7 tp -110.7 -31.28 7.26 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.538 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -152.44 147.42 26.23 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.711 0.291 . . . . 0.0 111.066 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.406 HG21 HD21 ' B' ' 158' ' ' LEU . 13.5 mt -137.18 117.73 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.452 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . 0.472 ' OD1' ' HA ' ' B' ' 156' ' ' LEU . 0.1 OUTLIER 49.4 43.34 23.35 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.515 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.98 18.73 79.32 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.344 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 93.1 m -120.77 144.11 48.46 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.997 0.398 . . . . 0.0 110.28 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 t -74.14 140.07 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.457 . . . . 0.0 111.609 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.458 ' HA ' HD12 ' B' ' 106' ' ' ILE . 52.8 p -93.01 -22.08 19.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.129 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.09 142.35 38.17 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.925 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.5 p30 53.13 10.74 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.811 0.694 . . . . 0.0 112.467 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -86.52 144.18 27.36 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.902 0.382 . . . . 0.0 110.808 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.11 144.76 46.87 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.515 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.75 -46.0 92.12 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.925 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 9.7 t -55.28 -42.64 73.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -40.9 84.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.617 0.246 . . . . 0.0 110.769 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.15 99.44 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.037 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -38.13 79.34 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -38.08 82.37 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.779 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.98 -44.82 94.24 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.649 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 8.2 mt -67.79 -37.31 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.03 -48.76 62.14 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.0 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -67.44 -24.95 65.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.683 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 22.9 m -75.58 70.39 2.41 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.212 0.53 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -86.5 78.38 9.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.667 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 164.55 -81.89 0.11 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.62 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.0 128.96 29.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.534 0.206 . . . . 0.0 110.628 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.472 ' HA ' ' OD1' ' B' ' 133' ' ' ASN . 0.9 OUTLIER -127.86 131.78 49.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.948 0.404 . . . . 0.0 111.2 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -91.1 142.56 27.62 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.083 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.406 HD21 HG21 ' B' ' 132' ' ' ILE . 2.3 mt -132.55 134.51 45.05 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.809 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.09 134.0 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.636 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 6.1 m -127.99 152.9 36.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 111.719 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.826 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.98 0.419 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.74 156.6 22.89 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.774 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 6' ' ' LEU . 22.8 t -132.77 133.39 59.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.702 0.287 . . . . 0.0 111.093 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.46 111.44 23.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.815 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.439 ' HB3' ' CE1' ' A' ' 15' ' ' TYR . 10.4 mp -90.6 141.88 28.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.25 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 37.2 ttm -120.05 165.3 14.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.988 0.423 . . . . 0.0 110.9 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 pttp . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.937 179.844 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 120.817 0.342 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.439 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 70.4 m-85 -78.26 -30.89 48.84 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.728 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.88 28.34 46.62 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.464 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.85 121.39 42.02 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.646 0.26 . . . . 0.0 110.668 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.38 114.04 27.88 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.03 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -111.44 124.82 53.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.192 0.52 . . . . 0.0 111.763 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.91 -177.56 22.24 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.556 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.26 149.3 47.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.155 0.478 . . . . 0.0 111.058 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -132.87 140.2 47.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.231 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.499 ' CD1' HG22 ' A' ' 54' ' ' THR . 49.4 mt -88.05 120.54 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.003 0.43 . . . . 0.0 110.433 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -119.88 172.91 7.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.912 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.476 ' CG2' HD11 ' A' ' 40' ' ' LEU . 45.6 t -79.5 92.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.118 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.94 -51.85 59.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.217 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.13 162.6 39.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 36.0 mtp -138.4 156.46 47.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.107 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.434 ' HB ' ' HA3' ' B' ' 99' ' ' GLY . 3.7 t -69.33 145.32 53.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.693 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -75.52 130.13 38.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.674 0.273 . . . . 0.0 110.944 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.23 28.25 5.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.141 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.5 -163.38 36.2 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.369 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 mt -73.93 -30.19 62.43 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.98 -37.17 61.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.467 0.175 . . . . 0.0 111.409 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.52 -34.05 47.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.153 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -63.97 -36.49 84.12 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.428 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.84 -32.58 11.27 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.362 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.48 47.78 20.63 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.238 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -57.51 -35.15 69.89 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.476 HD11 ' CG2' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -163.49 163.83 24.61 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.727 0.299 . . . . 0.0 111.025 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.39 150.39 22.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.706 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -61.68 114.4 3.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.12 0.486 . . . . 0.0 111.233 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.93 9.86 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.755 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -60.6 135.85 57.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.919 0.359 . . . . 0.0 110.368 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 pt -75.06 121.82 27.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.895 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.5 mt -88.95 138.14 19.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.118 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.0 tp -97.43 -45.55 6.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.484 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.74 147.93 33.55 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.873 0.368 . . . . 0.0 111.59 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 22.4 mm -138.61 120.77 17.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.432 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 53.47 41.55 32.09 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.242 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.48 13.0 80.29 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.436 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m -120.97 137.52 54.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.038 0.419 . . . . 0.0 110.431 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 t -57.58 146.11 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.274 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.499 HG22 ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -123.32 17.74 9.82 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.416 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -121.59 127.85 51.34 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 70.88 -4.07 1.83 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.288 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.11 174.63 3.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 111.27 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.92 147.8 25.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.1 mp -61.9 -48.95 78.16 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.85 -37.98 80.81 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.221 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.19 -47.89 69.55 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.946 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.94 -40.15 94.54 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.204 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -70.24 -38.41 75.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -38.16 83.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.677 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tp -60.49 -44.36 96.05 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.735 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 12.3 mt -68.33 -37.57 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.604 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.94 -41.42 78.1 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.641 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -6.7 57.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.72 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.94 56.64 4.02 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 110.862 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.68 78.86 7.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.381 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' B' ' 91' ' ' LYS . . . 162.29 -78.77 0.15 Allowed Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.295 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -136.2 129.87 32.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.774 -0.213 . . . . 0.0 110.787 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.402 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.6 OUTLIER -128.05 126.98 42.32 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.108 0.48 . . . . 0.0 110.871 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 37.4 tt0 -97.83 142.62 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.279 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.76 124.02 25.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.772 0.32 . . . . 0.0 110.75 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.6 t -109.57 134.6 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.747 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 t -116.29 135.21 57.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.048 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tp . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 179.767 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.429 HD12 HG21 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.288 0 CA-C-O 120.765 0.317 . . . . 0.0 110.953 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.03 155.48 16.29 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.75 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 25.9 t -129.6 134.33 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 111.088 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.64 122.42 44.98 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.6 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tp -109.09 124.63 51.09 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.542 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' MET . . . . . 0.495 ' HG3' ' N ' ' B' ' 91' ' ' LYS . 3.7 tpp -100.12 162.85 12.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.072 0.463 . . . . 0.0 110.772 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . 0.495 ' N ' ' HG3' ' B' ' 90' ' ' MET . 6.6 pttm . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.349 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.465 0.295 0 CA-C-O 121.053 0.454 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . 0.402 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 67.4 m-85 -76.26 -25.55 55.07 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.517 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . 0.434 ' HA3' ' HB ' ' A' ' 29' ' ' THR . . . 93.62 20.2 32.53 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.458 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.78 118.21 36.46 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.651 0.262 . . . . 0.0 110.708 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -92.07 113.26 25.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.949 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 mp -96.34 124.93 40.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 110.922 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.91 171.9 13.94 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.822 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.71 145.07 44.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.835 0.35 . . . . 0.0 110.891 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -130.44 139.71 50.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.274 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.494 ' HB ' ' CG2' ' B' ' 137' ' ' THR . 1.9 mt -88.3 120.64 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.069 0.461 . . . . 0.0 110.238 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.4 ' CE2' ' HD3' ' B' ' 109' ' ' LYS . 40.1 p90 -119.62 172.58 7.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.928 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 t -81.36 97.62 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.013 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . 0.4 ' HD3' ' CE2' ' B' ' 107' ' ' PHE . 0.5 OUTLIER -67.57 -50.58 57.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.717 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -167.48 143.61 4.17 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.805 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.68 159.53 34.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.795 0.331 . . . . 0.0 111.119 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 64.2 p -75.75 124.63 27.61 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.435 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.64 156.77 15.92 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.967 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.68 34.79 17.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.299 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.11 -175.54 20.26 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.913 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.84 -35.6 80.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.57 0.224 . . . . 0.0 111.559 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.95 -34.82 62.1 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.26 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -34.1 44.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.13 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.47 -35.41 80.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.199 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -100.07 -27.95 13.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.648 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 65.8 57.39 11.09 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.094 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -94.82 -33.63 12.79 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 47.9 mt -122.36 135.96 54.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.636 0.255 . . . . 0.0 111.55 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 142.93 34.22 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.581 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -56.68 111.39 1.0 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 111.249 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.32 -16.47 24.6 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.266 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . 0.4 ' HB3' HG11 ' B' ' 160' ' ' VAL . 25.4 m-20 -60.47 135.8 57.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.332 0.566 . . . . 0.0 110.64 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 pt -79.82 111.01 16.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 59.4 mt -72.48 140.96 17.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.108 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.0 -45.14 6.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.114 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -148.84 147.8 29.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.911 0.386 . . . . 0.0 111.477 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.404 HG13 ' OG1' ' B' ' 137' ' ' THR . 13.9 mt -134.01 123.87 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.264 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 54.86 33.49 19.97 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.687 0.279 . . . . 0.0 111.182 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.65 17.55 77.28 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.92 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 6.8 m -120.66 143.85 48.49 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.8 0.3 . . . . 0.0 110.341 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.46 144.26 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.199 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.494 ' CG2' ' HB ' ' B' ' 106' ' ' ILE . 2.9 m -117.23 21.56 13.07 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.603 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.87 129.38 56.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 71.42 -5.23 1.65 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.361 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 4.8 ttt -68.37 150.72 47.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.812 0.339 . . . . 0.0 110.826 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 51.1 m -71.78 144.22 49.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.307 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.75 -46.03 92.01 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.06 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 4.4 t -58.04 -38.89 77.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.107 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.03 -42.85 84.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.803 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.42 96.18 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.086 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -67.94 -39.46 83.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.318 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -37.86 86.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.85 -45.27 92.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.735 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 46.3 mt -68.42 -37.01 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.773 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.41 -46.3 70.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -65.49 -26.91 68.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.292 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 20.7 p -87.17 74.89 9.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.194 0.521 . . . . 0.0 111.052 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.93 51.98 2.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.708 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -164.39 -83.36 0.05 OUTLIER Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.465 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.54 126.88 46.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.685 0.278 . . . . 0.0 110.424 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.81 143.07 50.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.46 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -109.09 138.61 45.16 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.487 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.36 127.31 33.21 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.762 0.315 . . . . 0.0 111.04 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.93 139.93 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.578 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' B' ' 127' ' ' ASP . 22.3 t -135.74 154.9 35.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.35 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.254 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.759 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.235 0.336 0 CA-C-O 120.648 0.261 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.97 161.75 12.88 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.575 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.6 t -127.33 134.62 65.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.818 0.342 . . . . 0.0 111.277 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 mt -98.03 123.47 42.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.979 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.73 137.42 51.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.503 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.9 ttt -109.67 164.87 12.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.53 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.116 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.456 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 57.5 m-85 -60.37 -27.26 67.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.865 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.87 18.58 43.41 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.707 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.7 mp -108.02 119.07 38.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.723 0.297 . . . . 0.0 110.73 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.2 113.44 25.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.192 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 mp -92.94 124.9 37.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.262 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.6 -169.59 21.85 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.615 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.6 148.54 32.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.934 0.367 . . . . 0.0 111.367 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.26 133.13 45.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.878 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.463 ' HB ' HG21 ' A' ' 54' ' ' THR . 53.9 mt -87.76 120.28 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 0.0 110.542 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -124.83 173.22 8.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.207 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.8 t -83.33 100.5 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.659 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -47.71 53.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.613 0.244 . . . . 0.0 111.044 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -161.69 144.64 12.11 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.592 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -130.35 155.75 45.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 111.333 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.0 t -65.35 144.71 56.92 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.975 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.0 tpt85 -79.72 148.6 31.47 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.407 HG22 ' HE2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER 60.2 30.57 19.98 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.486 179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.58 -170.98 27.93 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.108 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.52 -32.66 72.77 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.642 0.221 . . . . 0.0 111.585 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.99 -35.42 64.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.07 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.29 -33.99 42.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.241 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HE2' HG22 ' A' ' 31' ' ' THR . 1.0 OUTLIER -62.59 -37.55 86.69 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.165 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.94 -26.61 13.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.452 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.7 38.75 93.41 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.986 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.405 ' HB3' HG11 ' B' ' 87' ' ' VAL . 3.6 p30 -68.87 -46.85 67.4 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.459 0.17 . . . . 0.0 111.459 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.8 mt -116.62 129.3 56.08 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.717 0.294 . . . . 0.0 111.125 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.78 150.49 21.78 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.426 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -60.37 110.88 1.36 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.095 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.5 -15.43 17.47 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.153 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -64.19 132.79 51.39 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 117.268 0.534 . . . . 0.0 110.425 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.5 pt -79.9 112.74 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.83 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 mt -78.01 134.28 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.98 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 tp -91.72 -45.49 8.41 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.706 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -148.92 149.84 31.9 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.801 0.334 . . . . 0.0 111.68 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 23.0 mt -138.02 119.99 18.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.621 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 55.7 36.48 27.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.314 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.33 2.46 90.6 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.6 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -111.91 134.89 53.19 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.295 0.547 . . . . 0.0 110.411 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 t -57.88 146.81 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.268 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.463 HG21 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -120.39 23.6 10.79 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.373 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.81 139.18 50.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.411 ' HB2' ' CD1' ' B' ' 142' ' ' LEU . 11.9 p30 53.68 9.22 0.18 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.614 0.571 . . . . 0.0 112.22 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.511 ' HG3' ' N ' ' A' ' 58' ' ' SER . 14.2 tpp -82.95 159.82 22.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.779 0.323 . . . . 0.0 110.734 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.511 ' N ' ' HG3' ' A' ' 57' ' ' MET . 0.1 OUTLIER -72.77 138.1 46.26 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.194 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.0 -47.23 81.34 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.097 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.0 p -58.1 -41.28 83.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.189 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.25 -47.78 84.46 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.019 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.64 -40.81 88.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.981 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.19 -40.5 94.31 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.709 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -65.32 -38.74 91.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.905 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.3 tt -60.06 -43.92 95.06 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.942 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.0 mt -68.46 -37.11 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.809 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.7 -49.28 69.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.902 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.0 pttt -64.1 -23.5 67.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.27 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.7 m -81.36 66.99 7.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.098 0.475 . . . . 0.0 110.431 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.95 64.27 8.03 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.008 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.91 -76.29 0.07 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.588 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.82 129.61 32.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.274 . . . . 0.0 110.629 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.454 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -129.82 136.82 50.02 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 26.6 mt-30 -98.32 143.08 29.17 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.454 ' HG ' ' CD1' ' A' ' 73' ' ' LEU . 1.9 mp -135.75 128.79 31.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.043 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.84 144.21 25.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.695 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.6 m -141.57 167.67 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.957 0.408 . . . . 0.0 111.595 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.174 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.916 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.595 0.236 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.4 159.6 25.3 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.929 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 39' ' ' ASN . 9.1 t -130.06 135.16 61.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.681 0.276 . . . . 0.0 111.078 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.51 114.08 25.81 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.792 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.35 137.85 38.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.642 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.21 170.42 8.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.379 0.609 . . . . 0.0 111.47 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 27.8 tttm . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.375 -179.876 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 120.865 0.364 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.1 -26.74 22.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.955 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.42 14.05 72.03 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.618 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.55 122.22 40.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 110.522 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.85 113.72 27.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.267 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -107.84 125.01 50.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.082 0.468 . . . . 0.0 111.329 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -104.33 -163.05 24.54 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.067 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.32 146.51 30.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.696 0.248 . . . . 0.0 111.162 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -127.14 137.14 52.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.026 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.512 ' CD1' HG22 ' B' ' 137' ' ' THR . 28.4 mt -88.18 120.42 37.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.591 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.45 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 47.4 p90 -123.88 172.55 8.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.988 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' B' ' 123' ' ' LEU . 96.6 t -85.16 98.55 6.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.924 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . 0.45 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -68.3 -57.57 5.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.416 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.08 139.84 23.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.743 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 6.1 ptt? -131.07 152.84 49.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 111.626 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 p -72.82 142.28 48.02 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.261 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -78.24 154.92 30.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.963 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.1 m 62.9 34.6 14.09 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.68 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.11 -175.28 20.23 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.96 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -32.54 73.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.669 0.234 . . . . 0.0 111.625 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.93 -37.92 61.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.657 0.265 . . . . 0.0 111.021 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.0 -33.71 44.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.246 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -58.68 -39.79 81.7 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.315 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.38 -31.71 9.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.544 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 49.28 11.01 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.434 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . 0.428 ' ND2' ' HG ' ' B' ' 123' ' ' LEU . 14.4 p-10 -78.73 -44.05 24.34 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . 0.438 ' HB3' HG22 ' B' ' 108' ' ' VAL . 85.1 mt -111.62 118.57 36.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.609 0.242 . . . . 0.0 110.993 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 131.44 34.64 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.252 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -48.14 109.49 0.24 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.083 0.468 . . . . 0.0 111.382 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 108.15 -1.99 33.25 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.344 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -70.83 135.61 48.2 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.456 0.628 . . . . 0.0 111.468 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -79.95 107.47 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.592 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 42.7 mt -75.76 147.56 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.342 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 2.3 tp -110.21 -42.45 4.16 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.607 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -144.0 148.19 34.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.747 0.308 . . . . 0.0 111.387 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 34.8 mt -138.81 118.23 14.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.765 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 4.0 m120 52.37 48.01 23.53 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.36 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.23 16.66 67.2 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.201 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 46.2 m -120.83 140.48 51.69 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.811 0.305 . . . . 0.0 110.293 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.36 147.53 11.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.001 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.512 HG22 ' CD1' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -125.84 19.51 7.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.464 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.95 133.95 53.81 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 72.51 -9.2 1.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.514 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.34 169.59 7.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.96 0.409 . . . . 0.0 111.228 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 30.7 t -90.77 148.71 22.38 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.994 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.411 ' CD1' ' HB2' ' A' ' 56' ' ' ASN . 5.2 tt -58.1 -48.95 78.61 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.369 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 64.6 p -58.62 -39.75 81.37 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.709 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -46.39 85.04 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.19 90.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -66.46 -39.49 88.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.443 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -42.16 98.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.984 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 tp -61.56 -43.18 99.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.454 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 12.0 mt -68.73 -37.54 77.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.727 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.55 -49.51 73.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.003 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -64.83 -24.27 67.49 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.366 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.6 m -79.44 70.0 5.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.924 0.393 . . . . 0.0 110.956 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.42 60.19 6.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.547 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.19 -82.76 0.05 OUTLIER Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.498 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -132.77 131.54 41.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.569 0.224 . . . . 0.0 110.489 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -128.56 137.11 51.56 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.06 0.457 . . . . 0.0 111.275 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 24.8 tt0 -101.92 140.49 36.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.395 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.78 129.42 32.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.874 0.368 . . . . 0.0 111.091 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 13.3 t -113.99 132.17 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.707 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -129.36 165.83 28.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.551 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.232 0.165 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.983 179.767 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.463 0.22 0 CA-C-O 120.773 0.32 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -127.15 158.05 20.91 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.761 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.1 134.37 62.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.587 0.232 . . . . 0.0 111.029 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.93 107.35 18.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 tp -108.19 123.96 49.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.454 ' HB3' ' HB3' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -104.0 150.97 23.76 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.925 0.393 . . . . 0.0 111.341 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.224 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.248 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.465 0.325 0 CA-C-O 120.725 0.298 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.427 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 59.3 m-85 -72.27 -15.83 61.91 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.468 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.66 25.97 48.09 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.511 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.05 117.69 34.68 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.579 0.228 . . . . 0.0 110.9 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -97.02 113.34 24.87 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.06 124.93 48.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.183 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -103.42 -164.68 25.45 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.752 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.9 OUTLIER -147.0 147.96 31.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.023 0.411 . . . . 0.0 111.281 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -131.82 137.38 48.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.124 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.445 ' CD1' HG21 ' A' ' 54' ' ' THR . 64.3 mt -87.89 120.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.619 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.469 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 45.2 p90 -124.91 172.11 9.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.339 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.0 100.21 6.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.89 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 1.2 tptp -68.05 -57.5 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.235 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -159.59 134.37 7.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.651 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.403 ' SD ' ' HB1' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -114.15 156.75 23.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.01 0.434 . . . . 0.0 111.299 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -65.55 138.21 57.9 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 148.64 47.93 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.917 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.87 31.82 21.07 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.53 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.08 -154.84 30.16 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.411 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mt -85.54 -31.75 22.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.547 0.213 . . . . 0.0 111.455 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.403 ' HB1' ' SD ' ' A' ' 28' ' ' MET . . . -75.21 -34.93 61.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.118 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.99 -33.81 44.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.988 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -38.6 83.93 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.358 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -103.16 -32.73 9.5 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.513 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.58 49.88 13.29 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.395 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -82.82 -47.68 11.63 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 mt -105.95 128.45 53.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.41 133.36 38.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.543 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -54.96 110.44 0.66 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.191 0.519 . . . . 0.0 111.168 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.43 -7.91 28.45 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.816 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -73.37 135.67 44.31 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.244 0.545 . . . . 0.0 111.047 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.4 pt -74.38 114.59 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.543 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.0 mt -80.63 138.84 19.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.212 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.79 -46.99 6.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.535 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.5 148.19 28.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.8 0.333 . . . . 0.0 111.567 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 43.5 mt -137.04 118.36 18.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.78 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 55.95 45.06 24.62 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.152 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.41 15.26 70.22 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.355 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.9 m -120.81 137.08 54.72 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.935 0.368 . . . . 0.0 110.474 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.42 147.18 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.294 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.445 HG21 ' CD1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -125.2 21.76 7.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.534 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.45 129.73 56.01 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 70.5 -3.84 1.79 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.354 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.69 173.15 5.42 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.831 0.348 . . . . 0.0 111.162 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.74 139.72 30.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.99 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 tt -56.35 -42.24 77.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.527 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.4 m -65.15 -37.21 86.7 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.004 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -44.81 78.67 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.637 0.256 . . . . 0.0 110.839 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.8 91.66 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.496 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.0 ptt85 -71.65 -35.85 70.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.714 0.292 . . . . 0.0 110.711 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.2 -38.62 82.15 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.664 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -44.96 93.5 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.773 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.3 mt -68.32 -36.8 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.08 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -48.78 63.78 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.742 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -29.16 70.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.146 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.2 m -84.31 85.39 7.38 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.842 0.353 . . . . 0.0 111.035 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.81 113.12 25.1 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.61 -89.07 0.24 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.593 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.84 131.85 53.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.662 0.268 . . . . 0.0 110.655 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.53 138.5 51.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.961 0.41 . . . . 0.0 111.323 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.7 tt0 -101.65 138.95 37.96 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.673 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.64 125.12 28.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.949 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.66 146.55 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.52 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.21 140.51 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.278 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.2 tp . . . . . 0 N--CA 1.465 0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.911 -179.795 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 10.3 tt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.669 0.271 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.17 157.37 25.47 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.732 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.08 132.65 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.79 0.328 . . . . 0.0 111.096 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.84 107.07 19.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 tp -91.26 141.55 28.67 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.513 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' MET . . . . . 0.506 ' HG3' ' N ' ' B' ' 91' ' ' LYS . 9.4 tpp -118.44 163.15 17.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.695 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . 0.506 ' N ' ' HG3' ' B' ' 90' ' ' MET . 7.2 pttt . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.144 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 120.916 0.388 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -68.28 -23.74 64.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.455 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.09 20.28 73.16 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.46 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.06 117.05 31.54 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.664 0.268 . . . . 0.0 110.605 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.23 113.4 25.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.101 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -110.6 124.84 52.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.125 0.488 . . . . 0.0 111.07 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -111.05 -164.04 18.33 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.243 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.58 148.91 40.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.706 0.288 . . . . 0.0 111.078 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 21' ' ' SER . 1.8 pt20 -127.65 136.73 52.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.135 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.494 ' CD1' HG21 ' B' ' 137' ' ' THR . 42.1 mt -87.78 120.2 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.345 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -122.97 172.98 8.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.121 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 33.2 t -81.59 95.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.044 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -43.97 88.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.143 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.93 140.43 2.52 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.839 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.46 161.09 28.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.891 0.377 . . . . 0.0 111.434 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 18.8 p -77.09 122.77 25.44 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.208 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -64.64 150.33 47.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.963 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m 62.63 32.76 16.17 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.31 -166.48 24.73 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.128 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mt -75.45 -30.99 60.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.647 0.224 . . . . 0.0 111.417 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.72 -34.4 62.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.17 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.77 -33.96 45.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.084 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.84 -37.71 87.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.336 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.08 -31.66 12.02 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.663 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.61 51.37 7.28 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.345 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -66.56 -35.58 80.57 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . 0.419 HD23 HD12 ' B' ' 129' ' ' ILE . 0.5 OUTLIER -154.27 164.19 38.95 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.804 0.335 . . . . 0.0 111.11 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 148.33 30.79 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.882 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -56.16 112.3 1.18 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.103 0.478 . . . . 0.0 110.981 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.2 -16.67 22.33 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.965 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -61.79 138.81 58.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.071 0.462 . . . . 0.0 111.222 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.406 ' O ' HG13 ' B' ' 128' ' ' ILE . 44.3 pt -78.56 124.9 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.794 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.419 HD12 HD23 ' B' ' 123' ' ' LEU . 33.2 mm -90.91 131.69 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 15.9 tp -94.89 -44.01 7.93 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.563 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -148.62 152.69 37.18 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.424 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 35.5 mt -141.11 118.24 8.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.573 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 55.79 38.74 30.43 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.15 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.04 2.08 88.37 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.517 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 47.8 m -109.69 131.65 54.86 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 117.054 0.427 . . . . 0.0 110.349 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.2 t -58.47 146.95 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.494 HG21 ' CD1' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -120.93 18.91 11.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.675 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.42 130.2 55.51 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 71.6 -6.11 1.49 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.375 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.61 168.5 7.44 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.909 0.385 . . . . 0.0 111.1 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 14.5 t -89.37 149.44 22.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.167 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -47.11 87.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.633 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 12.0 p -60.21 -37.22 79.61 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.17 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.1 -41.47 67.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.606 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.82 98.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.256 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -36.47 71.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.661 0.267 . . . . 0.0 110.482 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -68.02 -38.35 82.46 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.526 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -44.38 93.96 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.95 -38.34 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.713 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -68.71 -49.62 57.39 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.777 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -25.64 68.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.2 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 6.0 m -81.28 63.74 5.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.907 0.385 . . . . 0.0 110.502 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -76.71 121.99 24.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.95 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 120.1 -83.7 0.36 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.31 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 7' ' ' MET . 0.0 OUTLIER -132.75 130.35 39.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.722 0.296 . . . . 0.0 110.687 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.427 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.94 134.14 48.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.111 0.481 . . . . 0.0 111.156 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.52 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.6 tm0? -93.21 141.21 28.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.258 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.33 123.73 24.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.704 0.288 . . . . 0.0 110.678 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . 0.422 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 32.6 t -107.88 135.85 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.291 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.28 141.51 43.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.771 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.198 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.967 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.234 0.273 0 CA-C-O 120.659 0.266 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.3 158.85 23.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.728 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.3 t -129.85 134.89 62.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 110.848 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.99 113.09 26.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.754 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.2 tp -99.69 144.88 28.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.77 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.0 ttt -112.78 164.08 13.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.147 0.499 . . . . 0.0 110.793 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.195 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 N--CA 1.463 0.213 0 CA-C-O 120.963 0.411 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.453 ' CZ ' HD21 ' B' ' 156' ' ' LEU . 72.8 m-85 -104.54 -30.94 9.69 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.355 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.24 25.39 44.14 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.527 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.78 122.01 44.83 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -102.44 113.42 26.74 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.15 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -108.96 124.98 51.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.111 0.481 . . . . 0.0 111.646 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -106.66 -162.48 22.32 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.855 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.66 149.33 35.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' B' ' 104' ' ' SER . 3.1 pt20 -129.67 136.15 49.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.011 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.445 HG23 HD13 ' A' ' 23' ' ' ILE . 38.8 mt -88.01 120.69 37.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.0 110.631 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -121.97 173.38 7.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.177 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.93 98.18 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.611 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -55.68 10.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.121 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -162.4 145.0 11.15 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 32.0 mtm -119.57 149.54 41.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.955 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 p -65.55 148.98 50.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -75.13 151.66 38.56 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.817 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.47 34.47 20.46 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.633 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.94 172.59 18.29 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.753 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -29.65 69.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.76 -39.55 61.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.205 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.97 -33.71 44.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.115 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -39.77 79.26 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.386 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -106.9 -27.54 10.64 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.558 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.87 59.03 7.99 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.418 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.456 ' HB3' ' CG2' ' B' ' 87' ' ' VAL . 5.7 m-80 -88.62 -33.82 17.5 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.6 0.2 . . . . 0.0 111.328 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mt -111.82 134.78 53.17 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.144 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.1 132.71 43.4 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.751 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -57.18 113.48 1.74 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.11 0.481 . . . . 0.0 111.27 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.22 -18.93 13.64 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.793 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -62.37 137.2 58.21 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.879 0.371 . . . . 0.0 110.512 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.4 pt -76.39 128.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.916 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.404 HG21 ' CG1' ' A' ' 49' ' ' ILE . 17.0 mt -95.45 137.39 23.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.872 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.4 tp -103.72 -36.67 7.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.444 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -148.25 147.85 29.82 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.896 0.379 . . . . 0.0 111.547 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 35.8 mt -142.27 117.58 5.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.957 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 51.3 29.47 5.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.369 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.84 -10.83 64.4 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.615 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -103.67 124.79 49.5 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 117.329 0.565 . . . . 0.0 110.845 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.435 HG21 ' N ' ' A' ' 54' ' ' THR . 2.4 p -56.97 149.61 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.147 0.499 . . . . 0.0 110.941 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.435 ' N ' HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.59 31.15 6.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.511 -178.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.6 128.52 45.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 71.02 -5.82 1.43 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.299 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ttt -78.14 156.06 30.13 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.837 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -71.94 138.72 48.3 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.08 -45.04 87.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.195 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.9 p -59.31 -44.92 92.5 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.141 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.16 -47.19 87.35 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.07 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.38 94.59 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.87 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -64.4 -40.57 96.04 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.948 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -65.76 -38.53 89.32 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.813 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -59.93 -44.23 94.47 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.751 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.8 mt -68.18 -37.02 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -63.19 -49.33 74.68 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.829 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -69.59 -26.84 64.65 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.352 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -76.13 68.82 2.62 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.056 0.455 . . . . 0.0 110.879 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -87.42 99.47 12.03 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.546 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.13 -82.87 0.17 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.631 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.25 130.65 37.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.627 0.251 . . . . 0.0 110.566 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.59 140.7 51.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.423 . . . . 0.0 111.219 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.9 tt0 -109.87 140.24 44.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.597 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 mp -130.24 126.44 37.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.605 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.4 t -115.51 133.59 61.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.05 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -122.78 165.8 18.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.249 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 C--O 1.232 0.173 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.675 179.761 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.73 0.3 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.79 157.6 26.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.835 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 39' ' ' ASN . 16.9 t -122.92 135.24 63.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.659 0.266 . . . . 0.0 111.096 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.87 127.47 52.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.511 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.52 144.57 40.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.775 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 4.1 ttt -111.28 163.68 13.7 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.855 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.682 0.277 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -55.75 -30.52 61.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.548 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.5 19.51 77.99 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.554 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.2 118.48 31.29 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.57 113.36 26.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.211 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -105.12 124.94 50.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -108.46 -177.36 21.89 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.972 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 1.0 OUTLIER -139.06 148.62 43.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.857 0.361 . . . . 0.0 111.193 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -129.1 139.91 51.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.78 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 20' ' ' GLY . 35.6 mt -88.13 121.66 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 110.828 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.47 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 44.7 p90 -124.29 170.57 10.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.204 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . 0.41 HG23 ' HB3' ' B' ' 123' ' ' LEU . 58.6 t -83.74 98.28 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.139 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . 0.47 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -66.24 -56.36 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.259 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -153.48 142.0 20.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.654 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -130.7 158.61 39.61 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.832 0.348 . . . . 0.0 111.308 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 89.9 m -65.28 134.87 54.55 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.974 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.93 149.7 44.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.8 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.78 30.39 18.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.461 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.83 -171.61 32.89 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.1 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.3 mp -68.11 -32.51 72.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.94 -38.65 61.69 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.547 0.213 . . . . 0.0 111.349 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -33.52 45.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.18 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -60.81 -39.04 87.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.026 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.08 -31.63 11.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.375 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.57 45.79 21.64 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.45 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -77.68 -39.5 44.59 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . 0.41 ' HB3' HG23 ' B' ' 108' ' ' VAL . 78.6 mt -122.59 127.2 49.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.778 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.99 131.28 38.12 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -48.11 110.77 0.36 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.009 0.433 . . . . 0.0 111.255 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.95 -5.71 30.73 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.452 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -68.3 136.47 53.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.264 0.532 . . . . 0.0 111.396 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -79.0 101.28 4.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.271 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.418 HG22 ' CD1' ' B' ' 132' ' ' ILE . 7.7 mt -64.68 148.38 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.02 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 tt -111.12 -44.53 3.56 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.616 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -151.6 148.05 27.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.79 0.329 . . . . 0.0 111.687 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 36.5 mm -132.83 118.53 34.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.526 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 56.81 42.92 25.89 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.31 15.35 74.81 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.216 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 7.5 m -120.89 140.27 52.04 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.957 0.378 . . . . 0.0 110.219 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 t -61.46 148.36 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.825 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.4 HG21 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -129.12 22.78 5.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.135 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.17 135.27 53.04 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.379 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 72.11 -9.53 0.99 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.484 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 4.0 tpp -66.55 170.65 5.93 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.02 148.62 22.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.987 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.04 -35.76 71.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.759 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' B' ' 146' ' ' ARG . 3.8 m -65.68 -37.24 85.95 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.159 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.38 -38.68 65.57 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 110.607 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.57 97.06 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.089 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' B' ' 143' ' ' THR . 7.0 ppt_? -72.63 -35.53 67.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.65 0.262 . . . . 0.0 110.59 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -39.23 82.83 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.773 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.85 -45.15 93.35 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.602 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 47.7 mt -68.56 -36.79 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.772 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.57 -48.77 71.26 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.985 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -70.35 -24.94 63.07 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.61 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 96.9 p -78.06 67.35 3.88 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.064 0.459 . . . . 0.0 110.751 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 6.7 mtm-85 -76.62 128.31 34.46 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.587 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.57 -91.47 0.59 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.506 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.42 134.57 50.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.783 0.325 . . . . 0.0 110.723 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.453 HD21 ' CZ ' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -129.76 141.68 50.83 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.331 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 7.8 tt0 -100.37 139.57 35.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.676 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.0 128.79 35.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.91 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.56 137.11 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -125.01 143.83 37.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.248 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 C--N 1.332 -0.177 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.486 179.786 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.739 0.304 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.97 158.77 23.48 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.564 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.8 t -132.07 133.34 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.68 0.276 . . . . 0.0 110.963 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.01 107.62 18.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.104 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 tp -91.03 128.5 36.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.118 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.2 ttt -114.97 162.27 17.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.295 0.569 . . . . 0.0 111.274 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 tttm . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.798 -179.755 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.524 0.202 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.426 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 86.9 m-85 -58.2 -27.44 63.9 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.42 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.36 29.02 58.86 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.666 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.67 118.84 37.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.278 . . . . 0.0 110.727 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.18 113.43 25.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.928 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.423 HD12 HG21 ' B' ' 108' ' ' VAL . 5.9 mp -97.06 124.88 41.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 111.342 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -110.33 179.85 20.48 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -132.61 150.18 52.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.194 0.497 . . . . 0.0 111.354 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' B' ' 104' ' ' SER . 7.9 pt20 -134.42 141.56 46.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.473 HG13 HG21 ' A' ' 54' ' ' THR . 2.9 mm -87.84 121.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.401 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -126.41 171.54 10.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.205 0.526 . . . . 0.0 111.392 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.76 100.46 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.853 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -55.76 5.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.082 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -156.58 133.8 10.58 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.559 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.06 145.12 48.82 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.896 0.379 . . . . 0.0 111.28 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.5 m -65.31 120.07 12.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.588 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.82 164.59 7.75 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.003 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.63 27.77 14.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.34 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.52 -175.18 20.55 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.182 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.01 -31.1 69.69 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.17 -34.88 61.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.52 0.2 . . . . 0.0 111.138 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.84 -34.09 45.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.216 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -37.75 85.5 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.49 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -102.41 -32.7 9.86 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.349 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.56 53.92 8.07 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.141 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -70.03 -47.68 61.08 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.523 0.202 . . . . 0.0 111.296 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.49 136.17 53.22 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.902 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.81 141.79 28.32 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.207 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -56.99 109.66 0.68 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.186 0.517 . . . . 0.0 110.856 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.8 -7.77 38.95 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.708 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -67.16 138.58 57.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.078 0.466 . . . . 0.0 110.955 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 pt -77.33 120.93 28.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.811 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.42 HG22 ' CD1' ' A' ' 49' ' ' ILE . 24.1 mt -90.38 152.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.877 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tp -111.7 -52.2 2.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.831 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.14 147.9 40.86 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 111.568 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 37.4 mm -132.78 118.35 33.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 m120 53.28 36.71 23.44 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.754 0.311 . . . . 0.0 111.264 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.55 16.74 77.2 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.162 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 m -120.54 143.68 48.46 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.905 0.353 . . . . 0.0 110.094 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.421 ' HB ' ' CE ' ' A' ' 57' ' ' MET . 2.3 t -63.79 143.93 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 111.295 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.473 HG21 HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -127.72 27.86 5.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.945 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.99 126.76 46.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.013 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 72.0 -5.71 1.66 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.403 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.421 ' CE ' ' HB ' ' A' ' 53' ' ' VAL . 2.3 tpp -67.97 172.59 5.37 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.96 0.409 . . . . 0.0 111.439 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.7 t -90.81 150.96 21.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.244 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -42.01 82.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.793 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.7 t -57.66 -41.94 82.52 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.9 -46.11 86.31 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.95 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.06 92.28 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.29 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -71.38 -37.33 71.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.435 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -67.92 -38.24 82.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.63 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.72 -45.39 92.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.81 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.5 mt -68.73 -36.82 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.872 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -48.71 62.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.879 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.9 -24.52 62.49 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.775 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.4 p -79.38 65.37 4.53 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.116 0.484 . . . . 0.0 110.973 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -78.07 119.92 22.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.69 -89.45 0.46 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.29 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -126.35 130.22 50.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.625 0.25 . . . . 0.0 110.681 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.455 HD23 ' CZ ' ' B' ' 98' ' ' TYR . 0.6 OUTLIER -122.78 143.47 49.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.947 0.404 . . . . 0.0 111.233 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.2 tm0? -105.85 142.14 36.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.867 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -137.71 125.78 22.89 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.914 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.5 t -112.65 133.46 58.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.775 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.53 161.53 41.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.312 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.257 -179.775 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 120.663 0.268 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.13 158.84 22.16 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.88 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 15.3 t -129.67 135.05 62.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.691 0.282 . . . . 0.0 111.028 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 7.4 tt -105.35 109.31 21.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.464 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.45 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 10.6 tp -94.04 141.34 28.64 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.2 ttt -115.09 165.73 12.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.096 0.474 . . . . 0.0 111.167 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.623 179.84 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 120.756 0.312 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . 0.455 ' CZ ' HD23 ' A' ' 73' ' ' LEU . 53.1 m-85 -80.34 -29.52 38.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.756 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.89 20.04 38.06 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.552 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 4.8 mp -100.1 120.17 39.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.701 0.286 . . . . 0.0 110.804 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.35 113.57 26.77 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.973 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -113.51 125.02 53.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.151 0.501 . . . . 0.0 111.339 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -108.16 -162.11 20.85 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.003 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -141.72 146.51 36.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -126.66 143.19 51.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.222 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.495 ' CD1' HG21 ' B' ' 137' ' ' THR . 30.2 mt -88.4 120.71 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -122.15 172.3 8.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.805 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . 0.423 HG21 HD12 ' A' ' 19' ' ' LEU . 57.9 t -84.06 94.14 3.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.174 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -64.17 -51.66 62.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.264 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -155.42 133.24 11.32 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.742 0.306 . . . . 0.0 110.784 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -121.45 144.26 48.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 89.3 m -66.51 123.43 20.02 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.01 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -65.53 162.07 18.85 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.127 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 62.03 35.31 16.05 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.122 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -117.94 -175.75 16.93 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.175 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 mt -65.43 -33.54 76.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.519 0.199 . . . . 0.0 111.48 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.95 -35.06 62.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.306 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.86 -33.9 45.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.186 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -62.65 -37.52 86.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.303 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.16 -29.93 11.84 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.563 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.75 48.27 43.27 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.289 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -72.26 -41.64 66.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.48 127.49 46.56 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.665 0.269 . . . . 0.0 110.827 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.08 136.35 33.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.0 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -49.71 107.0 0.13 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.051 0.453 . . . . 0.0 111.666 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.68 -2.95 24.65 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.411 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -76.17 139.96 41.5 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 117.654 0.727 . . . . 0.0 111.275 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.72 113.07 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.068 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 6.8 mt -82.52 137.22 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.294 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 tp -96.82 -40.24 9.03 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -148.61 148.23 29.89 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 111.909 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.482 HD12 HG21 ' B' ' 132' ' ' ILE . 18.4 mm -135.02 118.22 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.087 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 54.88 42.58 30.99 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.988 0.423 . . . . 0.0 111.074 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.14 16.09 76.79 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.139 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 13.2 m -120.74 137.47 54.48 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.934 0.367 . . . . 0.0 110.586 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.4 145.16 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.034 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.495 HG21 ' CD1' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -118.5 18.35 13.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.428 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' B' ' 140' ' ' MET . 0.3 OUTLIER -105.67 140.6 38.48 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.3 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 52.64 9.91 0.13 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.705 0.628 . . . . 0.0 112.349 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' MET . . . . . 0.41 ' H ' ' C ' ' B' ' 138' ' ' GLU . 0.0 OUTLIER -73.89 173.68 9.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 111.264 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.19 137.22 32.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.956 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.62 -40.73 69.22 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.388 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 1.2 p -64.16 -38.03 89.59 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.218 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.78 -48.22 72.54 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.756 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.49 -42.26 87.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.942 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -69.45 -37.49 77.38 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.576 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -67.81 -38.64 83.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.551 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 6.7 tt -60.02 -44.85 94.33 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.586 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 11.8 mt -68.34 -36.64 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.92 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -69.14 -41.75 76.89 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.714 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.1 0.07 52.83 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 97.1 p -91.51 54.8 2.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.263 0.554 . . . . 0.0 110.945 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.32 83.94 1.42 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.377 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 159.58 -90.27 0.11 Allowed Glycine 0 C--O 1.226 -0.375 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.302 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.24 133.71 41.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.501 0.191 . . . . 0.0 110.804 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.426 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.64 125.61 38.46 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 111.297 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 2.7 mt-30 -92.33 119.13 31.6 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.447 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.41 129.84 55.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.699 0.285 . . . . 0.0 110.988 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 27.0 t -116.48 140.29 39.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 t -132.19 138.01 53.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.092 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.861 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.829 0.347 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.22 158.69 24.45 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.57 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.3 t -131.87 134.44 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.68 0.276 . . . . 0.0 110.829 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.15 115.95 30.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.622 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 tp -102.79 142.53 33.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.444 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.492 ' HG3' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -107.47 162.21 14.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.218 0.533 . . . . 0.0 110.589 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.492 ' N ' ' HG3' ' A' ' 7' ' ' MET . 11.2 ttpt . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.008 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.439 ' CE2' ' CD2' ' B' ' 156' ' ' LEU . 52.9 m-85 -58.79 -32.97 69.82 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.325 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.76 20.54 55.8 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.383 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -105.31 123.32 47.66 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.872 0.336 . . . . 0.0 110.556 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.73 113.57 26.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.337 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 mp -92.39 124.87 36.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.108 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.38 -173.84 22.43 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.52 147.34 31.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.291 . . . . 0.0 110.836 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -130.84 133.85 46.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.193 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 23' ' ' ILE . 46.1 mt -87.94 120.32 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.958 0.408 . . . . 0.0 110.327 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -126.72 173.19 9.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.191 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.3 t -85.5 97.71 5.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.018 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -55.4 21.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.266 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -147.19 144.64 29.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.922 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.24 148.76 45.08 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.948 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.4 t -65.83 132.86 49.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.056 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -74.72 148.33 40.59 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.566 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.7 31.4 21.11 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.24 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.46 -144.11 16.19 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.355 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 -38.45 17.61 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.71 0.29 . . . . 0.0 111.154 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.91 -30.17 61.19 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.251 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -35.48 42.05 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.93 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -36.69 84.76 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.991 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.0 -28.14 13.92 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.102 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.34 49.19 53.72 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.507 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.407 ' HB2' ' HB ' ' B' ' 87' ' ' VAL . 11.8 p-10 -94.12 -32.16 13.87 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.64 131.08 56.84 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.674 0.273 . . . . 0.0 110.997 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.16 117.91 35.37 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -43.9 108.53 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.133 0.492 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.51 -5.37 31.35 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.346 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -75.85 139.99 42.0 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.854 0.827 . . . . 0.0 111.751 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.4 pt -80.13 118.45 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.175 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 mt -85.0 134.43 27.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.801 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 tp -99.42 -29.9 12.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.677 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -157.59 148.47 21.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.775 0.321 . . . . 0.0 111.425 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.5 mt -140.73 118.12 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.563 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 56.52 35.89 26.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.275 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 12.33 83.87 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.176 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.9 m -120.15 135.88 54.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.864 0.332 . . . . 0.0 110.398 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 t -59.83 147.46 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.826 0.346 . . . . 0.0 111.037 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.413 HG22 ' CD1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -122.17 19.02 10.75 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.396 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.423 ' C ' ' H ' ' A' ' 57' ' ' MET . 0.9 OUTLIER -106.27 144.4 33.02 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 p30 52.58 7.82 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 123.644 0.59 . . . . 0.0 112.376 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.423 ' H ' ' C ' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -76.15 176.58 7.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 111.123 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 t -92.12 146.72 23.5 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.756 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.52 -43.93 96.59 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.599 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.4 p -62.47 -38.22 89.0 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.069 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -48.01 75.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.905 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.4 ' CB ' HD11 ' A' ' 23' ' ' ILE . . . -62.22 -40.55 96.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.994 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -67.6 -39.28 84.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.77 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -66.59 -38.49 87.12 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.2 tt -59.91 -45.38 92.73 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.529 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.7 mt -68.5 -37.05 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.94 -49.46 57.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.108 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.48 -19.43 63.75 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.253 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 t -79.33 63.99 4.11 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.196 0.522 . . . . 0.0 110.574 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 mtm105 -79.08 97.72 6.24 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.413 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.67 -93.99 0.18 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.214 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.38 125.96 45.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.581 0.229 . . . . 0.0 110.66 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.442 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 2.3 pp -124.73 143.85 50.55 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.896 0.379 . . . . 0.0 111.188 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -105.14 142.65 34.54 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.779 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.442 ' HG ' ' CD1' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -135.34 132.28 37.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.819 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.53 135.0 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.292 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.5 m -122.98 146.59 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.196 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.9 tp . . . . . 0 C--O 1.231 0.112 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.552 179.658 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.409 HG21 HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.903 0.382 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.84 157.21 15.27 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.447 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 39' ' ' ASN . 17.3 t -130.82 134.54 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 0.0 111.063 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.92 107.35 18.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.619 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 9.4 tp -95.19 139.54 31.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.392 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 8.2 ttt -114.52 164.4 14.04 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.993 0.425 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.172 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.25 0 CA-C-O 120.76 0.314 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . 0.429 ' CE1' ' CD2' ' A' ' 73' ' ' LEU . 71.0 m-85 -59.48 -30.6 68.66 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.377 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.44 24.74 32.74 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.512 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 mp -108.48 120.5 42.6 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.757 0.313 . . . . 0.0 110.699 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -92.91 117.05 29.62 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.761 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 tp -94.7 125.2 39.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -116.46 177.09 16.7 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.658 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.22 146.59 46.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.904 0.352 . . . . 0.0 110.922 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -128.14 137.01 51.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.219 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.435 ' HB ' ' CG2' ' B' ' 137' ' ' THR . 42.3 mt -88.27 120.48 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.908 0.385 . . . . 0.0 110.457 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -124.73 172.59 9.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.079 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.74 96.03 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.146 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -57.6 6.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.689 0.28 . . . . 0.0 111.178 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.28 138.46 21.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.615 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -132.25 140.12 48.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.017 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 38.6 p -69.37 120.48 15.24 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -63.04 169.24 3.49 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.738 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m 62.01 23.66 13.97 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.946 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.16 -164.51 24.77 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.255 -0.497 . . . . 0.0 112.326 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.58 -31.41 53.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.579 0.228 . . . . 0.0 111.295 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.45 -34.96 63.3 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.186 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 2.1 p -79.0 -34.05 44.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.085 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -58.81 -39.53 81.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.264 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -103.92 -29.14 11.15 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.465 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.7 46.26 47.75 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.251 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -73.37 -38.44 65.69 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.514 0.197 . . . . 0.0 111.355 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 mp -127.61 139.37 52.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.763 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.2 148.35 27.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.43 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -60.31 113.32 2.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.086 0.469 . . . . 0.0 110.962 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.48 -16.12 24.38 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.009 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -60.6 136.09 57.95 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.317 0.559 . . . . 0.0 111.295 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.92 99.15 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.377 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 4.7 mt -63.52 147.42 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.681 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 18.2 tp -110.28 -35.46 6.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.617 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -157.32 148.26 21.54 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.783 0.325 . . . . 0.0 111.19 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 43.8 mt -141.04 118.25 8.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.752 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 3.9 m120 53.83 50.52 16.73 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.065 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.15 18.71 60.73 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.031 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 2.9 m -120.57 139.09 53.45 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.702 0.251 . . . . 0.0 110.33 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.4 t -65.73 145.11 14.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 111.293 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.435 ' CG2' ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -113.96 -1.79 13.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.196 179.38 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' B' ' 140' ' ' MET . 0.2 OUTLIER -99.6 150.36 22.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 p30 52.41 8.57 0.08 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.571 0.544 . . . . 0.0 112.242 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' MET . . . . . 0.434 ' H ' ' C ' ' B' ' 138' ' ' GLU . 2.9 ttm -90.98 151.0 21.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.722 0.296 . . . . 0.0 110.764 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 30.0 t -71.8 145.78 48.45 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.014 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 tt -60.19 -47.97 83.7 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.705 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 3.2 p -55.52 -38.38 69.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.023 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.02 -47.93 69.94 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.69 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.54 -40.81 92.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.048 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -67.24 -39.23 86.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.664 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -66.85 -38.39 86.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.788 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.05 -44.45 94.68 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.772 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 29.6 mt -68.18 -37.46 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.967 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -68.95 -49.36 58.64 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.811 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -67.83 -25.46 65.57 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.02 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 43.8 t -76.39 65.69 2.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.039 0.447 . . . . 0.0 110.632 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -78.7 100.49 7.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.348 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 144.21 -94.78 0.18 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.962 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.9 126.25 46.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.636 0.255 . . . . 0.0 110.898 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.439 ' CD2' ' CE2' ' A' ' 15' ' ' TYR . 2.1 pp -123.76 132.71 53.86 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.837 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 0.0 OUTLIER -93.08 142.79 26.9 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.495 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.426 ' HG ' ' CD1' ' B' ' 156' ' ' LEU . 0.3 OUTLIER -133.26 128.22 35.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.022 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.43 140.2 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.589 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.57 160.69 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.836 0.351 . . . . 0.0 111.184 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.654 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.714 0.292 . . . . 0.0 111.335 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -120.93 157.03 16.03 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.781 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' B' ' 122' ' ' ASN . 21.8 t -130.41 135.21 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 0.0 111.352 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.12 108.99 20.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.639 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 tp -98.78 141.93 30.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.736 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.3 ttt -118.7 163.51 16.74 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.097 0.475 . . . . 0.0 110.904 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.072 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.275 0 CA-C-O 121.275 0.559 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.415 ' CE1' HD22 ' B' ' 156' ' ' LEU . 62.0 m-85 -77.29 -9.62 58.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.85 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.55 24.12 71.23 Favored Glycine 0 C--N 1.341 0.851 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.483 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 mp -105.93 123.52 48.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.657 0.265 . . . . 0.0 110.508 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.19 113.04 24.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.013 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.79 124.79 40.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.57 -168.43 22.69 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.74 155.45 43.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.281 0.541 . . . . 0.0 110.687 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -136.81 131.35 33.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.437 ' HB ' HG21 ' A' ' 54' ' ' THR . 40.5 mt -87.72 120.28 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.012 0.434 . . . . 0.0 109.903 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.461 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 42.8 p90 -121.79 173.15 7.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.193 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.0 t -83.99 96.58 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.972 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -64.09 -52.57 58.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.932 -179.276 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -163.95 142.89 7.71 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.695 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -134.45 139.01 45.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.046 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.0 t -65.72 126.1 27.38 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.699 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 ptt85 -63.9 172.78 2.1 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.028 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.65 27.42 13.2 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.198 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.98 -174.17 18.58 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.243 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 mp -74.78 -26.92 60.09 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.52 -36.87 63.19 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.186 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.99 -33.8 44.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -65.71 -36.22 83.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.157 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.31 -29.79 12.96 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.406 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.1 42.1 85.26 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.112 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -70.72 -46.24 63.43 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.39 0.138 . . . . 0.0 111.291 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.438 ' CD1' HD21 ' A' ' 75' ' ' LEU . 8.5 mt -114.56 127.11 55.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.813 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 142.49 29.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.502 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -59.22 109.59 0.89 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.108 0.48 . . . . 0.0 110.465 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.83 -9.65 55.34 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.731 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -60.79 139.64 57.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.103 0.478 . . . . 0.0 111.172 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.19 118.4 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.765 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 46' ' ' ILE . 34.7 mt -89.09 152.04 3.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.786 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.35 -43.12 2.84 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.083 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 148.85 31.79 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.023 0.439 . . . . 0.0 111.958 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 66.8 mt -141.27 121.29 12.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.462 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 m120 55.34 34.2 22.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.398 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.92 9.58 84.22 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.663 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.2 m -119.86 138.16 53.57 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.155 0.478 . . . . 0.0 110.333 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 t -57.12 145.82 7.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.124 0.488 . . . . 0.0 111.006 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.437 HG21 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -130.54 28.88 4.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.972 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -98.3 -102.0 0.21 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.411 ' HB2' ' CD1' ' B' ' 142' ' ' LEU . 6.7 p30 -66.37 -2.86 4.96 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.2 tpt -52.77 164.18 0.39 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.167 0.508 . . . . 0.0 111.7 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 m -79.01 147.35 32.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.592 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' B' ' 139' ' ' ASN . 0.5 OUTLIER -61.99 -46.54 88.77 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.781 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 t -59.56 -41.77 90.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.83 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -66.85 -43.13 84.46 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.702 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.055 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -68.59 -38.59 80.79 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.463 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -38.4 82.78 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.816 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -43.5 98.44 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.75 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.4 mt -68.55 -38.08 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.709 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -68.49 -49.49 59.37 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.651 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -23.11 66.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.343 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.0 m -76.1 68.27 2.53 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.962 0.411 . . . . 0.0 110.67 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.0 119.29 20.53 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.505 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.84 -94.03 0.56 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.278 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.69 127.25 43.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.705 0.288 . . . . 0.0 110.804 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.416 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 2.2 pp -119.49 133.69 55.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 4.9 mm-40 -93.56 142.69 27.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.91 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.438 HD21 ' CD1' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -133.82 123.82 25.46 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.53 134.42 53.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.032 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.0 m -128.62 150.13 34.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.785 0.326 . . . . 0.0 111.549 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 tp . . . . . 0 C--O 1.233 0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.281 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.649 0.261 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.27 157.75 15.63 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.56 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 17.7 t -130.53 135.22 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.618 0.246 . . . . 0.0 111.206 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.51 113.99 27.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.81 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 tp -105.02 144.67 31.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 4.0 ttt -109.74 163.9 13.06 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.202 0.525 . . . . 0.0 110.848 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.089 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.646 0.26 . . . . 0.0 110.729 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -51.51 -31.5 24.18 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.49 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.14 26.62 65.92 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.579 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.14 119.47 38.8 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.682 0.277 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.01 113.37 25.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.294 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 mp -97.01 125.11 41.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -108.91 -179.0 21.52 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.427 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.62 144.74 29.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.018 0.409 . . . . 0.0 111.101 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -130.65 137.91 49.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.164 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.46 ' HB ' ' CG2' ' B' ' 137' ' ' THR . 18.8 mt -87.93 120.6 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.337 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -122.13 172.11 8.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.231 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 40.9 t -80.97 96.71 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.772 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -57.06 7.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.103 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -155.13 147.68 24.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.657 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -138.13 147.9 44.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 111.007 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -65.28 121.86 15.79 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.849 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -69.04 157.03 37.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 68.68 14.16 8.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.484 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.59 -158.26 33.79 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.302 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp -81.85 -30.43 32.09 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.528 0.204 . . . . 0.0 111.543 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.06 -34.23 61.8 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.362 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.12 -33.96 43.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -37.8 85.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.353 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.89 -26.43 12.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.729 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.57 44.64 89.46 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.085 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . 0.415 ' HB2' ' HB ' ' A' ' 4' ' ' VAL . 9.5 p30 -58.75 -44.64 90.59 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.7 mp -133.14 142.51 48.71 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.692 0.282 . . . . 0.0 111.048 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.05 144.47 25.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.432 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -59.6 111.15 1.31 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 111.185 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.69 -9.0 23.84 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.186 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -68.1 135.55 52.35 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 117.307 0.553 . . . . 0.0 110.558 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -77.63 113.7 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.754 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 16.3 mt -81.6 133.98 28.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.268 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.17 -38.81 10.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.241 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -147.32 148.03 30.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 111.694 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 26.0 mt -136.35 119.43 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.414 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . 0.404 ' CB ' HD21 ' B' ' 148' ' ' LEU . 2.5 t-20 57.11 40.66 28.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.841 0.353 . . . . 0.0 111.024 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.5 15.4 77.42 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.142 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.84 141.56 50.45 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.0 0.4 . . . . 0.0 110.389 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.17 147.87 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.051 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.46 ' CG2' ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -121.69 20.31 11.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.807 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -105.75 138.53 41.79 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.473 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . 0.405 ' HB2' ' CD1' ' A' ' 59' ' ' LEU . 11.4 p30 52.98 9.95 0.14 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.618 0.574 . . . . 0.0 112.295 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.77 172.08 10.44 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.771 0.319 . . . . 0.0 111.483 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 44.8 t -91.38 142.64 27.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.411 ' CD1' ' HB2' ' A' ' 56' ' ' ASN . 2.7 tt -59.18 -42.52 91.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.643 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.1 p -60.37 -39.67 88.06 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.771 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -48.21 74.83 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.957 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.01 94.82 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.88 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -66.3 -39.92 89.67 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.437 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -38.23 82.33 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.398 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . 0.404 HD21 ' CB ' ' B' ' 133' ' ' ASN . 0.8 OUTLIER -59.97 -44.78 94.24 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.687 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 11.3 mt -68.49 -36.69 75.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.885 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.05 -48.85 61.78 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.81 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.01 -26.23 67.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.487 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.0 m -74.18 69.32 1.52 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.729 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.45 80.27 6.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.524 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 160.46 -81.94 0.14 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.025 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.1 125.89 25.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.544 0.211 . . . . 0.0 110.906 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.415 HD22 ' CE1' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -123.41 141.09 52.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.958 0.408 . . . . 0.0 111.226 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -102.77 136.86 41.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.727 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mt -131.85 129.87 40.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.971 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 34.2 t -115.0 136.26 52.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.786 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 10.0 m -141.19 161.91 22.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.912 0.386 . . . . 0.0 111.39 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 C--N 1.332 -0.167 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.687 179.711 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.764 0.316 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -138.57 156.78 24.31 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.867 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.5 t -129.06 134.27 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.868 0.366 . . . . 0.0 111.208 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.68 107.31 18.19 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.517 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.5 tp -94.47 137.47 33.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.501 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 17.5 ttt -113.65 163.81 14.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.991 0.424 . . . . 0.0 110.639 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.802 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 120.768 0.318 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -67.21 -27.69 67.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.526 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.69 23.18 70.57 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.384 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.77 120.23 38.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.593 0.235 . . . . 0.0 110.761 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.96 113.4 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.076 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 mp -99.12 124.85 44.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.163 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.85 -169.17 20.81 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.37 152.72 39.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.167 0.483 . . . . 0.0 110.582 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 6.9 pt20 -136.37 137.25 40.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.38 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' B' ' 103' ' ' GLY . 41.0 mt -88.03 120.37 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.131 0.491 . . . . 0.0 110.204 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.419 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 45.5 p90 -121.0 172.33 8.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.109 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -82.19 94.51 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.015 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.419 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -62.7 -52.33 63.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.042 -179.379 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.09 144.03 20.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.807 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 10.1 ptp -132.26 145.49 51.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.153 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -66.95 119.89 12.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.958 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.01 154.8 9.06 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.056 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.1 m 63.62 30.28 14.97 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.918 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.49 -173.16 25.94 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.158 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.49 -32.26 72.96 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.37 -35.81 63.54 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.024 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -34.07 44.29 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.046 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -39.94 77.54 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.563 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.35 -33.81 8.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.513 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.2 56.77 3.61 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.105 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.45 -52.76 4.35 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.543 0.211 . . . . 0.0 110.942 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.9 mp -103.34 116.43 32.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.579 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.52 138.1 31.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.371 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.29 110.14 0.58 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.209 0.528 . . . . 0.0 110.875 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.99 -9.95 29.46 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.693 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -65.97 137.5 57.17 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 121.036 0.446 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 pt -78.47 110.79 14.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.671 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.3 mt -77.76 133.95 29.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.921 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.11 -46.16 8.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.547 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -154.21 152.23 30.11 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.953 0.406 . . . . 0.0 111.48 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.7 mt -137.33 118.18 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.58 39.66 30.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.426 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.48 14.63 82.28 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.489 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.1 m -119.95 137.57 53.97 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 117.042 0.421 . . . . 0.0 110.279 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -60.63 144.32 13.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.092 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.404 HG21 HD13 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -128.4 26.71 5.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.365 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 9.8 tt0 -97.29 -109.92 0.16 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.417 ' HB2' HD13 ' B' ' 142' ' ' LEU . 6.7 p30 -63.45 -5.32 3.53 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.2 tpt -49.33 164.09 0.09 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.231 0.538 . . . . 0.0 111.895 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.7 147.26 45.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.587 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.92 -51.53 66.55 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.261 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.0 t -57.64 -38.69 75.47 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.301 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -64.17 -47.82 78.38 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.632 0.253 . . . . 0.0 110.766 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.81 -42.01 88.13 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.239 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 51.4 mtt-85 -69.65 -38.23 77.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -38.45 84.51 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.828 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.51 -43.75 96.76 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.89 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.1 mt -68.25 -37.3 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 110.692 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -49.75 59.53 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.769 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -68.32 -23.42 64.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.163 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.6 t -82.17 61.95 5.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 110.711 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -78.99 118.76 21.29 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.447 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.11 -99.77 0.59 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.966 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -118.03 131.58 56.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.754 0.311 . . . . 0.0 110.873 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.408 HD23 ' CZ ' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -128.16 144.24 51.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.039 -179.79 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.12 128.47 54.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.39 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.7 128.6 48.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.446 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.08 120.1 62.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.468 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -109.42 156.82 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.612 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.3 tt . . . . . 0 C--O 1.232 0.178 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 179.818 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.732 0.301 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.83 160.59 22.85 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.831 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 21.1 t -130.71 131.75 64.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.781 0.324 . . . . 0.0 111.0 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -95.35 113.1 24.74 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.82 144.68 30.83 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.881 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.86 171.52 8.01 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.462 0.648 . . . . 0.0 111.125 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 tttp . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.26 -179.636 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 120.68 0.276 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . 0.408 ' CZ ' HD23 ' A' ' 73' ' ' LEU . 70.0 m-85 -67.31 -26.56 66.58 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.306 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.98 25.68 68.58 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.472 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -105.51 116.01 31.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.716 0.293 . . . . 0.0 110.385 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 125.7 34.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.528 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 mp -104.95 124.86 50.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.493 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -116.2 172.18 14.1 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.391 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 2.1 p -128.77 151.09 49.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.419 0.609 . . . . 0.0 111.763 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -133.41 136.97 45.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.162 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.493 ' HB ' HG21 ' B' ' 137' ' ' THR . 50.8 mt -87.98 120.16 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.963 0.411 . . . . 0.0 110.36 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -122.51 173.11 7.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.266 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 35.2 t -82.72 97.82 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.845 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.39 -47.76 63.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.048 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -162.56 145.2 10.99 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -134.84 155.6 50.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.854 0.359 . . . . 0.0 111.166 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.36 120.07 12.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.702 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 145.36 47.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.135 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.7 27.89 14.84 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.156 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.33 -150.76 27.33 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.559 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 mt -84.38 -34.1 23.65 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -72.88 -32.26 65.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.176 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.81 -34.9 44.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.046 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -63.7 -36.41 83.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.162 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -98.21 -33.96 10.91 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.297 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.38 40.1 41.15 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.401 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -92.4 -36.64 13.02 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.469 0.176 . . . . 0.0 111.399 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 mt -98.73 74.99 2.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.03 130.73 47.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.561 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -56.63 108.08 0.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.271 0.558 . . . . 0.0 110.85 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.69 -13.05 46.59 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.785 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -58.53 137.17 57.59 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.2 0.524 . . . . 0.0 111.087 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pt -81.57 114.21 22.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.661 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 36.6 mt -84.85 149.51 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.072 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 8.3 tp -113.63 -41.54 3.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.751 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -147.23 148.31 31.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.894 0.378 . . . . 0.0 111.769 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 23.2 mt -138.92 119.77 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.391 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.44 38.16 29.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.47 15.2 81.68 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.211 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 39.3 m -120.61 141.21 50.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.965 0.382 . . . . 0.0 110.347 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.56 144.16 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.256 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.493 HG21 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -122.37 19.67 10.53 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.296 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.8 128.52 55.37 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 70.24 -3.51 1.8 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.188 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 140' ' ' MET . . . . . 0.452 ' HG3' ' N ' ' B' ' 141' ' ' SER . 0.1 OUTLIER -73.3 149.87 42.36 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.79 0.328 . . . . 0.0 110.496 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 141' ' ' SER . . . . . 0.452 ' N ' ' HG3' ' B' ' 140' ' ' MET . 33.4 t -71.49 150.08 45.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.372 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -58.08 -45.14 87.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.261 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 34.9 p -56.31 -40.22 74.02 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.08 -46.42 71.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.763 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.3 -39.83 94.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.338 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -70.23 -37.36 74.98 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.82 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.13 -38.79 82.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.634 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.19 -44.03 95.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.032 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 12.3 mt -68.38 -37.01 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.864 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.13 -49.69 54.72 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.067 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.21 -28.04 69.1 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.168 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 30.2 t -75.35 79.73 2.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 110.773 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -88.67 121.64 31.25 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.599 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 115.32 -92.22 0.58 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.308 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.46 135.05 53.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.639 0.257 . . . . 0.0 110.983 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 2.5 pp -122.59 133.3 54.55 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -99.35 139.09 35.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.148 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 3.9 tt -137.29 142.08 41.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.839 0.352 . . . . 0.0 111.368 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 6.9 t -122.04 130.44 74.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.297 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 31.9 m -121.2 146.41 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.73 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.234 0.239 0 CA-C-O 120.759 0.314 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.42 168.46 23.09 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.978 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.449 ' CG2' ' HB2' ' B' ' 122' ' ' ASN . 23.5 t -128.51 132.94 67.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.658 0.266 . . . . 0.0 110.978 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 mp -95.79 124.28 39.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.8 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mp -108.31 134.25 51.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.623 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.3 ttm -109.11 163.83 12.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.239 0.543 . . . . 0.0 111.06 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.9 tttm . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.064 -179.759 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 121.333 0.587 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -77.81 -32.72 52.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.499 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.09 22.93 28.69 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.576 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.404 HD21 ' CB ' ' B' ' 117' ' ' ALA . 3.6 mp -102.76 119.09 38.23 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.647 0.26 . . . . 0.0 110.738 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.73 124.25 43.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.88 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -122.42 124.96 44.84 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.204 0.526 . . . . 0.0 111.741 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.24 -169.56 21.33 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.584 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.7 OUTLIER -146.75 148.76 32.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.162 0.481 . . . . 0.0 111.167 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -131.19 146.54 52.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.37 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.524 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 5.6 mt -88.8 121.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.995 0.426 . . . . 0.0 111.045 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.416 ' CD1' ' HG2' ' B' ' 105' ' ' GLN . 39.7 p90 -121.5 172.83 7.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.017 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.7 t -86.3 96.65 5.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.126 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -63.11 -57.26 11.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.92 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -151.57 135.43 16.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.94 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.8 148.28 41.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.6 t -65.28 142.05 58.4 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.074 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 154.72 26.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 55.37 29.23 12.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.466 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.24 -165.72 25.67 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.097 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.19 -30.32 54.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.614 0.207 . . . . 0.0 111.429 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.78 -35.85 64.98 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.216 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.64 -33.75 46.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.096 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -38.67 87.09 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.376 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -101.22 -31.81 10.82 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.641 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.1 43.21 27.06 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.177 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -51.42 -49.57 61.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.155 0.182 . . . . 0.0 111.328 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.93 157.76 45.44 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.869 0.366 . . . . 0.0 111.13 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 147.29 25.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.598 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.25 109.97 0.86 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.302 0.573 . . . . 0.0 110.935 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.93 -4.28 28.86 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.745 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -70.55 135.44 48.52 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.201 0.524 . . . . 0.0 111.099 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 pt -78.87 111.49 15.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.493 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 53.8 mt -79.77 146.1 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.302 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.3 tp -107.46 -37.58 6.17 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.73 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.04 147.76 31.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.874 0.369 . . . . 0.0 111.591 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 23.8 mt -137.7 118.34 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m120 52.92 35.69 19.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.874 0.368 . . . . 0.0 111.383 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.68 15.89 74.52 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.146 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -120.89 141.05 50.98 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 117.061 0.43 . . . . 0.0 110.383 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.86 144.44 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 111.078 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.524 ' CG2' ' HB ' ' A' ' 23' ' ' ILE . 2.7 m -116.42 13.69 15.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.891 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.94 133.22 56.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.405 ' HA ' ' CD2' ' B' ' 142' ' ' LEU . 5.2 m-80 71.36 -6.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.391 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.1 tpt -69.75 170.89 10.06 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.846 0.355 . . . . 0.0 110.987 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -89.94 139.73 30.32 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.051 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.1 tt -55.89 -44.57 78.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.605 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -58.9 -40.14 83.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.821 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.2 -46.78 76.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.784 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.1 92.82 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.951 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.35 -37.9 80.95 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.581 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -68.05 -38.56 82.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.719 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 tt -61.13 -43.92 98.13 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.724 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 8.0 mt -68.6 -37.03 77.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.023 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.16 -49.12 59.69 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.749 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.36 -25.06 67.87 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.372 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 t -77.51 68.12 3.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.083 0.468 . . . . 0.0 110.723 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.1 mtt85 -84.06 66.46 9.24 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.397 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.89 -75.61 0.07 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.659 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.94 128.94 29.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.711 -0.245 . . . . 0.0 111.242 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.445 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.9 OUTLIER -125.7 132.34 52.41 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.958 0.408 . . . . 0.0 111.077 179.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 4.2 tt0 -102.15 136.41 42.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.621 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.12 130.71 50.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.28 133.93 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.254 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.07 165.68 30.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.811 0.339 . . . . 0.0 111.443 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.232 0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.089 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.47 HG21 HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.259 0 CA-C-O 120.787 0.327 . . . . 0.0 110.904 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -118.57 157.99 14.98 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 18.8 t -125.46 134.78 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.698 0.285 . . . . 0.0 110.962 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.42 125.6 50.76 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.713 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 11.0 tp -119.02 138.6 52.72 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.243 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.0 ttt -100.45 163.87 12.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.119 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.595 0.236 . . . . 0.0 110.672 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . 0.445 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 52.3 m-85 -57.97 -25.37 60.92 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.388 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.24 17.76 66.14 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.319 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.63 114.93 29.03 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 113.38 24.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.27 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.14 124.92 46.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.107 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.45 172.99 15.51 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.5 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 1.1 p -124.43 153.6 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.996 0.398 . . . . 0.0 111.167 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 21' ' ' SER . 2.4 pt20 -134.23 134.29 41.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.164 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.512 ' CD1' HG22 ' B' ' 137' ' ' THR . 19.9 mt -87.76 120.52 36.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.034 0.445 . . . . 0.0 109.866 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.455 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 47.8 p90 -121.8 173.72 7.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.218 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 39.8 t -84.68 101.49 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . 0.455 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 5.6 mmtt -70.35 -53.23 17.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.732 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -161.72 145.08 12.31 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.798 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -138.37 139.32 38.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 10.0 t -65.39 125.7 25.92 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.473 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . 0.417 ' HA ' ' CG2' ' B' ' 118' ' ' THR . 0.0 OUTLIER -75.6 61.38 1.32 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.333 0.587 . . . . 0.0 111.3 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.41 27.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.955 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -130.11 -173.65 13.46 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.598 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.34 -32.17 72.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.595 0.236 . . . . 0.0 111.273 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.404 ' CB ' HD21 ' A' ' 17' ' ' LEU . . . -65.8 -41.19 92.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.325 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' THR . . . . . 0.417 ' CG2' ' HA ' ' B' ' 113' ' ' ARG . 11.0 m -78.91 -33.01 45.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.821 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -39.37 84.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.269 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.74 -32.76 9.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.618 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.89 40.12 26.55 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.275 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . 0.449 ' HB2' ' CG2' ' A' ' 4' ' ' VAL . 7.1 p-10 -71.04 -47.05 60.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.389 0.138 . . . . 0.0 111.207 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . 0.426 HD11 ' CD1' ' B' ' 158' ' ' LEU . 21.0 mt -92.8 119.74 32.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.676 0.274 . . . . 0.0 110.717 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.6 136.87 34.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.459 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -58.45 107.76 0.54 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.164 0.507 . . . . 0.0 110.534 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 102.49 -7.84 54.27 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.64 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -63.02 138.92 58.7 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.154 0.502 . . . . 0.0 111.252 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 pt -76.41 121.73 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.707 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 12.7 mt -89.66 135.02 27.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 tp -97.1 -41.94 8.1 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.579 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -148.5 147.92 29.65 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.792 0.33 . . . . 0.0 111.487 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 20.1 mt -141.41 119.65 9.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.662 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 58.3 40.55 24.44 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.243 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.54 10.11 79.01 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.396 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.44 138.79 52.23 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 117.138 0.469 . . . . 0.0 110.204 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 t -59.45 147.93 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.163 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.512 HG22 ' CD1' ' B' ' 106' ' ' ILE . 0.3 OUTLIER -121.64 20.48 11.03 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.709 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.8 130.71 55.5 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 73.01 -10.49 0.99 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.499 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 1.2 tpt -65.49 169.21 6.3 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 121.016 0.436 . . . . 0.0 111.052 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 25.0 t -92.54 150.18 20.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.405 ' CD2' ' HA ' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -58.56 -44.15 89.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.89 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 8.9 t -59.25 -40.19 85.16 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.631 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.28 -44.98 82.04 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.716 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.79 -41.77 96.25 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.019 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.7 -37.82 76.75 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.37 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -67.86 -38.42 83.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.526 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -44.76 93.15 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.651 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . 0.433 HD13 HG21 ' B' ' 149' ' ' ILE . 59.1 mt -68.3 -36.95 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.685 0.278 . . . . 0.0 110.763 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -69.18 -49.08 59.91 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.882 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -70.2 -23.3 62.93 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.613 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 80.1 p -79.06 66.29 4.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.122 0.486 . . . . 0.0 110.625 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -74.55 126.6 31.12 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.544 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 115.12 -90.36 0.53 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.452 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.18 133.94 48.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 0.0 110.617 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.418 ' CD1' ' HG ' ' B' ' 158' ' ' LEU . 2.0 pp -124.59 144.26 50.25 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.412 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 55.5 tt0 -109.51 141.6 41.74 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.426 ' CD1' HD11 ' B' ' 123' ' ' LEU . 1.1 mt -135.02 132.5 38.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.972 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.02 137.78 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.297 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 7.8 m -135.21 161.77 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.818 0.342 . . . . 0.0 111.403 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 4.9 tt . . . . . 0 CA--C 1.529 0.159 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.017 179.945 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.247 0 CA-C-O 120.846 0.355 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -139.45 156.81 24.82 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.835 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.451 ' CB ' ' HB2' ' B' ' 122' ' ' ASN . 18.1 t -131.34 134.63 60.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.777 0.322 . . . . 0.0 111.041 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.24 107.12 17.81 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.732 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 tp -92.7 134.79 34.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.289 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.97 171.37 7.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.387 0.613 . . . . 0.0 111.354 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.8 pttt . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.564 -179.477 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.417 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 77.7 m-85 -100.28 -24.99 14.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.809 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.59 30.9 65.87 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.546 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.94 123.84 48.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.658 0.266 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HB2' ' HG3' ' B' ' 110' ' ' GLU . 0.0 OUTLIER -100.19 113.22 25.73 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.08 179.487 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.0 mp -94.15 124.84 38.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.024 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.18 172.09 14.85 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.531 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.3 OUTLIER -132.47 149.02 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.006 0.403 . . . . 0.0 111.223 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' B' ' 104' ' ' SER . 7.0 pt20 -131.94 141.53 49.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.181 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.512 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 4.1 mm -87.81 121.69 38.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.304 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -125.93 171.5 10.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.413 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.7 t -84.36 100.18 7.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.04 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -56.12 8.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.893 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -157.15 145.84 19.74 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.992 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.53 143.8 41.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.274 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.8 p -65.71 121.08 14.18 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.616 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.68 163.85 6.76 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.204 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 62.88 25.09 14.9 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.278 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.37 -169.09 25.76 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.391 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.75 -30.17 62.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.81 -35.09 62.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.642 0.258 . . . . 0.0 111.025 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -78.68 -34.18 46.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.133 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -61.73 -38.15 86.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.197 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -98.98 -30.69 12.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.273 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.05 47.02 25.92 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.037 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -85.31 -40.0 17.04 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -106.34 125.46 51.02 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.652 0.263 . . . . 0.0 111.07 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 132.12 41.25 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.236 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.02 107.07 0.43 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.225 0.536 . . . . 0.0 111.012 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.87 -9.07 43.4 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.917 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -69.56 144.07 53.19 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.26 0.553 . . . . 0.0 111.294 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 pt -81.65 116.59 26.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.666 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.0 mt -83.03 137.72 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.71 -51.5 5.21 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.5 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -150.52 152.19 33.8 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.71 0.29 . . . . 0.0 111.2 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 29.7 mt -140.67 118.11 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.86 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.53 39.85 30.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.177 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.56 3.95 87.08 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.207 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.2 m -107.71 129.76 55.0 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.64 146.15 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.979 0.418 . . . . 0.0 111.079 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.512 ' CG2' ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -120.41 22.76 11.18 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.354 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.24 124.62 39.32 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 72.35 -9.23 1.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.444 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -69.94 174.48 5.26 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.868 0.366 . . . . 0.0 111.146 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.62 132.31 34.19 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.007 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 tt -54.25 -42.83 70.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.751 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -63.6 -38.48 91.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.085 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.2 -48.13 74.46 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.075 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.33 -40.52 86.59 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.227 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.69 -37.62 76.68 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.792 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -38.68 82.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.776 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.71 -44.21 93.81 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.787 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 8.2 mt -67.97 -37.47 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.825 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.86 -49.56 67.71 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.806 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -65.94 -26.74 67.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.423 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 86.0 p -84.85 60.69 6.35 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.114 0.483 . . . . 0.0 110.791 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -73.46 96.67 2.42 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.839 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.36 -92.19 0.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.249 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.28 130.45 52.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.709 0.29 . . . . 0.0 110.353 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.45 HD21 ' CZ ' ' B' ' 98' ' ' TYR . 0.7 OUTLIER -129.51 139.69 51.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.21 0.528 . . . . 0.0 111.528 -179.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -98.12 138.59 35.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.999 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 mp -136.6 127.62 27.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 111.316 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.4 t -113.53 134.45 56.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.372 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.7 t -129.26 140.81 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.073 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.749 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.63 160.96 22.84 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.744 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 26.3 t -130.77 135.1 60.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.72 0.295 . . . . 0.0 111.289 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tt -97.87 109.07 21.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.536 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 tp -104.44 144.84 31.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.075 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 38.9 ttm -113.13 164.19 13.81 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.117 0.484 . . . . 0.0 110.657 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.141 -179.618 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.191 0.519 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . 0.45 ' CZ ' HD21 ' A' ' 73' ' ' LEU . 52.0 m-85 -72.86 -31.57 64.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.274 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.98 17.39 72.46 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.563 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -97.96 118.41 34.49 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -99.41 113.36 25.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.188 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -110.95 125.08 53.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.165 0.507 . . . . 0.0 111.16 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -107.4 -162.66 21.67 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.278 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -144.77 145.75 31.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 110.856 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 21' ' ' SER . 7.7 pt20 -128.12 140.35 51.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.496 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.47 ' CD1' HG23 ' B' ' 137' ' ' THR . 45.3 mt -88.14 120.38 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -121.62 172.94 7.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.874 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 42.9 t -81.66 93.51 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.31 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -63.51 -50.48 69.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.013 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . 0.4 ' HG3' ' HB2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -165.21 149.03 8.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.1 mtm -128.4 161.4 29.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.061 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 10.1 t -65.62 125.36 25.0 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.708 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -57.85 136.52 57.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.21 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m 60.86 30.28 19.55 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.05 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.6 -156.43 30.02 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.447 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 13.4 mt -82.44 -30.12 30.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.511 0.196 . . . . 0.0 111.349 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.23 -34.69 61.46 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.285 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.9 -33.85 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.074 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -38.69 84.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.374 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -103.04 -29.88 11.1 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.673 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.68 44.21 57.74 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.151 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . 0.451 ' HB2' ' CB ' ' A' ' 4' ' ' VAL . 8.5 p30 -63.31 -39.89 95.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.464 0.173 . . . . 0.0 111.341 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 pp -133.26 163.88 28.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.923 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.5 135.16 52.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.62 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -53.77 113.09 1.07 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.188 0.518 . . . . 0.0 111.076 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.08 -14.5 23.65 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.527 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -66.22 136.64 56.17 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.129 0.49 . . . . 0.0 110.887 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 5.8 pt -74.75 117.49 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.663 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.416 HD12 HG22 ' B' ' 129' ' ' ILE . 27.3 mm -83.19 137.55 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.909 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 13.4 tp -98.67 -40.94 7.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.001 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -150.03 150.83 32.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.969 0.414 . . . . 0.0 111.806 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.41 HG21 HD12 ' B' ' 132' ' ' ILE . 34.4 mm -137.01 118.82 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.89 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 56.2 31.54 18.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.682 0.277 . . . . 0.0 111.228 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.89 -2.3 85.65 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.178 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 13.4 m -104.66 131.98 51.45 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.075 0.437 . . . . 0.0 110.227 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.1 t -56.44 147.16 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.937 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.47 HG23 ' CD1' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -118.55 19.54 13.25 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.6 134.43 49.75 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 52.18 12.24 0.2 Allowed 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.636 0.585 . . . . 0.0 112.175 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.22 173.38 5.72 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.413 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.3 141.36 30.13 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 mp -58.41 -47.93 82.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.028 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 4.5 t -63.04 -37.06 85.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.776 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -65.61 -48.12 73.36 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.815 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.15 90.45 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.397 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 17.8 mtt85 -68.27 -38.66 81.95 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.629 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -67.5 -38.35 84.17 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.97 -44.17 94.63 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.915 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 5.3 mt -68.17 -38.09 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.832 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.01 -48.47 62.94 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.922 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -69.53 -19.07 63.71 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.266 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 3.2 m -74.33 69.77 1.63 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.772 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -82.97 120.3 25.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.716 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.69 -88.94 0.51 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.515 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.04 130.65 51.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.683 0.278 . . . . 0.0 110.809 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.417 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -120.04 130.97 54.95 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.095 0.474 . . . . 0.0 111.394 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 9.4 tt0 -93.75 135.43 35.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.68 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.4 127.99 38.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 20.9 t -114.15 145.64 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.74 161.26 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.178 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 C--O 1.233 0.185 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.38 -179.637 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.9 tt . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.838 0.352 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.8 156.87 21.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.711 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.9 t -132.67 134.18 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.777 0.322 . . . . 0.0 110.872 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.86 107.04 18.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.691 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.4 HD22 ' CA ' ' B' ' 117' ' ' ALA . 2.8 tp -91.87 134.01 35.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.312 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 ttt -123.09 163.18 21.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.127 0.489 . . . . 0.0 110.911 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.537 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.771 0.32 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.412 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 78.6 m-85 -73.76 -27.95 61.43 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.67 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.97 27.59 58.08 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.653 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mp -108.04 121.07 44.07 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.748 0.308 . . . . 0.0 110.737 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -102.42 113.73 27.31 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.427 ' HG ' ' CG2' ' B' ' 106' ' ' ILE . 1.9 pt? -105.46 125.18 50.69 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.211 0.529 . . . . 0.0 112.098 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.36 -178.53 21.89 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.611 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -132.4 148.59 52.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.296 0.548 . . . . 0.0 111.565 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' B' ' 104' ' ' SER . 9.9 pt20 -135.37 145.73 47.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.593 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.473 HD13 HG23 ' A' ' 54' ' ' THR . 4.8 mt -88.42 121.34 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.036 0.446 . . . . 0.0 111.051 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -122.28 172.32 8.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.957 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.3 t -84.01 97.5 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.92 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -58.5 4.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.306 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -149.2 136.46 20.01 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.34 134.61 36.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.072 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.1 p -73.23 127.64 33.19 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.518 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.473 ' HA ' ' CG2' ' A' ' 35' ' ' THR . 14.7 ptt-85 -72.91 65.69 0.75 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.254 0.55 . . . . 0.0 111.219 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.41 25.38 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.023 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.22 -172.63 13.39 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.714 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 mp -69.97 -30.5 67.87 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.639 0.22 . . . . 0.0 111.567 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.62 -41.3 79.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.544 0.212 . . . . 0.0 111.133 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.473 ' CG2' ' HA ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -78.78 -33.4 46.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.827 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -65.49 -36.42 83.81 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.188 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.58 -32.33 11.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.483 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.0 40.15 57.5 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.268 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -83.01 -31.06 27.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.425 0.155 . . . . 0.0 111.311 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mt -115.28 123.67 49.39 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.699 0.285 . . . . 0.0 110.96 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.06 139.71 30.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.443 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.88 110.24 0.77 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 110.664 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.82 -11.25 45.53 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.705 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.84 138.13 57.42 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 121.05 0.452 . . . . 0.0 111.201 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -84.13 99.15 6.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.248 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mt -64.82 139.33 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tp -92.62 -38.98 11.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.416 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -149.95 150.7 32.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.745 0.307 . . . . 0.0 111.388 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.7 mt -138.1 118.1 15.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.402 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 m120 53.14 41.95 32.16 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.277 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.73 6.13 76.54 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.972 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -104.98 131.59 52.3 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.2 144.88 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.791 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.473 HG23 HD13 ' A' ' 23' ' ' ILE . 20.7 m -109.95 23.1 14.81 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.419 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -126.2 130.6 51.28 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.344 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.0 p30 51.53 11.63 0.13 Allowed 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.762 0.664 . . . . 0.0 112.718 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -174.77 0.68 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.899 0.38 . . . . 0.0 111.114 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.8 124.6 35.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tt -58.39 -44.19 88.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.784 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 7.1 t -63.5 -37.33 86.9 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.01 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -34.72 62.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.653 0.264 . . . . 0.0 110.593 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.34 91.08 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.24 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 60' ' ' THR . 1.4 ptt180 -71.97 -36.81 69.92 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.52 -37.85 83.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.239 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.41 -45.25 92.05 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.794 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 7.2 mt -68.77 -37.58 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.947 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -49.34 56.61 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -23.36 67.2 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.258 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.5 m -76.03 67.81 2.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 110.805 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 -90.85 53.16 2.32 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.705 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -171.83 -82.46 0.05 OUTLIER Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.294 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.83 126.38 36.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.637 0.256 . . . . 0.0 110.742 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.403 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -129.9 134.55 47.57 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.289 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -92.01 140.68 29.41 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.939 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.403 ' HG ' ' CD1' ' A' ' 73' ' ' LEU . 1.2 mp -134.07 128.14 33.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.962 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.8 t -115.78 142.95 26.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.851 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.62 155.43 41.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.798 0.332 . . . . 0.0 111.39 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.093 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 18.1 tt . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.805 0.336 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -123.62 158.63 18.23 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.671 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.5 134.0 61.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.856 0.36 . . . . 0.0 111.255 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.63 107.92 19.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.408 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.432 ' HB3' ' CE2' ' B' ' 98' ' ' TYR . 7.1 mp -96.37 144.73 26.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 9.8 ttt -116.35 163.57 15.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.814 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.155 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' B' ' 89' ' ' LEU . 38.1 m-85 -93.86 -6.95 44.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.844 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.98 9.99 86.46 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.648 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.7 mp -105.7 115.06 29.6 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.659 0.266 . . . . 0.0 110.518 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.45 113.27 21.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.979 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.6 mp -96.77 124.75 40.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.064 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.28 174.84 15.55 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.558 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -133.17 144.73 50.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.983 0.391 . . . . 0.0 111.083 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -131.43 144.77 51.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.324 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 20' ' ' GLY . 0.9 OUTLIER -88.31 121.35 38.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.006 0.431 . . . . 0.0 110.803 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.408 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 32.1 p90 -119.26 171.82 8.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 35.5 t -79.69 91.91 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.97 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . 0.408 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -63.39 -45.54 90.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.971 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -163.49 132.14 3.84 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.718 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.92 146.88 50.15 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.826 0.346 . . . . 0.0 111.31 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 74.4 p -65.29 123.56 19.89 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 18.9 ttm105 -63.72 155.26 30.63 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.28 30.53 19.92 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.262 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.35 -168.74 26.81 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.24 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 mt -65.24 -36.74 85.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.538 0.208 . . . . 0.0 111.168 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . 0.4 ' CA ' HD22 ' A' ' 6' ' ' LEU . . . -74.87 -33.14 62.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.387 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.77 -34.26 45.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.122 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -37.94 86.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.222 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.16 -30.57 12.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.484 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.15 51.5 10.07 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.314 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -87.12 -44.73 11.3 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 mp -123.46 124.84 43.77 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.741 0.305 . . . . 0.0 111.1 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.65 151.77 19.03 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.493 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -60.42 111.29 1.51 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.176 0.513 . . . . 0.0 111.048 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.28 -18.49 20.85 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.96 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -61.13 135.12 57.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.162 0.481 . . . . 0.0 110.523 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.63 120.76 30.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.264 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 29.0 mt -87.95 137.92 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.772 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 tp -100.14 -35.65 9.59 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.546 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -150.44 147.97 28.18 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 111.4 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 14.9 mt -140.66 118.42 9.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.541 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 5.8 m120 57.03 47.5 17.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.969 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 66.2 17.28 65.75 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.236 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 75.6 m -120.91 137.13 54.74 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.753 0.276 . . . . 0.0 110.286 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.71 145.24 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.875 0.369 . . . . 0.0 110.851 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.445 ' O ' HG12 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -114.8 0.65 13.87 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.815 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.77 129.14 34.86 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 69.95 -4.12 1.57 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.633 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.02 171.12 10.02 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.965 0.412 . . . . 0.0 111.156 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 3.6 m -91.91 146.97 23.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.28 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tt -61.55 -44.91 96.18 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.887 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 23.3 p -57.5 -46.29 83.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.115 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.87 -46.31 89.98 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.003 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.69 89.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.119 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 13.7 ttt180 -70.36 -37.24 74.56 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.411 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -38.41 82.81 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.745 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 7.2 tt -59.67 -45.19 92.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 35.0 mt -68.37 -36.89 76.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.807 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -61.79 -48.25 81.48 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.786 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -25.23 66.46 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.383 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 70.7 m -74.59 78.36 1.99 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.536 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -94.21 46.94 1.18 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.185 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -165.85 -83.34 0.05 OUTLIER Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.378 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -128.03 131.36 49.16 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.291 0.236 . . . . 0.0 110.521 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.412 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -129.9 136.48 49.56 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.001 0.429 . . . . 0.0 111.285 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 12.8 tt0 -97.39 140.95 31.09 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.551 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 5.0 mt -135.92 125.09 24.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.154 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 18.8 t -114.64 133.03 62.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 30.0 m -129.05 162.42 36.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.846 0.355 . . . . 0.0 111.284 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--O 1.232 0.182 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 179.811 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.455 HG21 HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.863 0.363 . . . . 0.0 110.904 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -117.45 159.09 14.25 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.924 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.0 t -123.92 134.57 66.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.789 0.328 . . . . 0.0 111.154 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.96 116.5 30.32 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.738 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 tp -109.79 144.53 38.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.731 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.7 ttt -112.39 163.2 14.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.188 0.518 . . . . 0.0 110.837 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.079 -179.904 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.429 ' CZ ' HD21 ' B' ' 156' ' ' LEU . 43.8 m-85 -86.48 -28.19 23.6 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.089 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.34 20.42 32.57 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.625 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.78 119.35 38.65 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.666 0.233 . . . . 0.0 110.678 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -96.25 113.52 25.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.81 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -108.13 124.76 50.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.18 0.514 . . . . 0.0 111.48 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.24 -166.25 21.24 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.922 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.3 OUTLIER -146.12 145.04 30.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.836 0.318 . . . . 0.0 111.254 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -125.24 138.88 54.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.885 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.459 ' HB ' HG21 ' A' ' 54' ' ' THR . 34.9 mt -88.0 120.49 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.649 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.443 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 46.6 p90 -123.55 171.15 9.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.15 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.6 t -81.47 98.68 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.775 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.443 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 1.6 tptp -70.46 -55.53 8.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.049 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -157.06 135.97 11.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.859 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.3 ptt? -120.55 150.74 40.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 111.244 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.6 m -66.36 122.31 17.24 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.96 162.68 18.73 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.925 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.24 30.84 20.19 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.358 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.74 -161.29 16.39 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.116 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.11 -31.43 39.18 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.868 0.334 . . . . 0.0 111.809 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.88 -37.41 62.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.521 0.2 . . . . 0.0 111.117 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.89 -33.62 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.225 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -59.52 -39.37 83.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.565 0.221 . . . . 0.0 111.491 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -102.63 -34.43 9.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.38 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.77 53.81 7.0 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.743 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -75.74 -36.99 59.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.421 0.153 . . . . 0.0 111.369 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mp -129.16 138.44 51.77 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.775 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.98 145.71 25.2 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.694 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -61.38 112.36 2.15 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.208 0.528 . . . . 0.0 111.188 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.77 -10.76 18.54 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.015 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -67.53 134.66 51.7 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 117.291 0.546 . . . . 0.0 110.215 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -77.54 111.7 14.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.835 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.9 mt -77.4 138.72 19.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.051 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.7 tp -101.05 -38.05 8.34 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.24 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -149.81 148.06 28.74 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 120.943 0.401 . . . . 0.0 111.763 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 14.2 mt -139.58 118.6 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.155 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 56.86 37.08 28.57 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.31 6.66 88.85 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.594 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.6 m -114.12 138.97 49.73 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.166 0.483 . . . . 0.0 110.381 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 t -59.45 147.69 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.459 HG21 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -123.39 19.85 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.808 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.51 128.48 55.48 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 70.09 -4.38 1.54 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.606 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.5 173.89 5.49 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.937 0.399 . . . . 0.0 111.238 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.9 143.17 27.53 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.265 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -41.49 86.87 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.692 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -63.63 -39.39 94.24 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.011 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.67 -48.59 71.59 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.837 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.43 90.59 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.461 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -72.46 -37.52 68.5 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.452 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -67.89 -38.27 82.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -45.28 92.54 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.552 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.5 mt -68.58 -36.78 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.912 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -68.94 -49.48 57.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.776 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -67.07 -24.42 65.97 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.314 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 t -75.49 71.33 2.42 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.03 0.443 . . . . 0.0 110.781 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.07 91.32 8.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.39 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.84 -83.02 0.15 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.082 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.454 ' CG ' ' HB3' ' B' ' 90' ' ' MET . 5.0 mttp -136.93 122.88 20.17 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.465 0.306 . . . . 0.0 110.455 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.402 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -108.62 141.46 40.53 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 111.315 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.3 tt0 -107.98 141.68 39.26 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.848 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -135.29 125.3 25.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.982 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.6 132.12 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.373 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.36 168.35 23.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.187 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.235 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.8 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.513 HG21 HD11 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.925 0.393 . . . . 0.0 111.048 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.24 158.04 22.76 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.666 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 15.2 t -131.47 135.17 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.73 0.3 . . . . 0.0 111.391 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 tt -102.58 124.12 47.55 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.572 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 8.8 mp -106.08 124.49 49.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.758 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' MET . . . . . 0.454 ' HB3' ' CG ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -96.97 155.74 16.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.042 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 3.8 tttm . . . . . 0 C--O 1.234 0.273 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.375 -179.714 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -60.31 -26.27 66.41 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.21 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.88 21.14 54.09 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.866 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.76 122.84 38.97 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.733 0.301 . . . . 0.0 110.691 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.17 113.24 26.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.929 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -109.32 124.8 51.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.247 0.546 . . . . 0.0 111.074 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -105.09 -164.76 23.93 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.898 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.31 150.07 37.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.909 0.385 . . . . 0.0 110.831 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -130.02 135.98 48.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.819 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 20' ' ' GLY . 83.2 mt -87.91 120.89 37.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.369 . . . . 0.0 110.51 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.41 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 42.5 p90 -123.16 172.11 8.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.129 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 35.6 t -83.47 97.32 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.136 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . 0.41 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -65.31 -52.11 56.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.033 -179.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -162.31 138.49 7.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.879 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -121.66 152.48 39.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.907 0.384 . . . . 0.0 111.311 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 23.4 m -78.84 127.62 32.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.798 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 165.39 12.07 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.065 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.24 28.72 15.88 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.52 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.54 -174.94 19.97 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.318 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.04 -28.9 63.66 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.0 -35.09 62.02 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.181 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.14 -34.08 43.59 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.989 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -60.82 -38.44 85.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.563 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.25 -29.86 11.01 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.708 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.81 49.62 34.76 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.245 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -71.88 -40.3 69.02 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 mp -122.78 146.33 47.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.626 0.251 . . . . 0.0 111.045 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -104.53 139.61 39.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.584 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -55.0 112.76 1.12 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.2 0.524 . . . . 0.0 110.67 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.58 -13.44 39.09 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.391 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -62.16 138.1 58.35 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.974 0.416 . . . . 0.0 110.809 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 pp -76.77 125.65 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.641 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 20.8 mt -93.26 147.8 5.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.714 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 32.3 tp -114.9 -40.76 3.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.777 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -147.19 148.04 31.1 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.394 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 38.7 mt -141.45 118.85 8.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.215 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 8.6 m120 58.35 35.53 24.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.987 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.51 9.3 86.63 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.412 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -119.12 130.16 55.42 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 117.098 0.449 . . . . 0.0 110.395 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.22 147.03 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.101 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.435 HG21 ' CD1' ' B' ' 106' ' ' ILE . 0.0 OUTLIER -115.55 4.8 14.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.998 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.98 131.23 38.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 71.44 -4.84 1.74 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.458 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.78 171.04 9.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.997 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 38.5 t -87.01 144.4 26.92 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.11 -46.2 88.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.512 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.01 -37.16 83.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.774 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.8 -47.56 80.37 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.7 -41.84 87.23 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.935 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 76.9 ttt-85 -66.63 -39.97 88.52 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.299 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -38.15 86.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.805 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 8.3 tt -59.73 -44.31 93.83 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 39.1 mt -68.35 -37.19 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.611 0.244 . . . . 0.0 110.76 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -49.36 59.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.932 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -25.47 62.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.408 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 29.1 t -80.39 79.74 6.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.995 0.426 . . . . 0.0 110.597 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.82 126.64 35.77 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.542 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.16 -92.99 0.57 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.119 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -122.95 135.14 54.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.629 0.252 . . . . 0.0 110.717 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.429 HD21 ' CZ ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -129.58 132.31 46.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.119 0.485 . . . . 0.0 111.139 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.1 tm0? -94.58 139.09 31.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.316 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 5.5 mt -134.07 123.4 24.42 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.712 0.291 . . . . 0.0 111.009 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.91 135.71 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.465 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 18.4 m -136.13 158.57 38.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.175 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 18.9 mt . . . . . 0 CA--C 1.531 0.229 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.253 -179.823 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.4 tt . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.717 0.294 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.48 157.8 22.21 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.74 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.5 t -131.12 134.48 61.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.981 0.42 . . . . 0.0 111.351 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.39 108.59 20.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 tp -94.7 141.91 28.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.619 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 ttt -126.19 164.27 21.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.116 0.484 . . . . 0.0 111.122 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.076 -179.668 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.621 0.248 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -66.75 -28.69 68.61 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.972 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.4 19.8 37.28 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.694 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -98.49 116.57 31.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.572 0.225 . . . . 0.0 110.708 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.413 ' HB2' ' HG2' ' B' ' 110' ' ' GLU . 55.8 mtt85 -91.2 113.49 25.76 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.4 124.97 39.7 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.451 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.67 175.2 20.0 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.3 OUTLIER -137.08 144.41 43.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.033 0.416 . . . . 0.0 111.136 -179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' B' ' 104' ' ' SER . 9.8 pt20 -128.31 140.81 51.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.338 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.501 ' HB ' HG23 ' A' ' 54' ' ' THR . 15.8 mt -88.17 120.49 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -123.9 171.71 9.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.639 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.574 HG21 ' HB3' ' A' ' 40' ' ' LEU . 95.8 t -81.19 98.47 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.577 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -69.27 -57.76 4.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.356 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -156.13 139.77 16.01 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.786 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -124.83 156.42 37.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.289 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.8 p -65.26 121.54 15.02 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -58.84 145.99 38.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.064 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.2 m 64.32 32.92 11.86 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.312 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.25 -171.66 29.68 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.205 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.6 mt -69.25 -32.4 71.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.515 0.198 . . . . 0.0 111.332 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.02 -33.58 61.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.006 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.83 -34.67 45.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.044 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -63.48 -36.96 85.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.078 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -97.72 -31.6 12.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.422 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.81 50.59 10.8 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.729 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.401 ' HB2' ' CB ' ' B' ' 87' ' ' VAL . 13.3 p30 -89.32 -39.68 13.3 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.574 ' HB3' HG21 ' A' ' 25' ' ' VAL . 26.8 mt -111.72 121.18 44.41 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.668 0.27 . . . . 0.0 110.978 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 119.42 34.17 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.245 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -42.52 107.26 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.984 0.421 . . . . 0.0 111.818 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 117.02 -11.43 14.9 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.712 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -69.72 131.79 45.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.532 0.666 . . . . 0.0 111.286 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.6 pt -75.86 104.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.263 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.7 mm -66.0 141.65 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.394 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.72 -43.02 6.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.249 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -152.8 148.16 26.88 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.884 0.373 . . . . 0.0 111.588 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 41.6 mt -135.17 121.61 33.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.211 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 52.7 40.27 30.02 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.759 0.314 . . . . 0.0 111.11 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.15 17.61 78.81 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.062 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.5 m -120.37 141.64 49.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.861 0.331 . . . . 0.0 110.204 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.44 143.95 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.165 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.501 HG23 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -117.87 15.43 14.33 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.457 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.75 133.38 56.09 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 73.29 -11.57 0.89 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.328 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.466 ' HG3' ' N ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -73.8 152.92 40.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.671 0.272 . . . . 0.0 110.532 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.466 ' N ' ' HG3' ' A' ' 57' ' ' MET . 48.0 t -71.3 144.7 49.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.005 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tt -54.7 -42.32 71.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.753 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.24 -38.27 76.54 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.023 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.66 -47.83 77.01 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.839 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.36 -42.15 90.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.908 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.17 -40.09 90.22 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.66 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -64.88 -39.71 93.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -43.29 97.97 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 7.8 mt -68.61 -37.71 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.797 0.332 . . . . 0.0 110.656 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -69.05 -49.15 60.01 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -20.09 65.62 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.456 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -75.74 68.96 2.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.955 0.407 . . . . 0.0 110.915 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.28 109.14 14.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.49 -82.93 0.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.068 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 141.89 49.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.615 0.245 . . . . 0.0 110.673 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.521 HD21 ' CZ ' ' B' ' 98' ' ' TYR . 1.2 pt? -130.36 132.42 45.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.879 0.371 . . . . 0.0 111.475 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 52.9 tt0 -98.67 127.93 44.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.411 ' HG ' HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -125.34 129.44 49.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.822 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.95 131.94 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.532 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.47 138.87 48.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.492 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 tt . . . . . 0 C--O 1.233 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.653 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 10.8 tt . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.798 0.332 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.22 156.46 17.33 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.577 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.401 ' CB ' ' HB2' ' A' ' 39' ' ' ASN . 17.7 t -132.62 134.52 58.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.718 0.294 . . . . 0.0 111.103 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 107.03 17.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.536 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.41 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 16.9 tp -99.89 140.52 33.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.451 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 51.1 ttm -120.96 161.77 21.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.201 0.524 . . . . 0.0 110.783 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.824 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.961 0.41 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . 0.521 ' CZ ' HD21 ' A' ' 73' ' ' LEU . 69.2 m-85 -73.56 -30.18 62.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.228 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.06 23.44 35.01 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.68 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 mp -103.61 122.27 44.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.758 0.279 . . . . 0.0 110.522 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -102.66 113.56 27.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.303 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 9.4 mp -98.16 124.78 42.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.949 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.48 -176.36 24.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.772 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -136.09 146.19 46.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.823 0.344 . . . . 0.0 111.0 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 21' ' ' SER . 8.9 pt20 -126.82 139.71 52.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.324 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.505 ' CD1' HG23 ' B' ' 137' ' ' THR . 50.2 mt -88.19 120.5 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.407 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -121.41 172.44 8.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.954 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 38.3 t -81.73 96.24 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.117 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -58.05 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.884 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 18' ' ' ARG . 1.7 pt-20 -157.24 137.74 13.01 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -119.79 161.44 20.76 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 111.68 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 51.9 m -78.46 140.31 38.64 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.33 152.24 36.44 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.103 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 64.88 16.59 10.58 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.168 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.31 -168.46 41.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.224 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.69 -27.32 58.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.8 -37.98 62.23 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.587 0.232 . . . . 0.0 111.213 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -33.74 43.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.827 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.0 -38.49 86.24 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.333 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.32 -37.6 9.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.222 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.08 55.7 3.46 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.309 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.98 -45.52 5.16 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.409 0.147 . . . . 0.0 111.377 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mp -85.25 119.92 26.17 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.79 0.328 . . . . 0.0 110.672 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.44 125.54 42.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.43 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -56.42 107.69 0.4 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.065 0.46 . . . . 0.0 110.916 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.13 -14.15 44.33 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.024 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.78 137.34 58.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.042 0.449 . . . . 0.0 110.983 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.75 105.19 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.288 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 7.8 mt -71.78 143.98 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.82 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 19.3 tp -105.81 -33.68 7.91 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.878 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -155.73 148.09 23.73 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.79 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 24.2 mt -137.95 117.73 15.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.146 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . 0.416 ' OD1' ' HB2' ' B' ' 156' ' ' LEU . 6.3 m120 56.73 36.81 28.22 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.043 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.5 13.74 82.21 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.305 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.5 m -120.45 128.46 53.19 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.922 0.361 . . . . 0.0 110.4 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.37 144.46 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 111.208 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.505 HG23 ' CD1' ' B' ' 106' ' ' ILE . 0.0 OUTLIER -109.16 11.28 25.65 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.595 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.79 132.98 44.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 72.47 -11.62 0.8 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.657 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -64.07 168.45 5.33 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 111.141 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.38 148.22 22.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.257 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.22 -42.88 82.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.861 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 69.4 p -63.03 -39.81 95.86 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.176 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -41.53 97.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.035 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.91 -44.57 91.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.868 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -69.91 -36.6 75.49 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.506 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -67.85 -39.28 83.83 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.766 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.81 -42.42 98.99 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.785 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 14.7 mt -68.3 -38.16 79.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.589 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.16 -49.36 57.54 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.709 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -65.42 -25.86 67.72 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.236 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 10.7 t -84.44 63.41 7.81 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.015 0.436 . . . . 0.0 110.575 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.81 103.91 8.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.274 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 141.69 -93.11 0.18 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.088 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -123.8 126.98 47.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.543 0.211 . . . . 0.0 110.963 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.416 ' HB2' ' OD1' ' B' ' 133' ' ' ASN . 1.2 pp -124.18 126.89 46.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.999 0.428 . . . . 0.0 111.353 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.8 mt-30 -94.45 141.49 28.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.219 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 3.7 tt -137.33 140.51 41.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.034 0.445 . . . . 0.0 111.536 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 25.3 t -120.08 134.59 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.278 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.71 159.34 31.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.753 0.311 . . . . 0.0 111.309 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.8 tt . . . . . 0 C--O 1.234 0.241 0 CA-C-O 120.725 0.298 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -128.86 157.28 21.49 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.906 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' B' ' 122' ' ' ASN . 21.9 t -132.12 133.66 60.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.743 0.306 . . . . 0.0 111.193 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 mt -98.19 111.67 23.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.784 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 tp -102.16 134.11 45.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.394 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.4 ttm -109.11 164.16 12.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.643 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.729 -179.905 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.614 0.245 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.485 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 62.7 m-85 -52.2 -27.4 14.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.776 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.71 18.16 62.27 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.431 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.75 115.14 27.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.715 0.293 . . . . 0.0 110.287 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -93.32 113.47 25.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.849 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -105.97 124.92 50.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 111.565 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -109.42 -176.81 21.33 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.55 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.34 146.46 35.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.905 0.353 . . . . 0.0 111.067 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -127.27 135.52 50.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.492 ' HB ' HG21 ' A' ' 54' ' ' THR . 42.2 mt -87.91 120.56 37.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.002 0.43 . . . . 0.0 110.557 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -123.71 172.57 8.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.062 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.0 t -82.37 100.15 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.795 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -70.66 -59.68 2.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.399 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.7 136.05 20.3 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.753 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 13.0 ptp -122.1 151.4 40.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.892 0.377 . . . . 0.0 111.211 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -65.53 134.34 53.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -71.86 146.95 47.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.773 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.27 33.58 14.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.258 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.78 -171.75 26.57 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.272 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -31.6 68.83 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.646 0.223 . . . . 0.0 111.423 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.93 -34.26 62.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.261 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.09 -34.0 43.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.079 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -64.06 -36.63 84.62 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.336 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.48 -30.5 11.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.421 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.36 45.26 61.39 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.281 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -74.61 -38.55 62.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.508 0.194 . . . . 0.0 111.391 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.6 mt -128.43 133.86 48.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.924 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.88 148.32 24.58 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.593 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -59.33 112.23 1.66 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.097 0.475 . . . . 0.0 111.001 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.26 -15.84 20.25 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.394 -0.821 . . . . 0.0 113.177 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -63.04 133.69 54.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.242 0.521 . . . . 0.0 110.285 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 pt -81.8 104.69 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 46' ' ' ILE . 64.4 mt -65.35 148.63 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.031 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.85 -45.81 4.1 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.6 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -149.27 148.16 29.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 111.768 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.446 ' CD1' HG22 ' A' ' 54' ' ' THR . 26.6 mt -129.74 118.06 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.496 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 m120 49.99 32.19 5.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.642 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.51 16.46 58.63 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.199 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.6 m -120.79 135.83 55.05 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.869 0.334 . . . . 0.0 110.355 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -57.83 142.38 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.848 0.356 . . . . 0.0 111.295 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.492 HG21 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -119.39 16.79 13.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.401 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.87 129.33 52.5 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 71.56 -6.6 1.37 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.255 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.03 173.95 4.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.937 0.399 . . . . 0.0 111.043 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.77 135.89 33.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.63 -43.08 79.9 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.889 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 43.4 p -64.72 -39.07 93.01 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.064 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.32 -47.99 68.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.816 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.37 -40.17 95.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.756 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -62.78 -39.79 95.3 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.447 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -65.35 -38.35 89.82 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.981 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -46.33 89.45 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.668 0.271 . . . . 0.0 110.745 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 mp -69.04 -36.49 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.841 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.6 -46.36 69.53 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.155 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -64.05 -28.22 69.64 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.0 t -78.53 88.8 4.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.959 0.409 . . . . 0.0 110.76 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -99.16 40.45 1.21 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.456 ' O ' ' HD2' ' B' ' 91' ' ' LYS . . . -151.37 -88.17 0.07 OUTLIER Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.284 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -129.46 122.16 28.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.619 0.247 . . . . 0.0 110.474 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.97 136.37 53.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.031 0.443 . . . . 0.0 111.116 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 22.1 tt0 -100.96 134.41 44.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.506 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 mt -127.4 137.94 52.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.015 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.3 t -120.16 139.55 47.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.7 t -115.34 142.49 28.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.183 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.6 tt . . . . . 0 C--O 1.233 0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 179.528 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.233 0.236 0 CA-C-O 120.53 0.205 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.22 158.63 27.3 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.923 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.43 135.18 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 111.021 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.77 107.46 18.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tp -90.71 136.49 33.03 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.871 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 9.9 ttm -104.32 164.85 11.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 111.005 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . 0.456 ' HD2' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.128 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 120.696 0.284 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -58.41 -27.62 64.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.652 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.87 14.39 55.08 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.525 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 8.4 mp -101.55 119.94 39.55 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.746 0.308 . . . . 0.0 110.655 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -101.79 113.56 26.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.156 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -102.93 125.02 49.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 111.301 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.67 -170.81 20.31 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.377 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.59 152.16 38.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.979 0.389 . . . . 0.0 110.887 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -128.88 138.64 52.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.13 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.476 ' HB ' HG23 ' B' ' 137' ' ' THR . 26.8 mt -88.08 120.49 37.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.447 . . . . 0.0 110.492 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -121.69 173.23 7.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.044 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 46.1 t -82.51 98.03 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.046 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -44.98 71.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.039 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -155.0 160.91 41.43 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.947 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 18.1 mtp -138.13 162.13 35.02 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 111.136 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 5.7 p -95.9 124.39 39.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.643 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 160.51 19.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.03 0.443 . . . . 0.0 110.866 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 58.13 22.84 9.49 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.02 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -103.31 -172.04 26.02 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.203 -0.523 . . . . 0.0 111.961 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.24 -29.59 64.07 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.39 63.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.559 0.218 . . . . 0.0 111.077 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.23 -34.03 43.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.246 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -57.81 -39.76 78.37 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.444 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -104.14 -36.16 7.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.028 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.2 53.34 5.7 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.756 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . 0.424 ' HB2' ' CG2' ' A' ' 4' ' ' VAL . 8.5 p-10 -84.49 -36.5 22.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mt -115.44 128.02 55.74 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.735 0.302 . . . . 0.0 111.218 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.77 140.37 34.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.351 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -57.27 110.43 0.84 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.068 0.461 . . . . 0.0 111.33 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 115.47 -16.44 16.98 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.264 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.09 132.68 54.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.389 0.594 . . . . 0.0 110.499 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 pt -79.15 106.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.854 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 36.8 mm -71.15 146.5 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.247 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 9.7 tp -109.5 -43.09 4.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.323 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.31 147.91 34.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.785 0.326 . . . . 0.0 111.461 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 24.6 mt -137.86 118.14 16.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.39 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 m120 56.79 37.34 28.74 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.102 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.17 16.36 80.76 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.985 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -120.73 142.72 49.26 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.82 0.31 . . . . 0.0 110.21 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.75 144.47 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.003 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.476 HG23 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -122.64 19.64 10.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.313 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' B' ' 140' ' ' MET . 0.6 OUTLIER -112.0 142.15 44.77 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.365 179.608 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 53.15 9.08 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.218 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 140' ' ' MET . . . . . 0.411 ' H ' ' C ' ' B' ' 138' ' ' GLU . 0.0 OUTLIER -77.23 176.12 9.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 111.268 179.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 47.2 t -91.93 142.74 27.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.09 -45.14 95.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.896 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 10.0 t -65.29 -37.14 86.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.845 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.2 -47.89 66.67 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.82 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.42 97.36 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.843 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -61.68 -41.13 97.15 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.274 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -38.31 90.58 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.943 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 9.3 tt -59.6 -45.87 90.65 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.556 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.63 -36.72 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.795 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.94 -49.06 61.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.819 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -26.9 67.54 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.419 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 32.4 t -75.1 71.83 2.18 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.138 0.494 . . . . 0.0 110.634 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -86.57 97.9 10.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.328 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 147.46 -85.01 0.17 Allowed Glycine 0 C--O 1.228 -0.275 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.244 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 131.1 37.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.646 0.26 . . . . 0.0 110.682 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.485 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.59 143.64 51.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.002 0.429 . . . . 0.0 111.545 -179.565 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 32.7 tt0 -103.16 142.44 34.14 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.403 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 mp -136.24 128.34 29.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 110.951 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -117.09 134.01 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 22.6 m -124.44 156.32 32.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.195 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.914 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.719 0.295 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.12 157.79 22.84 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.507 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.5 t -131.55 134.99 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.302 . . . . 0.0 111.368 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.5 107.24 18.9 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.512 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 tp -95.27 127.79 41.6 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.692 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 ttt -106.99 165.67 11.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.954 0.407 . . . . 0.0 110.945 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.1 pttt . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.016 179.843 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.586 0.231 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -60.13 -30.17 69.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.557 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.88 28.09 39.26 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.338 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.59 120.54 42.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.673 0.273 . . . . 0.0 110.62 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.68 114.82 27.47 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.399 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.09 124.92 42.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.153 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -110.23 177.88 19.83 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.764 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.11 146.66 49.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.067 0.434 . . . . 0.0 111.321 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -129.59 139.18 51.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.109 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.418 ' HB ' HG21 ' A' ' 54' ' ' THR . 55.9 mt -88.11 120.41 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.036 0.446 . . . . 0.0 110.71 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -121.18 172.44 7.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.912 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.92 93.76 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.967 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -50.68 63.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.928 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.412 ' HB3' ' HD3' ' B' ' 101' ' ' ARG . 6.3 tt0 -158.47 151.82 23.01 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.985 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.48 146.01 41.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.122 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.5 p -65.56 121.41 14.85 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.959 0.409 . . . . 0.0 110.767 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 151.08 22.1 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.101 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.05 31.74 13.34 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.281 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.76 -168.07 26.32 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.43 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 mt -70.32 -34.33 72.56 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 110.686 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.02 -33.7 61.81 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.896 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.1 -34.43 43.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.019 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.73 -38.76 82.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.406 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.9 -26.27 12.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.709 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.56 50.53 54.18 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.051 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.403 ' HB3' ' CG2' ' B' ' 87' ' ' VAL . 16.6 m-80 -78.19 -34.19 49.65 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.401 HD21 HG11 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -129.07 137.41 51.25 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.672 0.272 . . . . 0.0 110.897 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 143.0 32.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.74 113.44 1.65 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 111.344 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.4 -17.44 14.2 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.845 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.57 136.98 58.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.094 0.473 . . . . 0.0 110.999 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -81.19 109.86 15.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.575 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.3 mt -79.93 145.2 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.217 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -110.87 -27.29 8.89 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.007 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.25 147.97 19.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.263 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 28.8 mt -142.32 117.9 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.739 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 51.09 33.41 9.18 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.306 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.43 83.17 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.609 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -105.16 129.02 53.65 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 117.141 0.47 . . . . 0.0 110.443 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.42 146.81 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.392 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.418 HG21 ' HB ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -105.35 -10.52 16.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.487 179.518 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.84 142.33 27.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 p30 53.39 9.44 0.16 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.668 0.605 . . . . 0.0 112.271 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 ttm -90.43 149.66 22.15 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.675 0.274 . . . . 0.0 110.596 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 m -71.71 139.22 49.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.762 0.315 . . . . 0.0 111.14 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.1 tp -57.93 -42.68 85.34 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.396 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.8 m -56.98 -38.27 72.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.756 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -68.46 -47.93 65.86 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.533 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.04 -40.5 93.86 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.423 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -69.8 -38.44 76.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.5 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -38.34 85.47 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.52 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -44.5 94.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.873 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.6 mt -68.26 -37.49 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.72 0.295 . . . . 0.0 110.698 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.06 -37.96 78.8 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.946 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -89.8 1.42 56.17 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.1 p -90.94 56.52 3.23 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.196 0.522 . . . . 0.0 110.842 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.82 100.23 1.5 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.829 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.24 -91.52 0.17 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.273 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.65 135.44 47.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.571 0.224 . . . . 0.0 110.719 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.31 130.31 45.97 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.949 0.404 . . . . 0.0 111.009 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 15.8 mt-30 -98.05 142.44 29.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.785 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.38 127.93 40.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.908 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.02 142.77 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.6 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.401 HG11 HD21 ' A' ' 40' ' ' LEU . 34.1 m -136.12 158.55 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.178 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 tp . . . . . 0 C--O 1.233 0.228 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.952 -179.94 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . 0.497 HG23 HD11 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.651 0.262 . . . . 0.0 110.844 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -151.55 159.92 28.49 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.938 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . 0.403 ' CG2' ' HB3' ' A' ' 39' ' ' ASN . 7.1 t -129.17 134.7 63.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.707 0.289 . . . . 0.0 111.262 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 9.7 tt -101.95 125.54 48.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.05 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 9.1 mp -112.35 124.72 53.1 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.966 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.3 ttt -116.07 159.26 21.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.632 0.73 . . . . 0.0 112.005 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.522 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.388 0.613 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -94.11 -29.39 15.19 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.468 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.94 29.72 58.6 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.884 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.73 125.5 51.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.646 0.26 . . . . 0.0 110.756 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . 0.412 ' HD3' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -108.09 114.61 28.63 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.012 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . 0.406 ' HB3' ' CG2' ' A' ' 23' ' ' ILE . 3.6 mp -89.38 128.5 35.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.264 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.16 168.48 13.36 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.601 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 2.4 p -127.66 149.93 49.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.036 0.446 . . . . 0.0 111.196 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . 0.436 ' NE2' HG22 ' B' ' 128' ' ' ILE . 6.9 pt20 -132.72 137.02 46.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.97 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.456 ' HB ' HG22 ' B' ' 137' ' ' THR . 69.4 mt -88.0 120.55 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 121.112 0.482 . . . . 0.0 110.482 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -122.82 172.79 8.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.972 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 39.3 t -80.42 95.96 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.778 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -65.69 -55.96 14.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.918 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.19 144.8 17.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.003 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -136.15 155.44 50.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.936 0.398 . . . . 0.0 111.394 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 11.8 p -78.62 124.59 28.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 ttp-105 -65.06 166.0 10.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.82 31.86 18.24 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.19 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -112.23 -158.05 13.91 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.259 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 2.0 mp -84.99 -29.96 24.59 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.526 0.203 . . . . 0.0 111.451 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.15 -37.49 61.33 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.634 0.254 . . . . 0.0 111.33 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -33.64 44.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.089 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -57.27 -40.86 78.59 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.198 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -102.09 -28.61 12.23 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.661 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.22 24.24 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.152 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -74.22 -47.25 36.62 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 6.6 mp -123.68 123.41 40.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.673 0.273 . . . . 0.0 110.842 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.41 150.52 21.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.769 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -59.46 111.09 1.26 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.08 0.467 . . . . 0.0 111.082 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.83 -18.76 19.18 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 115.41 -0.813 . . . . 0.0 113.26 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -59.14 135.41 57.63 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.236 0.518 . . . . 0.0 110.701 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.436 HG22 ' NE2' ' B' ' 105' ' ' GLN . 4.0 pt -81.77 113.7 21.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.196 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.431 HG23 ' CD1' ' B' ' 132' ' ' ILE . 5.7 mt -81.95 147.23 6.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.522 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 6.8 tt -110.25 -40.83 4.57 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.582 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -147.57 148.9 31.64 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.836 0.35 . . . . 0.0 111.937 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 32.6 mm -133.78 117.97 28.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 52.28 33.71 13.23 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.547 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.56 4.79 79.6 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.57 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 91.3 m -113.57 133.72 55.1 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 117.076 0.438 . . . . 0.0 110.464 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.1 146.16 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.456 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -125.78 25.09 6.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.47 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.03 130.88 55.99 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.073 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 70.8 -4.44 1.71 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.425 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.22 172.05 5.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.79 0.328 . . . . 0.0 111.007 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 43.4 t -88.34 145.33 25.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.375 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -40.84 83.24 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.848 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -39.21 86.62 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.81 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -65.57 -47.18 76.66 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.835 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.69 -40.94 94.05 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.15 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -69.52 -38.0 77.39 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.637 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -65.85 -40.1 91.39 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.947 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.03 -43.84 98.29 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.678 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 14.0 mt -68.32 -37.4 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.762 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -68.22 -49.58 59.77 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.044 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -68.39 -22.86 64.61 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.466 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.8 m -76.28 68.15 2.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.018 0.437 . . . . 0.0 110.771 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.13 91.31 7.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.467 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 155.85 -94.7 0.14 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.298 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -126.42 132.31 51.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.624 0.25 . . . . 0.0 110.406 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.456 ' CD1' ' HG ' ' B' ' 158' ' ' LEU . 1.3 pp -128.69 144.14 51.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.482 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 21.9 tt0 -111.05 143.05 42.37 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.633 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.456 ' HG ' ' CD1' ' B' ' 156' ' ' LEU . 0.5 OUTLIER -133.82 128.2 34.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.679 0.276 . . . . 0.0 110.969 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 12.9 t -112.2 131.89 62.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.519 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.0 143.46 40.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.889 0.376 . . . . 0.0 111.496 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.203 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.775 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.865 0.364 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.37 165.13 12.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.667 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.97 134.71 62.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 120.653 0.264 . . . . 0.0 111.116 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 mt -99.86 106.85 18.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.751 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tp -100.94 127.52 47.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.452 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.67 159.53 14.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.823 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.832 0.349 . . . . 0.0 110.971 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 121.028 0.442 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.5 ' CZ ' HD23 ' B' ' 156' ' ' LEU . 70.0 m-85 -63.58 -30.45 71.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.158 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.75 22.59 33.1 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.667 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.71 118.31 36.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.827 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.16 113.54 25.33 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.274 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.71 124.95 42.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.152 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -115.21 -172.77 17.37 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.778 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.09 151.36 39.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.813 0.34 . . . . 0.0 110.935 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -133.11 134.47 44.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.963 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.481 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 50.0 mt -87.82 120.18 36.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.061 0.458 . . . . 0.0 110.15 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -123.31 171.2 9.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.913 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.9 t -84.6 97.04 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.087 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -40.17 96.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.916 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -170.22 156.42 5.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.02 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -138.37 157.24 46.62 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.862 0.363 . . . . 0.0 111.159 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.43 126.53 28.54 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -62.07 145.03 54.4 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.77 33.26 22.69 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.472 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.59 -167.71 31.08 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.321 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 mt -67.23 -35.59 79.88 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.581 0.229 . . . . 0.0 111.211 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.08 -35.19 61.82 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.163 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.84 -33.87 45.62 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.022 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -40.23 81.83 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.245 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.1 -27.62 12.81 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.73 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.61 43.75 51.46 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.035 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -59.71 -48.91 79.8 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.43 147.28 43.14 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.697 0.284 . . . . 0.0 110.91 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 156.68 16.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.519 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -71.46 121.95 19.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.492 0.663 . . . . 0.0 109.898 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.41 3.24 35.38 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.948 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -85.94 135.14 33.79 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.419 0.609 . . . . 0.0 110.485 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.88 112.21 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.022 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.7 mt -79.04 146.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.502 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.4 tp -102.57 -43.95 5.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.394 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -151.93 150.98 30.65 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 111.372 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 28.3 mt -140.91 118.09 8.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.726 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 m120 54.44 33.72 19.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.125 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.0 -2.39 87.05 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.123 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.1 m -104.64 126.46 51.75 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.985 0.393 . . . . 0.0 110.385 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.37 146.19 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.881 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.481 ' CG2' ' HB ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.96 14.05 18.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.566 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.404 ' C ' ' H ' ' A' ' 57' ' ' MET . 0.5 OUTLIER -106.91 132.92 52.32 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.343 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.403 ' HB2' ' CD1' ' B' ' 142' ' ' LEU . 10.1 p30 53.18 8.89 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 123.672 0.608 . . . . 0.0 112.579 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.404 ' H ' ' C ' ' A' ' 55' ' ' GLU . 31.2 tpp -82.69 161.06 22.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.686 0.279 . . . . 0.0 110.831 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.91 128.21 35.03 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.987 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 tt -53.15 -42.57 66.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -61.65 -38.49 87.93 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.221 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.04 -48.05 77.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.939 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.34 90.39 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.061 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -71.03 -35.47 72.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.654 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.1 tpmp? -66.5 -40.73 89.38 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.026 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.66 -41.79 99.26 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.868 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.8 mt -68.3 -38.06 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.033 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -48.99 62.44 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -64.19 -26.59 68.59 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.062 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.4 t -83.97 93.34 8.04 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.797 0.332 . . . . 0.0 110.707 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.48 40.38 1.27 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -143.71 -87.68 0.09 OUTLIER Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.273 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.65 133.52 50.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.758 -0.221 . . . . 0.0 110.558 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.464 HD21 ' CZ ' ' B' ' 98' ' ' TYR . 0.8 OUTLIER -125.03 134.02 52.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.044 0.45 . . . . 0.0 111.369 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -97.65 141.08 31.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.464 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.12 124.6 22.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.73 0.3 . . . . 0.0 110.856 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.5 143.51 30.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.218 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 m -127.47 154.75 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.056 0.455 . . . . 0.0 111.705 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.6 tp . . . . . 0 C--O 1.233 0.209 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.534 179.451 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.733 0.301 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.4 158.63 22.18 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.618 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 20.9 t -129.76 134.52 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.652 0.263 . . . . 0.0 111.292 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 8.8 tt -99.82 110.06 22.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.344 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 2.8 tp -99.37 143.14 29.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.66 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 21.8 ttt -117.72 162.75 17.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.206 0.527 . . . . 0.0 111.316 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.001 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 CA--C 1.533 0.305 0 CA-C-O 120.823 0.344 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' TYR . . . . . 0.464 ' CZ ' HD21 ' A' ' 73' ' ' LEU . 58.8 m-85 -63.82 -27.06 68.92 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.207 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.76 22.17 37.35 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.727 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 mp -104.22 125.55 50.59 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.747 0.308 . . . . 0.0 110.552 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -105.97 113.82 27.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.21 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -106.66 124.96 50.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.192 0.52 . . . . 0.0 111.642 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -105.71 -165.15 23.39 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.978 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.67 148.86 33.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.825 0.345 . . . . 0.0 111.17 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -132.45 139.03 47.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.153 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' ILE . . . . . 0.531 ' HB ' ' CG2' ' B' ' 137' ' ' THR . 10.8 mt -88.19 120.62 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 110.588 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -122.42 171.98 8.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.181 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 29.7 t -82.08 98.04 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.806 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.03 -53.26 40.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.195 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . 0.4 ' HA ' ' HG2' ' B' ' 125' ' ' GLU . 2.6 pt-20 -162.06 138.67 8.04 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.927 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.2 161.35 19.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 111.31 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.5 p -78.03 120.26 22.61 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.65 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -61.34 149.28 38.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.157 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.2 m 67.67 25.51 8.14 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.377 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.18 -171.18 27.24 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.42 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -29.32 62.88 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.07 -34.42 61.78 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.124 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 1.2 p -78.94 -34.15 44.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.95 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -38.63 83.76 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.358 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -102.02 -31.2 10.77 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.401 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.26 45.96 28.83 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.251 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -75.68 -39.28 57.81 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.539 0.17 . . . . 0.0 111.4 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' LEU . . . . . 0.418 HD12 ' HG ' ' B' ' 158' ' ' LEU . 16.2 mt -121.82 121.86 38.16 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.994 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.48 147.31 23.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' B' ' 110' ' ' GLU . 4.8 mt-10 -59.45 111.22 1.31 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.955 0.407 . . . . 0.0 111.17 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.31 -16.33 24.68 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.46 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -58.13 134.35 56.39 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.408 0.604 . . . . 0.0 110.777 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 8.5 pt -83.74 99.79 6.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.601 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 9.9 mt -66.78 136.74 26.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.246 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 tp -96.09 -42.13 8.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.619 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -146.23 147.79 31.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.764 0.316 . . . . 0.0 111.548 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 34.2 mt -134.9 117.93 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.757 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 50.9 44.18 28.35 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.494 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.22 18.42 78.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.008 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 30.6 m -120.72 142.22 49.71 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.81 146.08 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.982 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 137' ' ' THR . . . . . 0.531 ' CG2' ' HB ' ' B' ' 106' ' ' ILE . 1.4 m -120.98 16.94 11.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.917 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -117.45 131.34 56.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 71.12 -6.55 1.29 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.554 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.2 171.49 5.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.002 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 20.8 m -87.35 139.6 30.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.218 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 142' ' ' LEU . . . . . 0.403 ' CD1' ' HB2' ' A' ' 56' ' ' ASN . 9.0 tt -56.01 -44.87 79.11 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 58.1 p -61.91 -40.2 94.64 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.805 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -62.97 -48.08 80.42 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.19 -42.03 85.23 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.071 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -69.49 -37.46 77.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.746 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -68.11 -39.4 82.81 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.661 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.92 -43.8 94.69 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.675 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 11.7 mt -68.27 -37.58 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.837 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.78 -49.68 56.65 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -21.64 63.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.294 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 37.8 t -82.2 66.48 7.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.13 0.491 . . . . 0.0 110.532 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -77.24 122.78 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 126.01 -92.09 0.4 Allowed Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.158 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.59 133.72 48.4 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 156' ' ' LEU . . . . . 0.5 HD23 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -124.3 143.01 50.81 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.925 0.393 . . . . 0.0 111.357 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 2.6 tt0 -105.23 131.67 52.4 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.849 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 158' ' ' LEU . . . . . 0.43 ' CD1' HG22 ' B' ' 132' ' ' ILE . 0.4 OUTLIER -127.78 133.47 49.46 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.82 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.29 140.1 44.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.669 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 9.0 m -133.24 152.02 34.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.421 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--O 1.233 0.216 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 179.727 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.4 mtm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.714 0.292 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.55 124.38 7.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.343 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.28 157.48 21.47 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.402 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.35 134.03 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.708 0.29 . . . . 0.0 111.288 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.0 mp -103.13 115.02 29.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.508 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 tp -104.98 126.28 51.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.709 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.16 161.41 13.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.743 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -98.27 132.16 43.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.983 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.3 m -126.55 34.81 4.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.936 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -159.15 120.75 3.37 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.527 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.1 43.26 1.09 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.96 0.41 . . . . 0.0 111.241 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -111.8 -39.93 4.43 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.011 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -157.53 -178.15 7.12 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.911 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -74.04 -175.7 2.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.535 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -58.24 -23.15 54.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.346 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.93 27.53 68.6 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.432 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.06 120.84 41.39 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.631 0.253 . . . . 0.0 110.782 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.48 113.36 25.35 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.1 mp -105.99 124.95 50.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 111.215 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.19 178.31 19.49 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.637 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.6 OUTLIER -139.99 142.92 36.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.152 0.476 . . . . 0.0 111.205 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' B' ' 104' ' ' SER . 11.0 pt20 -129.31 154.42 46.88 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.673 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.513 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 3.2 mt -90.32 120.77 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.378 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.406 ' CE1' ' CG ' ' B' ' 105' ' ' GLN . 39.9 p90 -118.31 173.02 7.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.558 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.426 HG22 HD21 ' A' ' 40' ' ' LEU . 21.5 t -79.16 94.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.102 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -48.94 71.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -167.01 153.74 8.54 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.907 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.37 161.47 34.43 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.834 0.35 . . . . 0.0 111.063 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -70.55 135.66 48.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.002 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -68.91 144.75 54.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.707 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 58.06 31.02 20.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.337 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.78 -174.35 29.37 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.165 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.22 -31.06 71.17 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.15 -39.06 60.7 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.568 0.223 . . . . 0.0 111.452 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -33.71 44.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.167 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -63.28 -37.06 85.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.382 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -100.3 -30.91 11.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.684 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.25 47.14 24.25 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.341 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -63.07 -48.33 79.12 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.46 0.171 . . . . 0.0 111.319 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.426 HD21 HG22 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -134.06 144.29 48.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.723 0.296 . . . . 0.0 111.21 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 148.24 22.35 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.629 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -59.01 110.91 1.13 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 111.234 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.75 -16.4 21.15 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.191 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -60.39 134.71 57.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.244 0.522 . . . . 0.0 110.704 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.8 pt -79.86 119.86 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.961 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.434 ' HB ' HG22 ' A' ' 54' ' ' THR . 38.0 mt -88.97 137.54 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.961 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.82 -41.82 8.27 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.329 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.68 147.67 34.62 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.744 0.306 . . . . 0.0 111.069 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.42 ' CG1' HG21 ' A' ' 46' ' ' ILE . 14.7 mt -136.65 117.94 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.676 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 52.25 44.54 29.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 111.224 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.17 17.86 76.15 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.042 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.3 m -120.74 139.39 53.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.759 0.28 . . . . 0.0 110.374 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.8 145.86 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.149 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.513 ' CG2' ' HB ' ' A' ' 23' ' ' ILE . 2.5 m -120.69 20.89 11.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.686 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -119.33 129.65 54.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 70.66 -7.67 1.02 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.57 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 10.5 ttt -66.07 150.66 48.36 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.808 0.337 . . . . 0.0 110.622 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.9 t -71.8 143.47 49.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.079 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.73 -46.19 84.78 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -40.43 82.37 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.055 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -64.08 -47.64 79.31 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.006 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.25 -41.55 89.02 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.003 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -37.96 81.74 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.635 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -38.68 83.18 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.733 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.87 -43.32 94.79 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.923 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 14.3 mt -68.18 -37.84 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.546 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -66.83 -49.56 65.38 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.781 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -68.77 -22.22 64.3 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.437 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.9 t -74.87 73.15 2.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.034 0.445 . . . . 0.0 110.704 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.26 105.84 16.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.474 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.1 -91.19 0.21 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.239 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -129.34 134.11 47.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.735 0.302 . . . . 0.0 110.652 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.1 pp -123.47 143.96 49.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -112.22 140.48 46.88 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.867 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.42 128.64 31.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.861 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.0 t -109.74 138.84 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.939 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.2 t -121.13 154.31 24.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.288 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 tt -108.76 116.33 31.78 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.511 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 60.27 173.04 0.09 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.187 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t70 65.58 113.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.39 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.3 -63.11 0.91 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.502 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.06 -72.58 0.66 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.747 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 C--O 1.252 1.204 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.497 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 5.9 mtt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.481 HG21 HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -122.6 121.54 63.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.876 0.369 . . . . 0.0 111.007 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.02 157.69 15.55 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.791 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 t -131.58 135.31 59.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.769 0.318 . . . . 0.0 111.313 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 mp -104.47 114.94 29.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.62 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 tp -102.16 133.36 47.13 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.978 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 5.7 ttm -105.06 164.47 11.78 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.036 0.446 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -87.93 148.01 24.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.908 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 3.0 p -79.53 171.05 15.68 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.642 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -77.31 70.24 3.68 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.218 0.532 . . . . 0.0 110.556 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -174.93 132.76 0.33 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.323 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -63.44 95.9 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.787 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.32 177.52 6.77 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.229 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -98.96 -179.79 4.38 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -77.0 -32.12 56.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.394 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.73 26.83 55.57 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.394 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 6.2 mp -104.83 123.12 47.13 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.03 113.68 25.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.245 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 mp -98.26 124.69 43.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.983 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.88 166.21 12.14 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.918 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 1.6 p -121.07 150.71 40.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.028 0.414 . . . . 0.0 111.244 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -137.49 145.38 42.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.459 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.505 ' HB ' ' CG2' ' B' ' 137' ' ' THR . 2.6 mt -88.86 121.14 38.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.175 0.512 . . . . 0.0 111.324 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -118.78 174.54 6.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.568 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' B' ' 123' ' ' LEU . 39.0 t -83.37 95.57 3.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.135 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -63.32 -56.33 17.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 110.573 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -163.99 146.26 9.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -133.37 156.02 48.4 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.804 0.335 . . . . 0.0 111.349 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.26 132.49 49.2 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -67.57 147.82 52.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.929 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 5.2 m 61.85 33.78 17.45 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.243 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.38 -170.31 28.08 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.146 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 7.4 mt -72.84 -30.06 63.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.676 0.238 . . . . 0.0 111.477 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.18 -36.73 61.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.173 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.79 -33.86 52.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -61.57 -38.43 87.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.217 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.88 -28.29 13.18 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.763 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.55 39.07 50.67 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.266 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -59.51 -42.4 92.12 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.428 ' HB3' ' CG2' ' B' ' 108' ' ' VAL . 1.1 mt -133.05 143.87 49.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.766 0.317 . . . . 0.0 111.171 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.04 141.39 28.59 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.56 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -58.19 109.71 0.81 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.104 0.478 . . . . 0.0 110.789 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 108' ' ' VAL . . . 104.99 -15.75 47.47 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.592 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -62.54 141.97 58.19 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.172 0.511 . . . . 0.0 111.459 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 29.6 pt -79.8 127.96 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.898 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 26.8 mt -94.91 143.79 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.425 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.46 -36.63 10.28 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.629 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -154.81 152.43 29.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.627 0.251 . . . . 0.0 111.28 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.4 117.5 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.324 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . 0.413 ' HB2' HD13 ' B' ' 148' ' ' LEU . 2.4 m120 51.16 34.7 11.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.373 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.63 85.7 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.178 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 58.6 m -102.47 132.48 48.48 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.955 0.377 . . . . 0.0 110.201 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.4 t -54.19 145.32 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.075 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.505 ' CG2' ' HB ' ' B' ' 106' ' ' ILE . 27.8 m -113.59 20.19 16.18 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.662 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -119.44 127.7 53.33 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 70.56 -5.55 1.39 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.755 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.25 169.75 5.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.858 0.361 . . . . 0.0 111.131 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.38 146.77 23.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.481 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -42.22 98.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.004 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 44.2 p -64.12 -39.44 94.04 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.982 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -63.74 -47.92 79.11 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.931 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.37 90.26 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -69.33 -38.86 78.39 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.546 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -67.43 -38.06 83.97 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.631 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . 0.413 HD13 ' HB2' ' B' ' 133' ' ' ASN . 0.2 OUTLIER -60.04 -44.57 94.58 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.63 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 37.9 mt -68.4 -37.57 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.928 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -69.48 -49.22 56.85 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.787 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -24.92 66.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.628 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 99.6 p -83.53 61.17 6.08 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.053 0.454 . . . . 0.0 110.746 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -69.65 110.96 5.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.568 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.62 -84.08 0.3 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 2.9 ttmm -132.24 135.14 46.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.657 0.265 . . . . 0.0 110.792 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.47 ' HG ' ' CD2' ' B' ' 158' ' ' LEU . 0.9 OUTLIER -128.64 143.49 50.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.939 0.4 . . . . 0.0 111.11 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -105.61 142.76 34.79 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.213 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.47 ' CD2' ' HG ' ' B' ' 156' ' ' LEU . 3.6 mm? -134.98 146.84 49.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.314 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 6.2 t -120.67 128.93 76.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.299 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.31 146.63 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.617 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.21 116.12 29.93 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.524 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -177.65 42.76 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 2.9 t70 69.46 135.48 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.997 0.427 . . . . 0.0 111.206 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.51 121.07 21.81 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.023 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 mt -142.61 141.06 31.88 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.062 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.806 0.336 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.8 pp -143.68 154.58 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.394 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.96 159.93 23.43 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.654 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 t -123.56 131.76 72.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.696 0.284 . . . . 0.0 110.977 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 tt -100.28 108.57 20.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.706 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 tp -95.88 136.58 36.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.718 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.4 ttm -110.75 165.09 12.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.013 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -79.0 137.63 37.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.977 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.89 137.63 1.67 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.213 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 65.58 101.26 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 69.84 126.83 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.474 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.12 50.18 1.74 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.31 70.66 0.89 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.303 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 49.07 -173.3 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.211 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.411 ' HB3' ' CD1' ' A' ' 17' ' ' LEU . 64.9 m-85 -88.26 -32.24 18.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.312 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.13 23.32 35.18 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.733 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.411 ' CD1' ' HB3' ' A' ' 15' ' ' TYR . 3.4 mp -104.98 115.46 30.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.786 0.293 . . . . 0.0 110.794 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.99 113.53 22.83 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 mp -102.02 124.8 48.26 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.596 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -114.82 -167.51 15.57 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.77 147.92 31.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.241 0.521 . . . . 0.0 111.136 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -133.47 140.57 47.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.414 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.48 ' CD1' HG21 ' A' ' 54' ' ' THR . 27.5 mt -88.22 120.55 37.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.41 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.402 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 40.1 p90 -122.26 173.95 7.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.01 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.1 t -80.16 94.12 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.778 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -65.12 -56.25 14.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.039 -179.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -147.53 151.18 35.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.416 ' HG3' ' HG ' ' B' ' 100' ' ' LEU . 3.2 tmm? -138.26 142.72 39.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.82 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.76 120.06 12.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.623 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 153.68 23.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.083 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.98 22.46 12.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.327 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.87 -168.77 36.55 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.568 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 mp -71.34 -30.8 66.62 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.97 -33.39 61.88 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.14 -34.7 43.05 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.176 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -36.88 85.12 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.21 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -98.39 -37.56 9.57 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.424 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.35 45.7 9.67 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.789 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -71.93 -49.45 37.48 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -129.82 132.01 46.35 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.661 0.267 . . . . 0.0 111.107 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.25 145.95 24.06 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.651 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -58.05 111.84 1.32 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.077 0.465 . . . . 0.0 111.075 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.68 -19.4 12.55 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.856 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -62.9 134.27 55.95 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.105 0.452 . . . . 0.0 110.587 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 pt -78.65 130.25 36.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.058 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.1 mt -96.07 138.06 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.503 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 tp -98.93 -40.61 7.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.984 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.49 148.21 27.14 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.832 0.349 . . . . 0.0 111.409 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mt -138.74 118.83 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.66 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 53.23 44.64 29.93 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 111.182 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.47 15.37 72.88 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.172 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 m -120.84 135.45 55.17 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.855 0.328 . . . . 0.0 110.389 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 t -62.67 146.98 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.927 0.394 . . . . 0.0 111.266 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.48 HG21 ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -126.71 16.32 7.5 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.334 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.7 131.61 55.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 71.46 -6.18 1.44 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.281 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.85 175.03 6.9 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.9 m -90.14 143.81 26.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 tt -58.41 -40.48 82.57 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.788 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 m -63.17 -42.06 99.34 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.88 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -63.99 -48.05 77.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.768 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.47 -40.57 91.7 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.169 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -63.62 -41.03 98.33 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.949 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -38.27 86.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.711 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 tp -60.75 -43.4 98.03 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.6 mt -67.21 -38.01 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.681 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -67.65 -49.51 62.56 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -64.31 -23.28 67.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.257 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 t -75.7 73.03 2.67 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.123 0.487 . . . . 0.0 110.821 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.15 100.63 13.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.552 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.08 -95.33 0.19 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.943 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.18 135.84 49.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.591 0.234 . . . . 0.0 110.439 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.12 141.83 51.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.093 0.473 . . . . 0.0 111.309 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -101.87 128.36 48.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.112 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 mp -126.53 129.18 48.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.664 0.269 . . . . 0.0 111.383 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.3 m -119.57 114.8 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.685 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -107.9 157.57 8.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.541 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mt -102.05 137.18 40.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.831 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -138.89 -176.1 4.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.602 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.3 t70 62.8 66.65 0.74 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.101 0.477 . . . . 0.0 110.557 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 63.8 p -76.87 122.75 25.26 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.029 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.9 mp 66.15 177.14 0.22 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.57 -0.729 . . . . 0.0 111.251 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.909 0.385 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.26 133.89 68.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.163 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.43 155.87 16.83 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.632 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 17.4 t -131.49 135.11 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.725 0.297 . . . . 0.0 111.118 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 4.7 tt -103.65 107.12 17.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.612 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 21.3 tp -99.88 129.27 45.95 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.332 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.4 ttt -109.37 164.64 12.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.984 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 129.59 38.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.991 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -161.47 59.53 0.27 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.305 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.39 132.64 0.79 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.108 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.82 81.93 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.713 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -148.94 -178.69 6.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.081 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' B' ' 97' ' ' GLU . 4.9 mm-40 -95.5 111.66 23.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.793 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' B' ' 96' ' ' GLU . 7.9 pm0 47.95 -172.36 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.314 0.578 . . . . 0.0 112.225 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -71.49 -32.03 67.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.417 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.01 26.74 47.94 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.467 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . 0.416 ' HG ' ' HG3' ' A' ' 28' ' ' MET . 4.2 mp -104.73 116.64 32.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.665 0.269 . . . . 0.0 110.846 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -92.74 113.52 25.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.231 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 5.0 mp -94.79 125.01 39.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.288 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -110.27 178.36 20.02 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.581 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.12 146.45 46.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.094 0.447 . . . . 0.0 111.017 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -134.1 141.79 47.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.43 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 20' ' ' GLY . 5.6 mt -88.14 122.05 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.597 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -122.25 171.47 9.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.047 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 38.8 t -83.78 93.59 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.059 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . 0.418 ' HG3' ' HA3' ' A' ' 20' ' ' GLY . 7.1 mtpt -61.94 -51.55 67.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.64 121.44 3.72 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.102 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -116.92 143.89 45.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.025 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 36.1 p -65.65 137.17 57.15 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.628 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.07 162.87 25.58 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.997 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.4 m 59.73 23.07 11.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.286 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.6 -154.99 27.36 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.095 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 2.2 mt -82.86 -33.38 27.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.529 0.204 . . . . 0.0 111.374 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.43 66.53 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.165 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 1.3 p -78.63 -33.88 46.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.277 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -60.83 -38.35 85.15 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.311 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -100.19 -36.05 9.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.42 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.06 44.03 7.28 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.907 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -55.38 -54.1 47.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.383 0.135 . . . . 0.0 111.261 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.4 156.66 45.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 111.296 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.81 150.8 20.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.591 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -59.83 109.44 0.94 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.092 0.472 . . . . 0.0 110.874 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 111.04 0.08 28.49 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.98 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -78.42 138.66 38.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 117.347 0.573 . . . . 0.0 110.719 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -76.1 124.38 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.327 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 19.8 mt -91.99 144.05 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.173 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 tp -98.39 -41.89 7.61 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.356 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -145.83 148.06 32.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 111.195 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 32.2 mt -138.35 118.42 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.809 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . 0.42 ' HB3' HD12 ' B' ' 148' ' ' LEU . 2.3 t-20 53.87 48.09 22.09 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.317 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 65.58 18.02 65.3 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.993 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.21 144.8 47.54 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 t -63.52 146.88 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.503 ' CG2' ' HB ' ' B' ' 106' ' ' ILE . 18.2 m -115.32 1.42 13.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.865 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . 0.402 ' HG2' ' HE2' ' A' ' 26' ' ' LYS . 1.5 tt0 -100.39 131.63 46.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.67 0.271 . . . . 0.0 110.357 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 71.85 -7.65 1.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.435 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 36.7 ttm -65.51 155.42 35.69 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.012 0.434 . . . . 0.0 111.377 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 28.6 t -79.58 149.56 31.33 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.387 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 tt -60.8 -48.13 83.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.893 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 39.1 p -58.47 -38.22 77.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.882 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.21 -43.21 95.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.841 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . 0.409 ' HB2' ' CD1' ' B' ' 106' ' ' ILE . . . -59.71 -42.88 94.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.173 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -67.67 -38.3 83.57 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.654 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -67.63 -38.35 83.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.485 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . 0.42 HD12 ' HB3' ' B' ' 133' ' ' ASN . 0.1 OUTLIER -60.3 -44.09 95.71 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.844 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 15.7 mt -68.13 -37.7 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.915 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -69.16 -48.39 62.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.773 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -71.22 -23.62 62.05 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.992 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 80.1 p -77.25 66.97 3.12 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.147 0.498 . . . . 0.0 110.628 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -74.51 127.94 34.31 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.564 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 109.39 -91.64 0.66 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.274 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -124.17 138.36 54.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.71 135.19 48.19 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.035 0.445 . . . . 0.0 111.14 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -97.86 136.93 37.46 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.643 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.03 128.77 35.0 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.803 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.1 t -113.69 136.6 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.893 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -128.84 149.67 33.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.266 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 6.9 tp -84.2 123.29 29.95 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.548 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -83.66 65.2 8.38 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.596 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 19.9 t0 174.8 124.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.917 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 74.6 m -156.19 -47.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.13 115.8 25.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.916 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.252 1.217 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.127 179.905 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.6 0.238 . . . . 0.0 111.377 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.5 tt -147.03 119.79 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.781 0.324 . . . . 0.0 110.968 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.12 156.1 15.74 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.669 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.47 133.03 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.377 . . . . 0.0 111.058 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.35 114.81 29.14 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 1.1 mp -98.42 144.53 27.69 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 30.8 ttm -113.24 164.05 14.02 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.893 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.32 142.67 27.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.109 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -165.29 106.94 0.79 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.603 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.13 34.8 21.2 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.203 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.33 107.4 7.15 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -94.14 -34.53 12.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.51 53.77 2.91 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.938 0.399 . . . . 0.0 111.161 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 64.65 -177.06 0.17 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.426 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.466 ' CZ ' HD21 ' B' ' 156' ' ' LEU . 57.2 m-85 -71.82 -22.25 61.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.817 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.48 20.38 38.12 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.704 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.9 mp -102.48 115.95 31.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.821 0.31 . . . . 0.0 110.786 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.99 114.58 24.74 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 mp -97.9 124.81 42.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 111.776 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -114.73 174.93 15.71 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 p -130.17 151.04 51.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.608 0.704 . . . . 0.0 111.84 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -136.75 135.83 38.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.176 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.559 HD12 HG22 ' A' ' 54' ' ' THR . 21.5 mt -88.14 121.47 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.931 0.396 . . . . 0.0 110.125 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.401 ' CE2' ' HG2' ' A' ' 26' ' ' LYS . 41.7 p90 -125.42 172.92 9.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.314 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.401 ' CG2' ' HB3' ' A' ' 40' ' ' LEU . 40.8 t -82.29 97.53 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.745 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.401 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -67.65 -57.01 7.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.282 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.39 141.33 17.17 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.953 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -126.66 144.31 50.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.17 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.5 m -73.73 127.83 33.87 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.583 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -63.29 168.25 4.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.73 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.63 29.8 15.03 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.445 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.87 -174.09 17.58 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.194 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.39 -28.19 61.88 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.38 -36.49 63.55 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.502 0.191 . . . . 0.0 111.203 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.9 -34.05 45.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.062 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -62.77 -37.14 85.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.339 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.62 -33.41 10.31 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.493 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.48 44.74 32.26 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.165 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.409 ' HB2' ' CG2' ' B' ' 87' ' ' VAL . 10.4 p-10 -81.65 -49.04 10.95 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.453 HD13 ' CD2' ' A' ' 75' ' ' LEU . 13.2 mt -95.64 113.18 24.8 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.904 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.47 130.29 34.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.552 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -54.39 111.62 0.83 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.125 0.488 . . . . 0.0 110.868 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.95 -14.1 37.66 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.865 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.33 138.64 58.6 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.038 0.447 . . . . 0.0 111.31 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.403 ' O ' HG13 ' A' ' 45' ' ' ILE . 24.3 pt -79.96 119.49 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.674 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.419 HG21 ' CD1' ' A' ' 49' ' ' ILE . 7.8 mt -83.33 144.11 10.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.343 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 tt -105.23 -42.56 5.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.438 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 mttm -152.38 147.97 26.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.68 0.276 . . . . 0.0 111.368 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.459 HG23 HD12 ' A' ' 49' ' ' ILE . 27.8 mm -137.47 118.97 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.431 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.91 40.14 31.85 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.217 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.27 14.58 80.59 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.32 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 m -120.23 139.64 52.38 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.028 0.414 . . . . 0.0 110.51 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.69 145.63 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.203 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.559 HG22 HD12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -124.18 20.13 9.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.433 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.79 132.13 56.77 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 71.1 -7.57 1.11 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.65 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.403 ' HB3' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -68.38 172.13 6.41 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 111.125 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.81 146.16 24.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.308 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.9 -38.62 86.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.27 -46.94 84.47 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -44.2 93.94 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.796 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.96 93.61 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.951 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -39.66 88.57 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.695 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.97 -38.39 86.01 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 tp -60.32 -43.35 96.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.026 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 24.5 mt -68.33 -37.48 78.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.78 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.0 -49.44 57.75 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.078 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -64.89 -30.5 71.5 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.212 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 m -81.95 62.01 5.52 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.201 0.524 . . . . 0.0 110.791 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 147.26 41.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.785 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.0 -86.59 0.59 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.224 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -134.95 126.87 29.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.663 0.268 . . . . 0.0 110.568 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.462 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 2.3 pp -125.87 143.84 50.91 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.45 141.46 34.29 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.462 ' HG ' ' CD1' ' A' ' 73' ' ' LEU . 0.8 OUTLIER -133.4 128.08 34.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.965 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 t -107.97 134.62 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.248 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.98 164.58 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.518 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tp -89.55 135.91 33.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.594 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -91.91 42.66 1.11 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.229 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.16 111.19 0.64 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.691 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.23 95.27 0.09 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.946 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.0 mt -149.87 161.62 41.92 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.009 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.038 179.789 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pp -117.03 143.06 28.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.218 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.89 166.96 20.34 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.924 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.409 ' CG2' ' HB2' ' A' ' 39' ' ' ASN . 21.4 t -129.69 134.86 62.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.641 0.258 . . . . 0.0 111.086 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tt -96.99 121.91 39.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.516 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 7.6 tp -115.3 144.62 43.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.581 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.7 ttt -107.1 163.61 12.85 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.144 0.497 . . . . 0.0 110.922 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . 0.401 ' HE3' ' HA ' ' B' ' 97' ' ' GLU . 4.1 tttt -93.54 146.39 23.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.914 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -136.83 146.95 46.24 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.041 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 68.62 104.23 0.05 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.766 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.16 80.46 1.27 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -165.18 -48.03 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.733 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -119.84 178.79 4.46 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.099 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . 0.401 ' HA ' ' HE3' ' B' ' 91' ' ' LYS . 0.8 OUTLIER -95.77 -174.03 3.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.818 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . 0.408 ' CE2' ' CD2' ' A' ' 73' ' ' LEU . 47.0 m-85 -49.74 -31.14 10.72 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.685 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.25 15.36 74.52 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.521 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 mp -101.3 119.82 39.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.659 0.266 . . . . 0.0 110.668 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -96.13 113.43 25.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.211 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.41 124.78 41.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.625 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.44 177.13 17.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.978 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.37 145.76 50.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.847 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -130.05 140.16 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.413 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.432 ' HB ' HG23 ' B' ' 137' ' ' THR . 9.1 mt -88.37 120.46 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.176 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -119.68 170.48 9.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.714 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' B' ' 126' ' ' GLY . 41.2 t -81.07 89.5 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.038 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -53.77 -42.46 68.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.816 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.03 132.17 0.51 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -114.24 146.31 40.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.079 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 25.2 p -77.13 126.57 31.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.704 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.78 165.87 12.04 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.289 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.3 m 64.95 22.85 12.52 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.183 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -105.19 -171.7 24.11 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.172 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.15 -30.81 66.93 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.25 -35.03 63.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.489 0.185 . . . . 0.0 110.941 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 2.1 p -78.95 -34.1 44.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.184 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -59.15 -38.85 80.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.424 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.58 -29.9 10.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.539 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.16 58.44 5.59 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.2 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.95 -32.68 12.49 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 39.4 mt -131.34 133.02 44.91 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.641 0.258 . . . . 0.0 111.195 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.79 161.86 13.4 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' B' ' 125' ' ' GLU . 2.1 pt-20 -73.64 120.55 19.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.518 0.675 . . . . 0.0 110.178 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 108' ' ' VAL . . . 106.89 -15.77 40.25 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.587 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -63.97 135.31 56.37 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 111.082 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 13.7 pt -78.25 121.32 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.825 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 mt -91.2 143.7 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.149 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.77 -35.47 6.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.902 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.83 148.04 31.47 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.541 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 45.4 mt -140.93 118.68 9.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.616 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 55.7 44.14 26.84 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.931 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.83 17.43 73.29 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.051 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.84 137.71 54.42 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 116.948 0.374 . . . . 0.0 110.478 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.87 145.04 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.838 0.351 . . . . 0.0 110.872 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.432 HG23 ' HB ' ' B' ' 106' ' ' ILE . 1.8 m -119.03 9.9 11.98 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.788 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.28 131.13 49.06 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 70.85 -4.33 1.75 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -65.65 169.52 6.2 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 111.285 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.69 141.72 28.28 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.168 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.14 -44.38 87.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.555 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 7.2 t -61.46 -39.29 90.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.693 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -64.81 -46.73 80.77 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.54 -42.56 88.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -65.72 -40.27 92.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.502 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -66.39 -38.63 87.93 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.886 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 5.3 tt -59.94 -44.78 94.16 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.713 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 4.9 mt -68.5 -37.35 77.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.773 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.85 -47.57 65.63 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.055 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -66.33 -27.77 68.16 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 3.6 m -79.24 63.23 3.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.006 0.431 . . . . 0.0 110.747 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 18.2 mmm-85 -83.93 74.78 10.18 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.422 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 167.54 -73.32 0.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.251 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.41 127.49 27.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.712 0.291 . . . . 0.0 110.875 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.466 HD21 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -129.84 139.51 51.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 4.4 tt0 -103.57 141.01 36.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.195 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.72 128.13 32.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 111.001 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.24 135.27 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.47 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 16.9 m -128.46 152.82 37.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.854 0.359 . . . . 0.0 111.711 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 15.0 tp -115.73 122.26 44.97 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 69.73 141.4 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.171 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 175.81 142.63 0.06 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.162 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 21.5 m -72.75 170.35 14.78 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.979 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 1.3 tp -138.56 103.18 4.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.908 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.085 -179.86 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.1 pt -126.87 155.2 37.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.625 0.25 . . . . 0.0 111.255 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.74 158.6 22.64 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.865 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.0 t -130.01 132.73 65.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.758 0.313 . . . . 0.0 110.94 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.88 113.68 25.25 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.023 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.416 ' HB3' ' CE1' ' A' ' 15' ' ' TYR . 8.0 mp -91.23 131.56 36.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.656 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.0 ttt -107.62 162.21 14.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.228 0.537 . . . . 0.0 111.143 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.65 119.63 37.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.738 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 p -114.42 36.07 3.93 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.256 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.49 114.35 1.18 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.734 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.55 49.49 1.8 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.07 0.462 . . . . 0.0 111.419 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -171.84 35.18 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.119 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -175.43 -178.92 1.2 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 111.558 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -113.71 175.66 5.36 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.866 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.416 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 50.6 m-85 -61.56 -29.76 70.23 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.95 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.48 27.25 57.71 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.196 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mp -113.75 117.86 32.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.71 0.29 . . . . 0.0 110.66 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.38 113.33 25.27 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.1 mp -98.01 124.86 42.69 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.193 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -105.27 -167.46 23.88 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.8 OUTLIER -146.02 149.24 33.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.258 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' B' ' 104' ' ' SER . 1.9 pt20 -132.1 133.47 44.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.964 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' B' ' 103' ' ' GLY . 68.8 mt -87.75 120.23 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.115 0.483 . . . . 0.0 110.29 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -122.86 172.92 8.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.297 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.1 t -82.54 99.78 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.767 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -58.69 3.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.216 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -156.42 147.56 22.22 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.631 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.32 163.15 30.65 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.894 0.378 . . . . 0.0 111.428 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.8 m -65.38 139.89 58.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -76.51 156.92 32.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.977 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 50.35 30.9 4.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.918 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.17 -170.55 30.84 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.152 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.37 -31.09 68.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.02 -36.94 61.9 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.236 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -33.85 45.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.175 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -60.86 -39.21 88.29 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.149 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.14 -30.83 11.71 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.789 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.38 47.92 20.64 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.226 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -65.24 -47.34 77.13 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.44 136.57 50.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.812 0.339 . . . . 0.0 111.386 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.96 148.48 22.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.489 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -59.53 109.49 0.91 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.27 0.557 . . . . 0.0 111.08 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.23 -13.6 16.27 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.286 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -62.86 135.43 57.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.232 0.516 . . . . 0.0 110.391 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.55 112.43 18.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.085 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.9 mt -77.49 130.43 36.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.176 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.2 tp -92.21 -40.96 10.7 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.322 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -151.36 148.66 28.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.852 0.358 . . . . 0.0 111.833 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.7 mt -138.33 119.66 17.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.344 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.5 m120 55.23 39.99 31.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.124 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.77 11.65 84.41 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.424 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 m -119.82 135.3 54.92 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 117.113 0.456 . . . . 0.0 110.203 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 t -61.69 147.79 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.843 0.354 . . . . 0.0 111.146 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.424 HG21 ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -118.42 6.55 11.81 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.751 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.01 135.73 33.55 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 p30 52.59 11.79 0.21 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.649 0.593 . . . . 0.0 112.198 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -73.32 171.92 12.16 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.003 0.43 . . . . 0.0 111.357 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.6 130.66 35.22 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.883 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.97 -35.69 59.27 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.9 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.9 -46.75 80.44 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.063 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.67 -46.06 89.92 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.684 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.12 84.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -70.31 -37.46 74.75 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.466 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -67.85 -38.17 82.81 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.568 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.1 tt -59.69 -44.77 93.51 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.706 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.5 mt -68.22 -37.66 78.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.763 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.03 -49.61 56.05 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.791 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -65.19 -27.24 68.55 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.207 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.5 t -80.55 63.13 4.89 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.002 0.43 . . . . 0.0 110.557 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -77.76 94.83 4.54 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.537 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.06 -84.1 0.18 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.521 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.6 131.08 46.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.641 0.257 . . . . 0.0 110.761 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.83 140.71 50.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 111.323 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -106.37 140.64 38.98 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.553 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 mp -136.11 134.64 38.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.102 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.4 t -118.87 140.69 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.93 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.17 134.97 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.321 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 tt -99.76 135.03 41.8 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.774 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 65.38 105.58 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.945 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.02 103.36 0.03 OUTLIER 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.63 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.9 t -95.0 83.84 4.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.28 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.24 -41.71 69.78 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.784 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.488 -0.768 . . . . 0.0 111.14 179.65 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 5.2 ttt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 111.522 0.194 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.0 pp -132.55 135.57 57.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.912 0.387 . . . . 0.0 111.614 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.49 157.03 15.59 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.409 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 13.8 t -131.09 134.28 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.895 0.378 . . . . 0.0 111.328 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 7.9 tt -106.19 108.1 19.44 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.573 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.8 tp -99.04 144.69 27.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.831 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 9.2 ttm -117.81 163.13 16.99 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.133 0.492 . . . . 0.0 111.051 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.33 118.49 30.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.102 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.36 42.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.866 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.37 24.71 12.5 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.187 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 49.27 38.55 13.85 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.924 0.393 . . . . 0.0 111.371 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -151.7 -173.22 4.45 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.989 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -104.98 131.2 52.79 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.765 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 68.36 166.17 0.25 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.386 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -79.33 -26.26 42.18 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.377 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.39 28.57 43.53 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.395 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mp -105.07 123.49 47.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.722 0.296 . . . . 0.0 110.702 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.47 113.65 27.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.371 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -109.3 124.86 51.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.459 . . . . 0.0 111.453 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -106.8 -170.2 22.55 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.258 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.6 OUTLIER -134.71 147.54 50.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.882 0.373 . . . . 0.0 111.375 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 21' ' ' SER . 3.3 pt20 -125.34 139.04 54.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.225 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' B' ' 137' ' ' THR . 33.7 mt -88.15 120.42 37.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.963 0.411 . . . . 0.0 111.034 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -124.2 171.58 9.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.083 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 39.3 t -80.27 95.22 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.92 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -53.18 50.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.112 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -156.21 141.35 17.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.688 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.12 151.04 49.38 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.867 0.365 . . . . 0.0 111.463 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -65.73 143.34 57.59 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.165 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -73.15 148.71 43.62 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.148 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 54.85 32.84 18.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.61 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' B' ' 119' ' ' LYS . . . -96.47 -164.98 33.34 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.323 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.36 -37.12 84.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.1 -33.73 61.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.273 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -33.72 44.47 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.286 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' B' ' 115' ' ' GLY . 12.1 ttmt -64.17 -37.07 86.14 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 111.266 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.99 -30.8 12.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.467 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.82 45.69 63.55 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.2 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -81.83 -53.4 6.21 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 10.2 mp -118.5 119.41 34.47 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.68 0.276 . . . . 0.0 110.944 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.17 152.84 22.5 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.619 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -60.5 110.65 1.32 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.169 0.509 . . . . 0.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.55 -15.16 24.69 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.894 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -62.85 135.75 57.49 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 117.245 0.522 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -81.05 108.86 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.103 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 29.3 mt -76.41 152.49 5.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.322 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 13.7 tp -110.7 -31.28 7.26 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.538 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -152.44 147.42 26.23 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.711 0.291 . . . . 0.0 111.066 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.406 HG21 HD21 ' B' ' 158' ' ' LEU . 13.5 mt -137.18 117.73 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.452 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . 0.472 ' OD1' ' HA ' ' B' ' 156' ' ' LEU . 0.1 OUTLIER 49.4 43.34 23.35 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.515 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.98 18.73 79.32 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.344 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 93.1 m -120.77 144.11 48.46 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.997 0.398 . . . . 0.0 110.28 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 t -74.14 140.07 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.457 . . . . 0.0 111.609 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.458 ' HA ' HD12 ' B' ' 106' ' ' ILE . 52.8 p -93.01 -22.08 19.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.129 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.09 142.35 38.17 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.925 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.5 p30 53.13 10.74 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.811 0.694 . . . . 0.0 112.467 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -86.52 144.18 27.36 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.902 0.382 . . . . 0.0 110.808 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.11 144.76 46.87 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.515 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.75 -46.0 92.12 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.925 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 9.7 t -55.28 -42.64 73.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -40.9 84.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.617 0.246 . . . . 0.0 110.769 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.15 99.44 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.037 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -38.13 79.34 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -38.08 82.37 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.779 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 7.7 tt -59.98 -44.82 94.24 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.649 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 8.2 mt -67.79 -37.31 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.03 -48.76 62.14 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.0 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -67.44 -24.95 65.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.683 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 22.9 m -75.58 70.39 2.41 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.212 0.53 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -86.5 78.38 9.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.667 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 164.55 -81.89 0.11 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.62 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.0 128.96 29.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.534 0.206 . . . . 0.0 110.628 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.472 ' HA ' ' OD1' ' B' ' 133' ' ' ASN . 0.9 OUTLIER -127.86 131.78 49.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.948 0.404 . . . . 0.0 111.2 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -91.1 142.56 27.62 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.083 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.406 HD21 HG21 ' B' ' 132' ' ' ILE . 2.3 mt -132.55 134.51 45.05 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.809 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.09 134.0 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.636 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 6.1 m -127.99 152.9 36.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 111.719 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.58 119.13 38.56 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.826 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.85 55.13 0.94 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.738 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 2.0 t70 70.35 151.88 0.1 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.263 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 23.1 t -77.56 164.37 25.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.316 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.29 89.84 3.2 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.223 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 C--O 1.252 1.204 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.014 -179.964 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 120.644 0.259 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.8 tp -140.91 121.98 13.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.98 0.419 . . . . 0.0 111.282 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.74 156.6 22.89 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.774 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.4 HG11 HD11 ' A' ' 6' ' ' LEU . 22.8 t -132.77 133.39 59.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.702 0.287 . . . . 0.0 111.093 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.46 111.44 23.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.815 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.439 ' HB3' ' CE1' ' A' ' 15' ' ' TYR . 10.4 mp -90.6 141.88 28.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.25 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 37.2 ttm -120.05 165.3 14.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.988 0.423 . . . . 0.0 110.9 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -93.33 141.31 28.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.937 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 m -146.43 51.18 1.13 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -155.89 32.32 0.35 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.452 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 52.9 72.14 0.44 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.92 0.39 . . . . 0.0 111.759 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.8 t30 63.24 90.96 0.07 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.347 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -152.95 151.73 30.65 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.246 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -73.81 157.35 36.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.439 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 70.4 m-85 -78.26 -30.89 48.84 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.728 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.88 28.34 46.62 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.464 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.85 121.39 42.02 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.646 0.26 . . . . 0.0 110.668 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.38 114.04 27.88 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.03 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -111.44 124.82 53.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.192 0.52 . . . . 0.0 111.763 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.91 -177.56 22.24 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.556 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.26 149.3 47.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.155 0.478 . . . . 0.0 111.058 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -132.87 140.2 47.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.231 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.499 ' CD1' HG22 ' A' ' 54' ' ' THR . 49.4 mt -88.05 120.54 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.003 0.43 . . . . 0.0 110.433 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -119.88 172.91 7.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.912 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.476 ' CG2' HD11 ' A' ' 40' ' ' LEU . 45.6 t -79.5 92.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.118 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.94 -51.85 59.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.217 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.13 162.6 39.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 36.0 mtp -138.4 156.46 47.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.107 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.434 ' HB ' ' HA3' ' B' ' 99' ' ' GLY . 3.7 t -69.33 145.32 53.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.693 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -75.52 130.13 38.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.674 0.273 . . . . 0.0 110.944 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.23 28.25 5.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.141 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.5 -163.38 36.2 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.369 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 mt -73.93 -30.19 62.43 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.98 -37.17 61.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.467 0.175 . . . . 0.0 111.409 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.52 -34.05 47.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.153 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -63.97 -36.49 84.12 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.428 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.84 -32.58 11.27 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.362 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.48 47.78 20.63 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.238 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -57.51 -35.15 69.89 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.476 HD11 ' CG2' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -163.49 163.83 24.61 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.727 0.299 . . . . 0.0 111.025 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.39 150.39 22.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.706 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -61.68 114.4 3.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.12 0.486 . . . . 0.0 111.233 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.93 9.86 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.755 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -60.6 135.85 57.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.919 0.359 . . . . 0.0 110.368 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 pt -75.06 121.82 27.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.895 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.5 mt -88.95 138.14 19.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.118 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.0 tp -97.43 -45.55 6.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.484 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.74 147.93 33.55 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.873 0.368 . . . . 0.0 111.59 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 22.4 mm -138.61 120.77 17.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.432 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 53.47 41.55 32.09 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.242 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.48 13.0 80.29 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.436 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m -120.97 137.52 54.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.038 0.419 . . . . 0.0 110.431 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 t -57.58 146.11 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.274 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.499 HG22 ' CD1' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -123.32 17.74 9.82 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.416 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -121.59 127.85 51.34 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 70.88 -4.07 1.83 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.288 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.11 174.63 3.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 111.27 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.92 147.8 25.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.1 mp -61.9 -48.95 78.16 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.85 -37.98 80.81 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.221 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.19 -47.89 69.55 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.946 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.94 -40.15 94.54 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.204 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -70.24 -38.41 75.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -38.16 83.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.677 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 tp -60.49 -44.36 96.05 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.735 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 12.3 mt -68.33 -37.57 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.604 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.94 -41.42 78.1 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.641 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -6.7 57.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.72 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.94 56.64 4.02 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 110.862 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.68 78.86 7.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.381 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' B' ' 91' ' ' LYS . . . 162.29 -78.77 0.15 Allowed Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.295 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -136.2 129.87 32.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.774 -0.213 . . . . 0.0 110.787 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.402 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.6 OUTLIER -128.05 126.98 42.32 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.108 0.48 . . . . 0.0 110.871 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 37.4 tt0 -97.83 142.62 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.279 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.76 124.02 25.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.772 0.32 . . . . 0.0 110.75 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.6 t -109.57 134.6 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.747 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 t -116.29 135.21 57.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.048 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 tp -115.32 134.74 54.84 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.25 116.02 28.69 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.465 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.11 155.94 1.18 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.015 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.02 -45.78 89.84 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.121 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.7 mp -73.92 168.81 18.72 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.85 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.451 179.827 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.429 HD12 HG21 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -138.32 122.39 21.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.765 0.317 . . . . 0.0 110.953 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.03 155.48 16.29 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.75 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 25.9 t -129.6 134.33 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 111.088 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.64 122.42 44.98 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.6 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tp -109.09 124.63 51.09 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.542 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' MET . . . . . 0.495 ' HG3' ' N ' ' B' ' 91' ' ' LYS . 3.7 tpp -100.12 162.85 12.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.072 0.463 . . . . 0.0 110.772 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . 0.495 ' N ' ' HG3' ' B' ' 90' ' ' MET . 6.6 pttm -85.81 126.06 33.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.349 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.31 35.61 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.472 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 175.84 114.11 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.708 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 66.52 113.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.737 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -78.01 -168.78 1.36 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.754 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.8 68.27 0.59 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.615 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 63.38 173.76 0.16 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.517 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . 0.402 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 67.4 m-85 -76.26 -25.55 55.07 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.517 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . 0.434 ' HA3' ' HB ' ' A' ' 29' ' ' THR . . . 93.62 20.2 32.53 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.458 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.78 118.21 36.46 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.651 0.262 . . . . 0.0 110.708 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -92.07 113.26 25.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.949 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 mp -96.34 124.93 40.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 110.922 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.91 171.9 13.94 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.822 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.71 145.07 44.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.835 0.35 . . . . 0.0 110.891 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -130.44 139.71 50.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.274 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.494 ' HB ' ' CG2' ' B' ' 137' ' ' THR . 1.9 mt -88.3 120.64 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.069 0.461 . . . . 0.0 110.238 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.4 ' CE2' ' HD3' ' B' ' 109' ' ' LYS . 40.1 p90 -119.62 172.58 7.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.928 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 t -81.36 97.62 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.013 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . 0.4 ' HD3' ' CE2' ' B' ' 107' ' ' PHE . 0.5 OUTLIER -67.57 -50.58 57.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.717 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -167.48 143.61 4.17 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.805 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.68 159.53 34.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.795 0.331 . . . . 0.0 111.119 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 64.2 p -75.75 124.63 27.61 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.435 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.64 156.77 15.92 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.967 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.68 34.79 17.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.299 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.11 -175.54 20.26 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.913 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.84 -35.6 80.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.57 0.224 . . . . 0.0 111.559 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.95 -34.82 62.1 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.26 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -34.1 44.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.13 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.47 -35.41 80.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.199 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -100.07 -27.95 13.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.648 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 65.8 57.39 11.09 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.094 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -94.82 -33.63 12.79 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 47.9 mt -122.36 135.96 54.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.636 0.255 . . . . 0.0 111.55 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 142.93 34.22 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.581 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -56.68 111.39 1.0 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 111.249 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.32 -16.47 24.6 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.266 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . 0.4 ' HB3' HG11 ' B' ' 160' ' ' VAL . 25.4 m-20 -60.47 135.8 57.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.332 0.566 . . . . 0.0 110.64 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 pt -79.82 111.01 16.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 59.4 mt -72.48 140.96 17.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.108 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 tp -98.0 -45.14 6.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.114 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -148.84 147.8 29.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.911 0.386 . . . . 0.0 111.477 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.404 HG13 ' OG1' ' B' ' 137' ' ' THR . 13.9 mt -134.01 123.87 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.264 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 54.86 33.49 19.97 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.687 0.279 . . . . 0.0 111.182 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.65 17.55 77.28 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.92 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 6.8 m -120.66 143.85 48.49 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.8 0.3 . . . . 0.0 110.341 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.46 144.26 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.199 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.494 ' CG2' ' HB ' ' B' ' 106' ' ' ILE . 2.9 m -117.23 21.56 13.07 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.603 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.87 129.38 56.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 71.42 -5.23 1.65 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.361 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 4.8 ttt -68.37 150.72 47.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.812 0.339 . . . . 0.0 110.826 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 51.1 m -71.78 144.22 49.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.307 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.75 -46.03 92.01 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.06 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 4.4 t -58.04 -38.89 77.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.107 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.03 -42.85 84.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.803 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.42 96.18 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.086 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -67.94 -39.46 83.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.318 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -37.86 86.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.85 -45.27 92.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.735 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 46.3 mt -68.42 -37.01 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.773 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.41 -46.3 70.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -65.49 -26.91 68.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.292 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 20.7 p -87.17 74.89 9.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.194 0.521 . . . . 0.0 111.052 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.93 51.98 2.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.708 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -164.39 -83.36 0.05 OUTLIER Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.465 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.54 126.88 46.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.685 0.278 . . . . 0.0 110.424 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.81 143.07 50.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.46 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -109.09 138.61 45.16 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.487 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.36 127.31 33.21 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.762 0.315 . . . . 0.0 111.04 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.93 139.93 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.578 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' B' ' 127' ' ' ASP . 22.3 t -135.74 154.9 35.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.35 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.69 116.56 24.77 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.759 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 45.6 ptt85 -122.59 131.77 53.98 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.65 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -47.96 133.15 14.87 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.408 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.54 158.33 34.1 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.092 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.06 110.23 13.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.32 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.007 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 mtt . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp -144.55 141.69 23.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 120.648 0.261 . . . . 0.0 111.147 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.97 161.75 12.88 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.575 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.6 t -127.33 134.62 65.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.818 0.342 . . . . 0.0 111.277 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 mt -98.03 123.47 42.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.979 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.73 137.42 51.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.503 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.9 ttt -109.67 164.87 12.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.53 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.81 119.1 25.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.116 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.0 m -151.28 115.92 5.15 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.48 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 59.72 51.67 6.07 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.071 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.49 99.29 6.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.77 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -60.66 -35.19 75.63 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.233 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.47 90.69 1.74 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.813 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 66.77 174.59 0.25 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.053 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.456 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 57.5 m-85 -60.37 -27.26 67.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.865 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.87 18.58 43.41 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.707 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.7 mp -108.02 119.07 38.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.723 0.297 . . . . 0.0 110.73 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.2 113.44 25.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.192 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 mp -92.94 124.9 37.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.262 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.6 -169.59 21.85 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.615 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.6 148.54 32.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.934 0.367 . . . . 0.0 111.367 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.26 133.13 45.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.878 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.463 ' HB ' HG21 ' A' ' 54' ' ' THR . 53.9 mt -87.76 120.28 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 0.0 110.542 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -124.83 173.22 8.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.207 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.8 t -83.33 100.5 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.659 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -47.71 53.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.613 0.244 . . . . 0.0 111.044 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -161.69 144.64 12.11 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.592 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -130.35 155.75 45.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 111.333 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.0 t -65.35 144.71 56.92 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.975 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.0 tpt85 -79.72 148.6 31.47 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.407 HG22 ' HE2' ' A' ' 36' ' ' LYS . 0.2 OUTLIER 60.2 30.57 19.98 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.486 179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.58 -170.98 27.93 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.108 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.52 -32.66 72.77 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.642 0.221 . . . . 0.0 111.585 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.99 -35.42 64.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.07 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.29 -33.99 42.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.241 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HE2' HG22 ' A' ' 31' ' ' THR . 1.0 OUTLIER -62.59 -37.55 86.69 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.165 -179.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.94 -26.61 13.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.452 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.7 38.75 93.41 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.986 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.405 ' HB3' HG11 ' B' ' 87' ' ' VAL . 3.6 p30 -68.87 -46.85 67.4 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.459 0.17 . . . . 0.0 111.459 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.8 mt -116.62 129.3 56.08 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.717 0.294 . . . . 0.0 111.125 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.78 150.49 21.78 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.426 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -60.37 110.88 1.36 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.095 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.5 -15.43 17.47 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.153 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -64.19 132.79 51.39 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 117.268 0.534 . . . . 0.0 110.425 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.5 pt -79.9 112.74 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.83 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 mt -78.01 134.28 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.98 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 tp -91.72 -45.49 8.41 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.706 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -148.92 149.84 31.9 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.801 0.334 . . . . 0.0 111.68 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 23.0 mt -138.02 119.99 18.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.621 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 55.7 36.48 27.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.314 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.33 2.46 90.6 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.6 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -111.91 134.89 53.19 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.295 0.547 . . . . 0.0 110.411 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 t -57.88 146.81 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.268 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.463 HG21 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -120.39 23.6 10.79 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.373 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.81 139.18 50.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.411 ' HB2' ' CD1' ' B' ' 142' ' ' LEU . 11.9 p30 53.68 9.22 0.18 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.614 0.571 . . . . 0.0 112.22 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.511 ' HG3' ' N ' ' A' ' 58' ' ' SER . 14.2 tpp -82.95 159.82 22.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.779 0.323 . . . . 0.0 110.734 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.511 ' N ' ' HG3' ' A' ' 57' ' ' MET . 0.1 OUTLIER -72.77 138.1 46.26 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.194 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.0 -47.23 81.34 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.097 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.0 p -58.1 -41.28 83.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.189 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.25 -47.78 84.46 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.019 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.64 -40.81 88.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.981 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.19 -40.5 94.31 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.709 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -65.32 -38.74 91.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.905 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.3 tt -60.06 -43.92 95.06 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.942 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.0 mt -68.46 -37.11 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.809 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.7 -49.28 69.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.902 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.0 pttt -64.1 -23.5 67.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.27 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.7 m -81.36 66.99 7.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.098 0.475 . . . . 0.0 110.431 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.95 64.27 8.03 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.008 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.91 -76.29 0.07 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.588 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.82 129.61 32.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.274 . . . . 0.0 110.629 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.454 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -129.82 136.82 50.02 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 26.6 mt-30 -98.32 143.08 29.17 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.454 ' HG ' ' CD1' ' A' ' 73' ' ' LEU . 1.9 mp -135.75 128.79 31.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.043 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.84 144.21 25.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.695 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.6 m -141.57 167.67 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.957 0.408 . . . . 0.0 111.595 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.58 122.94 33.83 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.916 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.31 115.67 4.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.591 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 58.72 88.48 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.403 0.439 . . . . 0.0 111.206 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 p -76.78 -72.07 0.36 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.408 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.52 -61.84 1.64 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.95 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.872 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.84 148.52 31.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-O 120.595 0.236 . . . . 0.0 111.008 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.4 159.6 25.3 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.929 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 39' ' ' ASN . 9.1 t -130.06 135.16 61.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.681 0.276 . . . . 0.0 111.078 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.51 114.08 25.81 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.792 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.35 137.85 38.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.642 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.21 170.42 8.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.379 0.609 . . . . 0.0 111.47 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -87.28 144.88 26.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.375 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 94.9 p -141.63 27.91 1.83 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.841 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.69 84.88 0.14 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.96 0.409 . . . . 0.0 111.202 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.76 85.01 1.68 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.989 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 57.82 29.16 17.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.248 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.84 48.65 10.91 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.091 0.472 . . . . 0.0 111.232 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -179.27 176.64 0.83 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.187 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -88.1 -26.74 22.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.955 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.42 14.05 72.03 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.618 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.55 122.22 40.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 110.522 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.85 113.72 27.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.267 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -107.84 125.01 50.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.082 0.468 . . . . 0.0 111.329 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -104.33 -163.05 24.54 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.067 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.32 146.51 30.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.696 0.248 . . . . 0.0 111.162 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -127.14 137.14 52.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.026 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.512 ' CD1' HG22 ' B' ' 137' ' ' THR . 28.4 mt -88.18 120.42 37.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.591 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.45 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 47.4 p90 -123.88 172.55 8.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.988 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' B' ' 123' ' ' LEU . 96.6 t -85.16 98.55 6.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.924 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . 0.45 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -68.3 -57.57 5.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.416 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.08 139.84 23.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.743 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 6.1 ptt? -131.07 152.84 49.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 111.626 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 p -72.82 142.28 48.02 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.261 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -78.24 154.92 30.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.963 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.1 m 62.9 34.6 14.09 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.68 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.11 -175.28 20.23 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.96 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -32.54 73.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.669 0.234 . . . . 0.0 111.625 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.93 -37.92 61.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.657 0.265 . . . . 0.0 111.021 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.0 -33.71 44.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.246 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -58.68 -39.79 81.7 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.315 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.38 -31.71 9.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.544 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 49.28 11.01 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.434 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . 0.428 ' ND2' ' HG ' ' B' ' 123' ' ' LEU . 14.4 p-10 -78.73 -44.05 24.34 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.438 ' HB3' HG22 ' B' ' 108' ' ' VAL . 85.1 mt -111.62 118.57 36.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.609 0.242 . . . . 0.0 110.993 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 131.44 34.64 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.252 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -48.14 109.49 0.24 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.083 0.468 . . . . 0.0 111.382 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 108.15 -1.99 33.25 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.344 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -70.83 135.61 48.2 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.456 0.628 . . . . 0.0 111.468 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -79.95 107.47 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.592 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 42.7 mt -75.76 147.56 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.342 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 2.3 tp -110.21 -42.45 4.16 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.607 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -144.0 148.19 34.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.747 0.308 . . . . 0.0 111.387 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 34.8 mt -138.81 118.23 14.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.765 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 4.0 m120 52.37 48.01 23.53 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.36 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.23 16.66 67.2 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.201 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 46.2 m -120.83 140.48 51.69 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.811 0.305 . . . . 0.0 110.293 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.36 147.53 11.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.001 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.512 HG22 ' CD1' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -125.84 19.51 7.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.464 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.95 133.95 53.81 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 72.51 -9.2 1.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.514 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.34 169.59 7.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.96 0.409 . . . . 0.0 111.228 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 30.7 t -90.77 148.71 22.38 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.994 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.411 ' CD1' ' HB2' ' A' ' 56' ' ' ASN . 5.2 tt -58.1 -48.95 78.61 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.369 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 64.6 p -58.62 -39.75 81.37 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.709 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -46.39 85.04 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.19 90.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -66.46 -39.49 88.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.443 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -42.16 98.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.984 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 tp -61.56 -43.18 99.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.454 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 12.0 mt -68.73 -37.54 77.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.727 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.55 -49.51 73.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.003 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -64.83 -24.27 67.49 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.366 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.6 m -79.44 70.0 5.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.924 0.393 . . . . 0.0 110.956 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.42 60.19 6.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.547 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.19 -82.76 0.05 OUTLIER Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.498 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -132.77 131.54 41.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.569 0.224 . . . . 0.0 110.489 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -128.56 137.11 51.56 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.06 0.457 . . . . 0.0 111.275 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 24.8 tt0 -101.92 140.49 36.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.395 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.78 129.42 32.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.874 0.368 . . . . 0.0 111.091 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 13.3 t -113.99 132.17 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.707 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -129.36 165.83 28.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.551 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 1.1 mp -116.71 131.66 56.89 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.983 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.44 40.08 2.06 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.016 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 23.9 t70 67.54 153.58 0.09 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.236 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 23.2 t -94.49 -66.37 0.92 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.811 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 5.6 mt -153.73 -55.03 0.11 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.756 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.773 179.944 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mmt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.635 0.255 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 pp -132.6 158.39 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.773 0.32 . . . . 0.0 111.17 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -127.15 158.05 20.91 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.761 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.1 134.37 62.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.587 0.232 . . . . 0.0 111.029 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.93 107.35 18.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 tp -108.19 123.96 49.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.454 ' HB3' ' HB3' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -104.0 150.97 23.76 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.925 0.393 . . . . 0.0 111.341 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.37 136.31 39.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.248 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -160.58 62.78 0.31 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.182 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.36 27.75 0.35 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 48.92 71.87 0.34 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -145.62 161.13 40.54 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.311 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -94.68 110.0 21.88 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.444 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 67.54 161.22 0.17 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.094 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.427 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 59.3 m-85 -72.27 -15.83 61.91 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.468 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.66 25.97 48.09 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.511 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.05 117.69 34.68 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.579 0.228 . . . . 0.0 110.9 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -97.02 113.34 24.87 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.06 124.93 48.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.183 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -103.42 -164.68 25.45 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.752 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.9 OUTLIER -147.0 147.96 31.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.023 0.411 . . . . 0.0 111.281 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -131.82 137.38 48.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.124 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.445 ' CD1' HG21 ' A' ' 54' ' ' THR . 64.3 mt -87.89 120.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.619 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.469 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 45.2 p90 -124.91 172.11 9.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.339 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.0 100.21 6.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.89 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 1.2 tptp -68.05 -57.5 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.235 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -159.59 134.37 7.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.651 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.403 ' SD ' ' HB1' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -114.15 156.75 23.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.01 0.434 . . . . 0.0 111.299 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -65.55 138.21 57.9 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 148.64 47.93 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.917 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.87 31.82 21.07 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.53 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.08 -154.84 30.16 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.411 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mt -85.54 -31.75 22.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.547 0.213 . . . . 0.0 111.455 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.403 ' HB1' ' SD ' ' A' ' 28' ' ' MET . . . -75.21 -34.93 61.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.118 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.99 -33.81 44.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.988 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -38.6 83.93 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.358 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -103.16 -32.73 9.5 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.513 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.58 49.88 13.29 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.395 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -82.82 -47.68 11.63 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.6 mt -105.95 128.45 53.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.41 133.36 38.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.543 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -54.96 110.44 0.66 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.191 0.519 . . . . 0.0 111.168 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.43 -7.91 28.45 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.816 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -73.37 135.67 44.31 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.244 0.545 . . . . 0.0 111.047 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.4 pt -74.38 114.59 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.543 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.0 mt -80.63 138.84 19.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.212 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.79 -46.99 6.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.535 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.5 148.19 28.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.8 0.333 . . . . 0.0 111.567 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 43.5 mt -137.04 118.36 18.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.78 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 55.95 45.06 24.62 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.152 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.41 15.26 70.22 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.355 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.9 m -120.81 137.08 54.72 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.935 0.368 . . . . 0.0 110.474 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.42 147.18 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.294 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.445 HG21 ' CD1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -125.2 21.76 7.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.534 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.45 129.73 56.01 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 70.5 -3.84 1.79 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.354 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.69 173.15 5.42 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.831 0.348 . . . . 0.0 111.162 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.74 139.72 30.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.99 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 tt -56.35 -42.24 77.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.527 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.4 m -65.15 -37.21 86.7 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.004 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -44.81 78.67 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.637 0.256 . . . . 0.0 110.839 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.72 -41.8 91.66 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.496 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.0 ptt85 -71.65 -35.85 70.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.714 0.292 . . . . 0.0 110.711 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.2 -38.62 82.15 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.664 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -44.96 93.5 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.773 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 59.3 mt -68.32 -36.8 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.08 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -48.78 63.78 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.742 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -29.16 70.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.146 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.2 m -84.31 85.39 7.38 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.842 0.353 . . . . 0.0 111.035 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.81 113.12 25.1 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.61 -89.07 0.24 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.593 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.84 131.85 53.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.662 0.268 . . . . 0.0 110.655 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.53 138.5 51.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.961 0.41 . . . . 0.0 111.323 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.7 tt0 -101.65 138.95 37.96 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.673 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.64 125.12 28.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.949 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.66 146.55 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.52 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.7 m -121.21 140.51 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.278 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.2 tp -84.15 131.96 34.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.911 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 63.09 -174.25 0.15 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.39 76.44 0.32 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.933 0.397 . . . . 0.0 111.328 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.9 t -168.05 121.02 0.88 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.86 -64.01 0.68 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.93 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.49 -0.767 . . . . 0.0 111.186 -179.941 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 1.9 tmt? . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 120.724 0.297 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 10.3 tt -147.52 147.82 17.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.006 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.17 157.37 25.47 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.732 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.08 132.65 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.79 0.328 . . . . 0.0 111.096 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.84 107.07 19.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 tp -91.26 141.55 28.67 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.513 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' MET . . . . . 0.506 ' HG3' ' N ' ' B' ' 91' ' ' LYS . 9.4 tpp -118.44 163.15 17.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.695 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . 0.506 ' N ' ' HG3' ' B' ' 90' ' ' MET . 7.2 pttt -83.16 134.26 34.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.144 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 7.9 m -150.3 112.53 4.64 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.177 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 68.18 119.76 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.517 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 66.5 104.63 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.489 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -87.28 51.89 2.36 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 111.477 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -109.71 53.64 0.68 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.229 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 65.43 162.98 0.15 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.519 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -68.28 -23.74 64.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.455 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.09 20.28 73.16 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.46 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.06 117.05 31.54 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.664 0.268 . . . . 0.0 110.605 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.23 113.4 25.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.101 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -110.6 124.84 52.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.125 0.488 . . . . 0.0 111.07 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -111.05 -164.04 18.33 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.243 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.58 148.91 40.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.706 0.288 . . . . 0.0 111.078 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 21' ' ' SER . 1.8 pt20 -127.65 136.73 52.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.135 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.494 ' CD1' HG21 ' B' ' 137' ' ' THR . 42.1 mt -87.78 120.2 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.345 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -122.97 172.98 8.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.121 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 33.2 t -81.59 95.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.044 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -43.97 88.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.143 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.93 140.43 2.52 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.839 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.46 161.09 28.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.891 0.377 . . . . 0.0 111.434 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 18.8 p -77.09 122.77 25.44 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.208 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -64.64 150.33 47.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.963 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m 62.63 32.76 16.17 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.31 -166.48 24.73 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.128 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mt -75.45 -30.99 60.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.647 0.224 . . . . 0.0 111.417 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.72 -34.4 62.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.17 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.77 -33.96 45.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.084 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.84 -37.71 87.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.336 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.08 -31.66 12.02 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.663 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.61 51.37 7.28 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.345 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -66.56 -35.58 80.57 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.419 HD23 HD12 ' B' ' 129' ' ' ILE . 0.5 OUTLIER -154.27 164.19 38.95 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.804 0.335 . . . . 0.0 111.11 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 148.33 30.79 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.882 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -56.16 112.3 1.18 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.103 0.478 . . . . 0.0 110.981 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.2 -16.67 22.33 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.965 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -61.79 138.81 58.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.071 0.462 . . . . 0.0 111.222 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.406 ' O ' HG13 ' B' ' 128' ' ' ILE . 44.3 pt -78.56 124.9 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.794 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.419 HD12 HD23 ' B' ' 123' ' ' LEU . 33.2 mm -90.91 131.69 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 15.9 tp -94.89 -44.01 7.93 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.563 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -148.62 152.69 37.18 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.424 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 35.5 mt -141.11 118.24 8.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.573 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 55.79 38.74 30.43 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.15 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.04 2.08 88.37 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.517 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 47.8 m -109.69 131.65 54.86 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 117.054 0.427 . . . . 0.0 110.349 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.2 t -58.47 146.95 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.494 HG21 ' CD1' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -120.93 18.91 11.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.675 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.42 130.2 55.51 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 71.6 -6.11 1.49 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.375 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.61 168.5 7.44 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.909 0.385 . . . . 0.0 111.1 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 14.5 t -89.37 149.44 22.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.167 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -47.11 87.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.633 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 12.0 p -60.21 -37.22 79.61 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.17 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.1 -41.47 67.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.606 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.82 98.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.256 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -36.47 71.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.661 0.267 . . . . 0.0 110.482 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -68.02 -38.35 82.46 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.526 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -44.38 93.96 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 7.9 mt -65.95 -38.34 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.713 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -68.71 -49.62 57.39 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.777 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -25.64 68.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.2 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 6.0 m -81.28 63.74 5.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.907 0.385 . . . . 0.0 110.502 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -76.71 121.99 24.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.95 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 120.1 -83.7 0.36 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.31 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 7' ' ' MET . 0.0 OUTLIER -132.75 130.35 39.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.722 0.296 . . . . 0.0 110.687 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.427 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.94 134.14 48.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.111 0.481 . . . . 0.0 111.156 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.52 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.6 tm0? -93.21 141.21 28.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.258 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.33 123.73 24.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.704 0.288 . . . . 0.0 110.678 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . 0.422 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 32.6 t -107.88 135.85 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.291 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.28 141.51 43.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.771 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.66 116.7 32.38 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.967 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.0 127.96 3.6 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.715 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.0 167.63 0.18 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.436 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.04 -62.9 1.28 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.754 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 2.1 mt 64.47 106.86 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.566 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.86 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 mmt . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.479 0.181 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.37 148.15 33.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.959 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.3 158.85 23.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.728 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.3 t -129.85 134.89 62.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 110.848 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.99 113.09 26.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.754 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.2 tp -99.69 144.88 28.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.77 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.0 ttt -112.78 164.08 13.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.147 0.499 . . . . 0.0 110.793 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HE3' ' HA ' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -99.41 129.93 45.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.195 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.44 179.93 5.24 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.991 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -76.03 72.07 2.84 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.897 0.38 . . . . 0.0 111.05 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.81 96.05 0.13 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.029 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 67.16 133.89 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.316 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.412 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 2.2 mt-10 -77.34 59.67 1.87 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.092 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -170.45 175.36 4.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.11 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.453 ' CZ ' HD21 ' B' ' 156' ' ' LEU . 72.8 m-85 -104.54 -30.94 9.69 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.355 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.24 25.39 44.14 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.527 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.78 122.01 44.83 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -102.44 113.42 26.74 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.15 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -108.96 124.98 51.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.111 0.481 . . . . 0.0 111.646 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -106.66 -162.48 22.32 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.855 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.66 149.33 35.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' B' ' 104' ' ' SER . 3.1 pt20 -129.67 136.15 49.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.011 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.445 HG23 HD13 ' A' ' 23' ' ' ILE . 38.8 mt -88.01 120.69 37.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.0 110.631 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -121.97 173.38 7.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.177 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.93 98.18 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.611 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -55.68 10.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.121 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -162.4 145.0 11.15 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 32.0 mtm -119.57 149.54 41.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.955 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 p -65.55 148.98 50.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -75.13 151.66 38.56 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.817 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.47 34.47 20.46 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.633 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.94 172.59 18.29 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.753 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -29.65 69.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.76 -39.55 61.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.205 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.97 -33.71 44.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.115 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -39.77 79.26 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.386 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -106.9 -27.54 10.64 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.558 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.87 59.03 7.99 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.418 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.456 ' HB3' ' CG2' ' B' ' 87' ' ' VAL . 5.7 m-80 -88.62 -33.82 17.5 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.6 0.2 . . . . 0.0 111.328 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mt -111.82 134.78 53.17 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.144 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.1 132.71 43.4 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.751 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -57.18 113.48 1.74 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.11 0.481 . . . . 0.0 111.27 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.22 -18.93 13.64 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.793 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -62.37 137.2 58.21 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.879 0.371 . . . . 0.0 110.512 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.4 pt -76.39 128.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.916 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.404 HG21 ' CG1' ' A' ' 49' ' ' ILE . 17.0 mt -95.45 137.39 23.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.872 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.4 tp -103.72 -36.67 7.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.444 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -148.25 147.85 29.82 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.896 0.379 . . . . 0.0 111.547 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 35.8 mt -142.27 117.58 5.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.957 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 51.3 29.47 5.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.369 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.84 -10.83 64.4 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.615 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -103.67 124.79 49.5 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 117.329 0.565 . . . . 0.0 110.845 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.435 HG21 ' N ' ' A' ' 54' ' ' THR . 2.4 p -56.97 149.61 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.147 0.499 . . . . 0.0 110.941 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.435 ' N ' HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.59 31.15 6.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.511 -178.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.6 128.52 45.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 71.02 -5.82 1.43 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.299 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ttt -78.14 156.06 30.13 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.837 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -71.94 138.72 48.3 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.08 -45.04 87.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.195 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.9 p -59.31 -44.92 92.5 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.141 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.16 -47.19 87.35 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.07 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.38 94.59 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.87 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 51.6 mtp85 -64.4 -40.57 96.04 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.948 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -65.76 -38.53 89.32 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.813 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -59.93 -44.23 94.47 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.751 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.8 mt -68.18 -37.02 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -63.19 -49.33 74.68 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.829 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -69.59 -26.84 64.65 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.352 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -76.13 68.82 2.62 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.056 0.455 . . . . 0.0 110.879 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -87.42 99.47 12.03 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.546 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.13 -82.87 0.17 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.631 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.25 130.65 37.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.627 0.251 . . . . 0.0 110.566 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.59 140.7 51.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.423 . . . . 0.0 111.219 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.9 tt0 -109.87 140.24 44.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.597 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 mp -130.24 126.44 37.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.605 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.4 t -115.51 133.59 61.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.05 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -122.78 165.8 18.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.249 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 tt -104.82 124.08 48.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.675 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.86 -173.81 0.14 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.789 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 66.04 107.4 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.153 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.63 -60.02 0.89 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.028 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.12 -55.66 2.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.757 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--O 1.253 1.237 0 CA-C-O 118.608 -0.711 . . . . 0.0 111.145 179.789 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.478 0.18 . . . . 0.0 111.393 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.06 140.72 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.026 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.79 157.6 26.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.835 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.456 ' CG2' ' HB3' ' A' ' 39' ' ' ASN . 16.9 t -122.92 135.24 63.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.659 0.266 . . . . 0.0 111.096 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.87 127.47 52.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.511 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.52 144.57 40.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.775 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 4.1 ttt -111.28 163.68 13.7 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -98.72 130.47 45.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.855 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 7.5 t -107.56 111.89 24.37 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.839 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 45.8 ttt-85 70.24 134.33 0.03 OUTLIER 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.474 0.484 . . . . 0.0 110.63 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.97 72.34 0.57 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.36 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.72 120.33 3.08 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.475 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 67.33 148.8 0.05 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.534 0.521 . . . . 0.0 111.719 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.36 -178.54 7.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.658 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -55.75 -30.52 61.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.548 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.5 19.51 77.99 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.554 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.2 118.48 31.29 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.57 113.36 26.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.211 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -105.12 124.94 50.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -108.46 -177.36 21.89 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.972 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 1.0 OUTLIER -139.06 148.62 43.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.857 0.361 . . . . 0.0 111.193 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -129.1 139.91 51.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.78 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 20' ' ' GLY . 35.6 mt -88.13 121.66 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 110.828 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.47 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 44.7 p90 -124.29 170.57 10.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.204 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.41 HG23 ' HB3' ' B' ' 123' ' ' LEU . 58.6 t -83.74 98.28 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.139 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . 0.47 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -66.24 -56.36 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.259 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -153.48 142.0 20.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.654 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -130.7 158.61 39.61 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.832 0.348 . . . . 0.0 111.308 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 89.9 m -65.28 134.87 54.55 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.974 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.93 149.7 44.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.8 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.78 30.39 18.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.461 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.83 -171.61 32.89 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.1 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.3 mp -68.11 -32.51 72.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.94 -38.65 61.69 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.547 0.213 . . . . 0.0 111.349 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -33.52 45.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.18 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -60.81 -39.04 87.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.026 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.08 -31.63 11.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.375 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.57 45.79 21.64 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.45 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -77.68 -39.5 44.59 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.41 ' HB3' HG23 ' B' ' 108' ' ' VAL . 78.6 mt -122.59 127.2 49.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.778 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.99 131.28 38.12 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -48.11 110.77 0.36 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.009 0.433 . . . . 0.0 111.255 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.95 -5.71 30.73 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.452 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -68.3 136.47 53.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.264 0.532 . . . . 0.0 111.396 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -79.0 101.28 4.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.271 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.418 HG22 ' CD1' ' B' ' 132' ' ' ILE . 7.7 mt -64.68 148.38 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.02 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 tt -111.12 -44.53 3.56 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.616 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -151.6 148.05 27.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.79 0.329 . . . . 0.0 111.687 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 36.5 mm -132.83 118.53 34.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.526 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 56.81 42.92 25.89 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.31 15.35 74.81 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.216 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 7.5 m -120.89 140.27 52.04 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.957 0.378 . . . . 0.0 110.219 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 t -61.46 148.36 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.825 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.4 HG21 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -129.12 22.78 5.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.135 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.17 135.27 53.04 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.379 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 72.11 -9.53 0.99 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.484 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 4.0 tpp -66.55 170.65 5.93 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.02 148.62 22.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.987 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.04 -35.76 71.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.759 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' B' ' 146' ' ' ARG . 3.8 m -65.68 -37.24 85.95 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.159 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.38 -38.68 65.57 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 110.607 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.57 97.06 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.089 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' B' ' 143' ' ' THR . 7.0 ppt_? -72.63 -35.53 67.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.65 0.262 . . . . 0.0 110.59 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -39.23 82.83 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.773 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.85 -45.15 93.35 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.602 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 47.7 mt -68.56 -36.79 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.772 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.57 -48.77 71.26 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.985 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -70.35 -24.94 63.07 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.61 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 96.9 p -78.06 67.35 3.88 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.064 0.459 . . . . 0.0 110.751 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 6.7 mtm-85 -76.62 128.31 34.46 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.587 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.57 -91.47 0.59 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.506 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.42 134.57 50.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.783 0.325 . . . . 0.0 110.723 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.453 HD21 ' CZ ' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -129.76 141.68 50.83 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.331 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 7.8 tt0 -100.37 139.57 35.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.676 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.0 128.79 35.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.91 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.56 137.11 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -125.01 143.83 37.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.248 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 5.9 tt -125.03 130.64 52.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.486 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.96 61.28 0.19 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.061 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 11.8 t70 66.76 169.26 0.24 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.179 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 5.9 p -97.46 152.75 18.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.384 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 71.33 108.11 0.06 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.703 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.978 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.609 0.243 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 pp -137.84 147.79 25.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.469 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.97 158.77 23.48 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.564 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.8 t -132.07 133.34 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.68 0.276 . . . . 0.0 110.963 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.01 107.62 18.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.104 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 tp -91.03 128.5 36.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.118 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 21.2 ttt -114.97 162.27 17.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.295 0.569 . . . . 0.0 111.274 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -99.48 123.48 43.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.798 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 t -159.32 126.34 4.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.784 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.04 33.79 23.56 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.326 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.81 120.73 3.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.206 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -85.53 -176.0 5.9 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.539 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 68.7 159.96 0.18 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.79 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.66 171.69 6.08 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.684 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.426 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 86.9 m-85 -58.2 -27.44 63.9 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.42 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.36 29.02 58.86 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.666 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.67 118.84 37.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.278 . . . . 0.0 110.727 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.18 113.43 25.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.928 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.423 HD12 HG21 ' B' ' 108' ' ' VAL . 5.9 mp -97.06 124.88 41.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 111.342 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -110.33 179.85 20.48 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -132.61 150.18 52.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.194 0.497 . . . . 0.0 111.354 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' B' ' 104' ' ' SER . 7.9 pt20 -134.42 141.56 46.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.473 HG13 HG21 ' A' ' 54' ' ' THR . 2.9 mm -87.84 121.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.401 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -126.41 171.54 10.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.205 0.526 . . . . 0.0 111.392 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.76 100.46 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.853 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -55.76 5.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.082 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -156.58 133.8 10.58 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.559 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.06 145.12 48.82 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.896 0.379 . . . . 0.0 111.28 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.5 m -65.31 120.07 12.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.588 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.82 164.59 7.75 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.003 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.63 27.77 14.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.34 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.52 -175.18 20.55 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.182 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.01 -31.1 69.69 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.17 -34.88 61.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.52 0.2 . . . . 0.0 111.138 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.84 -34.09 45.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.216 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -37.75 85.5 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.49 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -102.41 -32.7 9.86 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.349 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.56 53.92 8.07 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.141 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -70.03 -47.68 61.08 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.523 0.202 . . . . 0.0 111.296 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.49 136.17 53.22 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.902 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.81 141.79 28.32 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.207 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -56.99 109.66 0.68 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.186 0.517 . . . . 0.0 110.856 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.8 -7.77 38.95 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.708 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -67.16 138.58 57.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.078 0.466 . . . . 0.0 110.955 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 pt -77.33 120.93 28.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.811 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.42 HG22 ' CD1' ' A' ' 49' ' ' ILE . 24.1 mt -90.38 152.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.877 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tp -111.7 -52.2 2.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.831 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.14 147.9 40.86 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 111.568 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 37.4 mm -132.78 118.35 33.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 m120 53.28 36.71 23.44 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.754 0.311 . . . . 0.0 111.264 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.55 16.74 77.2 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.162 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 m -120.54 143.68 48.46 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.905 0.353 . . . . 0.0 110.094 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.421 ' HB ' ' CE ' ' A' ' 57' ' ' MET . 2.3 t -63.79 143.93 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 111.295 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.473 HG21 HG13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -127.72 27.86 5.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.945 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -123.99 126.76 46.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.013 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 72.0 -5.71 1.66 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.403 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.421 ' CE ' ' HB ' ' A' ' 53' ' ' VAL . 2.3 tpp -67.97 172.59 5.37 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.96 0.409 . . . . 0.0 111.439 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.7 t -90.81 150.96 21.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.244 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -42.01 82.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.793 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.7 t -57.66 -41.94 82.52 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.9 -46.11 86.31 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.95 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.06 92.28 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.29 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -71.38 -37.33 71.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.435 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -67.92 -38.24 82.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.63 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.72 -45.39 92.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.81 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.5 mt -68.73 -36.82 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.872 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -48.71 62.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.879 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.9 -24.52 62.49 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.775 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.4 p -79.38 65.37 4.53 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.116 0.484 . . . . 0.0 110.973 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -78.07 119.92 22.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.69 -89.45 0.46 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.29 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -126.35 130.22 50.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.625 0.25 . . . . 0.0 110.681 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.455 HD23 ' CZ ' ' B' ' 98' ' ' TYR . 0.6 OUTLIER -122.78 143.47 49.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.947 0.404 . . . . 0.0 111.233 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.2 tm0? -105.85 142.14 36.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.867 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -137.71 125.78 22.89 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.914 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.5 t -112.65 133.46 58.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.775 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.53 161.53 41.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.312 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.7 mp -101.42 131.28 47.6 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.257 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -144.14 63.8 1.32 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.538 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -48.81 102.91 0.04 OUTLIER 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.636 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.9 t -73.03 -29.59 63.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.087 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.9 mp -60.17 135.18 57.64 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.925 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.982 -179.923 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.659 0.266 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp -133.45 140.05 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.273 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.13 158.84 22.16 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.88 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 15.3 t -129.67 135.05 62.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.691 0.282 . . . . 0.0 111.028 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 7.4 tt -105.35 109.31 21.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.464 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.45 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 10.6 tp -94.04 141.34 28.64 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 13.2 ttt -115.09 165.73 12.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.096 0.474 . . . . 0.0 111.167 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -89.74 140.69 29.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.623 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -97.05 102.99 14.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.435 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 56.06 35.56 25.82 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.923 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 67.36 125.33 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.963 0.411 . . . . 0.0 111.478 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -149.81 149.12 30.04 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.195 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -68.5 86.23 0.3 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.675 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 67.13 164.69 0.21 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.155 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . 0.455 ' CZ ' HD23 ' A' ' 73' ' ' LEU . 53.1 m-85 -80.34 -29.52 38.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.756 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.89 20.04 38.06 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.552 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 4.8 mp -100.1 120.17 39.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.701 0.286 . . . . 0.0 110.804 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.35 113.57 26.77 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.973 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -113.51 125.02 53.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.151 0.501 . . . . 0.0 111.339 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -108.16 -162.11 20.85 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.003 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -141.72 146.51 36.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -126.66 143.19 51.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.222 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.495 ' CD1' HG21 ' B' ' 137' ' ' THR . 30.2 mt -88.4 120.71 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -122.15 172.3 8.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.805 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.423 HG21 HD12 ' A' ' 19' ' ' LEU . 57.9 t -84.06 94.14 3.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.174 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -64.17 -51.66 62.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.264 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -155.42 133.24 11.32 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.742 0.306 . . . . 0.0 110.784 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -121.45 144.26 48.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 89.3 m -66.51 123.43 20.02 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.01 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -65.53 162.07 18.85 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.127 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 62.03 35.31 16.05 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.122 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -117.94 -175.75 16.93 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.175 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 mt -65.43 -33.54 76.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.519 0.199 . . . . 0.0 111.48 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.95 -35.06 62.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.306 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.86 -33.9 45.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.186 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -62.65 -37.52 86.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.303 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.16 -29.93 11.84 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.563 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.75 48.27 43.27 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.289 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -72.26 -41.64 66.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.48 127.49 46.56 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.665 0.269 . . . . 0.0 110.827 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.08 136.35 33.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.0 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -49.71 107.0 0.13 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.051 0.453 . . . . 0.0 111.666 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.68 -2.95 24.65 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.411 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -76.17 139.96 41.5 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 117.654 0.727 . . . . 0.0 111.275 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.72 113.07 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.068 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 6.8 mt -82.52 137.22 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.294 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 tp -96.82 -40.24 9.03 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -148.61 148.23 29.89 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 111.909 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.482 HD12 HG21 ' B' ' 132' ' ' ILE . 18.4 mm -135.02 118.22 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.087 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 54.88 42.58 30.99 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.988 0.423 . . . . 0.0 111.074 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.14 16.09 76.79 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.139 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 13.2 m -120.74 137.47 54.48 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.934 0.367 . . . . 0.0 110.586 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.3 t -59.4 145.16 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.034 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.495 HG21 ' CD1' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -118.5 18.35 13.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.428 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' B' ' 140' ' ' MET . 0.3 OUTLIER -105.67 140.6 38.48 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.3 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 52.64 9.91 0.13 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.705 0.628 . . . . 0.0 112.349 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' MET . . . . . 0.41 ' H ' ' C ' ' B' ' 138' ' ' GLU . 0.0 OUTLIER -73.89 173.68 9.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 111.264 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.19 137.22 32.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.956 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.62 -40.73 69.22 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.388 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 1.2 p -64.16 -38.03 89.59 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.218 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.78 -48.22 72.54 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.756 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.49 -42.26 87.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.942 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -69.45 -37.49 77.38 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.576 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -67.81 -38.64 83.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.551 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 6.7 tt -60.02 -44.85 94.33 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.586 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 11.8 mt -68.34 -36.64 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.92 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -69.14 -41.75 76.89 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.714 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.1 0.07 52.83 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 97.1 p -91.51 54.8 2.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.263 0.554 . . . . 0.0 110.945 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.32 83.94 1.42 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.377 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 159.58 -90.27 0.11 Allowed Glycine 0 C--O 1.226 -0.375 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.302 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.24 133.71 41.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.501 0.191 . . . . 0.0 110.804 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.426 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.64 125.61 38.46 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 111.297 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 2.7 mt-30 -92.33 119.13 31.6 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.447 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.41 129.84 55.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.699 0.285 . . . . 0.0 110.988 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 27.0 t -116.48 140.29 39.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 27.0 t -132.19 138.01 53.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.092 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.18 117.94 27.42 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.861 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -97.43 166.26 11.62 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.922 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -46.85 128.36 10.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.639 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 28.3 m -140.27 172.9 12.09 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.463 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 pp -163.01 172.62 14.73 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.584 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptm . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.008 0.432 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 pp -130.99 155.61 42.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.253 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.22 158.69 24.45 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.57 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.3 t -131.87 134.44 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.68 0.276 . . . . 0.0 110.829 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.15 115.95 30.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.622 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 tp -102.79 142.53 33.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.444 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.492 ' HG3' ' N ' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -107.47 162.21 14.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.218 0.533 . . . . 0.0 110.589 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.492 ' N ' ' HG3' ' A' ' 7' ' ' MET . 11.2 ttpt -97.32 137.79 35.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.008 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -128.04 178.94 5.86 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.361 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 71.28 136.83 0.04 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.577 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.88 84.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.044 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 71.43 101.72 0.06 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.932 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -174.21 124.3 0.32 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.993 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.11 160.31 10.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.927 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.439 ' CE2' ' CD2' ' B' ' 156' ' ' LEU . 52.9 m-85 -58.79 -32.97 69.82 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.325 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.76 20.54 55.8 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.383 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -105.31 123.32 47.66 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.872 0.336 . . . . 0.0 110.556 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.73 113.57 26.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.337 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 mp -92.39 124.87 36.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.108 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.38 -173.84 22.43 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.52 147.34 31.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.291 . . . . 0.0 110.836 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -130.84 133.85 46.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.193 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 23' ' ' ILE . 46.1 mt -87.94 120.32 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.958 0.408 . . . . 0.0 110.327 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -126.72 173.19 9.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.191 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.3 t -85.5 97.71 5.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.018 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -55.4 21.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.266 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -147.19 144.64 29.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.922 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.24 148.76 45.08 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.948 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.4 t -65.83 132.86 49.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.056 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -74.72 148.33 40.59 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.566 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.7 31.4 21.11 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.24 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.46 -144.11 16.19 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.355 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 -38.45 17.61 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.71 0.29 . . . . 0.0 111.154 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.91 -30.17 61.19 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.251 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.14 -35.48 42.05 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.93 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -36.69 84.76 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.991 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.0 -28.14 13.92 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.102 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.34 49.19 53.72 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.507 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.407 ' HB2' ' HB ' ' B' ' 87' ' ' VAL . 11.8 p-10 -94.12 -32.16 13.87 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.64 131.08 56.84 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.674 0.273 . . . . 0.0 110.997 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.16 117.91 35.37 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -43.9 108.53 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.133 0.492 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.51 -5.37 31.35 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.346 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -75.85 139.99 42.0 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.854 0.827 . . . . 0.0 111.751 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.4 pt -80.13 118.45 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.175 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 mt -85.0 134.43 27.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.801 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 tp -99.42 -29.9 12.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.677 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -157.59 148.47 21.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.775 0.321 . . . . 0.0 111.425 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.5 mt -140.73 118.12 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.563 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 56.52 35.89 26.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.275 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 12.33 83.87 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.176 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.9 m -120.15 135.88 54.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.864 0.332 . . . . 0.0 110.398 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.3 t -59.83 147.46 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.826 0.346 . . . . 0.0 111.037 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.413 HG22 ' CD1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -122.17 19.02 10.75 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.396 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.423 ' C ' ' H ' ' A' ' 57' ' ' MET . 0.9 OUTLIER -106.27 144.4 33.02 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 p30 52.58 7.82 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 123.644 0.59 . . . . 0.0 112.376 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.423 ' H ' ' C ' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -76.15 176.58 7.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 111.123 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 t -92.12 146.72 23.5 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.756 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.52 -43.93 96.59 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.599 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.4 p -62.47 -38.22 89.0 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.069 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -48.01 75.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.905 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.4 ' CB ' HD11 ' A' ' 23' ' ' ILE . . . -62.22 -40.55 96.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.994 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -67.6 -39.28 84.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.77 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -66.59 -38.49 87.12 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.2 tt -59.91 -45.38 92.73 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.529 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.7 mt -68.5 -37.05 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.94 -49.46 57.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.108 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.48 -19.43 63.75 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.253 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 t -79.33 63.99 4.11 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.196 0.522 . . . . 0.0 110.574 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 mtm105 -79.08 97.72 6.24 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.413 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.67 -93.99 0.18 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.214 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.38 125.96 45.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.581 0.229 . . . . 0.0 110.66 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.442 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 2.3 pp -124.73 143.85 50.55 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.896 0.379 . . . . 0.0 111.188 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -105.14 142.65 34.54 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.779 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.442 ' HG ' ' CD1' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -135.34 132.28 37.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.819 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.53 135.0 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.292 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.5 m -122.98 146.59 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.196 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.9 tp -92.86 116.38 28.99 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.552 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.39 155.89 18.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.476 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 168.34 80.19 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.465 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 t -70.91 104.41 2.94 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.069 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.2 mt 64.42 162.75 0.13 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.597 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.409 HG21 HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -139.8 124.16 19.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.903 0.382 . . . . 0.0 110.751 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.84 157.21 15.27 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.447 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 39' ' ' ASN . 17.3 t -130.82 134.54 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 0.0 111.063 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.92 107.35 18.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.619 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 9.4 tp -95.19 139.54 31.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.392 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 8.2 ttt -114.52 164.4 14.04 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.993 0.425 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.02 119.15 36.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.172 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 12.8 m -155.4 34.89 0.37 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.917 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.77 115.61 1.63 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.238 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 65.78 123.04 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.864 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -70.04 79.09 0.49 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.71 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -169.92 179.6 3.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.796 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.2 167.18 4.23 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . 0.429 ' CE1' ' CD2' ' A' ' 73' ' ' LEU . 71.0 m-85 -59.48 -30.6 68.66 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.377 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.44 24.74 32.74 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.512 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 mp -108.48 120.5 42.6 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.757 0.313 . . . . 0.0 110.699 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -92.91 117.05 29.62 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.761 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 tp -94.7 125.2 39.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -116.46 177.09 16.7 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.658 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.22 146.59 46.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.904 0.352 . . . . 0.0 110.922 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -128.14 137.01 51.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.219 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.435 ' HB ' ' CG2' ' B' ' 137' ' ' THR . 42.3 mt -88.27 120.48 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.908 0.385 . . . . 0.0 110.457 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -124.73 172.59 9.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.079 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.74 96.03 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.146 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -57.6 6.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.689 0.28 . . . . 0.0 111.178 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.28 138.46 21.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.615 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -132.25 140.12 48.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.017 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 38.6 p -69.37 120.48 15.24 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -63.04 169.24 3.49 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.738 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m 62.01 23.66 13.97 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.946 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.16 -164.51 24.77 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.255 -0.497 . . . . 0.0 112.326 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.58 -31.41 53.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.579 0.228 . . . . 0.0 111.295 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.45 -34.96 63.3 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.186 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 2.1 p -79.0 -34.05 44.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.085 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -58.81 -39.53 81.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.264 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -103.92 -29.14 11.15 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.465 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.7 46.26 47.75 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.251 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -73.37 -38.44 65.69 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.514 0.197 . . . . 0.0 111.355 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 mp -127.61 139.37 52.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.763 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.2 148.35 27.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.43 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -60.31 113.32 2.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.086 0.469 . . . . 0.0 110.962 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.48 -16.12 24.38 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.009 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -60.6 136.09 57.95 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.317 0.559 . . . . 0.0 111.295 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.92 99.15 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.377 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 4.7 mt -63.52 147.42 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.681 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 18.2 tp -110.28 -35.46 6.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.617 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -157.32 148.26 21.54 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.783 0.325 . . . . 0.0 111.19 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 43.8 mt -141.04 118.25 8.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.752 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 3.9 m120 53.83 50.52 16.73 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.065 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.15 18.71 60.73 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.031 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 2.9 m -120.57 139.09 53.45 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.702 0.251 . . . . 0.0 110.33 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.4 t -65.73 145.11 14.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 111.293 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.435 ' CG2' ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -113.96 -1.79 13.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.196 179.38 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . 0.434 ' C ' ' H ' ' B' ' 140' ' ' MET . 0.2 OUTLIER -99.6 150.36 22.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 p30 52.41 8.57 0.08 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.571 0.544 . . . . 0.0 112.242 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' MET . . . . . 0.434 ' H ' ' C ' ' B' ' 138' ' ' GLU . 2.9 ttm -90.98 151.0 21.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.722 0.296 . . . . 0.0 110.764 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 30.0 t -71.8 145.78 48.45 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.014 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 6.1 tt -60.19 -47.97 83.7 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.705 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 3.2 p -55.52 -38.38 69.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.023 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.02 -47.93 69.94 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.69 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.54 -40.81 92.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.048 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -67.24 -39.23 86.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.664 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -66.85 -38.39 86.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.788 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.05 -44.45 94.68 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.772 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 29.6 mt -68.18 -37.46 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.967 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -68.95 -49.36 58.64 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.811 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -67.83 -25.46 65.57 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.02 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 43.8 t -76.39 65.69 2.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.039 0.447 . . . . 0.0 110.632 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -78.7 100.49 7.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.348 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 144.21 -94.78 0.18 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.962 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.9 126.25 46.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.636 0.255 . . . . 0.0 110.898 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.439 ' CD2' ' CE2' ' A' ' 15' ' ' TYR . 2.1 pp -123.76 132.71 53.86 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.837 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 0.0 OUTLIER -93.08 142.79 26.9 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.495 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.426 ' HG ' ' CD1' ' B' ' 156' ' ' LEU . 0.3 OUTLIER -133.26 128.22 35.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.022 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.43 140.2 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.589 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.57 160.69 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.836 0.351 . . . . 0.0 111.184 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.7 123.53 44.02 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.654 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 64.01 169.45 0.17 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.2 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 167.6 144.21 0.02 OUTLIER 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.828 0.451 . . . . 0.0 110.45 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 1.5 m 61.72 -176.23 0.13 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.404 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.04 171.19 7.48 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.982 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.193 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 tpt . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 120.757 0.313 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.95 133.48 13.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.335 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -120.93 157.03 16.03 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.781 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' B' ' 122' ' ' ASN . 21.8 t -130.41 135.21 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 0.0 111.352 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.12 108.99 20.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.639 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 tp -98.78 141.93 30.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.736 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.3 ttt -118.7 163.51 16.74 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.097 0.475 . . . . 0.0 110.904 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.24 134.69 37.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.072 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -168.63 125.38 1.0 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.695 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.43 35.59 23.0 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.342 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.48 124.01 1.64 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.276 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -104.42 -174.74 2.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.69 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 58.87 57.65 3.53 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.061 0.457 . . . . 0.0 110.443 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.48 -171.9 0.13 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.275 0.559 . . . . 0.0 110.844 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.415 ' CE1' HD22 ' B' ' 156' ' ' LEU . 62.0 m-85 -77.29 -9.62 58.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.85 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.55 24.12 71.23 Favored Glycine 0 C--N 1.341 0.851 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.483 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.8 mp -105.93 123.52 48.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.657 0.265 . . . . 0.0 110.508 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.19 113.04 24.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.013 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.79 124.79 40.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -106.57 -168.43 22.69 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.74 155.45 43.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.281 0.541 . . . . 0.0 110.687 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -136.81 131.35 33.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.437 ' HB ' HG21 ' A' ' 54' ' ' THR . 40.5 mt -87.72 120.28 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.012 0.434 . . . . 0.0 109.903 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.461 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 42.8 p90 -121.79 173.15 7.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.193 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.0 t -83.99 96.58 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.972 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.461 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -64.09 -52.57 58.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.932 -179.276 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -163.95 142.89 7.71 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.695 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -134.45 139.01 45.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.046 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.0 t -65.72 126.1 27.38 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.699 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 ptt85 -63.9 172.78 2.1 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.028 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.65 27.42 13.2 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.198 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.98 -174.17 18.58 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.243 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 mp -74.78 -26.92 60.09 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.52 -36.87 63.19 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.186 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.99 -33.8 44.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -65.71 -36.22 83.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.157 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.31 -29.79 12.96 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.406 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.1 42.1 85.26 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.112 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -70.72 -46.24 63.43 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.39 0.138 . . . . 0.0 111.291 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.438 ' CD1' HD21 ' A' ' 75' ' ' LEU . 8.5 mt -114.56 127.11 55.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.813 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 142.49 29.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.502 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -59.22 109.59 0.89 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.108 0.48 . . . . 0.0 110.465 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.83 -9.65 55.34 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.731 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -60.79 139.64 57.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.103 0.478 . . . . 0.0 111.172 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.19 118.4 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.765 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 46' ' ' ILE . 34.7 mt -89.09 152.04 3.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.786 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.35 -43.12 2.84 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.083 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 148.85 31.79 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.023 0.439 . . . . 0.0 111.958 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 66.8 mt -141.27 121.29 12.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.462 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 m120 55.34 34.2 22.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.398 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.92 9.58 84.22 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.663 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.2 m -119.86 138.16 53.57 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.155 0.478 . . . . 0.0 110.333 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 t -57.12 145.82 7.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.124 0.488 . . . . 0.0 111.006 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.437 HG21 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -130.54 28.88 4.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.972 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -98.3 -102.0 0.21 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.411 ' HB2' ' CD1' ' B' ' 142' ' ' LEU . 6.7 p30 -66.37 -2.86 4.96 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.2 tpt -52.77 164.18 0.39 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.167 0.508 . . . . 0.0 111.7 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 m -79.01 147.35 32.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.592 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' B' ' 139' ' ' ASN . 0.5 OUTLIER -61.99 -46.54 88.77 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.781 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 t -59.56 -41.77 90.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.83 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -66.85 -43.13 84.46 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.702 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.055 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -68.59 -38.59 80.79 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.463 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -38.4 82.78 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.816 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -43.5 98.44 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.75 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 11.4 mt -68.55 -38.08 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.709 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -68.49 -49.49 59.37 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.651 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -23.11 66.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.343 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.0 m -76.1 68.27 2.53 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.962 0.411 . . . . 0.0 110.67 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.0 119.29 20.53 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.505 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.84 -94.03 0.56 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.278 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.69 127.25 43.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.705 0.288 . . . . 0.0 110.804 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.416 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 2.2 pp -119.49 133.69 55.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 4.9 mm-40 -93.56 142.69 27.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.91 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.438 HD21 ' CD1' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -133.82 123.82 25.46 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.53 134.42 53.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.032 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.0 m -128.62 150.13 34.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.785 0.326 . . . . 0.0 111.549 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.8 tp -91.18 136.1 33.32 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.281 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.87 -169.09 1.97 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.63 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.07 136.27 0.03 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.782 0.325 . . . . 0.0 110.827 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 t -80.42 164.34 23.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.182 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.19 175.13 10.3 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.199 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.089 -0.958 . . . . 0.0 111.165 179.89 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.543 0.211 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pp -126.98 143.31 40.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.204 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.27 157.75 15.63 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.56 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 17.7 t -130.53 135.22 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.618 0.246 . . . . 0.0 111.206 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.51 113.99 27.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.81 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 tp -105.02 144.67 31.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 4.0 ttt -109.74 163.9 13.06 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.202 0.525 . . . . 0.0 110.848 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.45 138.39 34.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.089 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 60.4 p -117.47 141.99 47.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.743 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 65.41 106.95 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.759 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.98 70.63 1.04 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.072 0.463 . . . . 0.0 110.801 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -138.46 -49.79 0.55 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.579 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -127.24 178.84 5.78 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.132 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.1 -179.78 5.06 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.729 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -51.51 -31.5 24.18 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.49 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.14 26.62 65.92 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.579 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.14 119.47 38.8 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.682 0.277 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.01 113.37 25.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.294 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 mp -97.01 125.11 41.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -108.91 -179.0 21.52 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.427 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.62 144.74 29.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.018 0.409 . . . . 0.0 111.101 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -130.65 137.91 49.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.164 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.46 ' HB ' ' CG2' ' B' ' 137' ' ' THR . 18.8 mt -87.93 120.6 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.337 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -122.13 172.11 8.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.231 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 40.9 t -80.97 96.71 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.772 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.07 -57.06 7.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.103 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -155.13 147.68 24.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.657 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -138.13 147.9 44.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 111.007 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -65.28 121.86 15.79 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.849 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -69.04 157.03 37.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 68.68 14.16 8.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.484 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.59 -158.26 33.79 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.302 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp -81.85 -30.43 32.09 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.528 0.204 . . . . 0.0 111.543 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.06 -34.23 61.8 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.362 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.12 -33.96 43.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -37.8 85.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.353 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.89 -26.43 12.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.729 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.57 44.64 89.46 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.085 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . 0.415 ' HB2' ' HB ' ' A' ' 4' ' ' VAL . 9.5 p30 -58.75 -44.64 90.59 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.7 mp -133.14 142.51 48.71 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.692 0.282 . . . . 0.0 111.048 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.05 144.47 25.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.432 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -59.6 111.15 1.31 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 111.185 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.69 -9.0 23.84 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.186 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -68.1 135.55 52.35 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 117.307 0.553 . . . . 0.0 110.558 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -77.63 113.7 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.754 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 16.3 mt -81.6 133.98 28.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.268 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.17 -38.81 10.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.241 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -147.32 148.03 30.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 111.694 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 26.0 mt -136.35 119.43 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.414 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . 0.404 ' CB ' HD21 ' B' ' 148' ' ' LEU . 2.5 t-20 57.11 40.66 28.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.841 0.353 . . . . 0.0 111.024 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.5 15.4 77.42 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.142 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.84 141.56 50.45 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.0 0.4 . . . . 0.0 110.389 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.17 147.87 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.051 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.46 ' CG2' ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -121.69 20.31 11.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.807 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -105.75 138.53 41.79 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.473 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.405 ' HB2' ' CD1' ' A' ' 59' ' ' LEU . 11.4 p30 52.98 9.95 0.14 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.618 0.574 . . . . 0.0 112.295 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.77 172.08 10.44 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.771 0.319 . . . . 0.0 111.483 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 44.8 t -91.38 142.64 27.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.411 ' CD1' ' HB2' ' A' ' 56' ' ' ASN . 2.7 tt -59.18 -42.52 91.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.643 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.1 p -60.37 -39.67 88.06 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.771 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -48.21 74.83 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.957 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.81 -41.01 94.82 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.88 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -66.3 -39.92 89.67 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.437 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -38.23 82.33 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.398 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . 0.404 HD21 ' CB ' ' B' ' 133' ' ' ASN . 0.8 OUTLIER -59.97 -44.78 94.24 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.687 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 11.3 mt -68.49 -36.69 75.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.885 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.05 -48.85 61.78 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.81 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.01 -26.23 67.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.487 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.0 m -74.18 69.32 1.52 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.729 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.45 80.27 6.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.524 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 160.46 -81.94 0.14 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.025 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.1 125.89 25.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.544 0.211 . . . . 0.0 110.906 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.415 HD22 ' CE1' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -123.41 141.09 52.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.958 0.408 . . . . 0.0 111.226 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -102.77 136.86 41.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.727 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mt -131.85 129.87 40.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.971 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 34.2 t -115.0 136.26 52.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.786 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 10.0 m -141.19 161.91 22.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.912 0.386 . . . . 0.0 111.39 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.73 122.94 41.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.687 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -82.05 67.78 8.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.193 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 61.42 102.44 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.578 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.13 -60.29 2.39 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.749 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 mp -141.68 34.26 1.62 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.177 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.67 179.768 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpp? . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.655 0.264 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.59 142.36 43.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.199 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -138.57 156.78 24.31 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.867 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.5 t -129.06 134.27 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.868 0.366 . . . . 0.0 111.208 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.68 107.31 18.19 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.517 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.5 tp -94.47 137.47 33.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.501 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 17.5 ttt -113.65 163.81 14.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.991 0.424 . . . . 0.0 110.639 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.96 132.84 36.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.802 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.403 ' HB2' HD21 ' B' ' 116' ' ' LEU . 20.7 t -73.52 -171.55 1.02 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.047 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -74.79 69.24 1.81 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.052 0.454 . . . . 0.0 110.996 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.55 111.2 0.67 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.618 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.95 86.28 0.05 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.789 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -160.84 164.34 31.41 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.842 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -71.79 167.51 19.79 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.794 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -67.21 -27.69 67.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.526 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.69 23.18 70.57 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.384 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.77 120.23 38.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.593 0.235 . . . . 0.0 110.761 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.96 113.4 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.076 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 mp -99.12 124.85 44.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.163 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.85 -169.17 20.81 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.37 152.72 39.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.167 0.483 . . . . 0.0 110.582 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 6.9 pt20 -136.37 137.25 40.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.38 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' B' ' 103' ' ' GLY . 41.0 mt -88.03 120.37 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.131 0.491 . . . . 0.0 110.204 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.419 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 45.5 p90 -121.0 172.33 8.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.109 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -82.19 94.51 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.015 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.419 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -62.7 -52.33 63.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.042 -179.379 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.09 144.03 20.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.807 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 10.1 ptp -132.26 145.49 51.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.153 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -66.95 119.89 12.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.958 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.01 154.8 9.06 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.056 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.1 m 63.62 30.28 14.97 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.918 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.49 -173.16 25.94 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.158 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.49 -32.26 72.96 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.37 -35.81 63.54 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.024 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -34.07 44.29 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.046 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -39.94 77.54 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.563 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.35 -33.81 8.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.513 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.2 56.77 3.61 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.105 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.45 -52.76 4.35 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.543 0.211 . . . . 0.0 110.942 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.9 mp -103.34 116.43 32.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.579 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.52 138.1 31.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.371 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.29 110.14 0.58 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.209 0.528 . . . . 0.0 110.875 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.99 -9.95 29.46 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.693 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -65.97 137.5 57.17 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 121.036 0.446 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 pt -78.47 110.79 14.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.671 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.3 mt -77.76 133.95 29.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.921 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.11 -46.16 8.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.547 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -154.21 152.23 30.11 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.953 0.406 . . . . 0.0 111.48 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.7 mt -137.33 118.18 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.58 39.66 30.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.426 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.48 14.63 82.28 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.489 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.1 m -119.95 137.57 53.97 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 117.042 0.421 . . . . 0.0 110.279 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -60.63 144.32 13.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.092 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.404 HG21 HD13 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -128.4 26.71 5.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.365 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 9.8 tt0 -97.29 -109.92 0.16 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.417 ' HB2' HD13 ' B' ' 142' ' ' LEU . 6.7 p30 -63.45 -5.32 3.53 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.2 tpt -49.33 164.09 0.09 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.231 0.538 . . . . 0.0 111.895 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.7 147.26 45.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.587 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.92 -51.53 66.55 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.261 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.0 t -57.64 -38.69 75.47 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.301 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -64.17 -47.82 78.38 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.632 0.253 . . . . 0.0 110.766 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.81 -42.01 88.13 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.239 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 51.4 mtt-85 -69.65 -38.23 77.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -38.45 84.51 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.828 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.51 -43.75 96.76 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.89 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.1 mt -68.25 -37.3 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 110.692 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -49.75 59.53 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.769 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -68.32 -23.42 64.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.163 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.6 t -82.17 61.95 5.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 110.711 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -78.99 118.76 21.29 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.447 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.11 -99.77 0.59 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.966 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -118.03 131.58 56.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.754 0.311 . . . . 0.0 110.873 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.408 HD23 ' CZ ' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -128.16 144.24 51.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.039 -179.79 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.12 128.47 54.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.39 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.7 128.6 48.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.446 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.08 120.1 62.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.468 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -109.42 156.82 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.612 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.3 tt -111.2 125.25 53.6 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.87 -176.39 4.97 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.606 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 65.4 93.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.902 0.382 . . . . 0.0 111.042 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.5 p -95.49 29.41 2.58 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.544 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mt -159.24 -64.09 0.08 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.148 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 2.6 ptt? . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.532 0.206 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pp -131.73 146.61 33.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.354 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.83 160.59 22.85 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.831 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 21.1 t -130.71 131.75 64.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.781 0.324 . . . . 0.0 111.0 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -95.35 113.1 24.74 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.82 144.68 30.83 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.881 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.86 171.52 8.01 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.462 0.648 . . . . 0.0 111.125 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -89.65 135.98 33.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.26 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 3.8 m -118.88 179.22 4.21 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.009 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -85.05 82.52 8.4 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.955 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.1 -146.25 0.34 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.442 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -72.9 -69.08 0.43 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.678 0.275 . . . . 0.0 110.529 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.07 134.28 0.33 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 64.61 174.08 0.2 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . 0.408 ' CZ ' HD23 ' A' ' 73' ' ' LEU . 70.0 m-85 -67.31 -26.56 66.58 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.306 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.98 25.68 68.58 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.472 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -105.51 116.01 31.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.716 0.293 . . . . 0.0 110.385 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 125.7 34.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.528 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 mp -104.95 124.86 50.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.493 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -116.2 172.18 14.1 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.391 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 2.1 p -128.77 151.09 49.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.419 0.609 . . . . 0.0 111.763 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -133.41 136.97 45.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.162 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.493 ' HB ' HG21 ' B' ' 137' ' ' THR . 50.8 mt -87.98 120.16 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.963 0.411 . . . . 0.0 110.36 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -122.51 173.11 7.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.266 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 35.2 t -82.72 97.82 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.845 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.39 -47.76 63.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.048 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -162.56 145.2 10.99 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 11.3 ptt? -134.84 155.6 50.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.854 0.359 . . . . 0.0 111.166 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.36 120.07 12.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.702 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 145.36 47.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.135 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.7 27.89 14.84 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.156 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.33 -150.76 27.33 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.559 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 9' ' ' SER . 3.6 mt -84.38 -34.1 23.65 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -72.88 -32.26 65.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.176 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.81 -34.9 44.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.046 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -63.7 -36.41 83.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.162 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -98.21 -33.96 10.91 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.297 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.38 40.1 41.15 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.401 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -92.4 -36.64 13.02 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.469 0.176 . . . . 0.0 111.399 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 1.6 mt -98.73 74.99 2.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.03 130.73 47.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.561 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -56.63 108.08 0.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.271 0.558 . . . . 0.0 110.85 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.69 -13.05 46.59 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.785 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -58.53 137.17 57.59 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.2 0.524 . . . . 0.0 111.087 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pt -81.57 114.21 22.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.661 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 36.6 mt -84.85 149.51 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.072 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 8.3 tp -113.63 -41.54 3.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.751 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -147.23 148.31 31.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.894 0.378 . . . . 0.0 111.769 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 23.2 mt -138.92 119.77 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.391 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.44 38.16 29.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.47 15.2 81.68 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.211 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 39.3 m -120.61 141.21 50.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.965 0.382 . . . . 0.0 110.347 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.56 144.16 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.256 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.493 HG21 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -122.37 19.67 10.53 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.296 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.8 128.52 55.37 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 70.24 -3.51 1.8 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.188 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' MET . . . . . 0.452 ' HG3' ' N ' ' B' ' 141' ' ' SER . 0.1 OUTLIER -73.3 149.87 42.36 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.79 0.328 . . . . 0.0 110.496 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' SER . . . . . 0.452 ' N ' ' HG3' ' B' ' 140' ' ' MET . 33.4 t -71.49 150.08 45.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.372 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 56' ' ' ASN . 0.2 OUTLIER -58.08 -45.14 87.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.261 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 34.9 p -56.31 -40.22 74.02 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.08 -46.42 71.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.763 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.3 -39.83 94.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.338 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -70.23 -37.36 74.98 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.82 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.13 -38.79 82.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.634 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.19 -44.03 95.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.032 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 12.3 mt -68.38 -37.01 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.864 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.13 -49.69 54.72 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.067 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.21 -28.04 69.1 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.168 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 30.2 t -75.35 79.73 2.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 110.773 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -88.67 121.64 31.25 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.599 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 115.32 -92.22 0.58 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.308 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.46 135.05 53.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.639 0.257 . . . . 0.0 110.983 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . . . . . . . . . 2.5 pp -122.59 133.3 54.55 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -99.35 139.09 35.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.148 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 3.9 tt -137.29 142.08 41.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.839 0.352 . . . . 0.0 111.368 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 6.9 t -122.04 130.44 74.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.297 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 31.9 m -121.2 146.41 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.75 128.46 35.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.73 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 63.01 -176.75 0.15 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.889 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 65.0 105.03 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.461 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 2.6 m -162.29 155.03 19.77 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.47 152.86 23.65 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.755 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.518 -0.754 . . . . 0.0 111.477 -179.912 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.55 0.214 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp -143.14 156.66 17.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.421 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.42 168.46 23.09 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.978 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.449 ' CG2' ' HB2' ' B' ' 122' ' ' ASN . 23.5 t -128.51 132.94 67.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.658 0.266 . . . . 0.0 110.978 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 mp -95.79 124.28 39.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.8 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mp -108.31 134.25 51.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.623 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.3 ttm -109.11 163.83 12.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.239 0.543 . . . . 0.0 111.06 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -86.38 141.19 29.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.064 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 1.4 m -150.96 129.87 12.49 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.59 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 9' ' ' SER . 20.3 mtm180 72.25 138.51 0.05 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.527 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.78 82.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.005 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -128.59 148.16 50.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.481 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.84 108.27 2.09 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.673 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 49.05 -172.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.333 0.587 . . . . 0.0 112.243 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -77.81 -32.72 52.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.499 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.09 22.93 28.69 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.576 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.404 HD21 ' CB ' ' B' ' 117' ' ' ALA . 3.6 mp -102.76 119.09 38.23 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.647 0.26 . . . . 0.0 110.738 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.73 124.25 43.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.88 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -122.42 124.96 44.84 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.204 0.526 . . . . 0.0 111.741 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.24 -169.56 21.33 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.584 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.7 OUTLIER -146.75 148.76 32.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.162 0.481 . . . . 0.0 111.167 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -131.19 146.54 52.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.37 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.524 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 5.6 mt -88.8 121.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.995 0.426 . . . . 0.0 111.045 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.416 ' CD1' ' HG2' ' B' ' 105' ' ' GLN . 39.7 p90 -121.5 172.83 7.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.017 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.7 t -86.3 96.65 5.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.126 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -63.11 -57.26 11.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.92 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -151.57 135.43 16.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.94 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.8 148.28 41.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.6 t -65.28 142.05 58.4 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.074 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 154.72 26.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 55.37 29.23 12.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.466 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.24 -165.72 25.67 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.097 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.19 -30.32 54.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.614 0.207 . . . . 0.0 111.429 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.78 -35.85 64.98 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.216 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.64 -33.75 46.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.096 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -38.67 87.09 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.376 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -101.22 -31.81 10.82 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.641 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.1 43.21 27.06 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.177 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -51.42 -49.57 61.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.155 0.182 . . . . 0.0 111.328 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.93 157.76 45.44 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.869 0.366 . . . . 0.0 111.13 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 147.29 25.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.598 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.25 109.97 0.86 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.302 0.573 . . . . 0.0 110.935 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.93 -4.28 28.86 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.745 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -70.55 135.44 48.52 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.201 0.524 . . . . 0.0 111.099 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 pt -78.87 111.49 15.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.493 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 53.8 mt -79.77 146.1 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.302 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.3 tp -107.46 -37.58 6.17 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.73 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.04 147.76 31.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.874 0.369 . . . . 0.0 111.591 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 23.8 mt -137.7 118.34 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.5 m120 52.92 35.69 19.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.874 0.368 . . . . 0.0 111.383 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.68 15.89 74.52 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.146 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -120.89 141.05 50.98 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 117.061 0.43 . . . . 0.0 110.383 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.86 144.44 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 111.078 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.524 ' CG2' ' HB ' ' A' ' 23' ' ' ILE . 2.7 m -116.42 13.69 15.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.891 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.94 133.22 56.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.405 ' HA ' ' CD2' ' B' ' 142' ' ' LEU . 5.2 m-80 71.36 -6.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.391 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.1 tpt -69.75 170.89 10.06 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.846 0.355 . . . . 0.0 110.987 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -89.94 139.73 30.32 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.051 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.1 tt -55.89 -44.57 78.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.605 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -58.9 -40.14 83.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.821 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.2 -46.78 76.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.784 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.83 -42.1 92.82 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.951 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.35 -37.9 80.95 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.581 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -68.05 -38.56 82.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.719 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.2 tt -61.13 -43.92 98.13 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.724 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 8.0 mt -68.6 -37.03 77.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.023 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.16 -49.12 59.69 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.749 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.36 -25.06 67.87 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.372 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 t -77.51 68.12 3.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.083 0.468 . . . . 0.0 110.723 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.1 mtt85 -84.06 66.46 9.24 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.397 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.89 -75.61 0.07 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.659 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.94 128.94 29.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.711 -0.245 . . . . 0.0 111.242 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.445 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.9 OUTLIER -125.7 132.34 52.41 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.958 0.408 . . . . 0.0 111.077 179.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 4.2 tt0 -102.15 136.41 42.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.621 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.12 130.71 50.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.28 133.93 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.254 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.07 165.68 30.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.811 0.339 . . . . 0.0 111.443 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mp -115.44 116.86 28.93 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.089 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.05 115.61 17.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.707 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.36 116.01 1.05 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.453 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.2 p -66.93 116.81 8.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.048 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.2 -51.71 0.09 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.883 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.244 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.01 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 1.9 mtt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.861 0.363 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.47 HG21 HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -145.96 124.65 5.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -118.57 157.99 14.98 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 18.8 t -125.46 134.78 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.698 0.285 . . . . 0.0 110.962 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.42 125.6 50.76 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.713 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 11.0 tp -119.02 138.6 52.72 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.243 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.0 ttt -100.45 163.87 12.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 139.82 32.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.119 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.67 124.75 49.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.788 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 69.18 134.26 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.808 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.64 67.48 1.13 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.074 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -174.16 145.3 1.04 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.281 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 65.73 160.4 0.13 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.98 0.419 . . . . 0.0 111.535 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.95 178.35 5.69 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.672 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . 0.445 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 52.3 m-85 -57.97 -25.37 60.92 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.388 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.24 17.76 66.14 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.319 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.63 114.93 29.03 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 113.38 24.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.27 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.14 124.92 46.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.107 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.45 172.99 15.51 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.5 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 1.1 p -124.43 153.6 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.996 0.398 . . . . 0.0 111.167 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 21' ' ' SER . 2.4 pt20 -134.23 134.29 41.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.164 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.512 ' CD1' HG22 ' B' ' 137' ' ' THR . 19.9 mt -87.76 120.52 36.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.034 0.445 . . . . 0.0 109.866 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.455 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 47.8 p90 -121.8 173.72 7.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.218 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 39.8 t -84.68 101.49 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . 0.455 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 5.6 mmtt -70.35 -53.23 17.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.732 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -161.72 145.08 12.31 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.798 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -138.37 139.32 38.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 10.0 t -65.39 125.7 25.92 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.473 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.417 ' HA ' ' CG2' ' B' ' 118' ' ' THR . 0.0 OUTLIER -75.6 61.38 1.32 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.333 0.587 . . . . 0.0 111.3 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.41 27.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.955 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -130.11 -173.65 13.46 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.598 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.34 -32.17 72.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.595 0.236 . . . . 0.0 111.273 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.404 ' CB ' HD21 ' A' ' 17' ' ' LEU . . . -65.8 -41.19 92.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.325 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' THR . . . . . 0.417 ' CG2' ' HA ' ' B' ' 113' ' ' ARG . 11.0 m -78.91 -33.01 45.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.821 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -39.37 84.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.269 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.74 -32.76 9.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.618 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.89 40.12 26.55 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.275 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . 0.449 ' HB2' ' CG2' ' A' ' 4' ' ' VAL . 7.1 p-10 -71.04 -47.05 60.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.389 0.138 . . . . 0.0 111.207 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.426 HD11 ' CD1' ' B' ' 158' ' ' LEU . 21.0 mt -92.8 119.74 32.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.676 0.274 . . . . 0.0 110.717 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.6 136.87 34.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.459 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -58.45 107.76 0.54 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.164 0.507 . . . . 0.0 110.534 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 102.49 -7.84 54.27 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.64 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -63.02 138.92 58.7 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.154 0.502 . . . . 0.0 111.252 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 pt -76.41 121.73 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.707 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 12.7 mt -89.66 135.02 27.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 tp -97.1 -41.94 8.1 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.579 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -148.5 147.92 29.65 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.792 0.33 . . . . 0.0 111.487 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 20.1 mt -141.41 119.65 9.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.662 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 58.3 40.55 24.44 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.243 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.54 10.11 79.01 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.396 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.44 138.79 52.23 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 117.138 0.469 . . . . 0.0 110.204 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.3 t -59.45 147.93 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.163 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.512 HG22 ' CD1' ' B' ' 106' ' ' ILE . 0.3 OUTLIER -121.64 20.48 11.03 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.709 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.8 130.71 55.5 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 73.01 -10.49 0.99 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.499 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 1.2 tpt -65.49 169.21 6.3 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 121.016 0.436 . . . . 0.0 111.052 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 25.0 t -92.54 150.18 20.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.405 ' CD2' ' HA ' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -58.56 -44.15 89.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.89 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 8.9 t -59.25 -40.19 85.16 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.631 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.28 -44.98 82.04 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.716 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.79 -41.77 96.25 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.019 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.7 -37.82 76.75 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.37 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -67.86 -38.42 83.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.526 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -44.76 93.15 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.651 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . 0.433 HD13 HG21 ' B' ' 149' ' ' ILE . 59.1 mt -68.3 -36.95 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.685 0.278 . . . . 0.0 110.763 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -69.18 -49.08 59.91 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.882 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -70.2 -23.3 62.93 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.613 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 80.1 p -79.06 66.29 4.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.122 0.486 . . . . 0.0 110.625 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -74.55 126.6 31.12 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.544 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 115.12 -90.36 0.53 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.452 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.18 133.94 48.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 0.0 110.617 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.418 ' CD1' ' HG ' ' B' ' 158' ' ' LEU . 2.0 pp -124.59 144.26 50.25 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.412 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.412 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 55.5 tt0 -109.51 141.6 41.74 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.426 ' CD1' HD11 ' B' ' 123' ' ' LEU . 1.1 mt -135.02 132.5 38.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.972 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.02 137.78 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.297 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 7.8 m -135.21 161.77 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.818 0.342 . . . . 0.0 111.403 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 4.9 tt -119.72 125.82 49.57 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.017 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -99.5 168.54 9.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.897 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -46.24 146.69 1.29 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.933 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.47 157.54 26.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.304 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 3.8 tt -160.71 -59.79 0.06 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.162 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.612 -0.709 . . . . 0.0 111.296 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.566 0.222 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.46 131.91 14.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.944 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -139.45 156.81 24.82 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.835 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.451 ' CB ' ' HB2' ' B' ' 122' ' ' ASN . 18.1 t -131.34 134.63 60.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.777 0.322 . . . . 0.0 111.041 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.24 107.12 17.81 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.732 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.4 tp -92.7 134.79 34.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.289 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.97 171.37 7.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.387 0.613 . . . . 0.0 111.354 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.8 pttt -87.12 128.77 35.11 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.564 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.6 m -162.86 47.69 0.15 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.837 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -143.93 63.35 1.34 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.746 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 57.17 25.37 10.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.967 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.0 79.87 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.018 0.437 . . . . 0.0 111.725 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -158.12 70.49 0.55 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.757 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 47.91 -173.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.417 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 77.7 m-85 -100.28 -24.99 14.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.809 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.59 30.9 65.87 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.546 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.94 123.84 48.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.658 0.266 . . . . 0.0 110.942 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HB2' ' HG3' ' B' ' 110' ' ' GLU . 0.0 OUTLIER -100.19 113.22 25.73 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.08 179.487 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.0 mp -94.15 124.84 38.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.024 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.18 172.09 14.85 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.531 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.3 OUTLIER -132.47 149.02 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.006 0.403 . . . . 0.0 111.223 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' B' ' 104' ' ' SER . 7.0 pt20 -131.94 141.53 49.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.181 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.512 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 4.1 mm -87.81 121.69 38.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.304 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -125.93 171.5 10.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.413 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.7 t -84.36 100.18 7.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.04 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -56.12 8.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.893 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -157.15 145.84 19.74 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.992 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.53 143.8 41.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.274 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.8 p -65.71 121.08 14.18 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.616 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.68 163.85 6.76 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.204 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 62.88 25.09 14.9 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.278 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.37 -169.09 25.76 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.391 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.75 -30.17 62.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.81 -35.09 62.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.642 0.258 . . . . 0.0 111.025 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -78.68 -34.18 46.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.133 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -61.73 -38.15 86.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.197 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -98.98 -30.69 12.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.273 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.05 47.02 25.92 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.037 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -85.31 -40.0 17.04 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -106.34 125.46 51.02 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.652 0.263 . . . . 0.0 111.07 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 132.12 41.25 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.236 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.02 107.07 0.43 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.225 0.536 . . . . 0.0 111.012 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.87 -9.07 43.4 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.917 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -69.56 144.07 53.19 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.26 0.553 . . . . 0.0 111.294 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.2 pt -81.65 116.59 26.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.666 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.0 mt -83.03 137.72 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.71 -51.5 5.21 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.5 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -150.52 152.19 33.8 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.71 0.29 . . . . 0.0 111.2 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 29.7 mt -140.67 118.11 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.86 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.53 39.85 30.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.177 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.56 3.95 87.08 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.207 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.2 m -107.71 129.76 55.0 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.64 146.15 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.979 0.418 . . . . 0.0 111.079 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.512 ' CG2' ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -120.41 22.76 11.18 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.354 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.24 124.62 39.32 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 72.35 -9.23 1.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.444 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -69.94 174.48 5.26 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.868 0.366 . . . . 0.0 111.146 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.62 132.31 34.19 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.007 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 tt -54.25 -42.83 70.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.751 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -63.6 -38.48 91.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.085 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.2 -48.13 74.46 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.075 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.33 -40.52 86.59 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.227 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.69 -37.62 76.68 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.792 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -38.68 82.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.776 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.71 -44.21 93.81 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.787 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 8.2 mt -67.97 -37.47 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.825 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.86 -49.56 67.71 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.806 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -65.94 -26.74 67.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.423 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 86.0 p -84.85 60.69 6.35 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.114 0.483 . . . . 0.0 110.791 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -73.46 96.67 2.42 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.839 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.36 -92.19 0.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.249 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.28 130.45 52.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.709 0.29 . . . . 0.0 110.353 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.45 HD21 ' CZ ' ' B' ' 98' ' ' TYR . 0.7 OUTLIER -129.51 139.69 51.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.21 0.528 . . . . 0.0 111.528 -179.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -98.12 138.59 35.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.999 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 mp -136.6 127.62 27.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 111.316 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.4 t -113.53 134.45 56.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.372 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.7 t -129.26 140.81 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.073 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.69 137.62 32.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.749 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -87.75 54.93 3.28 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.037 0.446 . . . . 0.0 110.883 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.83 163.99 4.12 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.735 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.6 p -113.21 156.37 23.39 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.428 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.8 tp -135.35 121.75 20.49 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.026 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.885 -179.893 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 3.3 ttp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.794 0.33 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.06 132.75 39.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.013 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.63 160.96 22.84 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.744 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 26.3 t -130.77 135.1 60.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.72 0.295 . . . . 0.0 111.289 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tt -97.87 109.07 21.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.536 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 tp -104.44 144.84 31.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.075 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 38.9 ttm -113.13 164.19 13.81 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.117 0.484 . . . . 0.0 110.657 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -92.19 148.59 22.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.141 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -77.37 -174.25 3.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.83 26.4 9.11 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.571 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -166.03 37.4 0.05 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.641 0.258 . . . . 0.0 111.692 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.87 154.08 34.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.976 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -84.87 114.15 21.9 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.313 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 49.3 -173.23 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.686 0.616 . . . . 0.0 112.185 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . 0.45 ' CZ ' HD21 ' A' ' 73' ' ' LEU . 52.0 m-85 -72.86 -31.57 64.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.274 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.98 17.39 72.46 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.563 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -97.96 118.41 34.49 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -99.41 113.36 25.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.188 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -110.95 125.08 53.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.165 0.507 . . . . 0.0 111.16 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -107.4 -162.66 21.67 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.278 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -144.77 145.75 31.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 110.856 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 21' ' ' SER . 7.7 pt20 -128.12 140.35 51.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.496 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.47 ' CD1' HG23 ' B' ' 137' ' ' THR . 45.3 mt -88.14 120.38 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -121.62 172.94 7.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.874 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 42.9 t -81.66 93.51 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.31 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -63.51 -50.48 69.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.013 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . 0.4 ' HG3' ' HB2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -165.21 149.03 8.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.1 mtm -128.4 161.4 29.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.061 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 10.1 t -65.62 125.36 25.0 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.708 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -57.85 136.52 57.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.21 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m 60.86 30.28 19.55 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.05 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -87.6 -156.43 30.02 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.447 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 13.4 mt -82.44 -30.12 30.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.511 0.196 . . . . 0.0 111.349 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.23 -34.69 61.46 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.285 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.9 -33.85 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.074 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -38.69 84.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.374 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -103.04 -29.88 11.1 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.673 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.68 44.21 57.74 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.151 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . 0.451 ' HB2' ' CB ' ' A' ' 4' ' ' VAL . 8.5 p30 -63.31 -39.89 95.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.464 0.173 . . . . 0.0 111.341 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.1 pp -133.26 163.88 28.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.923 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.5 135.16 52.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.62 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -53.77 113.09 1.07 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.188 0.518 . . . . 0.0 111.076 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.08 -14.5 23.65 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.527 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -66.22 136.64 56.17 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.129 0.49 . . . . 0.0 110.887 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 5.8 pt -74.75 117.49 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.663 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.416 HD12 HG22 ' B' ' 129' ' ' ILE . 27.3 mm -83.19 137.55 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.909 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 13.4 tp -98.67 -40.94 7.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.001 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -150.03 150.83 32.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.969 0.414 . . . . 0.0 111.806 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.41 HG21 HD12 ' B' ' 132' ' ' ILE . 34.4 mm -137.01 118.82 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.89 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 56.2 31.54 18.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.682 0.277 . . . . 0.0 111.228 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.89 -2.3 85.65 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.178 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 13.4 m -104.66 131.98 51.45 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.075 0.437 . . . . 0.0 110.227 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.1 t -56.44 147.16 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.937 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.47 HG23 ' CD1' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -118.55 19.54 13.25 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.6 134.43 49.75 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 52.18 12.24 0.2 Allowed 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.636 0.585 . . . . 0.0 112.175 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.22 173.38 5.72 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.413 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.3 141.36 30.13 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 mp -58.41 -47.93 82.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.028 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 4.5 t -63.04 -37.06 85.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.776 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -65.61 -48.12 73.36 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.815 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.77 -41.15 90.45 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.397 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 17.8 mtt85 -68.27 -38.66 81.95 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.629 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -67.5 -38.35 84.17 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.97 -44.17 94.63 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.915 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 5.3 mt -68.17 -38.09 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.832 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.01 -48.47 62.94 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.922 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -69.53 -19.07 63.71 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.266 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 3.2 m -74.33 69.77 1.63 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.772 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -82.97 120.3 25.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.716 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.69 -88.94 0.51 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.515 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.04 130.65 51.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.683 0.278 . . . . 0.0 110.809 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.417 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -120.04 130.97 54.95 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.095 0.474 . . . . 0.0 111.394 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 9.4 tt0 -93.75 135.43 35.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.68 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.4 127.99 38.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 20.9 t -114.15 145.64 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.74 161.26 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.178 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 9.0 tp -89.19 118.63 29.03 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.38 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.41 139.31 1.66 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.646 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 21.6 t0 59.37 87.18 0.08 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.032 0.444 . . . . 0.0 111.174 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.15 112.4 17.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.738 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.16 154.96 32.47 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.091 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.152 179.928 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 tpt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.571 0.224 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.9 tt -145.8 123.18 4.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.113 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.8 156.87 21.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.711 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.9 t -132.67 134.18 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.777 0.322 . . . . 0.0 110.872 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.86 107.04 18.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.691 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.4 HD22 ' CA ' ' B' ' 117' ' ' ALA . 2.8 tp -91.87 134.01 35.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.312 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 ttt -123.09 163.18 21.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.127 0.489 . . . . 0.0 110.911 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.44 115.99 30.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.537 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.1 m -140.65 36.94 1.82 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.184 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.99 107.05 0.13 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.723 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 65.38 121.65 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.425 0.453 . . . . 0.0 111.447 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -69.64 83.48 0.44 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.939 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -145.78 165.34 29.11 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.795 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -66.53 169.91 6.95 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.206 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.412 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 78.6 m-85 -73.76 -27.95 61.43 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.67 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.97 27.59 58.08 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.653 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mp -108.04 121.07 44.07 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.748 0.308 . . . . 0.0 110.737 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -102.42 113.73 27.31 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.427 ' HG ' ' CG2' ' B' ' 106' ' ' ILE . 1.9 pt? -105.46 125.18 50.69 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.211 0.529 . . . . 0.0 112.098 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.36 -178.53 21.89 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.611 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -132.4 148.59 52.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.296 0.548 . . . . 0.0 111.565 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' B' ' 104' ' ' SER . 9.9 pt20 -135.37 145.73 47.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.593 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.473 HD13 HG23 ' A' ' 54' ' ' THR . 4.8 mt -88.42 121.34 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.036 0.446 . . . . 0.0 111.051 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -122.28 172.32 8.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.957 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.3 t -84.01 97.5 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.92 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -58.5 4.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.306 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -149.2 136.46 20.01 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.34 134.61 36.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.072 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.1 p -73.23 127.64 33.19 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.518 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.473 ' HA ' ' CG2' ' A' ' 35' ' ' THR . 14.7 ptt-85 -72.91 65.69 0.75 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.254 0.55 . . . . 0.0 111.219 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.41 25.38 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.023 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.22 -172.63 13.39 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.714 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 mp -69.97 -30.5 67.87 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.639 0.22 . . . . 0.0 111.567 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.62 -41.3 79.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.544 0.212 . . . . 0.0 111.133 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.473 ' CG2' ' HA ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -78.78 -33.4 46.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.827 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -65.49 -36.42 83.81 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.188 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.58 -32.33 11.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.483 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.0 40.15 57.5 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.268 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -83.01 -31.06 27.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.425 0.155 . . . . 0.0 111.311 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mt -115.28 123.67 49.39 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.699 0.285 . . . . 0.0 110.96 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.06 139.71 30.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.443 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.88 110.24 0.77 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 110.664 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.82 -11.25 45.53 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.705 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.84 138.13 57.42 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 121.05 0.452 . . . . 0.0 111.201 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -84.13 99.15 6.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.248 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mt -64.82 139.33 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tp -92.62 -38.98 11.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.416 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -149.95 150.7 32.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.745 0.307 . . . . 0.0 111.388 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.7 mt -138.1 118.1 15.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.402 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 m120 53.14 41.95 32.16 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.277 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.73 6.13 76.54 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.972 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -104.98 131.59 52.3 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.2 144.88 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.791 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.473 HG23 HD13 ' A' ' 23' ' ' ILE . 20.7 m -109.95 23.1 14.81 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.419 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -126.2 130.6 51.28 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.344 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.0 p30 51.53 11.63 0.13 Allowed 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.762 0.664 . . . . 0.0 112.718 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -174.77 0.68 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.899 0.38 . . . . 0.0 111.114 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.8 124.6 35.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tt -58.39 -44.19 88.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.784 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.445 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 7.1 t -63.5 -37.33 86.9 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.01 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -34.72 62.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.653 0.264 . . . . 0.0 110.593 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.34 91.08 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.24 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 60' ' ' THR . 1.4 ptt180 -71.97 -36.81 69.92 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.52 -37.85 83.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.239 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.41 -45.25 92.05 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.794 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 7.2 mt -68.77 -37.58 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.947 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -49.34 56.61 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -23.36 67.2 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.258 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.5 m -76.03 67.81 2.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 110.805 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 -90.85 53.16 2.32 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.705 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -171.83 -82.46 0.05 OUTLIER Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.294 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.83 126.38 36.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.637 0.256 . . . . 0.0 110.742 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.403 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -129.9 134.55 47.57 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.289 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -92.01 140.68 29.41 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.939 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.403 ' HG ' ' CD1' ' A' ' 73' ' ' LEU . 1.2 mp -134.07 128.14 33.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.962 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.8 t -115.78 142.95 26.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.851 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.62 155.43 41.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.798 0.332 . . . . 0.0 111.39 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.34 121.04 44.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.093 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.34 41.45 1.15 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.152 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 46.43 66.23 1.01 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.819 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.19 104.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.204 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.95 142.47 46.74 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.537 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.548 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 4.3 mtm . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.767 0.318 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 18.1 tt -132.2 134.27 59.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.055 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -123.62 158.63 18.23 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.671 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.5 134.0 61.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.856 0.36 . . . . 0.0 111.255 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.63 107.92 19.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.408 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.432 ' HB3' ' CE2' ' B' ' 98' ' ' TYR . 7.1 mp -96.37 144.73 26.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 9.8 ttt -116.35 163.57 15.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.814 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.89 133.67 36.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.155 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.91 175.46 10.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.091 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 40.5 mtt85 -94.23 57.69 2.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -173.42 101.21 0.12 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.365 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.1 t30 69.24 160.76 0.2 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.32 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -83.16 175.26 10.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.197 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 68.39 167.61 0.26 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.611 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' B' ' 89' ' ' LEU . 38.1 m-85 -93.86 -6.95 44.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.844 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.98 9.99 86.46 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.648 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.7 mp -105.7 115.06 29.6 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.659 0.266 . . . . 0.0 110.518 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.45 113.27 21.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.979 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.6 mp -96.77 124.75 40.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.064 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.28 174.84 15.55 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.558 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -133.17 144.73 50.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.983 0.391 . . . . 0.0 111.083 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -131.43 144.77 51.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.324 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.464 ' HA ' ' O ' ' A' ' 20' ' ' GLY . 0.9 OUTLIER -88.31 121.35 38.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.006 0.431 . . . . 0.0 110.803 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.408 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 32.1 p90 -119.26 171.82 8.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 35.5 t -79.69 91.91 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.97 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . 0.408 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -63.39 -45.54 90.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.971 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -163.49 132.14 3.84 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.718 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.92 146.88 50.15 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.826 0.346 . . . . 0.0 111.31 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 74.4 p -65.29 123.56 19.89 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 18.9 ttm105 -63.72 155.26 30.63 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.28 30.53 19.92 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.262 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.35 -168.74 26.81 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.24 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 mt -65.24 -36.74 85.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.538 0.208 . . . . 0.0 111.168 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.4 ' CA ' HD22 ' A' ' 6' ' ' LEU . . . -74.87 -33.14 62.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.387 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.77 -34.26 45.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.122 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -37.94 86.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.222 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.16 -30.57 12.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.484 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.15 51.5 10.07 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.314 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -87.12 -44.73 11.3 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 7.9 mp -123.46 124.84 43.77 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.741 0.305 . . . . 0.0 111.1 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.65 151.77 19.03 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.493 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -60.42 111.29 1.51 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.176 0.513 . . . . 0.0 111.048 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.28 -18.49 20.85 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.96 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -61.13 135.12 57.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.162 0.481 . . . . 0.0 110.523 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.63 120.76 30.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.264 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 29.0 mt -87.95 137.92 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.772 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 tp -100.14 -35.65 9.59 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.546 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 14.4 mttp -150.44 147.97 28.18 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 111.4 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 14.9 mt -140.66 118.42 9.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.541 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 5.8 m120 57.03 47.5 17.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.969 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 66.2 17.28 65.75 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.236 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 75.6 m -120.91 137.13 54.74 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.753 0.276 . . . . 0.0 110.286 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.71 145.24 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.875 0.369 . . . . 0.0 110.851 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.445 ' O ' HG12 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -114.8 0.65 13.87 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.815 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.77 129.14 34.86 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 69.95 -4.12 1.57 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.633 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.02 171.12 10.02 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.965 0.412 . . . . 0.0 111.156 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 3.6 m -91.91 146.97 23.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.28 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tt -61.55 -44.91 96.18 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.887 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 23.3 p -57.5 -46.29 83.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.115 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.87 -46.31 89.98 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.003 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.69 89.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.119 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 13.7 ttt180 -70.36 -37.24 74.56 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.411 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -38.41 82.81 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.745 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 7.2 tt -59.67 -45.19 92.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 35.0 mt -68.37 -36.89 76.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.807 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -61.79 -48.25 81.48 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.786 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -25.23 66.46 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.383 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 70.7 m -74.59 78.36 1.99 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.536 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -94.21 46.94 1.18 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.185 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -165.85 -83.34 0.05 OUTLIER Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.378 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -128.03 131.36 49.16 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.291 0.236 . . . . 0.0 110.521 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.412 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -129.9 136.48 49.56 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.001 0.429 . . . . 0.0 111.285 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 12.8 tt0 -97.39 140.95 31.09 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.551 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 5.0 mt -135.92 125.09 24.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.154 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 18.8 t -114.64 133.03 62.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 30.0 m -129.05 162.42 36.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.846 0.355 . . . . 0.0 111.284 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 9.6 tp -124.13 127.05 47.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -93.36 95.14 9.13 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.382 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.86 162.81 1.65 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.787 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 1.7 m 72.07 179.18 0.24 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.432 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -103.0 112.25 24.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.747 0.308 . . . . 0.0 110.672 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.318 -179.737 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.737 0.303 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.455 HG21 HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -127.66 123.3 60.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.904 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -117.45 159.09 14.25 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.924 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.0 t -123.92 134.57 66.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.789 0.328 . . . . 0.0 111.154 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.96 116.5 30.32 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.738 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 tp -109.79 144.53 38.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.731 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.7 ttt -112.39 163.2 14.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.188 0.518 . . . . 0.0 110.837 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -81.43 144.82 31.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.079 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.87 -169.08 1.44 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.866 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -78.57 64.06 3.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.899 0.38 . . . . 0.0 110.758 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.62 43.91 2.93 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 65.36 -81.87 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.092 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -158.21 163.89 37.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.52 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 69.48 151.08 0.09 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.429 ' CZ ' HD21 ' B' ' 156' ' ' LEU . 43.8 m-85 -86.48 -28.19 23.6 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.089 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.34 20.42 32.57 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.625 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.78 119.35 38.65 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.666 0.233 . . . . 0.0 110.678 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -96.25 113.52 25.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.81 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -108.13 124.76 50.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.18 0.514 . . . . 0.0 111.48 -179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.24 -166.25 21.24 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.922 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.3 OUTLIER -146.12 145.04 30.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.836 0.318 . . . . 0.0 111.254 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -125.24 138.88 54.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.885 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.459 ' HB ' HG21 ' A' ' 54' ' ' THR . 34.9 mt -88.0 120.49 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.649 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.443 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 46.6 p90 -123.55 171.15 9.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.15 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.6 t -81.47 98.68 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.775 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.443 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 1.6 tptp -70.46 -55.53 8.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.049 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -157.06 135.97 11.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.859 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.3 ptt? -120.55 150.74 40.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 111.244 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.6 m -66.36 122.31 17.24 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.96 162.68 18.73 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.925 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.24 30.84 20.19 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.358 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.74 -161.29 16.39 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.116 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.11 -31.43 39.18 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.868 0.334 . . . . 0.0 111.809 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.88 -37.41 62.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.521 0.2 . . . . 0.0 111.117 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.89 -33.62 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.225 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -59.52 -39.37 83.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.565 0.221 . . . . 0.0 111.491 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -102.63 -34.43 9.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.38 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.77 53.81 7.0 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.743 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -75.74 -36.99 59.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.421 0.153 . . . . 0.0 111.369 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 mp -129.16 138.44 51.77 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.775 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.98 145.71 25.2 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.694 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -61.38 112.36 2.15 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.208 0.528 . . . . 0.0 111.188 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.77 -10.76 18.54 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.015 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -67.53 134.66 51.7 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 117.291 0.546 . . . . 0.0 110.215 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -77.54 111.7 14.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.835 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.9 mt -77.4 138.72 19.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.051 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.7 tp -101.05 -38.05 8.34 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.24 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -149.81 148.06 28.74 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 120.943 0.401 . . . . 0.0 111.763 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 14.2 mt -139.58 118.6 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.155 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 56.86 37.08 28.57 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.31 6.66 88.85 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.594 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.6 m -114.12 138.97 49.73 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.166 0.483 . . . . 0.0 110.381 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 t -59.45 147.69 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.459 HG21 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -123.39 19.85 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.808 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.51 128.48 55.48 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 70.09 -4.38 1.54 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.606 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.5 173.89 5.49 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.937 0.399 . . . . 0.0 111.238 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.9 143.17 27.53 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.265 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -41.49 86.87 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.692 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -63.63 -39.39 94.24 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.011 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.67 -48.59 71.59 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.837 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.37 -39.43 90.59 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.461 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -72.46 -37.52 68.5 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.452 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -67.89 -38.27 82.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -45.28 92.54 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.552 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.5 mt -68.58 -36.78 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.912 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -68.94 -49.48 57.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.776 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -67.07 -24.42 65.97 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.314 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 t -75.49 71.33 2.42 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.03 0.443 . . . . 0.0 110.781 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.07 91.32 8.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.39 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.84 -83.02 0.15 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.082 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.454 ' CG ' ' HB3' ' B' ' 90' ' ' MET . 5.0 mttp -136.93 122.88 20.17 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.465 0.306 . . . . 0.0 110.455 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.402 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -108.62 141.46 40.53 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 111.315 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.3 tt0 -107.98 141.68 39.26 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.848 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.402 ' HG ' ' CD1' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -135.29 125.3 25.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.982 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.6 132.12 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.373 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.36 168.35 23.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.187 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.49 116.89 31.64 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.8 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.62 111.93 20.52 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.707 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -53.54 155.73 2.88 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.34 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.7 35.31 4.84 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.436 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.5 mt -89.81 155.57 19.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.718 0.294 . . . . 0.0 110.599 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.142 -0.933 . . . . 0.0 110.807 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.621 0.248 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.513 HG21 HD11 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -134.13 119.11 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.925 0.393 . . . . 0.0 111.048 179.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.24 158.04 22.76 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.666 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 15.2 t -131.47 135.17 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.73 0.3 . . . . 0.0 111.391 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 tt -102.58 124.12 47.55 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.572 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 8.8 mp -106.08 124.49 49.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.758 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' MET . . . . . 0.454 ' HB3' ' CG ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -96.97 155.74 16.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.042 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -88.67 119.4 29.11 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.375 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.41 144.45 22.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.761 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 58.54 33.32 23.01 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.499 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -169.31 125.26 0.88 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.056 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.66 29.52 3.68 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.164 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.26 -179.64 5.91 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.6 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -55.83 159.75 2.98 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 110.827 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -60.31 -26.27 66.41 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.21 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.88 21.14 54.09 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.866 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.76 122.84 38.97 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.733 0.301 . . . . 0.0 110.691 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.17 113.24 26.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.929 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -109.32 124.8 51.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.247 0.546 . . . . 0.0 111.074 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -105.09 -164.76 23.93 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.898 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.31 150.07 37.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.909 0.385 . . . . 0.0 110.831 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -130.02 135.98 48.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.819 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 20' ' ' GLY . 83.2 mt -87.91 120.89 37.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.369 . . . . 0.0 110.51 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.41 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 42.5 p90 -123.16 172.11 8.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.129 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 35.6 t -83.47 97.32 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.136 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . 0.41 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -65.31 -52.11 56.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.033 -179.542 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -162.31 138.49 7.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.879 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -121.66 152.48 39.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.907 0.384 . . . . 0.0 111.311 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 23.4 m -78.84 127.62 32.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.798 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 165.39 12.07 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.065 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.24 28.72 15.88 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.52 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.54 -174.94 19.97 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.318 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.04 -28.9 63.66 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.0 -35.09 62.02 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.181 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.14 -34.08 43.59 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.989 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -60.82 -38.44 85.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.563 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.25 -29.86 11.01 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.708 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.81 49.62 34.76 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.245 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -71.88 -40.3 69.02 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 mp -122.78 146.33 47.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.626 0.251 . . . . 0.0 111.045 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -104.53 139.61 39.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.584 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -55.0 112.76 1.12 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.2 0.524 . . . . 0.0 110.67 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.58 -13.44 39.09 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.391 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -62.16 138.1 58.35 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.974 0.416 . . . . 0.0 110.809 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 pp -76.77 125.65 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.641 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 20.8 mt -93.26 147.8 5.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.714 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 32.3 tp -114.9 -40.76 3.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.777 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -147.19 148.04 31.1 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.394 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 38.7 mt -141.45 118.85 8.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.215 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 8.6 m120 58.35 35.53 24.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.987 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.51 9.3 86.63 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.412 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -119.12 130.16 55.42 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 117.098 0.449 . . . . 0.0 110.395 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.22 147.03 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.101 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.435 HG21 ' CD1' ' B' ' 106' ' ' ILE . 0.0 OUTLIER -115.55 4.8 14.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.998 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.98 131.23 38.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 71.44 -4.84 1.74 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.458 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.78 171.04 9.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.997 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 38.5 t -87.01 144.4 26.92 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.11 -46.2 88.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.512 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.01 -37.16 83.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.774 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.8 -47.56 80.37 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.7 -41.84 87.23 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.935 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 76.9 ttt-85 -66.63 -39.97 88.52 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.299 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -38.15 86.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.805 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 8.3 tt -59.73 -44.31 93.83 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 39.1 mt -68.35 -37.19 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.611 0.244 . . . . 0.0 110.76 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -49.36 59.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.932 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -25.47 62.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.408 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 29.1 t -80.39 79.74 6.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.995 0.426 . . . . 0.0 110.597 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.82 126.64 35.77 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.542 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.16 -92.99 0.57 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.119 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -122.95 135.14 54.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.629 0.252 . . . . 0.0 110.717 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.429 HD21 ' CZ ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -129.58 132.31 46.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.119 0.485 . . . . 0.0 111.139 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.1 tm0? -94.58 139.09 31.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.316 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 5.5 mt -134.07 123.4 24.42 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.712 0.291 . . . . 0.0 111.009 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.91 135.71 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.465 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 18.4 m -136.13 158.57 38.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.175 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 18.9 mt -117.56 117.57 29.77 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.253 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -97.71 172.95 7.37 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.073 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.51 84.09 0.01 OUTLIER 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.805 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 28.3 p -170.81 -64.5 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.399 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.62 169.19 10.94 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.012 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.969 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.452 ' HG2' ' HB2' ' B' ' 162' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 120.415 0.15 . . . . 0.0 111.361 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.4 tt -141.43 139.27 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.717 0.294 . . . . 0.0 111.348 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.48 157.8 22.21 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.74 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.5 t -131.12 134.48 61.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.981 0.42 . . . . 0.0 111.351 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.0 mp -101.39 108.59 20.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.1 tp -94.7 141.91 28.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.619 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 ttt -126.19 164.27 21.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.116 0.484 . . . . 0.0 111.122 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -99.28 139.3 35.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.076 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -152.5 39.29 0.56 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.952 0.406 . . . . 0.0 111.456 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -138.44 -149.16 0.29 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.68 36.95 4.52 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.815 0.34 . . . . 0.0 111.48 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -133.66 145.38 49.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.605 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -98.0 51.4 1.04 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.027 0.442 . . . . 0.0 110.73 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -175.01 127.46 0.28 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.746 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -66.75 -28.69 68.61 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.972 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.4 19.8 37.28 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.694 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -98.49 116.57 31.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.572 0.225 . . . . 0.0 110.708 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.413 ' HB2' ' HG2' ' B' ' 110' ' ' GLU . 55.8 mtt85 -91.2 113.49 25.76 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.4 124.97 39.7 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.451 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.67 175.2 20.0 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.3 OUTLIER -137.08 144.41 43.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.033 0.416 . . . . 0.0 111.136 -179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' B' ' 104' ' ' SER . 9.8 pt20 -128.31 140.81 51.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.338 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.501 ' HB ' HG23 ' A' ' 54' ' ' THR . 15.8 mt -88.17 120.49 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -123.9 171.71 9.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.639 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.574 HG21 ' HB3' ' A' ' 40' ' ' LEU . 95.8 t -81.19 98.47 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.577 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -69.27 -57.76 4.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.356 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -156.13 139.77 16.01 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.786 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -124.83 156.42 37.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.289 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.8 p -65.26 121.54 15.02 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -58.84 145.99 38.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.064 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.2 m 64.32 32.92 11.86 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.312 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.25 -171.66 29.68 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.205 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.6 mt -69.25 -32.4 71.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.515 0.198 . . . . 0.0 111.332 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.02 -33.58 61.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.006 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.83 -34.67 45.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.044 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -63.48 -36.96 85.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.078 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -97.72 -31.6 12.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.422 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.81 50.59 10.8 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.729 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.401 ' HB2' ' CB ' ' B' ' 87' ' ' VAL . 13.3 p30 -89.32 -39.68 13.3 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.574 ' HB3' HG21 ' A' ' 25' ' ' VAL . 26.8 mt -111.72 121.18 44.41 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.668 0.27 . . . . 0.0 110.978 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 119.42 34.17 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.245 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -42.52 107.26 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.984 0.421 . . . . 0.0 111.818 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 117.02 -11.43 14.9 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.712 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -69.72 131.79 45.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.532 0.666 . . . . 0.0 111.286 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.6 pt -75.86 104.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.263 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.7 mm -66.0 141.65 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.394 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.72 -43.02 6.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.249 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -152.8 148.16 26.88 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.884 0.373 . . . . 0.0 111.588 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 41.6 mt -135.17 121.61 33.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.211 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 52.7 40.27 30.02 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.759 0.314 . . . . 0.0 111.11 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.15 17.61 78.81 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.062 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.5 m -120.37 141.64 49.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.861 0.331 . . . . 0.0 110.204 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.44 143.95 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.165 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.501 HG23 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -117.87 15.43 14.33 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.457 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.75 133.38 56.09 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 73.29 -11.57 0.89 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.328 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.466 ' HG3' ' N ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -73.8 152.92 40.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.671 0.272 . . . . 0.0 110.532 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.466 ' N ' ' HG3' ' A' ' 57' ' ' MET . 48.0 t -71.3 144.7 49.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.005 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tt -54.7 -42.32 71.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.753 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.24 -38.27 76.54 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.023 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.66 -47.83 77.01 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.839 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.36 -42.15 90.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.908 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.17 -40.09 90.22 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.66 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -64.88 -39.71 93.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -43.29 97.97 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 7.8 mt -68.61 -37.71 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.797 0.332 . . . . 0.0 110.656 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -69.05 -49.15 60.01 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -20.09 65.62 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.456 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -75.74 68.96 2.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.955 0.407 . . . . 0.0 110.915 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.28 109.14 14.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.49 -82.93 0.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.068 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 141.89 49.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.615 0.245 . . . . 0.0 110.673 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.521 HD21 ' CZ ' ' B' ' 98' ' ' TYR . 1.2 pt? -130.36 132.42 45.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.879 0.371 . . . . 0.0 111.475 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 52.9 tt0 -98.67 127.93 44.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.411 ' HG ' HD13 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -125.34 129.44 49.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.822 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.95 131.94 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.532 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.47 138.87 48.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.492 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 tt -121.62 117.53 26.94 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -100.73 77.07 1.85 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.02 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.9 t0 58.76 91.83 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.415 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -151.31 134.88 16.27 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.4 mt -78.73 176.41 9.54 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.298 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.093 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.881 0.372 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 10.8 tt -144.55 120.66 4.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.95 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.22 156.46 17.33 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.577 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.401 ' CB ' ' HB2' ' A' ' 39' ' ' ASN . 17.7 t -132.62 134.52 58.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.718 0.294 . . . . 0.0 111.103 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 107.03 17.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.536 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.41 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 16.9 tp -99.89 140.52 33.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.451 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 51.1 ttm -120.96 161.77 21.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.201 0.524 . . . . 0.0 110.783 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.59 144.79 28.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.824 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.45 22.46 7.88 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.72 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 178.76 124.76 0.05 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.733 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.7 83.76 7.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.88 0.372 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -148.56 -49.55 0.16 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.491 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -120.64 -179.9 4.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.018 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -90.06 -178.82 5.53 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.064 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . 0.521 ' CZ ' HD21 ' A' ' 73' ' ' LEU . 69.2 m-85 -73.56 -30.18 62.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.228 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.06 23.44 35.01 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.68 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 mp -103.61 122.27 44.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.758 0.279 . . . . 0.0 110.522 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -102.66 113.56 27.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.303 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 9.4 mp -98.16 124.78 42.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.949 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.48 -176.36 24.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.772 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -136.09 146.19 46.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.823 0.344 . . . . 0.0 111.0 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 21' ' ' SER . 8.9 pt20 -126.82 139.71 52.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.324 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.505 ' CD1' HG23 ' B' ' 137' ' ' THR . 50.2 mt -88.19 120.5 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.407 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -121.41 172.44 8.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.954 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 38.3 t -81.73 96.24 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.117 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -58.05 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.884 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 18' ' ' ARG . 1.7 pt-20 -157.24 137.74 13.01 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -119.79 161.44 20.76 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 111.68 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 51.9 m -78.46 140.31 38.64 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.33 152.24 36.44 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.103 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 64.88 16.59 10.58 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.168 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.31 -168.46 41.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.224 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.69 -27.32 58.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.8 -37.98 62.23 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.587 0.232 . . . . 0.0 111.213 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -33.74 43.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.827 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.0 -38.49 86.24 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.333 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.32 -37.6 9.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.222 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.08 55.7 3.46 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.309 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.98 -45.52 5.16 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.409 0.147 . . . . 0.0 111.377 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mp -85.25 119.92 26.17 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.79 0.328 . . . . 0.0 110.672 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.44 125.54 42.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.43 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -56.42 107.69 0.4 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.065 0.46 . . . . 0.0 110.916 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.13 -14.15 44.33 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.024 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.78 137.34 58.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.042 0.449 . . . . 0.0 110.983 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.75 105.19 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.288 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 7.8 mt -71.78 143.98 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.82 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 19.3 tp -105.81 -33.68 7.91 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.878 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -155.73 148.09 23.73 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.79 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 24.2 mt -137.95 117.73 15.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.146 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . 0.416 ' OD1' ' HB2' ' B' ' 156' ' ' LEU . 6.3 m120 56.73 36.81 28.22 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.043 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.5 13.74 82.21 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.305 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.5 m -120.45 128.46 53.19 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.922 0.361 . . . . 0.0 110.4 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.37 144.46 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 111.208 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.505 HG23 ' CD1' ' B' ' 106' ' ' ILE . 0.0 OUTLIER -109.16 11.28 25.65 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.595 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.79 132.98 44.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 72.47 -11.62 0.8 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.657 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -64.07 168.45 5.33 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 111.141 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.38 148.22 22.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.257 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.22 -42.88 82.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.861 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 69.4 p -63.03 -39.81 95.86 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.176 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -41.53 97.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.035 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.91 -44.57 91.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.868 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -69.91 -36.6 75.49 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.506 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -67.85 -39.28 83.83 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.766 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 5.6 tt -61.81 -42.42 98.99 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.785 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 14.7 mt -68.3 -38.16 79.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.589 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.16 -49.36 57.54 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.709 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -65.42 -25.86 67.72 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.236 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 10.7 t -84.44 63.41 7.81 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.015 0.436 . . . . 0.0 110.575 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.81 103.91 8.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.274 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 141.69 -93.11 0.18 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.088 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -123.8 126.98 47.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.543 0.211 . . . . 0.0 110.963 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.416 ' HB2' ' OD1' ' B' ' 133' ' ' ASN . 1.2 pp -124.18 126.89 46.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.999 0.428 . . . . 0.0 111.353 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.8 mt-30 -94.45 141.49 28.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.219 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 3.7 tt -137.33 140.51 41.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.034 0.445 . . . . 0.0 111.536 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 25.3 t -120.08 134.59 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.278 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.71 159.34 31.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.753 0.311 . . . . 0.0 111.309 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.41 128.99 54.46 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . 0.452 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 0.1 OUTLIER -100.45 164.06 12.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.174 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 66.43 175.31 0.24 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.298 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 1.3 m -142.14 36.95 1.55 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 62.1 83.9 0.15 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.843 0.354 . . . . 0.0 110.954 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.176 179.91 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.8 tt -142.79 123.17 10.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.725 0.298 . . . . 0.0 111.108 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -128.86 157.28 21.49 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.906 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' B' ' 122' ' ' ASN . 21.9 t -132.12 133.66 60.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.743 0.306 . . . . 0.0 111.193 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 mt -98.19 111.67 23.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.784 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 tp -102.16 134.11 45.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.394 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.4 ttm -109.11 164.16 12.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.643 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -98.03 116.34 30.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.729 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 t -104.26 30.92 4.92 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.126 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.05 125.27 3.48 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.391 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.1 56.32 3.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.025 0.441 . . . . 0.0 111.198 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 178.9 138.05 0.09 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 67.9 135.79 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.935 0.398 . . . . 0.0 110.985 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.54 177.88 1.82 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.485 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 62.7 m-85 -52.2 -27.4 14.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.776 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.71 18.16 62.27 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.431 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.75 115.14 27.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.715 0.293 . . . . 0.0 110.287 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -93.32 113.47 25.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.849 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -105.97 124.92 50.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 111.565 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -109.42 -176.81 21.33 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.55 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.34 146.46 35.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.905 0.353 . . . . 0.0 111.067 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -127.27 135.52 50.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.492 ' HB ' HG21 ' A' ' 54' ' ' THR . 42.2 mt -87.91 120.56 37.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.002 0.43 . . . . 0.0 110.557 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -123.71 172.57 8.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.062 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.0 t -82.37 100.15 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.795 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -70.66 -59.68 2.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.399 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.7 136.05 20.3 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.753 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 13.0 ptp -122.1 151.4 40.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.892 0.377 . . . . 0.0 111.211 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -65.53 134.34 53.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -71.86 146.95 47.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.773 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.27 33.58 14.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.258 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.78 -171.75 26.57 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.272 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -31.6 68.83 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.646 0.223 . . . . 0.0 111.423 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.93 -34.26 62.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.261 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.09 -34.0 43.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.079 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -64.06 -36.63 84.62 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.336 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.48 -30.5 11.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.421 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.36 45.26 61.39 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.281 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -74.61 -38.55 62.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.508 0.194 . . . . 0.0 111.391 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.6 mt -128.43 133.86 48.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.924 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.88 148.32 24.58 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.593 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -59.33 112.23 1.66 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.097 0.475 . . . . 0.0 111.001 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.26 -15.84 20.25 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.394 -0.821 . . . . 0.0 113.177 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -63.04 133.69 54.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.242 0.521 . . . . 0.0 110.285 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 pt -81.8 104.69 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 46' ' ' ILE . 64.4 mt -65.35 148.63 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.031 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -106.85 -45.81 4.1 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.6 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -149.27 148.16 29.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 111.768 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.446 ' CD1' HG22 ' A' ' 54' ' ' THR . 26.6 mt -129.74 118.06 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.496 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 m120 49.99 32.19 5.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.642 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.51 16.46 58.63 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.199 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.6 m -120.79 135.83 55.05 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.869 0.334 . . . . 0.0 110.355 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -57.83 142.38 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.848 0.356 . . . . 0.0 111.295 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.492 HG21 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -119.39 16.79 13.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.401 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.87 129.33 52.5 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 71.56 -6.6 1.37 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.255 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.03 173.95 4.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.937 0.399 . . . . 0.0 111.043 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.77 135.89 33.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.63 -43.08 79.9 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.889 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 43.4 p -64.72 -39.07 93.01 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.064 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.32 -47.99 68.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.816 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.37 -40.17 95.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.756 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -62.78 -39.79 95.3 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.447 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -65.35 -38.35 89.82 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.981 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -46.33 89.45 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.668 0.271 . . . . 0.0 110.745 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 mp -69.04 -36.49 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.841 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.6 -46.36 69.53 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.155 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -64.05 -28.22 69.64 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.0 t -78.53 88.8 4.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.959 0.409 . . . . 0.0 110.76 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -99.16 40.45 1.21 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.456 ' O ' ' HD2' ' B' ' 91' ' ' LYS . . . -151.37 -88.17 0.07 OUTLIER Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.284 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -129.46 122.16 28.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.619 0.247 . . . . 0.0 110.474 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.97 136.37 53.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.031 0.443 . . . . 0.0 111.116 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 22.1 tt0 -100.96 134.41 44.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.506 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 mt -127.4 137.94 52.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.015 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.3 t -120.16 139.55 47.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.7 t -115.34 142.49 28.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.183 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.6 tt -84.87 122.63 29.44 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -156.63 101.11 1.98 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.856 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.9 t70 176.47 108.81 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.633 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.9 m -143.69 127.81 17.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.043 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 69.93 150.96 0.09 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.808 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.395 179.932 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 120.602 0.239 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.5 pp -130.17 153.71 39.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.09 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.22 158.63 27.3 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.923 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.43 135.18 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 111.021 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.77 107.46 18.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tp -90.71 136.49 33.03 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.871 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 9.9 ttm -104.32 164.85 11.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 111.005 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . 0.456 ' HD2' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -81.52 146.0 30.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.128 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.7 t -163.09 97.84 0.93 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.413 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 59.02 32.29 22.12 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.079 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.94 82.12 6.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.925 0.393 . . . . 0.0 110.794 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -59.01 -32.94 70.17 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.369 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -141.63 74.71 1.47 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.798 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.98 173.8 0.23 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -58.41 -27.62 64.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.652 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.87 14.39 55.08 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.525 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 8.4 mp -101.55 119.94 39.55 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.746 0.308 . . . . 0.0 110.655 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -101.79 113.56 26.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.156 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -102.93 125.02 49.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 111.301 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.67 -170.81 20.31 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.377 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.59 152.16 38.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.979 0.389 . . . . 0.0 110.887 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -128.88 138.64 52.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.13 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.476 ' HB ' HG23 ' B' ' 137' ' ' THR . 26.8 mt -88.08 120.49 37.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.447 . . . . 0.0 110.492 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -121.69 173.23 7.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.044 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 46.1 t -82.51 98.03 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.046 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -44.98 71.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.039 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -155.0 160.91 41.43 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.947 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 18.1 mtp -138.13 162.13 35.02 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 111.136 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 5.7 p -95.9 124.39 39.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.643 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 160.51 19.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.03 0.443 . . . . 0.0 110.866 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 58.13 22.84 9.49 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.02 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -103.31 -172.04 26.02 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.203 -0.523 . . . . 0.0 111.961 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.24 -29.59 64.07 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.39 63.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.559 0.218 . . . . 0.0 111.077 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.23 -34.03 43.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.246 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -57.81 -39.76 78.37 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.444 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -104.14 -36.16 7.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.028 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.2 53.34 5.7 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.756 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . 0.424 ' HB2' ' CG2' ' A' ' 4' ' ' VAL . 8.5 p-10 -84.49 -36.5 22.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mt -115.44 128.02 55.74 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.735 0.302 . . . . 0.0 111.218 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.77 140.37 34.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.351 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -57.27 110.43 0.84 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.068 0.461 . . . . 0.0 111.33 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 115.47 -16.44 16.98 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.264 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.09 132.68 54.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.389 0.594 . . . . 0.0 110.499 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 pt -79.15 106.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.854 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 36.8 mm -71.15 146.5 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.247 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 9.7 tp -109.5 -43.09 4.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.323 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.31 147.91 34.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.785 0.326 . . . . 0.0 111.461 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 24.6 mt -137.86 118.14 16.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.39 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 m120 56.79 37.34 28.74 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.102 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.17 16.36 80.76 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.985 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -120.73 142.72 49.26 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.82 0.31 . . . . 0.0 110.21 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.75 144.47 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.003 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.476 HG23 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -122.64 19.64 10.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.313 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' B' ' 140' ' ' MET . 0.6 OUTLIER -112.0 142.15 44.77 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.365 179.608 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 53.15 9.08 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.218 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 140' ' ' MET . . . . . 0.411 ' H ' ' C ' ' B' ' 138' ' ' GLU . 0.0 OUTLIER -77.23 176.12 9.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 111.268 179.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 47.2 t -91.93 142.74 27.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.09 -45.14 95.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.896 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 10.0 t -65.29 -37.14 86.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.845 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.2 -47.89 66.67 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.82 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.83 -40.42 97.36 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.843 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -61.68 -41.13 97.15 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.274 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -38.31 90.58 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.943 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 9.3 tt -59.6 -45.87 90.65 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.556 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.63 -36.72 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.795 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.94 -49.06 61.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.819 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -26.9 67.54 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.419 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 32.4 t -75.1 71.83 2.18 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.138 0.494 . . . . 0.0 110.634 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -86.57 97.9 10.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.328 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 147.46 -85.01 0.17 Allowed Glycine 0 C--O 1.228 -0.275 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.244 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 131.1 37.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.646 0.26 . . . . 0.0 110.682 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.485 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.59 143.64 51.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.002 0.429 . . . . 0.0 111.545 -179.565 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 32.7 tt0 -103.16 142.44 34.14 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.403 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.7 mp -136.24 128.34 29.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 110.951 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -117.09 134.01 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 22.6 m -124.44 156.32 32.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.195 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt -124.58 123.08 39.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -104.6 137.98 41.63 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.147 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.74 117.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.474 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.22 -24.08 63.04 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.356 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.94 -29.77 70.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.669 0.271 . . . . 0.0 111.096 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.373 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 pp -138.62 140.62 38.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.719 0.295 . . . . 0.0 111.081 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.12 157.79 22.84 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.507 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.5 t -131.55 134.99 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.302 . . . . 0.0 111.368 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.5 107.24 18.9 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.512 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 tp -95.27 127.79 41.6 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.692 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 ttt -106.99 165.67 11.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.954 0.407 . . . . 0.0 110.945 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -93.31 145.96 24.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.016 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -147.99 47.93 1.07 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.986 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.27 -147.14 0.25 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.211 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.58 79.43 1.91 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.893 0.378 . . . . 0.0 111.301 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.54 78.13 0.3 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.328 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -151.38 177.82 9.89 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.156 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.51 155.83 18.22 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.501 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -60.13 -30.17 69.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.557 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.88 28.09 39.26 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.338 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.59 120.54 42.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.673 0.273 . . . . 0.0 110.62 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.68 114.82 27.47 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.399 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.09 124.92 42.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.153 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -110.23 177.88 19.83 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.764 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.11 146.66 49.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.067 0.434 . . . . 0.0 111.321 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -129.59 139.18 51.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.109 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.418 ' HB ' HG21 ' A' ' 54' ' ' THR . 55.9 mt -88.11 120.41 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.036 0.446 . . . . 0.0 110.71 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -121.18 172.44 7.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.912 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.92 93.76 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.967 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -50.68 63.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.928 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.412 ' HB3' ' HD3' ' B' ' 101' ' ' ARG . 6.3 tt0 -158.47 151.82 23.01 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.985 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.48 146.01 41.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.122 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.5 p -65.56 121.41 14.85 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.959 0.409 . . . . 0.0 110.767 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 151.08 22.1 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.101 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.05 31.74 13.34 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.281 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.76 -168.07 26.32 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.43 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 mt -70.32 -34.33 72.56 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 110.686 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.02 -33.7 61.81 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.896 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.1 -34.43 43.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.019 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.73 -38.76 82.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.406 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.9 -26.27 12.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.709 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.56 50.53 54.18 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.051 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.403 ' HB3' ' CG2' ' B' ' 87' ' ' VAL . 16.6 m-80 -78.19 -34.19 49.65 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.401 HD21 HG11 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -129.07 137.41 51.25 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.672 0.272 . . . . 0.0 110.897 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 143.0 32.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.74 113.44 1.65 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 111.344 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.4 -17.44 14.2 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.845 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.57 136.98 58.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.094 0.473 . . . . 0.0 110.999 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -81.19 109.86 15.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.575 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.3 mt -79.93 145.2 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.217 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -110.87 -27.29 8.89 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.007 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.25 147.97 19.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.263 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 28.8 mt -142.32 117.9 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.739 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 51.09 33.41 9.18 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.306 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.43 83.17 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.609 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -105.16 129.02 53.65 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 117.141 0.47 . . . . 0.0 110.443 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.8 t -64.42 146.81 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.392 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.418 HG21 ' HB ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -105.35 -10.52 16.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.487 179.518 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.84 142.33 27.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 p30 53.39 9.44 0.16 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.668 0.605 . . . . 0.0 112.271 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 ttm -90.43 149.66 22.15 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.675 0.274 . . . . 0.0 110.596 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 m -71.71 139.22 49.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.762 0.315 . . . . 0.0 111.14 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.1 tp -57.93 -42.68 85.34 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.396 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.8 m -56.98 -38.27 72.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.756 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -68.46 -47.93 65.86 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.533 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.04 -40.5 93.86 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.423 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -69.8 -38.44 76.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.5 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -38.34 85.47 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.52 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -44.5 94.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.873 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 10.6 mt -68.26 -37.49 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.72 0.295 . . . . 0.0 110.698 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.06 -37.96 78.8 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.946 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -89.8 1.42 56.17 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.1 p -90.94 56.52 3.23 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.196 0.522 . . . . 0.0 110.842 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.82 100.23 1.5 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.829 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.24 -91.52 0.17 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.273 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.65 135.44 47.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.571 0.224 . . . . 0.0 110.719 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.31 130.31 45.97 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.949 0.404 . . . . 0.0 111.009 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 15.8 mt-30 -98.05 142.44 29.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.785 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.38 127.93 40.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.908 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.02 142.77 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.6 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.401 HG11 HD21 ' A' ' 40' ' ' LEU . 34.1 m -136.12 158.55 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.178 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 tp -88.68 122.17 31.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.952 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.2 138.97 34.69 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.932 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 67.36 166.17 0.23 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.104 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.0 m -121.55 84.96 2.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.889 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mp -75.63 -55.98 5.14 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.753 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.879 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 3.9 mmt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.432 0.158 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . 0.497 HG23 HD11 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -122.8 133.12 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.844 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -151.55 159.92 28.49 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.938 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . 0.403 ' CG2' ' HB3' ' A' ' 39' ' ' ASN . 7.1 t -129.17 134.7 63.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.707 0.289 . . . . 0.0 111.262 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 9.7 tt -101.95 125.54 48.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.05 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 9.1 mp -112.35 124.72 53.1 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.966 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.3 ttt -116.07 159.26 21.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.632 0.73 . . . . 0.0 112.005 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.81 128.92 45.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.522 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.45 76.35 0.1 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.754 0.312 . . . . 0.0 111.11 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 177.41 36.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.022 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 41.31 75.01 0.09 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.863 0.363 . . . . 0.0 111.444 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -136.93 -176.78 4.48 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.996 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -118.45 113.0 20.68 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 46.89 -172.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.388 0.613 . . . . 0.0 112.444 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -94.11 -29.39 15.19 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.468 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.94 29.72 58.6 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.884 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.73 125.5 51.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.646 0.26 . . . . 0.0 110.756 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . 0.412 ' HD3' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -108.09 114.61 28.63 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.012 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.406 ' HB3' ' CG2' ' A' ' 23' ' ' ILE . 3.6 mp -89.38 128.5 35.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.264 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.16 168.48 13.36 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.601 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 2.4 p -127.66 149.93 49.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.036 0.446 . . . . 0.0 111.196 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . 0.436 ' NE2' HG22 ' B' ' 128' ' ' ILE . 6.9 pt20 -132.72 137.02 46.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.97 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.456 ' HB ' HG22 ' B' ' 137' ' ' THR . 69.4 mt -88.0 120.55 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 121.112 0.482 . . . . 0.0 110.482 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -122.82 172.79 8.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.972 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 39.3 t -80.42 95.96 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.778 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -65.69 -55.96 14.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.918 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.19 144.8 17.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.003 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -136.15 155.44 50.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.936 0.398 . . . . 0.0 111.394 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 11.8 p -78.62 124.59 28.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 ttp-105 -65.06 166.0 10.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.82 31.86 18.24 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.19 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -112.23 -158.05 13.91 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.259 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 2.0 mp -84.99 -29.96 24.59 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.526 0.203 . . . . 0.0 111.451 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.15 -37.49 61.33 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.634 0.254 . . . . 0.0 111.33 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -33.64 44.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.089 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -57.27 -40.86 78.59 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.198 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -102.09 -28.61 12.23 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.661 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.22 24.24 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.152 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -74.22 -47.25 36.62 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 6.6 mp -123.68 123.41 40.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.673 0.273 . . . . 0.0 110.842 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.41 150.52 21.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.769 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -59.46 111.09 1.26 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.08 0.467 . . . . 0.0 111.082 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.83 -18.76 19.18 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 115.41 -0.813 . . . . 0.0 113.26 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -59.14 135.41 57.63 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.236 0.518 . . . . 0.0 110.701 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.436 HG22 ' NE2' ' B' ' 105' ' ' GLN . 4.0 pt -81.77 113.7 21.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.196 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.431 HG23 ' CD1' ' B' ' 132' ' ' ILE . 5.7 mt -81.95 147.23 6.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.522 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 6.8 tt -110.25 -40.83 4.57 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.582 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -147.57 148.9 31.64 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.836 0.35 . . . . 0.0 111.937 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 32.6 mm -133.78 117.97 28.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 52.28 33.71 13.23 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.547 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.56 4.79 79.6 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.57 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 91.3 m -113.57 133.72 55.1 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 117.076 0.438 . . . . 0.0 110.464 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.1 146.16 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.456 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -125.78 25.09 6.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.47 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.03 130.88 55.99 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.073 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 70.8 -4.44 1.71 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.425 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.22 172.05 5.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.79 0.328 . . . . 0.0 111.007 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 43.4 t -88.34 145.33 25.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.375 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -40.84 83.24 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.848 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -39.21 86.62 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.81 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -65.57 -47.18 76.66 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.835 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.69 -40.94 94.05 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.15 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -69.52 -38.0 77.39 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.637 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -65.85 -40.1 91.39 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.947 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.03 -43.84 98.29 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.678 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 14.0 mt -68.32 -37.4 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.762 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -68.22 -49.58 59.77 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.044 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -68.39 -22.86 64.61 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.466 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.8 m -76.28 68.15 2.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.018 0.437 . . . . 0.0 110.771 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.13 91.31 7.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.467 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 155.85 -94.7 0.14 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.298 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -126.42 132.31 51.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.624 0.25 . . . . 0.0 110.406 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.456 ' CD1' ' HG ' ' B' ' 158' ' ' LEU . 1.3 pp -128.69 144.14 51.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.482 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 21.9 tt0 -111.05 143.05 42.37 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.633 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.456 ' HG ' ' CD1' ' B' ' 156' ' ' LEU . 0.5 OUTLIER -133.82 128.2 34.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.679 0.276 . . . . 0.0 110.969 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 12.9 t -112.2 131.89 62.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.519 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.0 143.46 40.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.889 0.376 . . . . 0.0 111.496 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.36 123.26 48.1 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.775 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 65.95 176.69 0.22 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.956 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 36.0 t70 177.31 156.93 0.33 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.676 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.8 t 60.39 33.84 20.7 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.961 0.41 . . . . 0.0 110.831 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.36 -178.86 5.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.827 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.169 -179.964 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttm . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 120.381 0.134 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp -117.3 126.55 74.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.865 0.364 . . . . 0.0 111.069 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.37 165.13 12.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.667 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.97 134.71 62.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 120.653 0.264 . . . . 0.0 111.116 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 mt -99.86 106.85 18.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.751 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tp -100.94 127.52 47.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.452 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.67 159.53 14.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.823 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.98 116.2 28.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.832 0.349 . . . . 0.0 110.971 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.3 t -147.84 113.7 5.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.24 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.74 58.77 2.72 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.119 0.485 . . . . 0.0 110.633 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.78 111.07 7.03 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.846 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.28 124.3 31.08 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.688 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 74.66 65.58 0.08 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.996 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 59.66 -172.52 0.12 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.552 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.5 ' CZ ' HD23 ' B' ' 156' ' ' LEU . 70.0 m-85 -63.58 -30.45 71.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.158 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.75 22.59 33.1 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.667 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.71 118.31 36.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.827 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.16 113.54 25.33 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.274 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.71 124.95 42.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.152 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -115.21 -172.77 17.37 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.778 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.09 151.36 39.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.813 0.34 . . . . 0.0 110.935 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -133.11 134.47 44.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.963 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.481 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 50.0 mt -87.82 120.18 36.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.061 0.458 . . . . 0.0 110.15 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -123.31 171.2 9.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.913 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.9 t -84.6 97.04 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.087 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -40.17 96.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.916 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -170.22 156.42 5.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.02 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -138.37 157.24 46.62 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.862 0.363 . . . . 0.0 111.159 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.43 126.53 28.54 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -62.07 145.03 54.4 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.77 33.26 22.69 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.472 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.59 -167.71 31.08 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.321 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 mt -67.23 -35.59 79.88 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.581 0.229 . . . . 0.0 111.211 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.08 -35.19 61.82 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.163 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.84 -33.87 45.62 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.022 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -40.23 81.83 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.245 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.1 -27.62 12.81 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.73 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.61 43.75 51.46 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.035 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -59.71 -48.91 79.8 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.43 147.28 43.14 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.697 0.284 . . . . 0.0 110.91 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 156.68 16.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.519 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -71.46 121.95 19.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.492 0.663 . . . . 0.0 109.898 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.41 3.24 35.38 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.948 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -85.94 135.14 33.79 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.419 0.609 . . . . 0.0 110.485 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.88 112.21 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.022 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.7 mt -79.04 146.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.502 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.4 tp -102.57 -43.95 5.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.394 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -151.93 150.98 30.65 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 111.372 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 28.3 mt -140.91 118.09 8.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.726 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 m120 54.44 33.72 19.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.125 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.0 -2.39 87.05 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.123 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.1 m -104.64 126.46 51.75 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.985 0.393 . . . . 0.0 110.385 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.37 146.19 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.881 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.481 ' CG2' ' HB ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.96 14.05 18.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.566 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.404 ' C ' ' H ' ' A' ' 57' ' ' MET . 0.5 OUTLIER -106.91 132.92 52.32 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.343 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.403 ' HB2' ' CD1' ' B' ' 142' ' ' LEU . 10.1 p30 53.18 8.89 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 123.672 0.608 . . . . 0.0 112.579 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.404 ' H ' ' C ' ' A' ' 55' ' ' GLU . 31.2 tpp -82.69 161.06 22.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.686 0.279 . . . . 0.0 110.831 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.91 128.21 35.03 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.987 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.9 tt -53.15 -42.57 66.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -61.65 -38.49 87.93 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.221 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.04 -48.05 77.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.939 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.34 90.39 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.061 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -71.03 -35.47 72.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.654 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.1 tpmp? -66.5 -40.73 89.38 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.026 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.66 -41.79 99.26 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.868 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.8 mt -68.3 -38.06 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.033 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -48.99 62.44 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -64.19 -26.59 68.59 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.062 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.4 t -83.97 93.34 8.04 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.797 0.332 . . . . 0.0 110.707 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.48 40.38 1.27 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -143.71 -87.68 0.09 OUTLIER Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.273 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.65 133.52 50.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.758 -0.221 . . . . 0.0 110.558 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.464 HD21 ' CZ ' ' B' ' 98' ' ' TYR . 0.8 OUTLIER -125.03 134.02 52.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.044 0.45 . . . . 0.0 111.369 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.491 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -97.65 141.08 31.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.464 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.12 124.6 22.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.73 0.3 . . . . 0.0 110.856 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.5 143.51 30.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.218 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 m -127.47 154.75 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.056 0.455 . . . . 0.0 111.705 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.82 137.77 47.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.534 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 63.93 -174.6 0.16 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.576 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 67.38 125.97 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.744 0.307 . . . . 0.0 111.438 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p 67.36 144.23 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.111 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 mt 68.38 154.25 0.1 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.048 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.969 -179.977 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.65 0.262 . . . . 0.0 111.706 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.59 152.62 23.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.733 0.301 . . . . 0.0 111.239 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.4 158.63 22.18 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.618 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 20.9 t -129.76 134.52 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.652 0.263 . . . . 0.0 111.292 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 8.8 tt -99.82 110.06 22.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.344 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 73' ' ' LEU . 2.8 tp -99.37 143.14 29.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.66 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 21.8 ttt -117.72 162.75 17.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.206 0.527 . . . . 0.0 111.316 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.28 145.53 28.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.001 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.33 70.38 0.19 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.017 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 41.2 mtt-85 61.07 92.79 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.612 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.1 29.84 1.45 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.979 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 69.06 -69.37 0.16 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.367 0.267 . . . . 0.0 111.523 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -160.12 118.66 2.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.74 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 66.14 165.34 0.19 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' TYR . . . . . 0.464 ' CZ ' HD21 ' A' ' 73' ' ' LEU . 58.8 m-85 -63.82 -27.06 68.92 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.207 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.76 22.17 37.35 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.727 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 mp -104.22 125.55 50.59 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.747 0.308 . . . . 0.0 110.552 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -105.97 113.82 27.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.21 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -106.66 124.96 50.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.192 0.52 . . . . 0.0 111.642 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -105.71 -165.15 23.39 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.978 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -145.67 148.86 33.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.825 0.345 . . . . 0.0 111.17 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -132.45 139.03 47.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.153 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' ILE . . . . . 0.531 ' HB ' ' CG2' ' B' ' 137' ' ' THR . 10.8 mt -88.19 120.62 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 110.588 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -122.42 171.98 8.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.181 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 29.7 t -82.08 98.04 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.806 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.03 -53.26 40.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.195 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . 0.4 ' HA ' ' HG2' ' B' ' 125' ' ' GLU . 2.6 pt-20 -162.06 138.67 8.04 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.927 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.2 161.35 19.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 111.31 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.5 p -78.03 120.26 22.61 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.65 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -61.34 149.28 38.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.157 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.2 m 67.67 25.51 8.14 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.377 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.18 -171.18 27.24 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.42 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -29.32 62.88 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.07 -34.42 61.78 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.124 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 1.2 p -78.94 -34.15 44.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.95 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -38.63 83.76 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.358 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -102.02 -31.2 10.77 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.401 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.26 45.96 28.83 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.251 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -75.68 -39.28 57.81 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.539 0.17 . . . . 0.0 111.4 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.418 HD12 ' HG ' ' B' ' 158' ' ' LEU . 16.2 mt -121.82 121.86 38.16 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.994 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.48 147.31 23.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.4 ' HG2' ' HA ' ' B' ' 110' ' ' GLU . 4.8 mt-10 -59.45 111.22 1.31 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.955 0.407 . . . . 0.0 111.17 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.31 -16.33 24.68 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.46 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -58.13 134.35 56.39 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.408 0.604 . . . . 0.0 110.777 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 8.5 pt -83.74 99.79 6.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.601 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . . . . . . . . . 9.9 mt -66.78 136.74 26.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.246 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 tp -96.09 -42.13 8.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.619 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -146.23 147.79 31.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.764 0.316 . . . . 0.0 111.548 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 34.2 mt -134.9 117.93 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.757 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 50.9 44.18 28.35 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.494 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.22 18.42 78.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.008 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 30.6 m -120.72 142.22 49.71 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.81 146.08 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.982 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' THR . . . . . 0.531 ' CG2' ' HB ' ' B' ' 106' ' ' ILE . 1.4 m -120.98 16.94 11.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.917 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -117.45 131.34 56.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 71.12 -6.55 1.29 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.554 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.2 171.49 5.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.002 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 20.8 m -87.35 139.6 30.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.218 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' LEU . . . . . 0.403 ' CD1' ' HB2' ' A' ' 56' ' ' ASN . 9.0 tt -56.01 -44.87 79.11 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 58.1 p -61.91 -40.2 94.64 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.805 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -62.97 -48.08 80.42 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.19 -42.03 85.23 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.071 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -69.49 -37.46 77.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.746 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -68.11 -39.4 82.81 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.661 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.92 -43.8 94.69 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.675 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 11.7 mt -68.27 -37.58 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.837 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.78 -49.68 56.65 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -21.64 63.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.294 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 37.8 t -82.2 66.48 7.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.13 0.491 . . . . 0.0 110.532 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -77.24 122.78 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 126.01 -92.09 0.4 Allowed Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.158 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.59 133.72 48.4 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 156' ' ' LEU . . . . . 0.5 HD23 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -124.3 143.01 50.81 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.925 0.393 . . . . 0.0 111.357 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 2.6 tt0 -105.23 131.67 52.4 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.849 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' LEU . . . . . 0.43 ' CD1' HG22 ' B' ' 132' ' ' ILE . 0.4 OUTLIER -127.78 133.47 49.46 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.82 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.29 140.1 44.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.669 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 9.0 m -133.24 152.02 34.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.421 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 4.3 mt -103.72 123.68 47.49 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -132.16 159.98 37.38 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.969 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 1.3 t0 63.0 87.27 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.909 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 18.8 m -81.44 115.56 20.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.009 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 4.8 mt -135.78 90.64 2.62 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.834 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.443 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.819 0.342 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -96.28 157.48 21.47 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.402 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' B' ' 122' ' ' ASN . 21.4 t -131.35 134.03 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.708 0.29 . . . . 0.0 111.288 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.76 HD23 ' HD3' ' B' ' 155' ' ' LYS . 4.0 mp -103.13 115.02 29.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.508 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.505 HD21 ' N ' ' B' ' 117' ' ' ALA . 3.5 tp -104.98 126.28 51.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.709 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.71 ' O ' HD13 ' B' ' 116' ' ' LEU . 0.0 OUTLIER -98.16 161.41 13.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.743 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.983 -179.806 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.744 0.307 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.709 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 78.7 m-85 -58.24 -23.15 54.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.346 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.93 27.53 68.6 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.432 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.495 HD11 ' CB ' ' B' ' 117' ' ' ALA . 0.2 OUTLIER -103.06 120.84 41.39 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.631 0.253 . . . . 0.0 110.782 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.406 ' HB2' ' HG3' ' B' ' 110' ' ' GLU . 0.2 OUTLIER -98.48 113.36 25.35 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.463 HD22 HD11 ' B' ' 149' ' ' ILE . 10.1 mp -105.99 124.95 50.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 111.215 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.19 178.31 19.49 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.637 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.562 ' OG ' HD12 ' B' ' 142' ' ' LEU . 0.6 OUTLIER -139.99 142.92 36.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.152 0.476 . . . . 0.0 111.205 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' B' ' 104' ' ' SER . 11.0 pt20 -129.31 154.42 46.88 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.673 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.593 HD11 ' HB3' ' A' ' 57' ' ' MET . 3.2 mt -90.32 120.77 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.378 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.406 ' CE1' ' CG ' ' B' ' 105' ' ' GLN . 39.9 p90 -118.31 173.02 7.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.558 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.871 HG21 ' HB3' ' A' ' 40' ' ' LEU . 21.5 t -79.16 94.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.102 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -48.94 71.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.423 ' HG2' ' HB3' ' B' ' 101' ' ' ARG . 5.1 pt-20 -167.01 153.74 8.54 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.907 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.37 161.47 34.43 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.834 0.35 . . . . 0.0 111.063 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -70.55 135.66 48.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.002 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -68.91 144.75 54.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.707 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 58.06 31.02 20.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.337 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.78 -174.35 29.37 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.165 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.591 HD13 ' O ' ' B' ' 90' ' ' MET . 0.2 OUTLIER -67.22 -31.06 71.17 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.45 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -75.15 -39.06 60.7 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.568 0.223 . . . . 0.0 111.452 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -33.71 44.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.167 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -63.28 -37.06 85.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.382 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -100.3 -30.91 11.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.684 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.25 47.14 24.25 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.341 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.665 ' CB ' HG11 ' B' ' 87' ' ' VAL . 10.4 p-10 -63.07 -48.33 79.12 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.46 0.171 . . . . 0.0 111.319 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.871 ' HB3' HG21 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -134.06 144.29 48.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.723 0.296 . . . . 0.0 111.21 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 148.24 22.35 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.629 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 27' ' ' GLU . 4.5 mt-10 -59.01 110.91 1.13 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 111.234 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.75 -16.4 21.15 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.191 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -60.39 134.71 57.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.244 0.522 . . . . 0.0 110.704 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.8 pt -79.86 119.86 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.961 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.709 ' HB ' HG21 ' A' ' 54' ' ' THR . 38.0 mt -88.97 137.54 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.961 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.82 -41.82 8.27 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.329 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.68 147.67 34.62 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.744 0.306 . . . . 0.0 111.069 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.418 HG13 ' OG1' ' A' ' 54' ' ' THR . 14.7 mt -136.65 117.94 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.676 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 52.25 44.54 29.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 111.224 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.17 17.86 76.15 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.042 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.3 m -120.74 139.39 53.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.759 0.28 . . . . 0.0 110.374 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.5 t -59.8 145.86 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.149 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.709 HG21 ' HB ' ' A' ' 46' ' ' ILE . 2.5 m -120.69 20.89 11.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.686 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.512 ' H ' HG12 ' A' ' 53' ' ' VAL . 2.7 tt0 -119.33 129.65 54.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 70.66 -7.67 1.02 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.57 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.593 ' HB3' HD11 ' A' ' 23' ' ' ILE . 10.5 ttt -66.07 150.66 48.36 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.808 0.337 . . . . 0.0 110.622 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.9 t -71.8 143.47 49.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.079 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' B' ' 139' ' ' ASN . 1.1 tt -57.73 -46.19 84.78 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -40.43 82.37 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.055 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -64.08 -47.64 79.31 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.006 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.501 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -59.25 -41.55 89.02 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.003 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -37.96 81.74 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.635 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -38.68 83.18 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.733 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.417 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -59.87 -43.32 94.79 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.923 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.668 HD11 HD22 ' B' ' 102' ' ' LEU . 14.3 mt -68.18 -37.84 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.546 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -66.83 -49.56 65.38 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.781 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 65' ' ' LEU . 14.6 pttp -68.77 -22.22 64.3 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.437 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.9 t -74.87 73.15 2.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.034 0.445 . . . . 0.0 110.704 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.26 105.84 16.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.474 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.1 -91.19 0.21 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.239 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -129.34 134.11 47.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.735 0.302 . . . . 0.0 110.652 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.881 HD23 ' CE2' ' B' ' 98' ' ' TYR . 2.1 pp -123.47 143.96 49.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.488 ' OE1' HD11 ' B' ' 88' ' ' LEU . 31.9 tt0 -112.22 140.48 46.88 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.867 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.774 HD11 HD11 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -135.42 128.64 31.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.861 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.0 t -109.74 138.84 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.939 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.781 HG22 HD21 ' A' ' 40' ' ' LEU . 4.2 t -121.13 154.31 24.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.288 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 N--CA 1.463 0.197 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.511 179.335 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.523 ' C ' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.876 0.369 . . . . 0.0 111.007 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.48 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -120.02 157.69 15.55 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.791 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.665 HG11 ' CB ' ' A' ' 39' ' ' ASN . 16.8 t -131.58 135.31 59.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.769 0.318 . . . . 0.0 111.313 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.488 HD11 ' OE1' ' A' ' 74' ' ' GLN . 2.7 mp -104.47 114.94 29.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.62 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 tp -102.16 133.36 47.13 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.978 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' MET . . . . . 0.591 ' O ' HD13 ' A' ' 33' ' ' LEU . 5.7 ttm -105.06 164.47 11.78 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.036 0.446 . . . . 0.0 110.95 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 3.7 pttm . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.908 179.8 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 120.713 0.292 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.881 ' CE2' HD23 ' A' ' 73' ' ' LEU . 70.6 m-85 -77.0 -32.12 56.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.394 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.73 26.83 55.57 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.394 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.672 HD13 ' HB3' ' B' ' 98' ' ' TYR . 6.2 mp -104.83 123.12 47.13 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 110.812 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' ARG . . . . . 0.423 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -98.03 113.68 25.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.245 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.668 HD22 HD11 ' A' ' 66' ' ' ILE . 1.9 mp -98.26 124.69 43.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.983 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.88 166.21 12.14 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.918 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 1.6 p -121.07 150.71 40.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.028 0.414 . . . . 0.0 111.244 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -137.49 145.38 42.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.459 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.633 HD12 HG23 ' B' ' 137' ' ' THR . 2.6 mt -88.86 121.14 38.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.175 0.512 . . . . 0.0 111.324 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -118.78 174.54 6.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.568 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 0.919 HG21 ' HB3' ' B' ' 123' ' ' LEU . 39.0 t -83.37 95.57 3.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.135 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -63.32 -56.33 17.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 110.573 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.406 ' HG3' ' HB2' ' A' ' 18' ' ' ARG . 14.0 pt-20 -163.99 146.26 9.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -133.37 156.02 48.4 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.804 0.335 . . . . 0.0 111.349 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.26 132.49 49.2 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -67.57 147.82 52.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.929 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 5.2 m 61.85 33.78 17.45 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.243 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.38 -170.31 28.08 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.146 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.71 HD13 ' O ' ' A' ' 7' ' ' MET . 7.4 mt -72.84 -30.06 63.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.676 0.238 . . . . 0.0 111.477 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.505 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -75.18 -36.73 61.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.173 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.79 -33.86 52.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -61.57 -38.43 87.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.217 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.88 -28.29 13.18 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.763 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.55 39.07 50.67 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.266 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.464 ' HB3' HG11 ' A' ' 4' ' ' VAL . 26.2 p-10 -59.51 -42.4 92.12 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.919 ' HB3' HG21 ' B' ' 108' ' ' VAL . 1.1 mt -133.05 143.87 49.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.766 0.317 . . . . 0.0 111.171 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.04 141.39 28.59 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.56 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -58.19 109.71 0.81 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.104 0.478 . . . . 0.0 110.789 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 108' ' ' VAL . . . 104.99 -15.75 47.47 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.592 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' ASP . . . . . 0.593 ' OD1' HG13 ' B' ' 160' ' ' VAL . 10.1 t70 -62.54 141.97 58.19 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.172 0.511 . . . . 0.0 111.459 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.438 HG22 ' NE2' ' B' ' 105' ' ' GLN . 29.6 pt -79.8 127.96 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.898 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.865 ' HB ' HG21 ' B' ' 137' ' ' THR . 26.8 mt -94.91 143.79 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.425 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.404 ' CD1' HD12 ' B' ' 161' ' ' LEU . 0.8 OUTLIER -97.46 -36.63 10.28 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.629 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -154.81 152.43 29.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.627 0.251 . . . . 0.0 111.28 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.539 HG23 ' CD1' ' B' ' 158' ' ' LEU . 10.0 mt -132.4 117.5 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.324 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 133' ' ' ASN . . . . . 0.412 ' HB2' ' CD1' ' B' ' 148' ' ' LEU . 2.4 m120 51.16 34.7 11.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.373 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.63 85.7 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.178 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 58.6 m -102.47 132.48 48.48 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.955 0.377 . . . . 0.0 110.201 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.454 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.4 t -54.19 145.32 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.075 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.865 HG21 ' HB ' ' B' ' 129' ' ' ILE . 27.8 m -113.59 20.19 16.18 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.662 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.454 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.6 OUTLIER -119.44 127.7 53.33 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 139' ' ' ASN . . . . . 0.417 ' HA ' HD12 ' A' ' 59' ' ' LEU . 2.4 m-80 70.56 -5.55 1.39 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.755 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.484 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.1 OUTLIER -65.25 169.75 5.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.858 0.361 . . . . 0.0 111.131 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.38 146.77 23.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.481 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.562 HD12 ' OG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -61.71 -42.22 98.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.004 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 44.2 p -64.12 -39.44 94.04 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.982 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -63.74 -47.92 79.11 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.931 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.37 90.26 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -69.33 -38.86 78.39 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.546 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -67.43 -38.06 83.97 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.631 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 148' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' B' ' 133' ' ' ASN . 0.2 OUTLIER -60.04 -44.57 94.58 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.63 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.618 HG23 HD13 ' B' ' 156' ' ' LEU . 37.9 mt -68.4 -37.57 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.928 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -69.48 -49.22 56.85 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.787 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -24.92 66.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.628 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 99.6 p -83.53 61.17 6.08 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.053 0.454 . . . . 0.0 110.746 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -69.65 110.96 5.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.568 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.62 -84.08 0.3 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 155' ' ' LYS . . . . . 0.76 ' HD3' HD23 ' A' ' 5' ' ' LEU . 2.9 ttmm -132.24 135.14 46.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.657 0.265 . . . . 0.0 110.792 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.709 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -128.64 143.49 50.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.939 0.4 . . . . 0.0 111.11 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.633 ' C ' HD22 ' B' ' 158' ' ' LEU . 50.3 tt0 -105.61 142.76 34.79 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.213 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.633 HD22 ' C ' ' B' ' 157' ' ' GLN . 3.6 mm? -134.98 146.84 49.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.314 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 6.2 t -120.67 128.93 76.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.299 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.593 HG13 ' OD1' ' B' ' 127' ' ' ASP . 53.9 t -122.31 146.63 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.617 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 161' ' ' LEU . . . . . 0.404 HD12 ' CD1' ' B' ' 130' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.524 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.729 0.299 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.96 159.93 23.43 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.654 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' B' ' 122' ' ' ASN . 27.3 t -123.56 131.76 72.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.696 0.284 . . . . 0.0 110.977 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 tt -100.28 108.57 20.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.706 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.521 HD21 ' N ' ' B' ' 117' ' ' ALA . 4.1 tp -95.88 136.58 36.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.718 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.611 ' O ' HD13 ' B' ' 116' ' ' LEU . 24.4 ttm -110.75 165.09 12.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.013 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.421 ' HE3' ' HA2' ' B' ' 154' ' ' GLY . 10.7 pttp . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.977 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 N--CA 1.47 0.565 0 CA-C-O 121.352 0.596 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.692 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 64.9 m-85 -88.26 -32.24 18.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.312 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.13 23.32 35.18 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.733 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 15' ' ' TYR . 3.4 mp -104.98 115.46 30.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.786 0.293 . . . . 0.0 110.794 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.99 113.53 22.83 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.68 HD22 HD11 ' B' ' 149' ' ' ILE . 1.7 mp -102.02 124.8 48.26 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.596 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -114.82 -167.51 15.57 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.77 147.92 31.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.241 0.521 . . . . 0.0 111.136 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -133.47 140.57 47.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.414 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.895 HD13 ' HB2' ' A' ' 62' ' ' ALA . 27.5 mt -88.22 120.55 37.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.41 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.414 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 40.1 p90 -122.26 173.95 7.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.01 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.762 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.1 t -80.16 94.12 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.778 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.42 ' HE2' ' HG2' ' B' ' 138' ' ' GLU . 0.0 OUTLIER -65.12 -56.25 14.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.039 -179.026 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -147.53 151.18 35.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.77 ' SD ' HG23 ' A' ' 35' ' ' THR . 3.2 tmm? -138.26 142.72 39.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.82 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.76 120.06 12.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.623 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 153.68 23.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.083 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.98 22.46 12.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.327 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.87 -168.77 36.55 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.568 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.507 ' H ' HD12 ' A' ' 33' ' ' LEU . 1.1 mp -71.34 -30.8 66.62 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -74.97 -33.39 61.88 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.77 HG23 ' SD ' ' A' ' 28' ' ' MET . 0.7 OUTLIER -79.14 -34.7 43.05 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.176 179.654 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -36.88 85.12 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.21 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -98.39 -37.56 9.57 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.424 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.35 45.7 9.67 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.789 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.616 ' CB ' HG11 ' B' ' 87' ' ' VAL . 13.3 p-10 -71.93 -49.45 37.48 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.762 ' HB3' HG21 ' A' ' 25' ' ' VAL . 4.8 mp -129.82 132.01 46.35 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.661 0.267 . . . . 0.0 111.107 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.25 145.95 24.06 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.651 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -58.05 111.84 1.32 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.077 0.465 . . . . 0.0 111.075 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.68 -19.4 12.55 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.856 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -62.9 134.27 55.95 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.105 0.452 . . . . 0.0 110.587 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 pt -78.65 130.25 36.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.058 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.635 HD13 HD21 ' B' ' 102' ' ' LEU . 5.1 mt -96.07 138.06 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.503 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.004 HD13 HD21 ' A' ' 78' ' ' LEU . 2.8 tp -98.93 -40.61 7.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.984 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.403 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -152.49 148.21 27.14 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.832 0.349 . . . . 0.0 111.409 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.472 ' CG1' HG21 ' A' ' 46' ' ' ILE . 42.1 mt -138.74 118.83 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.66 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 53.23 44.64 29.93 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 111.182 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.47 15.37 72.88 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.172 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 m -120.84 135.45 55.17 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.855 0.328 . . . . 0.0 110.389 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.2 t -62.67 146.98 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.927 0.394 . . . . 0.0 111.266 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.671 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -126.71 16.32 7.5 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.334 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.662 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -112.7 131.61 55.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 71.46 -6.18 1.44 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.281 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.478 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.85 175.03 6.9 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.9 m -90.14 143.81 26.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.496 HD12 ' OG ' ' B' ' 104' ' ' SER . 2.2 tt -58.41 -40.48 82.57 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.788 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 m -63.17 -42.06 99.34 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.88 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -63.99 -48.05 77.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.768 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.895 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -60.47 -40.57 91.7 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.169 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.477 ' HA ' HD12 ' A' ' 66' ' ' ILE . 4.6 ttt-85 -63.62 -41.03 98.33 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.949 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -38.27 86.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.711 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 tp -60.75 -43.4 98.03 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.903 HD11 HD22 ' B' ' 102' ' ' LEU . 5.6 mt -67.21 -38.01 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.681 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -67.65 -49.51 62.56 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -64.31 -23.28 67.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.257 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 t -75.7 73.03 2.67 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.123 0.487 . . . . 0.0 110.821 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.15 100.63 13.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.552 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.08 -95.33 0.19 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.943 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.18 135.84 49.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.591 0.234 . . . . 0.0 110.439 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.707 HD11 HD21 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -128.12 141.83 51.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.093 0.473 . . . . 0.0 111.309 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -101.87 128.36 48.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.112 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.707 HD21 HD11 ' A' ' 73' ' ' LEU . 1.7 mp -126.53 129.18 48.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.664 0.269 . . . . 0.0 111.383 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.408 ' HA ' ' HA2' ' B' ' 86' ' ' GLY . 8.3 m -119.57 114.8 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.685 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -107.9 157.57 8.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.541 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.004 HD21 HD13 ' A' ' 47' ' ' LEU . 4.4 mt . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.831 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.728 0.299 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -105.43 155.87 16.83 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.632 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.616 HG11 ' CB ' ' A' ' 39' ' ' ASN . 17.4 t -131.49 135.11 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.725 0.297 . . . . 0.0 111.118 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 4.7 tt -103.65 107.12 17.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.612 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 21.3 tp -99.88 129.27 45.95 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.332 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.4 ttt -109.37 164.64 12.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.984 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.991 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 . . . . . 0 N--CA 1.471 0.581 0 CA-C-O 121.314 0.578 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.498 ' CE2' HD22 ' A' ' 73' ' ' LEU . 69.0 m-85 -71.49 -32.03 67.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.417 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.01 26.74 47.94 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.467 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 34' ' ' ALA . 4.2 mp -104.73 116.64 32.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.665 0.269 . . . . 0.0 110.846 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -92.74 113.52 25.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.231 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.903 HD22 HD11 ' A' ' 66' ' ' ILE . 5.0 mp -94.79 125.01 39.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.288 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' GLY . . . . . 0.443 ' HA2' HD11 ' A' ' 59' ' ' LEU . . . -110.27 178.36 20.02 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.581 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.496 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -136.12 146.45 46.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.094 0.447 . . . . 0.0 111.017 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -134.1 141.79 47.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.43 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.703 HD11 ' HB3' ' B' ' 140' ' ' MET . 5.6 mt -88.14 122.05 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.597 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -122.25 171.47 9.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.047 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 0.735 HG21 ' CD2' ' B' ' 123' ' ' LEU . 38.8 t -83.78 93.59 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.059 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' LYS . . . . . 0.413 ' HG3' ' HA3' ' A' ' 20' ' ' GLY . 7.1 mtpt -61.94 -51.55 67.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.64 121.44 3.72 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.102 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.402 ' HG2' ' HG3' ' B' ' 125' ' ' GLU . 1.0 OUTLIER -116.92 143.89 45.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.025 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 36.1 p -65.65 137.17 57.15 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.628 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' ARG . . . . . 0.643 ' HA ' HG21 ' B' ' 118' ' ' THR . 0.0 OUTLIER -79.07 162.87 25.58 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.997 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.4 m 59.73 23.07 11.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.286 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.6 -154.99 27.36 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.095 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.611 HD13 ' O ' ' A' ' 7' ' ' MET . 2.2 mt -82.86 -33.38 27.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.529 0.204 . . . . 0.0 111.374 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.521 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -73.12 -35.43 66.53 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.165 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.643 HG21 ' HA ' ' B' ' 113' ' ' ARG . 1.3 p -78.63 -33.88 46.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.277 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -60.83 -38.35 85.15 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.311 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -100.19 -36.05 9.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.42 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.06 44.03 7.28 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.907 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.624 ' HA ' HG21 ' A' ' 4' ' ' VAL . 7.0 p30 -55.38 -54.1 47.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.383 0.135 . . . . 0.0 111.261 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.735 ' CD2' HG21 ' B' ' 108' ' ' VAL . 0.0 OUTLIER -142.4 156.66 45.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 111.296 179.169 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.81 150.8 20.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.591 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' B' ' 111' ' ' MET . 5.3 mt-10 -59.83 109.44 0.94 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.092 0.472 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 111.04 0.08 28.49 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.98 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -78.42 138.66 38.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 117.347 0.573 . . . . 0.0 110.719 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -76.1 124.38 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.327 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.855 ' HB ' HG21 ' B' ' 137' ' ' THR . 19.8 mt -91.99 144.05 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.173 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 tp -98.39 -41.89 7.61 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.356 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -145.83 148.06 32.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 111.195 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 32.2 mt -138.35 118.42 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.809 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' ASN . . . . . 0.556 ' HB3' HD11 ' B' ' 148' ' ' LEU . 6.0 t30 53.87 48.09 22.09 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.317 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 65.58 18.02 65.3 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.993 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.21 144.8 47.54 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.667 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.0 t -63.52 146.88 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.855 HG21 ' HB ' ' B' ' 129' ' ' ILE . 18.2 m -115.32 1.42 13.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.865 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.667 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.5 tt0 -100.39 131.63 46.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.67 0.271 . . . . 0.0 110.357 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 71.85 -7.65 1.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.435 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.703 ' HB3' HD11 ' B' ' 106' ' ' ILE . 36.7 ttm -65.51 155.42 35.69 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.012 0.434 . . . . 0.0 111.377 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 28.6 t -79.58 149.56 31.33 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.387 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 tt -60.8 -48.13 83.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.893 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 39.1 p -58.47 -38.22 77.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.882 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.21 -43.21 95.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.841 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.655 ' HB1' HG21 ' B' ' 106' ' ' ILE . . . -59.71 -42.88 94.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.173 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -67.67 -38.3 83.57 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.654 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -67.63 -38.35 83.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.485 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 148' ' ' LEU . . . . . 0.556 HD11 ' HB3' ' B' ' 133' ' ' ASN . 0.1 OUTLIER -60.3 -44.09 95.71 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.844 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.68 HD11 HD22 ' A' ' 19' ' ' LEU . 15.7 mt -68.13 -37.7 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.915 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -69.16 -48.39 62.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.773 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -71.22 -23.62 62.05 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.992 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 80.1 p -77.25 66.97 3.12 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.147 0.498 . . . . 0.0 110.628 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -74.51 127.94 34.31 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.564 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 154' ' ' GLY . . . . . 0.421 ' HA2' ' HE3' ' A' ' 8' ' ' LYS . . . 109.39 -91.64 0.66 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.274 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -124.17 138.36 54.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.692 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -129.71 135.19 48.19 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.035 0.445 . . . . 0.0 111.14 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -97.86 136.93 37.46 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.643 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.483 HD13 HD11 ' B' ' 123' ' ' LEU . 1.2 mt -134.03 128.77 35.0 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.803 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.408 ' O ' HG23 ' B' ' 129' ' ' ILE . 21.1 t -113.69 136.6 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.893 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' B' ' 123' ' ' LEU . 21.9 t -128.84 149.67 33.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.266 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 N--CA 1.462 0.142 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.548 179.603 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 2' ' ' ILE . 13.5 tt . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.781 0.324 . . . . 0.0 110.968 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.12 156.1 15.74 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.669 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' B' ' 122' ' ' ASN . 21.6 t -132.47 133.03 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.377 . . . . 0.0 111.058 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.35 114.81 29.14 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.438 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 1.1 mp -98.42 144.53 27.69 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.604 ' O ' HD13 ' B' ' 116' ' ' LEU . 30.8 ttm -113.24 164.05 14.02 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.893 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.405 ' N ' ' HG2' ' A' ' 7' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.109 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.952 0.406 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.811 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 57.2 m-85 -71.82 -22.25 61.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.817 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.48 20.38 38.12 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.704 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.9 mp -102.48 115.95 31.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.821 0.31 . . . . 0.0 110.786 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.99 114.58 24.74 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.911 HD22 HD11 ' B' ' 149' ' ' ILE . 2.1 mp -97.9 124.81 42.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 111.776 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -114.73 174.93 15.71 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 p -130.17 151.04 51.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.608 0.704 . . . . 0.0 111.84 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -136.75 135.83 38.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.176 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.565 ' HB ' HG22 ' A' ' 54' ' ' THR . 21.5 mt -88.14 121.47 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.931 0.396 . . . . 0.0 110.125 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' ' HG2' ' A' ' 26' ' ' LYS . 41.7 p90 -125.42 172.92 9.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.314 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.886 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.8 t -82.29 97.53 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.745 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.415 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -67.65 -57.01 7.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.282 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.39 141.33 17.17 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.953 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -126.66 144.31 50.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.17 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.5 m -73.73 127.83 33.87 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.583 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -63.29 168.25 4.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.73 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.63 29.8 15.03 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.445 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.87 -174.09 17.58 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.194 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.39 -28.19 61.88 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' N ' HD21 ' B' ' 89' ' ' LEU . . . -74.38 -36.49 63.55 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.502 0.191 . . . . 0.0 111.203 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.9 -34.05 45.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.062 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -62.77 -37.14 85.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.339 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.62 -33.41 10.31 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.493 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.48 44.74 32.26 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.165 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.836 ' HB3' HG11 ' B' ' 87' ' ' VAL . 10.4 p-10 -81.65 -49.04 10.95 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.886 ' HB3' HG21 ' A' ' 25' ' ' VAL . 13.2 mt -95.64 113.18 24.8 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.904 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.47 130.29 34.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.552 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -54.39 111.62 0.83 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.125 0.488 . . . . 0.0 110.868 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.95 -14.1 37.66 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.865 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.33 138.64 58.6 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.038 0.447 . . . . 0.0 111.31 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 45' ' ' ILE . 24.3 pt -79.96 119.49 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.674 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.701 HG21 HD11 ' A' ' 49' ' ' ILE . 7.8 mt -83.33 144.11 10.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.343 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.425 HD23 ' HB2' ' A' ' 48' ' ' LYS . 3.5 tt -105.23 -42.56 5.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.438 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HB2' HD23 ' A' ' 47' ' ' LEU . 3.1 mttm -152.38 147.97 26.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.68 0.276 . . . . 0.0 111.368 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.994 HD12 HD23 ' A' ' 75' ' ' LEU . 27.8 mm -137.47 118.97 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.431 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 54.91 40.14 31.85 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.217 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.27 14.58 80.59 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.32 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 m -120.23 139.64 52.38 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.028 0.414 . . . . 0.0 110.51 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.3 t -59.69 145.63 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.203 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.565 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -124.18 20.13 9.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.433 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.517 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -116.79 132.13 56.77 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.397 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 71.1 -7.57 1.11 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.65 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.5 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -68.38 172.13 6.41 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 111.125 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.81 146.16 24.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.308 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' B' ' 139' ' ' ASN . 0.9 OUTLIER -60.9 -38.62 86.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.27 -46.94 84.47 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -44.2 93.94 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.796 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.96 93.61 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.951 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -39.66 88.57 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.695 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.97 -38.39 86.01 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 2.2 tp -60.32 -43.35 96.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.026 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.775 HD11 HD22 ' B' ' 102' ' ' LEU . 24.5 mt -68.33 -37.48 78.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.78 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.0 -49.44 57.75 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.078 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 65' ' ' LEU . 1.8 ptpt -64.89 -30.5 71.5 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.212 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 m -81.95 62.01 5.52 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.201 0.524 . . . . 0.0 110.791 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 147.26 41.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.785 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.0 -86.59 0.59 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.224 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -134.95 126.87 29.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.663 0.268 . . . . 0.0 110.568 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.781 HD23 ' CE2' ' B' ' 98' ' ' TYR . 2.3 pp -125.87 143.84 50.91 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -101.45 141.46 34.29 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.994 HD23 HD12 ' A' ' 49' ' ' ILE . 0.8 OUTLIER -133.4 128.08 34.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.965 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 t -107.97 134.62 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.248 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.98 164.58 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.518 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tp . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.594 179.658 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.89 166.96 20.34 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.924 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.836 HG11 ' HB3' ' A' ' 39' ' ' ASN . 21.4 t -129.69 134.86 62.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.641 0.258 . . . . 0.0 111.086 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tt -96.99 121.91 39.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.516 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.551 HD21 ' N ' ' A' ' 34' ' ' ALA . 7.6 tp -115.3 144.62 43.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.581 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.7 ttt -107.1 163.61 12.85 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.144 0.497 . . . . 0.0 110.922 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' B' ' 97' ' ' GLU . 4.1 tttt . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.914 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' GLU . . . . . 0.405 ' HA ' ' HE3' ' B' ' 91' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.827 0.346 . . . . 0.0 110.818 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.781 ' CE2' HD23 ' A' ' 73' ' ' LEU . 47.0 m-85 -49.74 -31.14 10.72 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.685 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.25 15.36 74.52 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.521 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.429 HD11 ' CB ' ' A' ' 34' ' ' ALA . 2.6 mp -101.3 119.82 39.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.659 0.266 . . . . 0.0 110.668 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -96.13 113.43 25.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.211 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.775 HD22 HD11 ' A' ' 66' ' ' ILE . 7.9 mp -97.41 124.78 41.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.625 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.44 177.13 17.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.978 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.37 145.76 50.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.847 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -130.05 140.16 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.413 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 1.046 HD13 ' HB2' ' B' ' 145' ' ' ALA . 9.1 mt -88.37 120.46 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.176 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -119.68 170.48 9.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.714 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' B' ' 126' ' ' GLY . 41.2 t -81.07 89.5 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.038 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -53.77 -42.46 68.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.816 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.03 132.17 0.51 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -114.24 146.31 40.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.079 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 25.2 p -77.13 126.57 31.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.704 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' ARG . . . . . 0.687 ' HA ' HG21 ' B' ' 118' ' ' THR . 0.0 OUTLIER -65.78 165.87 12.04 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.289 -179.708 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.3 m 64.95 22.85 12.52 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.183 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -105.19 -171.7 24.11 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.172 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.604 HD13 ' O ' ' A' ' 7' ' ' MET . 0.2 OUTLIER -71.15 -30.81 66.93 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.405 ' CA ' HD21 ' A' ' 6' ' ' LEU . . . -74.25 -35.03 63.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.489 0.185 . . . . 0.0 110.941 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.687 HG21 ' HA ' ' B' ' 113' ' ' ARG . 2.1 p -78.95 -34.1 44.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.184 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -59.15 -38.85 80.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.424 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.58 -29.9 10.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.539 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.16 58.44 5.59 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.2 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.608 ' HB2' HG21 ' A' ' 4' ' ' VAL . 1.2 p-10 -95.95 -32.68 12.49 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.569 HD11 ' CB ' ' B' ' 158' ' ' LEU . 39.4 mt -131.34 133.02 44.91 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.641 0.258 . . . . 0.0 111.195 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.79 161.86 13.4 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' B' ' 125' ' ' GLU . 2.1 pt-20 -73.64 120.55 19.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.518 0.675 . . . . 0.0 110.178 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 108' ' ' VAL . . . 106.89 -15.77 40.25 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.587 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' ASP . . . . . 0.4 ' OD2' HG11 ' B' ' 160' ' ' VAL . 50.2 t0 -63.97 135.31 56.37 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 111.082 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 13.7 pt -78.25 121.32 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.825 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.434 HD13 HD21 ' A' ' 19' ' ' LEU . 15.6 mt -91.2 143.7 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.149 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.77 -35.47 6.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.902 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.83 148.04 31.47 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.541 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 45.4 mt -140.93 118.68 9.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.616 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 55.7 44.14 26.84 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.931 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.83 17.43 73.29 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.051 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.84 137.71 54.42 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 116.948 0.374 . . . . 0.0 110.478 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.56 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.3 t -59.87 145.04 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.838 0.351 . . . . 0.0 110.872 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.633 ' CG2' HD12 ' B' ' 106' ' ' ILE . 1.8 m -119.03 9.9 11.98 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.788 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.56 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.3 OUTLIER -102.28 131.13 49.06 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.218 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 139' ' ' ASN . . . . . 0.509 ' HA ' HD12 ' A' ' 59' ' ' LEU . 4.9 m-80 70.85 -4.33 1.75 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.548 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.2 OUTLIER -65.65 169.52 6.2 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 111.285 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.69 141.72 28.28 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.168 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.404 HD22 ' NE ' ' B' ' 146' ' ' ARG . 0.8 OUTLIER -58.14 -44.38 87.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.555 179.488 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 7.2 t -61.46 -39.29 90.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.693 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -64.81 -46.73 80.77 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 1.046 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.54 -42.56 88.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 146' ' ' ARG . . . . . 0.404 ' NE ' HD22 ' B' ' 142' ' ' LEU . 91.0 mtt180 -65.72 -40.27 92.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.502 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -66.39 -38.63 87.93 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.886 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 148' ' ' LEU . . . . . 0.524 ' O ' HD23 ' B' ' 148' ' ' LEU . 5.3 tt -59.94 -44.78 94.16 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.713 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.911 HD11 HD22 ' A' ' 19' ' ' LEU . 4.9 mt -68.5 -37.35 77.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.773 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.85 -47.57 65.63 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.055 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -66.33 -27.77 68.16 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 3.6 m -79.24 63.23 3.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.006 0.431 . . . . 0.0 110.747 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 18.2 mmm-85 -83.93 74.78 10.18 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.422 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 167.54 -73.32 0.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.251 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.41 127.49 27.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.712 0.291 . . . . 0.0 110.875 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.811 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -129.84 139.51 51.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 4.4 tt0 -103.57 141.01 36.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.195 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.569 ' CB ' HD11 ' B' ' 123' ' ' LEU . 1.0 OUTLIER -134.72 128.13 32.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 111.001 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.24 135.27 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.47 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.4 HG11 ' OD2' ' B' ' 127' ' ' ASP . 16.9 m -128.46 152.82 37.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.854 0.359 . . . . 0.0 111.711 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 15.0 tp . . . . . 0 C--O 1.232 0.173 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 -179.844 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.1 pt . . . . . 0 C--O 1.235 0.307 0 CA-C-O 120.625 0.25 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.74 158.6 22.64 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.865 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' B' ' 122' ' ' ASN . 23.0 t -130.01 132.73 65.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.758 0.313 . . . . 0.0 110.94 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.756 HD22 ' HD2' ' B' ' 155' ' ' LYS . 0.4 OUTLIER -96.88 113.68 25.25 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.023 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.995 HD13 HD12 ' B' ' 158' ' ' LEU . 8.0 mp -91.23 131.56 36.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.656 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.0 ttt -107.62 162.21 14.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.228 0.537 . . . . 0.0 111.143 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.738 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.711 0.291 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.934 ' CE2' HD23 ' B' ' 156' ' ' LEU . 50.6 m-85 -61.56 -29.76 70.23 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.95 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.48 27.25 57.71 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.196 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' B' ' 117' ' ' ALA . 2.4 mp -113.75 117.86 32.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.71 0.29 . . . . 0.0 110.66 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.38 113.33 25.27 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.596 HD22 HD11 ' B' ' 149' ' ' ILE . 7.1 mp -98.01 124.86 42.69 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.193 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -105.27 -167.46 23.88 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.8 OUTLIER -146.02 149.24 33.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.258 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' B' ' 104' ' ' SER . 1.9 pt20 -132.1 133.47 44.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.964 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.761 ' HB ' HG22 ' A' ' 54' ' ' THR . 68.8 mt -87.75 120.23 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.115 0.483 . . . . 0.0 110.29 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.409 ' CE2' ' HG2' ' A' ' 26' ' ' LYS . 46.4 p90 -122.86 172.92 8.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.297 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.1 t -82.54 99.78 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.767 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -70.93 -58.69 3.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.216 -179.071 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -156.42 147.56 22.22 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.631 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.32 163.15 30.65 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.894 0.378 . . . . 0.0 111.428 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.8 m -65.38 139.89 58.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -76.51 156.92 32.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.977 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 50.35 30.9 4.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.918 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.17 -170.55 30.84 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.152 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.37 -31.09 68.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -75.02 -36.94 61.9 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.236 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -33.85 45.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.175 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -60.86 -39.21 88.29 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.149 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.14 -30.83 11.71 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.789 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.38 47.92 20.64 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.226 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.724 ' HB3' HG11 ' B' ' 87' ' ' VAL . 21.7 p-10 -65.24 -47.34 77.13 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.721 HD11 HD22 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -129.44 136.57 50.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.812 0.339 . . . . 0.0 111.386 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.96 148.48 22.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.489 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -59.53 109.49 0.91 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.27 0.557 . . . . 0.0 111.08 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.23 -13.6 16.27 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.286 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -62.86 135.43 57.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.232 0.516 . . . . 0.0 110.391 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.55 112.43 18.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.085 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.432 HG21 ' CG1' ' A' ' 49' ' ' ILE . 5.9 mt -77.49 130.43 36.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.176 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.2 tp -92.21 -40.96 10.7 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.322 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -151.36 148.66 28.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.852 0.358 . . . . 0.0 111.833 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.432 ' CG1' HG21 ' A' ' 46' ' ' ILE . 29.7 mt -138.33 119.66 17.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.344 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HB2' HD21 ' A' ' 65' ' ' LEU . 6.5 m120 55.23 39.99 31.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.124 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.77 11.65 84.41 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.424 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 m -119.82 135.3 54.92 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 117.113 0.456 . . . . 0.0 110.203 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.686 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.3 t -61.69 147.79 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.843 0.354 . . . . 0.0 111.146 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.761 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -118.42 6.55 11.81 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.751 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.686 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -91.01 135.73 33.55 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 p30 52.59 11.79 0.21 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.649 0.593 . . . . 0.0 112.198 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.41 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -73.32 171.92 12.16 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.003 0.43 . . . . 0.0 111.357 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.6 130.66 35.22 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.883 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.97 -35.69 59.27 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.9 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.9 -46.75 80.44 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.063 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.67 -46.06 89.92 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.684 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.701 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -58.04 -42.12 84.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -70.31 -37.46 74.75 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.466 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -67.85 -38.17 82.81 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.568 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.568 HD21 ' HB2' ' A' ' 50' ' ' ASN . 9.1 tt -59.69 -44.77 93.51 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.706 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.497 ' CD1' HD22 ' B' ' 102' ' ' LEU . 37.5 mt -68.22 -37.66 78.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.763 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.03 -49.61 56.05 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.791 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -65.19 -27.24 68.55 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.207 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.5 t -80.55 63.13 4.89 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.002 0.43 . . . . 0.0 110.557 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -77.76 94.83 4.54 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.537 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.06 -84.1 0.18 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.521 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.8 ' CG ' HD21 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -129.6 131.08 46.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.641 0.257 . . . . 0.0 110.761 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.749 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -129.83 140.71 50.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 111.323 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -106.37 140.64 38.98 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.553 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.721 HD22 HD11 ' A' ' 40' ' ' LEU . 1.7 mp -136.11 134.64 38.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.102 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.4 t -118.87 140.69 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.93 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.17 134.97 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.321 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 tt . . . . . 0 CA--C 1.53 0.182 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.774 179.461 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.912 0.387 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.49 157.03 15.59 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.409 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.724 HG11 ' HB3' ' A' ' 39' ' ' ASN . 13.8 t -131.09 134.28 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.895 0.378 . . . . 0.0 111.328 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.8 HD21 ' CG ' ' A' ' 72' ' ' LYS . 7.9 tt -106.19 108.1 19.44 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.573 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.8 tp -99.04 144.69 27.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.831 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 9.2 ttm -117.81 163.13 16.99 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.133 0.492 . . . . 0.0 111.051 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.102 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 121.006 0.432 . . . . 0.0 111.386 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.749 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 69.3 m-85 -79.33 -26.26 42.18 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.377 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.39 28.57 43.53 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.395 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.556 HD13 ' HB3' ' B' ' 98' ' ' TYR . 5.9 mp -105.07 123.49 47.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.722 0.296 . . . . 0.0 110.702 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.47 113.65 27.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.371 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.701 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.9 pt? -109.3 124.86 51.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.459 . . . . 0.0 111.453 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -106.8 -170.2 22.55 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.258 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.6 OUTLIER -134.71 147.54 50.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.882 0.373 . . . . 0.0 111.375 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 21' ' ' SER . 12.9 pt20 -125.34 139.04 54.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.225 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.819 HD13 ' HB2' ' B' ' 145' ' ' ALA . 33.7 mt -88.15 120.42 37.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.963 0.411 . . . . 0.0 111.034 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -124.2 171.58 9.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.083 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' B' ' 123' ' ' LEU . 39.3 t -80.27 95.22 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.92 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -53.18 50.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.112 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -156.21 141.35 17.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.688 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.12 151.04 49.38 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.867 0.365 . . . . 0.0 111.463 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -65.73 143.34 57.59 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.165 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -73.15 148.71 43.62 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.148 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 54.85 32.84 18.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.61 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' B' ' 119' ' ' LYS . . . -96.47 -164.98 33.34 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.323 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.36 -37.12 84.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.567 ' HB2' HD21 ' A' ' 17' ' ' LEU . . . -75.1 -33.73 61.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.273 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -33.72 44.47 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.286 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' B' ' 115' ' ' GLY . 12.1 ttmt -64.17 -37.07 86.14 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 111.266 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.99 -30.8 12.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.467 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.82 45.69 63.55 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.2 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.693 ' HB3' HG11 ' A' ' 4' ' ' VAL . 3.3 p30 -81.83 -53.4 6.21 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.695 ' HB3' HG21 ' B' ' 108' ' ' VAL . 10.2 mp -118.5 119.41 34.47 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.68 0.276 . . . . 0.0 110.944 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.17 152.84 22.5 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.619 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -60.5 110.65 1.32 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.169 0.509 . . . . 0.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.55 -15.16 24.69 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.894 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -62.85 135.75 57.49 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 117.245 0.522 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -81.05 108.86 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.103 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.476 ' CD1' HD21 ' A' ' 19' ' ' LEU . 29.3 mt -76.41 152.49 5.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.322 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.548 HD22 ' CD1' ' B' ' 161' ' ' LEU . 13.7 tp -110.7 -31.28 7.26 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.538 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -152.44 147.42 26.23 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.711 0.291 . . . . 0.0 111.066 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 13.5 mt -137.18 117.73 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.452 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' B' ' 156' ' ' LEU . 0.1 OUTLIER 49.4 43.34 23.35 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.515 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.98 18.73 79.32 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.344 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 93.1 m -120.77 144.11 48.46 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.997 0.398 . . . . 0.0 110.28 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 t -74.14 140.07 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.457 . . . . 0.0 111.609 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.545 ' HA ' HD12 ' B' ' 106' ' ' ILE . 52.8 p -93.01 -22.08 19.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.129 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.09 142.35 38.17 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.925 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.5 p30 53.13 10.74 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.811 0.694 . . . . 0.0 112.467 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.656 ' HG2' HD11 ' B' ' 106' ' ' ILE . 0.5 OUTLIER -86.52 144.18 27.36 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.902 0.382 . . . . 0.0 110.808 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.11 144.76 46.87 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.515 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.528 ' O ' HD23 ' B' ' 142' ' ' LEU . 6.2 tt -60.75 -46.0 92.12 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.925 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 9.7 t -55.28 -42.64 73.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -40.9 84.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.617 0.246 . . . . 0.0 110.769 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -61.87 -43.15 99.44 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.037 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -38.13 79.34 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -38.08 82.37 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.779 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 148' ' ' LEU . . . . . 0.514 HD23 ' C ' ' B' ' 148' ' ' LEU . 7.7 tt -59.98 -44.82 94.24 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.649 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.596 HD11 HD22 ' A' ' 19' ' ' LEU . 8.2 mt -67.79 -37.31 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.03 -48.76 62.14 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.0 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -67.44 -24.95 65.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.683 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 22.9 m -75.58 70.39 2.41 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.212 0.53 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -86.5 78.38 9.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.667 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 164.55 -81.89 0.11 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.62 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 155' ' ' LYS . . . . . 0.756 ' HD2' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -137.0 128.96 29.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.534 0.206 . . . . 0.0 110.628 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.934 HD23 ' CE2' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -127.86 131.78 49.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.948 0.404 . . . . 0.0 111.2 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -91.1 142.56 27.62 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.083 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.995 HD12 HD13 ' A' ' 6' ' ' LEU . 2.3 mt -132.55 134.51 45.05 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.809 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.09 134.0 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.636 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 6.1 m -127.99 152.9 36.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 111.719 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 161' ' ' LEU . . . . . 0.548 ' CD1' HD22 ' B' ' 130' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.826 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.98 0.419 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.74 156.6 22.89 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.774 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.586 HG21 ' CB ' ' B' ' 122' ' ' ASN . 22.8 t -132.77 133.39 59.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.702 0.287 . . . . 0.0 111.093 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.5 HD22 ' HD3' ' B' ' 155' ' ' LYS . 0.2 OUTLIER -101.46 111.44 23.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.815 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.648 HD11 ' ND2' ' B' ' 122' ' ' ASN . 10.4 mp -90.6 141.88 28.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.25 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 37.2 ttm -120.05 165.3 14.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.988 0.423 . . . . 0.0 110.9 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 pttp . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.937 179.844 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 120.817 0.342 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.456 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 70.4 m-85 -78.26 -30.89 48.84 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.728 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.453 ' O ' HG23 ' B' ' 112' ' ' THR . . . 80.88 28.34 46.62 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.464 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' B' ' 117' ' ' ALA . 0.3 OUTLIER -101.85 121.39 42.02 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.646 0.26 . . . . 0.0 110.668 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.38 114.04 27.88 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.03 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.997 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.8 pt? -111.44 124.82 53.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.192 0.52 . . . . 0.0 111.763 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.91 -177.56 22.24 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.556 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.26 149.3 47.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.155 0.478 . . . . 0.0 111.058 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -132.87 140.2 47.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.231 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.863 ' HB ' HG22 ' A' ' 54' ' ' THR . 49.4 mt -88.05 120.54 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.003 0.43 . . . . 0.0 110.433 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -119.88 172.91 7.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.912 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.919 HG21 HD13 ' A' ' 40' ' ' LEU . 45.6 t -79.5 92.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.118 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.94 -51.85 59.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.217 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.13 162.6 39.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 36.0 mtp -138.4 156.46 47.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.107 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.622 HG23 ' HA3' ' A' ' 32' ' ' GLY . 3.7 t -69.33 145.32 53.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.693 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -75.52 130.13 38.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.674 0.273 . . . . 0.0 110.944 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.23 28.25 5.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.141 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.622 ' HA3' HG23 ' A' ' 29' ' ' THR . . . -84.5 -163.38 36.2 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.369 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.494 ' C ' HD21 ' B' ' 89' ' ' LEU . 1.6 mt -73.93 -30.19 62.43 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.98 -37.17 61.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.467 0.175 . . . . 0.0 111.409 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.52 -34.05 47.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.153 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -63.97 -36.49 84.12 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.428 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.84 -32.58 11.27 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.362 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.48 47.78 20.63 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.238 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -57.51 -35.15 69.89 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.919 HD13 HG21 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -163.49 163.83 24.61 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.727 0.299 . . . . 0.0 111.025 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.39 150.39 22.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.706 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -61.68 114.4 3.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.12 0.486 . . . . 0.0 111.233 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.93 9.86 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.755 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -60.6 135.85 57.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.919 0.359 . . . . 0.0 110.368 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 pt -75.06 121.82 27.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.895 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.994 HG21 HD11 ' A' ' 49' ' ' ILE . 16.5 mt -88.95 138.14 19.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.118 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.883 HD13 HD22 ' A' ' 78' ' ' LEU . 10.0 tp -97.43 -45.55 6.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.484 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.74 147.93 33.55 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.873 0.368 . . . . 0.0 111.59 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.994 HD11 HG21 ' A' ' 46' ' ' ILE . 22.4 mm -138.61 120.77 17.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.432 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 53.47 41.55 32.09 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.242 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.48 13.0 80.29 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.436 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m -120.97 137.52 54.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.038 0.419 . . . . 0.0 110.431 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.647 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.1 t -57.58 146.11 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.274 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.863 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -123.32 17.74 9.82 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.416 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.647 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -121.59 127.85 51.34 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.29 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 70.88 -4.07 1.83 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.288 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.11 174.63 3.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 111.27 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.92 147.8 25.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.418 HD11 ' OG ' ' B' ' 104' ' ' SER . 2.1 mp -61.9 -48.95 78.16 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.85 -37.98 80.81 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.221 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.19 -47.89 69.55 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.946 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.602 ' CB ' HD13 ' A' ' 23' ' ' ILE . . . -61.94 -40.15 94.54 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.204 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -70.24 -38.41 75.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -38.16 83.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.677 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.44 HD21 HG22 ' A' ' 49' ' ' ILE . 1.2 tp -60.49 -44.36 96.05 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.735 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.708 HD11 HD22 ' B' ' 102' ' ' LEU . 12.3 mt -68.33 -37.57 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.604 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.94 -41.42 78.1 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.641 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -6.7 57.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.72 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.94 56.64 4.02 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 110.862 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.68 78.86 7.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.381 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' B' ' 91' ' ' LYS . . . 162.29 -78.77 0.15 Allowed Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.295 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -136.2 129.87 32.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.774 -0.213 . . . . 0.0 110.787 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.729 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.6 OUTLIER -128.05 126.98 42.32 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.108 0.48 . . . . 0.0 110.871 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 37.4 tt0 -97.83 142.62 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.279 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.74 ' HA ' HD13 ' A' ' 49' ' ' ILE . 0.8 OUTLIER -133.76 124.02 25.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.772 0.32 . . . . 0.0 110.75 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.6 t -109.57 134.6 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.747 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 t -116.29 135.21 57.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.048 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.883 HD22 HD13 ' A' ' 47' ' ' LEU . 5.4 tp . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.521 ' C ' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.288 0 CA-C-O 120.765 0.317 . . . . 0.0 110.953 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.478 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -114.03 155.48 16.29 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.75 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 25.9 t -129.6 134.33 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 111.088 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.432 ' O ' HD12 ' B' ' 88' ' ' LEU . 0.3 OUTLIER -103.64 122.42 44.98 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.6 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.494 HD21 ' C ' ' A' ' 33' ' ' LEU . 1.3 tp -109.09 124.63 51.09 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.542 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' MET . . . . . 0.487 ' HG3' ' N ' ' B' ' 91' ' ' LYS . 3.7 tpp -100.12 162.85 12.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.072 0.463 . . . . 0.0 110.772 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' LYS . . . . . 0.487 ' N ' ' HG3' ' B' ' 90' ' ' MET . 6.6 pttm . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.349 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.465 0.295 0 CA-C-O 121.053 0.454 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.729 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 67.4 m-85 -76.26 -25.55 55.07 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.517 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' GLY . . . . . 0.436 ' HA3' ' HB ' ' A' ' 29' ' ' THR . . . 93.62 20.2 32.53 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.458 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.625 ' CD2' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -101.78 118.21 36.46 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.651 0.262 . . . . 0.0 110.708 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -92.07 113.26 25.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.949 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.708 HD22 HD11 ' A' ' 66' ' ' ILE . 5.2 mp -96.34 124.93 40.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 110.922 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.91 171.9 13.94 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.822 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.418 ' OG ' HD11 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -136.71 145.07 44.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.835 0.35 . . . . 0.0 110.891 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -130.44 139.71 50.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.274 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.845 HD13 ' HB2' ' B' ' 145' ' ' ALA . 1.9 mt -88.3 120.64 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.069 0.461 . . . . 0.0 110.238 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.419 ' CE2' ' HD3' ' B' ' 109' ' ' LYS . 40.1 p90 -119.62 172.58 7.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.928 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 0.601 HG21 ' HB3' ' B' ' 123' ' ' LEU . 27.7 t -81.36 97.62 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.013 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' LYS . . . . . 0.419 ' HD3' ' CE2' ' B' ' 107' ' ' PHE . 0.5 OUTLIER -67.57 -50.58 57.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.717 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -167.48 143.61 4.17 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.805 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.463 ' SD ' HG11 ' B' ' 108' ' ' VAL . 0.0 OUTLIER -127.68 159.53 34.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.795 0.331 . . . . 0.0 111.119 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 16' ' ' GLY . 64.2 p -75.75 124.63 27.61 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.435 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.64 156.77 15.92 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.967 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.68 34.79 17.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.299 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.11 -175.54 20.26 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.913 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.84 -35.6 80.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.57 0.224 . . . . 0.0 111.559 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.499 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -74.95 -34.82 62.1 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.26 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -34.1 44.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.13 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.47 -35.41 80.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.199 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -100.07 -27.95 13.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.648 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 65.8 57.39 11.09 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.094 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.648 ' ND2' HD11 ' A' ' 6' ' ' LEU . 1.5 p30 -94.82 -33.63 12.79 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.705 HD11 HD13 ' B' ' 158' ' ' LEU . 47.9 mt -122.36 135.96 54.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.636 0.255 . . . . 0.0 111.55 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 142.93 34.22 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.581 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -56.68 111.39 1.0 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 111.249 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.32 -16.47 24.6 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.266 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -60.47 135.8 57.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.332 0.566 . . . . 0.0 110.64 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 pt -79.82 111.01 16.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.751 ' HB ' HG21 ' B' ' 137' ' ' THR . 59.4 mt -72.48 140.96 17.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.108 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.416 HD13 ' CD1' ' B' ' 161' ' ' LEU . 1.1 tp -98.0 -45.14 6.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.114 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -148.84 147.8 29.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.911 0.386 . . . . 0.0 111.477 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.408 HG13 ' OG1' ' B' ' 137' ' ' THR . 13.9 mt -134.01 123.87 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.264 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 133' ' ' ASN . . . . . 0.585 ' HB2' HD21 ' B' ' 148' ' ' LEU . 6.0 m120 54.86 33.49 19.97 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.687 0.279 . . . . 0.0 111.182 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.65 17.55 77.28 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.92 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 6.8 m -120.66 143.85 48.49 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.8 0.3 . . . . 0.0 110.341 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.432 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.2 t -59.46 144.26 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.199 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.751 HG21 ' HB ' ' B' ' 129' ' ' ILE . 2.9 m -117.23 21.56 13.07 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.603 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.432 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.8 OUTLIER -115.87 129.38 56.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.487 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 m120 71.42 -5.23 1.65 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.361 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.739 ' HB3' HD11 ' B' ' 106' ' ' ILE . 4.8 ttt -68.37 150.72 47.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.812 0.339 . . . . 0.0 110.826 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 51.1 m -71.78 144.22 49.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.307 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.75 -46.03 92.01 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.06 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 4.4 t -58.04 -38.89 77.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.107 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.03 -42.85 84.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.803 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.997 ' HB1' HD11 ' A' ' 19' ' ' LEU . . . -60.47 -42.42 96.18 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.086 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -67.94 -39.46 83.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.318 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -37.86 86.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 148' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' B' ' 133' ' ' ASN . 6.9 tt -59.85 -45.27 92.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.735 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.6 HD12 HD22 ' A' ' 19' ' ' LEU . 46.3 mt -68.42 -37.01 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.773 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.41 -46.3 70.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -65.49 -26.91 68.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.292 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 20.7 p -87.17 74.89 9.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.194 0.521 . . . . 0.0 111.052 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.93 51.98 2.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.708 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -164.39 -83.36 0.05 OUTLIER Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.465 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 155' ' ' LYS . . . . . 0.5 ' HD3' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -124.54 126.88 46.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.685 0.278 . . . . 0.0 110.424 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.772 HD21 HD11 ' B' ' 158' ' ' LEU . 0.0 OUTLIER -129.81 143.07 50.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.46 -179.176 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -109.09 138.61 45.16 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.487 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.772 HD11 HD21 ' B' ' 156' ' ' LEU . 0.6 OUTLIER -133.36 127.31 33.21 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.762 0.315 . . . . 0.0 111.04 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.93 139.93 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.578 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.442 HG21 ' CD2' ' B' ' 123' ' ' LEU . 22.3 t -135.74 154.9 35.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.35 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 161' ' ' LEU . . . . . 0.416 ' CD1' HD13 ' B' ' 130' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.254 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.759 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.235 0.336 0 CA-C-O 120.648 0.261 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -109.97 161.75 12.88 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.575 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.725 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.6 t -127.33 134.62 65.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.818 0.342 . . . . 0.0 111.277 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 mt -98.03 123.47 42.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.979 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.73 137.42 51.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.503 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.683 ' O ' HD13 ' B' ' 116' ' ' LEU . 3.9 ttt -109.67 164.87 12.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.53 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.116 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.748 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 57.5 m-85 -60.37 -27.26 67.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.865 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.87 18.58 43.41 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.707 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.677 HD21 ' CB ' ' B' ' 117' ' ' ALA . 8.7 mp -108.02 119.07 38.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.723 0.297 . . . . 0.0 110.73 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.2 113.44 25.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.192 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.854 HD22 HD11 ' B' ' 149' ' ' ILE . 1.5 mp -92.94 124.9 37.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.262 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.6 -169.59 21.85 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.615 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.6 148.54 32.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.934 0.367 . . . . 0.0 111.367 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.26 133.13 45.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.878 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.768 ' HB ' HG22 ' A' ' 54' ' ' THR . 53.9 mt -87.76 120.28 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 0.0 110.542 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -124.83 173.22 8.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.207 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 40' ' ' LEU . 39.8 t -83.33 100.5 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.659 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -47.71 53.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.613 0.244 . . . . 0.0 111.044 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -161.69 144.64 12.11 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.592 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -130.35 155.75 45.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 111.333 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.0 t -65.35 144.71 56.92 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.975 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.0 tpt85 -79.72 148.6 31.47 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.2 30.57 19.98 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.486 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.58 -170.98 27.93 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.108 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.562 HD22 ' O ' ' B' ' 90' ' ' MET . 0.1 OUTLIER -68.52 -32.66 72.77 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.642 0.221 . . . . 0.0 111.585 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.994 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -73.99 -35.42 64.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.07 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.29 -33.99 42.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.241 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.59 -37.55 86.69 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.165 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.94 -26.61 13.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.452 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.7 38.75 93.41 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.986 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.701 ' HB3' HG11 ' B' ' 87' ' ' VAL . 3.6 p30 -68.87 -46.85 67.4 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.459 0.17 . . . . 0.0 111.459 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.692 ' CD1' HD22 ' A' ' 75' ' ' LEU . 57.8 mt -116.62 129.3 56.08 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.717 0.294 . . . . 0.0 111.125 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.78 150.49 21.78 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.426 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -60.37 110.88 1.36 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.095 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.5 -15.43 17.47 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.153 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -64.19 132.79 51.39 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 117.268 0.534 . . . . 0.0 110.425 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.5 pt -79.9 112.74 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.83 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.452 ' HA ' HG12 ' A' ' 77' ' ' VAL . 19.6 mt -78.01 134.28 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.98 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 tp -91.72 -45.49 8.41 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.706 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -148.92 149.84 31.9 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.801 0.334 . . . . 0.0 111.68 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 23.0 mt -138.02 119.99 18.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.621 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 55.7 36.48 27.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.314 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.33 2.46 90.6 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.6 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -111.91 134.89 53.19 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.295 0.547 . . . . 0.0 110.411 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.2 t -57.88 146.81 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.268 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.768 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -120.39 23.6 10.79 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.373 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.56 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -116.81 139.18 50.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.438 ' HB2' ' CD1' ' B' ' 142' ' ' LEU . 11.9 p30 53.68 9.22 0.18 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.614 0.571 . . . . 0.0 112.22 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.513 ' HB3' HD11 ' A' ' 23' ' ' ILE . 14.2 tpp -82.95 159.82 22.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.779 0.323 . . . . 0.0 110.734 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.506 ' N ' ' HG3' ' A' ' 57' ' ' MET . 0.1 OUTLIER -72.77 138.1 46.26 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.194 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.0 -47.23 81.34 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.097 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.0 p -58.1 -41.28 83.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.189 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.25 -47.78 84.46 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.019 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.6 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -59.64 -40.81 88.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.981 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.19 -40.5 94.31 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.709 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -65.32 -38.74 91.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.905 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.3 tt -60.06 -43.92 95.06 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.942 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.487 ' CD1' HD22 ' B' ' 102' ' ' LEU . 57.0 mt -68.46 -37.11 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.809 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.7 -49.28 69.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.902 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.0 pttt -64.1 -23.5 67.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.27 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.7 m -81.36 66.99 7.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.098 0.475 . . . . 0.0 110.431 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.95 64.27 8.03 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.008 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.91 -76.29 0.07 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.588 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.82 129.61 32.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.274 . . . . 0.0 110.629 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.849 HD23 ' CE1' ' B' ' 98' ' ' TYR . 0.4 OUTLIER -129.82 136.82 50.02 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 26.6 mt-30 -98.32 143.08 29.17 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.719 HD13 HD13 ' B' ' 89' ' ' LEU . 1.9 mp -135.75 128.79 31.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.043 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.84 144.21 25.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.695 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 46' ' ' ILE . 10.6 m -141.57 167.67 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.957 0.408 . . . . 0.0 111.595 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.174 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.916 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.595 0.236 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.4 159.6 25.3 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.929 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.701 HG11 ' HB3' ' A' ' 39' ' ' ASN . 9.1 t -130.06 135.16 61.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.681 0.276 . . . . 0.0 111.078 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.51 114.08 25.81 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.792 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.719 HD13 HD13 ' A' ' 75' ' ' LEU . 10.9 mp -100.35 137.85 38.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.642 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' MET . . . . . 0.562 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -110.21 170.42 8.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.379 0.609 . . . . 0.0 111.47 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 27.8 tttm . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.375 -179.876 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 120.865 0.364 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.849 ' CE1' HD23 ' A' ' 73' ' ' LEU . 52.1 m-85 -88.1 -26.74 22.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.955 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.42 14.05 72.03 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.618 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.994 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -97.55 122.22 40.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 110.522 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.85 113.72 27.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.267 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.6 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.8 pt? -107.84 125.01 50.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.082 0.468 . . . . 0.0 111.329 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -104.33 -163.05 24.54 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.067 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.32 146.51 30.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.696 0.248 . . . . 0.0 111.162 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.475 ' NE2' HG21 ' B' ' 128' ' ' ILE . 6.1 pt20 -127.14 137.14 52.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.026 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 1.081 HD13 ' HB2' ' B' ' 145' ' ' ALA . 28.4 mt -88.18 120.42 37.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.591 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.466 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 47.4 p90 -123.88 172.55 8.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.988 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 0.602 HG21 ' HB3' ' B' ' 123' ' ' LEU . 96.6 t -85.16 98.55 6.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.924 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' LYS . . . . . 0.466 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -68.3 -57.57 5.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.416 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.08 139.84 23.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.743 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 6.1 ptt? -131.07 152.84 49.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 111.626 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 p -72.82 142.28 48.02 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.261 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -78.24 154.92 30.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.963 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.1 m 62.9 34.6 14.09 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.68 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.11 -175.28 20.23 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.96 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.683 HD13 ' O ' ' A' ' 7' ' ' MET . 0.2 OUTLIER -67.24 -32.54 73.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.669 0.234 . . . . 0.0 111.625 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.677 ' CB ' HD21 ' A' ' 17' ' ' LEU . . . -74.93 -37.92 61.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.657 0.265 . . . . 0.0 111.021 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.0 -33.71 44.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.246 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -58.68 -39.79 81.7 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.315 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.38 -31.71 9.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.544 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 49.28 11.01 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.434 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.725 ' HB3' HG11 ' A' ' 4' ' ' VAL . 14.4 p-10 -78.73 -44.05 24.34 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.764 ' CD1' HD13 ' B' ' 158' ' ' LEU . 85.1 mt -111.62 118.57 36.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.609 0.242 . . . . 0.0 110.993 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 131.44 34.64 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.252 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -48.14 109.49 0.24 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.083 0.468 . . . . 0.0 111.382 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 108.15 -1.99 33.25 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.344 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -70.83 135.61 48.2 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.456 0.628 . . . . 0.0 111.468 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.475 HG21 ' NE2' ' B' ' 105' ' ' GLN . 1.5 pt -79.95 107.47 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.592 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.642 ' CD1' HD21 ' A' ' 19' ' ' LEU . 42.7 mt -75.76 147.56 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.342 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.702 HD13 HD13 ' B' ' 161' ' ' LEU . 2.3 tp -110.21 -42.45 4.16 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.607 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -144.0 148.19 34.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.747 0.308 . . . . 0.0 111.387 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 34.8 mt -138.81 118.23 14.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.765 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 4.0 m120 52.37 48.01 23.53 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.36 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.23 16.66 67.2 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.201 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 46.2 m -120.83 140.48 51.69 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.811 0.305 . . . . 0.0 110.293 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.612 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.3 t -62.36 147.53 11.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.001 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.701 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -125.84 19.51 7.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.464 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.612 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.4 tt0 -111.95 133.95 53.81 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 72.51 -9.2 1.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.514 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.677 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.1 OUTLIER -66.34 169.59 7.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.96 0.409 . . . . 0.0 111.228 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 30.7 t -90.77 148.71 22.38 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.994 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.438 ' CD1' ' HB2' ' A' ' 56' ' ' ASN . 5.2 tt -58.1 -48.95 78.61 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.369 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 64.6 p -58.62 -39.75 81.37 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.709 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -46.39 85.04 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 1.081 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.73 -43.19 90.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -66.46 -39.49 88.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.443 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -42.16 98.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.984 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 tp -61.56 -43.18 99.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.454 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.854 HD11 HD22 ' A' ' 19' ' ' LEU . 12.0 mt -68.73 -37.54 77.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.727 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.55 -49.51 73.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.003 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -64.83 -24.27 67.49 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.366 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.6 m -79.44 70.0 5.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.924 0.393 . . . . 0.0 110.956 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.42 60.19 6.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.547 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.19 -82.76 0.05 OUTLIER Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.498 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -132.77 131.54 41.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.569 0.224 . . . . 0.0 110.489 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.748 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -128.56 137.11 51.56 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.06 0.457 . . . . 0.0 111.275 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 24.8 tt0 -101.92 140.49 36.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.395 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.764 HD13 ' CD1' ' B' ' 123' ' ' LEU . 1.0 OUTLIER -135.78 129.42 32.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.874 0.368 . . . . 0.0 111.091 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.403 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 13.3 t -113.99 132.17 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.707 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -129.36 165.83 28.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.551 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 161' ' ' LEU . . . . . 0.702 HD13 HD13 ' B' ' 130' ' ' LEU . 1.1 mp . . . . . 0 C--O 1.232 0.165 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.983 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.463 0.22 0 CA-C-O 120.773 0.32 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -127.15 158.05 20.91 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.761 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.1 134.37 62.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.587 0.232 . . . . 0.0 111.029 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.93 107.35 18.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 tp -108.19 123.96 49.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.478 ' HB3' ' HB3' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -104.0 150.97 23.76 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.925 0.393 . . . . 0.0 111.341 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.54 ' HA ' HD13 ' B' ' 116' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.224 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.248 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.465 0.325 0 CA-C-O 120.725 0.298 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.712 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 59.3 m-85 -72.27 -15.83 61.91 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.468 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.66 25.97 48.09 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.511 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.807 HD21 HD11 ' B' ' 123' ' ' LEU . 0.4 OUTLIER -106.05 117.69 34.68 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.579 0.228 . . . . 0.0 110.9 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.413 ' HB2' ' HG2' ' B' ' 110' ' ' GLU . 6.3 mtt85 -97.02 113.34 24.87 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.411 HD21 HG13 ' B' ' 129' ' ' ILE . 7.7 mp -102.06 124.93 48.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.183 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -103.42 -164.68 25.45 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.752 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.9 OUTLIER -147.0 147.96 31.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.023 0.411 . . . . 0.0 111.281 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -131.82 137.38 48.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.124 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.85 HD13 ' HB2' ' A' ' 62' ' ' ALA . 64.3 mt -87.89 120.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.619 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.471 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 45.2 p90 -124.91 172.11 9.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.339 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.756 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.3 t -83.0 100.21 6.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.89 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.471 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 1.2 tptp -68.05 -57.5 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.235 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -159.59 134.37 7.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.651 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -114.15 156.75 23.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.01 0.434 . . . . 0.0 111.299 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -65.55 138.21 57.9 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 148.64 47.93 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.917 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.87 31.82 21.07 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.53 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.08 -154.84 30.16 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.411 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.564 HD22 ' O ' ' B' ' 90' ' ' MET . 1.2 mt -85.54 -31.75 22.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.547 0.213 . . . . 0.0 111.455 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.819 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -75.21 -34.93 61.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.118 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.99 -33.81 44.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.988 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -38.6 83.93 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.358 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -103.16 -32.73 9.5 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.513 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.58 49.88 13.29 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.395 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.619 ' HB3' HG11 ' B' ' 87' ' ' VAL . 7.9 p-10 -82.82 -47.68 11.63 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.756 ' HB3' HG21 ' A' ' 25' ' ' VAL . 17.6 mt -105.95 128.45 53.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 111.147 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.41 133.36 38.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.543 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -54.96 110.44 0.66 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.191 0.519 . . . . 0.0 111.168 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.43 -7.91 28.45 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.816 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -73.37 135.67 44.31 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.244 0.545 . . . . 0.0 111.047 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.4 pt -74.38 114.59 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.543 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.0 mt -80.63 138.84 19.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.212 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.582 HD12 HD13 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -95.79 -46.99 6.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.535 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.4 OUTLIER -150.5 148.19 28.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.8 0.333 . . . . 0.0 111.567 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 43.5 mt -137.04 118.36 18.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.78 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 55.95 45.06 24.62 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.152 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.41 15.26 70.22 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.355 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.9 m -120.81 137.08 54.72 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.935 0.368 . . . . 0.0 110.474 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.603 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.2 t -60.42 147.18 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.294 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.806 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -125.2 21.76 7.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.534 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.603 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -117.45 129.73 56.01 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.9 m120 70.5 -3.84 1.79 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.354 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.712 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -68.69 173.15 5.42 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.831 0.348 . . . . 0.0 111.162 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.74 139.72 30.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.99 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' B' ' 139' ' ' ASN . 5.6 tt -56.35 -42.24 77.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.527 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.4 m -65.15 -37.21 86.7 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.004 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -44.81 78.67 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.637 0.256 . . . . 0.0 110.839 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 1.001 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -59.72 -41.8 91.66 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.496 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.0 ptt85 -71.65 -35.85 70.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.714 0.292 . . . . 0.0 110.711 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.2 -38.62 82.15 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.664 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -44.96 93.5 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.773 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.584 HD12 HD22 ' B' ' 102' ' ' LEU . 59.3 mt -68.32 -36.8 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.08 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -48.78 63.78 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.742 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -29.16 70.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.146 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.2 m -84.31 85.39 7.38 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.842 0.353 . . . . 0.0 111.035 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.81 113.12 25.1 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.61 -89.07 0.24 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.593 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.84 131.85 53.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.662 0.268 . . . . 0.0 110.655 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.758 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.4 OUTLIER -129.53 138.5 51.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.961 0.41 . . . . 0.0 111.323 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.7 tt0 -101.65 138.95 37.96 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.673 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.71 HD13 HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -133.64 125.12 28.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.949 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.66 146.55 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.52 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.443 HG22 ' O ' ' B' ' 85' ' ' ILE . 32.7 m -121.21 140.51 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.278 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.582 HD13 HD12 ' A' ' 47' ' ' LEU . 21.2 tp . . . . . 0 N--CA 1.465 0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.911 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.443 ' O ' HG22 ' A' ' 77' ' ' VAL . 10.3 tt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.669 0.271 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.17 157.37 25.47 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.732 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 39' ' ' ASN . 21.5 t -131.08 132.65 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.79 0.328 . . . . 0.0 111.096 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.426 HD12 ' HG3' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -97.84 107.07 19.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.417 HD21 ' N ' ' A' ' 34' ' ' ALA . 2.2 tp -91.26 141.55 28.67 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.513 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' MET . . . . . 0.564 ' O ' HD22 ' A' ' 33' ' ' LEU . 9.4 tpp -118.44 163.15 17.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.695 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' LYS . . . . . 0.498 ' N ' ' HG3' ' B' ' 90' ' ' MET . 7.2 pttt . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.144 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 120.916 0.388 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.758 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 60.2 m-85 -68.28 -23.74 64.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.455 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.09 20.28 73.16 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.46 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -98.06 117.05 31.54 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.664 0.268 . . . . 0.0 110.605 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.23 113.4 25.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.101 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 1.001 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.8 pt? -110.6 124.84 52.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.125 0.488 . . . . 0.0 111.07 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -111.05 -164.04 18.33 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.243 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.58 148.91 40.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.706 0.288 . . . . 0.0 111.078 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 21' ' ' SER . 1.8 pt20 -127.65 136.73 52.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.135 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.783 HD13 ' HB2' ' B' ' 145' ' ' ALA . 42.1 mt -87.78 120.2 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.345 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -122.97 172.98 8.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.121 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 0.964 HG21 HD13 ' B' ' 123' ' ' LEU . 33.2 t -81.59 95.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.044 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -43.97 88.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.143 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -168.93 140.43 2.52 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.839 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.578 ' SD ' HG23 ' B' ' 118' ' ' THR . 0.2 OUTLIER -126.46 161.09 28.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.891 0.377 . . . . 0.0 111.434 -179.772 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 18.8 p -77.09 122.77 25.44 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.208 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -64.64 150.33 47.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.963 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m 62.63 32.76 16.17 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.31 -166.48 24.73 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.128 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.54 HD13 ' HA ' ' A' ' 8' ' ' LYS . 4.4 mt -75.45 -30.99 60.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.647 0.224 . . . . 0.0 111.417 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.72 -34.4 62.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.17 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.578 HG23 ' SD ' ' B' ' 111' ' ' MET . 0.1 OUTLIER -78.77 -33.96 45.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.084 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.84 -37.71 87.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.336 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.08 -31.66 12.02 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.663 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.61 51.37 7.28 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.345 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -66.56 -35.58 80.57 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.964 HD13 HG21 ' B' ' 108' ' ' VAL . 0.5 OUTLIER -154.27 164.19 38.95 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.804 0.335 . . . . 0.0 111.11 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 148.33 30.79 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.882 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -56.16 112.3 1.18 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.103 0.478 . . . . 0.0 110.981 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.2 -16.67 22.33 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.965 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -61.79 138.81 58.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.071 0.462 . . . . 0.0 111.222 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.424 ' O ' HG13 ' B' ' 128' ' ' ILE . 44.3 pt -78.56 124.9 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.794 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.418 HD11 HD22 ' B' ' 123' ' ' LEU . 33.2 mm -90.91 131.69 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.543 HD13 HD13 ' B' ' 161' ' ' LEU . 15.9 tp -94.89 -44.01 7.93 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.563 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -148.62 152.69 37.18 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.424 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 35.5 mt -141.11 118.24 8.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.573 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 55.79 38.74 30.43 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.15 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.04 2.08 88.37 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.517 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 47.8 m -109.69 131.65 54.86 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 117.054 0.427 . . . . 0.0 110.349 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.625 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.2 t -58.47 146.95 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.696 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -120.93 18.91 11.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.675 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.625 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.1 OUTLIER -109.42 130.2 55.51 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.224 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 139' ' ' ASN . . . . . 0.473 ' HB3' HD13 ' A' ' 59' ' ' LEU . 5.1 m-80 71.6 -6.11 1.49 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.375 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.606 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -65.61 168.5 7.44 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.909 0.385 . . . . 0.0 111.1 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 14.5 t -89.37 149.44 22.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.167 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -47.11 87.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.633 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 12.0 p -60.21 -37.22 79.61 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.17 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.1 -41.47 67.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.606 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.783 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -63.5 -41.82 98.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.256 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 146' ' ' ARG . . . . . 0.468 ' HA ' HD12 ' B' ' 149' ' ' ILE . 0.0 OUTLIER -71.3 -36.47 71.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.661 0.267 . . . . 0.0 110.482 179.515 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -68.02 -38.35 82.46 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.526 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 148' ' ' LEU . . . . . 0.428 HD13 ' O ' ' B' ' 148' ' ' LEU . 0.4 OUTLIER -59.79 -44.38 93.96 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' B' ' 146' ' ' ARG . 7.9 mt -65.95 -38.34 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.713 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -68.71 -49.62 57.39 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.777 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -25.64 68.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.2 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 6.0 m -81.28 63.74 5.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.907 0.385 . . . . 0.0 110.502 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -76.71 121.99 24.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.95 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 120.1 -83.7 0.36 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.31 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 155' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 7' ' ' MET . 0.0 OUTLIER -132.75 130.35 39.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.722 0.296 . . . . 0.0 110.687 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.712 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.94 134.14 48.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.111 0.481 . . . . 0.0 111.156 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.6 tm0? -93.21 141.21 28.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.258 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.33 123.73 24.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.704 0.288 . . . . 0.0 110.678 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.453 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 32.6 t -107.88 135.85 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.291 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.28 141.51 43.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.771 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 161' ' ' LEU . . . . . 0.543 HD13 HD13 ' B' ' 130' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.198 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.967 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.234 0.273 0 CA-C-O 120.659 0.266 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.3 158.85 23.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.728 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.3 t -129.85 134.89 62.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 110.848 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.99 113.09 26.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.754 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.2 tp -99.69 144.88 28.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.77 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.656 ' O ' HD22 ' B' ' 116' ' ' LEU . 3.0 ttt -112.78 164.08 13.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.147 0.499 . . . . 0.0 110.793 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.195 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 N--CA 1.463 0.213 0 CA-C-O 120.963 0.411 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.781 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 72.8 m-85 -104.54 -30.94 9.69 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.355 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.24 25.39 44.14 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.527 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' B' ' 117' ' ' ALA . 1.0 OUTLIER -104.78 122.01 44.83 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -102.44 113.42 26.74 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.15 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.798 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.7 pt? -108.96 124.98 51.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.111 0.481 . . . . 0.0 111.646 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -106.66 -162.48 22.32 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.855 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.66 149.33 35.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' B' ' 104' ' ' SER . 12.1 pt20 -129.67 136.15 49.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.011 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.667 ' HB ' HG22 ' A' ' 54' ' ' THR . 38.8 mt -88.01 120.69 37.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.0 110.631 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -121.97 173.38 7.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.177 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.43 HG21 HD22 ' A' ' 40' ' ' LEU . 40.4 t -79.93 98.18 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.611 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -55.68 10.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.121 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -162.4 145.0 11.15 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 32.0 mtm -119.57 149.54 41.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.955 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 p -65.55 148.98 50.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -75.13 151.66 38.56 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.817 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.47 34.47 20.46 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.633 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.94 172.59 18.29 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.753 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -29.65 69.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.598 ' N ' HD21 ' B' ' 89' ' ' LEU . . . -74.76 -39.55 61.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.205 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.97 -33.71 44.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.115 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -39.77 79.26 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.386 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -106.9 -27.54 10.64 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.558 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.87 59.03 7.99 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.418 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.881 ' CB ' HG11 ' B' ' 87' ' ' VAL . 5.5 m120 -88.62 -33.82 17.5 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.6 0.2 . . . . 0.0 111.328 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.578 ' CD1' HD22 ' A' ' 75' ' ' LEU . 4.4 mt -111.82 134.78 53.17 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.144 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.1 132.71 43.4 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.751 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -57.18 113.48 1.74 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.11 0.481 . . . . 0.0 111.27 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.22 -18.93 13.64 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.793 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -62.37 137.2 58.21 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.879 0.371 . . . . 0.0 110.512 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.4 pt -76.39 128.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.916 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.467 HG22 ' OG1' ' A' ' 54' ' ' THR . 17.0 mt -95.45 137.39 23.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.872 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.4 tp -103.72 -36.67 7.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.444 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -148.25 147.85 29.82 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.896 0.379 . . . . 0.0 111.547 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 35.8 mt -142.27 117.58 5.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.957 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.0 t30 51.3 29.47 5.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.369 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.84 -10.83 64.4 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.615 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -103.67 124.79 49.5 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 117.329 0.565 . . . . 0.0 110.845 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.747 HG22 ' H ' ' A' ' 55' ' ' GLU . 2.4 p -56.97 149.61 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.147 0.499 . . . . 0.0 110.941 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -118.59 31.15 6.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.511 -178.696 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.747 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -127.6 128.52 45.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 71.02 -5.82 1.43 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.299 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ttt -78.14 156.06 30.13 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.837 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -71.94 138.72 48.3 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.459 HD11 ' HA2' ' B' ' 103' ' ' GLY . 0.7 OUTLIER -58.08 -45.04 87.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.195 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.9 p -59.31 -44.92 92.5 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.141 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.16 -47.19 87.35 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.07 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.714 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -61.6 -40.38 94.59 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.87 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.459 ' HA ' HD12 ' A' ' 66' ' ' ILE . 51.6 mtp85 -64.4 -40.57 96.04 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.948 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -65.76 -38.53 89.32 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.813 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 65' ' ' LEU . 1.3 tm? -59.93 -44.23 94.47 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.751 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 63' ' ' ARG . 4.8 mt -68.18 -37.02 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -63.19 -49.33 74.68 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.829 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -69.59 -26.84 64.65 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.352 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -76.13 68.82 2.62 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.056 0.455 . . . . 0.0 110.879 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -87.42 99.47 12.03 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.546 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.13 -82.87 0.17 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.631 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.25 130.65 37.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.627 0.251 . . . . 0.0 110.566 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.746 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.7 OUTLIER -129.59 140.7 51.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.423 . . . . 0.0 111.219 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.9 tt0 -109.87 140.24 44.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.597 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.578 HD22 ' CD1' ' A' ' 40' ' ' LEU . 1.5 mp -130.24 126.44 37.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.605 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.4 t -115.51 133.59 61.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.05 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -122.78 165.8 18.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.249 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 C--O 1.232 0.173 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.675 179.761 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.668 HD13 ' N ' ' B' ' 86' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.73 0.3 . . . . 0.0 111.026 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.668 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -142.79 157.6 26.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.835 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.881 HG11 ' CB ' ' A' ' 39' ' ' ASN . 16.9 t -122.92 135.24 63.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.659 0.266 . . . . 0.0 111.096 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.431 ' O ' HD12 ' B' ' 88' ' ' LEU . 0.4 OUTLIER -104.87 127.47 52.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.511 179.468 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.598 HD21 ' N ' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -111.52 144.57 40.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.775 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 4.1 ttt -111.28 163.68 13.7 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.855 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.682 0.277 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.746 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 43.0 m-85 -55.75 -30.52 61.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.548 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.5 19.51 77.99 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.554 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -93.2 118.48 31.29 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.57 113.36 26.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.211 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.714 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.7 pt? -105.12 124.94 50.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' GLY . . . . . 0.459 ' HA2' HD11 ' A' ' 59' ' ' LEU . . . -108.46 -177.36 21.89 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.972 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.438 ' OG ' HD12 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -139.06 148.62 43.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.857 0.361 . . . . 0.0 111.193 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -129.1 139.91 51.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.78 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.943 HD13 ' HB2' ' B' ' 145' ' ' ALA . 35.6 mt -88.13 121.66 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 110.828 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.485 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 44.7 p90 -124.29 170.57 10.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.204 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.74 98.28 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.139 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' LYS . . . . . 0.485 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -66.24 -56.36 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.259 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -153.48 142.0 20.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.654 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -130.7 158.61 39.61 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.832 0.348 . . . . 0.0 111.308 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 89.9 m -65.28 134.87 54.55 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.974 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.93 149.7 44.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.8 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.78 30.39 18.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.461 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.83 -171.61 32.89 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.1 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.656 HD22 ' O ' ' A' ' 7' ' ' MET . 1.3 mp -68.11 -32.51 72.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.499 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -74.94 -38.65 61.69 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.547 0.213 . . . . 0.0 111.349 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -33.52 45.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.18 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -60.81 -39.04 87.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.026 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.08 -31.63 11.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.375 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.57 45.79 21.64 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.45 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.65 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.4 p-10 -77.68 -39.5 44.59 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.449 ' CD1' HD13 ' B' ' 158' ' ' LEU . 78.6 mt -122.59 127.2 49.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.778 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.99 131.28 38.12 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -48.11 110.77 0.36 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.009 0.433 . . . . 0.0 111.255 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.95 -5.71 30.73 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.452 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -68.3 136.47 53.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.264 0.532 . . . . 0.0 111.396 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -79.0 101.28 4.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.271 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.748 HG21 HD11 ' B' ' 132' ' ' ILE . 7.7 mt -64.68 148.38 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.02 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 tt -111.12 -44.53 3.56 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.616 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -151.6 148.05 27.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.79 0.329 . . . . 0.0 111.687 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 1.105 HD12 HD23 ' B' ' 158' ' ' LEU . 36.5 mm -132.83 118.53 34.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.526 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 56.81 42.92 25.89 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.31 15.35 74.81 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.216 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 7.5 m -120.89 140.27 52.04 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.957 0.378 . . . . 0.0 110.219 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.627 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.6 t -61.46 148.36 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.825 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.755 HG22 HD12 ' B' ' 106' ' ' ILE . 0.2 OUTLIER -129.12 22.78 5.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.135 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.627 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.0 OUTLIER -112.17 135.27 53.04 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.379 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 72.11 -9.53 0.99 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.484 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.629 ' HB3' HD11 ' B' ' 106' ' ' ILE . 4.0 tpp -66.55 170.65 5.93 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.02 148.62 22.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.987 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.04 -35.76 71.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.759 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' B' ' 146' ' ' ARG . 3.8 m -65.68 -37.24 85.95 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.159 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.38 -38.68 65.57 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 110.607 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.943 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -64.03 -42.57 97.06 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.089 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 146' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' B' ' 143' ' ' THR . 7.0 ppt_? -72.63 -35.53 67.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.65 0.262 . . . . 0.0 110.59 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -39.23 82.83 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.773 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.85 -45.15 93.35 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.602 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.505 HD12 HD22 ' A' ' 19' ' ' LEU . 47.7 mt -68.56 -36.79 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.772 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.57 -48.77 71.26 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.985 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -70.35 -24.94 63.07 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.61 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 96.9 p -78.06 67.35 3.88 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.064 0.459 . . . . 0.0 110.751 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 6.7 mtm-85 -76.62 128.31 34.46 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.587 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.57 -91.47 0.59 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.506 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.42 134.57 50.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.783 0.325 . . . . 0.0 110.723 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.781 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -129.76 141.68 50.83 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.331 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 7.8 tt0 -100.37 139.57 35.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.676 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 1.105 HD23 HD12 ' B' ' 132' ' ' ILE . 0.7 OUTLIER -134.0 128.79 35.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.91 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.56 137.11 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -125.01 143.83 37.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.248 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 C--N 1.332 -0.177 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.486 179.786 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.739 0.304 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.97 158.77 23.48 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.564 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.713 HG11 ' HB3' ' B' ' 122' ' ' ASN . 25.8 t -132.07 133.34 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.68 0.276 . . . . 0.0 110.963 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.497 HD23 ' OE1' ' B' ' 157' ' ' GLN . 0.3 OUTLIER -107.01 107.62 18.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.104 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.487 HD21 ' N ' ' B' ' 117' ' ' ALA . 5.9 tp -91.03 128.5 36.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.118 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.497 ' O ' HD13 ' B' ' 116' ' ' LEU . 21.2 ttt -114.97 162.27 17.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.295 0.569 . . . . 0.0 111.274 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 tttm . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.798 -179.755 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.524 0.202 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.716 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 86.9 m-85 -58.2 -27.44 63.9 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.42 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.36 29.02 58.86 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.666 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.67 118.84 37.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.278 . . . . 0.0 110.727 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.18 113.43 25.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.928 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.704 HD21 HD13 ' B' ' 129' ' ' ILE . 5.9 mp -97.06 124.88 41.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 111.342 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -110.33 179.85 20.48 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -132.61 150.18 52.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.194 0.497 . . . . 0.0 111.354 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' B' ' 104' ' ' SER . 7.9 pt20 -134.42 141.56 46.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.794 ' HB ' HG22 ' A' ' 54' ' ' THR . 2.9 mm -87.84 121.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.401 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -126.41 171.54 10.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.205 0.526 . . . . 0.0 111.392 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.76 100.46 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.853 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -55.76 5.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.082 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -156.58 133.8 10.58 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.559 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.06 145.12 48.82 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.896 0.379 . . . . 0.0 111.28 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.5 m -65.31 120.07 12.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.588 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.82 164.59 7.75 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.003 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.63 27.77 14.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.34 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.52 -175.18 20.55 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.182 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.648 HD22 ' O ' ' B' ' 90' ' ' MET . 0.6 OUTLIER -69.01 -31.1 69.69 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.5 ' N ' HD21 ' B' ' 89' ' ' LEU . . . -75.17 -34.88 61.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.52 0.2 . . . . 0.0 111.138 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.84 -34.09 45.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.216 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -37.75 85.5 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.49 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -102.41 -32.7 9.86 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.349 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.56 53.92 8.07 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.141 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.67 ' OD1' HG11 ' B' ' 87' ' ' VAL . 5.1 m-80 -70.03 -47.68 61.08 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.523 0.202 . . . . 0.0 111.296 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.638 HD13 ' C ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -116.49 136.17 53.22 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.902 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.81 141.79 28.32 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.207 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -56.99 109.66 0.68 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.186 0.517 . . . . 0.0 110.856 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.8 -7.77 38.95 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.708 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -67.16 138.58 57.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.078 0.466 . . . . 0.0 110.955 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 pt -77.33 120.93 28.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.811 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.915 HG21 HD11 ' A' ' 49' ' ' ILE . 24.1 mt -90.38 152.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.877 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.859 HD13 HD11 ' A' ' 78' ' ' LEU . 2.5 tp -111.7 -52.2 2.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.831 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.14 147.9 40.86 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 111.568 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 46' ' ' ILE . 37.4 mm -132.78 118.35 33.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 m120 53.28 36.71 23.44 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.754 0.311 . . . . 0.0 111.264 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.55 16.74 77.2 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.162 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.615 HG21 HD11 ' A' ' 65' ' ' LEU . 1.6 m -120.54 143.68 48.46 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.905 0.353 . . . . 0.0 110.094 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.449 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.3 t -63.79 143.93 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 111.295 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.794 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -127.72 27.86 5.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.945 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.449 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -123.99 126.76 46.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.013 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 72.0 -5.71 1.66 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.403 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.427 ' CE ' ' HB ' ' A' ' 53' ' ' VAL . 2.3 tpp -67.97 172.59 5.37 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.96 0.409 . . . . 0.0 111.439 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.7 t -90.81 150.96 21.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.244 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -42.01 82.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.793 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.7 t -57.66 -41.94 82.52 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.9 -46.11 86.31 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.95 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' B' ' 102' ' ' LEU . . . -60.22 -41.06 92.28 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.29 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -71.38 -37.33 71.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.435 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -67.92 -38.24 82.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.63 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 52' ' ' THR . 0.1 OUTLIER -59.72 -45.39 92.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.81 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.547 ' CD1' HD22 ' B' ' 102' ' ' LEU . 48.5 mt -68.73 -36.82 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.872 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -48.71 62.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.879 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.9 -24.52 62.49 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.775 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.4 p -79.38 65.37 4.53 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.116 0.484 . . . . 0.0 110.973 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -78.07 119.92 22.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.69 -89.45 0.46 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.29 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -126.35 130.22 50.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.625 0.25 . . . . 0.0 110.681 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.663 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.6 OUTLIER -122.78 143.47 49.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.947 0.404 . . . . 0.0 111.233 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.2 tm0? -105.85 142.14 36.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.867 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' HA ' HD13 ' A' ' 49' ' ' ILE . 1.4 mp -137.71 125.78 22.89 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.914 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.5 t -112.65 133.46 58.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.775 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.53 161.53 41.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.312 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.859 HD11 HD13 ' A' ' 47' ' ' LEU . 6.7 mp . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.257 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 120.663 0.268 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.13 158.84 22.16 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.88 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.67 HG11 ' OD1' ' A' ' 39' ' ' ASN . 15.3 t -129.67 135.05 62.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.691 0.282 . . . . 0.0 111.028 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 7.4 tt -105.35 109.31 21.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.464 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.5 HD21 ' N ' ' A' ' 34' ' ' ALA . 10.6 tp -94.04 141.34 28.64 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' MET . . . . . 0.648 ' O ' HD22 ' A' ' 33' ' ' LEU . 13.2 ttt -115.09 165.73 12.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.096 0.474 . . . . 0.0 111.167 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.623 179.84 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 120.756 0.312 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.663 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 53.1 m-85 -80.34 -29.52 38.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.756 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.89 20.04 38.06 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.552 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.415 HD21 ' CB ' ' A' ' 34' ' ' ALA . 4.8 mp -100.1 120.17 39.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.701 0.286 . . . . 0.0 110.804 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.35 113.57 26.77 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.973 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.547 HD22 ' CD1' ' A' ' 66' ' ' ILE . 1.7 pt? -113.51 125.02 53.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.151 0.501 . . . . 0.0 111.339 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -108.16 -162.11 20.85 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.003 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -141.72 146.51 36.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -126.66 143.19 51.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.222 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 1.063 HD13 ' HB2' ' B' ' 145' ' ' ALA . 30.2 mt -88.4 120.71 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -122.15 172.3 8.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.805 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 57.9 t -84.06 94.14 3.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.174 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -64.17 -51.66 62.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.264 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -155.42 133.24 11.32 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.742 0.306 . . . . 0.0 110.784 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -121.45 144.26 48.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 89.3 m -66.51 123.43 20.02 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.01 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -65.53 162.07 18.85 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.127 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 62.03 35.31 16.05 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.122 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -117.94 -175.75 16.93 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.175 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 7' ' ' MET . 4.0 mt -65.43 -33.54 76.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.519 0.199 . . . . 0.0 111.48 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.487 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -74.95 -35.06 62.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.306 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.86 -33.9 45.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.186 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -62.65 -37.52 86.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.303 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.16 -29.93 11.84 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.563 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.75 48.27 43.27 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.289 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.713 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.2 p30 -72.26 -41.64 66.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.447 HD13 HD13 ' B' ' 158' ' ' LEU . 2.9 mp -125.48 127.49 46.56 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.665 0.269 . . . . 0.0 110.827 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.08 136.35 33.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.0 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -49.71 107.0 0.13 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.051 0.453 . . . . 0.0 111.666 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.68 -2.95 24.65 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.411 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -76.17 139.96 41.5 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 117.654 0.727 . . . . 0.0 111.275 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.72 113.07 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.068 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 1.028 HG21 HD11 ' B' ' 132' ' ' ILE . 6.8 mt -82.52 137.22 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.294 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 tp -96.82 -40.24 9.03 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -148.61 148.23 29.89 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 111.909 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 1.028 HD11 HG21 ' B' ' 129' ' ' ILE . 18.4 mm -135.02 118.22 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.087 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 133' ' ' ASN . . . . . 0.471 ' HB2' HD21 ' B' ' 148' ' ' LEU . 12.7 t30 54.88 42.58 30.99 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.988 0.423 . . . . 0.0 111.074 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.14 16.09 76.79 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.139 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 13.2 m -120.74 137.47 54.48 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.934 0.367 . . . . 0.0 110.586 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.513 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.3 t -59.4 145.16 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.034 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.826 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -118.5 18.35 13.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.428 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.513 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.3 OUTLIER -105.67 140.6 38.48 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.3 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 52.64 9.91 0.13 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.705 0.628 . . . . 0.0 112.349 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.73 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -73.89 173.68 9.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 111.264 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.19 137.22 32.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.956 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.62 -40.73 69.22 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.388 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 1.2 p -64.16 -38.03 89.59 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.218 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.78 -48.22 72.54 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.756 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 1.063 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.49 -42.26 87.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.942 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -69.45 -37.49 77.38 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.576 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -67.81 -38.64 83.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.551 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 148' ' ' LEU . . . . . 0.51 ' O ' HD23 ' B' ' 148' ' ' LEU . 6.7 tt -60.02 -44.85 94.33 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.586 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.547 HD11 HD22 ' A' ' 19' ' ' LEU . 11.8 mt -68.34 -36.64 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.92 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -69.14 -41.75 76.89 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.714 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.1 0.07 52.83 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 97.1 p -91.51 54.8 2.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.263 0.554 . . . . 0.0 110.945 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.32 83.94 1.42 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.377 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 159.58 -90.27 0.11 Allowed Glycine 0 C--O 1.226 -0.375 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.302 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.24 133.71 41.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.501 0.191 . . . . 0.0 110.804 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.716 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.64 125.61 38.46 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 111.297 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.497 ' OE1' HD23 ' A' ' 5' ' ' LEU . 2.7 mt-30 -92.33 119.13 31.6 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.447 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.69 HD23 HD12 ' B' ' 132' ' ' ILE . 0.4 OUTLIER -111.41 129.84 55.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.699 0.285 . . . . 0.0 110.988 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 27.0 t -116.48 140.29 39.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.431 HG21 ' HG ' ' B' ' 123' ' ' LEU . 27.0 t -132.19 138.01 53.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.092 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.861 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.829 0.347 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.22 158.69 24.45 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.57 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.672 HG11 ' HB3' ' B' ' 122' ' ' ASN . 23.3 t -131.87 134.44 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.68 0.276 . . . . 0.0 110.829 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.15 115.95 30.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.622 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.45 HD21 ' N ' ' B' ' 117' ' ' ALA . 1.6 tp -102.79 142.53 33.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.444 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.634 ' O ' HD22 ' B' ' 116' ' ' LEU . 0.7 OUTLIER -107.47 162.21 14.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.218 0.533 . . . . 0.0 110.589 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.487 ' N ' ' HG3' ' A' ' 7' ' ' MET . 11.2 ttpt . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.008 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.883 ' CE2' HD23 ' B' ' 156' ' ' LEU . 52.9 m-85 -58.79 -32.97 69.82 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.325 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' O ' HG23 ' B' ' 112' ' ' THR . . . 85.76 20.54 55.8 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.383 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -105.31 123.32 47.66 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.872 0.336 . . . . 0.0 110.556 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.413 ' HB2' ' HG2' ' B' ' 110' ' ' GLU . 0.0 OUTLIER -100.73 113.57 26.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.337 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.865 HD22 HD11 ' B' ' 149' ' ' ILE . 1.2 mp -92.39 124.87 36.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.108 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.38 -173.84 22.43 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.52 147.34 31.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.291 . . . . 0.0 110.836 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.471 ' NE2' HG21 ' A' ' 45' ' ' ILE . 7.8 pt20 -130.84 133.85 46.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.193 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.969 HD13 ' HB2' ' A' ' 62' ' ' ALA . 46.1 mt -87.94 120.32 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.958 0.408 . . . . 0.0 110.327 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -126.72 173.19 9.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.191 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.816 ' CG2' HD12 ' A' ' 40' ' ' LEU . 60.3 t -85.5 97.71 5.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.018 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -55.4 21.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.266 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -147.19 144.64 29.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.922 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.426 ' SD ' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -138.24 148.76 45.08 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.948 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.4 t -65.83 132.86 49.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.056 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -74.72 148.33 40.59 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.566 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.7 31.4 21.11 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.24 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.46 -144.11 16.19 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.355 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 -38.45 17.61 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.71 0.29 . . . . 0.0 111.154 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' CB ' HD21 ' B' ' 100' ' ' LEU . . . -74.91 -30.17 61.19 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.251 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.426 HG23 ' SD ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -79.14 -35.48 42.05 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.93 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -36.69 84.76 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.991 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.0 -28.14 13.92 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.102 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.34 49.19 53.72 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.507 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.846 ' HB3' HG11 ' B' ' 87' ' ' VAL . 11.8 p-10 -94.12 -32.16 13.87 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.816 HD12 ' CG2' ' A' ' 25' ' ' VAL . 3.3 mm? -114.64 131.08 56.84 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.674 0.273 . . . . 0.0 110.997 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.16 117.91 35.37 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -43.9 108.53 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.133 0.492 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.51 -5.37 31.35 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.346 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.401 ' OD2' HD13 ' A' ' 40' ' ' LEU . 50.3 p-10 -75.85 139.99 42.0 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.854 0.827 . . . . 0.0 111.751 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.471 HG21 ' NE2' ' A' ' 22' ' ' GLN . 14.4 pt -80.13 118.45 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.175 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.645 HD11 HD11 ' B' ' 102' ' ' LEU . 26.4 mt -85.0 134.43 27.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.801 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 tp -99.42 -29.9 12.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.677 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -157.59 148.47 21.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.775 0.321 . . . . 0.0 111.425 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.558 HD11 HD21 ' B' ' 102' ' ' LEU . 37.5 mt -140.73 118.12 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.563 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.444 ' HB2' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER 56.52 35.89 26.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.275 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 12.33 83.87 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.176 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.9 m -120.15 135.88 54.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.864 0.332 . . . . 0.0 110.398 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.3 t -59.83 147.46 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.826 0.346 . . . . 0.0 111.037 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -122.17 19.02 10.75 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.396 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -106.27 144.4 33.02 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 p30 52.58 7.82 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 123.644 0.59 . . . . 0.0 112.376 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.713 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -76.15 176.58 7.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 111.123 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 t -92.12 146.72 23.5 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.756 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.52 -43.93 96.59 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.599 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.4 p -62.47 -38.22 89.0 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.069 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -48.01 75.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.905 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.969 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -62.22 -40.55 96.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.994 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -67.6 -39.28 84.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.77 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -66.59 -38.49 87.12 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.545 ' O ' HD23 ' A' ' 65' ' ' LEU . 6.2 tt -59.91 -45.38 92.73 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.529 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.886 HD11 HD22 ' B' ' 102' ' ' LEU . 5.7 mt -68.5 -37.05 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.94 -49.46 57.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.108 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.48 -19.43 63.75 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.253 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 t -79.33 63.99 4.11 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.196 0.522 . . . . 0.0 110.574 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 mtm105 -79.08 97.72 6.24 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.413 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.67 -93.99 0.18 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.214 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.38 125.96 45.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.581 0.229 . . . . 0.0 110.66 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.843 HD23 ' CE1' ' B' ' 98' ' ' TYR . 2.3 pp -124.73 143.85 50.55 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.896 0.379 . . . . 0.0 111.188 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -105.14 142.65 34.54 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.779 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.755 HD11 HD11 ' A' ' 73' ' ' LEU . 1.0 OUTLIER -135.34 132.28 37.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.819 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.53 135.0 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.292 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.5 m -122.98 146.59 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.196 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.9 tp . . . . . 0 C--O 1.231 0.112 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.552 179.658 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.603 HD13 ' N ' ' B' ' 86' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.903 0.382 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.603 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -117.84 157.21 15.27 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.447 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.846 HG11 ' HB3' ' A' ' 39' ' ' ASN . 17.3 t -130.82 134.54 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 0.0 111.063 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 73' ' ' LEU . 0.6 OUTLIER -102.92 107.35 18.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.619 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 9.4 tp -95.19 139.54 31.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.392 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 8.2 ttt -114.52 164.4 14.04 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.993 0.425 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.172 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.25 0 CA-C-O 120.76 0.314 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.843 ' CE1' HD23 ' A' ' 73' ' ' LEU . 71.0 m-85 -59.48 -30.6 68.66 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.377 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.44 24.74 32.74 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.512 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.487 HD21 ' CB ' ' A' ' 34' ' ' ALA . 11.2 mp -108.48 120.5 42.6 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.757 0.313 . . . . 0.0 110.699 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -92.91 117.05 29.62 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.761 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.886 HD22 HD11 ' A' ' 66' ' ' ILE . 1.1 tp -94.7 125.2 39.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -116.46 177.09 16.7 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.658 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.22 146.59 46.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.904 0.352 . . . . 0.0 110.922 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -128.14 137.01 51.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.219 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.966 HD13 ' HB2' ' B' ' 145' ' ' ALA . 42.3 mt -88.27 120.48 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.908 0.385 . . . . 0.0 110.457 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -124.73 172.59 9.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.079 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' B' ' 123' ' ' LEU . 40.2 t -82.74 96.03 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.146 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -57.6 6.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.689 0.28 . . . . 0.0 111.178 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -149.28 138.46 21.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.615 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -132.25 140.12 48.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.017 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 16' ' ' GLY . 38.6 p -69.37 120.48 15.24 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.788 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 113' ' ' ARG . . . . . 0.676 ' HA ' HG21 ' B' ' 118' ' ' THR . 8.0 ptt180 -63.04 169.24 3.49 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.738 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m 62.01 23.66 13.97 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.946 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.16 -164.51 24.77 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.255 -0.497 . . . . 0.0 112.326 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.634 HD22 ' O ' ' A' ' 7' ' ' MET . 0.0 OUTLIER -77.58 -31.41 53.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.579 0.228 . . . . 0.0 111.295 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.45 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -74.45 -34.96 63.3 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.186 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.676 HG21 ' HA ' ' B' ' 113' ' ' ARG . 2.1 p -79.0 -34.05 44.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.085 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -58.81 -39.53 81.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.264 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -103.92 -29.14 11.15 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.465 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.7 46.26 47.75 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.251 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.672 ' HB3' HG11 ' A' ' 4' ' ' VAL . 12.0 p-10 -73.37 -38.44 65.69 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.514 0.197 . . . . 0.0 111.355 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' B' ' 158' ' ' LEU . 1.5 mp -127.61 139.37 52.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.763 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.2 148.35 27.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.43 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -60.31 113.32 2.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.086 0.469 . . . . 0.0 110.962 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.48 -16.12 24.38 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.009 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -60.6 136.09 57.95 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.317 0.559 . . . . 0.0 111.295 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.92 99.15 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.377 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.84 HD13 HD21 ' A' ' 19' ' ' LEU . 4.7 mt -63.52 147.42 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.681 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 18.2 tp -110.28 -35.46 6.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.617 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -157.32 148.26 21.54 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.783 0.325 . . . . 0.0 111.19 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.555 HD11 HD21 ' A' ' 19' ' ' LEU . 43.8 mt -141.04 118.25 8.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.752 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 3.9 m120 53.83 50.52 16.73 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.065 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.15 18.71 60.73 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.031 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 2.9 m -120.57 139.09 53.45 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.702 0.251 . . . . 0.0 110.33 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.611 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.4 t -65.73 145.11 14.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 111.293 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.879 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -113.96 -1.79 13.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.196 179.38 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.611 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.2 OUTLIER -99.6 150.36 22.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.039 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 p30 52.41 8.57 0.08 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.571 0.544 . . . . 0.0 112.242 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.455 ' HB3' HD11 ' B' ' 106' ' ' ILE . 2.9 ttm -90.98 151.0 21.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.722 0.296 . . . . 0.0 110.764 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 30.0 t -71.8 145.78 48.45 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.014 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.489 ' O ' HD23 ' B' ' 142' ' ' LEU . 6.1 tt -60.19 -47.97 83.7 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.705 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 3.2 p -55.52 -38.38 69.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.023 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.02 -47.93 69.94 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.69 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.966 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -60.54 -40.81 92.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.048 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -67.24 -39.23 86.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.664 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -66.85 -38.39 86.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.788 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.05 -44.45 94.68 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.772 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.865 HD11 HD22 ' A' ' 19' ' ' LEU . 29.6 mt -68.18 -37.46 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.967 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -68.95 -49.36 58.64 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.811 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -67.83 -25.46 65.57 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.02 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 43.8 t -76.39 65.69 2.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.039 0.447 . . . . 0.0 110.632 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -78.7 100.49 7.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.348 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 144.21 -94.78 0.18 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.962 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.9 126.25 46.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.636 0.255 . . . . 0.0 110.898 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.883 HD23 ' CE2' ' A' ' 15' ' ' TYR . 2.1 pp -123.76 132.71 53.86 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.837 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 0.0 OUTLIER -93.08 142.79 26.9 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.495 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.765 HD21 HD11 ' B' ' 156' ' ' LEU . 0.3 OUTLIER -133.26 128.22 35.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.022 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.43 140.2 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.589 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.57 160.69 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.836 0.351 . . . . 0.0 111.184 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.654 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.5 HD13 ' C ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.714 0.292 . . . . 0.0 111.335 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.403 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -120.93 157.03 16.03 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.781 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.528 HG11 ' CB ' ' B' ' 122' ' ' ASN . 21.8 t -130.41 135.21 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 0.0 111.352 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' B' ' 157' ' ' GLN . 0.9 OUTLIER -103.12 108.99 20.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.639 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.521 HD23 ' CD2' ' A' ' 15' ' ' TYR . 15.4 tp -98.78 141.93 30.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.736 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.3 ttt -118.7 163.51 16.74 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.097 0.475 . . . . 0.0 110.904 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.072 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.275 0 CA-C-O 121.275 0.559 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.584 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 62.0 m-85 -77.29 -9.62 58.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.85 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.55 24.12 71.23 Favored Glycine 0 C--N 1.341 0.851 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.483 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.625 HD11 ' HB2' ' B' ' 117' ' ' ALA . 6.8 mp -105.93 123.52 48.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.657 0.265 . . . . 0.0 110.508 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.19 113.04 24.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.013 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.795 HD22 HD11 ' B' ' 149' ' ' ILE . 9.4 mp -96.79 124.79 40.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' B' ' 109' ' ' LYS . . . -106.57 -168.43 22.69 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.45 ' OG ' HD12 ' B' ' 142' ' ' LEU . 0.1 OUTLIER -144.74 155.45 43.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.281 0.541 . . . . 0.0 110.687 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' B' ' 104' ' ' SER . 2.3 pt20 -136.81 131.35 33.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.799 HD13 ' HB2' ' A' ' 62' ' ' ALA . 40.5 mt -87.72 120.28 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.012 0.434 . . . . 0.0 109.903 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.484 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 42.8 p90 -121.79 173.15 7.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.193 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.793 HG21 ' HB3' ' A' ' 40' ' ' LEU . 32.0 t -83.99 96.58 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.972 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -64.09 -52.57 58.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.932 -179.276 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -163.95 142.89 7.71 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.695 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -134.45 139.01 45.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.046 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.0 t -65.72 126.1 27.38 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.699 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 ptt85 -63.9 172.78 2.1 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.028 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.65 27.42 13.2 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.198 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.98 -174.17 18.58 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.243 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.631 HD22 ' O ' ' B' ' 90' ' ' MET . 2.8 mp -74.78 -26.92 60.09 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.52 -36.87 63.19 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.186 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.99 -33.8 44.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -65.71 -36.22 83.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.157 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.31 -29.79 12.96 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.406 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.1 42.1 85.26 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.112 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.707 ' HB3' HG11 ' B' ' 87' ' ' VAL . 11.8 p-10 -70.72 -46.24 63.43 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.39 0.138 . . . . 0.0 111.291 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.793 ' HB3' HG21 ' A' ' 25' ' ' VAL . 8.5 mt -114.56 127.11 55.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.813 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 142.49 29.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.502 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -59.22 109.59 0.89 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.108 0.48 . . . . 0.0 110.465 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.83 -9.65 55.34 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.731 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -60.79 139.64 57.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.103 0.478 . . . . 0.0 111.172 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.19 118.4 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.765 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.463 ' CD1' HD21 ' B' ' 102' ' ' LEU . 34.7 mt -89.09 152.04 3.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.786 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.922 HD13 HD13 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -117.35 -43.12 2.84 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.083 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 148.85 31.79 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.023 0.439 . . . . 0.0 111.958 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.51 ' CD1' HG21 ' A' ' 54' ' ' THR . 66.8 mt -141.27 121.29 12.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.462 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 m120 55.34 34.2 22.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.398 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.92 9.58 84.22 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.663 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.2 m -119.86 138.16 53.57 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.155 0.478 . . . . 0.0 110.333 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.2 t -57.12 145.82 7.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.124 0.488 . . . . 0.0 111.006 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.661 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -130.54 28.88 4.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.972 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.523 ' H ' HG12 ' A' ' 53' ' ' VAL . 8.5 tt0 -98.3 -102.0 0.21 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.428 ' HB2' ' CD1' ' B' ' 142' ' ' LEU . 6.7 p30 -66.37 -2.86 4.96 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.513 ' HB3' HD11 ' A' ' 23' ' ' ILE . 1.2 tpt -52.77 164.18 0.39 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.167 0.508 . . . . 0.0 111.7 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 m -79.01 147.35 32.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.592 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' B' ' 139' ' ' ASN . 0.5 OUTLIER -61.99 -46.54 88.77 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.781 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 t -59.56 -41.77 90.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.83 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -66.85 -43.13 84.46 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.702 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.799 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.055 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -68.59 -38.59 80.79 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.463 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -38.4 82.78 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.816 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -43.5 98.44 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.75 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.816 HD11 HD22 ' B' ' 102' ' ' LEU . 11.4 mt -68.55 -38.08 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.709 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -68.49 -49.49 59.37 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.651 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -23.11 66.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.343 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.0 m -76.1 68.27 2.53 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.962 0.411 . . . . 0.0 110.67 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.0 119.29 20.53 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.505 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.84 -94.03 0.56 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.278 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.69 127.25 43.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.705 0.288 . . . . 0.0 110.804 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.872 HD23 ' CE2' ' B' ' 98' ' ' TYR . 2.2 pp -119.49 133.69 55.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 4.9 mm-40 -93.56 142.69 27.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.91 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.698 HD21 HD11 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -133.82 123.82 25.46 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.53 134.42 53.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.032 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 46' ' ' ILE . 35.0 m -128.62 150.13 34.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.785 0.326 . . . . 0.0 111.549 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.922 HD13 HD13 ' A' ' 47' ' ' LEU . 3.8 tp . . . . . 0 C--O 1.233 0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.281 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.649 0.261 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.27 157.75 15.63 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.56 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.707 HG11 ' HB3' ' A' ' 39' ' ' ASN . 17.7 t -130.53 135.22 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.618 0.246 . . . . 0.0 111.206 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.51 113.99 27.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.81 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.463 HD23 ' CD1' ' B' ' 98' ' ' TYR . 2.2 tp -105.02 144.67 31.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' MET . . . . . 0.631 ' O ' HD22 ' A' ' 33' ' ' LEU . 4.0 ttt -109.74 163.9 13.06 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.202 0.525 . . . . 0.0 110.848 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.089 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 97' ' ' GLU . . . . . 0.61 ' OE2' HG22 ' A' ' 66' ' ' ILE . 0.7 OUTLIER . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.646 0.26 . . . . 0.0 110.729 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.872 ' CE2' HD23 ' A' ' 73' ' ' LEU . 72.2 m-85 -51.51 -31.5 24.18 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.49 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.14 26.62 65.92 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.579 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.14 119.47 38.8 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.682 0.277 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.01 113.37 25.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.294 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.816 HD22 HD11 ' A' ' 66' ' ' ILE . 1.1 mp -97.01 125.11 41.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 103' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -108.91 -179.0 21.52 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.427 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.411 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -146.62 144.74 29.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.018 0.409 . . . . 0.0 111.101 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.413 ' NE2' HG21 ' B' ' 128' ' ' ILE . 5.7 pt20 -130.65 137.91 49.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.164 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.927 HD13 ' HB2' ' B' ' 145' ' ' ALA . 18.8 mt -87.93 120.6 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.337 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -122.13 172.11 8.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.231 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' B' ' 123' ' ' LEU . 40.9 t -80.97 96.71 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.772 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 109' ' ' LYS . . . . . 0.427 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 0.4 OUTLIER -67.07 -57.06 7.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.103 -179.167 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -155.13 147.68 24.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.657 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -138.13 147.9 44.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 111.007 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -65.28 121.86 15.79 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.849 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 113' ' ' ARG . . . . . 0.642 ' HA ' HG21 ' B' ' 118' ' ' THR . 20.0 ttt180 -69.04 157.03 37.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.556 HG22 ' O ' ' B' ' 113' ' ' ARG . 0.5 OUTLIER 68.68 14.16 8.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.484 -179.305 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.59 -158.26 33.79 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.302 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp -81.85 -30.43 32.09 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.528 0.204 . . . . 0.0 111.543 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.625 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -75.06 -34.23 61.8 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.362 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.642 HG21 ' HA ' ' B' ' 113' ' ' ARG . 0.8 OUTLIER -79.12 -33.96 43.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -37.8 85.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.353 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.89 -26.43 12.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.729 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.57 44.64 89.46 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.085 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.528 ' CB ' HG11 ' A' ' 4' ' ' VAL . 9.5 p30 -58.75 -44.64 90.59 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.553 ' HB3' HG21 ' B' ' 108' ' ' VAL . 4.7 mp -133.14 142.51 48.71 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.692 0.282 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.05 144.47 25.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.432 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -59.6 111.15 1.31 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 111.185 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.69 -9.0 23.84 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.186 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -68.1 135.55 52.35 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 117.307 0.553 . . . . 0.0 110.558 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.413 HG21 ' NE2' ' B' ' 105' ' ' GLN . 1.9 pt -77.63 113.7 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.754 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.434 ' HA ' HG12 ' B' ' 160' ' ' VAL . 16.3 mt -81.6 133.98 28.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.268 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.424 HD13 HD13 ' B' ' 161' ' ' LEU . 5.0 tp -95.17 -38.81 10.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.241 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -147.32 148.03 30.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 111.694 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 26.0 mt -136.35 119.43 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.414 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 57.11 40.66 28.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.841 0.353 . . . . 0.0 111.024 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.5 15.4 77.42 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.142 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.84 141.56 50.45 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.0 0.4 . . . . 0.0 110.389 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.573 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.2 t -60.17 147.87 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.051 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.684 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -121.69 20.31 11.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.807 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.573 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.5 tt0 -105.75 138.53 41.79 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.473 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 139' ' ' ASN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 59' ' ' LEU . 11.4 p30 52.98 9.95 0.14 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.618 0.574 . . . . 0.0 112.295 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.415 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.3 OUTLIER -71.77 172.08 10.44 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.771 0.319 . . . . 0.0 111.483 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 44.8 t -91.38 142.64 27.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.45 HD12 ' OG ' ' A' ' 21' ' ' SER . 2.7 tt -59.18 -42.52 91.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.643 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.1 p -60.37 -39.67 88.06 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.771 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -48.21 74.83 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.957 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.927 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -60.81 -41.01 94.82 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.88 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -66.3 -39.92 89.67 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.437 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -38.23 82.33 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.398 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 148' ' ' LEU . . . . . 0.407 ' HA ' ' HG2' ' B' ' 151' ' ' LYS . 0.8 OUTLIER -59.97 -44.78 94.24 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.687 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.795 HD11 HD22 ' A' ' 19' ' ' LEU . 11.3 mt -68.49 -36.69 75.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.885 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.05 -48.85 61.78 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.81 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 151' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' B' ' 148' ' ' LEU . 0.5 OUTLIER -66.01 -26.23 67.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.487 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.0 m -74.18 69.32 1.52 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.729 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.45 80.27 6.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.524 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 160.46 -81.94 0.14 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.025 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.1 125.89 25.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.544 0.211 . . . . 0.0 110.906 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.584 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -123.41 141.09 52.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.958 0.408 . . . . 0.0 111.226 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.401 ' HB2' HD21 ' A' ' 5' ' ' LEU . 29.3 tt0 -102.77 136.86 41.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.727 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mt -131.85 129.87 40.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.971 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 34.2 t -115.0 136.26 52.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.786 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' B' ' 129' ' ' ILE . 10.0 m -141.19 161.91 22.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.912 0.386 . . . . 0.0 111.39 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 161' ' ' LEU . . . . . 0.424 HD13 HD13 ' B' ' 130' ' ' LEU . 6.7 mp . . . . . 0 C--N 1.332 -0.167 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.687 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.627 HD13 ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.764 0.316 . . . . 0.0 111.199 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.627 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -138.57 156.78 24.31 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.867 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.825 HG11 ' HB3' ' B' ' 122' ' ' ASN . 19.5 t -129.06 134.27 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.868 0.366 . . . . 0.0 111.208 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.68 107.31 18.19 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.517 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.479 HD21 ' N ' ' B' ' 117' ' ' ALA . 5.5 tp -94.47 137.47 33.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.501 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.478 ' O ' HD13 ' B' ' 116' ' ' LEU . 17.5 ttt -113.65 163.81 14.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.991 0.424 . . . . 0.0 110.639 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.802 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 120.768 0.318 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.866 ' CE1' HD23 ' B' ' 156' ' ' LEU . 64.6 m-85 -67.21 -27.69 67.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.526 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.69 23.18 70.57 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.384 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.672 ' CD2' HD13 ' B' ' 123' ' ' LEU . 0.2 OUTLIER -98.77 120.23 38.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.593 0.235 . . . . 0.0 110.761 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.96 113.4 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.076 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.541 HD22 HD11 ' B' ' 149' ' ' ILE . 5.1 mp -99.12 124.85 44.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.163 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.85 -169.17 20.81 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.37 152.72 39.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.167 0.483 . . . . 0.0 110.582 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.466 ' NE2' HG21 ' A' ' 45' ' ' ILE . 6.9 pt20 -136.37 137.25 40.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.38 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.805 ' HB ' HG22 ' A' ' 54' ' ' THR . 41.0 mt -88.03 120.37 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.131 0.491 . . . . 0.0 110.204 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.416 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 45.5 p90 -121.0 172.33 8.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.109 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.685 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.7 t -82.19 94.51 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.015 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -62.7 -52.33 63.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.042 -179.379 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.09 144.03 20.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.807 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.422 ' HE1' ' HB1' ' A' ' 34' ' ' ALA . 10.1 ptp -132.26 145.49 51.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.153 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -66.95 119.89 12.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.958 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.01 154.8 9.06 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.056 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.1 m 63.62 30.28 14.97 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.918 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.49 -173.16 25.94 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.158 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.569 HD22 ' O ' ' B' ' 90' ' ' MET . 0.3 OUTLIER -67.49 -32.26 72.96 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HB1' ' HE1' ' A' ' 28' ' ' MET . . . -74.37 -35.81 63.54 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.024 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -34.07 44.29 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.046 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -39.94 77.54 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.563 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.35 -33.81 8.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.513 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.2 56.77 3.61 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.105 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.701 ' HB3' HG11 ' B' ' 87' ' ' VAL . 0.4 OUTLIER -93.45 -52.76 4.35 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.543 0.211 . . . . 0.0 110.942 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.685 ' HB3' HG21 ' A' ' 25' ' ' VAL . 5.9 mp -103.34 116.43 32.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.579 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.52 138.1 31.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.371 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.29 110.14 0.58 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.209 0.528 . . . . 0.0 110.875 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.99 -9.95 29.46 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.693 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -65.97 137.5 57.17 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 121.036 0.446 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.466 HG21 ' NE2' ' A' ' 22' ' ' GLN . 3.3 pt -78.47 110.79 14.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.671 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.699 HD13 HD21 ' B' ' 102' ' ' LEU . 8.3 mt -77.76 133.95 29.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.921 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.401 HD13 ' HB2' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -91.11 -46.16 8.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.547 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HB2' ' CG2' ' A' ' 76' ' ' VAL . 7.5 mttt -154.21 152.23 30.11 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.953 0.406 . . . . 0.0 111.48 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.501 HD11 HD21 ' B' ' 102' ' ' LEU . 48.7 mt -137.33 118.18 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.58 39.66 30.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.426 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.48 14.63 82.28 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.489 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.1 m -119.95 137.57 53.97 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 117.042 0.421 . . . . 0.0 110.279 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.3 t -60.63 144.32 13.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.092 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.805 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -128.4 26.71 5.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.365 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 9.8 tt0 -97.29 -109.92 0.16 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -63.45 -5.32 3.53 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.2 tpt -49.33 164.09 0.09 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.231 0.538 . . . . 0.0 111.895 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.7 147.26 45.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.587 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.453 HD11 ' OG ' ' B' ' 104' ' ' SER . 1.4 mp -62.92 -51.53 66.55 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.261 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.0 t -57.64 -38.69 75.47 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.301 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -64.17 -47.82 78.38 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.632 0.253 . . . . 0.0 110.766 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.804 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -58.81 -42.01 88.13 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.239 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 51.4 mtt-85 -69.65 -38.23 77.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -38.45 84.51 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.828 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.51 -43.75 96.76 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.89 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.872 HD11 HD22 ' B' ' 102' ' ' LEU . 10.1 mt -68.25 -37.3 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 110.692 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -49.75 59.53 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.769 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -68.32 -23.42 64.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.163 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.6 t -82.17 61.95 5.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 110.711 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -78.99 118.76 21.29 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.447 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.11 -99.77 0.59 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.966 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -118.03 131.58 56.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.754 0.311 . . . . 0.0 110.873 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.797 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -128.16 144.24 51.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.039 -179.79 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.12 128.47 54.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.39 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.544 HD11 HD21 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -125.7 128.6 48.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.446 -179.261 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.549 HG12 ' HA3' ' B' ' 86' ' ' GLY . 4.5 m -120.08 120.1 62.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.468 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -109.42 156.82 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.612 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.401 ' HB2' HD13 ' A' ' 47' ' ' LEU . 10.3 tt . . . . . 0 C--O 1.232 0.178 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.732 0.301 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.549 ' HA3' HG12 ' A' ' 76' ' ' VAL . . . -129.83 160.59 22.85 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.831 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.701 HG11 ' HB3' ' A' ' 39' ' ' ASN . 21.1 t -130.71 131.75 64.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.781 0.324 . . . . 0.0 111.0 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -95.35 113.1 24.74 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.626 HD23 ' CD1' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -102.82 144.68 30.83 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.881 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 90' ' ' MET . . . . . 0.569 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -117.86 171.52 8.01 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.462 0.648 . . . . 0.0 111.125 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 tttp . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.26 -179.636 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 120.68 0.276 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.797 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 70.0 m-85 -67.31 -26.56 66.58 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.306 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.98 25.68 68.58 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.472 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.613 HD13 ' HB3' ' B' ' 98' ' ' TYR . 7.8 mp -105.51 116.01 31.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.716 0.293 . . . . 0.0 110.385 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 125.7 34.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.528 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.872 HD22 HD11 ' A' ' 66' ' ' ILE . 2.2 mp -104.95 124.86 50.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.493 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 103' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -116.2 172.18 14.1 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.391 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.453 ' OG ' HD11 ' A' ' 59' ' ' LEU . 2.1 p -128.77 151.09 49.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.419 0.609 . . . . 0.0 111.763 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -133.41 136.97 45.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.162 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.756 ' HB ' HG22 ' B' ' 137' ' ' THR . 50.8 mt -87.98 120.16 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.963 0.411 . . . . 0.0 110.36 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -122.51 173.11 7.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.266 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 0.679 HG21 ' HB3' ' B' ' 123' ' ' LEU . 35.2 t -82.72 97.82 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.845 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.39 -47.76 63.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.048 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -162.56 145.2 10.99 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.473 ' HB2' HD12 ' A' ' 17' ' ' LEU . 11.3 ptt? -134.84 155.6 50.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.854 0.359 . . . . 0.0 111.166 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.36 120.07 12.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.702 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 145.36 47.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.135 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.7 27.89 14.84 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.156 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.33 -150.76 27.33 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.559 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 7' ' ' MET . 3.6 mt -84.38 -34.1 23.65 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.592 ' CB ' HD12 ' B' ' 123' ' ' LEU . . . -72.88 -32.26 65.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.176 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.81 -34.9 44.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.046 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -63.7 -36.41 83.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.162 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -98.21 -33.96 10.91 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.297 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.38 40.1 41.15 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.401 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.825 ' HB3' HG11 ' A' ' 4' ' ' VAL . 14.6 p-10 -92.4 -36.64 13.02 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.469 0.176 . . . . 0.0 111.399 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.679 ' HB3' HG21 ' B' ' 108' ' ' VAL . 1.6 mt -98.73 74.99 2.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.03 130.73 47.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.561 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -56.63 108.08 0.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.271 0.558 . . . . 0.0 110.85 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.69 -13.05 46.59 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.785 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -58.53 137.17 57.59 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.2 0.524 . . . . 0.0 111.087 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pt -81.57 114.21 22.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.661 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.54 ' CD1' HD21 ' A' ' 19' ' ' LEU . 36.6 mt -84.85 149.51 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.072 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.693 HD13 HD12 ' B' ' 161' ' ' LEU . 8.3 tp -113.63 -41.54 3.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.751 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -147.23 148.31 31.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.894 0.378 . . . . 0.0 111.769 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.456 HD11 HG21 ' B' ' 137' ' ' THR . 23.2 mt -138.92 119.77 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.391 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.44 38.16 29.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.47 15.2 81.68 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.211 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 135' ' ' THR . . . . . 0.451 ' CB ' HD11 ' B' ' 148' ' ' LEU . 39.3 m -120.61 141.21 50.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.965 0.382 . . . . 0.0 110.347 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.49 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.1 t -62.56 144.16 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.256 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.756 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -122.37 19.67 10.53 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.296 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.49 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.2 OUTLIER -116.8 128.52 55.37 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 m120 70.24 -3.51 1.8 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.188 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.459 ' HG3' ' N ' ' B' ' 141' ' ' SER . 0.1 OUTLIER -73.3 149.87 42.36 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.79 0.328 . . . . 0.0 110.496 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 141' ' ' SER . . . . . 0.459 ' N ' ' HG3' ' B' ' 140' ' ' MET . 33.4 t -71.49 150.08 45.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.372 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.08 -45.14 87.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.261 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 34.9 p -56.31 -40.22 74.02 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.08 -46.42 71.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.763 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.74 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -62.3 -39.83 94.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.338 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -70.23 -37.36 74.98 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.82 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.13 -38.79 82.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.634 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 148' ' ' LEU . . . . . 0.451 HD11 ' CB ' ' B' ' 135' ' ' THR . 0.2 OUTLIER -60.19 -44.03 95.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.032 179.734 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.541 HD11 HD22 ' A' ' 19' ' ' LEU . 12.3 mt -68.38 -37.01 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.864 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.13 -49.69 54.72 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.067 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.21 -28.04 69.1 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.168 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 30.2 t -75.35 79.73 2.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 110.773 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -88.67 121.64 31.25 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.599 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 115.32 -92.22 0.58 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.308 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.46 135.05 53.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.639 0.257 . . . . 0.0 110.983 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.866 HD23 ' CE1' ' A' ' 15' ' ' TYR . 2.5 pp -122.59 133.3 54.55 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -99.35 139.09 35.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.148 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.617 HD13 ' CD2' ' B' ' 123' ' ' LEU . 3.9 tt -137.29 142.08 41.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.839 0.352 . . . . 0.0 111.368 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 6.9 t -122.04 130.44 74.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.297 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.527 HG13 ' CD2' ' B' ' 158' ' ' LEU . 31.9 m -121.2 146.41 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 161' ' ' LEU . . . . . 0.693 HD12 HD13 ' B' ' 130' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.73 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.234 0.239 0 CA-C-O 120.759 0.314 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.42 168.46 23.09 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.978 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.758 HG21 ' HB2' ' B' ' 122' ' ' ASN . 23.5 t -128.51 132.94 67.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.658 0.266 . . . . 0.0 110.978 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.63 HD23 ' CD ' ' B' ' 155' ' ' LYS . 1.8 mp -95.79 124.28 39.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.8 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' B' ' 117' ' ' ALA . 1.1 mp -108.31 134.25 51.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.623 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.3 ttm -109.11 163.83 12.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.239 0.543 . . . . 0.0 111.06 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.9 tttm . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.064 -179.759 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 121.333 0.587 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.859 ' CE1' HD23 ' B' ' 156' ' ' LEU . 62.8 m-85 -77.81 -32.72 52.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.499 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.09 22.93 28.69 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.576 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.487 HD11 ' CB ' ' B' ' 117' ' ' ALA . 3.6 mp -102.76 119.09 38.23 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.647 0.26 . . . . 0.0 110.738 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.432 ' HB3' ' HG3' ' B' ' 110' ' ' GLU . 0.0 OUTLIER -98.73 124.25 43.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.88 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.863 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.7 pt? -122.42 124.96 44.84 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.204 0.526 . . . . 0.0 111.741 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.24 -169.56 21.33 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.584 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.7 OUTLIER -146.75 148.76 32.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.162 0.481 . . . . 0.0 111.167 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -131.19 146.54 52.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.37 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.978 HD13 ' HB2' ' A' ' 62' ' ' ALA . 5.6 mt -88.8 121.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.995 0.426 . . . . 0.0 111.045 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.41 ' CD1' ' HG2' ' B' ' 105' ' ' GLN . 39.7 p90 -121.5 172.83 7.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.017 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.653 HG21 ' HG ' ' A' ' 40' ' ' LEU . 38.7 t -86.3 96.65 5.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.126 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -63.11 -57.26 11.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.92 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -151.57 135.43 16.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.94 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.419 ' HB3' HD23 ' B' ' 100' ' ' LEU . 0.0 OUTLIER -116.8 148.28 41.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.6 t -65.28 142.05 58.4 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.074 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 154.72 26.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 55.37 29.23 12.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.466 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.24 -165.72 25.67 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.097 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.606 HD13 ' O ' ' B' ' 90' ' ' MET . 0.3 OUTLIER -77.19 -30.32 54.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.614 0.207 . . . . 0.0 111.429 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.861 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -73.78 -35.85 64.98 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.216 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.64 -33.75 46.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.096 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -38.67 87.09 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.376 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -101.22 -31.81 10.82 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.641 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.1 43.21 27.06 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.177 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.479 ' CG ' HD13 ' A' ' 40' ' ' LEU . 1.7 p30 -51.42 -49.57 61.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.155 0.182 . . . . 0.0 111.328 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.653 ' HG ' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -138.93 157.76 45.44 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.869 0.366 . . . . 0.0 111.13 179.01 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 147.29 25.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.598 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.25 109.97 0.86 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.302 0.573 . . . . 0.0 110.935 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.93 -4.28 28.86 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.745 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -70.55 135.44 48.52 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.201 0.524 . . . . 0.0 111.099 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 pt -78.87 111.49 15.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.493 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.741 ' HB ' HG21 ' A' ' 54' ' ' THR . 53.8 mt -79.77 146.1 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.302 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.534 HD22 ' CD1' ' A' ' 78' ' ' LEU . 19.3 tp -107.46 -37.58 6.17 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.73 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.04 147.76 31.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.874 0.369 . . . . 0.0 111.591 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 23.8 mt -137.7 118.34 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.514 ' HB2' HD21 ' A' ' 65' ' ' LEU . 5.5 m120 52.92 35.69 19.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.874 0.368 . . . . 0.0 111.383 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.68 15.89 74.52 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.146 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -120.89 141.05 50.98 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 117.061 0.43 . . . . 0.0 110.383 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.4 t -59.86 144.44 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 111.078 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.741 HG21 ' HB ' ' A' ' 46' ' ' ILE . 2.7 m -116.42 13.69 15.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.891 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.573 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -116.94 133.22 56.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.838 ' HA ' HD21 ' B' ' 142' ' ' LEU . 5.2 m-80 71.36 -6.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.391 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.506 ' HB3' HD11 ' A' ' 23' ' ' ILE . 1.1 tpt -69.75 170.89 10.06 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.846 0.355 . . . . 0.0 110.987 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -89.94 139.73 30.32 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.051 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.527 HD12 ' OG ' ' B' ' 104' ' ' SER . 6.1 tt -55.89 -44.57 78.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.605 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -58.9 -40.14 83.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.821 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.2 -46.78 76.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.784 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.978 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -59.83 -42.1 92.82 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.951 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.35 -37.9 80.95 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.581 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -68.05 -38.56 82.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.719 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.527 ' C ' HD23 ' A' ' 65' ' ' LEU . 9.2 tt -61.13 -43.92 98.13 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.724 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.666 HD11 HD22 ' B' ' 102' ' ' LEU . 8.0 mt -68.6 -37.03 77.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.023 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.16 -49.12 59.69 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.749 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.36 -25.06 67.87 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.372 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 t -77.51 68.12 3.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.083 0.468 . . . . 0.0 110.723 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.1 mtt85 -84.06 66.46 9.24 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.397 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.89 -75.61 0.07 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.659 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.94 128.94 29.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.711 -0.245 . . . . 0.0 111.242 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.79 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.9 OUTLIER -125.7 132.34 52.41 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.958 0.408 . . . . 0.0 111.077 179.662 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.589 ' O ' HD13 ' A' ' 75' ' ' LEU . 10.7 tt0 -102.15 136.41 42.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.621 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.603 HD22 ' N ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -127.12 130.71 50.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.28 133.93 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.254 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.07 165.68 30.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.811 0.339 . . . . 0.0 111.443 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.534 ' CD1' HD22 ' A' ' 47' ' ' LEU . 1.3 mp . . . . . 0 C--O 1.232 0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.089 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.507 ' C ' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.259 0 CA-C-O 120.787 0.327 . . . . 0.0 110.904 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.454 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -118.57 157.99 14.98 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 39' ' ' ASN . 18.8 t -125.46 134.78 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.698 0.285 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.42 125.6 50.76 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.713 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.531 HD11 ' O ' ' A' ' 33' ' ' LEU . 11.0 tp -119.02 138.6 52.72 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.243 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' MET . . . . . 0.606 ' O ' HD13 ' A' ' 33' ' ' LEU . 3.0 ttt -100.45 163.87 12.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.119 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.595 0.236 . . . . 0.0 110.672 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.79 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 52.3 m-85 -57.97 -25.37 60.92 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.388 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.24 17.76 66.14 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.319 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.861 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -100.63 114.93 29.03 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 113.38 24.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.27 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.666 HD22 HD11 ' A' ' 66' ' ' ILE . 0.9 OUTLIER -100.14 124.92 46.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.107 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.45 172.99 15.51 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.5 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.527 ' OG ' HD12 ' A' ' 59' ' ' LEU . 1.1 p -124.43 153.6 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.996 0.398 . . . . 0.0 111.167 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 21' ' ' SER . 2.4 pt20 -134.23 134.29 41.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.164 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.983 HD13 ' HB2' ' B' ' 145' ' ' ALA . 19.9 mt -87.76 120.52 36.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.034 0.445 . . . . 0.0 109.866 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.462 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 47.8 p90 -121.8 173.72 7.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.218 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 0.82 HG21 ' HB3' ' B' ' 123' ' ' LEU . 39.8 t -84.68 101.49 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 109' ' ' LYS . . . . . 0.462 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 5.6 mmtt -70.35 -53.23 17.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.732 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.432 ' HG3' ' HB3' ' A' ' 18' ' ' ARG . 5.1 pt-20 -161.72 145.08 12.31 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.798 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -138.37 139.32 38.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 10.0 t -65.39 125.7 25.92 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.473 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 113' ' ' ARG . . . . . 0.726 ' HA ' HG21 ' B' ' 118' ' ' THR . 0.0 OUTLIER -75.6 61.38 1.32 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.333 0.587 . . . . 0.0 111.3 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.41 27.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.955 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -130.11 -173.65 13.46 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.598 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.34 -32.17 72.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.595 0.236 . . . . 0.0 111.273 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.514 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -65.8 -41.19 92.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.325 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.726 HG21 ' HA ' ' B' ' 113' ' ' ARG . 11.0 m -78.91 -33.01 45.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.821 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -39.37 84.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.269 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.74 -32.76 9.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.618 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.89 40.12 26.55 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.275 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.758 ' HB2' HG21 ' A' ' 4' ' ' VAL . 7.1 p-10 -71.04 -47.05 60.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.389 0.138 . . . . 0.0 111.207 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.82 ' HB3' HG21 ' B' ' 108' ' ' VAL . 21.0 mt -92.8 119.74 32.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.676 0.274 . . . . 0.0 110.717 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.6 136.87 34.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.459 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -58.45 107.76 0.54 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.164 0.507 . . . . 0.0 110.534 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 102.49 -7.84 54.27 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.64 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -63.02 138.92 58.7 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.154 0.502 . . . . 0.0 111.252 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' B' ' 161' ' ' LEU . 1.3 pt -76.41 121.73 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.707 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.562 HG21 HD11 ' B' ' 132' ' ' ILE . 12.7 mt -89.66 135.02 27.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 tp -97.1 -41.94 8.1 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.579 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -148.5 147.92 29.65 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.792 0.33 . . . . 0.0 111.487 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.562 HD11 HG21 ' B' ' 129' ' ' ILE . 20.1 mt -141.41 119.65 9.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.662 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 133' ' ' ASN . . . . . 0.526 HD22 ' HA ' ' B' ' 156' ' ' LEU . 28.2 m120 58.3 40.55 24.44 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.243 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.54 10.11 79.01 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.396 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.44 138.79 52.23 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 117.138 0.469 . . . . 0.0 110.204 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.602 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.3 t -59.45 147.93 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.163 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.807 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.3 OUTLIER -121.64 20.48 11.03 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.709 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.602 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.3 OUTLIER -110.8 130.71 55.5 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 73.01 -10.49 0.99 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.499 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.703 ' HB3' HD11 ' B' ' 106' ' ' ILE . 1.2 tpt -65.49 169.21 6.3 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 121.016 0.436 . . . . 0.0 111.052 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 25.0 t -92.54 150.18 20.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.838 HD21 ' HA ' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -58.56 -44.15 89.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.89 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 8.9 t -59.25 -40.19 85.16 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.631 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.28 -44.98 82.04 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.716 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.983 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -60.79 -41.77 96.25 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.019 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.7 -37.82 76.75 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.37 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -67.86 -38.42 83.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.526 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -44.76 93.15 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.651 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.506 HD12 HD22 ' A' ' 19' ' ' LEU . 59.1 mt -68.3 -36.95 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.685 0.278 . . . . 0.0 110.763 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -69.18 -49.08 59.91 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.882 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -70.2 -23.3 62.93 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.613 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 80.1 p -79.06 66.29 4.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.122 0.486 . . . . 0.0 110.625 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -74.55 126.6 31.12 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.544 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 115.12 -90.36 0.53 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.452 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 155' ' ' LYS . . . . . 0.63 ' CD ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -128.18 133.94 48.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 0.0 110.617 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.859 HD23 ' CE1' ' A' ' 15' ' ' TYR . 2.0 pp -124.59 144.26 50.25 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.412 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 55.5 tt0 -109.51 141.6 41.74 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.79 HD11 HD11 ' B' ' 156' ' ' LEU . 1.1 mt -135.02 132.5 38.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.972 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.02 137.78 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.297 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 7.8 m -135.21 161.77 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.818 0.342 . . . . 0.0 111.403 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 161' ' ' LEU . . . . . 0.549 ' HB3' HD11 ' B' ' 128' ' ' ILE . 4.9 tt . . . . . 0 CA--C 1.529 0.159 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.017 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.684 HD13 ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.247 0 CA-C-O 120.846 0.355 . . . . 0.0 110.944 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.684 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -139.45 156.81 24.82 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.835 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.551 HG11 ' CB ' ' B' ' 122' ' ' ASN . 18.1 t -131.34 134.63 60.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.777 0.322 . . . . 0.0 111.041 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.24 107.12 17.81 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.732 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.444 HD21 ' C ' ' B' ' 116' ' ' LEU . 6.4 tp -92.7 134.79 34.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.289 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.97 171.37 7.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.387 0.613 . . . . 0.0 111.354 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.8 pttt . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.564 -179.477 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.712 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 77.7 m-85 -100.28 -24.99 14.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.809 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.59 30.9 65.87 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.546 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' B' ' 117' ' ' ALA . 0.0 OUTLIER -104.94 123.84 48.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.658 0.266 . . . . 0.0 110.942 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.423 ' HB2' ' HG3' ' B' ' 110' ' ' GLU . 0.0 OUTLIER -100.19 113.22 25.73 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.08 179.487 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.746 HD22 HD11 ' B' ' 149' ' ' ILE . 8.0 mp -94.15 124.84 38.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.024 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.18 172.09 14.85 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.531 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.558 ' OG ' HD11 ' B' ' 142' ' ' LEU . 0.3 OUTLIER -132.47 149.02 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.006 0.403 . . . . 0.0 111.223 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' B' ' 104' ' ' SER . 7.0 pt20 -131.94 141.53 49.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.181 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.767 ' HB ' HG22 ' A' ' 54' ' ' THR . 4.1 mm -87.81 121.69 38.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.304 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -125.93 171.5 10.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.413 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.771 HG21 ' HB3' ' A' ' 40' ' ' LEU . 44.7 t -84.36 100.18 7.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.04 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -56.12 8.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.893 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -157.15 145.84 19.74 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.992 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.627 ' SD ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -137.53 143.8 41.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.274 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.8 p -65.71 121.08 14.18 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.616 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.68 163.85 6.76 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.204 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 62.88 25.09 14.9 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.278 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.37 -169.09 25.76 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.391 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.549 HD13 ' O ' ' B' ' 90' ' ' MET . 0.3 OUTLIER -73.75 -30.17 62.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.81 -35.09 62.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.642 0.258 . . . . 0.0 111.025 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.627 HG23 ' SD ' ' A' ' 28' ' ' MET . 1.2 p -78.68 -34.18 46.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.133 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -61.73 -38.15 86.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.197 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -98.98 -30.69 12.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.273 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.05 47.02 25.92 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.037 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.808 ' HB3' HG11 ' B' ' 87' ' ' VAL . 12.4 p-10 -85.31 -40.0 17.04 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.771 ' HB3' HG21 ' A' ' 25' ' ' VAL . 3.3 mm? -106.34 125.46 51.02 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.652 0.263 . . . . 0.0 111.07 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 132.12 41.25 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.236 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.02 107.07 0.43 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.225 0.536 . . . . 0.0 111.012 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.87 -9.07 43.4 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.917 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -69.56 144.07 53.19 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.26 0.553 . . . . 0.0 111.294 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 77' ' ' VAL . 20.2 pt -81.65 116.59 26.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.666 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.571 HG21 HD11 ' A' ' 49' ' ' ILE . 6.0 mt -83.03 137.72 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.947 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.442 HD12 HD12 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -91.71 -51.5 5.21 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.5 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -150.52 152.19 33.8 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.71 0.29 . . . . 0.0 111.2 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.571 HD11 HG21 ' A' ' 46' ' ' ILE . 29.7 mt -140.67 118.11 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.86 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.53 39.85 30.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.177 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.56 3.95 87.08 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.207 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.2 m -107.71 129.76 55.0 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.0 t -61.64 146.15 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.979 0.418 . . . . 0.0 111.079 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.767 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -120.41 22.76 11.18 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.354 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.574 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -127.24 124.62 39.32 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.147 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 72.35 -9.23 1.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.444 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -69.94 174.48 5.26 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.868 0.366 . . . . 0.0 111.146 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.62 132.31 34.19 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.007 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.577 HD12 ' OG ' ' B' ' 104' ' ' SER . 7.9 tt -54.25 -42.83 70.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.751 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -63.6 -38.48 91.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.085 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.2 -48.13 74.46 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.075 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -59.33 -40.52 86.59 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.227 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.69 -37.62 76.68 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.792 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -38.68 82.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.776 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.513 ' O ' HD13 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -59.71 -44.21 93.81 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.787 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 73' ' ' LEU . 8.2 mt -67.97 -37.47 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.825 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.86 -49.56 67.71 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.806 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -65.94 -26.74 67.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.423 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 86.0 p -84.85 60.69 6.35 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.114 0.483 . . . . 0.0 110.791 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -73.46 96.67 2.42 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.839 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.36 -92.19 0.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.249 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.28 130.45 52.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.709 0.29 . . . . 0.0 110.353 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.839 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.7 OUTLIER -129.51 139.69 51.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.21 0.528 . . . . 0.0 111.528 -179.48 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.471 ' OE1' HG23 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -98.12 138.59 35.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.999 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.515 HD11 HD21 ' A' ' 73' ' ' LEU . 1.6 mp -136.6 127.62 27.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 111.316 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.471 HG23 ' OE1' ' A' ' 74' ' ' GLN . 25.4 t -113.53 134.45 56.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.372 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 45' ' ' ILE . 18.7 t -129.26 140.81 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.073 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.442 HD12 HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.749 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -129.63 160.96 22.84 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.744 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.808 HG11 ' HB3' ' A' ' 39' ' ' ASN . 26.3 t -130.77 135.1 60.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.72 0.295 . . . . 0.0 111.289 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tt -97.87 109.07 21.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.536 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.486 HD23 ' CD1' ' B' ' 98' ' ' TYR . 1.1 tp -104.44 144.84 31.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.075 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' MET . . . . . 0.549 ' O ' HD13 ' A' ' 33' ' ' LEU . 38.9 ttm -113.13 164.19 13.81 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.117 0.484 . . . . 0.0 110.657 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 91' ' ' LYS . . . . . 0.404 ' HG3' ' CE2' ' B' ' 98' ' ' TYR . 10.6 mtpt . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.141 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.191 0.519 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.839 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 52.0 m-85 -72.86 -31.57 64.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.274 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.98 17.39 72.46 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.563 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -97.96 118.41 34.49 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -99.41 113.36 25.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.188 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.466 HD23 ' H ' ' B' ' 102' ' ' LEU . 1.7 pt? -110.95 125.08 53.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.165 0.507 . . . . 0.0 111.16 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 103' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -107.4 -162.66 21.67 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.278 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.577 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.3 OUTLIER -144.77 145.75 31.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 110.856 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 21' ' ' SER . 7.7 pt20 -128.12 140.35 51.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.496 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.848 ' HB ' HG22 ' B' ' 137' ' ' THR . 45.3 mt -88.14 120.38 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -121.62 172.94 7.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.874 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 1.039 HG21 HD13 ' B' ' 123' ' ' LEU . 42.9 t -81.66 93.51 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.31 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -63.51 -50.48 69.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.013 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.423 ' HG3' ' HB2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -165.21 149.03 8.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.651 ' SD ' HD11 ' B' ' 123' ' ' LEU . 9.1 mtm -128.4 161.4 29.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.061 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.423 HG23 ' HA3' ' B' ' 115' ' ' GLY . 10.1 t -65.62 125.36 25.0 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.708 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -57.85 136.52 57.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.21 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m 60.86 30.28 19.55 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.05 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 115' ' ' GLY . . . . . 0.423 ' HA3' HG23 ' B' ' 112' ' ' THR . . . -87.6 -156.43 30.02 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.447 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.444 ' C ' HD21 ' A' ' 6' ' ' LEU . 13.4 mt -82.44 -30.12 30.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.511 0.196 . . . . 0.0 111.349 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.497 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -75.23 -34.69 61.46 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.285 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.9 -33.85 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.074 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -38.69 84.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.374 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -103.04 -29.88 11.1 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.673 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.68 44.21 57.74 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.151 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.551 ' CB ' HG11 ' A' ' 4' ' ' VAL . 8.5 p30 -63.31 -39.89 95.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.464 0.173 . . . . 0.0 111.341 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 1.039 HD13 HG21 ' B' ' 108' ' ' VAL . 4.1 pp -133.26 163.88 28.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.923 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.5 135.16 52.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.62 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -53.77 113.09 1.07 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.188 0.518 . . . . 0.0 111.076 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.08 -14.5 23.65 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.527 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -66.22 136.64 56.17 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.129 0.49 . . . . 0.0 110.887 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 5.8 pt -74.75 117.49 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.663 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.941 HG21 HD11 ' B' ' 132' ' ' ILE . 27.3 mm -83.19 137.55 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.909 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 13.4 tp -98.67 -40.94 7.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.001 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -150.03 150.83 32.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.969 0.414 . . . . 0.0 111.806 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.996 HD12 HD23 ' B' ' 158' ' ' LEU . 34.4 mm -137.01 118.82 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.89 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 133' ' ' ASN . . . . . 0.528 ' HB2' HD11 ' B' ' 148' ' ' LEU . 5.3 m120 56.2 31.54 18.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.682 0.277 . . . . 0.0 111.228 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.89 -2.3 85.65 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.178 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 13.4 m -104.66 131.98 51.45 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.075 0.437 . . . . 0.0 110.227 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.588 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.1 t -56.44 147.16 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.937 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.848 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -118.55 19.54 13.25 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.588 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.4 OUTLIER -106.6 134.43 49.75 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.611 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 52.18 12.24 0.2 Allowed 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.636 0.585 . . . . 0.0 112.175 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.22 173.38 5.72 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.413 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.3 141.36 30.13 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.558 HD11 ' OG ' ' A' ' 21' ' ' SER . 2.9 mp -58.41 -47.93 82.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.028 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 4.5 t -63.04 -37.06 85.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.776 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -65.61 -48.12 73.36 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.815 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.635 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -59.77 -41.15 90.45 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.397 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 17.8 mtt85 -68.27 -38.66 81.95 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.629 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -67.5 -38.35 84.17 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 148' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' B' ' 133' ' ' ASN . 0.2 OUTLIER -59.97 -44.17 94.63 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.915 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.746 HD11 HD22 ' A' ' 19' ' ' LEU . 5.3 mt -68.17 -38.09 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.832 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.01 -48.47 62.94 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.922 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -69.53 -19.07 63.71 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.266 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 3.2 m -74.33 69.77 1.63 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.772 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -82.97 120.3 25.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.716 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.69 -88.94 0.51 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.515 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.04 130.65 51.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.683 0.278 . . . . 0.0 110.809 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.712 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -120.04 130.97 54.95 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.095 0.474 . . . . 0.0 111.394 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 9.4 tt0 -93.75 135.43 35.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.68 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.996 HD23 HD12 ' B' ' 132' ' ' ILE . 0.5 OUTLIER -131.4 127.99 38.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 20.9 t -114.15 145.64 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.437 HG12 HD13 ' B' ' 129' ' ' ILE . 27.1 m -136.74 161.26 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.178 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 161' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' B' ' 161' ' ' LEU . 9.0 tp . . . . . 0 C--O 1.233 0.185 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.38 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.9 tt . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.838 0.352 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.8 156.87 21.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.711 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' B' ' 122' ' ' ASN . 24.9 t -132.67 134.18 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.777 0.322 . . . . 0.0 110.872 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.86 107.04 18.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.691 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.523 HD21 ' N ' ' B' ' 117' ' ' ALA . 2.8 tp -91.87 134.01 35.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.312 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 ttt -123.09 163.18 21.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.127 0.489 . . . . 0.0 110.911 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.537 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.771 0.32 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.77 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 78.6 m-85 -73.76 -27.95 61.43 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.67 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' HG23 ' B' ' 112' ' ' THR . . . 77.97 27.59 58.08 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.653 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mp -108.04 121.07 44.07 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.748 0.308 . . . . 0.0 110.737 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -102.42 113.73 27.31 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.06 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.9 pt? -105.46 125.18 50.69 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.211 0.529 . . . . 0.0 112.098 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.36 -178.53 21.89 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.611 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.403 ' OG ' HD12 ' B' ' 142' ' ' LEU . 1.2 p -132.4 148.59 52.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.296 0.548 . . . . 0.0 111.565 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.465 ' NE2' HG21 ' A' ' 45' ' ' ILE . 9.9 pt20 -135.37 145.73 47.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.593 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.699 HD12 HG23 ' A' ' 54' ' ' THR . 4.8 mt -88.42 121.34 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.036 0.446 . . . . 0.0 111.051 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -122.28 172.32 8.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.957 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.597 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.3 t -84.01 97.5 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.92 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -58.5 4.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.306 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -149.2 136.46 20.01 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.34 134.61 36.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.072 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.1 p -73.23 127.64 33.19 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.518 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.806 ' HA ' HG21 ' A' ' 35' ' ' THR . 14.7 ptt-85 -72.91 65.69 0.75 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.254 0.55 . . . . 0.0 111.219 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.41 25.38 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.023 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.22 -172.63 13.39 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.714 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.676 HD22 ' H ' ' B' ' 90' ' ' MET . 1.6 mp -69.97 -30.5 67.87 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.639 0.22 . . . . 0.0 111.567 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.593 ' CB ' HD21 ' B' ' 100' ' ' LEU . . . -68.62 -41.3 79.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.544 0.212 . . . . 0.0 111.133 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.806 HG21 ' HA ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -78.78 -33.4 46.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.827 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -65.49 -36.42 83.81 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.188 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.58 -32.33 11.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.483 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.0 40.15 57.5 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.268 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.717 ' ND2' HD11 ' B' ' 89' ' ' LEU . 4.4 p30 -83.01 -31.06 27.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.425 0.155 . . . . 0.0 111.311 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.9 HD11 HD22 ' A' ' 75' ' ' LEU . 4.6 mt -115.28 123.67 49.39 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.699 0.285 . . . . 0.0 110.96 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.06 139.71 30.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.443 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.88 110.24 0.77 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 110.664 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.82 -11.25 45.53 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.705 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.84 138.13 57.42 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 121.05 0.452 . . . . 0.0 111.201 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.465 HG21 ' NE2' ' A' ' 22' ' ' GLN . 1.1 pt -84.13 99.15 6.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.248 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.598 HD13 HD21 ' B' ' 102' ' ' LEU . 5.7 mt -64.82 139.33 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.689 ' CD1' HD12 ' A' ' 78' ' ' LEU . 1.1 tp -92.62 -38.98 11.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.416 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -149.95 150.7 32.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.745 0.307 . . . . 0.0 111.388 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.7 mt -138.1 118.1 15.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.402 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.641 ' HB2' HD11 ' A' ' 65' ' ' LEU . 4.2 m120 53.14 41.95 32.16 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.277 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.73 6.13 76.54 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.972 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -104.98 131.59 52.3 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.2 144.88 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.791 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.699 HG23 HD12 ' A' ' 23' ' ' ILE . 20.7 m -109.95 23.1 14.81 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.419 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -126.2 130.6 51.28 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.344 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.0 p30 51.53 11.63 0.13 Allowed 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.762 0.664 . . . . 0.0 112.718 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.519 ' SD ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -69.23 -174.77 0.68 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.899 0.38 . . . . 0.0 111.114 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.8 124.6 35.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tt -58.39 -44.19 88.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.784 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.455 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 7.1 t -63.5 -37.33 86.9 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.01 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -34.72 62.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.653 0.264 . . . . 0.0 110.593 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.577 ' HB1' HD13 ' A' ' 23' ' ' ILE . . . -65.37 -43.34 91.08 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.24 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 60' ' ' THR . 1.4 ptt180 -71.97 -36.81 69.92 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.52 -37.85 83.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.239 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.641 HD11 ' HB2' ' A' ' 50' ' ' ASN . 2.9 tm? -59.41 -45.25 92.05 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.794 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.513 HD13 ' HB2' ' B' ' 102' ' ' LEU . 7.2 mt -68.77 -37.58 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.947 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -49.34 56.61 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -23.36 67.2 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.258 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.5 m -76.03 67.81 2.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 110.805 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 -90.85 53.16 2.32 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.705 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -171.83 -82.46 0.05 OUTLIER Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.294 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.83 126.38 36.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.637 0.256 . . . . 0.0 110.742 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.748 HD23 ' CE1' ' B' ' 98' ' ' TYR . 0.2 OUTLIER -129.9 134.55 47.57 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.289 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -92.01 140.68 29.41 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.939 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.9 HD22 HD11 ' A' ' 40' ' ' LEU . 1.2 mp -134.07 128.14 33.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.962 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 46' ' ' ILE . 19.8 t -115.78 142.95 26.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.851 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.468 HG22 ' O ' ' B' ' 85' ' ' ILE . 35.9 m -129.62 155.43 41.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.798 0.332 . . . . 0.0 111.39 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.689 HD12 ' CD1' ' A' ' 47' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.093 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 77' ' ' VAL . 18.1 tt . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.805 0.336 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -123.62 158.63 18.23 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.671 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.621 HG21 ' HB2' ' A' ' 39' ' ' ASN . 21.3 t -131.5 134.0 61.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.856 0.36 . . . . 0.0 111.255 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.63 107.92 19.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.408 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.717 HD11 ' ND2' ' A' ' 39' ' ' ASN . 7.1 mp -96.37 144.73 26.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 90' ' ' MET . . . . . 0.676 ' H ' HD22 ' A' ' 33' ' ' LEU . 9.8 ttt -116.35 163.57 15.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.814 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.155 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.748 ' CE1' HD23 ' A' ' 73' ' ' LEU . 38.1 m-85 -93.86 -6.95 44.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.844 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.98 9.99 86.46 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.648 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.593 HD21 ' CB ' ' A' ' 34' ' ' ALA . 3.7 mp -105.7 115.06 29.6 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.659 0.266 . . . . 0.0 110.518 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.45 113.27 21.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.979 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.598 HD21 HD13 ' A' ' 46' ' ' ILE . 1.6 mp -96.77 124.75 40.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.064 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.28 174.84 15.55 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.558 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -133.17 144.73 50.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.983 0.391 . . . . 0.0 111.083 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -131.43 144.77 51.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.324 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.776 HG13 HG22 ' B' ' 137' ' ' THR . 0.9 OUTLIER -88.31 121.35 38.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.006 0.431 . . . . 0.0 110.803 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.418 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 32.1 p90 -119.26 171.82 8.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 0.665 HG21 ' HB3' ' B' ' 123' ' ' LEU . 35.5 t -79.69 91.91 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.97 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 109' ' ' LYS . . . . . 0.418 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -63.39 -45.54 90.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.971 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -163.49 132.14 3.84 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.718 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.92 146.88 50.15 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.826 0.346 . . . . 0.0 111.31 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 16' ' ' GLY . 74.4 p -65.29 123.56 19.89 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.885 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 18.9 ttm105 -63.72 155.26 30.63 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.28 30.53 19.92 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.262 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.35 -168.74 26.81 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.24 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 mt -65.24 -36.74 85.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.538 0.208 . . . . 0.0 111.168 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.523 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -74.87 -33.14 62.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.387 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.77 -34.26 45.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.122 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -37.94 86.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.222 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.16 -30.57 12.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.484 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.15 51.5 10.07 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.314 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.554 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.0 p-10 -87.12 -44.73 11.3 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.665 ' HB3' HG21 ' B' ' 108' ' ' VAL . 7.9 mp -123.46 124.84 43.77 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.741 0.305 . . . . 0.0 111.1 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.65 151.77 19.03 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.493 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -60.42 111.29 1.51 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.176 0.513 . . . . 0.0 111.048 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.28 -18.49 20.85 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.96 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -61.13 135.12 57.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.162 0.481 . . . . 0.0 110.523 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.63 120.76 30.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.264 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.401 HG21 HG12 ' B' ' 132' ' ' ILE . 29.0 mt -87.95 137.92 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.772 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 tp -100.14 -35.65 9.59 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.546 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 131' ' ' LYS . . . . . 0.448 ' HE3' HG22 ' B' ' 136' ' ' VAL . 14.4 mttp -150.44 147.97 28.18 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 111.4 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.696 HG23 HD23 ' B' ' 158' ' ' LEU . 14.9 mt -140.66 118.42 9.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.541 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 5.8 m120 57.03 47.5 17.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.969 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 66.2 17.28 65.75 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.236 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 75.6 m -120.91 137.13 54.74 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.753 0.276 . . . . 0.0 110.286 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.594 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.6 t -69.71 145.24 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.875 0.369 . . . . 0.0 110.851 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.776 HG22 HG13 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -114.8 0.65 13.87 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.815 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.594 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.0 OUTLIER -84.77 129.14 34.86 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.206 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 m120 69.95 -4.12 1.57 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.633 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.02 171.12 10.02 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.965 0.412 . . . . 0.0 111.156 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 3.6 m -91.91 146.97 23.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.28 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.403 HD12 ' OG ' ' A' ' 21' ' ' SER . 2.8 tt -61.55 -44.91 96.18 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.887 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 23.3 p -57.5 -46.29 83.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.115 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.87 -46.31 89.98 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.003 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 1.06 ' HB1' HD11 ' A' ' 19' ' ' LEU . . . -59.27 -41.69 89.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.119 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 13.7 ttt180 -70.36 -37.24 74.56 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.411 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -38.41 82.81 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.745 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 7.2 tt -59.67 -45.19 92.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.697 HD12 HD22 ' A' ' 19' ' ' LEU . 35.0 mt -68.37 -36.89 76.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.807 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -61.79 -48.25 81.48 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.786 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -25.23 66.46 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.383 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 70.7 m -74.59 78.36 1.99 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.536 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -94.21 46.94 1.18 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.185 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -165.85 -83.34 0.05 OUTLIER Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.378 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -128.03 131.36 49.16 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.291 0.236 . . . . 0.0 110.521 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.77 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -129.9 136.48 49.56 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.001 0.429 . . . . 0.0 111.285 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 12.8 tt0 -97.39 140.95 31.09 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.551 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.696 HD23 HG23 ' B' ' 132' ' ' ILE . 5.0 mt -135.92 125.09 24.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.154 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 18.8 t -114.64 133.03 62.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.458 HG11 ' HG ' ' B' ' 123' ' ' LEU . 30.0 m -129.05 162.42 36.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.846 0.355 . . . . 0.0 111.284 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--O 1.232 0.182 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 179.811 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.487 HD13 ' C ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.863 0.363 . . . . 0.0 110.904 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.455 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -117.45 159.09 14.25 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.924 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.769 HG11 ' HB3' ' B' ' 122' ' ' ASN . 21.0 t -123.92 134.57 66.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.789 0.328 . . . . 0.0 111.154 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.96 116.5 30.32 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.738 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.482 HD21 ' N ' ' B' ' 117' ' ' ALA . 8.4 tp -109.79 144.53 38.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.731 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.7 ttt -112.39 163.2 14.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.188 0.518 . . . . 0.0 110.837 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.079 -179.904 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.808 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 43.8 m-85 -86.48 -28.19 23.6 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.089 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.34 20.42 32.57 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.625 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.78 119.35 38.65 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.666 0.233 . . . . 0.0 110.678 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -96.25 113.52 25.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.81 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.98 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.5 pt? -108.13 124.76 50.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.18 0.514 . . . . 0.0 111.48 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.24 -166.25 21.24 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.922 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.3 OUTLIER -146.12 145.04 30.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.836 0.318 . . . . 0.0 111.254 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.581 ' NE2' HG21 ' A' ' 45' ' ' ILE . 5.4 pt20 -125.24 138.88 54.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.885 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.781 ' HB ' HG22 ' A' ' 54' ' ' THR . 34.9 mt -88.0 120.49 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.649 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 46.6 p90 -123.55 171.15 9.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.15 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.6 t -81.47 98.68 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.775 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 1.6 tptp -70.46 -55.53 8.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.049 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -157.06 135.97 11.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.859 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.3 ptt? -120.55 150.74 40.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 111.244 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.6 m -66.36 122.31 17.24 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.96 162.68 18.73 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.925 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.24 30.84 20.19 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.358 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.74 -161.29 16.39 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.116 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.11 -31.43 39.18 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.868 0.334 . . . . 0.0 111.809 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.592 ' CB ' HD11 ' B' ' 100' ' ' LEU . . . -74.88 -37.41 62.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.521 0.2 . . . . 0.0 111.117 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.89 -33.62 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.225 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -59.52 -39.37 83.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.565 0.221 . . . . 0.0 111.491 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -102.63 -34.43 9.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.38 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.77 53.81 7.0 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.743 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.707 ' ND2' HG11 ' B' ' 87' ' ' VAL . 9.8 m120 -75.74 -36.99 59.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.421 0.153 . . . . 0.0 111.369 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.757 HD11 HD13 ' A' ' 75' ' ' LEU . 2.8 mp -129.16 138.44 51.77 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.775 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.98 145.71 25.2 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.694 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -61.38 112.36 2.15 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.208 0.528 . . . . 0.0 111.188 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.77 -10.76 18.54 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.015 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -67.53 134.66 51.7 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 117.291 0.546 . . . . 0.0 110.215 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.581 HG21 ' NE2' ' A' ' 22' ' ' GLN . 1.2 pt -77.54 111.7 14.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.835 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.9 mt -77.4 138.72 19.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.051 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.7 tp -101.05 -38.05 8.34 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.24 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -149.81 148.06 28.74 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 120.943 0.401 . . . . 0.0 111.763 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.639 HG22 HD22 ' A' ' 50' ' ' ASN . 14.2 mt -139.58 118.6 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.155 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.639 HD22 HG22 ' A' ' 49' ' ' ILE . 67.8 m-80 56.86 37.08 28.57 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.31 6.66 88.85 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.594 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.6 m -114.12 138.97 49.73 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.166 0.483 . . . . 0.0 110.381 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.596 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.1 t -59.45 147.69 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.781 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -123.39 19.85 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.808 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.596 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -116.51 128.48 55.48 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.35 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.1 m120 70.09 -4.38 1.54 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.606 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.5 173.89 5.49 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.937 0.399 . . . . 0.0 111.238 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.9 143.17 27.53 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.265 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -41.49 86.87 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.692 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -63.63 -39.39 94.24 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.011 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.67 -48.59 71.59 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.837 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.804 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -61.37 -39.43 90.59 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.461 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -72.46 -37.52 68.5 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.452 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -67.89 -38.27 82.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -45.28 92.54 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.552 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.5 mt -68.58 -36.78 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.912 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -68.94 -49.48 57.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.776 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -67.07 -24.42 65.97 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.314 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 t -75.49 71.33 2.42 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.03 0.443 . . . . 0.0 110.781 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.07 91.32 8.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.39 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.84 -83.02 0.15 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.082 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.504 ' HB3' HD21 ' B' ' 88' ' ' LEU . 5.0 mttp -136.93 122.88 20.17 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.465 0.306 . . . . 0.0 110.455 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.584 HD23 ' CE1' ' B' ' 98' ' ' TYR . 0.4 OUTLIER -108.62 141.46 40.53 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 111.315 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.502 ' HB2' HD12 ' B' ' 88' ' ' LEU . 1.3 tt0 -107.98 141.68 39.26 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.848 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.757 HD13 HD11 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -135.29 125.3 25.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.982 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.6 132.12 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.373 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.36 168.35 23.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.187 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.235 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.8 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.531 ' C ' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.925 0.393 . . . . 0.0 111.048 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.498 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -132.24 158.04 22.76 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.666 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.707 HG11 ' ND2' ' A' ' 39' ' ' ASN . 15.2 t -131.47 135.17 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.73 0.3 . . . . 0.0 111.391 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 72' ' ' LYS . 1.1 tt -102.58 124.12 47.55 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.572 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.537 HD11 ' OD1' ' A' ' 39' ' ' ASN . 8.8 mp -106.08 124.49 49.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.758 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' MET . . . . . 0.46 ' HB3' ' CG ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -96.97 155.74 16.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.042 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 3.8 tttm . . . . . 0 C--O 1.234 0.273 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.375 -179.714 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.584 ' CE1' HD23 ' A' ' 73' ' ' LEU . 76.0 m-85 -60.31 -26.27 66.41 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.21 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.88 21.14 54.09 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.866 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.592 HD11 ' CB ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -95.76 122.84 38.97 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.733 0.301 . . . . 0.0 110.691 179.791 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.17 113.24 26.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.929 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.804 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.7 pt? -109.32 124.8 51.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.247 0.546 . . . . 0.0 111.074 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 103' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -105.09 -164.76 23.93 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.898 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.31 150.07 37.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.909 0.385 . . . . 0.0 110.831 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.429 HE22 HG22 ' B' ' 128' ' ' ILE . 0.0 OUTLIER -130.02 135.98 48.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.819 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.931 HD13 ' HB2' ' B' ' 145' ' ' ALA . 83.2 mt -87.91 120.89 37.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.369 . . . . 0.0 110.51 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.424 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 42.5 p90 -123.16 172.11 8.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.129 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 0.751 ' CG2' HD23 ' B' ' 123' ' ' LEU . 35.6 t -83.47 97.32 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.136 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 109' ' ' LYS . . . . . 0.424 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -65.31 -52.11 56.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.033 -179.542 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -162.31 138.49 7.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.879 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -121.66 152.48 39.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.907 0.384 . . . . 0.0 111.311 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 23.4 m -78.84 127.62 32.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.798 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 165.39 12.07 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.065 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.24 28.72 15.88 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.52 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.54 -174.94 19.97 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.318 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.04 -28.9 63.66 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.482 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -75.0 -35.09 62.02 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.181 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.14 -34.08 43.59 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.989 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -60.82 -38.44 85.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.563 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.25 -29.86 11.01 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.708 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.81 49.62 34.76 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.245 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.769 ' HB3' HG11 ' A' ' 4' ' ' VAL . 2.1 p-10 -71.88 -40.3 69.02 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.751 HD23 ' CG2' ' B' ' 108' ' ' VAL . 3.0 mp -122.78 146.33 47.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.626 0.251 . . . . 0.0 111.045 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -104.53 139.61 39.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.584 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -55.0 112.76 1.12 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.2 0.524 . . . . 0.0 110.67 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.58 -13.44 39.09 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.391 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -62.16 138.1 58.35 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.974 0.416 . . . . 0.0 110.809 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.782 HD11 ' HB2' ' B' ' 161' ' ' LEU . 1.4 pp -76.77 125.65 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.641 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.579 HD12 HG22 ' B' ' 106' ' ' ILE . 20.8 mt -93.26 147.8 5.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.714 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.46 HD22 HD11 ' B' ' 161' ' ' LEU . 32.3 tp -114.9 -40.76 3.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.777 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -147.19 148.04 31.1 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.394 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.676 HG23 HD23 ' B' ' 158' ' ' LEU . 38.7 mt -141.45 118.85 8.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.215 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 133' ' ' ASN . . . . . 0.558 ' HB2' HD21 ' B' ' 148' ' ' LEU . 8.6 m120 58.35 35.53 24.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.987 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.51 9.3 86.63 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.412 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -119.12 130.16 55.42 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 117.098 0.449 . . . . 0.0 110.395 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.681 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.4 t -59.22 147.03 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.101 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.869 HG22 HD12 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -115.55 4.8 14.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.998 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.681 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.2 OUTLIER -92.98 131.23 38.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.187 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 m120 71.44 -4.84 1.74 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.458 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.467 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.5 OUTLIER -69.78 171.04 9.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.997 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 38.5 t -87.01 144.4 26.92 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.11 -46.2 88.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.512 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.01 -37.16 83.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.774 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.8 -47.56 80.37 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.98 ' HB1' HD11 ' A' ' 19' ' ' LEU . . . -58.7 -41.84 87.23 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.935 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 76.9 ttt-85 -66.63 -39.97 88.52 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.299 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -38.15 86.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.805 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 148' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' B' ' 133' ' ' ASN . 8.3 tt -59.73 -44.31 93.83 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.532 HD12 HD22 ' A' ' 19' ' ' LEU . 39.1 mt -68.35 -37.19 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.611 0.244 . . . . 0.0 110.76 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -49.36 59.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.932 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -25.47 62.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.408 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 29.1 t -80.39 79.74 6.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.995 0.426 . . . . 0.0 110.597 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.82 126.64 35.77 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.542 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.16 -92.99 0.57 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.119 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -122.95 135.14 54.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.629 0.252 . . . . 0.0 110.717 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.808 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -129.58 132.31 46.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.119 0.485 . . . . 0.0 111.139 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.1 tm0? -94.58 139.09 31.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.316 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.676 HD23 HG23 ' B' ' 132' ' ' ILE . 5.5 mt -134.07 123.4 24.42 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.712 0.291 . . . . 0.0 111.009 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 21.4 t -110.91 135.71 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.465 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' B' ' 129' ' ' ILE . 18.4 m -136.13 158.57 38.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.175 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 161' ' ' LEU . . . . . 0.782 ' HB2' HD11 ' B' ' 128' ' ' ILE . 18.9 mt . . . . . 0 CA--C 1.531 0.229 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.253 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.4 tt . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.717 0.294 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.48 157.8 22.21 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.74 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.759 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.5 t -131.12 134.48 61.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.981 0.42 . . . . 0.0 111.351 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.568 HD23 ' NZ ' ' B' ' 155' ' ' LYS . 9.0 mp -101.39 108.59 20.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.874 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.691 HD23 ' CD2' ' A' ' 15' ' ' TYR . 3.1 tp -94.7 141.91 28.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.619 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.423 ' O ' HD13 ' B' ' 116' ' ' LEU . 2.9 ttt -126.19 164.27 21.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.116 0.484 . . . . 0.0 111.122 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.076 -179.668 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.621 0.248 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.881 ' CE1' HD23 ' B' ' 156' ' ' LEU . 52.2 m-85 -66.75 -28.69 68.61 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.972 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.4 19.8 37.28 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.694 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.797 HD22 HD22 ' B' ' 123' ' ' LEU . 1.3 mt -98.49 116.57 31.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.572 0.225 . . . . 0.0 110.708 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.459 ' HB2' ' HG2' ' B' ' 110' ' ' GLU . 55.8 mtt85 -91.2 113.49 25.76 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.744 HD22 HD11 ' B' ' 149' ' ' ILE . 6.6 mp -95.4 124.97 39.7 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.451 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.67 175.2 20.0 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.3 OUTLIER -137.08 144.41 43.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.033 0.416 . . . . 0.0 111.136 -179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' B' ' 104' ' ' SER . 9.8 pt20 -128.31 140.81 51.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.338 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.981 HD13 ' HB2' ' A' ' 62' ' ' ALA . 15.8 mt -88.17 120.49 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.411 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 43.7 p90 -123.9 171.71 9.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.639 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.806 HG21 ' HB3' ' A' ' 40' ' ' LEU . 95.8 t -81.19 98.47 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.577 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 3.0 tptp -69.27 -57.76 4.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.356 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -156.13 139.77 16.01 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.786 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -124.83 156.42 37.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.289 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.403 HG23 ' O ' ' B' ' 99' ' ' GLY . 32.8 p -65.26 121.54 15.02 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -58.84 145.99 38.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.064 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.2 m 64.32 32.92 11.86 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.312 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.25 -171.66 29.68 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.205 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.597 HD13 ' O ' ' B' ' 90' ' ' MET . 2.6 mt -69.25 -32.4 71.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.515 0.198 . . . . 0.0 111.332 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.02 -33.58 61.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.006 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.83 -34.67 45.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.044 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -63.48 -36.96 85.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.078 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -97.72 -31.6 12.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.422 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.81 50.59 10.8 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.729 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.885 ' HB3' HG11 ' B' ' 87' ' ' VAL . 13.3 p30 -89.32 -39.68 13.3 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.806 ' HB3' HG21 ' A' ' 25' ' ' VAL . 26.8 mt -111.72 121.18 44.41 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.668 0.27 . . . . 0.0 110.978 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 119.42 34.17 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.245 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -42.52 107.26 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.984 0.421 . . . . 0.0 111.818 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 117.02 -11.43 14.9 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.712 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -69.72 131.79 45.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.532 0.666 . . . . 0.0 111.286 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.6 pt -75.86 104.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.263 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 25' ' ' VAL . 39.7 mm -66.0 141.65 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.394 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.555 HD13 ' CD1' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -100.72 -43.02 6.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.249 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -152.8 148.16 26.88 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.884 0.373 . . . . 0.0 111.588 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.506 HG23 ' CD1' ' A' ' 75' ' ' LEU . 41.6 mt -135.17 121.61 33.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.211 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.2 m120 52.7 40.27 30.02 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.759 0.314 . . . . 0.0 111.11 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.15 17.61 78.81 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.062 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.5 m -120.37 141.64 49.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.861 0.331 . . . . 0.0 110.204 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.502 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.0 t -64.44 143.95 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.165 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.766 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -117.87 15.43 14.33 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.457 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.502 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -115.75 133.38 56.09 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.498 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 73.29 -11.57 0.89 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.328 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.47 ' HG3' ' N ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -73.8 152.92 40.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.671 0.272 . . . . 0.0 110.532 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.47 ' N ' ' HG3' ' A' ' 57' ' ' MET . 48.0 t -71.3 144.7 49.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.005 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tt -54.7 -42.32 71.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.753 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.24 -38.27 76.54 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.023 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.66 -47.83 77.01 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.839 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.981 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -59.36 -42.15 90.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.908 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.17 -40.09 90.22 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.66 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -64.88 -39.71 93.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -43.29 97.97 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.595 HD11 HD22 ' B' ' 102' ' ' LEU . 7.8 mt -68.61 -37.71 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.797 0.332 . . . . 0.0 110.656 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -69.05 -49.15 60.01 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -20.09 65.62 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.456 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -75.74 68.96 2.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.955 0.407 . . . . 0.0 110.915 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.28 109.14 14.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.49 -82.93 0.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.068 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 141.89 49.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.615 0.245 . . . . 0.0 110.673 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.714 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 1.2 pt? -130.36 132.42 45.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.879 0.371 . . . . 0.0 111.475 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.587 ' O ' HD13 ' A' ' 75' ' ' LEU . 52.9 tt0 -98.67 127.93 44.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.607 HD21 ' HG ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -125.34 129.44 49.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.822 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.95 131.94 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.532 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.47 138.87 48.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.492 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.555 ' CD1' HD13 ' A' ' 47' ' ' LEU . 3.5 tt . . . . . 0 C--O 1.233 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.416 ' O ' HG23 ' B' ' 85' ' ' ILE . 10.8 tt . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.798 0.332 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.22 156.46 17.33 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.577 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.885 HG11 ' HB3' ' A' ' 39' ' ' ASN . 17.7 t -132.62 134.52 58.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.718 0.294 . . . . 0.0 111.103 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 107.03 17.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.536 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 73' ' ' LEU . 16.9 tp -99.89 140.52 33.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.451 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' MET . . . . . 0.597 ' O ' HD13 ' A' ' 33' ' ' LEU . 51.1 ttm -120.96 161.77 21.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.201 0.524 . . . . 0.0 110.783 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.824 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.961 0.41 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.714 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 69.2 m-85 -73.56 -30.18 62.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.228 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 99' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 29' ' ' THR . . . 89.06 23.44 35.01 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.68 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 mp -103.61 122.27 44.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.758 0.279 . . . . 0.0 110.522 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -102.66 113.56 27.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.303 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.595 HD22 HD11 ' A' ' 66' ' ' ILE . 9.4 mp -98.16 124.78 42.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.949 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.48 -176.36 24.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.772 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -136.09 146.19 46.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.823 0.344 . . . . 0.0 111.0 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 21' ' ' SER . 8.9 pt20 -126.82 139.71 52.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.324 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 1.149 HD13 ' HB2' ' B' ' 145' ' ' ALA . 50.2 mt -88.19 120.5 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.407 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -121.41 172.44 8.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.954 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 0.694 HG22 HD23 ' B' ' 123' ' ' LEU . 38.3 t -81.73 96.24 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.117 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -58.05 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.884 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 18' ' ' ARG . 1.7 pt-20 -157.24 137.74 13.01 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.576 ' CB ' HD23 ' A' ' 17' ' ' LEU . 1.2 ptt? -119.79 161.44 20.76 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 111.68 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 51.9 m -78.46 140.31 38.64 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 113' ' ' ARG . . . . . 0.496 ' O ' HG22 ' B' ' 114' ' ' THR . 0.0 OUTLIER -76.33 152.24 36.44 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.103 179.724 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.563 HG23 ' O ' ' B' ' 114' ' ' THR . 0.5 OUTLIER 64.88 16.59 10.58 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.168 179.666 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.31 -168.46 41.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.224 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 7' ' ' MET . 0.1 OUTLIER -75.69 -27.32 58.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.673 ' CB ' HD21 ' A' ' 17' ' ' LEU . . . -74.8 -37.98 62.23 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.587 0.232 . . . . 0.0 111.213 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -33.74 43.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.827 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.0 -38.49 86.24 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.333 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.32 -37.6 9.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.222 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.08 55.7 3.46 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.309 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.759 ' HB3' HG11 ' A' ' 4' ' ' VAL . 0.5 OUTLIER -101.98 -45.52 5.16 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.409 0.147 . . . . 0.0 111.377 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.797 HD22 HD22 ' A' ' 17' ' ' LEU . 4.4 mp -85.25 119.92 26.17 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.79 0.328 . . . . 0.0 110.672 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.44 125.54 42.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.43 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -56.42 107.69 0.4 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.065 0.46 . . . . 0.0 110.916 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.13 -14.15 44.33 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.024 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.78 137.34 58.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.042 0.449 . . . . 0.0 110.983 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.75 105.19 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.288 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.503 HG12 HD11 ' B' ' 158' ' ' LEU . 7.8 mt -71.78 143.98 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.82 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 19.3 tp -105.81 -33.68 7.91 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.878 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -155.73 148.09 23.73 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.79 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 24.2 mt -137.95 117.73 15.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.146 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 133' ' ' ASN . . . . . 0.762 ' HB2' HD21 ' B' ' 148' ' ' LEU . 6.3 m120 56.73 36.81 28.22 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.043 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.5 13.74 82.21 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.305 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.5 m -120.45 128.46 53.19 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.922 0.361 . . . . 0.0 110.4 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.535 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.2 t -59.37 144.46 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 111.208 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.805 HG22 HD12 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -109.16 11.28 25.65 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.595 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.535 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.4 OUTLIER -99.79 132.98 44.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 72.47 -11.62 0.8 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.657 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.627 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.5 OUTLIER -64.07 168.45 5.33 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 111.141 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.38 148.22 22.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.257 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.22 -42.88 82.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.861 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 69.4 p -63.03 -39.81 95.86 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.176 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -41.53 97.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.035 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 1.149 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.91 -44.57 91.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.868 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -69.91 -36.6 75.49 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.506 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -67.85 -39.28 83.83 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.766 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 148' ' ' LEU . . . . . 0.762 HD21 ' HB2' ' B' ' 133' ' ' ASN . 5.6 tt -61.81 -42.42 98.99 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.785 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.744 HD11 HD22 ' A' ' 19' ' ' LEU . 14.7 mt -68.3 -38.16 79.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.589 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.16 -49.36 57.54 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.709 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -65.42 -25.86 67.72 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.236 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 10.7 t -84.44 63.41 7.81 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.015 0.436 . . . . 0.0 110.575 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.81 103.91 8.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.274 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 141.69 -93.11 0.18 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.088 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 155' ' ' LYS . . . . . 0.568 ' NZ ' HD23 ' A' ' 5' ' ' LEU . 14.0 ttpp -123.8 126.98 47.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.543 0.211 . . . . 0.0 110.963 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.881 HD23 ' CE1' ' A' ' 15' ' ' TYR . 1.2 pp -124.18 126.89 46.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.999 0.428 . . . . 0.0 111.353 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.8 mt-30 -94.45 141.49 28.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.219 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.503 HD11 HG12 ' B' ' 129' ' ' ILE . 3.7 tt -137.33 140.51 41.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.034 0.445 . . . . 0.0 111.536 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 25.3 t -120.08 134.59 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.278 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.484 HG13 ' CD2' ' B' ' 158' ' ' LEU . 27.6 m -124.71 159.34 31.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.753 0.311 . . . . 0.0 111.309 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.433 HG23 HG23 ' B' ' 160' ' ' VAL . 11.8 tt . . . . . 0 C--O 1.234 0.241 0 CA-C-O 120.725 0.298 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -128.86 157.28 21.49 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.906 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.66 HG11 ' HB3' ' B' ' 122' ' ' ASN . 21.9 t -132.12 133.66 60.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.743 0.306 . . . . 0.0 111.193 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 mt -98.19 111.67 23.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.784 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 tp -102.16 134.11 45.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.394 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.551 ' O ' HD13 ' B' ' 116' ' ' LEU . 7.4 ttm -109.11 164.16 12.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.643 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.729 -179.905 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.614 0.245 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.746 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 62.7 m-85 -52.2 -27.4 14.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.776 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.71 18.16 62.27 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.431 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.646 HD23 HG13 ' B' ' 108' ' ' VAL . 0.1 OUTLIER -97.75 115.14 27.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.715 0.293 . . . . 0.0 110.287 179.794 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -93.32 113.47 25.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.849 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.559 HD12 HG21 ' B' ' 106' ' ' ILE . 1.9 pt? -105.97 124.92 50.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 111.565 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -109.42 -176.81 21.33 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.55 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.423 ' OG ' HD12 ' B' ' 142' ' ' LEU . 0.3 OUTLIER -142.34 146.46 35.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.905 0.353 . . . . 0.0 111.067 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.428 ' NE2' HG21 ' A' ' 45' ' ' ILE . 6.5 pt20 -127.27 135.52 50.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.848 ' HB ' HG22 ' A' ' 54' ' ' THR . 42.2 mt -87.91 120.56 37.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.002 0.43 . . . . 0.0 110.557 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -123.71 172.57 8.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.062 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.467 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.0 t -82.37 100.15 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.795 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -70.66 -59.68 2.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.399 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.7 136.05 20.3 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.753 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 13.0 ptp -122.1 151.4 40.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.892 0.377 . . . . 0.0 111.211 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -65.53 134.34 53.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -71.86 146.95 47.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.773 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.27 33.58 14.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.258 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.78 -171.75 26.57 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.272 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.632 HD13 ' O ' ' B' ' 90' ' ' MET . 0.1 OUTLIER -70.45 -31.6 68.83 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.646 0.223 . . . . 0.0 111.423 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.594 ' HB3' HD11 ' B' ' 100' ' ' LEU . . . -74.93 -34.26 62.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.261 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.09 -34.0 43.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.079 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -64.06 -36.63 84.62 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.336 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.48 -30.5 11.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.421 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.36 45.26 61.39 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.281 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.722 ' HB3' HG11 ' B' ' 87' ' ' VAL . 14.7 p-10 -74.61 -38.55 62.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.508 0.194 . . . . 0.0 111.391 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.669 ' CD1' HD13 ' A' ' 75' ' ' LEU . 5.6 mt -128.43 133.86 48.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.924 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.88 148.32 24.58 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.593 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -59.33 112.23 1.66 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.097 0.475 . . . . 0.0 111.001 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.26 -15.84 20.25 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.394 -0.821 . . . . 0.0 113.177 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -63.04 133.69 54.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.242 0.521 . . . . 0.0 110.285 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.428 HG21 ' NE2' ' A' ' 22' ' ' GLN . 4.3 pt -81.8 104.69 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.434 ' CG2' HG21 ' A' ' 54' ' ' THR . 64.4 mt -65.35 148.63 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.031 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.583 HD12 HD12 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -106.85 -45.81 4.1 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.6 -179.67 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -149.27 148.16 29.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 111.768 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.671 HD13 HD11 ' A' ' 66' ' ' ILE . 26.6 mt -129.74 118.06 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.496 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 m120 49.99 32.19 5.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.642 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.51 16.46 58.63 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.199 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.6 m -120.79 135.83 55.05 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.869 0.334 . . . . 0.0 110.355 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.1 t -57.83 142.38 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.848 0.356 . . . . 0.0 111.295 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.848 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -119.39 16.79 13.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.401 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.525 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -121.87 129.33 52.5 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 71.56 -6.6 1.37 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.255 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.03 173.95 4.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.937 0.399 . . . . 0.0 111.043 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.77 135.89 33.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.669 HD12 ' OG ' ' B' ' 104' ' ' SER . 0.2 OUTLIER -56.63 -43.08 79.9 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.889 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 43.4 p -64.72 -39.07 93.01 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.064 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.32 -47.99 68.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.816 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.572 ' O ' HD12 ' A' ' 66' ' ' ILE . . . -62.37 -40.17 95.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.756 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -62.78 -39.79 95.3 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.447 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -65.35 -38.35 89.82 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.981 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -46.33 89.45 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.668 0.271 . . . . 0.0 110.745 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.671 HD11 HD13 ' A' ' 49' ' ' ILE . 3.1 mp -69.04 -36.49 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.841 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.6 -46.36 69.53 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.155 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -64.05 -28.22 69.64 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.0 t -78.53 88.8 4.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.959 0.409 . . . . 0.0 110.76 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -99.16 40.45 1.21 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' HD2' ' B' ' 91' ' ' LYS . . . -151.37 -88.17 0.07 OUTLIER Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.284 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -129.46 122.16 28.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.619 0.247 . . . . 0.0 110.474 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.598 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -114.97 136.37 53.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.031 0.443 . . . . 0.0 111.116 -179.463 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -100.96 134.41 44.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.506 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.669 HD13 ' CD1' ' A' ' 40' ' ' LEU . 1.3 mt -127.4 137.94 52.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.015 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.3 t -120.16 139.55 47.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.425 ' CG2' HD23 ' A' ' 40' ' ' LEU . 19.7 t -115.34 142.49 28.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.183 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.583 HD12 HD12 ' A' ' 47' ' ' LEU . 8.6 tt . . . . . 0 C--O 1.233 0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.233 0.236 0 CA-C-O 120.53 0.205 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.22 158.63 27.3 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.923 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.722 HG11 ' HB3' ' A' ' 39' ' ' ASN . 21.4 t -131.43 135.18 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 111.021 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.77 107.46 18.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.432 HD23 ' CD2' ' B' ' 98' ' ' TYR . 1.3 tp -90.71 136.49 33.03 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.871 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' MET . . . . . 0.632 ' O ' HD13 ' A' ' 33' ' ' LEU . 9.9 ttm -104.32 164.85 11.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 111.005 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.128 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 120.696 0.284 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.598 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 50.0 m-85 -58.41 -27.62 64.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.652 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.87 14.39 55.08 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.525 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.594 HD11 ' HB3' ' A' ' 34' ' ' ALA . 8.4 mp -101.55 119.94 39.55 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.746 0.308 . . . . 0.0 110.655 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -101.79 113.56 26.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.156 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.451 HD23 ' H ' ' B' ' 102' ' ' LEU . 1.9 pt? -102.93 125.02 49.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 111.301 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.67 -170.81 20.31 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.377 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.669 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -146.59 152.16 38.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.979 0.389 . . . . 0.0 110.887 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -128.88 138.64 52.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.13 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.714 ' HB ' HG22 ' B' ' 137' ' ' THR . 26.8 mt -88.08 120.49 37.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.447 . . . . 0.0 110.492 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -121.69 173.23 7.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.044 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 0.678 HG21 ' HB3' ' B' ' 123' ' ' LEU . 46.1 t -82.51 98.03 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.046 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -44.98 71.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.039 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -155.0 160.91 41.43 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.947 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 18.1 mtp -138.13 162.13 35.02 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 111.136 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 5.7 p -95.9 124.39 39.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.643 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 113' ' ' ARG . . . . . 0.573 ' HA ' HG21 ' B' ' 118' ' ' THR . 0.0 OUTLIER -64.72 160.51 19.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.03 0.443 . . . . 0.0 110.866 179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 58.13 22.84 9.49 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.02 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -103.31 -172.04 26.02 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.203 -0.523 . . . . 0.0 111.961 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 7' ' ' MET . 0.2 OUTLIER -72.24 -29.59 64.07 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.39 63.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.559 0.218 . . . . 0.0 111.077 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 118' ' ' THR . . . . . 0.573 HG21 ' HA ' ' B' ' 113' ' ' ARG . 1.0 OUTLIER -79.23 -34.03 43.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.246 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -57.81 -39.76 78.37 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.444 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -104.14 -36.16 7.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.028 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.2 53.34 5.7 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.756 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.66 ' HB3' HG11 ' A' ' 4' ' ' VAL . 8.5 p-10 -84.49 -36.5 22.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.777 HD11 HD22 ' B' ' 158' ' ' LEU . 3.7 mt -115.44 128.02 55.74 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.735 0.302 . . . . 0.0 111.218 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.77 140.37 34.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.351 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -57.27 110.43 0.84 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.068 0.461 . . . . 0.0 111.33 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 115.47 -16.44 16.98 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.264 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.09 132.68 54.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.389 0.594 . . . . 0.0 110.499 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 pt -79.15 106.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.854 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.688 HD13 HG12 ' B' ' 160' ' ' VAL . 36.8 mm -71.15 146.5 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.247 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 9.7 tp -109.5 -43.09 4.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.323 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.31 147.91 34.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.785 0.326 . . . . 0.0 111.461 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.433 HD11 HG21 ' B' ' 137' ' ' THR . 24.6 mt -137.86 118.14 16.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.39 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 133' ' ' ASN . . . . . 0.577 ' HB2' HD21 ' B' ' 148' ' ' LEU . 1.1 m120 56.79 37.34 28.74 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.102 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.17 16.36 80.76 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.985 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -120.73 142.72 49.26 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.82 0.31 . . . . 0.0 110.21 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.511 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.3 t -61.75 144.47 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.003 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.714 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -122.64 19.64 10.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.313 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.511 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.6 OUTLIER -112.0 142.15 44.77 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.365 179.608 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 53.15 9.08 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.218 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.23 176.12 9.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 111.268 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 47.2 t -91.93 142.74 27.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.423 HD12 ' OG ' ' A' ' 21' ' ' SER . 2.1 tt -61.09 -45.14 95.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.896 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 10.0 t -65.29 -37.14 86.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.845 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.2 -47.89 66.67 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.82 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.523 ' CB ' HD13 ' B' ' 106' ' ' ILE . . . -62.83 -40.42 97.36 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.843 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -61.68 -41.13 97.15 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.274 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -38.31 90.58 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.943 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 148' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' B' ' 133' ' ' ASN . 9.3 tt -59.6 -45.87 90.65 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.556 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.63 -36.72 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.795 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.94 -49.06 61.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.819 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -26.9 67.54 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.419 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 32.4 t -75.1 71.83 2.18 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.138 0.494 . . . . 0.0 110.634 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -86.57 97.9 10.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.328 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 147.46 -85.01 0.17 Allowed Glycine 0 C--O 1.228 -0.275 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.244 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 131.1 37.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.646 0.26 . . . . 0.0 110.682 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.746 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.59 143.64 51.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.002 0.429 . . . . 0.0 111.545 -179.565 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 32.7 tt0 -103.16 142.44 34.14 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.403 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.777 HD22 HD11 ' B' ' 123' ' ' LEU . 1.7 mp -136.24 128.34 29.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 110.951 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.402 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 18.7 t -117.09 134.01 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.688 HG12 HD13 ' B' ' 129' ' ' ILE . 22.6 m -124.44 156.32 32.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.195 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.914 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.719 0.295 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.12 157.79 22.84 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.507 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.812 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.5 t -131.55 134.99 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.302 . . . . 0.0 111.368 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.702 HD22 ' HE3' ' B' ' 155' ' ' LYS . 0.8 OUTLIER -100.5 107.24 18.9 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.512 179.535 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 tp -95.27 127.79 41.6 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.692 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.737 ' O ' HD22 ' B' ' 116' ' ' LEU . 3.2 ttt -106.99 165.67 11.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.954 0.407 . . . . 0.0 110.945 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.1 pttt . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.016 179.843 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.586 0.231 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.868 ' CE1' HD23 ' B' ' 156' ' ' LEU . 76.0 m-85 -60.13 -30.17 69.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.557 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.88 28.09 39.26 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.338 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.561 HD11 ' CB ' ' B' ' 117' ' ' ALA . 0.2 OUTLIER -106.59 120.54 42.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.673 0.273 . . . . 0.0 110.62 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.68 114.82 27.47 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.399 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.704 HD22 HD11 ' B' ' 149' ' ' ILE . 5.7 mp -98.09 124.92 42.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.153 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -110.23 177.88 19.83 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.764 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.5 OUTLIER -135.11 146.66 49.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.067 0.434 . . . . 0.0 111.321 -179.791 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -129.59 139.18 51.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.109 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.862 HD13 ' HB2' ' A' ' 62' ' ' ALA . 55.9 mt -88.11 120.41 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.036 0.446 . . . . 0.0 110.71 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -121.18 172.44 7.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.912 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.575 ' CG2' HD22 ' A' ' 40' ' ' LEU . 42.6 t -79.92 93.76 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.967 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -50.68 63.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.928 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.408 ' HB3' ' CG ' ' B' ' 101' ' ' ARG . 6.3 tt0 -158.47 151.82 23.01 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.985 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.48 146.01 41.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.122 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.455 HG23 ' O ' ' B' ' 99' ' ' GLY . 26.5 p -65.56 121.41 14.85 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.959 0.409 . . . . 0.0 110.767 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 151.08 22.1 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.101 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.05 31.74 13.34 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.281 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.76 -168.07 26.32 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.43 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 mt -70.32 -34.33 72.56 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 110.686 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.66 ' HA ' HD21 ' B' ' 89' ' ' LEU . . . -75.02 -33.7 61.81 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.896 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.1 -34.43 43.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.019 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.73 -38.76 82.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.406 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.9 -26.27 12.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.709 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.56 50.53 54.18 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.051 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.685 ' CG ' HG11 ' B' ' 87' ' ' VAL . 12.6 m120 -78.19 -34.19 49.65 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.575 HD22 ' CG2' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -129.07 137.41 51.25 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.672 0.272 . . . . 0.0 110.897 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 143.0 32.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.74 113.44 1.65 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 111.344 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.4 -17.44 14.2 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.845 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.464 ' HB3' HD23 ' A' ' 40' ' ' LEU . 9.8 t70 -59.57 136.98 58.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.094 0.473 . . . . 0.0 110.999 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -81.19 109.86 15.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.575 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.688 HD13 HD21 ' B' ' 102' ' ' LEU . 9.3 mt -79.93 145.2 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.217 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -110.87 -27.29 8.89 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.007 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.619 ' HE3' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -158.25 147.97 19.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.263 179.533 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 28.8 mt -142.32 117.9 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.739 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 51.09 33.41 9.18 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.306 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.43 83.17 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.609 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -105.16 129.02 53.65 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 117.141 0.47 . . . . 0.0 110.443 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.666 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.8 t -64.42 146.81 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.392 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.567 ' HA ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -105.35 -10.52 16.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.487 179.518 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.666 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -87.84 142.33 27.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 p30 53.39 9.44 0.16 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.668 0.605 . . . . 0.0 112.271 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 ttm -90.43 149.66 22.15 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.675 0.274 . . . . 0.0 110.596 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 m -71.71 139.22 49.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.762 0.315 . . . . 0.0 111.14 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.683 HD11 ' O ' ' B' ' 102' ' ' LEU . 12.1 tp -57.93 -42.68 85.34 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.396 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.8 m -56.98 -38.27 72.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.756 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -68.46 -47.93 65.86 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.533 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.862 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -61.04 -40.5 93.86 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.423 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -69.8 -38.44 76.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.5 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -38.34 85.47 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.52 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -44.5 94.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.873 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.724 HD11 HD22 ' B' ' 102' ' ' LEU . 10.6 mt -68.26 -37.49 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.72 0.295 . . . . 0.0 110.698 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.06 -37.96 78.8 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.946 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -89.8 1.42 56.17 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.1 p -90.94 56.52 3.23 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.196 0.522 . . . . 0.0 110.842 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.82 100.23 1.5 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.829 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.24 -91.52 0.17 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.273 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.65 135.44 47.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.571 0.224 . . . . 0.0 110.719 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.862 HD23 ' CE2' ' B' ' 98' ' ' TYR . 0.8 OUTLIER -129.31 130.31 45.97 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.949 0.404 . . . . 0.0 111.009 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 15.8 mt-30 -98.05 142.44 29.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.785 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.443 ' HG ' HD12 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -130.38 127.93 40.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.908 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.02 142.77 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.6 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.408 HG23 HG23 ' B' ' 85' ' ' ILE . 34.1 m -136.12 158.55 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.178 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 tp . . . . . 0 C--O 1.233 0.228 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.952 -179.94 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 85' ' ' ILE . . . . . 0.629 HD13 ' N ' ' B' ' 86' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.651 0.262 . . . . 0.0 110.844 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' GLY . . . . . 0.629 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -151.55 159.92 28.49 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.938 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.685 HG11 ' CG ' ' A' ' 39' ' ' ASN . 7.1 t -129.17 134.7 63.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.707 0.289 . . . . 0.0 111.262 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.494 ' C ' HD23 ' B' ' 88' ' ' LEU . 9.7 tt -101.95 125.54 48.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.05 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.66 HD21 ' HA ' ' A' ' 34' ' ' ALA . 9.1 mp -112.35 124.72 53.1 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.966 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.3 ttt -116.07 159.26 21.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.632 0.73 . . . . 0.0 112.005 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.522 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.388 0.613 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.862 ' CE2' HD23 ' A' ' 73' ' ' LEU . 85.2 m-85 -94.11 -29.39 15.19 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.468 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 99' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 29' ' ' THR . . . 75.94 29.72 58.6 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.884 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.73 125.5 51.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.646 0.26 . . . . 0.0 110.756 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 101' ' ' ARG . . . . . 0.408 ' CG ' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -108.09 114.61 28.63 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.012 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.724 HD22 HD11 ' A' ' 66' ' ' ILE . 3.6 mp -89.38 128.5 35.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.264 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.16 168.48 13.36 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.601 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 2.4 p -127.66 149.93 49.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.036 0.446 . . . . 0.0 111.196 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 105' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 21' ' ' SER . 6.9 pt20 -132.72 137.02 46.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.97 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.763 HD12 HG22 ' B' ' 137' ' ' THR . 69.4 mt -88.0 120.55 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 121.112 0.482 . . . . 0.0 110.482 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -122.82 172.79 8.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.972 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 0.844 HG21 ' HB3' ' B' ' 123' ' ' LEU . 39.3 t -80.42 95.96 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.778 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -65.69 -55.96 14.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.918 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.19 144.8 17.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.003 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -136.15 155.44 50.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.936 0.398 . . . . 0.0 111.394 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 11.8 p -78.62 124.59 28.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 ttp-105 -65.06 166.0 10.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.82 31.86 18.24 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.19 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -112.23 -158.05 13.91 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.259 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.737 HD22 ' O ' ' A' ' 7' ' ' MET . 2.0 mp -84.99 -29.96 24.59 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.526 0.203 . . . . 0.0 111.451 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 117' ' ' ALA . . . . . 0.561 ' CB ' HD11 ' A' ' 17' ' ' LEU . . . -75.15 -37.49 61.33 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.634 0.254 . . . . 0.0 111.33 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -33.64 44.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.089 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -57.27 -40.86 78.59 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.198 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -102.09 -28.61 12.23 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.661 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.22 24.24 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.152 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.812 ' HB3' HG11 ' A' ' 4' ' ' VAL . 12.3 p-10 -74.22 -47.25 36.62 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.844 ' HB3' HG21 ' B' ' 108' ' ' VAL . 6.6 mp -123.68 123.41 40.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.673 0.273 . . . . 0.0 110.842 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.41 150.52 21.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.769 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -59.46 111.09 1.26 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.08 0.467 . . . . 0.0 111.082 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.83 -18.76 19.18 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 115.41 -0.813 . . . . 0.0 113.26 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 127' ' ' ASP . . . . . 0.476 ' HB3' HG11 ' B' ' 160' ' ' VAL . 23.0 m-20 -59.14 135.41 57.63 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.236 0.518 . . . . 0.0 110.701 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.417 ' O ' HG13 ' B' ' 160' ' ' VAL . 4.0 pt -81.77 113.7 21.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.196 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.756 HG21 HD11 ' B' ' 132' ' ' ILE . 5.7 mt -81.95 147.23 6.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.522 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.667 HD13 HD13 ' B' ' 161' ' ' LEU . 6.8 tt -110.25 -40.83 4.57 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.582 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -147.57 148.9 31.64 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.836 0.35 . . . . 0.0 111.937 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.756 HD11 HG21 ' B' ' 129' ' ' ILE . 32.6 mm -133.78 117.97 28.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 52.28 33.71 13.23 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.547 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.56 4.79 79.6 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.57 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 91.3 m -113.57 133.72 55.1 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 117.076 0.438 . . . . 0.0 110.464 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.456 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.6 t -59.1 146.16 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.763 HG22 HD12 ' B' ' 106' ' ' ILE . 0.2 OUTLIER -125.78 25.09 6.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.47 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.456 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.3 OUTLIER -113.03 130.88 55.99 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.073 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.5 m120 70.8 -4.44 1.71 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.425 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.475 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -67.22 172.05 5.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.79 0.328 . . . . 0.0 111.007 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 43.4 t -88.34 145.33 25.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.375 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -40.84 83.24 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.848 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -39.21 86.62 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.81 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -65.57 -47.18 76.66 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.835 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.724 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -60.69 -40.94 94.05 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -69.52 -38.0 77.39 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.637 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -65.85 -40.1 91.39 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.947 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.03 -43.84 98.29 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.678 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.704 HD11 HD22 ' A' ' 19' ' ' LEU . 14.0 mt -68.32 -37.4 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.762 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -68.22 -49.58 59.77 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.044 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -68.39 -22.86 64.61 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.466 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.8 m -76.28 68.15 2.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.018 0.437 . . . . 0.0 110.771 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.13 91.31 7.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.467 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 155.85 -94.7 0.14 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.298 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 155' ' ' LYS . . . . . 0.702 ' HE3' HD22 ' A' ' 5' ' ' LEU . 21.8 tttp -126.42 132.31 51.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.624 0.25 . . . . 0.0 110.406 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.868 HD23 ' CE1' ' A' ' 15' ' ' TYR . 1.3 pp -128.69 144.14 51.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 21.9 tt0 -111.05 143.05 42.37 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.633 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.749 HD23 HD12 ' B' ' 132' ' ' ILE . 0.5 OUTLIER -133.82 128.2 34.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.679 0.276 . . . . 0.0 110.969 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 12.9 t -112.2 131.89 62.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.519 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 160' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' B' ' 127' ' ' ASP . 21.3 t -130.0 143.46 40.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.889 0.376 . . . . 0.0 111.496 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 161' ' ' LEU . . . . . 0.667 HD13 HD13 ' B' ' 130' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.203 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.775 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.865 0.364 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.37 165.13 12.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.667 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.683 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.6 t -129.97 134.71 62.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 120.653 0.264 . . . . 0.0 111.116 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.439 HD22 ' HE2' ' B' ' 155' ' ' LYS . 1.7 mt -99.86 106.85 18.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.751 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.438 ' O ' HD23 ' B' ' 156' ' ' LEU . 4.4 tp -100.94 127.52 47.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.452 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.67 159.53 14.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.823 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.832 0.349 . . . . 0.0 110.971 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 121.028 0.442 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.684 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 70.0 m-85 -63.58 -30.45 71.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.158 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.75 22.59 33.1 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.667 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 15' ' ' TYR . 6.0 mp -101.71 118.31 36.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.827 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.16 113.54 25.33 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.274 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.848 HD22 HD11 ' B' ' 149' ' ' ILE . 1.0 OUTLIER -97.71 124.95 42.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.152 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -115.21 -172.77 17.37 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.778 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.592 ' OG ' HD12 ' B' ' 142' ' ' LEU . 0.2 OUTLIER -144.09 151.36 39.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.813 0.34 . . . . 0.0 110.935 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -133.11 134.47 44.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.963 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.779 ' HB ' HG22 ' A' ' 54' ' ' THR . 50.0 mt -87.82 120.18 36.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.061 0.458 . . . . 0.0 110.15 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -123.31 171.2 9.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.913 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.9 t -84.6 97.04 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.087 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -40.17 96.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.916 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -170.22 156.42 5.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.02 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -138.37 157.24 46.62 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.862 0.363 . . . . 0.0 111.159 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.43 126.53 28.54 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -62.07 145.03 54.4 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.77 33.26 22.69 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.472 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.59 -167.71 31.08 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.321 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 mt -67.23 -35.59 79.88 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.581 0.229 . . . . 0.0 111.211 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -75.08 -35.19 61.82 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.163 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.84 -33.87 45.62 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.022 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -40.23 81.83 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.245 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.1 -27.62 12.81 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.73 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.61 43.75 51.46 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.035 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.602 ' HB3' HG11 ' B' ' 87' ' ' VAL . 24.7 p-10 -59.71 -48.91 79.8 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -138.43 147.28 43.14 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.697 0.284 . . . . 0.0 110.91 179.752 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 156.68 16.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.519 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 1.2 pt-20 -71.46 121.95 19.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.492 0.663 . . . . 0.0 109.898 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.41 3.24 35.38 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.948 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -85.94 135.14 33.79 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.419 0.609 . . . . 0.0 110.485 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.429 HD13 ' H ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -73.88 112.21 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.022 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.421 HD13 HD11 ' A' ' 49' ' ' ILE . 30.7 mt -79.04 146.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.502 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 78' ' ' LEU . 10.4 tp -102.57 -43.95 5.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.394 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -151.93 150.98 30.65 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 111.372 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 28.3 mt -140.91 118.09 8.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.726 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.486 ' HB2' HD13 ' A' ' 65' ' ' LEU . 1.9 m120 54.44 33.72 19.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.125 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.0 -2.39 87.05 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.123 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.1 m -104.64 126.46 51.75 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.985 0.393 . . . . 0.0 110.385 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.9 t -59.37 146.19 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.881 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.779 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.96 14.05 18.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.566 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.617 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -106.91 132.92 52.32 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.343 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.538 ' HB2' HD13 ' B' ' 142' ' ' LEU . 1.3 p-10 53.18 8.89 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 123.672 0.608 . . . . 0.0 112.579 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 31.2 tpp -82.69 161.06 22.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.686 0.279 . . . . 0.0 110.831 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.91 128.21 35.03 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.987 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.464 HD12 ' OG ' ' B' ' 104' ' ' SER . 9.9 tt -53.15 -42.57 66.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -61.65 -38.49 87.93 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.221 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.04 -48.05 77.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.939 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.683 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -61.42 -39.34 90.39 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.061 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -71.03 -35.47 72.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.654 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.1 tpmp? -66.5 -40.73 89.38 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.026 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.595 HD23 ' HA ' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -62.66 -41.79 99.26 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.868 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.8 mt -68.3 -38.06 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.033 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -48.99 62.44 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -64.19 -26.59 68.59 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.062 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.4 t -83.97 93.34 8.04 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.797 0.332 . . . . 0.0 110.707 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.48 40.38 1.27 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -143.71 -87.68 0.09 OUTLIER Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.273 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.65 133.52 50.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.758 -0.221 . . . . 0.0 110.558 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.788 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.8 OUTLIER -125.03 134.02 52.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.044 0.45 . . . . 0.0 111.369 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -97.65 141.08 31.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.464 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.631 ' HB2' HD11 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -137.12 124.6 22.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.73 0.3 . . . . 0.0 110.856 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.5 143.51 30.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.218 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.534 HG13 HD22 ' A' ' 40' ' ' LEU . 3.3 m -127.47 154.75 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.056 0.455 . . . . 0.0 111.705 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 47' ' ' LEU . 5.6 tp . . . . . 0 C--O 1.233 0.209 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.534 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.733 0.301 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.4 158.63 22.18 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.618 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 87' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 39' ' ' ASN . 20.9 t -129.76 134.52 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.652 0.263 . . . . 0.0 111.292 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 8.8 tt -99.82 110.06 22.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.344 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.462 HD21 ' N ' ' A' ' 34' ' ' ALA . 2.8 tp -99.37 143.14 29.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.66 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 21.8 ttt -117.72 162.75 17.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.206 0.527 . . . . 0.0 111.316 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.001 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 97' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' B' ' 98' ' ' TYR . 33.0 tt0 . . . . . 0 CA--C 1.533 0.305 0 CA-C-O 120.823 0.344 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 98' ' ' TYR . . . . . 0.788 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 58.8 m-85 -63.82 -27.06 68.92 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.207 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.76 22.17 37.35 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.727 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 100' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 34' ' ' ALA . 3.5 mp -104.22 125.55 50.59 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.747 0.308 . . . . 0.0 110.552 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -105.97 113.82 27.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.21 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.683 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.8 pt? -106.66 124.96 50.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.192 0.52 . . . . 0.0 111.642 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 103' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' A' ' 59' ' ' LEU . . . -105.71 -165.15 23.39 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.978 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 104' ' ' SER . . . . . 0.464 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -145.67 148.86 33.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.825 0.345 . . . . 0.0 111.17 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -132.45 139.03 47.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.153 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 106' ' ' ILE . . . . . 0.941 HD13 ' HB2' ' B' ' 145' ' ' ALA . 10.8 mt -88.19 120.62 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 110.588 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -122.42 171.98 8.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.181 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 108' ' ' VAL . . . . . 0.894 HG21 ' HB3' ' B' ' 123' ' ' LEU . 29.7 t -82.08 98.04 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.806 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.03 -53.26 40.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.195 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.43 ' HA ' ' HG2' ' B' ' 125' ' ' GLU . 2.6 pt-20 -162.06 138.67 8.04 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.927 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.2 161.35 19.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 111.31 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.5 p -78.03 120.26 22.61 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.65 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -61.34 149.28 38.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.157 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.2 m 67.67 25.51 8.14 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.377 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.18 -171.18 27.24 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.42 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -29.32 62.88 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.07 -34.42 61.78 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.124 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 1.2 p -78.94 -34.15 44.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.95 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -38.63 83.76 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.358 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -102.02 -31.2 10.77 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.401 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.26 45.96 28.83 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.251 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 122' ' ' ASN . . . . . 0.683 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.0 p-10 -75.68 -39.28 57.81 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.539 0.17 . . . . 0.0 111.4 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 123' ' ' LEU . . . . . 0.894 ' HB3' HG21 ' B' ' 108' ' ' VAL . 16.2 mt -121.82 121.86 38.16 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.994 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.48 147.31 23.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' B' ' 110' ' ' GLU . 4.8 mt-10 -59.45 111.22 1.31 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.955 0.407 . . . . 0.0 111.17 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.31 -16.33 24.68 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.46 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -58.13 134.35 56.39 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.408 0.604 . . . . 0.0 110.777 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 8.5 pt -83.74 99.79 6.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.601 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.618 ' HB ' HG21 ' B' ' 137' ' ' THR . 9.9 mt -66.78 136.74 26.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.246 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 tp -96.09 -42.13 8.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.619 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -146.23 147.79 31.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.764 0.316 . . . . 0.0 111.548 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 34.2 mt -134.9 117.93 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.757 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.9 44.18 28.35 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.494 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.22 18.42 78.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.008 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 30.6 m -120.72 142.22 49.71 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.597 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.9 t -62.81 146.08 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.982 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 137' ' ' THR . . . . . 0.807 HG22 ' HB ' ' B' ' 106' ' ' ILE . 1.4 m -120.98 16.94 11.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.917 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 138' ' ' GLU . . . . . 0.597 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.3 tt0 -117.45 131.34 56.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.6 m120 71.12 -6.55 1.29 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.554 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 140' ' ' MET . . . . . 0.637 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.9 OUTLIER -67.2 171.49 5.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.002 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 20.8 m -87.35 139.6 30.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.218 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 142' ' ' LEU . . . . . 0.592 HD12 ' OG ' ' A' ' 21' ' ' SER . 9.0 tt -56.01 -44.87 79.11 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 58.1 p -61.91 -40.2 94.64 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.805 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -62.97 -48.08 80.42 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.941 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.19 -42.03 85.23 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.071 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -69.49 -37.46 77.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.746 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -68.11 -39.4 82.81 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.661 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.92 -43.8 94.69 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.675 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.848 HD11 HD22 ' A' ' 19' ' ' LEU . 11.7 mt -68.27 -37.58 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.837 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.78 -49.68 56.65 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -21.64 63.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.294 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 37.8 t -82.2 66.48 7.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.13 0.491 . . . . 0.0 110.532 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -77.24 122.78 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 126.01 -92.09 0.4 Allowed Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.158 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 155' ' ' LYS . . . . . 0.439 ' HE2' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -128.59 133.72 48.4 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.591 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 156' ' ' LEU . . . . . 0.684 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -124.3 143.01 50.81 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.925 0.393 . . . . 0.0 111.357 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.648 ' O ' HD13 ' B' ' 158' ' ' LEU . 2.6 tt0 -105.23 131.67 52.4 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.849 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 158' ' ' LEU . . . . . 0.648 HD13 ' O ' ' B' ' 157' ' ' GLN . 0.4 OUTLIER -127.78 133.47 49.46 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.82 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.29 140.1 44.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.669 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 9.0 m -133.24 152.02 34.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.421 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--O 1.233 0.216 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 179.727 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.4 mtm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.714 0.292 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.55 124.38 7.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.343 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -96.28 157.48 21.47 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.402 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' B' ' 122' ' ' ASN . 21.4 t -131.35 134.03 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.708 0.29 . . . . 0.0 111.288 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.76 HD23 ' HD3' ' B' ' 155' ' ' LYS . 4.0 mp -103.13 115.02 29.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.508 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.505 HD21 ' N ' ' B' ' 117' ' ' ALA . 3.5 tp -104.98 126.28 51.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.709 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.71 ' O ' HD13 ' B' ' 116' ' ' LEU . 0.0 OUTLIER -98.16 161.41 13.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.743 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -98.27 132.16 43.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.983 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.423 ' H ' HD11 ' B' ' 116' ' ' LEU . 71.3 m -126.55 34.81 4.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.936 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -159.15 120.75 3.37 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.527 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.1 43.26 1.09 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.96 0.41 . . . . 0.0 111.241 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -111.8 -39.93 4.43 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.011 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -157.53 -178.15 7.12 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.911 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -74.04 -175.7 2.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.535 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.709 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 78.7 m-85 -58.24 -23.15 54.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.346 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.93 27.53 68.6 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.432 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.495 HD11 ' CB ' ' B' ' 117' ' ' ALA . 0.2 OUTLIER -103.06 120.84 41.39 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.631 0.253 . . . . 0.0 110.782 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.406 ' HB2' ' HG3' ' B' ' 110' ' ' GLU . 0.2 OUTLIER -98.48 113.36 25.35 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.463 HD22 HD11 ' B' ' 149' ' ' ILE . 10.1 mp -105.99 124.95 50.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 111.215 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.19 178.31 19.49 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.637 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.562 ' OG ' HD12 ' B' ' 142' ' ' LEU . 0.6 OUTLIER -139.99 142.92 36.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.152 0.476 . . . . 0.0 111.205 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' B' ' 104' ' ' SER . 11.0 pt20 -129.31 154.42 46.88 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.673 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.593 HD11 ' HB3' ' A' ' 57' ' ' MET . 3.2 mt -90.32 120.77 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.378 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.406 ' CE1' ' CG ' ' B' ' 105' ' ' GLN . 39.9 p90 -118.31 173.02 7.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.558 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.871 HG21 ' HB3' ' A' ' 40' ' ' LEU . 21.5 t -79.16 94.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.102 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -48.94 71.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.423 ' HG2' ' HB3' ' B' ' 101' ' ' ARG . 5.1 pt-20 -167.01 153.74 8.54 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.907 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.37 161.47 34.43 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.834 0.35 . . . . 0.0 111.063 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -70.55 135.66 48.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.002 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -68.91 144.75 54.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.707 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 58.06 31.02 20.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.337 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.78 -174.35 29.37 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.165 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.591 HD13 ' O ' ' B' ' 90' ' ' MET . 0.2 OUTLIER -67.22 -31.06 71.17 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.45 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -75.15 -39.06 60.7 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.568 0.223 . . . . 0.0 111.452 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -33.71 44.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.167 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -63.28 -37.06 85.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.382 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -100.3 -30.91 11.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.684 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.25 47.14 24.25 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.341 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.665 ' CB ' HG11 ' B' ' 87' ' ' VAL . 10.4 p-10 -63.07 -48.33 79.12 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.46 0.171 . . . . 0.0 111.319 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.871 ' HB3' HG21 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -134.06 144.29 48.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.723 0.296 . . . . 0.0 111.21 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 148.24 22.35 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.629 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 27' ' ' GLU . 4.5 mt-10 -59.01 110.91 1.13 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 111.234 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.75 -16.4 21.15 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.191 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -60.39 134.71 57.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.244 0.522 . . . . 0.0 110.704 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.8 pt -79.86 119.86 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.961 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.709 ' HB ' HG21 ' A' ' 54' ' ' THR . 38.0 mt -88.97 137.54 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.961 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.82 -41.82 8.27 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.329 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.68 147.67 34.62 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.744 0.306 . . . . 0.0 111.069 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.418 HG13 ' OG1' ' A' ' 54' ' ' THR . 14.7 mt -136.65 117.94 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.676 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 52.25 44.54 29.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 111.224 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.17 17.86 76.15 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.042 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.3 m -120.74 139.39 53.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.759 0.28 . . . . 0.0 110.374 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.5 t -59.8 145.86 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.149 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.709 HG21 ' HB ' ' A' ' 46' ' ' ILE . 2.5 m -120.69 20.89 11.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.686 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.512 ' H ' HG12 ' A' ' 53' ' ' VAL . 2.7 tt0 -119.33 129.65 54.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 70.66 -7.67 1.02 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.57 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.593 ' HB3' HD11 ' A' ' 23' ' ' ILE . 10.5 ttt -66.07 150.66 48.36 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.808 0.337 . . . . 0.0 110.622 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.9 t -71.8 143.47 49.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.079 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' B' ' 139' ' ' ASN . 1.1 tt -57.73 -46.19 84.78 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -40.43 82.37 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.055 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -64.08 -47.64 79.31 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.006 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.501 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -59.25 -41.55 89.02 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.003 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -37.96 81.74 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.635 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -38.68 83.18 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.733 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.417 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -59.87 -43.32 94.79 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.923 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.668 HD11 HD22 ' B' ' 102' ' ' LEU . 14.3 mt -68.18 -37.84 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.546 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -66.83 -49.56 65.38 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.781 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 65' ' ' LEU . 14.6 pttp -68.77 -22.22 64.3 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.437 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.9 t -74.87 73.15 2.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.034 0.445 . . . . 0.0 110.704 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.26 105.84 16.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.474 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.1 -91.19 0.21 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.239 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -129.34 134.11 47.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.735 0.302 . . . . 0.0 110.652 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.881 HD23 ' CE2' ' B' ' 98' ' ' TYR . 2.1 pp -123.47 143.96 49.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.488 ' OE1' HD11 ' B' ' 88' ' ' LEU . 31.9 tt0 -112.22 140.48 46.88 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.867 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.774 HD11 HD11 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -135.42 128.64 31.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.861 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.0 t -109.74 138.84 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.939 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.781 HG22 HD21 ' A' ' 40' ' ' LEU . 4.2 t -121.13 154.31 24.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.288 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 tt -108.76 116.33 31.78 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.511 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 60.27 173.04 0.09 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.187 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t70 65.58 113.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.39 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.3 -63.11 0.91 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.502 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.06 -72.58 0.66 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.747 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 C--O 1.252 1.204 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.497 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 5.9 mtt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.523 ' C ' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -122.6 121.54 63.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.876 0.369 . . . . 0.0 111.007 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.48 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -120.02 157.69 15.55 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.791 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.665 HG11 ' CB ' ' A' ' 39' ' ' ASN . 16.8 t -131.58 135.31 59.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.769 0.318 . . . . 0.0 111.313 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.488 HD11 ' OE1' ' A' ' 74' ' ' GLN . 2.7 mp -104.47 114.94 29.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.62 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 tp -102.16 133.36 47.13 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.978 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' MET . . . . . 0.591 ' O ' HD13 ' A' ' 33' ' ' LEU . 5.7 ttm -105.06 164.47 11.78 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.036 0.446 . . . . 0.0 110.95 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -87.93 148.01 24.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.908 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 3.0 p -79.53 171.05 15.68 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.642 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -77.31 70.24 3.68 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.218 0.532 . . . . 0.0 110.556 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -174.93 132.76 0.33 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.323 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -63.44 95.9 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.787 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.32 177.52 6.77 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.229 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -98.96 -179.79 4.38 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.881 ' CE2' HD23 ' A' ' 73' ' ' LEU . 70.6 m-85 -77.0 -32.12 56.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.394 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.73 26.83 55.57 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.394 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.672 HD13 ' HB3' ' B' ' 98' ' ' TYR . 6.2 mp -104.83 123.12 47.13 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 110.812 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' ARG . . . . . 0.423 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -98.03 113.68 25.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.245 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.668 HD22 HD11 ' A' ' 66' ' ' ILE . 1.9 mp -98.26 124.69 43.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.983 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.88 166.21 12.14 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.918 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 1.6 p -121.07 150.71 40.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.028 0.414 . . . . 0.0 111.244 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -137.49 145.38 42.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.459 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.633 HD12 HG23 ' B' ' 137' ' ' THR . 2.6 mt -88.86 121.14 38.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.175 0.512 . . . . 0.0 111.324 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -118.78 174.54 6.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.568 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.919 HG21 ' HB3' ' B' ' 123' ' ' LEU . 39.0 t -83.37 95.57 3.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.135 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -63.32 -56.33 17.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 110.573 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.406 ' HG3' ' HB2' ' A' ' 18' ' ' ARG . 14.0 pt-20 -163.99 146.26 9.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -133.37 156.02 48.4 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.804 0.335 . . . . 0.0 111.349 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.26 132.49 49.2 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -67.57 147.82 52.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.929 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 5.2 m 61.85 33.78 17.45 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.243 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.38 -170.31 28.08 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.146 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.71 HD13 ' O ' ' A' ' 7' ' ' MET . 7.4 mt -72.84 -30.06 63.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.676 0.238 . . . . 0.0 111.477 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.505 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -75.18 -36.73 61.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.173 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.79 -33.86 52.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -61.57 -38.43 87.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.217 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.88 -28.29 13.18 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.763 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.55 39.07 50.67 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.266 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.464 ' HB3' HG11 ' A' ' 4' ' ' VAL . 26.2 p-10 -59.51 -42.4 92.12 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.919 ' HB3' HG21 ' B' ' 108' ' ' VAL . 1.1 mt -133.05 143.87 49.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.766 0.317 . . . . 0.0 111.171 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.04 141.39 28.59 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.56 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -58.19 109.71 0.81 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.104 0.478 . . . . 0.0 110.789 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 108' ' ' VAL . . . 104.99 -15.75 47.47 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.592 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ASP . . . . . 0.593 ' OD1' HG13 ' B' ' 160' ' ' VAL . 10.1 t70 -62.54 141.97 58.19 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.172 0.511 . . . . 0.0 111.459 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.438 HG22 ' NE2' ' B' ' 105' ' ' GLN . 29.6 pt -79.8 127.96 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.898 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.865 ' HB ' HG21 ' B' ' 137' ' ' THR . 26.8 mt -94.91 143.79 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.425 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.404 ' CD1' HD12 ' B' ' 161' ' ' LEU . 0.8 OUTLIER -97.46 -36.63 10.28 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.629 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -154.81 152.43 29.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.627 0.251 . . . . 0.0 111.28 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.539 HG23 ' CD1' ' B' ' 158' ' ' LEU . 10.0 mt -132.4 117.5 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.324 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' ASN . . . . . 0.412 ' HB2' ' CD1' ' B' ' 148' ' ' LEU . 2.4 m120 51.16 34.7 11.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.373 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.63 85.7 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.178 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 58.6 m -102.47 132.48 48.48 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.955 0.377 . . . . 0.0 110.201 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.454 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.4 t -54.19 145.32 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.075 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.865 HG21 ' HB ' ' B' ' 129' ' ' ILE . 27.8 m -113.59 20.19 16.18 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.662 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.454 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.6 OUTLIER -119.44 127.7 53.33 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.417 ' HA ' HD12 ' A' ' 59' ' ' LEU . 2.4 m-80 70.56 -5.55 1.39 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.755 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.484 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.1 OUTLIER -65.25 169.75 5.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.858 0.361 . . . . 0.0 111.131 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.38 146.77 23.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.481 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.562 HD12 ' OG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -61.71 -42.22 98.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.004 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 44.2 p -64.12 -39.44 94.04 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.982 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -63.74 -47.92 79.11 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.931 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.37 90.26 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -69.33 -38.86 78.39 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.546 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -67.43 -38.06 83.97 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.631 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' B' ' 133' ' ' ASN . 0.2 OUTLIER -60.04 -44.57 94.58 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.63 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.618 HG23 HD13 ' B' ' 156' ' ' LEU . 37.9 mt -68.4 -37.57 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.928 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -69.48 -49.22 56.85 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.787 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -24.92 66.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.628 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 99.6 p -83.53 61.17 6.08 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.053 0.454 . . . . 0.0 110.746 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -69.65 110.96 5.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.568 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.62 -84.08 0.3 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.76 ' HD3' HD23 ' A' ' 5' ' ' LEU . 2.9 ttmm -132.24 135.14 46.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.657 0.265 . . . . 0.0 110.792 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.709 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -128.64 143.49 50.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.939 0.4 . . . . 0.0 111.11 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.633 ' C ' HD22 ' B' ' 158' ' ' LEU . 50.3 tt0 -105.61 142.76 34.79 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.213 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.633 HD22 ' C ' ' B' ' 157' ' ' GLN . 3.6 mm? -134.98 146.84 49.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.314 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 6.2 t -120.67 128.93 76.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.299 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.593 HG13 ' OD1' ' B' ' 127' ' ' ASP . 53.9 t -122.31 146.63 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.617 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.404 HD12 ' CD1' ' B' ' 130' ' ' LEU . 0.5 OUTLIER -112.21 116.12 29.93 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.524 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -177.65 42.76 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 2.9 t70 69.46 135.48 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.997 0.427 . . . . 0.0 111.206 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.51 121.07 21.81 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.023 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 mt -142.61 141.06 31.88 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.062 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.806 0.336 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.8 pp -143.68 154.58 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.394 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.96 159.93 23.43 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.654 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' B' ' 122' ' ' ASN . 27.3 t -123.56 131.76 72.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.696 0.284 . . . . 0.0 110.977 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 tt -100.28 108.57 20.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.706 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.521 HD21 ' N ' ' B' ' 117' ' ' ALA . 4.1 tp -95.88 136.58 36.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.718 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.611 ' O ' HD13 ' B' ' 116' ' ' LEU . 24.4 ttm -110.75 165.09 12.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.013 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.421 ' HE3' ' HA2' ' B' ' 154' ' ' GLY . 10.7 pttp -79.0 137.63 37.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.977 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.89 137.63 1.67 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.213 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 65.58 101.26 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 69.84 126.83 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.474 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.12 50.18 1.74 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.31 70.66 0.89 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.303 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 49.07 -173.3 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.211 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.692 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 64.9 m-85 -88.26 -32.24 18.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.312 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.13 23.32 35.18 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.733 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 15' ' ' TYR . 3.4 mp -104.98 115.46 30.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.786 0.293 . . . . 0.0 110.794 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.99 113.53 22.83 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.68 HD22 HD11 ' B' ' 149' ' ' ILE . 1.7 mp -102.02 124.8 48.26 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.596 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -114.82 -167.51 15.57 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.77 147.92 31.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.241 0.521 . . . . 0.0 111.136 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -133.47 140.57 47.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.414 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.895 HD13 ' HB2' ' A' ' 62' ' ' ALA . 27.5 mt -88.22 120.55 37.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.41 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.414 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 40.1 p90 -122.26 173.95 7.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.01 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.762 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.1 t -80.16 94.12 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.778 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.42 ' HE2' ' HG2' ' B' ' 138' ' ' GLU . 0.0 OUTLIER -65.12 -56.25 14.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.039 -179.026 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -147.53 151.18 35.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.77 ' SD ' HG23 ' A' ' 35' ' ' THR . 3.2 tmm? -138.26 142.72 39.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.82 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.76 120.06 12.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.623 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 153.68 23.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.083 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.98 22.46 12.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.327 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.87 -168.77 36.55 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.568 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.507 ' H ' HD12 ' A' ' 33' ' ' LEU . 1.1 mp -71.34 -30.8 66.62 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -74.97 -33.39 61.88 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.77 HG23 ' SD ' ' A' ' 28' ' ' MET . 0.7 OUTLIER -79.14 -34.7 43.05 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.176 179.654 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -36.88 85.12 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.21 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -98.39 -37.56 9.57 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.424 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.35 45.7 9.67 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.789 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.616 ' CB ' HG11 ' B' ' 87' ' ' VAL . 13.3 p-10 -71.93 -49.45 37.48 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.762 ' HB3' HG21 ' A' ' 25' ' ' VAL . 4.8 mp -129.82 132.01 46.35 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.661 0.267 . . . . 0.0 111.107 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.25 145.95 24.06 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.651 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -58.05 111.84 1.32 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.077 0.465 . . . . 0.0 111.075 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.68 -19.4 12.55 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.856 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -62.9 134.27 55.95 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.105 0.452 . . . . 0.0 110.587 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 pt -78.65 130.25 36.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.058 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.635 HD13 HD21 ' B' ' 102' ' ' LEU . 5.1 mt -96.07 138.06 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.503 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.004 HD13 HD21 ' A' ' 78' ' ' LEU . 2.8 tp -98.93 -40.61 7.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.984 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.403 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -152.49 148.21 27.14 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.832 0.349 . . . . 0.0 111.409 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.472 ' CG1' HG21 ' A' ' 46' ' ' ILE . 42.1 mt -138.74 118.83 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.66 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 53.23 44.64 29.93 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 111.182 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.47 15.37 72.88 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.172 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 m -120.84 135.45 55.17 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.855 0.328 . . . . 0.0 110.389 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.2 t -62.67 146.98 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.927 0.394 . . . . 0.0 111.266 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.671 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -126.71 16.32 7.5 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.334 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.662 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -112.7 131.61 55.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 71.46 -6.18 1.44 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.281 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.478 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.85 175.03 6.9 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.9 m -90.14 143.81 26.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.496 HD12 ' OG ' ' B' ' 104' ' ' SER . 2.2 tt -58.41 -40.48 82.57 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.788 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 m -63.17 -42.06 99.34 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.88 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -63.99 -48.05 77.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.768 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.895 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -60.47 -40.57 91.7 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.169 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.477 ' HA ' HD12 ' A' ' 66' ' ' ILE . 4.6 ttt-85 -63.62 -41.03 98.33 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.949 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -38.27 86.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.711 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 tp -60.75 -43.4 98.03 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.903 HD11 HD22 ' B' ' 102' ' ' LEU . 5.6 mt -67.21 -38.01 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.681 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -67.65 -49.51 62.56 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -64.31 -23.28 67.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.257 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 t -75.7 73.03 2.67 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.123 0.487 . . . . 0.0 110.821 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.15 100.63 13.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.552 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.08 -95.33 0.19 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.943 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.18 135.84 49.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.591 0.234 . . . . 0.0 110.439 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.707 HD11 HD21 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -128.12 141.83 51.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.093 0.473 . . . . 0.0 111.309 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -101.87 128.36 48.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.112 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.707 HD21 HD11 ' A' ' 73' ' ' LEU . 1.7 mp -126.53 129.18 48.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.664 0.269 . . . . 0.0 111.383 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.408 ' HA ' ' HA2' ' B' ' 86' ' ' GLY . 8.3 m -119.57 114.8 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.685 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -107.9 157.57 8.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.541 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.004 HD21 HD13 ' A' ' 47' ' ' LEU . 4.4 mt -102.05 137.18 40.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.831 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -138.89 -176.1 4.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.602 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.3 t70 62.8 66.65 0.74 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.101 0.477 . . . . 0.0 110.557 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 63.8 p -76.87 122.75 25.26 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.029 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.9 mp 66.15 177.14 0.22 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.57 -0.729 . . . . 0.0 111.251 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.909 0.385 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.26 133.89 68.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.163 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -105.43 155.87 16.83 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.632 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.616 HG11 ' CB ' ' A' ' 39' ' ' ASN . 17.4 t -131.49 135.11 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.725 0.297 . . . . 0.0 111.118 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 4.7 tt -103.65 107.12 17.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.612 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 21.3 tp -99.88 129.27 45.95 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.332 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.4 ttt -109.37 164.64 12.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.984 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 129.59 38.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.991 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -161.47 59.53 0.27 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.305 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.39 132.64 0.79 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.108 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.82 81.93 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.713 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -148.94 -178.69 6.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.081 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.5 111.66 23.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.793 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 47.95 -172.36 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.314 0.578 . . . . 0.0 112.225 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.498 ' CE2' HD22 ' A' ' 73' ' ' LEU . 69.0 m-85 -71.49 -32.03 67.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.417 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.01 26.74 47.94 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.467 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 34' ' ' ALA . 4.2 mp -104.73 116.64 32.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.665 0.269 . . . . 0.0 110.846 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -92.74 113.52 25.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.231 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.903 HD22 HD11 ' A' ' 66' ' ' ILE . 5.0 mp -94.79 125.01 39.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.288 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' GLY . . . . . 0.443 ' HA2' HD11 ' A' ' 59' ' ' LEU . . . -110.27 178.36 20.02 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.581 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.496 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -136.12 146.45 46.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.094 0.447 . . . . 0.0 111.017 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -134.1 141.79 47.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.43 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.703 HD11 ' HB3' ' B' ' 140' ' ' MET . 5.6 mt -88.14 122.05 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.597 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -122.25 171.47 9.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.047 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.735 HG21 ' CD2' ' B' ' 123' ' ' LEU . 38.8 t -83.78 93.59 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.059 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' LYS . . . . . 0.413 ' HG3' ' HA3' ' A' ' 20' ' ' GLY . 7.1 mtpt -61.94 -51.55 67.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.64 121.44 3.72 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.102 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.402 ' HG2' ' HG3' ' B' ' 125' ' ' GLU . 1.0 OUTLIER -116.92 143.89 45.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.025 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 36.1 p -65.65 137.17 57.15 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.628 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.643 ' HA ' HG21 ' B' ' 118' ' ' THR . 0.0 OUTLIER -79.07 162.87 25.58 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.997 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.4 m 59.73 23.07 11.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.286 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.6 -154.99 27.36 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.095 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.611 HD13 ' O ' ' A' ' 7' ' ' MET . 2.2 mt -82.86 -33.38 27.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.529 0.204 . . . . 0.0 111.374 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.521 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -73.12 -35.43 66.53 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.165 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.643 HG21 ' HA ' ' B' ' 113' ' ' ARG . 1.3 p -78.63 -33.88 46.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.277 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -60.83 -38.35 85.15 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.311 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -100.19 -36.05 9.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.42 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.06 44.03 7.28 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.907 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.624 ' HA ' HG21 ' A' ' 4' ' ' VAL . 7.0 p30 -55.38 -54.1 47.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.383 0.135 . . . . 0.0 111.261 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.735 ' CD2' HG21 ' B' ' 108' ' ' VAL . 0.0 OUTLIER -142.4 156.66 45.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 111.296 179.169 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.81 150.8 20.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.591 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' B' ' 111' ' ' MET . 5.3 mt-10 -59.83 109.44 0.94 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.092 0.472 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 111.04 0.08 28.49 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.98 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -78.42 138.66 38.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 117.347 0.573 . . . . 0.0 110.719 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -76.1 124.38 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.327 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.855 ' HB ' HG21 ' B' ' 137' ' ' THR . 19.8 mt -91.99 144.05 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.173 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 tp -98.39 -41.89 7.61 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.356 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -145.83 148.06 32.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 111.195 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 32.2 mt -138.35 118.42 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.809 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' ASN . . . . . 0.556 ' HB3' HD11 ' B' ' 148' ' ' LEU . 6.0 t30 53.87 48.09 22.09 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.317 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 65.58 18.02 65.3 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.993 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.21 144.8 47.54 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.667 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.0 t -63.52 146.88 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.855 HG21 ' HB ' ' B' ' 129' ' ' ILE . 18.2 m -115.32 1.42 13.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.865 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.667 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.5 tt0 -100.39 131.63 46.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.67 0.271 . . . . 0.0 110.357 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 71.85 -7.65 1.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.435 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.703 ' HB3' HD11 ' B' ' 106' ' ' ILE . 36.7 ttm -65.51 155.42 35.69 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.012 0.434 . . . . 0.0 111.377 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 28.6 t -79.58 149.56 31.33 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.387 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 tt -60.8 -48.13 83.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.893 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 39.1 p -58.47 -38.22 77.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.882 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.21 -43.21 95.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.841 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.655 ' HB1' HG21 ' B' ' 106' ' ' ILE . . . -59.71 -42.88 94.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.173 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -67.67 -38.3 83.57 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.654 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -67.63 -38.35 83.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.485 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' LEU . . . . . 0.556 HD11 ' HB3' ' B' ' 133' ' ' ASN . 0.1 OUTLIER -60.3 -44.09 95.71 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.844 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.68 HD11 HD22 ' A' ' 19' ' ' LEU . 15.7 mt -68.13 -37.7 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.915 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -69.16 -48.39 62.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.773 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -71.22 -23.62 62.05 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.992 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 80.1 p -77.25 66.97 3.12 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.147 0.498 . . . . 0.0 110.628 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -74.51 127.94 34.31 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.564 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' GLY . . . . . 0.421 ' HA2' ' HE3' ' A' ' 8' ' ' LYS . . . 109.39 -91.64 0.66 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.274 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -124.17 138.36 54.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.692 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -129.71 135.19 48.19 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.035 0.445 . . . . 0.0 111.14 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -97.86 136.93 37.46 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.643 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.483 HD13 HD11 ' B' ' 123' ' ' LEU . 1.2 mt -134.03 128.77 35.0 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.803 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.408 ' O ' HG23 ' B' ' 129' ' ' ILE . 21.1 t -113.69 136.6 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.893 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' B' ' 123' ' ' LEU . 21.9 t -128.84 149.67 33.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.266 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 6.9 tp -84.2 123.29 29.95 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.548 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' B' ' 163' ' ' ASP . 21.6 ttp180 -83.66 65.2 8.38 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.596 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' B' ' 162' ' ' ARG . 19.9 t0 174.8 124.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.917 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 74.6 m -156.19 -47.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' LEU . . . . . 0.437 ' H ' HD23 ' B' ' 165' ' ' LEU . 0.4 OUTLIER -88.13 115.8 25.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.916 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.252 1.217 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.127 179.905 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.6 0.238 . . . . 0.0 111.377 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 2' ' ' ILE . 13.5 tt -147.03 119.79 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.781 0.324 . . . . 0.0 110.968 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.12 156.1 15.74 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.669 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' B' ' 122' ' ' ASN . 21.6 t -132.47 133.03 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.377 . . . . 0.0 111.058 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.35 114.81 29.14 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.438 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 1.1 mp -98.42 144.53 27.69 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.604 ' O ' HD13 ' B' ' 116' ' ' LEU . 30.8 ttm -113.24 164.05 14.02 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.893 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.405 ' N ' ' HG2' ' A' ' 7' ' ' MET . 0.0 OUTLIER -88.32 142.67 27.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.109 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -165.29 106.94 0.79 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.603 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.13 34.8 21.2 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.203 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.33 107.4 7.15 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -94.14 -34.53 12.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.51 53.77 2.91 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.938 0.399 . . . . 0.0 111.161 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 64.65 -177.06 0.17 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.426 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.811 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 57.2 m-85 -71.82 -22.25 61.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.817 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.48 20.38 38.12 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.704 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.9 mp -102.48 115.95 31.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.821 0.31 . . . . 0.0 110.786 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.99 114.58 24.74 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.911 HD22 HD11 ' B' ' 149' ' ' ILE . 2.1 mp -97.9 124.81 42.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 111.776 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -114.73 174.93 15.71 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 p -130.17 151.04 51.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.608 0.704 . . . . 0.0 111.84 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -136.75 135.83 38.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.176 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.565 ' HB ' HG22 ' A' ' 54' ' ' THR . 21.5 mt -88.14 121.47 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.931 0.396 . . . . 0.0 110.125 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' ' HG2' ' A' ' 26' ' ' LYS . 41.7 p90 -125.42 172.92 9.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.314 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.886 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.8 t -82.29 97.53 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.745 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.415 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -67.65 -57.01 7.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.282 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.39 141.33 17.17 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.953 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -126.66 144.31 50.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.17 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.5 m -73.73 127.83 33.87 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.583 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -63.29 168.25 4.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.73 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.63 29.8 15.03 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.445 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.87 -174.09 17.58 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.194 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.39 -28.19 61.88 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' N ' HD21 ' B' ' 89' ' ' LEU . . . -74.38 -36.49 63.55 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.502 0.191 . . . . 0.0 111.203 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.9 -34.05 45.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.062 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -62.77 -37.14 85.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.339 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.62 -33.41 10.31 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.493 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.48 44.74 32.26 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.165 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.836 ' HB3' HG11 ' B' ' 87' ' ' VAL . 10.4 p-10 -81.65 -49.04 10.95 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.886 ' HB3' HG21 ' A' ' 25' ' ' VAL . 13.2 mt -95.64 113.18 24.8 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.904 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.47 130.29 34.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.552 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -54.39 111.62 0.83 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.125 0.488 . . . . 0.0 110.868 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.95 -14.1 37.66 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.865 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.33 138.64 58.6 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.038 0.447 . . . . 0.0 111.31 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 45' ' ' ILE . 24.3 pt -79.96 119.49 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.674 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.701 HG21 HD11 ' A' ' 49' ' ' ILE . 7.8 mt -83.33 144.11 10.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.343 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.425 HD23 ' HB2' ' A' ' 48' ' ' LYS . 3.5 tt -105.23 -42.56 5.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.438 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HB2' HD23 ' A' ' 47' ' ' LEU . 3.1 mttm -152.38 147.97 26.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.68 0.276 . . . . 0.0 111.368 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.994 HD12 HD23 ' A' ' 75' ' ' LEU . 27.8 mm -137.47 118.97 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.431 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 54.91 40.14 31.85 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.217 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.27 14.58 80.59 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.32 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 m -120.23 139.64 52.38 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.028 0.414 . . . . 0.0 110.51 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.3 t -59.69 145.63 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.203 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.565 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -124.18 20.13 9.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.433 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.517 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -116.79 132.13 56.77 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.397 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 71.1 -7.57 1.11 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.65 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.5 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -68.38 172.13 6.41 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 111.125 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.81 146.16 24.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.308 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' B' ' 139' ' ' ASN . 0.9 OUTLIER -60.9 -38.62 86.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.27 -46.94 84.47 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -44.2 93.94 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.796 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.96 93.61 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.951 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -39.66 88.57 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.695 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.97 -38.39 86.01 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 2.2 tp -60.32 -43.35 96.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.026 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.775 HD11 HD22 ' B' ' 102' ' ' LEU . 24.5 mt -68.33 -37.48 78.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.78 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.0 -49.44 57.75 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.078 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 65' ' ' LEU . 1.8 ptpt -64.89 -30.5 71.5 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.212 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 m -81.95 62.01 5.52 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.201 0.524 . . . . 0.0 110.791 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 147.26 41.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.785 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.0 -86.59 0.59 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.224 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -134.95 126.87 29.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.663 0.268 . . . . 0.0 110.568 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.781 HD23 ' CE2' ' B' ' 98' ' ' TYR . 2.3 pp -125.87 143.84 50.91 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -101.45 141.46 34.29 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.994 HD23 HD12 ' A' ' 49' ' ' ILE . 0.8 OUTLIER -133.4 128.08 34.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.965 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 t -107.97 134.62 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.248 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.98 164.58 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.518 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tp -89.55 135.91 33.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.594 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -91.91 42.66 1.11 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.229 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.16 111.19 0.64 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.691 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.23 95.27 0.09 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.946 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.0 mt -149.87 161.62 41.92 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.009 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.038 179.789 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pp -117.03 143.06 28.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.218 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.89 166.96 20.34 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.924 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.836 HG11 ' HB3' ' A' ' 39' ' ' ASN . 21.4 t -129.69 134.86 62.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.641 0.258 . . . . 0.0 111.086 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tt -96.99 121.91 39.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.516 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.551 HD21 ' N ' ' A' ' 34' ' ' ALA . 7.6 tp -115.3 144.62 43.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.581 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.7 ttt -107.1 163.61 12.85 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.144 0.497 . . . . 0.0 110.922 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' B' ' 97' ' ' GLU . 4.1 tttt -93.54 146.39 23.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.914 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -136.83 146.95 46.24 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.041 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 68.62 104.23 0.05 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.766 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.16 80.46 1.27 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -165.18 -48.03 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.733 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -119.84 178.79 4.46 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.099 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' GLU . . . . . 0.405 ' HA ' ' HE3' ' B' ' 91' ' ' LYS . 0.8 OUTLIER -95.77 -174.03 3.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.818 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.781 ' CE2' HD23 ' A' ' 73' ' ' LEU . 47.0 m-85 -49.74 -31.14 10.72 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.685 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.25 15.36 74.52 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.521 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.429 HD11 ' CB ' ' A' ' 34' ' ' ALA . 2.6 mp -101.3 119.82 39.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.659 0.266 . . . . 0.0 110.668 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -96.13 113.43 25.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.211 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.775 HD22 HD11 ' A' ' 66' ' ' ILE . 7.9 mp -97.41 124.78 41.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.625 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.44 177.13 17.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.978 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.37 145.76 50.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.847 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -130.05 140.16 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.413 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 1.046 HD13 ' HB2' ' B' ' 145' ' ' ALA . 9.1 mt -88.37 120.46 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.176 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -119.68 170.48 9.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.714 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' B' ' 126' ' ' GLY . 41.2 t -81.07 89.5 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.038 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -53.77 -42.46 68.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.816 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.03 132.17 0.51 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -114.24 146.31 40.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.079 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 25.2 p -77.13 126.57 31.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.704 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.687 ' HA ' HG21 ' B' ' 118' ' ' THR . 0.0 OUTLIER -65.78 165.87 12.04 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.289 -179.708 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.3 m 64.95 22.85 12.52 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.183 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -105.19 -171.7 24.11 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.172 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.604 HD13 ' O ' ' A' ' 7' ' ' MET . 0.2 OUTLIER -71.15 -30.81 66.93 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.405 ' CA ' HD21 ' A' ' 6' ' ' LEU . . . -74.25 -35.03 63.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.489 0.185 . . . . 0.0 110.941 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.687 HG21 ' HA ' ' B' ' 113' ' ' ARG . 2.1 p -78.95 -34.1 44.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.184 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -59.15 -38.85 80.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.424 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.58 -29.9 10.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.539 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.16 58.44 5.59 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.2 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.608 ' HB2' HG21 ' A' ' 4' ' ' VAL . 1.2 p-10 -95.95 -32.68 12.49 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.569 HD11 ' CB ' ' B' ' 158' ' ' LEU . 39.4 mt -131.34 133.02 44.91 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.641 0.258 . . . . 0.0 111.195 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.79 161.86 13.4 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' B' ' 125' ' ' GLU . 2.1 pt-20 -73.64 120.55 19.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.518 0.675 . . . . 0.0 110.178 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 108' ' ' VAL . . . 106.89 -15.77 40.25 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.587 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ASP . . . . . 0.4 ' OD2' HG11 ' B' ' 160' ' ' VAL . 50.2 t0 -63.97 135.31 56.37 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 111.082 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 13.7 pt -78.25 121.32 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.825 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.434 HD13 HD21 ' A' ' 19' ' ' LEU . 15.6 mt -91.2 143.7 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.149 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.77 -35.47 6.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.902 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.83 148.04 31.47 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.541 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 45.4 mt -140.93 118.68 9.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.616 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 55.7 44.14 26.84 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.931 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.83 17.43 73.29 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.051 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.84 137.71 54.42 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 116.948 0.374 . . . . 0.0 110.478 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.56 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.3 t -59.87 145.04 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.838 0.351 . . . . 0.0 110.872 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.633 ' CG2' HD12 ' B' ' 106' ' ' ILE . 1.8 m -119.03 9.9 11.98 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.788 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.56 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.3 OUTLIER -102.28 131.13 49.06 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.218 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.509 ' HA ' HD12 ' A' ' 59' ' ' LEU . 4.9 m-80 70.85 -4.33 1.75 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.548 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.2 OUTLIER -65.65 169.52 6.2 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 111.285 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.69 141.72 28.28 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.168 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.404 HD22 ' NE ' ' B' ' 146' ' ' ARG . 0.8 OUTLIER -58.14 -44.38 87.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.555 179.488 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 7.2 t -61.46 -39.29 90.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.693 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -64.81 -46.73 80.77 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 1.046 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.54 -42.56 88.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 146' ' ' ARG . . . . . 0.404 ' NE ' HD22 ' B' ' 142' ' ' LEU . 91.0 mtt180 -65.72 -40.27 92.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.502 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -66.39 -38.63 87.93 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.886 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' LEU . . . . . 0.524 ' O ' HD23 ' B' ' 148' ' ' LEU . 5.3 tt -59.94 -44.78 94.16 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.713 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.911 HD11 HD22 ' A' ' 19' ' ' LEU . 4.9 mt -68.5 -37.35 77.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.773 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.85 -47.57 65.63 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.055 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -66.33 -27.77 68.16 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 3.6 m -79.24 63.23 3.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.006 0.431 . . . . 0.0 110.747 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 18.2 mmm-85 -83.93 74.78 10.18 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.422 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 167.54 -73.32 0.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.251 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.41 127.49 27.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.712 0.291 . . . . 0.0 110.875 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.811 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -129.84 139.51 51.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 4.4 tt0 -103.57 141.01 36.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.195 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.569 ' CB ' HD11 ' B' ' 123' ' ' LEU . 1.0 OUTLIER -134.72 128.13 32.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 111.001 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.24 135.27 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.47 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.4 HG11 ' OD2' ' B' ' 127' ' ' ASP . 16.9 m -128.46 152.82 37.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.854 0.359 . . . . 0.0 111.711 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 15.0 tp -115.73 122.26 44.97 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 69.73 141.4 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.171 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 175.81 142.63 0.06 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.162 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 21.5 m -72.75 170.35 14.78 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.979 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 1.3 tp -138.56 103.18 4.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.908 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.085 -179.86 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.509 HD11 ' NH1' ' B' ' 162' ' ' ARG . 14.1 pt -126.87 155.2 37.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.625 0.25 . . . . 0.0 111.255 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.74 158.6 22.64 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.865 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' B' ' 122' ' ' ASN . 23.0 t -130.01 132.73 65.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.758 0.313 . . . . 0.0 110.94 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.756 HD22 ' HD2' ' B' ' 155' ' ' LYS . 0.4 OUTLIER -96.88 113.68 25.25 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.023 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.995 HD13 HD12 ' B' ' 158' ' ' LEU . 8.0 mp -91.23 131.56 36.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.656 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.0 ttt -107.62 162.21 14.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.228 0.537 . . . . 0.0 111.143 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.65 119.63 37.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.738 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.491 ' OG ' HD21 ' B' ' 116' ' ' LEU . 2.0 p -114.42 36.07 3.93 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.256 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.49 114.35 1.18 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.734 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.55 49.49 1.8 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.07 0.462 . . . . 0.0 111.419 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -171.84 35.18 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.119 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -175.43 -178.92 1.2 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 111.558 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -113.71 175.66 5.36 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.866 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.934 ' CE2' HD23 ' B' ' 156' ' ' LEU . 50.6 m-85 -61.56 -29.76 70.23 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.95 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.48 27.25 57.71 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.196 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' B' ' 117' ' ' ALA . 2.4 mp -113.75 117.86 32.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.71 0.29 . . . . 0.0 110.66 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.38 113.33 25.27 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.596 HD22 HD11 ' B' ' 149' ' ' ILE . 7.1 mp -98.01 124.86 42.69 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.193 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -105.27 -167.46 23.88 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.8 OUTLIER -146.02 149.24 33.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.258 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' B' ' 104' ' ' SER . 1.9 pt20 -132.1 133.47 44.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.964 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.761 ' HB ' HG22 ' A' ' 54' ' ' THR . 68.8 mt -87.75 120.23 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.115 0.483 . . . . 0.0 110.29 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.409 ' CE2' ' HG2' ' A' ' 26' ' ' LYS . 46.4 p90 -122.86 172.92 8.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.297 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.1 t -82.54 99.78 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.767 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -70.93 -58.69 3.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.216 -179.071 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -156.42 147.56 22.22 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.631 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.32 163.15 30.65 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.894 0.378 . . . . 0.0 111.428 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.8 m -65.38 139.89 58.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -76.51 156.92 32.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.977 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 50.35 30.9 4.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.918 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.17 -170.55 30.84 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.152 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' B' ' 93' ' ' ARG . 0.2 OUTLIER -70.37 -31.09 68.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -75.02 -36.94 61.9 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.236 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -33.85 45.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.175 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -60.86 -39.21 88.29 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.149 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.14 -30.83 11.71 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.789 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.38 47.92 20.64 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.226 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.724 ' HB3' HG11 ' B' ' 87' ' ' VAL . 21.7 p-10 -65.24 -47.34 77.13 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.721 HD11 HD22 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -129.44 136.57 50.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.812 0.339 . . . . 0.0 111.386 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.96 148.48 22.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.489 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -59.53 109.49 0.91 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.27 0.557 . . . . 0.0 111.08 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.23 -13.6 16.27 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.286 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -62.86 135.43 57.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.232 0.516 . . . . 0.0 110.391 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.55 112.43 18.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.085 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.432 HG21 ' CG1' ' A' ' 49' ' ' ILE . 5.9 mt -77.49 130.43 36.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.176 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.2 tp -92.21 -40.96 10.7 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.322 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -151.36 148.66 28.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.852 0.358 . . . . 0.0 111.833 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.432 ' CG1' HG21 ' A' ' 46' ' ' ILE . 29.7 mt -138.33 119.66 17.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.344 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HB2' HD21 ' A' ' 65' ' ' LEU . 6.5 m120 55.23 39.99 31.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.124 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.77 11.65 84.41 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.424 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 m -119.82 135.3 54.92 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 117.113 0.456 . . . . 0.0 110.203 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.686 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.3 t -61.69 147.79 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.843 0.354 . . . . 0.0 111.146 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.761 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -118.42 6.55 11.81 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.751 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.686 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -91.01 135.73 33.55 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 p30 52.59 11.79 0.21 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.649 0.593 . . . . 0.0 112.198 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.41 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -73.32 171.92 12.16 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.003 0.43 . . . . 0.0 111.357 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.6 130.66 35.22 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.883 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.97 -35.69 59.27 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.9 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.9 -46.75 80.44 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.063 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.67 -46.06 89.92 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.684 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.701 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -58.04 -42.12 84.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -70.31 -37.46 74.75 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.466 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -67.85 -38.17 82.81 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.568 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.568 HD21 ' HB2' ' A' ' 50' ' ' ASN . 9.1 tt -59.69 -44.77 93.51 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.706 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.497 ' CD1' HD22 ' B' ' 102' ' ' LEU . 37.5 mt -68.22 -37.66 78.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.763 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.03 -49.61 56.05 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.791 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -65.19 -27.24 68.55 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.207 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.5 t -80.55 63.13 4.89 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.002 0.43 . . . . 0.0 110.557 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -77.76 94.83 4.54 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.537 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.06 -84.1 0.18 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.521 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.8 ' CG ' HD21 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -129.6 131.08 46.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.641 0.257 . . . . 0.0 110.761 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.749 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -129.83 140.71 50.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 111.323 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -106.37 140.64 38.98 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.553 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.721 HD22 HD11 ' A' ' 40' ' ' LEU . 1.7 mp -136.11 134.64 38.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.102 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.4 t -118.87 140.69 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.93 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.17 134.97 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.321 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 tt -99.76 135.03 41.8 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.774 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 65.38 105.58 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.945 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.02 103.36 0.03 OUTLIER 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.63 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.9 t -95.0 83.84 4.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.28 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.24 -41.71 69.78 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.784 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.488 -0.768 . . . . 0.0 111.14 179.65 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 5.2 ttt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 111.522 0.194 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.0 pp -132.55 135.57 57.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.912 0.387 . . . . 0.0 111.614 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.49 157.03 15.59 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.409 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.724 HG11 ' HB3' ' A' ' 39' ' ' ASN . 13.8 t -131.09 134.28 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.895 0.378 . . . . 0.0 111.328 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.8 HD21 ' CG ' ' A' ' 72' ' ' LYS . 7.9 tt -106.19 108.1 19.44 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.573 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.8 tp -99.04 144.69 27.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.831 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 9.2 ttm -117.81 163.13 16.99 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.133 0.492 . . . . 0.0 111.051 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.33 118.49 30.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.102 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.36 42.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.866 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' ARG . . . . . 0.424 ' HB2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -111.37 24.71 12.5 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.187 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 49.27 38.55 13.85 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.924 0.393 . . . . 0.0 111.371 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -151.7 -173.22 4.45 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.989 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -104.98 131.2 52.79 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.765 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 68.36 166.17 0.25 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.386 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.749 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 69.3 m-85 -79.33 -26.26 42.18 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.377 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.39 28.57 43.53 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.395 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.556 HD13 ' HB3' ' B' ' 98' ' ' TYR . 5.9 mp -105.07 123.49 47.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.722 0.296 . . . . 0.0 110.702 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.47 113.65 27.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.371 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.701 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.9 pt? -109.3 124.86 51.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.459 . . . . 0.0 111.453 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -106.8 -170.2 22.55 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.258 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.6 OUTLIER -134.71 147.54 50.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.882 0.373 . . . . 0.0 111.375 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 21' ' ' SER . 12.9 pt20 -125.34 139.04 54.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.225 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.819 HD13 ' HB2' ' B' ' 145' ' ' ALA . 33.7 mt -88.15 120.42 37.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.963 0.411 . . . . 0.0 111.034 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -124.2 171.58 9.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.083 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' B' ' 123' ' ' LEU . 39.3 t -80.27 95.22 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.92 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -53.18 50.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.112 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -156.21 141.35 17.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.688 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.12 151.04 49.38 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.867 0.365 . . . . 0.0 111.463 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -65.73 143.34 57.59 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.165 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -73.15 148.71 43.62 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.148 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 54.85 32.84 18.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.61 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' B' ' 119' ' ' LYS . . . -96.47 -164.98 33.34 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.323 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.491 HD21 ' OG ' ' A' ' 9' ' ' SER . 8.6 mt -66.36 -37.12 84.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.567 ' HB2' HD21 ' A' ' 17' ' ' LEU . . . -75.1 -33.73 61.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.273 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -33.72 44.47 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.286 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' B' ' 115' ' ' GLY . 12.1 ttmt -64.17 -37.07 86.14 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 111.266 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.99 -30.8 12.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.467 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.82 45.69 63.55 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.2 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.693 ' HB3' HG11 ' A' ' 4' ' ' VAL . 3.3 p30 -81.83 -53.4 6.21 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.695 ' HB3' HG21 ' B' ' 108' ' ' VAL . 10.2 mp -118.5 119.41 34.47 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.68 0.276 . . . . 0.0 110.944 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.17 152.84 22.5 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.619 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -60.5 110.65 1.32 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.169 0.509 . . . . 0.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.55 -15.16 24.69 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.894 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -62.85 135.75 57.49 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 117.245 0.522 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -81.05 108.86 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.103 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.476 ' CD1' HD21 ' A' ' 19' ' ' LEU . 29.3 mt -76.41 152.49 5.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.322 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.548 HD22 ' CD1' ' B' ' 161' ' ' LEU . 13.7 tp -110.7 -31.28 7.26 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.538 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -152.44 147.42 26.23 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.711 0.291 . . . . 0.0 111.066 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 13.5 mt -137.18 117.73 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.452 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' B' ' 156' ' ' LEU . 0.1 OUTLIER 49.4 43.34 23.35 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.515 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.98 18.73 79.32 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.344 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 93.1 m -120.77 144.11 48.46 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.997 0.398 . . . . 0.0 110.28 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 t -74.14 140.07 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.457 . . . . 0.0 111.609 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.545 ' HA ' HD12 ' B' ' 106' ' ' ILE . 52.8 p -93.01 -22.08 19.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.129 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.09 142.35 38.17 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.925 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.5 p30 53.13 10.74 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.811 0.694 . . . . 0.0 112.467 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.656 ' HG2' HD11 ' B' ' 106' ' ' ILE . 0.5 OUTLIER -86.52 144.18 27.36 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.902 0.382 . . . . 0.0 110.808 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.11 144.76 46.87 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.515 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.528 ' O ' HD23 ' B' ' 142' ' ' LEU . 6.2 tt -60.75 -46.0 92.12 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.925 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 9.7 t -55.28 -42.64 73.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -40.9 84.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.617 0.246 . . . . 0.0 110.769 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -61.87 -43.15 99.44 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.037 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -38.13 79.34 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -38.08 82.37 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.779 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 148' ' ' LEU . . . . . 0.514 HD23 ' C ' ' B' ' 148' ' ' LEU . 7.7 tt -59.98 -44.82 94.24 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.649 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.596 HD11 HD22 ' A' ' 19' ' ' LEU . 8.2 mt -67.79 -37.31 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.03 -48.76 62.14 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.0 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -67.44 -24.95 65.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.683 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 22.9 m -75.58 70.39 2.41 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.212 0.53 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -86.5 78.38 9.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.667 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 164.55 -81.89 0.11 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.62 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.756 ' HD2' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -137.0 128.96 29.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.534 0.206 . . . . 0.0 110.628 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.934 HD23 ' CE2' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -127.86 131.78 49.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.948 0.404 . . . . 0.0 111.2 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -91.1 142.56 27.62 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.083 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.995 HD12 HD13 ' A' ' 6' ' ' LEU . 2.3 mt -132.55 134.51 45.05 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.809 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.09 134.0 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.636 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 6.1 m -127.99 152.9 36.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 111.719 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.548 ' CD1' HD22 ' B' ' 130' ' ' LEU . 0.3 OUTLIER -107.58 119.13 38.56 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.826 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.509 ' NH1' HD11 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -99.85 55.13 0.94 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.738 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 2.0 t70 70.35 151.88 0.1 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.263 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 23.1 t -77.56 164.37 25.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.316 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.29 89.84 3.2 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.223 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 C--O 1.252 1.204 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.014 -179.964 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 120.644 0.259 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.8 tp -140.91 121.98 13.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.98 0.419 . . . . 0.0 111.282 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.74 156.6 22.89 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.774 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.586 HG21 ' CB ' ' B' ' 122' ' ' ASN . 22.8 t -132.77 133.39 59.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.702 0.287 . . . . 0.0 111.093 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.5 HD22 ' HD3' ' B' ' 155' ' ' LYS . 0.2 OUTLIER -101.46 111.44 23.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.815 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.648 HD11 ' ND2' ' B' ' 122' ' ' ASN . 10.4 mp -90.6 141.88 28.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.25 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 37.2 ttm -120.05 165.3 14.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.988 0.423 . . . . 0.0 110.9 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -93.33 141.31 28.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.937 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 m -146.43 51.18 1.13 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -155.89 32.32 0.35 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.452 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 52.9 72.14 0.44 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.92 0.39 . . . . 0.0 111.759 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.8 t30 63.24 90.96 0.07 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.347 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -152.95 151.73 30.65 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.246 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -73.81 157.35 36.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.456 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 70.4 m-85 -78.26 -30.89 48.84 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.728 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.453 ' O ' HG23 ' B' ' 112' ' ' THR . . . 80.88 28.34 46.62 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.464 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' B' ' 117' ' ' ALA . 0.3 OUTLIER -101.85 121.39 42.02 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.646 0.26 . . . . 0.0 110.668 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.38 114.04 27.88 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.03 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.997 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.8 pt? -111.44 124.82 53.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.192 0.52 . . . . 0.0 111.763 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.91 -177.56 22.24 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.556 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.26 149.3 47.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.155 0.478 . . . . 0.0 111.058 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -132.87 140.2 47.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.231 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.863 ' HB ' HG22 ' A' ' 54' ' ' THR . 49.4 mt -88.05 120.54 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.003 0.43 . . . . 0.0 110.433 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -119.88 172.91 7.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.912 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.919 HG21 HD13 ' A' ' 40' ' ' LEU . 45.6 t -79.5 92.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.118 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.94 -51.85 59.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.217 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.13 162.6 39.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 36.0 mtp -138.4 156.46 47.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.107 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.622 HG23 ' HA3' ' A' ' 32' ' ' GLY . 3.7 t -69.33 145.32 53.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.693 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -75.52 130.13 38.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.674 0.273 . . . . 0.0 110.944 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.23 28.25 5.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.141 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.622 ' HA3' HG23 ' A' ' 29' ' ' THR . . . -84.5 -163.38 36.2 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.369 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.494 ' C ' HD21 ' B' ' 89' ' ' LEU . 1.6 mt -73.93 -30.19 62.43 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.98 -37.17 61.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.467 0.175 . . . . 0.0 111.409 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.52 -34.05 47.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.153 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -63.97 -36.49 84.12 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.428 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.84 -32.58 11.27 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.362 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.48 47.78 20.63 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.238 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -57.51 -35.15 69.89 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.919 HD13 HG21 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -163.49 163.83 24.61 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.727 0.299 . . . . 0.0 111.025 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.39 150.39 22.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.706 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -61.68 114.4 3.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.12 0.486 . . . . 0.0 111.233 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.93 9.86 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.755 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -60.6 135.85 57.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.919 0.359 . . . . 0.0 110.368 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 pt -75.06 121.82 27.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.895 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.994 HG21 HD11 ' A' ' 49' ' ' ILE . 16.5 mt -88.95 138.14 19.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.118 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.883 HD13 HD22 ' A' ' 78' ' ' LEU . 10.0 tp -97.43 -45.55 6.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.484 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.74 147.93 33.55 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.873 0.368 . . . . 0.0 111.59 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.994 HD11 HG21 ' A' ' 46' ' ' ILE . 22.4 mm -138.61 120.77 17.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.432 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 53.47 41.55 32.09 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.242 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.48 13.0 80.29 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.436 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m -120.97 137.52 54.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.038 0.419 . . . . 0.0 110.431 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.647 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.1 t -57.58 146.11 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.274 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.863 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -123.32 17.74 9.82 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.416 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.647 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -121.59 127.85 51.34 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.29 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 70.88 -4.07 1.83 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.288 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.11 174.63 3.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 111.27 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.92 147.8 25.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.418 HD11 ' OG ' ' B' ' 104' ' ' SER . 2.1 mp -61.9 -48.95 78.16 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.85 -37.98 80.81 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.221 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.19 -47.89 69.55 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.946 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.602 ' CB ' HD13 ' A' ' 23' ' ' ILE . . . -61.94 -40.15 94.54 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.204 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -70.24 -38.41 75.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -38.16 83.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.677 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.44 HD21 HG22 ' A' ' 49' ' ' ILE . 1.2 tp -60.49 -44.36 96.05 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.735 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.708 HD11 HD22 ' B' ' 102' ' ' LEU . 12.3 mt -68.33 -37.57 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.604 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.94 -41.42 78.1 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.641 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -6.7 57.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.72 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.94 56.64 4.02 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 110.862 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.68 78.86 7.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.381 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' B' ' 91' ' ' LYS . . . 162.29 -78.77 0.15 Allowed Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.295 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -136.2 129.87 32.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.774 -0.213 . . . . 0.0 110.787 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.729 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.6 OUTLIER -128.05 126.98 42.32 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.108 0.48 . . . . 0.0 110.871 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 37.4 tt0 -97.83 142.62 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.279 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.74 ' HA ' HD13 ' A' ' 49' ' ' ILE . 0.8 OUTLIER -133.76 124.02 25.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.772 0.32 . . . . 0.0 110.75 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.6 t -109.57 134.6 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.747 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 t -116.29 135.21 57.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.048 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.883 HD22 HD13 ' A' ' 47' ' ' LEU . 5.4 tp -115.32 134.74 54.84 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.25 116.02 28.69 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.465 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.11 155.94 1.18 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.015 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.02 -45.78 89.84 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.121 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.7 mp -73.92 168.81 18.72 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.85 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.451 179.827 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.521 ' C ' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -138.32 122.39 21.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.765 0.317 . . . . 0.0 110.953 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.478 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -114.03 155.48 16.29 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.75 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 25.9 t -129.6 134.33 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 111.088 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.432 ' O ' HD12 ' B' ' 88' ' ' LEU . 0.3 OUTLIER -103.64 122.42 44.98 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.6 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.494 HD21 ' C ' ' A' ' 33' ' ' LEU . 1.3 tp -109.09 124.63 51.09 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.542 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' MET . . . . . 0.487 ' HG3' ' N ' ' B' ' 91' ' ' LYS . 3.7 tpp -100.12 162.85 12.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.072 0.463 . . . . 0.0 110.772 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' LYS . . . . . 0.487 ' N ' ' HG3' ' B' ' 90' ' ' MET . 6.6 pttm -85.81 126.06 33.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.349 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.31 35.61 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.472 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 175.84 114.11 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.708 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 66.52 113.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.737 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -78.01 -168.78 1.36 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.754 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.8 68.27 0.59 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.615 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 63.38 173.76 0.16 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.517 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.729 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 67.4 m-85 -76.26 -25.55 55.07 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.517 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.436 ' HA3' ' HB ' ' A' ' 29' ' ' THR . . . 93.62 20.2 32.53 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.458 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.625 ' CD2' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -101.78 118.21 36.46 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.651 0.262 . . . . 0.0 110.708 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -92.07 113.26 25.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.949 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.708 HD22 HD11 ' A' ' 66' ' ' ILE . 5.2 mp -96.34 124.93 40.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 110.922 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.91 171.9 13.94 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.822 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.418 ' OG ' HD11 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -136.71 145.07 44.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.835 0.35 . . . . 0.0 110.891 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -130.44 139.71 50.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.274 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.845 HD13 ' HB2' ' B' ' 145' ' ' ALA . 1.9 mt -88.3 120.64 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.069 0.461 . . . . 0.0 110.238 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.419 ' CE2' ' HD3' ' B' ' 109' ' ' LYS . 40.1 p90 -119.62 172.58 7.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.928 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.601 HG21 ' HB3' ' B' ' 123' ' ' LEU . 27.7 t -81.36 97.62 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.013 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' LYS . . . . . 0.419 ' HD3' ' CE2' ' B' ' 107' ' ' PHE . 0.5 OUTLIER -67.57 -50.58 57.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.717 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -167.48 143.61 4.17 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.805 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.463 ' SD ' HG11 ' B' ' 108' ' ' VAL . 0.0 OUTLIER -127.68 159.53 34.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.795 0.331 . . . . 0.0 111.119 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 16' ' ' GLY . 64.2 p -75.75 124.63 27.61 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.435 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.64 156.77 15.92 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.967 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.68 34.79 17.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.299 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.11 -175.54 20.26 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.913 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.84 -35.6 80.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.57 0.224 . . . . 0.0 111.559 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.499 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -74.95 -34.82 62.1 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.26 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -34.1 44.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.13 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.47 -35.41 80.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.199 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -100.07 -27.95 13.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.648 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 65.8 57.39 11.09 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.094 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.648 ' ND2' HD11 ' A' ' 6' ' ' LEU . 1.5 p30 -94.82 -33.63 12.79 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.705 HD11 HD13 ' B' ' 158' ' ' LEU . 47.9 mt -122.36 135.96 54.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.636 0.255 . . . . 0.0 111.55 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 142.93 34.22 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.581 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -56.68 111.39 1.0 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 111.249 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.32 -16.47 24.6 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.266 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -60.47 135.8 57.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.332 0.566 . . . . 0.0 110.64 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 pt -79.82 111.01 16.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.751 ' HB ' HG21 ' B' ' 137' ' ' THR . 59.4 mt -72.48 140.96 17.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.108 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.416 HD13 ' CD1' ' B' ' 161' ' ' LEU . 1.1 tp -98.0 -45.14 6.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.114 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -148.84 147.8 29.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.911 0.386 . . . . 0.0 111.477 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.408 HG13 ' OG1' ' B' ' 137' ' ' THR . 13.9 mt -134.01 123.87 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.264 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' ASN . . . . . 0.585 ' HB2' HD21 ' B' ' 148' ' ' LEU . 6.0 m120 54.86 33.49 19.97 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.687 0.279 . . . . 0.0 111.182 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.65 17.55 77.28 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.92 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 6.8 m -120.66 143.85 48.49 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.8 0.3 . . . . 0.0 110.341 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.432 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.2 t -59.46 144.26 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.199 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.751 HG21 ' HB ' ' B' ' 129' ' ' ILE . 2.9 m -117.23 21.56 13.07 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.603 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.432 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.8 OUTLIER -115.87 129.38 56.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.487 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 m120 71.42 -5.23 1.65 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.361 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.739 ' HB3' HD11 ' B' ' 106' ' ' ILE . 4.8 ttt -68.37 150.72 47.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.812 0.339 . . . . 0.0 110.826 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 51.1 m -71.78 144.22 49.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.307 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.75 -46.03 92.01 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.06 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 4.4 t -58.04 -38.89 77.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.107 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.03 -42.85 84.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.803 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.997 ' HB1' HD11 ' A' ' 19' ' ' LEU . . . -60.47 -42.42 96.18 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.086 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -67.94 -39.46 83.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.318 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -37.86 86.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' B' ' 133' ' ' ASN . 6.9 tt -59.85 -45.27 92.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.735 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.6 HD12 HD22 ' A' ' 19' ' ' LEU . 46.3 mt -68.42 -37.01 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.773 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.41 -46.3 70.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -65.49 -26.91 68.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.292 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 20.7 p -87.17 74.89 9.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.194 0.521 . . . . 0.0 111.052 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.93 51.98 2.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.708 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -164.39 -83.36 0.05 OUTLIER Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.465 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.5 ' HD3' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -124.54 126.88 46.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.685 0.278 . . . . 0.0 110.424 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.772 HD21 HD11 ' B' ' 158' ' ' LEU . 0.0 OUTLIER -129.81 143.07 50.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.46 -179.176 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -109.09 138.61 45.16 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.487 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.772 HD11 HD21 ' B' ' 156' ' ' LEU . 0.6 OUTLIER -133.36 127.31 33.21 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.762 0.315 . . . . 0.0 111.04 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.93 139.93 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.578 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.442 HG21 ' CD2' ' B' ' 123' ' ' LEU . 22.3 t -135.74 154.9 35.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.35 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.416 ' CD1' HD13 ' B' ' 130' ' ' LEU . 0.2 OUTLIER -121.69 116.56 24.77 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.759 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 45.6 ptt85 -122.59 131.77 53.98 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.65 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -47.96 133.15 14.87 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.408 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.54 158.33 34.1 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.092 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.06 110.23 13.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.32 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.007 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 mtt . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp -144.55 141.69 23.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 120.648 0.261 . . . . 0.0 111.147 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -109.97 161.75 12.88 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.575 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.725 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.6 t -127.33 134.62 65.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.818 0.342 . . . . 0.0 111.277 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 mt -98.03 123.47 42.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.979 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.73 137.42 51.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.503 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.683 ' O ' HD13 ' B' ' 116' ' ' LEU . 3.9 ttt -109.67 164.87 12.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.53 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.81 119.1 25.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.116 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.696 ' HB2' HD11 ' B' ' 116' ' ' LEU . 5.0 m -151.28 115.92 5.15 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.48 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 59.72 51.67 6.07 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.071 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 14' ' ' GLU . . . -119.49 99.29 6.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.77 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -60.66 -35.19 75.63 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.233 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.47 90.69 1.74 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.813 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.484 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 30.5 tt0 66.77 174.59 0.25 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.053 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.748 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 57.5 m-85 -60.37 -27.26 67.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.865 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.87 18.58 43.41 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.707 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.677 HD21 ' CB ' ' B' ' 117' ' ' ALA . 8.7 mp -108.02 119.07 38.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.723 0.297 . . . . 0.0 110.73 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.2 113.44 25.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.192 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.854 HD22 HD11 ' B' ' 149' ' ' ILE . 1.5 mp -92.94 124.9 37.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.262 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.6 -169.59 21.85 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.615 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.6 148.54 32.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.934 0.367 . . . . 0.0 111.367 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.26 133.13 45.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.878 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.768 ' HB ' HG22 ' A' ' 54' ' ' THR . 53.9 mt -87.76 120.28 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 0.0 110.542 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -124.83 173.22 8.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.207 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 40' ' ' LEU . 39.8 t -83.33 100.5 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.659 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -47.71 53.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.613 0.244 . . . . 0.0 111.044 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -161.69 144.64 12.11 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.592 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -130.35 155.75 45.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 111.333 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.0 t -65.35 144.71 56.92 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.975 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.0 tpt85 -79.72 148.6 31.47 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.2 30.57 19.98 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.486 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.58 -170.98 27.93 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.108 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.562 HD22 ' O ' ' B' ' 90' ' ' MET . 0.1 OUTLIER -68.52 -32.66 72.77 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.642 0.221 . . . . 0.0 111.585 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.994 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -73.99 -35.42 64.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.07 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.29 -33.99 42.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.241 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.59 -37.55 86.69 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.165 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.94 -26.61 13.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.452 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.7 38.75 93.41 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.986 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.701 ' HB3' HG11 ' B' ' 87' ' ' VAL . 3.6 p30 -68.87 -46.85 67.4 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.459 0.17 . . . . 0.0 111.459 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.692 ' CD1' HD22 ' A' ' 75' ' ' LEU . 57.8 mt -116.62 129.3 56.08 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.717 0.294 . . . . 0.0 111.125 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.78 150.49 21.78 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.426 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -60.37 110.88 1.36 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.095 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.5 -15.43 17.47 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.153 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -64.19 132.79 51.39 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 117.268 0.534 . . . . 0.0 110.425 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.5 pt -79.9 112.74 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.83 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.452 ' HA ' HG12 ' A' ' 77' ' ' VAL . 19.6 mt -78.01 134.28 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.98 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 tp -91.72 -45.49 8.41 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.706 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -148.92 149.84 31.9 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.801 0.334 . . . . 0.0 111.68 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 23.0 mt -138.02 119.99 18.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.621 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 55.7 36.48 27.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.314 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.33 2.46 90.6 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.6 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -111.91 134.89 53.19 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.295 0.547 . . . . 0.0 110.411 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.2 t -57.88 146.81 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.268 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.768 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -120.39 23.6 10.79 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.373 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.56 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -116.81 139.18 50.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.438 ' HB2' ' CD1' ' B' ' 142' ' ' LEU . 11.9 p30 53.68 9.22 0.18 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.614 0.571 . . . . 0.0 112.22 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.513 ' HB3' HD11 ' A' ' 23' ' ' ILE . 14.2 tpp -82.95 159.82 22.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.779 0.323 . . . . 0.0 110.734 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.506 ' N ' ' HG3' ' A' ' 57' ' ' MET . 0.1 OUTLIER -72.77 138.1 46.26 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.194 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.0 -47.23 81.34 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.097 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.0 p -58.1 -41.28 83.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.189 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.25 -47.78 84.46 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.019 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.6 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -59.64 -40.81 88.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.981 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.19 -40.5 94.31 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.709 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -65.32 -38.74 91.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.905 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.3 tt -60.06 -43.92 95.06 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.942 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.487 ' CD1' HD22 ' B' ' 102' ' ' LEU . 57.0 mt -68.46 -37.11 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.809 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.7 -49.28 69.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.902 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.0 pttt -64.1 -23.5 67.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.27 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.7 m -81.36 66.99 7.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.098 0.475 . . . . 0.0 110.431 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.95 64.27 8.03 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.008 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.91 -76.29 0.07 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.588 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.82 129.61 32.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.274 . . . . 0.0 110.629 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.849 HD23 ' CE1' ' B' ' 98' ' ' TYR . 0.4 OUTLIER -129.82 136.82 50.02 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 26.6 mt-30 -98.32 143.08 29.17 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.719 HD13 HD13 ' B' ' 89' ' ' LEU . 1.9 mp -135.75 128.79 31.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.043 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.84 144.21 25.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.695 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 46' ' ' ILE . 10.6 m -141.57 167.67 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.957 0.408 . . . . 0.0 111.595 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.58 122.94 33.83 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.916 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.31 115.67 4.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.591 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 58.72 88.48 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.403 0.439 . . . . 0.0 111.206 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 p -76.78 -72.07 0.36 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.408 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.52 -61.84 1.64 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.95 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.872 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.84 148.52 31.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-O 120.595 0.236 . . . . 0.0 111.008 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.4 159.6 25.3 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.929 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.701 HG11 ' HB3' ' A' ' 39' ' ' ASN . 9.1 t -130.06 135.16 61.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.681 0.276 . . . . 0.0 111.078 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.51 114.08 25.81 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.792 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.719 HD13 HD13 ' A' ' 75' ' ' LEU . 10.9 mp -100.35 137.85 38.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.642 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' MET . . . . . 0.562 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -110.21 170.42 8.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.379 0.609 . . . . 0.0 111.47 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -87.28 144.88 26.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.375 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 94.9 p -141.63 27.91 1.83 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.841 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.69 84.88 0.14 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.96 0.409 . . . . 0.0 111.202 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.76 85.01 1.68 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.989 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 57.82 29.16 17.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.248 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.84 48.65 10.91 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.091 0.472 . . . . 0.0 111.232 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -179.27 176.64 0.83 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.187 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.849 ' CE1' HD23 ' A' ' 73' ' ' LEU . 52.1 m-85 -88.1 -26.74 22.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.955 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.42 14.05 72.03 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.618 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.994 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -97.55 122.22 40.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 110.522 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.85 113.72 27.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.267 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.6 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.8 pt? -107.84 125.01 50.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.082 0.468 . . . . 0.0 111.329 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -104.33 -163.05 24.54 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.067 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.32 146.51 30.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.696 0.248 . . . . 0.0 111.162 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.475 ' NE2' HG21 ' B' ' 128' ' ' ILE . 6.1 pt20 -127.14 137.14 52.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.026 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 1.081 HD13 ' HB2' ' B' ' 145' ' ' ALA . 28.4 mt -88.18 120.42 37.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.591 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.466 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 47.4 p90 -123.88 172.55 8.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.988 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.602 HG21 ' HB3' ' B' ' 123' ' ' LEU . 96.6 t -85.16 98.55 6.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.924 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' LYS . . . . . 0.466 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -68.3 -57.57 5.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.416 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.08 139.84 23.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.743 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 6.1 ptt? -131.07 152.84 49.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 111.626 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 p -72.82 142.28 48.02 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.261 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -78.24 154.92 30.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.963 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.1 m 62.9 34.6 14.09 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.68 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.11 -175.28 20.23 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.96 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.696 HD11 ' HB2' ' A' ' 9' ' ' SER . 0.2 OUTLIER -67.24 -32.54 73.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.669 0.234 . . . . 0.0 111.625 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.677 ' CB ' HD21 ' A' ' 17' ' ' LEU . . . -74.93 -37.92 61.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.657 0.265 . . . . 0.0 111.021 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.0 -33.71 44.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.246 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -58.68 -39.79 81.7 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.315 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.38 -31.71 9.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.544 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 49.28 11.01 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.434 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.725 ' HB3' HG11 ' A' ' 4' ' ' VAL . 14.4 p-10 -78.73 -44.05 24.34 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.764 ' CD1' HD13 ' B' ' 158' ' ' LEU . 85.1 mt -111.62 118.57 36.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.609 0.242 . . . . 0.0 110.993 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 131.44 34.64 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.252 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -48.14 109.49 0.24 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.083 0.468 . . . . 0.0 111.382 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 108.15 -1.99 33.25 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.344 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -70.83 135.61 48.2 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.456 0.628 . . . . 0.0 111.468 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.475 HG21 ' NE2' ' B' ' 105' ' ' GLN . 1.5 pt -79.95 107.47 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.592 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.642 ' CD1' HD21 ' A' ' 19' ' ' LEU . 42.7 mt -75.76 147.56 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.342 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.702 HD13 HD13 ' B' ' 161' ' ' LEU . 2.3 tp -110.21 -42.45 4.16 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.607 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -144.0 148.19 34.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.747 0.308 . . . . 0.0 111.387 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 34.8 mt -138.81 118.23 14.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.765 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 4.0 m120 52.37 48.01 23.53 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.36 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.23 16.66 67.2 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.201 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 46.2 m -120.83 140.48 51.69 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.811 0.305 . . . . 0.0 110.293 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.612 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.3 t -62.36 147.53 11.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.001 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.701 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -125.84 19.51 7.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.464 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.612 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.4 tt0 -111.95 133.95 53.81 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 72.51 -9.2 1.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.514 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.677 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.1 OUTLIER -66.34 169.59 7.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.96 0.409 . . . . 0.0 111.228 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 30.7 t -90.77 148.71 22.38 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.994 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.438 ' CD1' ' HB2' ' A' ' 56' ' ' ASN . 5.2 tt -58.1 -48.95 78.61 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.369 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 64.6 p -58.62 -39.75 81.37 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.709 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -46.39 85.04 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 1.081 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.73 -43.19 90.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -66.46 -39.49 88.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.443 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -42.16 98.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.984 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 tp -61.56 -43.18 99.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.454 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.854 HD11 HD22 ' A' ' 19' ' ' LEU . 12.0 mt -68.73 -37.54 77.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.727 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.55 -49.51 73.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.003 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -64.83 -24.27 67.49 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.366 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.6 m -79.44 70.0 5.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.924 0.393 . . . . 0.0 110.956 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.42 60.19 6.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.547 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.19 -82.76 0.05 OUTLIER Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.498 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -132.77 131.54 41.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.569 0.224 . . . . 0.0 110.489 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.748 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -128.56 137.11 51.56 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.06 0.457 . . . . 0.0 111.275 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 24.8 tt0 -101.92 140.49 36.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.395 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.764 HD13 ' CD1' ' B' ' 123' ' ' LEU . 1.0 OUTLIER -135.78 129.42 32.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.874 0.368 . . . . 0.0 111.091 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.403 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 13.3 t -113.99 132.17 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.707 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -129.36 165.83 28.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.551 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.702 HD13 HD13 ' B' ' 130' ' ' LEU . 1.1 mp -116.71 131.66 56.89 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.983 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.44 40.08 2.06 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.016 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 23.9 t70 67.54 153.58 0.09 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.236 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 23.2 t -94.49 -66.37 0.92 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.811 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 5.6 mt -153.73 -55.03 0.11 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.756 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.773 179.944 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mmt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.635 0.255 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 pp -132.6 158.39 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.773 0.32 . . . . 0.0 111.17 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -127.15 158.05 20.91 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.761 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.1 134.37 62.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.587 0.232 . . . . 0.0 111.029 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.93 107.35 18.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 tp -108.19 123.96 49.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.478 ' HB3' ' HB3' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -104.0 150.97 23.76 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.925 0.393 . . . . 0.0 111.341 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.54 ' HA ' HD13 ' B' ' 116' ' ' LEU . 0.1 OUTLIER -99.37 136.31 39.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.248 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -160.58 62.78 0.31 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.182 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.36 27.75 0.35 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 48.92 71.87 0.34 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -145.62 161.13 40.54 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.311 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -94.68 110.0 21.88 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.444 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 67.54 161.22 0.17 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.094 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.712 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 59.3 m-85 -72.27 -15.83 61.91 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.468 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.66 25.97 48.09 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.511 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.807 HD21 HD11 ' B' ' 123' ' ' LEU . 0.4 OUTLIER -106.05 117.69 34.68 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.579 0.228 . . . . 0.0 110.9 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.413 ' HB2' ' HG2' ' B' ' 110' ' ' GLU . 6.3 mtt85 -97.02 113.34 24.87 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.411 HD21 HG13 ' B' ' 129' ' ' ILE . 7.7 mp -102.06 124.93 48.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.183 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -103.42 -164.68 25.45 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.752 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.9 OUTLIER -147.0 147.96 31.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.023 0.411 . . . . 0.0 111.281 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -131.82 137.38 48.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.124 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.85 HD13 ' HB2' ' A' ' 62' ' ' ALA . 64.3 mt -87.89 120.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.619 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.471 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 45.2 p90 -124.91 172.11 9.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.339 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.756 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.3 t -83.0 100.21 6.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.89 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.471 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 1.2 tptp -68.05 -57.5 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.235 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -159.59 134.37 7.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.651 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -114.15 156.75 23.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.01 0.434 . . . . 0.0 111.299 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -65.55 138.21 57.9 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 148.64 47.93 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.917 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.87 31.82 21.07 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.53 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.08 -154.84 30.16 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.411 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.564 HD22 ' O ' ' B' ' 90' ' ' MET . 1.2 mt -85.54 -31.75 22.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.547 0.213 . . . . 0.0 111.455 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.819 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -75.21 -34.93 61.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.118 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.99 -33.81 44.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.988 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -38.6 83.93 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.358 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -103.16 -32.73 9.5 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.513 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.58 49.88 13.29 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.395 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.619 ' HB3' HG11 ' B' ' 87' ' ' VAL . 7.9 p-10 -82.82 -47.68 11.63 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.756 ' HB3' HG21 ' A' ' 25' ' ' VAL . 17.6 mt -105.95 128.45 53.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 111.147 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.41 133.36 38.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.543 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -54.96 110.44 0.66 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.191 0.519 . . . . 0.0 111.168 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.43 -7.91 28.45 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.816 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -73.37 135.67 44.31 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.244 0.545 . . . . 0.0 111.047 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.4 pt -74.38 114.59 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.543 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.0 mt -80.63 138.84 19.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.212 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.582 HD12 HD13 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -95.79 -46.99 6.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.535 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.4 OUTLIER -150.5 148.19 28.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.8 0.333 . . . . 0.0 111.567 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 43.5 mt -137.04 118.36 18.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.78 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 55.95 45.06 24.62 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.152 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.41 15.26 70.22 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.355 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.9 m -120.81 137.08 54.72 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.935 0.368 . . . . 0.0 110.474 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.603 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.2 t -60.42 147.18 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.294 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.806 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -125.2 21.76 7.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.534 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.603 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -117.45 129.73 56.01 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.9 m120 70.5 -3.84 1.79 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.354 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.712 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -68.69 173.15 5.42 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.831 0.348 . . . . 0.0 111.162 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.74 139.72 30.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.99 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' B' ' 139' ' ' ASN . 5.6 tt -56.35 -42.24 77.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.527 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.4 m -65.15 -37.21 86.7 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.004 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -44.81 78.67 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.637 0.256 . . . . 0.0 110.839 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 1.001 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -59.72 -41.8 91.66 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.496 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.0 ptt85 -71.65 -35.85 70.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.714 0.292 . . . . 0.0 110.711 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.2 -38.62 82.15 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.664 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -44.96 93.5 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.773 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.584 HD12 HD22 ' B' ' 102' ' ' LEU . 59.3 mt -68.32 -36.8 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.08 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -48.78 63.78 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.742 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -29.16 70.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.146 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.2 m -84.31 85.39 7.38 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.842 0.353 . . . . 0.0 111.035 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.81 113.12 25.1 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.61 -89.07 0.24 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.593 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.84 131.85 53.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.662 0.268 . . . . 0.0 110.655 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.758 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.4 OUTLIER -129.53 138.5 51.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.961 0.41 . . . . 0.0 111.323 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.7 tt0 -101.65 138.95 37.96 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.673 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.71 HD13 HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -133.64 125.12 28.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.949 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.66 146.55 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.52 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.443 HG22 ' O ' ' B' ' 85' ' ' ILE . 32.7 m -121.21 140.51 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.278 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.582 HD13 HD12 ' A' ' 47' ' ' LEU . 21.2 tp -84.15 131.96 34.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.911 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 63.09 -174.25 0.15 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.39 76.44 0.32 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.933 0.397 . . . . 0.0 111.328 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.9 t -168.05 121.02 0.88 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.86 -64.01 0.68 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.93 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.49 -0.767 . . . . 0.0 111.186 -179.941 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 1.9 tmt? . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 120.724 0.297 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.443 ' O ' HG22 ' A' ' 77' ' ' VAL . 10.3 tt -147.52 147.82 17.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.006 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.17 157.37 25.47 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.732 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 39' ' ' ASN . 21.5 t -131.08 132.65 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.79 0.328 . . . . 0.0 111.096 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.426 HD12 ' HG3' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -97.84 107.07 19.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.417 HD21 ' N ' ' A' ' 34' ' ' ALA . 2.2 tp -91.26 141.55 28.67 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.513 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' MET . . . . . 0.564 ' O ' HD22 ' A' ' 33' ' ' LEU . 9.4 tpp -118.44 163.15 17.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.695 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' LYS . . . . . 0.498 ' N ' ' HG3' ' B' ' 90' ' ' MET . 7.2 pttt -83.16 134.26 34.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.144 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 7.9 m -150.3 112.53 4.64 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.177 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 68.18 119.76 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.517 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 66.5 104.63 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.489 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -87.28 51.89 2.36 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 111.477 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -109.71 53.64 0.68 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.229 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 65.43 162.98 0.15 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.519 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.758 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 60.2 m-85 -68.28 -23.74 64.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.455 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.09 20.28 73.16 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.46 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -98.06 117.05 31.54 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.664 0.268 . . . . 0.0 110.605 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.23 113.4 25.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.101 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 1.001 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.8 pt? -110.6 124.84 52.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.125 0.488 . . . . 0.0 111.07 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -111.05 -164.04 18.33 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.243 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.58 148.91 40.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.706 0.288 . . . . 0.0 111.078 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 21' ' ' SER . 1.8 pt20 -127.65 136.73 52.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.135 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.783 HD13 ' HB2' ' B' ' 145' ' ' ALA . 42.1 mt -87.78 120.2 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.345 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -122.97 172.98 8.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.121 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.964 HG21 HD13 ' B' ' 123' ' ' LEU . 33.2 t -81.59 95.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.044 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -43.97 88.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.143 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -168.93 140.43 2.52 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.839 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.578 ' SD ' HG23 ' B' ' 118' ' ' THR . 0.2 OUTLIER -126.46 161.09 28.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.891 0.377 . . . . 0.0 111.434 -179.772 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 18.8 p -77.09 122.77 25.44 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.208 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -64.64 150.33 47.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.963 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m 62.63 32.76 16.17 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.31 -166.48 24.73 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.128 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.54 HD13 ' HA ' ' A' ' 8' ' ' LYS . 4.4 mt -75.45 -30.99 60.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.647 0.224 . . . . 0.0 111.417 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.72 -34.4 62.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.17 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.578 HG23 ' SD ' ' B' ' 111' ' ' MET . 0.1 OUTLIER -78.77 -33.96 45.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.084 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.84 -37.71 87.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.336 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.08 -31.66 12.02 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.663 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.61 51.37 7.28 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.345 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -66.56 -35.58 80.57 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.964 HD13 HG21 ' B' ' 108' ' ' VAL . 0.5 OUTLIER -154.27 164.19 38.95 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.804 0.335 . . . . 0.0 111.11 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 148.33 30.79 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.882 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -56.16 112.3 1.18 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.103 0.478 . . . . 0.0 110.981 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.2 -16.67 22.33 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.965 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -61.79 138.81 58.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.071 0.462 . . . . 0.0 111.222 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.424 ' O ' HG13 ' B' ' 128' ' ' ILE . 44.3 pt -78.56 124.9 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.794 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.418 HD11 HD22 ' B' ' 123' ' ' LEU . 33.2 mm -90.91 131.69 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.543 HD13 HD13 ' B' ' 161' ' ' LEU . 15.9 tp -94.89 -44.01 7.93 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.563 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -148.62 152.69 37.18 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.424 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 35.5 mt -141.11 118.24 8.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.573 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 55.79 38.74 30.43 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.15 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.04 2.08 88.37 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.517 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 47.8 m -109.69 131.65 54.86 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 117.054 0.427 . . . . 0.0 110.349 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.625 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.2 t -58.47 146.95 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.696 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -120.93 18.91 11.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.675 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.625 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.1 OUTLIER -109.42 130.2 55.51 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.224 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.473 ' HB3' HD13 ' A' ' 59' ' ' LEU . 5.1 m-80 71.6 -6.11 1.49 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.375 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.606 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -65.61 168.5 7.44 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.909 0.385 . . . . 0.0 111.1 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 14.5 t -89.37 149.44 22.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.167 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -47.11 87.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.633 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 12.0 p -60.21 -37.22 79.61 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.17 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.1 -41.47 67.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.606 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.783 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -63.5 -41.82 98.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.256 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 146' ' ' ARG . . . . . 0.468 ' HA ' HD12 ' B' ' 149' ' ' ILE . 0.0 OUTLIER -71.3 -36.47 71.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.661 0.267 . . . . 0.0 110.482 179.515 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -68.02 -38.35 82.46 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.526 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' LEU . . . . . 0.428 HD13 ' O ' ' B' ' 148' ' ' LEU . 0.4 OUTLIER -59.79 -44.38 93.96 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' B' ' 146' ' ' ARG . 7.9 mt -65.95 -38.34 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.713 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -68.71 -49.62 57.39 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.777 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -25.64 68.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.2 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 6.0 m -81.28 63.74 5.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.907 0.385 . . . . 0.0 110.502 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -76.71 121.99 24.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.95 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 120.1 -83.7 0.36 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.31 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 7' ' ' MET . 0.0 OUTLIER -132.75 130.35 39.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.722 0.296 . . . . 0.0 110.687 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.712 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.94 134.14 48.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.111 0.481 . . . . 0.0 111.156 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.6 tm0? -93.21 141.21 28.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.258 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.33 123.73 24.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.704 0.288 . . . . 0.0 110.678 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.453 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 32.6 t -107.88 135.85 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.291 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.28 141.51 43.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.771 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.543 HD13 HD13 ' B' ' 130' ' ' LEU . 0.7 OUTLIER -106.66 116.7 32.38 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.967 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.0 127.96 3.6 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.715 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.0 167.63 0.18 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.436 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.04 -62.9 1.28 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.754 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 2.1 mt 64.47 106.86 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.566 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.86 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 mmt . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.479 0.181 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.37 148.15 33.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.959 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.3 158.85 23.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.728 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.3 t -129.85 134.89 62.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 110.848 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.99 113.09 26.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.754 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.2 tp -99.69 144.88 28.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.77 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.656 ' O ' HD22 ' B' ' 116' ' ' LEU . 3.0 ttt -112.78 164.08 13.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.147 0.499 . . . . 0.0 110.793 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -99.41 129.93 45.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.195 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.44 179.93 5.24 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.991 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -76.03 72.07 2.84 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.897 0.38 . . . . 0.0 111.05 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.81 96.05 0.13 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.029 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 67.16 133.89 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.316 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.42 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 2.2 mt-10 -77.34 59.67 1.87 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.092 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -170.45 175.36 4.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.11 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.781 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 72.8 m-85 -104.54 -30.94 9.69 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.355 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.24 25.39 44.14 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.527 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' B' ' 117' ' ' ALA . 1.0 OUTLIER -104.78 122.01 44.83 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -102.44 113.42 26.74 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.15 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.798 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.7 pt? -108.96 124.98 51.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.111 0.481 . . . . 0.0 111.646 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -106.66 -162.48 22.32 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.855 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.66 149.33 35.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' B' ' 104' ' ' SER . 12.1 pt20 -129.67 136.15 49.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.011 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.667 ' HB ' HG22 ' A' ' 54' ' ' THR . 38.8 mt -88.01 120.69 37.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.0 110.631 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -121.97 173.38 7.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.177 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.43 HG21 HD22 ' A' ' 40' ' ' LEU . 40.4 t -79.93 98.18 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.611 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -55.68 10.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.121 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -162.4 145.0 11.15 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 32.0 mtm -119.57 149.54 41.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.955 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 p -65.55 148.98 50.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -75.13 151.66 38.56 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.817 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.47 34.47 20.46 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.633 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.94 172.59 18.29 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.753 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -29.65 69.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.598 ' N ' HD21 ' B' ' 89' ' ' LEU . . . -74.76 -39.55 61.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.205 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.97 -33.71 44.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.115 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -39.77 79.26 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.386 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -106.9 -27.54 10.64 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.558 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.87 59.03 7.99 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.418 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.881 ' CB ' HG11 ' B' ' 87' ' ' VAL . 5.5 m120 -88.62 -33.82 17.5 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.6 0.2 . . . . 0.0 111.328 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.578 ' CD1' HD22 ' A' ' 75' ' ' LEU . 4.4 mt -111.82 134.78 53.17 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.144 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.1 132.71 43.4 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.751 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -57.18 113.48 1.74 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.11 0.481 . . . . 0.0 111.27 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.22 -18.93 13.64 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.793 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -62.37 137.2 58.21 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.879 0.371 . . . . 0.0 110.512 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.4 pt -76.39 128.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.916 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.467 HG22 ' OG1' ' A' ' 54' ' ' THR . 17.0 mt -95.45 137.39 23.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.872 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.4 tp -103.72 -36.67 7.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.444 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -148.25 147.85 29.82 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.896 0.379 . . . . 0.0 111.547 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 35.8 mt -142.27 117.58 5.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.957 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.0 t30 51.3 29.47 5.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.369 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.84 -10.83 64.4 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.615 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -103.67 124.79 49.5 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 117.329 0.565 . . . . 0.0 110.845 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.747 HG22 ' H ' ' A' ' 55' ' ' GLU . 2.4 p -56.97 149.61 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.147 0.499 . . . . 0.0 110.941 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -118.59 31.15 6.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.511 -178.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.747 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -127.6 128.52 45.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 71.02 -5.82 1.43 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.299 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ttt -78.14 156.06 30.13 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.837 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -71.94 138.72 48.3 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.459 HD11 ' HA2' ' B' ' 103' ' ' GLY . 0.7 OUTLIER -58.08 -45.04 87.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.195 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.9 p -59.31 -44.92 92.5 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.141 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.16 -47.19 87.35 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.07 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.714 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -61.6 -40.38 94.59 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.87 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.459 ' HA ' HD12 ' A' ' 66' ' ' ILE . 51.6 mtp85 -64.4 -40.57 96.04 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.948 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -65.76 -38.53 89.32 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.813 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 65' ' ' LEU . 1.3 tm? -59.93 -44.23 94.47 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.751 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 63' ' ' ARG . 4.8 mt -68.18 -37.02 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -63.19 -49.33 74.68 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.829 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -69.59 -26.84 64.65 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.352 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -76.13 68.82 2.62 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.056 0.455 . . . . 0.0 110.879 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -87.42 99.47 12.03 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.546 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.13 -82.87 0.17 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.631 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.25 130.65 37.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.627 0.251 . . . . 0.0 110.566 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.746 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.7 OUTLIER -129.59 140.7 51.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.423 . . . . 0.0 111.219 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.9 tt0 -109.87 140.24 44.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.597 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.578 HD22 ' CD1' ' A' ' 40' ' ' LEU . 1.5 mp -130.24 126.44 37.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.605 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.4 t -115.51 133.59 61.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.05 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -122.78 165.8 18.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.249 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 tt -104.82 124.08 48.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.675 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.86 -173.81 0.14 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.789 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 66.04 107.4 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.153 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.63 -60.02 0.89 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.028 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.12 -55.66 2.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.757 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--O 1.253 1.237 0 CA-C-O 118.608 -0.711 . . . . 0.0 111.145 179.789 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.478 0.18 . . . . 0.0 111.393 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.668 HD13 ' N ' ' B' ' 86' ' ' GLY . 0.0 OUTLIER -117.06 140.72 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.026 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.668 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -142.79 157.6 26.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.835 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.881 HG11 ' CB ' ' A' ' 39' ' ' ASN . 16.9 t -122.92 135.24 63.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.659 0.266 . . . . 0.0 111.096 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.431 ' O ' HD12 ' B' ' 88' ' ' LEU . 0.4 OUTLIER -104.87 127.47 52.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.511 179.468 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.598 HD21 ' N ' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -111.52 144.57 40.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.775 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 4.1 ttt -111.28 163.68 13.7 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -98.72 130.47 45.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.855 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 7.5 t -107.56 111.89 24.37 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.839 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 45.8 ttt-85 70.24 134.33 0.03 OUTLIER 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.474 0.484 . . . . 0.0 110.63 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.97 72.34 0.57 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.36 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.72 120.33 3.08 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.475 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 67.33 148.8 0.05 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.534 0.521 . . . . 0.0 111.719 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.36 -178.54 7.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.658 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.746 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 43.0 m-85 -55.75 -30.52 61.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.548 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.5 19.51 77.99 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.554 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -93.2 118.48 31.29 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.57 113.36 26.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.211 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.714 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.7 pt? -105.12 124.94 50.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' GLY . . . . . 0.459 ' HA2' HD11 ' A' ' 59' ' ' LEU . . . -108.46 -177.36 21.89 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.972 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.438 ' OG ' HD12 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -139.06 148.62 43.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.857 0.361 . . . . 0.0 111.193 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -129.1 139.91 51.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.78 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.943 HD13 ' HB2' ' B' ' 145' ' ' ALA . 35.6 mt -88.13 121.66 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 110.828 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.485 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 44.7 p90 -124.29 170.57 10.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.204 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.74 98.28 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.139 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' LYS . . . . . 0.485 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -66.24 -56.36 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.259 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -153.48 142.0 20.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.654 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -130.7 158.61 39.61 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.832 0.348 . . . . 0.0 111.308 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 89.9 m -65.28 134.87 54.55 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.974 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.93 149.7 44.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.8 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.78 30.39 18.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.461 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.83 -171.61 32.89 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.1 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.656 HD22 ' O ' ' A' ' 7' ' ' MET . 1.3 mp -68.11 -32.51 72.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.499 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -74.94 -38.65 61.69 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.547 0.213 . . . . 0.0 111.349 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -33.52 45.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.18 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -60.81 -39.04 87.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.026 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.08 -31.63 11.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.375 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.57 45.79 21.64 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.45 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.65 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.4 p-10 -77.68 -39.5 44.59 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.449 ' CD1' HD13 ' B' ' 158' ' ' LEU . 78.6 mt -122.59 127.2 49.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.778 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.99 131.28 38.12 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -48.11 110.77 0.36 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.009 0.433 . . . . 0.0 111.255 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.95 -5.71 30.73 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.452 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -68.3 136.47 53.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.264 0.532 . . . . 0.0 111.396 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -79.0 101.28 4.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.271 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.748 HG21 HD11 ' B' ' 132' ' ' ILE . 7.7 mt -64.68 148.38 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.02 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 tt -111.12 -44.53 3.56 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.616 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -151.6 148.05 27.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.79 0.329 . . . . 0.0 111.687 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 1.105 HD12 HD23 ' B' ' 158' ' ' LEU . 36.5 mm -132.83 118.53 34.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.526 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 56.81 42.92 25.89 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.31 15.35 74.81 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.216 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 7.5 m -120.89 140.27 52.04 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.957 0.378 . . . . 0.0 110.219 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.627 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.6 t -61.46 148.36 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.825 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.755 HG22 HD12 ' B' ' 106' ' ' ILE . 0.2 OUTLIER -129.12 22.78 5.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.135 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.627 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.0 OUTLIER -112.17 135.27 53.04 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.379 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 72.11 -9.53 0.99 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.484 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.629 ' HB3' HD11 ' B' ' 106' ' ' ILE . 4.0 tpp -66.55 170.65 5.93 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.02 148.62 22.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.987 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.04 -35.76 71.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.759 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' B' ' 146' ' ' ARG . 3.8 m -65.68 -37.24 85.95 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.159 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.38 -38.68 65.57 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 110.607 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.943 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -64.03 -42.57 97.06 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.089 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 146' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' B' ' 143' ' ' THR . 7.0 ppt_? -72.63 -35.53 67.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.65 0.262 . . . . 0.0 110.59 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -39.23 82.83 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.773 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.85 -45.15 93.35 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.602 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.505 HD12 HD22 ' A' ' 19' ' ' LEU . 47.7 mt -68.56 -36.79 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.772 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.57 -48.77 71.26 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.985 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -70.35 -24.94 63.07 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.61 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 96.9 p -78.06 67.35 3.88 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.064 0.459 . . . . 0.0 110.751 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 6.7 mtm-85 -76.62 128.31 34.46 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.587 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.57 -91.47 0.59 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.506 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.42 134.57 50.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.783 0.325 . . . . 0.0 110.723 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.781 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -129.76 141.68 50.83 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.331 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 7.8 tt0 -100.37 139.57 35.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.676 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 1.105 HD23 HD12 ' B' ' 132' ' ' ILE . 0.7 OUTLIER -134.0 128.79 35.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.91 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.56 137.11 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -125.01 143.83 37.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.248 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 5.9 tt -125.03 130.64 52.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.486 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.96 61.28 0.19 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.061 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 11.8 t70 66.76 169.26 0.24 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.179 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 5.9 p -97.46 152.75 18.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.384 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' B' ' 165' ' ' LEU . 0.3 OUTLIER 71.33 108.11 0.06 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.703 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.978 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.609 0.243 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 pp -137.84 147.79 25.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.469 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.97 158.77 23.48 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.564 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.713 HG11 ' HB3' ' B' ' 122' ' ' ASN . 25.8 t -132.07 133.34 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.68 0.276 . . . . 0.0 110.963 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.497 HD23 ' OE1' ' B' ' 157' ' ' GLN . 0.3 OUTLIER -107.01 107.62 18.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.104 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.487 HD21 ' N ' ' B' ' 117' ' ' ALA . 5.9 tp -91.03 128.5 36.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.118 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.497 ' O ' HD13 ' B' ' 116' ' ' LEU . 21.2 ttt -114.97 162.27 17.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.295 0.569 . . . . 0.0 111.274 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -99.48 123.48 43.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.798 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 t -159.32 126.34 4.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.784 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.04 33.79 23.56 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.326 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.81 120.73 3.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.206 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 13' ' ' GLU . 9.1 t30 -85.53 -176.0 5.9 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.539 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 29.9 tt0 68.7 159.96 0.18 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.79 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.66 171.69 6.08 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.684 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.716 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 86.9 m-85 -58.2 -27.44 63.9 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.42 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.36 29.02 58.86 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.666 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.67 118.84 37.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.278 . . . . 0.0 110.727 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.18 113.43 25.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.928 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.704 HD21 HD13 ' B' ' 129' ' ' ILE . 5.9 mp -97.06 124.88 41.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 111.342 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -110.33 179.85 20.48 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -132.61 150.18 52.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.194 0.497 . . . . 0.0 111.354 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' B' ' 104' ' ' SER . 7.9 pt20 -134.42 141.56 46.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.794 ' HB ' HG22 ' A' ' 54' ' ' THR . 2.9 mm -87.84 121.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.401 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -126.41 171.54 10.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.205 0.526 . . . . 0.0 111.392 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.76 100.46 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.853 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -55.76 5.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.082 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -156.58 133.8 10.58 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.559 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.06 145.12 48.82 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.896 0.379 . . . . 0.0 111.28 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.5 m -65.31 120.07 12.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.588 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.82 164.59 7.75 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.003 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.63 27.77 14.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.34 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.52 -175.18 20.55 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.182 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.648 HD22 ' O ' ' B' ' 90' ' ' MET . 0.6 OUTLIER -69.01 -31.1 69.69 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.5 ' N ' HD21 ' B' ' 89' ' ' LEU . . . -75.17 -34.88 61.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.52 0.2 . . . . 0.0 111.138 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.84 -34.09 45.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.216 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -37.75 85.5 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.49 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -102.41 -32.7 9.86 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.349 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.56 53.92 8.07 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.141 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.67 ' OD1' HG11 ' B' ' 87' ' ' VAL . 5.1 m-80 -70.03 -47.68 61.08 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.523 0.202 . . . . 0.0 111.296 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.638 HD13 ' C ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -116.49 136.17 53.22 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.902 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.81 141.79 28.32 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.207 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -56.99 109.66 0.68 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.186 0.517 . . . . 0.0 110.856 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.8 -7.77 38.95 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.708 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -67.16 138.58 57.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.078 0.466 . . . . 0.0 110.955 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 pt -77.33 120.93 28.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.811 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.915 HG21 HD11 ' A' ' 49' ' ' ILE . 24.1 mt -90.38 152.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.877 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.859 HD13 HD11 ' A' ' 78' ' ' LEU . 2.5 tp -111.7 -52.2 2.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.831 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.14 147.9 40.86 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 111.568 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 46' ' ' ILE . 37.4 mm -132.78 118.35 33.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 m120 53.28 36.71 23.44 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.754 0.311 . . . . 0.0 111.264 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.55 16.74 77.2 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.162 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.615 HG21 HD11 ' A' ' 65' ' ' LEU . 1.6 m -120.54 143.68 48.46 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.905 0.353 . . . . 0.0 110.094 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.449 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.3 t -63.79 143.93 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 111.295 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.794 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -127.72 27.86 5.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.945 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.449 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -123.99 126.76 46.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.013 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 72.0 -5.71 1.66 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.403 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.427 ' CE ' ' HB ' ' A' ' 53' ' ' VAL . 2.3 tpp -67.97 172.59 5.37 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.96 0.409 . . . . 0.0 111.439 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.7 t -90.81 150.96 21.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.244 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -42.01 82.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.793 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.7 t -57.66 -41.94 82.52 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.9 -46.11 86.31 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.95 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' B' ' 102' ' ' LEU . . . -60.22 -41.06 92.28 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.29 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -71.38 -37.33 71.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.435 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -67.92 -38.24 82.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.63 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 52' ' ' THR . 0.1 OUTLIER -59.72 -45.39 92.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.81 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.547 ' CD1' HD22 ' B' ' 102' ' ' LEU . 48.5 mt -68.73 -36.82 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.872 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -48.71 62.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.879 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.9 -24.52 62.49 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.775 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.4 p -79.38 65.37 4.53 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.116 0.484 . . . . 0.0 110.973 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -78.07 119.92 22.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.69 -89.45 0.46 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.29 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -126.35 130.22 50.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.625 0.25 . . . . 0.0 110.681 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.663 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.6 OUTLIER -122.78 143.47 49.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.947 0.404 . . . . 0.0 111.233 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.2 tm0? -105.85 142.14 36.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.867 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.484 ' HA ' HD13 ' A' ' 49' ' ' ILE . 1.4 mp -137.71 125.78 22.89 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.914 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.5 t -112.65 133.46 58.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.775 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.53 161.53 41.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.312 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.859 HD11 HD13 ' A' ' 47' ' ' LEU . 6.7 mp -101.42 131.28 47.6 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.257 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -144.14 63.8 1.32 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.538 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -48.81 102.91 0.04 OUTLIER 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.636 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.9 t -73.03 -29.59 63.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.087 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 82' ' ' LEU . 1.9 mp -60.17 135.18 57.64 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.925 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.982 -179.923 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.659 0.266 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp -133.45 140.05 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.273 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.13 158.84 22.16 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.88 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.67 HG11 ' OD1' ' A' ' 39' ' ' ASN . 15.3 t -129.67 135.05 62.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.691 0.282 . . . . 0.0 111.028 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 7.4 tt -105.35 109.31 21.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.464 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.5 HD21 ' N ' ' A' ' 34' ' ' ALA . 10.6 tp -94.04 141.34 28.64 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' MET . . . . . 0.648 ' O ' HD22 ' A' ' 33' ' ' LEU . 13.2 ttt -115.09 165.73 12.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.096 0.474 . . . . 0.0 111.167 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -89.74 140.69 29.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.623 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -97.05 102.99 14.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.435 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 56.06 35.56 25.82 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.923 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 67.36 125.33 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.963 0.411 . . . . 0.0 111.478 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -149.81 149.12 30.04 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.195 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -68.5 86.23 0.3 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.675 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 67.13 164.69 0.21 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.155 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.663 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 53.1 m-85 -80.34 -29.52 38.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.756 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.89 20.04 38.06 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.552 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.415 HD21 ' CB ' ' A' ' 34' ' ' ALA . 4.8 mp -100.1 120.17 39.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.701 0.286 . . . . 0.0 110.804 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.35 113.57 26.77 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.973 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.547 HD22 ' CD1' ' A' ' 66' ' ' ILE . 1.7 pt? -113.51 125.02 53.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.151 0.501 . . . . 0.0 111.339 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -108.16 -162.11 20.85 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.003 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -141.72 146.51 36.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -126.66 143.19 51.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.222 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 1.063 HD13 ' HB2' ' B' ' 145' ' ' ALA . 30.2 mt -88.4 120.71 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -122.15 172.3 8.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.805 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 57.9 t -84.06 94.14 3.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.174 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -64.17 -51.66 62.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.264 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -155.42 133.24 11.32 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.742 0.306 . . . . 0.0 110.784 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -121.45 144.26 48.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 89.3 m -66.51 123.43 20.02 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.01 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -65.53 162.07 18.85 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.127 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 62.03 35.31 16.05 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.122 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -117.94 -175.75 16.93 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.175 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 7' ' ' MET . 4.0 mt -65.43 -33.54 76.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.519 0.199 . . . . 0.0 111.48 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.487 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -74.95 -35.06 62.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.306 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.86 -33.9 45.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.186 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -62.65 -37.52 86.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.303 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.16 -29.93 11.84 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.563 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.75 48.27 43.27 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.289 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.713 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.2 p30 -72.26 -41.64 66.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.447 HD13 HD13 ' B' ' 158' ' ' LEU . 2.9 mp -125.48 127.49 46.56 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.665 0.269 . . . . 0.0 110.827 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.08 136.35 33.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.0 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -49.71 107.0 0.13 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.051 0.453 . . . . 0.0 111.666 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.68 -2.95 24.65 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.411 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -76.17 139.96 41.5 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 117.654 0.727 . . . . 0.0 111.275 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.72 113.07 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.068 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 1.028 HG21 HD11 ' B' ' 132' ' ' ILE . 6.8 mt -82.52 137.22 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.294 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 tp -96.82 -40.24 9.03 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -148.61 148.23 29.89 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 111.909 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 1.028 HD11 HG21 ' B' ' 129' ' ' ILE . 18.4 mm -135.02 118.22 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.087 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 133' ' ' ASN . . . . . 0.471 ' HB2' HD21 ' B' ' 148' ' ' LEU . 12.7 t30 54.88 42.58 30.99 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.988 0.423 . . . . 0.0 111.074 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.14 16.09 76.79 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.139 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 13.2 m -120.74 137.47 54.48 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.934 0.367 . . . . 0.0 110.586 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.513 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.3 t -59.4 145.16 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.034 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.826 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -118.5 18.35 13.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.428 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.513 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.3 OUTLIER -105.67 140.6 38.48 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.3 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 52.64 9.91 0.13 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.705 0.628 . . . . 0.0 112.349 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.73 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -73.89 173.68 9.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 111.264 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.19 137.22 32.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.956 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.62 -40.73 69.22 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.388 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 1.2 p -64.16 -38.03 89.59 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.218 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.78 -48.22 72.54 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.756 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 1.063 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.49 -42.26 87.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.942 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -69.45 -37.49 77.38 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.576 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -67.81 -38.64 83.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.551 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' LEU . . . . . 0.51 ' O ' HD23 ' B' ' 148' ' ' LEU . 6.7 tt -60.02 -44.85 94.33 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.586 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.547 HD11 HD22 ' A' ' 19' ' ' LEU . 11.8 mt -68.34 -36.64 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.92 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -69.14 -41.75 76.89 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.714 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.1 0.07 52.83 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 97.1 p -91.51 54.8 2.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.263 0.554 . . . . 0.0 110.945 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.32 83.94 1.42 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.377 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 159.58 -90.27 0.11 Allowed Glycine 0 C--O 1.226 -0.375 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.302 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.24 133.71 41.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.501 0.191 . . . . 0.0 110.804 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.716 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.64 125.61 38.46 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 111.297 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.497 ' OE1' HD23 ' A' ' 5' ' ' LEU . 2.7 mt-30 -92.33 119.13 31.6 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.447 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.69 HD23 HD12 ' B' ' 132' ' ' ILE . 0.4 OUTLIER -111.41 129.84 55.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.699 0.285 . . . . 0.0 110.988 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 27.0 t -116.48 140.29 39.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.431 HG21 ' HG ' ' B' ' 123' ' ' LEU . 27.0 t -132.19 138.01 53.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.092 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.18 117.94 27.42 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.861 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -97.43 166.26 11.62 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.922 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -46.85 128.36 10.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.639 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 28.3 m -140.27 172.9 12.09 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.463 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 pp -163.01 172.62 14.73 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.584 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptm . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.008 0.432 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 pp -130.99 155.61 42.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.253 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.22 158.69 24.45 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.57 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.672 HG11 ' HB3' ' B' ' 122' ' ' ASN . 23.3 t -131.87 134.44 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.68 0.276 . . . . 0.0 110.829 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.15 115.95 30.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.622 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.45 HD21 ' N ' ' B' ' 117' ' ' ALA . 1.6 tp -102.79 142.53 33.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.444 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.634 ' O ' HD22 ' B' ' 116' ' ' LEU . 0.7 OUTLIER -107.47 162.21 14.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.218 0.533 . . . . 0.0 110.589 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.487 ' N ' ' HG3' ' A' ' 7' ' ' MET . 11.2 ttpt -97.32 137.79 35.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.008 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -128.04 178.94 5.86 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.361 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 71.28 136.83 0.04 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.577 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.88 84.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.044 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 71.43 101.72 0.06 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.932 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -174.21 124.3 0.32 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.993 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.11 160.31 10.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.927 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.883 ' CE2' HD23 ' B' ' 156' ' ' LEU . 52.9 m-85 -58.79 -32.97 69.82 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.325 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' O ' HG23 ' B' ' 112' ' ' THR . . . 85.76 20.54 55.8 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.383 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -105.31 123.32 47.66 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.872 0.336 . . . . 0.0 110.556 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.413 ' HB2' ' HG2' ' B' ' 110' ' ' GLU . 0.0 OUTLIER -100.73 113.57 26.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.337 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.865 HD22 HD11 ' B' ' 149' ' ' ILE . 1.2 mp -92.39 124.87 36.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.108 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.38 -173.84 22.43 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.52 147.34 31.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.291 . . . . 0.0 110.836 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.471 ' NE2' HG21 ' A' ' 45' ' ' ILE . 7.8 pt20 -130.84 133.85 46.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.193 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.969 HD13 ' HB2' ' A' ' 62' ' ' ALA . 46.1 mt -87.94 120.32 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.958 0.408 . . . . 0.0 110.327 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -126.72 173.19 9.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.191 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.816 ' CG2' HD12 ' A' ' 40' ' ' LEU . 60.3 t -85.5 97.71 5.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.018 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -55.4 21.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.266 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -147.19 144.64 29.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.922 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.426 ' SD ' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -138.24 148.76 45.08 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.948 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.4 t -65.83 132.86 49.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.056 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -74.72 148.33 40.59 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.566 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.7 31.4 21.11 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.24 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.46 -144.11 16.19 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.355 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 -38.45 17.61 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.71 0.29 . . . . 0.0 111.154 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' CB ' HD21 ' B' ' 100' ' ' LEU . . . -74.91 -30.17 61.19 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.251 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.426 HG23 ' SD ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -79.14 -35.48 42.05 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.93 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -36.69 84.76 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.991 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.0 -28.14 13.92 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.102 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.34 49.19 53.72 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.507 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.846 ' HB3' HG11 ' B' ' 87' ' ' VAL . 11.8 p-10 -94.12 -32.16 13.87 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.816 HD12 ' CG2' ' A' ' 25' ' ' VAL . 3.3 mm? -114.64 131.08 56.84 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.674 0.273 . . . . 0.0 110.997 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.16 117.91 35.37 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -43.9 108.53 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.133 0.492 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.51 -5.37 31.35 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.346 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.401 ' OD2' HD13 ' A' ' 40' ' ' LEU . 50.3 p-10 -75.85 139.99 42.0 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.854 0.827 . . . . 0.0 111.751 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.471 HG21 ' NE2' ' A' ' 22' ' ' GLN . 14.4 pt -80.13 118.45 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.175 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.645 HD11 HD11 ' B' ' 102' ' ' LEU . 26.4 mt -85.0 134.43 27.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.801 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 tp -99.42 -29.9 12.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.677 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -157.59 148.47 21.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.775 0.321 . . . . 0.0 111.425 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.558 HD11 HD21 ' B' ' 102' ' ' LEU . 37.5 mt -140.73 118.12 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.563 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.444 ' HB2' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER 56.52 35.89 26.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.275 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 12.33 83.87 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.176 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.9 m -120.15 135.88 54.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.864 0.332 . . . . 0.0 110.398 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.3 t -59.83 147.46 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.826 0.346 . . . . 0.0 111.037 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -122.17 19.02 10.75 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.396 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -106.27 144.4 33.02 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 p30 52.58 7.82 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 123.644 0.59 . . . . 0.0 112.376 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.713 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -76.15 176.58 7.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 111.123 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 t -92.12 146.72 23.5 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.756 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.52 -43.93 96.59 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.599 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.4 p -62.47 -38.22 89.0 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.069 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -48.01 75.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.905 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.969 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -62.22 -40.55 96.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.994 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -67.6 -39.28 84.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.77 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -66.59 -38.49 87.12 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.545 ' O ' HD23 ' A' ' 65' ' ' LEU . 6.2 tt -59.91 -45.38 92.73 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.529 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.886 HD11 HD22 ' B' ' 102' ' ' LEU . 5.7 mt -68.5 -37.05 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.94 -49.46 57.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.108 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.48 -19.43 63.75 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.253 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 t -79.33 63.99 4.11 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.196 0.522 . . . . 0.0 110.574 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 mtm105 -79.08 97.72 6.24 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.413 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.67 -93.99 0.18 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.214 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.38 125.96 45.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.581 0.229 . . . . 0.0 110.66 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.843 HD23 ' CE1' ' B' ' 98' ' ' TYR . 2.3 pp -124.73 143.85 50.55 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.896 0.379 . . . . 0.0 111.188 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -105.14 142.65 34.54 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.779 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.755 HD11 HD11 ' A' ' 73' ' ' LEU . 1.0 OUTLIER -135.34 132.28 37.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.819 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.53 135.0 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.292 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.5 m -122.98 146.59 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.196 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.9 tp -92.86 116.38 28.99 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.552 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.39 155.89 18.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.476 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 168.34 80.19 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.465 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 t -70.91 104.41 2.94 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.069 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.2 mt 64.42 162.75 0.13 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.597 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.603 HD13 ' N ' ' B' ' 86' ' ' GLY . 0.0 OUTLIER -139.8 124.16 19.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.903 0.382 . . . . 0.0 110.751 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.603 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -117.84 157.21 15.27 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.447 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.846 HG11 ' HB3' ' A' ' 39' ' ' ASN . 17.3 t -130.82 134.54 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 0.0 111.063 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 73' ' ' LEU . 0.6 OUTLIER -102.92 107.35 18.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.619 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 9.4 tp -95.19 139.54 31.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.392 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 8.2 ttt -114.52 164.4 14.04 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.993 0.425 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.02 119.15 36.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.172 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 12.8 m -155.4 34.89 0.37 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.917 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.77 115.61 1.63 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.238 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 65.78 123.04 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.864 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -70.04 79.09 0.49 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.71 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -169.92 179.6 3.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.796 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.2 167.18 4.23 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.843 ' CE1' HD23 ' A' ' 73' ' ' LEU . 71.0 m-85 -59.48 -30.6 68.66 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.377 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.44 24.74 32.74 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.512 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.487 HD21 ' CB ' ' A' ' 34' ' ' ALA . 11.2 mp -108.48 120.5 42.6 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.757 0.313 . . . . 0.0 110.699 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -92.91 117.05 29.62 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.761 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.886 HD22 HD11 ' A' ' 66' ' ' ILE . 1.1 tp -94.7 125.2 39.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -116.46 177.09 16.7 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.658 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.22 146.59 46.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.904 0.352 . . . . 0.0 110.922 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -128.14 137.01 51.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.219 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.966 HD13 ' HB2' ' B' ' 145' ' ' ALA . 42.3 mt -88.27 120.48 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.908 0.385 . . . . 0.0 110.457 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -124.73 172.59 9.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.079 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' B' ' 123' ' ' LEU . 40.2 t -82.74 96.03 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.146 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -57.6 6.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.689 0.28 . . . . 0.0 111.178 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -149.28 138.46 21.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.615 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -132.25 140.12 48.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.017 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 16' ' ' GLY . 38.6 p -69.37 120.48 15.24 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.788 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.676 ' HA ' HG21 ' B' ' 118' ' ' THR . 8.0 ptt180 -63.04 169.24 3.49 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.738 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m 62.01 23.66 13.97 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.946 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.16 -164.51 24.77 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.255 -0.497 . . . . 0.0 112.326 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.634 HD22 ' O ' ' A' ' 7' ' ' MET . 0.0 OUTLIER -77.58 -31.41 53.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.579 0.228 . . . . 0.0 111.295 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.45 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -74.45 -34.96 63.3 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.186 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.676 HG21 ' HA ' ' B' ' 113' ' ' ARG . 2.1 p -79.0 -34.05 44.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.085 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -58.81 -39.53 81.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.264 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -103.92 -29.14 11.15 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.465 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.7 46.26 47.75 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.251 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.672 ' HB3' HG11 ' A' ' 4' ' ' VAL . 12.0 p-10 -73.37 -38.44 65.69 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.514 0.197 . . . . 0.0 111.355 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' B' ' 158' ' ' LEU . 1.5 mp -127.61 139.37 52.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.763 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.2 148.35 27.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.43 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -60.31 113.32 2.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.086 0.469 . . . . 0.0 110.962 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.48 -16.12 24.38 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.009 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -60.6 136.09 57.95 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.317 0.559 . . . . 0.0 111.295 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.92 99.15 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.377 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.84 HD13 HD21 ' A' ' 19' ' ' LEU . 4.7 mt -63.52 147.42 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.681 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 18.2 tp -110.28 -35.46 6.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.617 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -157.32 148.26 21.54 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.783 0.325 . . . . 0.0 111.19 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.555 HD11 HD21 ' A' ' 19' ' ' LEU . 43.8 mt -141.04 118.25 8.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.752 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 3.9 m120 53.83 50.52 16.73 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.065 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.15 18.71 60.73 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.031 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 2.9 m -120.57 139.09 53.45 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.702 0.251 . . . . 0.0 110.33 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.611 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.4 t -65.73 145.11 14.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 111.293 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.879 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -113.96 -1.79 13.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.196 179.38 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.611 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.2 OUTLIER -99.6 150.36 22.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.039 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 p30 52.41 8.57 0.08 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.571 0.544 . . . . 0.0 112.242 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.455 ' HB3' HD11 ' B' ' 106' ' ' ILE . 2.9 ttm -90.98 151.0 21.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.722 0.296 . . . . 0.0 110.764 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 30.0 t -71.8 145.78 48.45 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.014 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.489 ' O ' HD23 ' B' ' 142' ' ' LEU . 6.1 tt -60.19 -47.97 83.7 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.705 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 3.2 p -55.52 -38.38 69.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.023 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.02 -47.93 69.94 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.69 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.966 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -60.54 -40.81 92.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.048 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -67.24 -39.23 86.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.664 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -66.85 -38.39 86.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.788 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.05 -44.45 94.68 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.772 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.865 HD11 HD22 ' A' ' 19' ' ' LEU . 29.6 mt -68.18 -37.46 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.967 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -68.95 -49.36 58.64 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.811 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -67.83 -25.46 65.57 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.02 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 43.8 t -76.39 65.69 2.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.039 0.447 . . . . 0.0 110.632 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -78.7 100.49 7.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.348 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 144.21 -94.78 0.18 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.962 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.9 126.25 46.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.636 0.255 . . . . 0.0 110.898 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.883 HD23 ' CE2' ' A' ' 15' ' ' TYR . 2.1 pp -123.76 132.71 53.86 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.837 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 0.0 OUTLIER -93.08 142.79 26.9 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.495 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.765 HD21 HD11 ' B' ' 156' ' ' LEU . 0.3 OUTLIER -133.26 128.22 35.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.022 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.43 140.2 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.589 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.57 160.69 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.836 0.351 . . . . 0.0 111.184 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.7 123.53 44.02 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.654 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 64.01 169.45 0.17 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.2 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 167.6 144.21 0.02 OUTLIER 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.828 0.451 . . . . 0.0 110.45 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 1.5 m 61.72 -176.23 0.13 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.404 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.04 171.19 7.48 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.982 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.193 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 tpt . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 120.757 0.313 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.5 HD13 ' C ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -146.95 133.48 13.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.335 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.403 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -120.93 157.03 16.03 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.781 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.528 HG11 ' CB ' ' B' ' 122' ' ' ASN . 21.8 t -130.41 135.21 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 0.0 111.352 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' B' ' 157' ' ' GLN . 0.9 OUTLIER -103.12 108.99 20.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.639 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.521 HD23 ' CD2' ' A' ' 15' ' ' TYR . 15.4 tp -98.78 141.93 30.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.736 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.3 ttt -118.7 163.51 16.74 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.097 0.475 . . . . 0.0 110.904 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.24 134.69 37.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.072 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -168.63 125.38 1.0 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.695 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.43 35.59 23.0 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.342 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.536 ' HB3' HD11 ' B' ' 116' ' ' LEU . . . -165.48 124.01 1.64 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.276 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -104.42 -174.74 2.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.69 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 58.87 57.65 3.53 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.061 0.457 . . . . 0.0 110.443 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.48 -171.9 0.13 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.275 0.559 . . . . 0.0 110.844 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.584 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 62.0 m-85 -77.29 -9.62 58.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.85 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.55 24.12 71.23 Favored Glycine 0 C--N 1.341 0.851 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.483 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.625 HD11 ' HB2' ' B' ' 117' ' ' ALA . 6.8 mp -105.93 123.52 48.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.657 0.265 . . . . 0.0 110.508 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.19 113.04 24.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.013 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.795 HD22 HD11 ' B' ' 149' ' ' ILE . 9.4 mp -96.79 124.79 40.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' B' ' 109' ' ' LYS . . . -106.57 -168.43 22.69 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.45 ' OG ' HD12 ' B' ' 142' ' ' LEU . 0.1 OUTLIER -144.74 155.45 43.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.281 0.541 . . . . 0.0 110.687 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' B' ' 104' ' ' SER . 2.3 pt20 -136.81 131.35 33.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.799 HD13 ' HB2' ' A' ' 62' ' ' ALA . 40.5 mt -87.72 120.28 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.012 0.434 . . . . 0.0 109.903 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.484 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 42.8 p90 -121.79 173.15 7.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.193 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.793 HG21 ' HB3' ' A' ' 40' ' ' LEU . 32.0 t -83.99 96.58 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.972 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -64.09 -52.57 58.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.932 -179.276 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -163.95 142.89 7.71 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.695 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -134.45 139.01 45.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.046 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.0 t -65.72 126.1 27.38 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.699 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 ptt85 -63.9 172.78 2.1 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.028 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.65 27.42 13.2 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.198 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.98 -174.17 18.58 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.243 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' B' ' 92' ' ' SER . 2.8 mp -74.78 -26.92 60.09 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.52 -36.87 63.19 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.186 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.99 -33.8 44.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -65.71 -36.22 83.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.157 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.31 -29.79 12.96 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.406 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.1 42.1 85.26 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.112 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.707 ' HB3' HG11 ' B' ' 87' ' ' VAL . 11.8 p-10 -70.72 -46.24 63.43 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.39 0.138 . . . . 0.0 111.291 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.793 ' HB3' HG21 ' A' ' 25' ' ' VAL . 8.5 mt -114.56 127.11 55.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.813 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 142.49 29.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.502 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -59.22 109.59 0.89 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.108 0.48 . . . . 0.0 110.465 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.83 -9.65 55.34 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.731 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -60.79 139.64 57.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.103 0.478 . . . . 0.0 111.172 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.19 118.4 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.765 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.463 ' CD1' HD21 ' B' ' 102' ' ' LEU . 34.7 mt -89.09 152.04 3.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.786 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.922 HD13 HD13 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -117.35 -43.12 2.84 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.083 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 148.85 31.79 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.023 0.439 . . . . 0.0 111.958 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.51 ' CD1' HG21 ' A' ' 54' ' ' THR . 66.8 mt -141.27 121.29 12.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.462 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 m120 55.34 34.2 22.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.398 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.92 9.58 84.22 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.663 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.2 m -119.86 138.16 53.57 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.155 0.478 . . . . 0.0 110.333 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.2 t -57.12 145.82 7.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.124 0.488 . . . . 0.0 111.006 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.661 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -130.54 28.88 4.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.972 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.523 ' H ' HG12 ' A' ' 53' ' ' VAL . 8.5 tt0 -98.3 -102.0 0.21 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.428 ' HB2' ' CD1' ' B' ' 142' ' ' LEU . 6.7 p30 -66.37 -2.86 4.96 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.513 ' HB3' HD11 ' A' ' 23' ' ' ILE . 1.2 tpt -52.77 164.18 0.39 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.167 0.508 . . . . 0.0 111.7 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 m -79.01 147.35 32.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.592 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' B' ' 139' ' ' ASN . 0.5 OUTLIER -61.99 -46.54 88.77 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.781 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 t -59.56 -41.77 90.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.83 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -66.85 -43.13 84.46 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.702 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.799 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.055 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -68.59 -38.59 80.79 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.463 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -38.4 82.78 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.816 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -43.5 98.44 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.75 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.816 HD11 HD22 ' B' ' 102' ' ' LEU . 11.4 mt -68.55 -38.08 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.709 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -68.49 -49.49 59.37 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.651 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -23.11 66.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.343 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.0 m -76.1 68.27 2.53 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.962 0.411 . . . . 0.0 110.67 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.0 119.29 20.53 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.505 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.84 -94.03 0.56 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.278 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.69 127.25 43.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.705 0.288 . . . . 0.0 110.804 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.872 HD23 ' CE2' ' B' ' 98' ' ' TYR . 2.2 pp -119.49 133.69 55.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 4.9 mm-40 -93.56 142.69 27.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.91 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.698 HD21 HD11 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -133.82 123.82 25.46 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.53 134.42 53.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.032 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 46' ' ' ILE . 35.0 m -128.62 150.13 34.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.785 0.326 . . . . 0.0 111.549 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.922 HD13 HD13 ' A' ' 47' ' ' LEU . 3.8 tp -91.18 136.1 33.32 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.281 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.87 -169.09 1.97 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.63 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.07 136.27 0.03 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.782 0.325 . . . . 0.0 110.827 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 t -80.42 164.34 23.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.182 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.19 175.13 10.3 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.199 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.089 -0.958 . . . . 0.0 111.165 179.89 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.543 0.211 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pp -126.98 143.31 40.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.204 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.27 157.75 15.63 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.56 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.707 HG11 ' HB3' ' A' ' 39' ' ' ASN . 17.7 t -130.53 135.22 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.618 0.246 . . . . 0.0 111.206 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.51 113.99 27.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.81 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.463 HD23 ' CD1' ' B' ' 98' ' ' TYR . 2.2 tp -105.02 144.67 31.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' MET . . . . . 0.631 ' O ' HD22 ' A' ' 33' ' ' LEU . 4.0 ttt -109.74 163.9 13.06 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.202 0.525 . . . . 0.0 110.848 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.45 138.39 34.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.089 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 92' ' ' SER . . . . . 0.708 ' HB3' HD11 ' A' ' 33' ' ' LEU . 60.4 p -117.47 141.99 47.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.743 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 65.41 106.95 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.759 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.98 70.63 1.04 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.072 0.463 . . . . 0.0 110.801 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -138.46 -49.79 0.55 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.579 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -127.24 178.84 5.78 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.132 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' GLU . . . . . 0.61 ' OE2' HG22 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -94.1 -179.78 5.06 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.729 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.872 ' CE2' HD23 ' A' ' 73' ' ' LEU . 72.2 m-85 -51.51 -31.5 24.18 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.49 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.14 26.62 65.92 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.579 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.14 119.47 38.8 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.682 0.277 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.01 113.37 25.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.294 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.816 HD22 HD11 ' A' ' 66' ' ' ILE . 1.1 mp -97.01 125.11 41.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -108.91 -179.0 21.52 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.427 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.411 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -146.62 144.74 29.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.018 0.409 . . . . 0.0 111.101 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.413 ' NE2' HG21 ' B' ' 128' ' ' ILE . 5.7 pt20 -130.65 137.91 49.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.164 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.927 HD13 ' HB2' ' B' ' 145' ' ' ALA . 18.8 mt -87.93 120.6 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.337 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -122.13 172.11 8.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.231 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' B' ' 123' ' ' LEU . 40.9 t -80.97 96.71 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.772 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 109' ' ' LYS . . . . . 0.427 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 0.4 OUTLIER -67.07 -57.06 7.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.103 -179.167 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -155.13 147.68 24.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.657 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -138.13 147.9 44.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 111.007 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -65.28 121.86 15.79 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.849 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.642 ' HA ' HG21 ' B' ' 118' ' ' THR . 20.0 ttt180 -69.04 157.03 37.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.556 HG22 ' O ' ' B' ' 113' ' ' ARG . 0.5 OUTLIER 68.68 14.16 8.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.484 -179.305 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.59 -158.26 33.79 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.302 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 11' ' ' ALA . 1.2 mp -81.85 -30.43 32.09 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.528 0.204 . . . . 0.0 111.543 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.625 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -75.06 -34.23 61.8 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.362 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.642 HG21 ' HA ' ' B' ' 113' ' ' ARG . 0.8 OUTLIER -79.12 -33.96 43.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -37.8 85.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.353 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.89 -26.43 12.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.729 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.57 44.64 89.46 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.085 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.528 ' CB ' HG11 ' A' ' 4' ' ' VAL . 9.5 p30 -58.75 -44.64 90.59 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.553 ' HB3' HG21 ' B' ' 108' ' ' VAL . 4.7 mp -133.14 142.51 48.71 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.692 0.282 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.05 144.47 25.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.432 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -59.6 111.15 1.31 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 111.185 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.69 -9.0 23.84 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.186 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -68.1 135.55 52.35 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 117.307 0.553 . . . . 0.0 110.558 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.413 HG21 ' NE2' ' B' ' 105' ' ' GLN . 1.9 pt -77.63 113.7 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.754 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.434 ' HA ' HG12 ' B' ' 160' ' ' VAL . 16.3 mt -81.6 133.98 28.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.268 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.424 HD13 HD13 ' B' ' 161' ' ' LEU . 5.0 tp -95.17 -38.81 10.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.241 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -147.32 148.03 30.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 111.694 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 26.0 mt -136.35 119.43 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.414 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 57.11 40.66 28.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.841 0.353 . . . . 0.0 111.024 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.5 15.4 77.42 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.142 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.84 141.56 50.45 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.0 0.4 . . . . 0.0 110.389 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.573 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.2 t -60.17 147.87 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.051 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.684 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -121.69 20.31 11.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.807 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.573 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.5 tt0 -105.75 138.53 41.79 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.473 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 59' ' ' LEU . 11.4 p30 52.98 9.95 0.14 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.618 0.574 . . . . 0.0 112.295 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.415 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.3 OUTLIER -71.77 172.08 10.44 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.771 0.319 . . . . 0.0 111.483 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 44.8 t -91.38 142.64 27.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.45 HD12 ' OG ' ' A' ' 21' ' ' SER . 2.7 tt -59.18 -42.52 91.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.643 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.1 p -60.37 -39.67 88.06 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.771 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -48.21 74.83 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.957 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.927 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -60.81 -41.01 94.82 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.88 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -66.3 -39.92 89.67 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.437 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -38.23 82.33 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.398 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 148' ' ' LEU . . . . . 0.407 ' HA ' ' HG2' ' B' ' 151' ' ' LYS . 0.8 OUTLIER -59.97 -44.78 94.24 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.687 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.795 HD11 HD22 ' A' ' 19' ' ' LEU . 11.3 mt -68.49 -36.69 75.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.885 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.05 -48.85 61.78 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.81 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' B' ' 148' ' ' LEU . 0.5 OUTLIER -66.01 -26.23 67.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.487 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.0 m -74.18 69.32 1.52 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.729 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.45 80.27 6.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.524 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 160.46 -81.94 0.14 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.025 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.1 125.89 25.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.544 0.211 . . . . 0.0 110.906 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.584 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -123.41 141.09 52.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.958 0.408 . . . . 0.0 111.226 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.401 ' HB2' HD21 ' A' ' 5' ' ' LEU . 29.3 tt0 -102.77 136.86 41.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.727 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mt -131.85 129.87 40.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.971 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 34.2 t -115.0 136.26 52.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.786 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' B' ' 129' ' ' ILE . 10.0 m -141.19 161.91 22.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.912 0.386 . . . . 0.0 111.39 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.424 HD13 HD13 ' B' ' 130' ' ' LEU . 6.7 mp -120.73 122.94 41.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.687 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -82.05 67.78 8.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.193 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 61.42 102.44 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.578 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.13 -60.29 2.39 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.749 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 mp -141.68 34.26 1.62 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.177 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.67 179.768 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpp? . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.655 0.264 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.627 HD13 ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -127.59 142.36 43.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.199 -179.79 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.627 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -138.57 156.78 24.31 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.867 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.825 HG11 ' HB3' ' B' ' 122' ' ' ASN . 19.5 t -129.06 134.27 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.868 0.366 . . . . 0.0 111.208 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.68 107.31 18.19 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.517 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.479 HD21 ' N ' ' B' ' 117' ' ' ALA . 5.5 tp -94.47 137.47 33.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.501 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.478 ' O ' HD13 ' B' ' 116' ' ' LEU . 17.5 ttt -113.65 163.81 14.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.991 0.424 . . . . 0.0 110.639 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.96 132.84 36.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.802 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.7 t -73.52 -171.55 1.02 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.047 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -74.79 69.24 1.81 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.052 0.454 . . . . 0.0 110.996 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.55 111.2 0.67 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.618 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.95 86.28 0.05 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.789 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -160.84 164.34 31.41 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.842 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -71.79 167.51 19.79 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.794 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.866 ' CE1' HD23 ' B' ' 156' ' ' LEU . 64.6 m-85 -67.21 -27.69 67.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.526 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.69 23.18 70.57 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.384 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.672 ' CD2' HD13 ' B' ' 123' ' ' LEU . 0.2 OUTLIER -98.77 120.23 38.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.593 0.235 . . . . 0.0 110.761 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.96 113.4 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.076 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.541 HD22 HD11 ' B' ' 149' ' ' ILE . 5.1 mp -99.12 124.85 44.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.163 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.85 -169.17 20.81 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.37 152.72 39.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.167 0.483 . . . . 0.0 110.582 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.466 ' NE2' HG21 ' A' ' 45' ' ' ILE . 6.9 pt20 -136.37 137.25 40.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.38 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.805 ' HB ' HG22 ' A' ' 54' ' ' THR . 41.0 mt -88.03 120.37 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.131 0.491 . . . . 0.0 110.204 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.416 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 45.5 p90 -121.0 172.33 8.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.109 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.685 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.7 t -82.19 94.51 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.015 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -62.7 -52.33 63.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.042 -179.379 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.09 144.03 20.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.807 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.422 ' HE1' ' HB1' ' A' ' 34' ' ' ALA . 10.1 ptp -132.26 145.49 51.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.153 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -66.95 119.89 12.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.958 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.01 154.8 9.06 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.056 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.1 m 63.62 30.28 14.97 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.918 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.49 -173.16 25.94 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.158 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.569 HD22 ' O ' ' B' ' 90' ' ' MET . 0.3 OUTLIER -67.49 -32.26 72.96 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HB1' ' HE1' ' A' ' 28' ' ' MET . . . -74.37 -35.81 63.54 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.024 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -34.07 44.29 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.046 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -39.94 77.54 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.563 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.35 -33.81 8.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.513 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.2 56.77 3.61 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.105 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.701 ' HB3' HG11 ' B' ' 87' ' ' VAL . 0.4 OUTLIER -93.45 -52.76 4.35 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.543 0.211 . . . . 0.0 110.942 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.685 ' HB3' HG21 ' A' ' 25' ' ' VAL . 5.9 mp -103.34 116.43 32.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.579 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.52 138.1 31.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.371 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.29 110.14 0.58 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.209 0.528 . . . . 0.0 110.875 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.99 -9.95 29.46 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.693 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -65.97 137.5 57.17 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 121.036 0.446 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.466 HG21 ' NE2' ' A' ' 22' ' ' GLN . 3.3 pt -78.47 110.79 14.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.671 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.699 HD13 HD21 ' B' ' 102' ' ' LEU . 8.3 mt -77.76 133.95 29.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.921 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.401 HD13 ' HB2' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -91.11 -46.16 8.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.547 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HB2' ' CG2' ' A' ' 76' ' ' VAL . 7.5 mttt -154.21 152.23 30.11 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.953 0.406 . . . . 0.0 111.48 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.501 HD11 HD21 ' B' ' 102' ' ' LEU . 48.7 mt -137.33 118.18 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.58 39.66 30.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.426 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.48 14.63 82.28 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.489 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.1 m -119.95 137.57 53.97 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 117.042 0.421 . . . . 0.0 110.279 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.3 t -60.63 144.32 13.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.092 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.805 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -128.4 26.71 5.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.365 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 9.8 tt0 -97.29 -109.92 0.16 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -63.45 -5.32 3.53 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.2 tpt -49.33 164.09 0.09 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.231 0.538 . . . . 0.0 111.895 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.7 147.26 45.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.587 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.453 HD11 ' OG ' ' B' ' 104' ' ' SER . 1.4 mp -62.92 -51.53 66.55 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.261 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.0 t -57.64 -38.69 75.47 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.301 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -64.17 -47.82 78.38 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.632 0.253 . . . . 0.0 110.766 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.804 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -58.81 -42.01 88.13 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.239 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 51.4 mtt-85 -69.65 -38.23 77.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -38.45 84.51 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.828 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.51 -43.75 96.76 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.89 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.872 HD11 HD22 ' B' ' 102' ' ' LEU . 10.1 mt -68.25 -37.3 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 110.692 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -49.75 59.53 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.769 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -68.32 -23.42 64.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.163 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.6 t -82.17 61.95 5.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 110.711 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -78.99 118.76 21.29 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.447 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.11 -99.77 0.59 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.966 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -118.03 131.58 56.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.754 0.311 . . . . 0.0 110.873 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.797 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -128.16 144.24 51.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.039 -179.79 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.12 128.47 54.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.39 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.544 HD11 HD21 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -125.7 128.6 48.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.446 -179.261 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.549 HG12 ' HA3' ' B' ' 86' ' ' GLY . 4.5 m -120.08 120.1 62.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.468 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -109.42 156.82 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.612 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.401 ' HB2' HD13 ' A' ' 47' ' ' LEU . 10.3 tt -111.2 125.25 53.6 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.87 -176.39 4.97 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.606 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 65.4 93.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.902 0.382 . . . . 0.0 111.042 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.5 p -95.49 29.41 2.58 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.544 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mt -159.24 -64.09 0.08 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.148 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 2.6 ptt? . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.532 0.206 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pp -131.73 146.61 33.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.354 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.549 ' HA3' HG12 ' A' ' 76' ' ' VAL . . . -129.83 160.59 22.85 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.831 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.701 HG11 ' HB3' ' A' ' 39' ' ' ASN . 21.1 t -130.71 131.75 64.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.781 0.324 . . . . 0.0 111.0 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -95.35 113.1 24.74 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.626 HD23 ' CD1' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -102.82 144.68 30.83 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.881 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 90' ' ' MET . . . . . 0.569 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -117.86 171.52 8.01 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.462 0.648 . . . . 0.0 111.125 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -89.65 135.98 33.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.26 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' SER . . . . . 0.532 ' CB ' HD11 ' A' ' 33' ' ' LEU . 3.8 m -118.88 179.22 4.21 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.009 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -85.05 82.52 8.4 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.955 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.1 -146.25 0.34 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.442 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -72.9 -69.08 0.43 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.678 0.275 . . . . 0.0 110.529 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.07 134.28 0.33 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 64.61 174.08 0.2 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.797 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 70.0 m-85 -67.31 -26.56 66.58 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.306 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.98 25.68 68.58 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.472 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.613 HD13 ' HB3' ' B' ' 98' ' ' TYR . 7.8 mp -105.51 116.01 31.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.716 0.293 . . . . 0.0 110.385 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 125.7 34.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.528 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.872 HD22 HD11 ' A' ' 66' ' ' ILE . 2.2 mp -104.95 124.86 50.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.493 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 103' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -116.2 172.18 14.1 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.391 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.453 ' OG ' HD11 ' A' ' 59' ' ' LEU . 2.1 p -128.77 151.09 49.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.419 0.609 . . . . 0.0 111.763 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -133.41 136.97 45.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.162 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.756 ' HB ' HG22 ' B' ' 137' ' ' THR . 50.8 mt -87.98 120.16 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.963 0.411 . . . . 0.0 110.36 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -122.51 173.11 7.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.266 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.679 HG21 ' HB3' ' B' ' 123' ' ' LEU . 35.2 t -82.72 97.82 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.845 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.39 -47.76 63.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.048 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -162.56 145.2 10.99 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.473 ' HB2' HD12 ' A' ' 17' ' ' LEU . 11.3 ptt? -134.84 155.6 50.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.854 0.359 . . . . 0.0 111.166 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.36 120.07 12.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.702 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 145.36 47.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.135 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.7 27.89 14.84 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.156 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.33 -150.76 27.33 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.559 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 7' ' ' MET . 3.6 mt -84.38 -34.1 23.65 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.592 ' CB ' HD12 ' B' ' 123' ' ' LEU . . . -72.88 -32.26 65.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.176 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.81 -34.9 44.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.046 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -63.7 -36.41 83.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.162 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -98.21 -33.96 10.91 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.297 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.38 40.1 41.15 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.401 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.825 ' HB3' HG11 ' A' ' 4' ' ' VAL . 14.6 p-10 -92.4 -36.64 13.02 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.469 0.176 . . . . 0.0 111.399 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.679 ' HB3' HG21 ' B' ' 108' ' ' VAL . 1.6 mt -98.73 74.99 2.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.03 130.73 47.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.561 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -56.63 108.08 0.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.271 0.558 . . . . 0.0 110.85 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.69 -13.05 46.59 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.785 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -58.53 137.17 57.59 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.2 0.524 . . . . 0.0 111.087 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pt -81.57 114.21 22.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.661 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.54 ' CD1' HD21 ' A' ' 19' ' ' LEU . 36.6 mt -84.85 149.51 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.072 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.693 HD13 HD12 ' B' ' 161' ' ' LEU . 8.3 tp -113.63 -41.54 3.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.751 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -147.23 148.31 31.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.894 0.378 . . . . 0.0 111.769 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.456 HD11 HG21 ' B' ' 137' ' ' THR . 23.2 mt -138.92 119.77 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.391 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.44 38.16 29.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.47 15.2 81.68 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.211 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 135' ' ' THR . . . . . 0.451 ' CB ' HD11 ' B' ' 148' ' ' LEU . 39.3 m -120.61 141.21 50.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.965 0.382 . . . . 0.0 110.347 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.49 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.1 t -62.56 144.16 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.256 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.756 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -122.37 19.67 10.53 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.296 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.49 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.2 OUTLIER -116.8 128.52 55.37 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 3.0 m120 70.24 -3.51 1.8 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.188 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.459 ' HG3' ' N ' ' B' ' 141' ' ' SER . 0.1 OUTLIER -73.3 149.87 42.36 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.79 0.328 . . . . 0.0 110.496 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 141' ' ' SER . . . . . 0.459 ' N ' ' HG3' ' B' ' 140' ' ' MET . 33.4 t -71.49 150.08 45.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.372 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.08 -45.14 87.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.261 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 34.9 p -56.31 -40.22 74.02 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.08 -46.42 71.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.763 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.74 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -62.3 -39.83 94.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.338 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -70.23 -37.36 74.98 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.82 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.13 -38.79 82.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.634 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 148' ' ' LEU . . . . . 0.451 HD11 ' CB ' ' B' ' 135' ' ' THR . 0.2 OUTLIER -60.19 -44.03 95.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.032 179.734 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.541 HD11 HD22 ' A' ' 19' ' ' LEU . 12.3 mt -68.38 -37.01 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.864 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.13 -49.69 54.72 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.067 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.21 -28.04 69.1 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.168 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 30.2 t -75.35 79.73 2.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 110.773 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -88.67 121.64 31.25 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.599 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 115.32 -92.22 0.58 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.308 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.46 135.05 53.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.639 0.257 . . . . 0.0 110.983 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.866 HD23 ' CE1' ' A' ' 15' ' ' TYR . 2.5 pp -122.59 133.3 54.55 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -99.35 139.09 35.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.148 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.617 HD13 ' CD2' ' B' ' 123' ' ' LEU . 3.9 tt -137.29 142.08 41.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.839 0.352 . . . . 0.0 111.368 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 6.9 t -122.04 130.44 74.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.297 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.527 HG13 ' CD2' ' B' ' 158' ' ' LEU . 31.9 m -121.2 146.41 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.693 HD12 HD13 ' B' ' 130' ' ' LEU . 0.6 OUTLIER -88.75 128.46 35.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.73 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 63.01 -176.75 0.15 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.889 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 65.0 105.03 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.461 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 2.6 m -162.29 155.03 19.77 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.47 152.86 23.65 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.755 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.518 -0.754 . . . . 0.0 111.477 -179.912 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.55 0.214 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp -143.14 156.66 17.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.421 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.42 168.46 23.09 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.978 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.758 HG21 ' HB2' ' B' ' 122' ' ' ASN . 23.5 t -128.51 132.94 67.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.658 0.266 . . . . 0.0 110.978 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.63 HD23 ' CD ' ' B' ' 155' ' ' LYS . 1.8 mp -95.79 124.28 39.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.8 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' B' ' 117' ' ' ALA . 1.1 mp -108.31 134.25 51.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.623 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.3 ttm -109.11 163.83 12.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.239 0.543 . . . . 0.0 111.06 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -86.38 141.19 29.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.064 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 1.4 m -150.96 129.87 12.49 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.59 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 9' ' ' SER . 20.3 mtm180 72.25 138.51 0.05 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.527 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.78 82.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.005 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -128.59 148.16 50.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.481 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.84 108.27 2.09 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.673 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 49.05 -172.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.333 0.587 . . . . 0.0 112.243 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.859 ' CE1' HD23 ' B' ' 156' ' ' LEU . 62.8 m-85 -77.81 -32.72 52.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.499 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.09 22.93 28.69 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.576 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.487 HD11 ' CB ' ' B' ' 117' ' ' ALA . 3.6 mp -102.76 119.09 38.23 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.647 0.26 . . . . 0.0 110.738 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.432 ' HB3' ' HG3' ' B' ' 110' ' ' GLU . 0.0 OUTLIER -98.73 124.25 43.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.88 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.863 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.7 pt? -122.42 124.96 44.84 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.204 0.526 . . . . 0.0 111.741 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.24 -169.56 21.33 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.584 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.7 OUTLIER -146.75 148.76 32.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.162 0.481 . . . . 0.0 111.167 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -131.19 146.54 52.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.37 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.978 HD13 ' HB2' ' A' ' 62' ' ' ALA . 5.6 mt -88.8 121.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.995 0.426 . . . . 0.0 111.045 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.41 ' CD1' ' HG2' ' B' ' 105' ' ' GLN . 39.7 p90 -121.5 172.83 7.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.017 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.653 HG21 ' HG ' ' A' ' 40' ' ' LEU . 38.7 t -86.3 96.65 5.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.126 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -63.11 -57.26 11.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.92 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -151.57 135.43 16.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.94 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.419 ' HB3' HD23 ' B' ' 100' ' ' LEU . 0.0 OUTLIER -116.8 148.28 41.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.6 t -65.28 142.05 58.4 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.074 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 154.72 26.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 55.37 29.23 12.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.466 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.24 -165.72 25.67 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.097 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.606 HD13 ' O ' ' B' ' 90' ' ' MET . 0.3 OUTLIER -77.19 -30.32 54.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.614 0.207 . . . . 0.0 111.429 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.861 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -73.78 -35.85 64.98 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.216 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.64 -33.75 46.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.096 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -38.67 87.09 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.376 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -101.22 -31.81 10.82 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.641 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.1 43.21 27.06 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.177 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.479 ' CG ' HD13 ' A' ' 40' ' ' LEU . 1.7 p30 -51.42 -49.57 61.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.155 0.182 . . . . 0.0 111.328 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.653 ' HG ' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -138.93 157.76 45.44 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.869 0.366 . . . . 0.0 111.13 179.01 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 147.29 25.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.598 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.25 109.97 0.86 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.302 0.573 . . . . 0.0 110.935 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.93 -4.28 28.86 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.745 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -70.55 135.44 48.52 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.201 0.524 . . . . 0.0 111.099 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 pt -78.87 111.49 15.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.493 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.741 ' HB ' HG21 ' A' ' 54' ' ' THR . 53.8 mt -79.77 146.1 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.302 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.534 HD22 ' CD1' ' A' ' 78' ' ' LEU . 19.3 tp -107.46 -37.58 6.17 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.73 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.04 147.76 31.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.874 0.369 . . . . 0.0 111.591 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 23.8 mt -137.7 118.34 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.514 ' HB2' HD21 ' A' ' 65' ' ' LEU . 5.5 m120 52.92 35.69 19.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.874 0.368 . . . . 0.0 111.383 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.68 15.89 74.52 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.146 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -120.89 141.05 50.98 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 117.061 0.43 . . . . 0.0 110.383 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.4 t -59.86 144.44 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 111.078 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.741 HG21 ' HB ' ' A' ' 46' ' ' ILE . 2.7 m -116.42 13.69 15.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.891 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.573 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -116.94 133.22 56.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.838 ' HA ' HD21 ' B' ' 142' ' ' LEU . 5.2 m-80 71.36 -6.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.391 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.506 ' HB3' HD11 ' A' ' 23' ' ' ILE . 1.1 tpt -69.75 170.89 10.06 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.846 0.355 . . . . 0.0 110.987 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -89.94 139.73 30.32 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.051 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.527 HD12 ' OG ' ' B' ' 104' ' ' SER . 6.1 tt -55.89 -44.57 78.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.605 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -58.9 -40.14 83.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.821 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.2 -46.78 76.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.784 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.978 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -59.83 -42.1 92.82 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.951 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.35 -37.9 80.95 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.581 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -68.05 -38.56 82.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.719 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.527 ' C ' HD23 ' A' ' 65' ' ' LEU . 9.2 tt -61.13 -43.92 98.13 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.724 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.666 HD11 HD22 ' B' ' 102' ' ' LEU . 8.0 mt -68.6 -37.03 77.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.023 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.16 -49.12 59.69 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.749 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.36 -25.06 67.87 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.372 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 t -77.51 68.12 3.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.083 0.468 . . . . 0.0 110.723 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.1 mtt85 -84.06 66.46 9.24 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.397 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.89 -75.61 0.07 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.659 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.94 128.94 29.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.711 -0.245 . . . . 0.0 111.242 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.79 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.9 OUTLIER -125.7 132.34 52.41 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.958 0.408 . . . . 0.0 111.077 179.662 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.589 ' O ' HD13 ' A' ' 75' ' ' LEU . 10.7 tt0 -102.15 136.41 42.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.621 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.603 HD22 ' N ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -127.12 130.71 50.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.28 133.93 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.254 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.07 165.68 30.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.811 0.339 . . . . 0.0 111.443 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.534 ' CD1' HD22 ' A' ' 47' ' ' LEU . 1.3 mp -115.44 116.86 28.93 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.089 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.05 115.61 17.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.707 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.36 116.01 1.05 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.453 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.2 p -66.93 116.81 8.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.048 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.2 -51.71 0.09 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.883 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.244 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.01 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 1.9 mtt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.861 0.363 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.507 ' C ' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -145.96 124.65 5.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.454 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -118.57 157.99 14.98 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 39' ' ' ASN . 18.8 t -125.46 134.78 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.698 0.285 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.42 125.6 50.76 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.713 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.531 HD11 ' O ' ' A' ' 33' ' ' LEU . 11.0 tp -119.02 138.6 52.72 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.243 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' MET . . . . . 0.606 ' O ' HD13 ' A' ' 33' ' ' LEU . 3.0 ttt -100.45 163.87 12.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 139.82 32.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.119 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' B' ' 93' ' ' ARG . 0.5 OUTLIER -104.67 124.75 49.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.788 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 93' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' B' ' 92' ' ' SER . 3.1 mmm180 69.18 134.26 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.808 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.64 67.48 1.13 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.074 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -174.16 145.3 1.04 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.281 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 65.73 160.4 0.13 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.98 0.419 . . . . 0.0 111.535 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.95 178.35 5.69 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.672 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.79 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 52.3 m-85 -57.97 -25.37 60.92 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.388 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.24 17.76 66.14 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.319 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.861 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -100.63 114.93 29.03 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 113.38 24.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.27 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.666 HD22 HD11 ' A' ' 66' ' ' ILE . 0.9 OUTLIER -100.14 124.92 46.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.107 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.45 172.99 15.51 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.5 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.527 ' OG ' HD12 ' A' ' 59' ' ' LEU . 1.1 p -124.43 153.6 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.996 0.398 . . . . 0.0 111.167 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 21' ' ' SER . 2.4 pt20 -134.23 134.29 41.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.164 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.983 HD13 ' HB2' ' B' ' 145' ' ' ALA . 19.9 mt -87.76 120.52 36.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.034 0.445 . . . . 0.0 109.866 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.462 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 47.8 p90 -121.8 173.72 7.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.218 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.82 HG21 ' HB3' ' B' ' 123' ' ' LEU . 39.8 t -84.68 101.49 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 109' ' ' LYS . . . . . 0.462 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 5.6 mmtt -70.35 -53.23 17.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.732 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.432 ' HG3' ' HB3' ' A' ' 18' ' ' ARG . 5.1 pt-20 -161.72 145.08 12.31 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.798 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -138.37 139.32 38.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 10.0 t -65.39 125.7 25.92 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.473 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.726 ' HA ' HG21 ' B' ' 118' ' ' THR . 0.0 OUTLIER -75.6 61.38 1.32 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.333 0.587 . . . . 0.0 111.3 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.41 27.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.955 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -130.11 -173.65 13.46 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.598 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.34 -32.17 72.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.595 0.236 . . . . 0.0 111.273 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.514 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -65.8 -41.19 92.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.325 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.726 HG21 ' HA ' ' B' ' 113' ' ' ARG . 11.0 m -78.91 -33.01 45.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.821 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -39.37 84.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.269 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.74 -32.76 9.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.618 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.89 40.12 26.55 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.275 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.758 ' HB2' HG21 ' A' ' 4' ' ' VAL . 7.1 p-10 -71.04 -47.05 60.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.389 0.138 . . . . 0.0 111.207 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.82 ' HB3' HG21 ' B' ' 108' ' ' VAL . 21.0 mt -92.8 119.74 32.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.676 0.274 . . . . 0.0 110.717 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.6 136.87 34.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.459 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -58.45 107.76 0.54 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.164 0.507 . . . . 0.0 110.534 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 102.49 -7.84 54.27 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.64 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -63.02 138.92 58.7 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.154 0.502 . . . . 0.0 111.252 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' B' ' 161' ' ' LEU . 1.3 pt -76.41 121.73 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.707 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.562 HG21 HD11 ' B' ' 132' ' ' ILE . 12.7 mt -89.66 135.02 27.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 tp -97.1 -41.94 8.1 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.579 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -148.5 147.92 29.65 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.792 0.33 . . . . 0.0 111.487 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.562 HD11 HG21 ' B' ' 129' ' ' ILE . 20.1 mt -141.41 119.65 9.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.662 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 133' ' ' ASN . . . . . 0.526 HD22 ' HA ' ' B' ' 156' ' ' LEU . 28.2 m120 58.3 40.55 24.44 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.243 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.54 10.11 79.01 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.396 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.44 138.79 52.23 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 117.138 0.469 . . . . 0.0 110.204 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.602 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.3 t -59.45 147.93 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.163 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.807 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.3 OUTLIER -121.64 20.48 11.03 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.709 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.602 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.3 OUTLIER -110.8 130.71 55.5 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 73.01 -10.49 0.99 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.499 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.703 ' HB3' HD11 ' B' ' 106' ' ' ILE . 1.2 tpt -65.49 169.21 6.3 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 121.016 0.436 . . . . 0.0 111.052 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 25.0 t -92.54 150.18 20.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.838 HD21 ' HA ' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -58.56 -44.15 89.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.89 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 8.9 t -59.25 -40.19 85.16 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.631 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.28 -44.98 82.04 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.716 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.983 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -60.79 -41.77 96.25 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.019 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.7 -37.82 76.75 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.37 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -67.86 -38.42 83.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.526 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -44.76 93.15 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.651 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.506 HD12 HD22 ' A' ' 19' ' ' LEU . 59.1 mt -68.3 -36.95 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.685 0.278 . . . . 0.0 110.763 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -69.18 -49.08 59.91 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.882 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -70.2 -23.3 62.93 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.613 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 80.1 p -79.06 66.29 4.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.122 0.486 . . . . 0.0 110.625 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -74.55 126.6 31.12 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.544 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 115.12 -90.36 0.53 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.452 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.63 ' CD ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -128.18 133.94 48.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 0.0 110.617 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.859 HD23 ' CE1' ' A' ' 15' ' ' TYR . 2.0 pp -124.59 144.26 50.25 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.412 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 55.5 tt0 -109.51 141.6 41.74 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.79 HD11 HD11 ' B' ' 156' ' ' LEU . 1.1 mt -135.02 132.5 38.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.972 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.02 137.78 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.297 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 7.8 m -135.21 161.77 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.818 0.342 . . . . 0.0 111.403 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.549 ' HB3' HD11 ' B' ' 128' ' ' ILE . 4.9 tt -119.72 125.82 49.57 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.017 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.459 ' O ' HD23 ' B' ' 161' ' ' LEU . 30.5 mtt180 -99.5 168.54 9.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.897 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -46.24 146.69 1.29 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.933 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.47 157.54 26.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.304 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 3.8 tt -160.71 -59.79 0.06 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.162 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.612 -0.709 . . . . 0.0 111.296 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.566 0.222 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.684 HD13 ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -145.46 131.91 14.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.944 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.684 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -139.45 156.81 24.82 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.835 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.551 HG11 ' CB ' ' B' ' 122' ' ' ASN . 18.1 t -131.34 134.63 60.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.777 0.322 . . . . 0.0 111.041 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.24 107.12 17.81 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.732 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.444 HD21 ' C ' ' B' ' 116' ' ' LEU . 6.4 tp -92.7 134.79 34.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.289 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.97 171.37 7.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.387 0.613 . . . . 0.0 111.354 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.8 pttt -87.12 128.77 35.11 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.564 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.402 ' H ' HD11 ' B' ' 116' ' ' LEU . 2.6 m -162.86 47.69 0.15 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.837 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -143.93 63.35 1.34 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.746 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 57.17 25.37 10.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.967 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.0 79.87 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.018 0.437 . . . . 0.0 111.725 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -158.12 70.49 0.55 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.757 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 47.91 -173.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.712 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 77.7 m-85 -100.28 -24.99 14.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.809 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.59 30.9 65.87 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.546 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' B' ' 117' ' ' ALA . 0.0 OUTLIER -104.94 123.84 48.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.658 0.266 . . . . 0.0 110.942 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.423 ' HB2' ' HG3' ' B' ' 110' ' ' GLU . 0.0 OUTLIER -100.19 113.22 25.73 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.08 179.487 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.746 HD22 HD11 ' B' ' 149' ' ' ILE . 8.0 mp -94.15 124.84 38.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.024 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.18 172.09 14.85 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.531 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.558 ' OG ' HD11 ' B' ' 142' ' ' LEU . 0.3 OUTLIER -132.47 149.02 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.006 0.403 . . . . 0.0 111.223 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' B' ' 104' ' ' SER . 7.0 pt20 -131.94 141.53 49.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.181 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.767 ' HB ' HG22 ' A' ' 54' ' ' THR . 4.1 mm -87.81 121.69 38.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.304 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -125.93 171.5 10.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.413 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.771 HG21 ' HB3' ' A' ' 40' ' ' LEU . 44.7 t -84.36 100.18 7.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.04 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -56.12 8.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.893 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -157.15 145.84 19.74 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.992 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.627 ' SD ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -137.53 143.8 41.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.274 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.8 p -65.71 121.08 14.18 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.616 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.68 163.85 6.76 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.204 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 62.88 25.09 14.9 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.278 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.37 -169.09 25.76 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.391 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.549 HD13 ' O ' ' B' ' 90' ' ' MET . 0.3 OUTLIER -73.75 -30.17 62.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.81 -35.09 62.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.642 0.258 . . . . 0.0 111.025 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.627 HG23 ' SD ' ' A' ' 28' ' ' MET . 1.2 p -78.68 -34.18 46.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.133 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -61.73 -38.15 86.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.197 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -98.98 -30.69 12.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.273 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.05 47.02 25.92 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.037 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.808 ' HB3' HG11 ' B' ' 87' ' ' VAL . 12.4 p-10 -85.31 -40.0 17.04 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.771 ' HB3' HG21 ' A' ' 25' ' ' VAL . 3.3 mm? -106.34 125.46 51.02 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.652 0.263 . . . . 0.0 111.07 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 132.12 41.25 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.236 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.02 107.07 0.43 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.225 0.536 . . . . 0.0 111.012 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.87 -9.07 43.4 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.917 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -69.56 144.07 53.19 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.26 0.553 . . . . 0.0 111.294 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 77' ' ' VAL . 20.2 pt -81.65 116.59 26.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.666 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.571 HG21 HD11 ' A' ' 49' ' ' ILE . 6.0 mt -83.03 137.72 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.947 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.442 HD12 HD12 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -91.71 -51.5 5.21 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.5 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -150.52 152.19 33.8 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.71 0.29 . . . . 0.0 111.2 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.571 HD11 HG21 ' A' ' 46' ' ' ILE . 29.7 mt -140.67 118.11 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.86 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.53 39.85 30.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.177 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.56 3.95 87.08 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.207 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.2 m -107.71 129.76 55.0 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.0 t -61.64 146.15 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.979 0.418 . . . . 0.0 111.079 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.767 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -120.41 22.76 11.18 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.354 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.574 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -127.24 124.62 39.32 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.147 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 72.35 -9.23 1.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.444 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -69.94 174.48 5.26 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.868 0.366 . . . . 0.0 111.146 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.62 132.31 34.19 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.007 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.577 HD12 ' OG ' ' B' ' 104' ' ' SER . 7.9 tt -54.25 -42.83 70.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.751 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -63.6 -38.48 91.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.085 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.2 -48.13 74.46 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.075 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -59.33 -40.52 86.59 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.227 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.69 -37.62 76.68 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.792 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -38.68 82.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.776 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.513 ' O ' HD13 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -59.71 -44.21 93.81 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.787 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 73' ' ' LEU . 8.2 mt -67.97 -37.47 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.825 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.86 -49.56 67.71 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.806 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -65.94 -26.74 67.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.423 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 86.0 p -84.85 60.69 6.35 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.114 0.483 . . . . 0.0 110.791 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -73.46 96.67 2.42 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.839 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.36 -92.19 0.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.249 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.28 130.45 52.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.709 0.29 . . . . 0.0 110.353 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.839 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.7 OUTLIER -129.51 139.69 51.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.21 0.528 . . . . 0.0 111.528 -179.48 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.471 ' OE1' HG23 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -98.12 138.59 35.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.999 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.515 HD11 HD21 ' A' ' 73' ' ' LEU . 1.6 mp -136.6 127.62 27.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 111.316 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.471 HG23 ' OE1' ' A' ' 74' ' ' GLN . 25.4 t -113.53 134.45 56.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.372 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 45' ' ' ILE . 18.7 t -129.26 140.81 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.073 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.442 HD12 HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -86.69 137.62 32.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.749 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -87.75 54.93 3.28 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.037 0.446 . . . . 0.0 110.883 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.83 163.99 4.12 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.735 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.6 p -113.21 156.37 23.39 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.428 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.8 tp -135.35 121.75 20.49 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.026 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.885 -179.893 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 3.3 ttp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.794 0.33 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.06 132.75 39.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.013 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -129.63 160.96 22.84 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.744 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.808 HG11 ' HB3' ' A' ' 39' ' ' ASN . 26.3 t -130.77 135.1 60.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.72 0.295 . . . . 0.0 111.289 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tt -97.87 109.07 21.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.536 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.486 HD23 ' CD1' ' B' ' 98' ' ' TYR . 1.1 tp -104.44 144.84 31.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.075 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' MET . . . . . 0.549 ' O ' HD13 ' A' ' 33' ' ' LEU . 38.9 ttm -113.13 164.19 13.81 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.117 0.484 . . . . 0.0 110.657 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' LYS . . . . . 0.404 ' HG3' ' CE2' ' B' ' 98' ' ' TYR . 10.6 mtpt -92.19 148.59 22.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.141 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -77.37 -174.25 3.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.83 26.4 9.11 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.571 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -166.03 37.4 0.05 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.641 0.258 . . . . 0.0 111.692 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.87 154.08 34.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.976 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -84.87 114.15 21.9 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.313 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 49.3 -173.23 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.686 0.616 . . . . 0.0 112.185 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.839 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 52.0 m-85 -72.86 -31.57 64.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.274 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.98 17.39 72.46 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.563 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -97.96 118.41 34.49 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -99.41 113.36 25.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.188 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.466 HD23 ' H ' ' B' ' 102' ' ' LEU . 1.7 pt? -110.95 125.08 53.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.165 0.507 . . . . 0.0 111.16 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 103' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -107.4 -162.66 21.67 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.278 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.577 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.3 OUTLIER -144.77 145.75 31.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 110.856 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 21' ' ' SER . 7.7 pt20 -128.12 140.35 51.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.496 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.848 ' HB ' HG22 ' B' ' 137' ' ' THR . 45.3 mt -88.14 120.38 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -121.62 172.94 7.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.874 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 1.039 HG21 HD13 ' B' ' 123' ' ' LEU . 42.9 t -81.66 93.51 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.31 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -63.51 -50.48 69.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.013 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.423 ' HG3' ' HB2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -165.21 149.03 8.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.651 ' SD ' HD11 ' B' ' 123' ' ' LEU . 9.1 mtm -128.4 161.4 29.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.061 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.423 HG23 ' HA3' ' B' ' 115' ' ' GLY . 10.1 t -65.62 125.36 25.0 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.708 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -57.85 136.52 57.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.21 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m 60.86 30.28 19.55 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.05 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 115' ' ' GLY . . . . . 0.423 ' HA3' HG23 ' B' ' 112' ' ' THR . . . -87.6 -156.43 30.02 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.447 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.444 ' C ' HD21 ' A' ' 6' ' ' LEU . 13.4 mt -82.44 -30.12 30.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.511 0.196 . . . . 0.0 111.349 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.497 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -75.23 -34.69 61.46 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.285 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.9 -33.85 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.074 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -38.69 84.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.374 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -103.04 -29.88 11.1 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.673 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.68 44.21 57.74 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.151 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.551 ' CB ' HG11 ' A' ' 4' ' ' VAL . 8.5 p30 -63.31 -39.89 95.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.464 0.173 . . . . 0.0 111.341 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 1.039 HD13 HG21 ' B' ' 108' ' ' VAL . 4.1 pp -133.26 163.88 28.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.923 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.5 135.16 52.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.62 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -53.77 113.09 1.07 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.188 0.518 . . . . 0.0 111.076 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.08 -14.5 23.65 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.527 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -66.22 136.64 56.17 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.129 0.49 . . . . 0.0 110.887 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 5.8 pt -74.75 117.49 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.663 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.941 HG21 HD11 ' B' ' 132' ' ' ILE . 27.3 mm -83.19 137.55 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.909 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 13.4 tp -98.67 -40.94 7.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.001 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -150.03 150.83 32.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.969 0.414 . . . . 0.0 111.806 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.996 HD12 HD23 ' B' ' 158' ' ' LEU . 34.4 mm -137.01 118.82 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.89 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 133' ' ' ASN . . . . . 0.528 ' HB2' HD11 ' B' ' 148' ' ' LEU . 5.3 m120 56.2 31.54 18.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.682 0.277 . . . . 0.0 111.228 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.89 -2.3 85.65 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.178 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 13.4 m -104.66 131.98 51.45 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.075 0.437 . . . . 0.0 110.227 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.588 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.1 t -56.44 147.16 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.937 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.848 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -118.55 19.54 13.25 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.588 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.4 OUTLIER -106.6 134.43 49.75 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.611 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 52.18 12.24 0.2 Allowed 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.636 0.585 . . . . 0.0 112.175 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.22 173.38 5.72 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.413 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.3 141.36 30.13 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.558 HD11 ' OG ' ' A' ' 21' ' ' SER . 2.9 mp -58.41 -47.93 82.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.028 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 4.5 t -63.04 -37.06 85.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.776 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -65.61 -48.12 73.36 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.815 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.635 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -59.77 -41.15 90.45 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.397 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 17.8 mtt85 -68.27 -38.66 81.95 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.629 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -67.5 -38.35 84.17 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 148' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' B' ' 133' ' ' ASN . 0.2 OUTLIER -59.97 -44.17 94.63 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.915 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.746 HD11 HD22 ' A' ' 19' ' ' LEU . 5.3 mt -68.17 -38.09 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.832 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.01 -48.47 62.94 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.922 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -69.53 -19.07 63.71 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.266 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 3.2 m -74.33 69.77 1.63 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.772 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -82.97 120.3 25.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.716 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.69 -88.94 0.51 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.515 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.04 130.65 51.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.683 0.278 . . . . 0.0 110.809 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.712 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -120.04 130.97 54.95 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.095 0.474 . . . . 0.0 111.394 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 9.4 tt0 -93.75 135.43 35.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.68 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.996 HD23 HD12 ' B' ' 132' ' ' ILE . 0.5 OUTLIER -131.4 127.99 38.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 20.9 t -114.15 145.64 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.437 HG12 HD13 ' B' ' 129' ' ' ILE . 27.1 m -136.74 161.26 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.178 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' B' ' 161' ' ' LEU . 9.0 tp -89.19 118.63 29.03 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.38 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.41 139.31 1.66 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.646 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 21.6 t0 59.37 87.18 0.08 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.032 0.444 . . . . 0.0 111.174 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.15 112.4 17.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.738 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.16 154.96 32.47 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.091 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.152 179.928 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.602 ' CE ' HD22 ' B' ' 130' ' ' LEU . 4.0 tpt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.571 0.224 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.9 tt -145.8 123.18 4.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.113 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.8 156.87 21.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.711 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' B' ' 122' ' ' ASN . 24.9 t -132.67 134.18 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.777 0.322 . . . . 0.0 110.872 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.86 107.04 18.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.691 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.523 HD21 ' N ' ' B' ' 117' ' ' ALA . 2.8 tp -91.87 134.01 35.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.312 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 ttt -123.09 163.18 21.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.127 0.489 . . . . 0.0 110.911 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.44 115.99 30.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.537 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.1 m -140.65 36.94 1.82 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.184 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.99 107.05 0.13 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.723 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 65.38 121.65 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.425 0.453 . . . . 0.0 111.447 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -69.64 83.48 0.44 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.939 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -145.78 165.34 29.11 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.795 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -66.53 169.91 6.95 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.206 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.77 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 78.6 m-85 -73.76 -27.95 61.43 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.67 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' HG23 ' B' ' 112' ' ' THR . . . 77.97 27.59 58.08 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.653 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mp -108.04 121.07 44.07 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.748 0.308 . . . . 0.0 110.737 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -102.42 113.73 27.31 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.06 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.9 pt? -105.46 125.18 50.69 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.211 0.529 . . . . 0.0 112.098 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.36 -178.53 21.89 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.611 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.403 ' OG ' HD12 ' B' ' 142' ' ' LEU . 1.2 p -132.4 148.59 52.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.296 0.548 . . . . 0.0 111.565 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.465 ' NE2' HG21 ' A' ' 45' ' ' ILE . 9.9 pt20 -135.37 145.73 47.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.593 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.699 HD12 HG23 ' A' ' 54' ' ' THR . 4.8 mt -88.42 121.34 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.036 0.446 . . . . 0.0 111.051 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -122.28 172.32 8.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.957 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.597 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.3 t -84.01 97.5 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.92 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -58.5 4.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.306 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -149.2 136.46 20.01 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.34 134.61 36.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.072 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.1 p -73.23 127.64 33.19 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.518 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.806 ' HA ' HG21 ' A' ' 35' ' ' THR . 14.7 ptt-85 -72.91 65.69 0.75 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.254 0.55 . . . . 0.0 111.219 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.41 25.38 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.023 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.22 -172.63 13.39 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.714 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.676 HD22 ' H ' ' B' ' 90' ' ' MET . 1.6 mp -69.97 -30.5 67.87 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.639 0.22 . . . . 0.0 111.567 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.593 ' CB ' HD21 ' B' ' 100' ' ' LEU . . . -68.62 -41.3 79.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.544 0.212 . . . . 0.0 111.133 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.806 HG21 ' HA ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -78.78 -33.4 46.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.827 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -65.49 -36.42 83.81 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.188 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.58 -32.33 11.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.483 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.0 40.15 57.5 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.268 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.717 ' ND2' HD11 ' B' ' 89' ' ' LEU . 4.4 p30 -83.01 -31.06 27.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.425 0.155 . . . . 0.0 111.311 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.9 HD11 HD22 ' A' ' 75' ' ' LEU . 4.6 mt -115.28 123.67 49.39 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.699 0.285 . . . . 0.0 110.96 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.06 139.71 30.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.443 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.88 110.24 0.77 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 110.664 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.82 -11.25 45.53 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.705 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.84 138.13 57.42 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 121.05 0.452 . . . . 0.0 111.201 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.465 HG21 ' NE2' ' A' ' 22' ' ' GLN . 1.1 pt -84.13 99.15 6.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.248 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.598 HD13 HD21 ' B' ' 102' ' ' LEU . 5.7 mt -64.82 139.33 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.689 ' CD1' HD12 ' A' ' 78' ' ' LEU . 1.1 tp -92.62 -38.98 11.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.416 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -149.95 150.7 32.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.745 0.307 . . . . 0.0 111.388 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.7 mt -138.1 118.1 15.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.402 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.641 ' HB2' HD11 ' A' ' 65' ' ' LEU . 4.2 m120 53.14 41.95 32.16 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.277 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.73 6.13 76.54 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.972 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -104.98 131.59 52.3 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.2 144.88 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.791 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.699 HG23 HD12 ' A' ' 23' ' ' ILE . 20.7 m -109.95 23.1 14.81 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.419 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -126.2 130.6 51.28 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.344 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.0 p30 51.53 11.63 0.13 Allowed 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.762 0.664 . . . . 0.0 112.718 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.519 ' SD ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -69.23 -174.77 0.68 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.899 0.38 . . . . 0.0 111.114 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.8 124.6 35.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tt -58.39 -44.19 88.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.784 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.455 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 7.1 t -63.5 -37.33 86.9 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.01 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -34.72 62.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.653 0.264 . . . . 0.0 110.593 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.577 ' HB1' HD13 ' A' ' 23' ' ' ILE . . . -65.37 -43.34 91.08 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.24 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 60' ' ' THR . 1.4 ptt180 -71.97 -36.81 69.92 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.52 -37.85 83.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.239 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.641 HD11 ' HB2' ' A' ' 50' ' ' ASN . 2.9 tm? -59.41 -45.25 92.05 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.794 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.513 HD13 ' HB2' ' B' ' 102' ' ' LEU . 7.2 mt -68.77 -37.58 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.947 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -49.34 56.61 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -23.36 67.2 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.258 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.5 m -76.03 67.81 2.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 110.805 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 -90.85 53.16 2.32 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.705 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -171.83 -82.46 0.05 OUTLIER Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.294 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.83 126.38 36.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.637 0.256 . . . . 0.0 110.742 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.748 HD23 ' CE1' ' B' ' 98' ' ' TYR . 0.2 OUTLIER -129.9 134.55 47.57 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.289 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -92.01 140.68 29.41 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.939 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.9 HD22 HD11 ' A' ' 40' ' ' LEU . 1.2 mp -134.07 128.14 33.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.962 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 46' ' ' ILE . 19.8 t -115.78 142.95 26.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.851 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.468 HG22 ' O ' ' B' ' 85' ' ' ILE . 35.9 m -129.62 155.43 41.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.798 0.332 . . . . 0.0 111.39 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.689 HD12 ' CD1' ' A' ' 47' ' ' LEU . 0.9 OUTLIER -109.34 121.04 44.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.093 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.421 ' HB2' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -99.34 41.45 1.15 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.152 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 46.43 66.23 1.01 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.819 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.19 104.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.204 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -115.95 142.47 46.74 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.537 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.463 ' H ' HD23 ' A' ' 82' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.548 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 4.3 mtm . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.767 0.318 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 77' ' ' VAL . 18.1 tt -132.2 134.27 59.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.055 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -123.62 158.63 18.23 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.671 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.621 HG21 ' HB2' ' A' ' 39' ' ' ASN . 21.3 t -131.5 134.0 61.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.856 0.36 . . . . 0.0 111.255 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.63 107.92 19.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.408 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.717 HD11 ' ND2' ' A' ' 39' ' ' ASN . 7.1 mp -96.37 144.73 26.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 90' ' ' MET . . . . . 0.676 ' H ' HD22 ' A' ' 33' ' ' LEU . 9.8 ttt -116.35 163.57 15.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.814 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.89 133.67 36.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.155 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.91 175.46 10.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.091 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 40.5 mtt85 -94.23 57.69 2.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -173.42 101.21 0.12 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.365 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.1 t30 69.24 160.76 0.2 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.32 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -83.16 175.26 10.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.197 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 68.39 167.61 0.26 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.611 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.748 ' CE1' HD23 ' A' ' 73' ' ' LEU . 38.1 m-85 -93.86 -6.95 44.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.844 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.98 9.99 86.46 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.648 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.593 HD21 ' CB ' ' A' ' 34' ' ' ALA . 3.7 mp -105.7 115.06 29.6 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.659 0.266 . . . . 0.0 110.518 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.45 113.27 21.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.979 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.598 HD21 HD13 ' A' ' 46' ' ' ILE . 1.6 mp -96.77 124.75 40.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.064 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.28 174.84 15.55 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.558 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -133.17 144.73 50.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.983 0.391 . . . . 0.0 111.083 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -131.43 144.77 51.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.324 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.776 HG13 HG22 ' B' ' 137' ' ' THR . 0.9 OUTLIER -88.31 121.35 38.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.006 0.431 . . . . 0.0 110.803 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.418 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 32.1 p90 -119.26 171.82 8.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.665 HG21 ' HB3' ' B' ' 123' ' ' LEU . 35.5 t -79.69 91.91 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.97 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' LYS . . . . . 0.418 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -63.39 -45.54 90.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.971 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -163.49 132.14 3.84 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.718 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.92 146.88 50.15 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.826 0.346 . . . . 0.0 111.31 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 16' ' ' GLY . 74.4 p -65.29 123.56 19.89 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.885 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 18.9 ttm105 -63.72 155.26 30.63 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.28 30.53 19.92 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.262 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.35 -168.74 26.81 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.24 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 mt -65.24 -36.74 85.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.538 0.208 . . . . 0.0 111.168 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.523 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -74.87 -33.14 62.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.387 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.77 -34.26 45.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.122 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -37.94 86.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.222 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.16 -30.57 12.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.484 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.15 51.5 10.07 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.314 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.554 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.0 p-10 -87.12 -44.73 11.3 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.665 ' HB3' HG21 ' B' ' 108' ' ' VAL . 7.9 mp -123.46 124.84 43.77 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.741 0.305 . . . . 0.0 111.1 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.65 151.77 19.03 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.493 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -60.42 111.29 1.51 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.176 0.513 . . . . 0.0 111.048 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.28 -18.49 20.85 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.96 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -61.13 135.12 57.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.162 0.481 . . . . 0.0 110.523 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.63 120.76 30.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.264 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.401 HG21 HG12 ' B' ' 132' ' ' ILE . 29.0 mt -87.95 137.92 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.772 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.602 HD22 ' CE ' ' A' ' 1' ' ' MET . 2.8 tp -100.14 -35.65 9.59 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.546 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 131' ' ' LYS . . . . . 0.448 ' HE3' HG22 ' B' ' 136' ' ' VAL . 14.4 mttp -150.44 147.97 28.18 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 111.4 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.696 HG23 HD23 ' B' ' 158' ' ' LEU . 14.9 mt -140.66 118.42 9.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.541 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 5.8 m120 57.03 47.5 17.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.969 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 66.2 17.28 65.75 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.236 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 75.6 m -120.91 137.13 54.74 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.753 0.276 . . . . 0.0 110.286 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.594 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.6 t -69.71 145.24 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.875 0.369 . . . . 0.0 110.851 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.776 HG22 HG13 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -114.8 0.65 13.87 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.815 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.594 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.0 OUTLIER -84.77 129.14 34.86 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.206 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 m120 69.95 -4.12 1.57 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.633 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.02 171.12 10.02 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.965 0.412 . . . . 0.0 111.156 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 3.6 m -91.91 146.97 23.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.28 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.403 HD12 ' OG ' ' A' ' 21' ' ' SER . 2.8 tt -61.55 -44.91 96.18 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.887 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 23.3 p -57.5 -46.29 83.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.115 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.87 -46.31 89.98 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.003 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 1.06 ' HB1' HD11 ' A' ' 19' ' ' LEU . . . -59.27 -41.69 89.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.119 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 13.7 ttt180 -70.36 -37.24 74.56 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.411 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -38.41 82.81 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.745 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 7.2 tt -59.67 -45.19 92.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.697 HD12 HD22 ' A' ' 19' ' ' LEU . 35.0 mt -68.37 -36.89 76.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.807 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -61.79 -48.25 81.48 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.786 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -25.23 66.46 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.383 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 70.7 m -74.59 78.36 1.99 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.536 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -94.21 46.94 1.18 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.185 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -165.85 -83.34 0.05 OUTLIER Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.378 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -128.03 131.36 49.16 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.291 0.236 . . . . 0.0 110.521 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.77 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -129.9 136.48 49.56 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.001 0.429 . . . . 0.0 111.285 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 12.8 tt0 -97.39 140.95 31.09 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.551 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.696 HD23 HG23 ' B' ' 132' ' ' ILE . 5.0 mt -135.92 125.09 24.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.154 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 18.8 t -114.64 133.03 62.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.458 HG11 ' HG ' ' B' ' 123' ' ' LEU . 30.0 m -129.05 162.42 36.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.846 0.355 . . . . 0.0 111.284 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.531 HD13 ' HE1' ' A' ' 1' ' ' MET . 9.6 tp -124.13 127.05 47.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -93.36 95.14 9.13 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.382 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.86 162.81 1.65 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.787 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 1.7 m 72.07 179.18 0.24 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.432 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 165' ' ' LEU . . . . . 0.422 HD22 ' N ' ' B' ' 165' ' ' LEU . 3.6 mm? -103.0 112.25 24.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.747 0.308 . . . . 0.0 110.672 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.318 -179.737 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.737 0.303 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.487 HD13 ' C ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -127.66 123.3 60.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.904 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.455 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -117.45 159.09 14.25 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.924 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.769 HG11 ' HB3' ' B' ' 122' ' ' ASN . 21.0 t -123.92 134.57 66.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.789 0.328 . . . . 0.0 111.154 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.96 116.5 30.32 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.738 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.482 HD21 ' N ' ' B' ' 117' ' ' ALA . 8.4 tp -109.79 144.53 38.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.731 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.7 ttt -112.39 163.2 14.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.188 0.518 . . . . 0.0 110.837 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -81.43 144.82 31.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.079 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.424 ' HB2' HD12 ' B' ' 116' ' ' LEU . 0.2 OUTLIER -113.87 -169.08 1.44 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.866 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -78.57 64.06 3.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.899 0.38 . . . . 0.0 110.758 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.62 43.91 2.93 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 65.36 -81.87 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.092 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 11.8 pt-20 -158.21 163.89 37.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.52 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 13' ' ' GLU . 19.5 tt0 69.48 151.08 0.09 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.808 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 43.8 m-85 -86.48 -28.19 23.6 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.089 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.34 20.42 32.57 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.625 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.78 119.35 38.65 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.666 0.233 . . . . 0.0 110.678 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -96.25 113.52 25.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.81 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.98 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.5 pt? -108.13 124.76 50.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.18 0.514 . . . . 0.0 111.48 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.24 -166.25 21.24 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.922 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.3 OUTLIER -146.12 145.04 30.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.836 0.318 . . . . 0.0 111.254 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.581 ' NE2' HG21 ' A' ' 45' ' ' ILE . 5.4 pt20 -125.24 138.88 54.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.885 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.781 ' HB ' HG22 ' A' ' 54' ' ' THR . 34.9 mt -88.0 120.49 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.649 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 46.6 p90 -123.55 171.15 9.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.15 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.6 t -81.47 98.68 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.775 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 1.6 tptp -70.46 -55.53 8.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.049 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -157.06 135.97 11.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.859 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.3 ptt? -120.55 150.74 40.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 111.244 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.6 m -66.36 122.31 17.24 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.96 162.68 18.73 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.925 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.24 30.84 20.19 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.358 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.74 -161.29 16.39 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.116 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.11 -31.43 39.18 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.868 0.334 . . . . 0.0 111.809 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.592 ' CB ' HD11 ' B' ' 100' ' ' LEU . . . -74.88 -37.41 62.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.521 0.2 . . . . 0.0 111.117 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.89 -33.62 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.225 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -59.52 -39.37 83.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.565 0.221 . . . . 0.0 111.491 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -102.63 -34.43 9.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.38 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.77 53.81 7.0 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.743 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.707 ' ND2' HG11 ' B' ' 87' ' ' VAL . 9.8 m120 -75.74 -36.99 59.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.421 0.153 . . . . 0.0 111.369 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.757 HD11 HD13 ' A' ' 75' ' ' LEU . 2.8 mp -129.16 138.44 51.77 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.775 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.98 145.71 25.2 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.694 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -61.38 112.36 2.15 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.208 0.528 . . . . 0.0 111.188 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.77 -10.76 18.54 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.015 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -67.53 134.66 51.7 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 117.291 0.546 . . . . 0.0 110.215 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.581 HG21 ' NE2' ' A' ' 22' ' ' GLN . 1.2 pt -77.54 111.7 14.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.835 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.9 mt -77.4 138.72 19.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.051 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.7 tp -101.05 -38.05 8.34 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.24 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -149.81 148.06 28.74 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 120.943 0.401 . . . . 0.0 111.763 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.639 HG22 HD22 ' A' ' 50' ' ' ASN . 14.2 mt -139.58 118.6 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.155 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.639 HD22 HG22 ' A' ' 49' ' ' ILE . 67.8 m-80 56.86 37.08 28.57 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.31 6.66 88.85 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.594 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.6 m -114.12 138.97 49.73 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.166 0.483 . . . . 0.0 110.381 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.596 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.1 t -59.45 147.69 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.781 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -123.39 19.85 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.808 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.596 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -116.51 128.48 55.48 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.35 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.1 m120 70.09 -4.38 1.54 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.606 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.5 173.89 5.49 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.937 0.399 . . . . 0.0 111.238 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.9 143.17 27.53 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.265 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -41.49 86.87 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.692 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -63.63 -39.39 94.24 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.011 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.67 -48.59 71.59 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.837 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.804 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -61.37 -39.43 90.59 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.461 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -72.46 -37.52 68.5 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.452 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -67.89 -38.27 82.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -45.28 92.54 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.552 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.5 mt -68.58 -36.78 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.912 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -68.94 -49.48 57.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.776 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -67.07 -24.42 65.97 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.314 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 t -75.49 71.33 2.42 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.03 0.443 . . . . 0.0 110.781 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.07 91.32 8.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.39 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.84 -83.02 0.15 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.082 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.504 ' HB3' HD21 ' B' ' 88' ' ' LEU . 5.0 mttp -136.93 122.88 20.17 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.465 0.306 . . . . 0.0 110.455 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.584 HD23 ' CE1' ' B' ' 98' ' ' TYR . 0.4 OUTLIER -108.62 141.46 40.53 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 111.315 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.502 ' HB2' HD12 ' B' ' 88' ' ' LEU . 1.3 tt0 -107.98 141.68 39.26 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.848 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.757 HD13 HD11 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -135.29 125.3 25.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.982 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.6 132.12 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.373 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.36 168.35 23.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.187 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.49 116.89 31.64 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.8 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.558 ' HG3' HG21 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -85.62 111.93 20.52 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.707 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -53.54 155.73 2.88 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.34 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.7 35.31 4.84 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.436 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.5 mt -89.81 155.57 19.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.718 0.294 . . . . 0.0 110.599 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.142 -0.933 . . . . 0.0 110.807 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.621 0.248 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.558 HG21 ' HG3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -134.13 119.11 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.925 0.393 . . . . 0.0 111.048 179.698 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.498 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -132.24 158.04 22.76 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.666 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.707 HG11 ' ND2' ' A' ' 39' ' ' ASN . 15.2 t -131.47 135.17 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.73 0.3 . . . . 0.0 111.391 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 72' ' ' LYS . 1.1 tt -102.58 124.12 47.55 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.572 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.537 HD11 ' OD1' ' A' ' 39' ' ' ASN . 8.8 mp -106.08 124.49 49.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.758 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' MET . . . . . 0.46 ' HB3' ' CG ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -96.97 155.74 16.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.042 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -88.67 119.4 29.11 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.375 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.41 144.45 22.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.761 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 58.54 33.32 23.01 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.499 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -169.31 125.26 0.88 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.056 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.66 29.52 3.68 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.164 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.26 -179.64 5.91 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.6 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -55.83 159.75 2.98 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 110.827 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.584 ' CE1' HD23 ' A' ' 73' ' ' LEU . 76.0 m-85 -60.31 -26.27 66.41 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.21 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.88 21.14 54.09 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.866 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.592 HD11 ' CB ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -95.76 122.84 38.97 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.733 0.301 . . . . 0.0 110.691 179.791 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.17 113.24 26.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.929 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.804 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.7 pt? -109.32 124.8 51.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.247 0.546 . . . . 0.0 111.074 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -105.09 -164.76 23.93 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.898 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.31 150.07 37.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.909 0.385 . . . . 0.0 110.831 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.429 HE22 HG22 ' B' ' 128' ' ' ILE . 0.0 OUTLIER -130.02 135.98 48.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.819 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.931 HD13 ' HB2' ' B' ' 145' ' ' ALA . 83.2 mt -87.91 120.89 37.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.369 . . . . 0.0 110.51 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.424 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 42.5 p90 -123.16 172.11 8.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.129 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.751 ' CG2' HD23 ' B' ' 123' ' ' LEU . 35.6 t -83.47 97.32 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.136 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 109' ' ' LYS . . . . . 0.424 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -65.31 -52.11 56.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.033 -179.542 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -162.31 138.49 7.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.879 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -121.66 152.48 39.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.907 0.384 . . . . 0.0 111.311 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 23.4 m -78.84 127.62 32.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.798 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 165.39 12.07 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.065 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.24 28.72 15.88 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.52 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.54 -174.94 19.97 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.318 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 9' ' ' SER . 0.0 OUTLIER -72.04 -28.9 63.66 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.482 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -75.0 -35.09 62.02 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.181 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.14 -34.08 43.59 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.989 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -60.82 -38.44 85.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.563 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.25 -29.86 11.01 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.708 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.81 49.62 34.76 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.245 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.769 ' HB3' HG11 ' A' ' 4' ' ' VAL . 2.1 p-10 -71.88 -40.3 69.02 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.751 HD23 ' CG2' ' B' ' 108' ' ' VAL . 3.0 mp -122.78 146.33 47.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.626 0.251 . . . . 0.0 111.045 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -104.53 139.61 39.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.584 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -55.0 112.76 1.12 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.2 0.524 . . . . 0.0 110.67 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.58 -13.44 39.09 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.391 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -62.16 138.1 58.35 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.974 0.416 . . . . 0.0 110.809 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.782 HD11 ' HB2' ' B' ' 161' ' ' LEU . 1.4 pp -76.77 125.65 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.641 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.579 HD12 HG22 ' B' ' 106' ' ' ILE . 20.8 mt -93.26 147.8 5.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.714 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.46 HD22 HD11 ' B' ' 161' ' ' LEU . 32.3 tp -114.9 -40.76 3.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.777 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -147.19 148.04 31.1 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.394 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.676 HG23 HD23 ' B' ' 158' ' ' LEU . 38.7 mt -141.45 118.85 8.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.215 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 133' ' ' ASN . . . . . 0.558 ' HB2' HD21 ' B' ' 148' ' ' LEU . 8.6 m120 58.35 35.53 24.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.987 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.51 9.3 86.63 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.412 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -119.12 130.16 55.42 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 117.098 0.449 . . . . 0.0 110.395 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.681 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.4 t -59.22 147.03 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.101 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.869 HG22 HD12 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -115.55 4.8 14.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.998 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.681 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.2 OUTLIER -92.98 131.23 38.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.187 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 m120 71.44 -4.84 1.74 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.458 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.467 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.5 OUTLIER -69.78 171.04 9.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.997 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 38.5 t -87.01 144.4 26.92 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.11 -46.2 88.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.512 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.01 -37.16 83.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.774 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.8 -47.56 80.37 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.98 ' HB1' HD11 ' A' ' 19' ' ' LEU . . . -58.7 -41.84 87.23 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.935 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 76.9 ttt-85 -66.63 -39.97 88.52 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.299 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -38.15 86.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.805 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 148' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' B' ' 133' ' ' ASN . 8.3 tt -59.73 -44.31 93.83 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.532 HD12 HD22 ' A' ' 19' ' ' LEU . 39.1 mt -68.35 -37.19 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.611 0.244 . . . . 0.0 110.76 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -49.36 59.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.932 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -25.47 62.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.408 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 29.1 t -80.39 79.74 6.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.995 0.426 . . . . 0.0 110.597 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.82 126.64 35.77 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.542 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.16 -92.99 0.57 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.119 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -122.95 135.14 54.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.629 0.252 . . . . 0.0 110.717 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.808 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -129.58 132.31 46.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.119 0.485 . . . . 0.0 111.139 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.1 tm0? -94.58 139.09 31.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.316 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.676 HD23 HG23 ' B' ' 132' ' ' ILE . 5.5 mt -134.07 123.4 24.42 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.712 0.291 . . . . 0.0 111.009 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 21.4 t -110.91 135.71 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.465 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' B' ' 129' ' ' ILE . 18.4 m -136.13 158.57 38.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.175 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.782 ' HB2' HD11 ' B' ' 128' ' ' ILE . 18.9 mt -117.56 117.57 29.77 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.253 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -97.71 172.95 7.37 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.073 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.51 84.09 0.01 OUTLIER 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.805 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 28.3 p -170.81 -64.5 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.399 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.62 169.19 10.94 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.012 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.969 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.46 ' HG2' ' HB2' ' B' ' 162' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 120.415 0.15 . . . . 0.0 111.361 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.4 tt -141.43 139.27 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.717 0.294 . . . . 0.0 111.348 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.48 157.8 22.21 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.74 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.759 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.5 t -131.12 134.48 61.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.981 0.42 . . . . 0.0 111.351 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.568 HD23 ' NZ ' ' B' ' 155' ' ' LYS . 9.0 mp -101.39 108.59 20.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.874 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.691 HD23 ' CD2' ' A' ' 15' ' ' TYR . 3.1 tp -94.7 141.91 28.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.619 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.423 ' O ' HD13 ' B' ' 116' ' ' LEU . 2.9 ttt -126.19 164.27 21.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.116 0.484 . . . . 0.0 111.122 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -99.28 139.3 35.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.076 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -152.5 39.29 0.56 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.952 0.406 . . . . 0.0 111.456 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -138.44 -149.16 0.29 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.68 36.95 4.52 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.815 0.34 . . . . 0.0 111.48 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -133.66 145.38 49.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.605 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -98.0 51.4 1.04 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.027 0.442 . . . . 0.0 110.73 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -175.01 127.46 0.28 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.746 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.881 ' CE1' HD23 ' B' ' 156' ' ' LEU . 52.2 m-85 -66.75 -28.69 68.61 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.972 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.4 19.8 37.28 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.694 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.797 HD22 HD22 ' B' ' 123' ' ' LEU . 1.3 mt -98.49 116.57 31.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.572 0.225 . . . . 0.0 110.708 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.459 ' HB2' ' HG2' ' B' ' 110' ' ' GLU . 55.8 mtt85 -91.2 113.49 25.76 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.744 HD22 HD11 ' B' ' 149' ' ' ILE . 6.6 mp -95.4 124.97 39.7 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.451 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.67 175.2 20.0 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.3 OUTLIER -137.08 144.41 43.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.033 0.416 . . . . 0.0 111.136 -179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' B' ' 104' ' ' SER . 9.8 pt20 -128.31 140.81 51.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.338 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.981 HD13 ' HB2' ' A' ' 62' ' ' ALA . 15.8 mt -88.17 120.49 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.411 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 43.7 p90 -123.9 171.71 9.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.639 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.806 HG21 ' HB3' ' A' ' 40' ' ' LEU . 95.8 t -81.19 98.47 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.577 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 3.0 tptp -69.27 -57.76 4.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.356 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -156.13 139.77 16.01 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.786 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -124.83 156.42 37.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.289 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.403 HG23 ' O ' ' B' ' 99' ' ' GLY . 32.8 p -65.26 121.54 15.02 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -58.84 145.99 38.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.064 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.2 m 64.32 32.92 11.86 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.312 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.25 -171.66 29.68 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.205 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.597 HD13 ' O ' ' B' ' 90' ' ' MET . 2.6 mt -69.25 -32.4 71.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.515 0.198 . . . . 0.0 111.332 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.02 -33.58 61.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.006 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.83 -34.67 45.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.044 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -63.48 -36.96 85.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.078 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -97.72 -31.6 12.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.422 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.81 50.59 10.8 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.729 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.885 ' HB3' HG11 ' B' ' 87' ' ' VAL . 13.3 p30 -89.32 -39.68 13.3 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.806 ' HB3' HG21 ' A' ' 25' ' ' VAL . 26.8 mt -111.72 121.18 44.41 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.668 0.27 . . . . 0.0 110.978 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 119.42 34.17 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.245 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -42.52 107.26 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.984 0.421 . . . . 0.0 111.818 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 117.02 -11.43 14.9 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.712 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -69.72 131.79 45.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.532 0.666 . . . . 0.0 111.286 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.6 pt -75.86 104.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.263 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 25' ' ' VAL . 39.7 mm -66.0 141.65 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.394 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.555 HD13 ' CD1' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -100.72 -43.02 6.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.249 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -152.8 148.16 26.88 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.884 0.373 . . . . 0.0 111.588 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.506 HG23 ' CD1' ' A' ' 75' ' ' LEU . 41.6 mt -135.17 121.61 33.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.211 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.2 m120 52.7 40.27 30.02 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.759 0.314 . . . . 0.0 111.11 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.15 17.61 78.81 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.062 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.5 m -120.37 141.64 49.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.861 0.331 . . . . 0.0 110.204 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.502 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.0 t -64.44 143.95 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.165 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.766 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -117.87 15.43 14.33 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.457 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.502 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -115.75 133.38 56.09 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.498 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 73.29 -11.57 0.89 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.328 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.47 ' HG3' ' N ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -73.8 152.92 40.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.671 0.272 . . . . 0.0 110.532 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.47 ' N ' ' HG3' ' A' ' 57' ' ' MET . 48.0 t -71.3 144.7 49.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.005 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tt -54.7 -42.32 71.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.753 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.24 -38.27 76.54 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.023 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.66 -47.83 77.01 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.839 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.981 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -59.36 -42.15 90.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.908 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.17 -40.09 90.22 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.66 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -64.88 -39.71 93.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -43.29 97.97 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.595 HD11 HD22 ' B' ' 102' ' ' LEU . 7.8 mt -68.61 -37.71 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.797 0.332 . . . . 0.0 110.656 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -69.05 -49.15 60.01 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -20.09 65.62 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.456 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -75.74 68.96 2.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.955 0.407 . . . . 0.0 110.915 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.28 109.14 14.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.49 -82.93 0.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.068 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 141.89 49.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.615 0.245 . . . . 0.0 110.673 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.714 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 1.2 pt? -130.36 132.42 45.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.879 0.371 . . . . 0.0 111.475 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.587 ' O ' HD13 ' A' ' 75' ' ' LEU . 52.9 tt0 -98.67 127.93 44.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.607 HD21 ' HG ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -125.34 129.44 49.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.822 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.95 131.94 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.532 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.47 138.87 48.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.492 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.555 ' CD1' HD13 ' A' ' 47' ' ' LEU . 3.5 tt -121.62 117.53 26.94 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -100.73 77.07 1.85 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.02 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.9 t0 58.76 91.83 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.415 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.413 ' HB2' HD21 ' A' ' 78' ' ' LEU . 1.5 m -151.31 134.88 16.27 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.4 mt -78.73 176.41 9.54 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.298 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.093 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.881 0.372 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.416 ' O ' HG23 ' B' ' 85' ' ' ILE . 10.8 tt -144.55 120.66 4.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.95 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.22 156.46 17.33 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.577 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.885 HG11 ' HB3' ' A' ' 39' ' ' ASN . 17.7 t -132.62 134.52 58.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.718 0.294 . . . . 0.0 111.103 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 107.03 17.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.536 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 73' ' ' LEU . 16.9 tp -99.89 140.52 33.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.451 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' MET . . . . . 0.597 ' O ' HD13 ' A' ' 33' ' ' LEU . 51.1 ttm -120.96 161.77 21.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.201 0.524 . . . . 0.0 110.783 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.59 144.79 28.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.824 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.45 22.46 7.88 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.72 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 178.76 124.76 0.05 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.733 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.7 83.76 7.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.88 0.372 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -148.56 -49.55 0.16 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.491 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -120.64 -179.9 4.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.018 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -90.06 -178.82 5.53 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.064 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.714 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 69.2 m-85 -73.56 -30.18 62.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.228 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 29' ' ' THR . . . 89.06 23.44 35.01 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.68 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 mp -103.61 122.27 44.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.758 0.279 . . . . 0.0 110.522 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -102.66 113.56 27.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.303 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.595 HD22 HD11 ' A' ' 66' ' ' ILE . 9.4 mp -98.16 124.78 42.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.949 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.48 -176.36 24.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.772 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -136.09 146.19 46.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.823 0.344 . . . . 0.0 111.0 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 21' ' ' SER . 8.9 pt20 -126.82 139.71 52.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.324 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 1.149 HD13 ' HB2' ' B' ' 145' ' ' ALA . 50.2 mt -88.19 120.5 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.407 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -121.41 172.44 8.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.954 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.694 HG22 HD23 ' B' ' 123' ' ' LEU . 38.3 t -81.73 96.24 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.117 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -58.05 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.884 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 18' ' ' ARG . 1.7 pt-20 -157.24 137.74 13.01 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.576 ' CB ' HD23 ' A' ' 17' ' ' LEU . 1.2 ptt? -119.79 161.44 20.76 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 111.68 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 51.9 m -78.46 140.31 38.64 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.496 ' O ' HG22 ' B' ' 114' ' ' THR . 0.0 OUTLIER -76.33 152.24 36.44 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.103 179.724 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.563 HG23 ' O ' ' B' ' 114' ' ' THR . 0.5 OUTLIER 64.88 16.59 10.58 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.168 179.666 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.31 -168.46 41.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.224 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 7' ' ' MET . 0.1 OUTLIER -75.69 -27.32 58.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.673 ' CB ' HD21 ' A' ' 17' ' ' LEU . . . -74.8 -37.98 62.23 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.587 0.232 . . . . 0.0 111.213 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -33.74 43.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.827 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.0 -38.49 86.24 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.333 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.32 -37.6 9.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.222 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.08 55.7 3.46 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.309 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.759 ' HB3' HG11 ' A' ' 4' ' ' VAL . 0.5 OUTLIER -101.98 -45.52 5.16 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.409 0.147 . . . . 0.0 111.377 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.797 HD22 HD22 ' A' ' 17' ' ' LEU . 4.4 mp -85.25 119.92 26.17 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.79 0.328 . . . . 0.0 110.672 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.44 125.54 42.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.43 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -56.42 107.69 0.4 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.065 0.46 . . . . 0.0 110.916 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.13 -14.15 44.33 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.024 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.78 137.34 58.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.042 0.449 . . . . 0.0 110.983 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.75 105.19 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.288 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.503 HG12 HD11 ' B' ' 158' ' ' LEU . 7.8 mt -71.78 143.98 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.82 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 19.3 tp -105.81 -33.68 7.91 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.878 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -155.73 148.09 23.73 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.79 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 24.2 mt -137.95 117.73 15.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.146 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 133' ' ' ASN . . . . . 0.762 ' HB2' HD21 ' B' ' 148' ' ' LEU . 6.3 m120 56.73 36.81 28.22 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.043 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.5 13.74 82.21 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.305 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.5 m -120.45 128.46 53.19 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.922 0.361 . . . . 0.0 110.4 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.535 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.2 t -59.37 144.46 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 111.208 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.805 HG22 HD12 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -109.16 11.28 25.65 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.595 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.535 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.4 OUTLIER -99.79 132.98 44.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 72.47 -11.62 0.8 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.657 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.627 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.5 OUTLIER -64.07 168.45 5.33 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 111.141 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.38 148.22 22.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.257 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.22 -42.88 82.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.861 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 69.4 p -63.03 -39.81 95.86 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.176 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -41.53 97.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.035 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 1.149 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.91 -44.57 91.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.868 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -69.91 -36.6 75.49 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.506 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -67.85 -39.28 83.83 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.766 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 148' ' ' LEU . . . . . 0.762 HD21 ' HB2' ' B' ' 133' ' ' ASN . 5.6 tt -61.81 -42.42 98.99 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.785 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.744 HD11 HD22 ' A' ' 19' ' ' LEU . 14.7 mt -68.3 -38.16 79.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.589 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.16 -49.36 57.54 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.709 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -65.42 -25.86 67.72 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.236 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 10.7 t -84.44 63.41 7.81 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.015 0.436 . . . . 0.0 110.575 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.81 103.91 8.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.274 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 141.69 -93.11 0.18 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.088 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.568 ' NZ ' HD23 ' A' ' 5' ' ' LEU . 14.0 ttpp -123.8 126.98 47.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.543 0.211 . . . . 0.0 110.963 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.881 HD23 ' CE1' ' A' ' 15' ' ' TYR . 1.2 pp -124.18 126.89 46.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.999 0.428 . . . . 0.0 111.353 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.8 mt-30 -94.45 141.49 28.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.219 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.503 HD11 HG12 ' B' ' 129' ' ' ILE . 3.7 tt -137.33 140.51 41.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.034 0.445 . . . . 0.0 111.536 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 25.3 t -120.08 134.59 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.278 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.484 HG13 ' CD2' ' B' ' 158' ' ' LEU . 27.6 m -124.71 159.34 31.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.753 0.311 . . . . 0.0 111.309 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.41 128.99 54.46 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.46 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 0.1 OUTLIER -100.45 164.06 12.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.174 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 66.43 175.31 0.24 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.298 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 1.3 m -142.14 36.95 1.55 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 62.1 83.9 0.15 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.843 0.354 . . . . 0.0 110.954 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.176 179.91 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.433 HG23 HG23 ' B' ' 160' ' ' VAL . 11.8 tt -142.79 123.17 10.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.725 0.298 . . . . 0.0 111.108 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -128.86 157.28 21.49 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.906 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.66 HG11 ' HB3' ' B' ' 122' ' ' ASN . 21.9 t -132.12 133.66 60.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.743 0.306 . . . . 0.0 111.193 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 mt -98.19 111.67 23.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.784 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 tp -102.16 134.11 45.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.394 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.551 ' O ' HD13 ' B' ' 116' ' ' LEU . 7.4 ttm -109.11 164.16 12.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.643 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -98.03 116.34 30.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.729 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 t -104.26 30.92 4.92 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.126 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.05 125.27 3.48 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.391 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.1 56.32 3.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.025 0.441 . . . . 0.0 111.198 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 178.9 138.05 0.09 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 67.9 135.79 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.935 0.398 . . . . 0.0 110.985 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.54 177.88 1.82 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.746 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 62.7 m-85 -52.2 -27.4 14.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.776 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.71 18.16 62.27 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.431 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.646 HD23 HG13 ' B' ' 108' ' ' VAL . 0.1 OUTLIER -97.75 115.14 27.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.715 0.293 . . . . 0.0 110.287 179.794 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -93.32 113.47 25.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.849 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.559 HD12 HG21 ' B' ' 106' ' ' ILE . 1.9 pt? -105.97 124.92 50.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 111.565 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -109.42 -176.81 21.33 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.55 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.423 ' OG ' HD12 ' B' ' 142' ' ' LEU . 0.3 OUTLIER -142.34 146.46 35.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.905 0.353 . . . . 0.0 111.067 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.428 ' NE2' HG21 ' A' ' 45' ' ' ILE . 6.5 pt20 -127.27 135.52 50.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.848 ' HB ' HG22 ' A' ' 54' ' ' THR . 42.2 mt -87.91 120.56 37.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.002 0.43 . . . . 0.0 110.557 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -123.71 172.57 8.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.062 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.467 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.0 t -82.37 100.15 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.795 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -70.66 -59.68 2.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.399 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.7 136.05 20.3 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.753 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 13.0 ptp -122.1 151.4 40.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.892 0.377 . . . . 0.0 111.211 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -65.53 134.34 53.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -71.86 146.95 47.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.773 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.27 33.58 14.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.258 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.78 -171.75 26.57 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.272 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.632 HD13 ' O ' ' B' ' 90' ' ' MET . 0.1 OUTLIER -70.45 -31.6 68.83 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.646 0.223 . . . . 0.0 111.423 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.594 ' HB3' HD11 ' B' ' 100' ' ' LEU . . . -74.93 -34.26 62.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.261 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.09 -34.0 43.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.079 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -64.06 -36.63 84.62 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.336 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.48 -30.5 11.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.421 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.36 45.26 61.39 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.281 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.722 ' HB3' HG11 ' B' ' 87' ' ' VAL . 14.7 p-10 -74.61 -38.55 62.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.508 0.194 . . . . 0.0 111.391 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.669 ' CD1' HD13 ' A' ' 75' ' ' LEU . 5.6 mt -128.43 133.86 48.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.924 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.88 148.32 24.58 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.593 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -59.33 112.23 1.66 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.097 0.475 . . . . 0.0 111.001 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.26 -15.84 20.25 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.394 -0.821 . . . . 0.0 113.177 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -63.04 133.69 54.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.242 0.521 . . . . 0.0 110.285 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.428 HG21 ' NE2' ' A' ' 22' ' ' GLN . 4.3 pt -81.8 104.69 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.434 ' CG2' HG21 ' A' ' 54' ' ' THR . 64.4 mt -65.35 148.63 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.031 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.583 HD12 HD12 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -106.85 -45.81 4.1 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.6 -179.67 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -149.27 148.16 29.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 111.768 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.671 HD13 HD11 ' A' ' 66' ' ' ILE . 26.6 mt -129.74 118.06 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.496 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 m120 49.99 32.19 5.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.642 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.51 16.46 58.63 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.199 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.6 m -120.79 135.83 55.05 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.869 0.334 . . . . 0.0 110.355 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.1 t -57.83 142.38 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.848 0.356 . . . . 0.0 111.295 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.848 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -119.39 16.79 13.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.401 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.525 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -121.87 129.33 52.5 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 71.56 -6.6 1.37 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.255 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.03 173.95 4.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.937 0.399 . . . . 0.0 111.043 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.77 135.89 33.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.669 HD12 ' OG ' ' B' ' 104' ' ' SER . 0.2 OUTLIER -56.63 -43.08 79.9 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.889 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 43.4 p -64.72 -39.07 93.01 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.064 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.32 -47.99 68.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.816 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.572 ' O ' HD12 ' A' ' 66' ' ' ILE . . . -62.37 -40.17 95.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.756 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -62.78 -39.79 95.3 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.447 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -65.35 -38.35 89.82 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.981 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -46.33 89.45 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.668 0.271 . . . . 0.0 110.745 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.671 HD11 HD13 ' A' ' 49' ' ' ILE . 3.1 mp -69.04 -36.49 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.841 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.6 -46.36 69.53 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.155 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -64.05 -28.22 69.64 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.0 t -78.53 88.8 4.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.959 0.409 . . . . 0.0 110.76 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -99.16 40.45 1.21 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' HD2' ' B' ' 91' ' ' LYS . . . -151.37 -88.17 0.07 OUTLIER Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.284 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -129.46 122.16 28.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.619 0.247 . . . . 0.0 110.474 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.598 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -114.97 136.37 53.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.031 0.443 . . . . 0.0 111.116 -179.463 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -100.96 134.41 44.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.506 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.669 HD13 ' CD1' ' A' ' 40' ' ' LEU . 1.3 mt -127.4 137.94 52.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.015 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.3 t -120.16 139.55 47.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.425 ' CG2' HD23 ' A' ' 40' ' ' LEU . 19.7 t -115.34 142.49 28.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.183 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.583 HD12 HD12 ' A' ' 47' ' ' LEU . 8.6 tt -84.87 122.63 29.44 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -156.63 101.11 1.98 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.856 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.9 t70 176.47 108.81 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.633 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.9 m -143.69 127.81 17.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.043 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.479 HD13 ' H ' ' A' ' 83' ' ' GLU . 0.2 OUTLIER 69.93 150.96 0.09 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.808 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.479 ' H ' HD13 ' A' ' 82' ' ' LEU . 7.3 tp10 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.395 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 120.602 0.239 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.5 pp -130.17 153.71 39.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.09 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.22 158.63 27.3 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.923 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.722 HG11 ' HB3' ' A' ' 39' ' ' ASN . 21.4 t -131.43 135.18 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 111.021 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.77 107.46 18.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.432 HD23 ' CD2' ' B' ' 98' ' ' TYR . 1.3 tp -90.71 136.49 33.03 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.871 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' MET . . . . . 0.632 ' O ' HD13 ' A' ' 33' ' ' LEU . 9.9 ttm -104.32 164.85 11.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 111.005 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -81.52 146.0 30.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.128 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.7 t -163.09 97.84 0.93 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.413 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 59.02 32.29 22.12 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.079 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.94 82.12 6.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.925 0.393 . . . . 0.0 110.794 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -59.01 -32.94 70.17 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.369 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -141.63 74.71 1.47 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.798 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.98 173.8 0.23 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.598 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 50.0 m-85 -58.41 -27.62 64.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.652 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.87 14.39 55.08 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.525 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.594 HD11 ' HB3' ' A' ' 34' ' ' ALA . 8.4 mp -101.55 119.94 39.55 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.746 0.308 . . . . 0.0 110.655 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -101.79 113.56 26.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.156 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.451 HD23 ' H ' ' B' ' 102' ' ' LEU . 1.9 pt? -102.93 125.02 49.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 111.301 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.67 -170.81 20.31 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.377 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.669 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -146.59 152.16 38.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.979 0.389 . . . . 0.0 110.887 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -128.88 138.64 52.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.13 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.714 ' HB ' HG22 ' B' ' 137' ' ' THR . 26.8 mt -88.08 120.49 37.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.447 . . . . 0.0 110.492 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -121.69 173.23 7.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.044 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.678 HG21 ' HB3' ' B' ' 123' ' ' LEU . 46.1 t -82.51 98.03 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.046 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -44.98 71.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.039 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -155.0 160.91 41.43 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.947 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 18.1 mtp -138.13 162.13 35.02 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 111.136 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 5.7 p -95.9 124.39 39.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.643 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.573 ' HA ' HG21 ' B' ' 118' ' ' THR . 0.0 OUTLIER -64.72 160.51 19.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.03 0.443 . . . . 0.0 110.866 179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 58.13 22.84 9.49 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.02 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -103.31 -172.04 26.02 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.203 -0.523 . . . . 0.0 111.961 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 7' ' ' MET . 0.2 OUTLIER -72.24 -29.59 64.07 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.39 63.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.559 0.218 . . . . 0.0 111.077 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 118' ' ' THR . . . . . 0.573 HG21 ' HA ' ' B' ' 113' ' ' ARG . 1.0 OUTLIER -79.23 -34.03 43.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.246 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -57.81 -39.76 78.37 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.444 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -104.14 -36.16 7.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.028 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.2 53.34 5.7 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.756 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.66 ' HB3' HG11 ' A' ' 4' ' ' VAL . 8.5 p-10 -84.49 -36.5 22.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.777 HD11 HD22 ' B' ' 158' ' ' LEU . 3.7 mt -115.44 128.02 55.74 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.735 0.302 . . . . 0.0 111.218 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.77 140.37 34.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.351 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -57.27 110.43 0.84 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.068 0.461 . . . . 0.0 111.33 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 115.47 -16.44 16.98 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.264 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.09 132.68 54.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.389 0.594 . . . . 0.0 110.499 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 pt -79.15 106.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.854 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.688 HD13 HG12 ' B' ' 160' ' ' VAL . 36.8 mm -71.15 146.5 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.247 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 9.7 tp -109.5 -43.09 4.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.323 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.31 147.91 34.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.785 0.326 . . . . 0.0 111.461 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.433 HD11 HG21 ' B' ' 137' ' ' THR . 24.6 mt -137.86 118.14 16.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.39 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 133' ' ' ASN . . . . . 0.577 ' HB2' HD21 ' B' ' 148' ' ' LEU . 1.1 m120 56.79 37.34 28.74 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.102 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.17 16.36 80.76 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.985 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -120.73 142.72 49.26 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.82 0.31 . . . . 0.0 110.21 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.511 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.3 t -61.75 144.47 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.003 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.714 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -122.64 19.64 10.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.313 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.511 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.6 OUTLIER -112.0 142.15 44.77 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.365 179.608 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 53.15 9.08 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.218 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.23 176.12 9.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 111.268 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 47.2 t -91.93 142.74 27.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.423 HD12 ' OG ' ' A' ' 21' ' ' SER . 2.1 tt -61.09 -45.14 95.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.896 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 10.0 t -65.29 -37.14 86.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.845 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.2 -47.89 66.67 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.82 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.523 ' CB ' HD13 ' B' ' 106' ' ' ILE . . . -62.83 -40.42 97.36 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.843 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -61.68 -41.13 97.15 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.274 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -38.31 90.58 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.943 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 148' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' B' ' 133' ' ' ASN . 9.3 tt -59.6 -45.87 90.65 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.556 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.63 -36.72 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.795 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.94 -49.06 61.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.819 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -26.9 67.54 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.419 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 32.4 t -75.1 71.83 2.18 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.138 0.494 . . . . 0.0 110.634 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -86.57 97.9 10.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.328 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 147.46 -85.01 0.17 Allowed Glycine 0 C--O 1.228 -0.275 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.244 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 131.1 37.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.646 0.26 . . . . 0.0 110.682 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.746 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.59 143.64 51.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.002 0.429 . . . . 0.0 111.545 -179.565 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 32.7 tt0 -103.16 142.44 34.14 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.403 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.777 HD22 HD11 ' B' ' 123' ' ' LEU . 1.7 mp -136.24 128.34 29.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 110.951 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.402 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 18.7 t -117.09 134.01 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.688 HG12 HD13 ' B' ' 129' ' ' ILE . 22.6 m -124.44 156.32 32.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.195 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt -124.58 123.08 39.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -104.6 137.98 41.63 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.147 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.74 117.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.474 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.22 -24.08 63.04 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.356 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 165' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' B' ' 165' ' ' LEU . 0.2 OUTLIER -61.94 -29.77 70.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.669 0.271 . . . . 0.0 111.096 179.676 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.373 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.441 ' CE ' HD11 ' B' ' 161' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 pp -138.62 140.62 38.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.719 0.295 . . . . 0.0 111.081 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.12 157.79 22.84 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.507 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.812 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.5 t -131.55 134.99 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.302 . . . . 0.0 111.368 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.702 HD22 ' HE3' ' B' ' 155' ' ' LYS . 0.8 OUTLIER -100.5 107.24 18.9 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.512 179.535 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 tp -95.27 127.79 41.6 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.692 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.737 ' O ' HD22 ' B' ' 116' ' ' LEU . 3.2 ttt -106.99 165.67 11.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.954 0.407 . . . . 0.0 110.945 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -93.31 145.96 24.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.016 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -147.99 47.93 1.07 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.986 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.27 -147.14 0.25 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.211 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.58 79.43 1.91 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.893 0.378 . . . . 0.0 111.301 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.54 78.13 0.3 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.328 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -151.38 177.82 9.89 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.156 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.51 155.83 18.22 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.501 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.868 ' CE1' HD23 ' B' ' 156' ' ' LEU . 76.0 m-85 -60.13 -30.17 69.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.557 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.88 28.09 39.26 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.338 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.561 HD11 ' CB ' ' B' ' 117' ' ' ALA . 0.2 OUTLIER -106.59 120.54 42.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.673 0.273 . . . . 0.0 110.62 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.68 114.82 27.47 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.399 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.704 HD22 HD11 ' B' ' 149' ' ' ILE . 5.7 mp -98.09 124.92 42.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.153 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -110.23 177.88 19.83 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.764 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.5 OUTLIER -135.11 146.66 49.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.067 0.434 . . . . 0.0 111.321 -179.791 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -129.59 139.18 51.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.109 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.862 HD13 ' HB2' ' A' ' 62' ' ' ALA . 55.9 mt -88.11 120.41 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.036 0.446 . . . . 0.0 110.71 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -121.18 172.44 7.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.912 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.575 ' CG2' HD22 ' A' ' 40' ' ' LEU . 42.6 t -79.92 93.76 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.967 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -50.68 63.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.928 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.408 ' HB3' ' CG ' ' B' ' 101' ' ' ARG . 6.3 tt0 -158.47 151.82 23.01 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.985 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.48 146.01 41.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.122 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.455 HG23 ' O ' ' B' ' 99' ' ' GLY . 26.5 p -65.56 121.41 14.85 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.959 0.409 . . . . 0.0 110.767 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 151.08 22.1 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.101 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.05 31.74 13.34 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.281 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.76 -168.07 26.32 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.43 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 mt -70.32 -34.33 72.56 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 110.686 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.66 ' HA ' HD21 ' B' ' 89' ' ' LEU . . . -75.02 -33.7 61.81 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.896 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.1 -34.43 43.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.019 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.73 -38.76 82.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.406 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.9 -26.27 12.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.709 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.56 50.53 54.18 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.051 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.685 ' CG ' HG11 ' B' ' 87' ' ' VAL . 12.6 m120 -78.19 -34.19 49.65 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.575 HD22 ' CG2' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -129.07 137.41 51.25 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.672 0.272 . . . . 0.0 110.897 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 143.0 32.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.74 113.44 1.65 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 111.344 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.4 -17.44 14.2 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.845 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.464 ' HB3' HD23 ' A' ' 40' ' ' LEU . 9.8 t70 -59.57 136.98 58.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.094 0.473 . . . . 0.0 110.999 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -81.19 109.86 15.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.575 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.688 HD13 HD21 ' B' ' 102' ' ' LEU . 9.3 mt -79.93 145.2 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.217 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -110.87 -27.29 8.89 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.007 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.619 ' HE3' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -158.25 147.97 19.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.263 179.533 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 28.8 mt -142.32 117.9 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.739 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 51.09 33.41 9.18 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.306 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.43 83.17 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.609 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -105.16 129.02 53.65 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 117.141 0.47 . . . . 0.0 110.443 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.666 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.8 t -64.42 146.81 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.392 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.567 ' HA ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -105.35 -10.52 16.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.487 179.518 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.666 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -87.84 142.33 27.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 p30 53.39 9.44 0.16 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.668 0.605 . . . . 0.0 112.271 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 ttm -90.43 149.66 22.15 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.675 0.274 . . . . 0.0 110.596 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 m -71.71 139.22 49.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.762 0.315 . . . . 0.0 111.14 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.683 HD11 ' O ' ' B' ' 102' ' ' LEU . 12.1 tp -57.93 -42.68 85.34 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.396 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.8 m -56.98 -38.27 72.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.756 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -68.46 -47.93 65.86 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.533 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.862 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -61.04 -40.5 93.86 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.423 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -69.8 -38.44 76.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.5 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -38.34 85.47 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.52 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -44.5 94.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.873 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.724 HD11 HD22 ' B' ' 102' ' ' LEU . 10.6 mt -68.26 -37.49 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.72 0.295 . . . . 0.0 110.698 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.06 -37.96 78.8 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.946 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -89.8 1.42 56.17 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.1 p -90.94 56.52 3.23 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.196 0.522 . . . . 0.0 110.842 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.82 100.23 1.5 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.829 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.24 -91.52 0.17 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.273 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.65 135.44 47.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.571 0.224 . . . . 0.0 110.719 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.862 HD23 ' CE2' ' B' ' 98' ' ' TYR . 0.8 OUTLIER -129.31 130.31 45.97 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.949 0.404 . . . . 0.0 111.009 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 15.8 mt-30 -98.05 142.44 29.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.785 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.443 ' HG ' HD12 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -130.38 127.93 40.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.908 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.02 142.77 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.6 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.408 HG23 HG23 ' B' ' 85' ' ' ILE . 34.1 m -136.12 158.55 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.178 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 tp -88.68 122.17 31.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.952 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.2 138.97 34.69 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.932 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 67.36 166.17 0.23 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.104 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.0 m -121.55 84.96 2.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.889 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mp -75.63 -55.98 5.14 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.753 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.879 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 3.9 mmt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.432 0.158 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 85' ' ' ILE . . . . . 0.629 HD13 ' N ' ' B' ' 86' ' ' GLY . 0.0 OUTLIER -122.8 133.12 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.844 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 86' ' ' GLY . . . . . 0.629 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -151.55 159.92 28.49 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.938 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.685 HG11 ' CG ' ' A' ' 39' ' ' ASN . 7.1 t -129.17 134.7 63.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.707 0.289 . . . . 0.0 111.262 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.494 ' C ' HD23 ' B' ' 88' ' ' LEU . 9.7 tt -101.95 125.54 48.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.05 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.66 HD21 ' HA ' ' A' ' 34' ' ' ALA . 9.1 mp -112.35 124.72 53.1 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.966 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.3 ttt -116.07 159.26 21.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.632 0.73 . . . . 0.0 112.005 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.81 128.92 45.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.522 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.45 76.35 0.1 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.754 0.312 . . . . 0.0 111.11 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 177.41 36.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.022 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 41.31 75.01 0.09 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.863 0.363 . . . . 0.0 111.444 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -136.93 -176.78 4.48 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.996 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -118.45 113.0 20.68 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 46.89 -172.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.388 0.613 . . . . 0.0 112.444 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.862 ' CE2' HD23 ' A' ' 73' ' ' LEU . 85.2 m-85 -94.11 -29.39 15.19 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.468 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 29' ' ' THR . . . 75.94 29.72 58.6 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.884 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.73 125.5 51.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.646 0.26 . . . . 0.0 110.756 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 101' ' ' ARG . . . . . 0.408 ' CG ' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -108.09 114.61 28.63 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.012 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.724 HD22 HD11 ' A' ' 66' ' ' ILE . 3.6 mp -89.38 128.5 35.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.264 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.16 168.48 13.36 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.601 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 2.4 p -127.66 149.93 49.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.036 0.446 . . . . 0.0 111.196 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 105' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 21' ' ' SER . 6.9 pt20 -132.72 137.02 46.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.97 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.763 HD12 HG22 ' B' ' 137' ' ' THR . 69.4 mt -88.0 120.55 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 121.112 0.482 . . . . 0.0 110.482 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -122.82 172.79 8.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.972 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.844 HG21 ' HB3' ' B' ' 123' ' ' LEU . 39.3 t -80.42 95.96 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.778 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -65.69 -55.96 14.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.918 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.19 144.8 17.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.003 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -136.15 155.44 50.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.936 0.398 . . . . 0.0 111.394 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 11.8 p -78.62 124.59 28.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 ttp-105 -65.06 166.0 10.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.82 31.86 18.24 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.19 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -112.23 -158.05 13.91 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.259 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.737 HD22 ' O ' ' A' ' 7' ' ' MET . 2.0 mp -84.99 -29.96 24.59 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.526 0.203 . . . . 0.0 111.451 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.561 ' CB ' HD11 ' A' ' 17' ' ' LEU . . . -75.15 -37.49 61.33 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.634 0.254 . . . . 0.0 111.33 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -33.64 44.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.089 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -57.27 -40.86 78.59 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.198 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -102.09 -28.61 12.23 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.661 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.22 24.24 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.152 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.812 ' HB3' HG11 ' A' ' 4' ' ' VAL . 12.3 p-10 -74.22 -47.25 36.62 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.844 ' HB3' HG21 ' B' ' 108' ' ' VAL . 6.6 mp -123.68 123.41 40.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.673 0.273 . . . . 0.0 110.842 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.41 150.52 21.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.769 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -59.46 111.09 1.26 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.08 0.467 . . . . 0.0 111.082 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.83 -18.76 19.18 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 115.41 -0.813 . . . . 0.0 113.26 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 127' ' ' ASP . . . . . 0.476 ' HB3' HG11 ' B' ' 160' ' ' VAL . 23.0 m-20 -59.14 135.41 57.63 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.236 0.518 . . . . 0.0 110.701 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.417 ' O ' HG13 ' B' ' 160' ' ' VAL . 4.0 pt -81.77 113.7 21.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.196 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.756 HG21 HD11 ' B' ' 132' ' ' ILE . 5.7 mt -81.95 147.23 6.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.522 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.667 HD13 HD13 ' B' ' 161' ' ' LEU . 6.8 tt -110.25 -40.83 4.57 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.582 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -147.57 148.9 31.64 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.836 0.35 . . . . 0.0 111.937 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.756 HD11 HG21 ' B' ' 129' ' ' ILE . 32.6 mm -133.78 117.97 28.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 52.28 33.71 13.23 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.547 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.56 4.79 79.6 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.57 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 91.3 m -113.57 133.72 55.1 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 117.076 0.438 . . . . 0.0 110.464 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.456 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.6 t -59.1 146.16 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.763 HG22 HD12 ' B' ' 106' ' ' ILE . 0.2 OUTLIER -125.78 25.09 6.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.47 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.456 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.3 OUTLIER -113.03 130.88 55.99 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.073 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.5 m120 70.8 -4.44 1.71 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.425 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.475 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -67.22 172.05 5.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.79 0.328 . . . . 0.0 111.007 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 43.4 t -88.34 145.33 25.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.375 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -40.84 83.24 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.848 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -39.21 86.62 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.81 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -65.57 -47.18 76.66 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.835 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.724 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -60.69 -40.94 94.05 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -69.52 -38.0 77.39 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.637 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -65.85 -40.1 91.39 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.947 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.03 -43.84 98.29 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.678 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.704 HD11 HD22 ' A' ' 19' ' ' LEU . 14.0 mt -68.32 -37.4 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.762 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -68.22 -49.58 59.77 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.044 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -68.39 -22.86 64.61 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.466 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.8 m -76.28 68.15 2.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.018 0.437 . . . . 0.0 110.771 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.13 91.31 7.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.467 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 155.85 -94.7 0.14 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.298 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.702 ' HE3' HD22 ' A' ' 5' ' ' LEU . 21.8 tttp -126.42 132.31 51.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.624 0.25 . . . . 0.0 110.406 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.868 HD23 ' CE1' ' A' ' 15' ' ' TYR . 1.3 pp -128.69 144.14 51.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 21.9 tt0 -111.05 143.05 42.37 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.633 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.749 HD23 HD12 ' B' ' 132' ' ' ILE . 0.5 OUTLIER -133.82 128.2 34.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.679 0.276 . . . . 0.0 110.969 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 12.9 t -112.2 131.89 62.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.519 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 160' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' B' ' 127' ' ' ASP . 21.3 t -130.0 143.46 40.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.889 0.376 . . . . 0.0 111.496 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.667 HD13 HD13 ' B' ' 130' ' ' LEU . 0.3 OUTLIER -107.36 123.26 48.1 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.775 179.653 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 162' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' B' ' 163' ' ' ASP . 0.2 OUTLIER 65.95 176.69 0.22 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.956 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 163' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' B' ' 162' ' ' ARG . 36.0 t70 177.31 156.93 0.33 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.676 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.8 t 60.39 33.84 20.7 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.961 0.41 . . . . 0.0 110.831 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.36 -178.86 5.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.827 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.169 -179.964 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttm . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 120.381 0.134 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp -117.3 126.55 74.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.865 0.364 . . . . 0.0 111.069 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.37 165.13 12.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.667 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.683 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.6 t -129.97 134.71 62.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 120.653 0.264 . . . . 0.0 111.116 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.439 HD22 ' HE2' ' B' ' 155' ' ' LYS . 1.7 mt -99.86 106.85 18.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.751 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.438 ' O ' HD23 ' B' ' 156' ' ' LEU . 4.4 tp -100.94 127.52 47.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.452 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.67 159.53 14.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.823 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.98 116.2 28.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.832 0.349 . . . . 0.0 110.971 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.3 t -147.84 113.7 5.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.24 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.74 58.77 2.72 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.119 0.485 . . . . 0.0 110.633 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.78 111.07 7.03 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.846 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.28 124.3 31.08 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.688 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 74.66 65.58 0.08 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.996 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 59.66 -172.52 0.12 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.552 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.684 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 70.0 m-85 -63.58 -30.45 71.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.158 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.75 22.59 33.1 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.667 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 15' ' ' TYR . 6.0 mp -101.71 118.31 36.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.827 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.16 113.54 25.33 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.274 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.848 HD22 HD11 ' B' ' 149' ' ' ILE . 1.0 OUTLIER -97.71 124.95 42.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.152 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -115.21 -172.77 17.37 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.778 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.592 ' OG ' HD12 ' B' ' 142' ' ' LEU . 0.2 OUTLIER -144.09 151.36 39.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.813 0.34 . . . . 0.0 110.935 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -133.11 134.47 44.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.963 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.779 ' HB ' HG22 ' A' ' 54' ' ' THR . 50.0 mt -87.82 120.18 36.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.061 0.458 . . . . 0.0 110.15 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -123.31 171.2 9.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.913 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.9 t -84.6 97.04 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.087 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -40.17 96.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.916 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -170.22 156.42 5.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.02 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -138.37 157.24 46.62 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.862 0.363 . . . . 0.0 111.159 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.43 126.53 28.54 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -62.07 145.03 54.4 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.77 33.26 22.69 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.472 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.59 -167.71 31.08 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.321 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 mt -67.23 -35.59 79.88 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.581 0.229 . . . . 0.0 111.211 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -75.08 -35.19 61.82 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.163 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.84 -33.87 45.62 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.022 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -40.23 81.83 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.245 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.1 -27.62 12.81 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.73 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.61 43.75 51.46 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.035 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.602 ' HB3' HG11 ' B' ' 87' ' ' VAL . 24.7 p-10 -59.71 -48.91 79.8 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -138.43 147.28 43.14 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.697 0.284 . . . . 0.0 110.91 179.752 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 156.68 16.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.519 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 1.2 pt-20 -71.46 121.95 19.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.492 0.663 . . . . 0.0 109.898 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.41 3.24 35.38 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.948 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -85.94 135.14 33.79 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.419 0.609 . . . . 0.0 110.485 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.429 HD13 ' H ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -73.88 112.21 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.022 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.421 HD13 HD11 ' A' ' 49' ' ' ILE . 30.7 mt -79.04 146.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.502 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 78' ' ' LEU . 10.4 tp -102.57 -43.95 5.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.394 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -151.93 150.98 30.65 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 111.372 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 28.3 mt -140.91 118.09 8.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.726 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.486 ' HB2' HD13 ' A' ' 65' ' ' LEU . 1.9 m120 54.44 33.72 19.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.125 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.0 -2.39 87.05 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.123 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.1 m -104.64 126.46 51.75 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.985 0.393 . . . . 0.0 110.385 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.9 t -59.37 146.19 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.881 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.779 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.96 14.05 18.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.566 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.617 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -106.91 132.92 52.32 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.343 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.538 ' HB2' HD13 ' B' ' 142' ' ' LEU . 1.3 p-10 53.18 8.89 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 123.672 0.608 . . . . 0.0 112.579 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 31.2 tpp -82.69 161.06 22.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.686 0.279 . . . . 0.0 110.831 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.91 128.21 35.03 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.987 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.464 HD12 ' OG ' ' B' ' 104' ' ' SER . 9.9 tt -53.15 -42.57 66.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -61.65 -38.49 87.93 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.221 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.04 -48.05 77.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.939 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.683 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -61.42 -39.34 90.39 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.061 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -71.03 -35.47 72.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.654 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.1 tpmp? -66.5 -40.73 89.38 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.026 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.595 HD23 ' HA ' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -62.66 -41.79 99.26 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.868 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.8 mt -68.3 -38.06 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.033 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -48.99 62.44 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -64.19 -26.59 68.59 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.062 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.4 t -83.97 93.34 8.04 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.797 0.332 . . . . 0.0 110.707 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.48 40.38 1.27 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -143.71 -87.68 0.09 OUTLIER Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.273 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.65 133.52 50.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.758 -0.221 . . . . 0.0 110.558 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.788 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.8 OUTLIER -125.03 134.02 52.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.044 0.45 . . . . 0.0 111.369 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -97.65 141.08 31.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.464 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.631 ' HB2' HD11 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -137.12 124.6 22.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.73 0.3 . . . . 0.0 110.856 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.5 143.51 30.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.218 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.534 HG13 HD22 ' A' ' 40' ' ' LEU . 3.3 m -127.47 154.75 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.056 0.455 . . . . 0.0 111.705 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 47' ' ' LEU . 5.6 tp -109.82 137.77 47.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.534 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 63.93 -174.6 0.16 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.576 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 67.38 125.97 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.744 0.307 . . . . 0.0 111.438 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p 67.36 144.23 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.111 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 mt 68.38 154.25 0.1 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.048 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.969 -179.977 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.65 0.262 . . . . 0.0 111.706 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.59 152.62 23.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.733 0.301 . . . . 0.0 111.239 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.4 158.63 22.18 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.618 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 39' ' ' ASN . 20.9 t -129.76 134.52 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.652 0.263 . . . . 0.0 111.292 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 8.8 tt -99.82 110.06 22.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.344 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.462 HD21 ' N ' ' A' ' 34' ' ' ALA . 2.8 tp -99.37 143.14 29.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.66 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 21.8 ttt -117.72 162.75 17.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.206 0.527 . . . . 0.0 111.316 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.28 145.53 28.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.001 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.33 70.38 0.19 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.017 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 41.2 mtt-85 61.07 92.79 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.612 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.1 29.84 1.45 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.979 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 69.06 -69.37 0.16 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.367 0.267 . . . . 0.0 111.523 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -160.12 118.66 2.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.74 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' B' ' 98' ' ' TYR . 33.0 tt0 66.14 165.34 0.19 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 98' ' ' TYR . . . . . 0.788 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 58.8 m-85 -63.82 -27.06 68.92 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.207 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.76 22.17 37.35 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.727 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 100' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 34' ' ' ALA . 3.5 mp -104.22 125.55 50.59 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.747 0.308 . . . . 0.0 110.552 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -105.97 113.82 27.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.21 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.683 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.8 pt? -106.66 124.96 50.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.192 0.52 . . . . 0.0 111.642 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 103' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' A' ' 59' ' ' LEU . . . -105.71 -165.15 23.39 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.978 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 104' ' ' SER . . . . . 0.464 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -145.67 148.86 33.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.825 0.345 . . . . 0.0 111.17 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -132.45 139.03 47.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.153 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 106' ' ' ILE . . . . . 0.941 HD13 ' HB2' ' B' ' 145' ' ' ALA . 10.8 mt -88.19 120.62 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 110.588 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -122.42 171.98 8.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.181 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.894 HG21 ' HB3' ' B' ' 123' ' ' LEU . 29.7 t -82.08 98.04 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.806 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.03 -53.26 40.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.195 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.43 ' HA ' ' HG2' ' B' ' 125' ' ' GLU . 2.6 pt-20 -162.06 138.67 8.04 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.927 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.2 161.35 19.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 111.31 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.5 p -78.03 120.26 22.61 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.65 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -61.34 149.28 38.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.157 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.2 m 67.67 25.51 8.14 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.377 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.18 -171.18 27.24 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.42 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -29.32 62.88 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.07 -34.42 61.78 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.124 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 1.2 p -78.94 -34.15 44.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.95 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -38.63 83.76 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.358 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -102.02 -31.2 10.77 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.401 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.26 45.96 28.83 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.251 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' ASN . . . . . 0.683 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.0 p-10 -75.68 -39.28 57.81 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.539 0.17 . . . . 0.0 111.4 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.894 ' HB3' HG21 ' B' ' 108' ' ' VAL . 16.2 mt -121.82 121.86 38.16 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.994 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.48 147.31 23.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' B' ' 110' ' ' GLU . 4.8 mt-10 -59.45 111.22 1.31 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.955 0.407 . . . . 0.0 111.17 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.31 -16.33 24.68 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.46 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -58.13 134.35 56.39 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.408 0.604 . . . . 0.0 110.777 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 8.5 pt -83.74 99.79 6.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.601 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.618 ' HB ' HG21 ' B' ' 137' ' ' THR . 9.9 mt -66.78 136.74 26.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.246 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 tp -96.09 -42.13 8.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.619 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -146.23 147.79 31.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.764 0.316 . . . . 0.0 111.548 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 34.2 mt -134.9 117.93 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.757 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.9 44.18 28.35 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.494 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.22 18.42 78.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.008 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 30.6 m -120.72 142.22 49.71 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.597 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.9 t -62.81 146.08 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.982 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 137' ' ' THR . . . . . 0.807 HG22 ' HB ' ' B' ' 106' ' ' ILE . 1.4 m -120.98 16.94 11.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.917 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 138' ' ' GLU . . . . . 0.597 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.3 tt0 -117.45 131.34 56.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.6 m120 71.12 -6.55 1.29 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.554 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 140' ' ' MET . . . . . 0.637 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.9 OUTLIER -67.2 171.49 5.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.002 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 20.8 m -87.35 139.6 30.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.218 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 142' ' ' LEU . . . . . 0.592 HD12 ' OG ' ' A' ' 21' ' ' SER . 9.0 tt -56.01 -44.87 79.11 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 58.1 p -61.91 -40.2 94.64 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.805 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -62.97 -48.08 80.42 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.941 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.19 -42.03 85.23 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.071 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -69.49 -37.46 77.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.746 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -68.11 -39.4 82.81 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.661 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.92 -43.8 94.69 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.675 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.848 HD11 HD22 ' A' ' 19' ' ' LEU . 11.7 mt -68.27 -37.58 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.837 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.78 -49.68 56.65 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -21.64 63.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.294 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 37.8 t -82.2 66.48 7.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.13 0.491 . . . . 0.0 110.532 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -77.24 122.78 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 126.01 -92.09 0.4 Allowed Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.158 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.439 ' HE2' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -128.59 133.72 48.4 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.591 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 156' ' ' LEU . . . . . 0.684 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -124.3 143.01 50.81 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.925 0.393 . . . . 0.0 111.357 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.648 ' O ' HD13 ' B' ' 158' ' ' LEU . 2.6 tt0 -105.23 131.67 52.4 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.849 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 158' ' ' LEU . . . . . 0.648 HD13 ' O ' ' B' ' 157' ' ' GLN . 0.4 OUTLIER -127.78 133.47 49.46 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.82 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.29 140.1 44.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.669 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 9.0 m -133.24 152.02 34.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.421 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 4.3 mt -103.72 123.68 47.49 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -132.16 159.98 37.38 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.969 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 1.3 t0 63.0 87.27 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.909 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 18.8 m -81.44 115.56 20.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.009 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 4.8 mt -135.78 90.64 2.62 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.834 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.443 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.819 0.342 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -96.28 157.48 21.47 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.402 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' B' ' 122' ' ' ASN . 21.4 t -131.35 134.03 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.708 0.29 . . . . 0.0 111.288 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.76 HD23 ' HD3' ' B' ' 155' ' ' LYS . 4.0 mp -103.13 115.02 29.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.508 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.505 HD21 ' N ' ' B' ' 117' ' ' ALA . 3.5 tp -104.98 126.28 51.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.709 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.71 ' O ' HD13 ' B' ' 116' ' ' LEU . 0.0 OUTLIER -98.16 161.41 13.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.743 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.983 -179.806 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 . . . . . 0 C--O 1.234 0.26 0 CA-C-O 120.744 0.307 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.709 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 78.7 m-85 -58.24 -23.15 54.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.346 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.93 27.53 68.6 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.432 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.495 HD11 ' CB ' ' B' ' 117' ' ' ALA . 0.2 OUTLIER -103.06 120.84 41.39 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.631 0.253 . . . . 0.0 110.782 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.406 ' HB2' ' HG3' ' B' ' 110' ' ' GLU . 0.2 OUTLIER -98.48 113.36 25.35 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.463 HD22 HD11 ' B' ' 149' ' ' ILE . 10.1 mp -105.99 124.95 50.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 111.215 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.19 178.31 19.49 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.637 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.562 ' OG ' HD12 ' B' ' 142' ' ' LEU . 0.6 OUTLIER -139.99 142.92 36.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.152 0.476 . . . . 0.0 111.205 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' B' ' 104' ' ' SER . 11.0 pt20 -129.31 154.42 46.88 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.673 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.593 HD11 ' HB3' ' A' ' 57' ' ' MET . 3.2 mt -90.32 120.77 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.378 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.406 ' CE1' ' CG ' ' B' ' 105' ' ' GLN . 39.9 p90 -118.31 173.02 7.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.558 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.871 HG21 ' HB3' ' A' ' 40' ' ' LEU . 21.5 t -79.16 94.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.102 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -48.94 71.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.423 ' HG2' ' HB3' ' B' ' 101' ' ' ARG . 5.1 pt-20 -167.01 153.74 8.54 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.907 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.37 161.47 34.43 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.834 0.35 . . . . 0.0 111.063 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -70.55 135.66 48.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.002 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -68.91 144.75 54.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.707 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 58.06 31.02 20.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.337 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.78 -174.35 29.37 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.165 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.591 HD13 ' O ' ' B' ' 90' ' ' MET . 0.2 OUTLIER -67.22 -31.06 71.17 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.45 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -75.15 -39.06 60.7 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.568 0.223 . . . . 0.0 111.452 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -33.71 44.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.167 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -63.28 -37.06 85.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.382 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -100.3 -30.91 11.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.684 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.25 47.14 24.25 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.341 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.665 ' CB ' HG11 ' B' ' 87' ' ' VAL . 10.4 p-10 -63.07 -48.33 79.12 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.46 0.171 . . . . 0.0 111.319 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.871 ' HB3' HG21 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -134.06 144.29 48.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.723 0.296 . . . . 0.0 111.21 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 148.24 22.35 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.629 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 27' ' ' GLU . 4.5 mt-10 -59.01 110.91 1.13 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 111.234 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.75 -16.4 21.15 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.191 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -60.39 134.71 57.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.244 0.522 . . . . 0.0 110.704 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.8 pt -79.86 119.86 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.961 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.709 ' HB ' HG21 ' A' ' 54' ' ' THR . 38.0 mt -88.97 137.54 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.961 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.82 -41.82 8.27 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.329 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.68 147.67 34.62 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.744 0.306 . . . . 0.0 111.069 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.418 HG13 ' OG1' ' A' ' 54' ' ' THR . 14.7 mt -136.65 117.94 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.676 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 52.25 44.54 29.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 111.224 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.17 17.86 76.15 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.042 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.3 m -120.74 139.39 53.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.759 0.28 . . . . 0.0 110.374 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.5 t -59.8 145.86 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.149 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.709 HG21 ' HB ' ' A' ' 46' ' ' ILE . 2.5 m -120.69 20.89 11.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.686 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.512 ' H ' HG12 ' A' ' 53' ' ' VAL . 2.7 tt0 -119.33 129.65 54.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 70.66 -7.67 1.02 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.57 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.593 ' HB3' HD11 ' A' ' 23' ' ' ILE . 10.5 ttt -66.07 150.66 48.36 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.808 0.337 . . . . 0.0 110.622 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.9 t -71.8 143.47 49.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.079 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' B' ' 139' ' ' ASN . 1.1 tt -57.73 -46.19 84.78 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -40.43 82.37 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.055 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -64.08 -47.64 79.31 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.006 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.501 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -59.25 -41.55 89.02 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.003 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -37.96 81.74 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.635 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -38.68 83.18 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.733 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.417 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -59.87 -43.32 94.79 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.923 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.668 HD11 HD22 ' B' ' 102' ' ' LEU . 14.3 mt -68.18 -37.84 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.546 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -66.83 -49.56 65.38 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.781 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 65' ' ' LEU . 14.6 pttp -68.77 -22.22 64.3 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.437 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.9 t -74.87 73.15 2.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.034 0.445 . . . . 0.0 110.704 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.26 105.84 16.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.474 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.1 -91.19 0.21 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.239 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -129.34 134.11 47.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.735 0.302 . . . . 0.0 110.652 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.881 HD23 ' CE2' ' B' ' 98' ' ' TYR . 2.1 pp -123.47 143.96 49.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.488 ' OE1' HD11 ' B' ' 88' ' ' LEU . 31.9 tt0 -112.22 140.48 46.88 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.867 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.774 HD11 HD11 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -135.42 128.64 31.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.861 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.0 t -109.74 138.84 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.939 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.781 HG22 HD21 ' A' ' 40' ' ' LEU . 4.2 t -121.13 154.31 24.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.288 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 N--CA 1.463 0.197 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.511 179.335 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.523 ' C ' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.876 0.369 . . . . 0.0 111.007 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.48 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -120.02 157.69 15.55 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.791 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.665 HG11 ' CB ' ' A' ' 39' ' ' ASN . 16.8 t -131.58 135.31 59.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.769 0.318 . . . . 0.0 111.313 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.488 HD11 ' OE1' ' A' ' 74' ' ' GLN . 2.7 mp -104.47 114.94 29.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.62 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 tp -102.16 133.36 47.13 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.978 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . 0.591 ' O ' HD13 ' A' ' 33' ' ' LEU . 5.7 ttm -105.06 164.47 11.78 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.036 0.446 . . . . 0.0 110.95 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 3.7 pttm . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.908 179.8 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 120.713 0.292 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.881 ' CE2' HD23 ' A' ' 73' ' ' LEU . 70.6 m-85 -77.0 -32.12 56.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.394 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.73 26.83 55.57 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.394 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.672 HD13 ' HB3' ' B' ' 98' ' ' TYR . 6.2 mp -104.83 123.12 47.13 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 110.812 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . 0.423 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -98.03 113.68 25.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.245 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.668 HD22 HD11 ' A' ' 66' ' ' ILE . 1.9 mp -98.26 124.69 43.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.983 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.88 166.21 12.14 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.918 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 1.6 p -121.07 150.71 40.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.028 0.414 . . . . 0.0 111.244 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -137.49 145.38 42.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.459 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.633 HD12 HG23 ' B' ' 137' ' ' THR . 2.6 mt -88.86 121.14 38.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.175 0.512 . . . . 0.0 111.324 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -118.78 174.54 6.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.568 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 0.919 HG21 ' HB3' ' B' ' 123' ' ' LEU . 39.0 t -83.37 95.57 3.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.135 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -63.32 -56.33 17.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 110.573 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.406 ' HG3' ' HB2' ' A' ' 18' ' ' ARG . 14.0 pt-20 -163.99 146.26 9.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -133.37 156.02 48.4 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.804 0.335 . . . . 0.0 111.349 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.26 132.49 49.2 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -67.57 147.82 52.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.929 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 5.2 m 61.85 33.78 17.45 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.243 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.38 -170.31 28.08 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.146 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.71 HD13 ' O ' ' A' ' 7' ' ' MET . 7.4 mt -72.84 -30.06 63.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.676 0.238 . . . . 0.0 111.477 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.505 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -75.18 -36.73 61.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.173 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.79 -33.86 52.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -61.57 -38.43 87.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.217 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.88 -28.29 13.18 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.763 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.55 39.07 50.67 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.266 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.464 ' HB3' HG11 ' A' ' 4' ' ' VAL . 26.2 p-10 -59.51 -42.4 92.12 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.919 ' HB3' HG21 ' B' ' 108' ' ' VAL . 1.1 mt -133.05 143.87 49.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.766 0.317 . . . . 0.0 111.171 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.04 141.39 28.59 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.56 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -58.19 109.71 0.81 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.104 0.478 . . . . 0.0 110.789 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 108' ' ' VAL . . . 104.99 -15.75 47.47 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.592 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . 0.593 ' OD1' HG13 ' B' ' 160' ' ' VAL . 10.1 t70 -62.54 141.97 58.19 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.172 0.511 . . . . 0.0 111.459 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.438 HG22 ' NE2' ' B' ' 105' ' ' GLN . 29.6 pt -79.8 127.96 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.898 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.865 ' HB ' HG21 ' B' ' 137' ' ' THR . 26.8 mt -94.91 143.79 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.425 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.404 ' CD1' HD12 ' B' ' 161' ' ' LEU . 0.8 OUTLIER -97.46 -36.63 10.28 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.629 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -154.81 152.43 29.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.627 0.251 . . . . 0.0 111.28 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.539 HG23 ' CD1' ' B' ' 158' ' ' LEU . 10.0 mt -132.4 117.5 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.324 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . 0.412 ' HB2' ' CD1' ' B' ' 148' ' ' LEU . 2.4 m120 51.16 34.7 11.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.373 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.63 85.7 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.178 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 58.6 m -102.47 132.48 48.48 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.955 0.377 . . . . 0.0 110.201 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.454 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.4 t -54.19 145.32 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.075 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.865 HG21 ' HB ' ' B' ' 129' ' ' ILE . 27.8 m -113.59 20.19 16.18 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.662 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.454 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.6 OUTLIER -119.44 127.7 53.33 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . 0.417 ' HA ' HD12 ' A' ' 59' ' ' LEU . 2.4 m-80 70.56 -5.55 1.39 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.755 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.484 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.1 OUTLIER -65.25 169.75 5.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.858 0.361 . . . . 0.0 111.131 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.38 146.77 23.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.481 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.562 HD12 ' OG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -61.71 -42.22 98.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.004 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 44.2 p -64.12 -39.44 94.04 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.982 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -63.74 -47.92 79.11 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.931 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.37 90.26 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -69.33 -38.86 78.39 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.546 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -67.43 -38.06 83.97 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.631 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' B' ' 133' ' ' ASN . 0.2 OUTLIER -60.04 -44.57 94.58 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.63 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.618 HG23 HD13 ' B' ' 156' ' ' LEU . 37.9 mt -68.4 -37.57 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.928 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -69.48 -49.22 56.85 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.787 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -24.92 66.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.628 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 99.6 p -83.53 61.17 6.08 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.053 0.454 . . . . 0.0 110.746 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -69.65 110.96 5.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.568 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.62 -84.08 0.3 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . 0.76 ' HD3' HD23 ' A' ' 5' ' ' LEU . 2.9 ttmm -132.24 135.14 46.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.657 0.265 . . . . 0.0 110.792 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.709 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -128.64 143.49 50.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.939 0.4 . . . . 0.0 111.11 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.633 ' C ' HD22 ' B' ' 158' ' ' LEU . 50.3 tt0 -105.61 142.76 34.79 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.213 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.633 HD22 ' C ' ' B' ' 157' ' ' GLN . 3.6 mm? -134.98 146.84 49.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.314 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 6.2 t -120.67 128.93 76.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.299 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.593 HG13 ' OD1' ' B' ' 127' ' ' ASP . 53.9 t -122.31 146.63 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.617 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . 0.404 HD12 ' CD1' ' B' ' 130' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.524 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.729 0.299 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.96 159.93 23.43 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.654 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' B' ' 122' ' ' ASN . 27.3 t -123.56 131.76 72.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.696 0.284 . . . . 0.0 110.977 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 tt -100.28 108.57 20.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.706 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.521 HD21 ' N ' ' B' ' 117' ' ' ALA . 4.1 tp -95.88 136.58 36.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.718 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.611 ' O ' HD13 ' B' ' 116' ' ' LEU . 24.4 ttm -110.75 165.09 12.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.013 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.421 ' HE3' ' HA2' ' B' ' 154' ' ' GLY . 10.7 pttp . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.977 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 N--CA 1.47 0.565 0 CA-C-O 121.352 0.596 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.692 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 64.9 m-85 -88.26 -32.24 18.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.312 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.13 23.32 35.18 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.733 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 15' ' ' TYR . 3.4 mp -104.98 115.46 30.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.786 0.293 . . . . 0.0 110.794 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.99 113.53 22.83 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.68 HD22 HD11 ' B' ' 149' ' ' ILE . 1.7 mp -102.02 124.8 48.26 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.596 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -114.82 -167.51 15.57 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.77 147.92 31.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.241 0.521 . . . . 0.0 111.136 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -133.47 140.57 47.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.414 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.895 HD13 ' HB2' ' A' ' 62' ' ' ALA . 27.5 mt -88.22 120.55 37.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.41 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.414 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 40.1 p90 -122.26 173.95 7.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.01 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.762 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.1 t -80.16 94.12 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.778 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.42 ' HE2' ' HG2' ' B' ' 138' ' ' GLU . 0.0 OUTLIER -65.12 -56.25 14.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.039 -179.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -147.53 151.18 35.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.77 ' SD ' HG23 ' A' ' 35' ' ' THR . 3.2 tmm? -138.26 142.72 39.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.82 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.76 120.06 12.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.623 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 153.68 23.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.083 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.98 22.46 12.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.327 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.87 -168.77 36.55 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.568 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.507 ' H ' HD12 ' A' ' 33' ' ' LEU . 1.1 mp -71.34 -30.8 66.62 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -74.97 -33.39 61.88 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.77 HG23 ' SD ' ' A' ' 28' ' ' MET . 0.7 OUTLIER -79.14 -34.7 43.05 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.176 179.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -36.88 85.12 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.21 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -98.39 -37.56 9.57 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.424 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.35 45.7 9.67 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.789 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.616 ' CB ' HG11 ' B' ' 87' ' ' VAL . 13.3 p-10 -71.93 -49.45 37.48 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.762 ' HB3' HG21 ' A' ' 25' ' ' VAL . 4.8 mp -129.82 132.01 46.35 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.661 0.267 . . . . 0.0 111.107 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.25 145.95 24.06 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.651 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -58.05 111.84 1.32 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.077 0.465 . . . . 0.0 111.075 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.68 -19.4 12.55 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.856 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -62.9 134.27 55.95 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.105 0.452 . . . . 0.0 110.587 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 pt -78.65 130.25 36.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.058 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.635 HD13 HD21 ' B' ' 102' ' ' LEU . 5.1 mt -96.07 138.06 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.503 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.004 HD13 HD21 ' A' ' 78' ' ' LEU . 2.8 tp -98.93 -40.61 7.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.984 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.403 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -152.49 148.21 27.14 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.832 0.349 . . . . 0.0 111.409 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.472 ' CG1' HG21 ' A' ' 46' ' ' ILE . 42.1 mt -138.74 118.83 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.66 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 53.23 44.64 29.93 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 111.182 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.47 15.37 72.88 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.172 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 m -120.84 135.45 55.17 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.855 0.328 . . . . 0.0 110.389 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.2 t -62.67 146.98 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.927 0.394 . . . . 0.0 111.266 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.671 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -126.71 16.32 7.5 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.334 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.662 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -112.7 131.61 55.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 71.46 -6.18 1.44 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.281 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.478 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.85 175.03 6.9 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.9 m -90.14 143.81 26.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.496 HD12 ' OG ' ' B' ' 104' ' ' SER . 2.2 tt -58.41 -40.48 82.57 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.788 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 m -63.17 -42.06 99.34 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.88 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -63.99 -48.05 77.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.768 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.895 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -60.47 -40.57 91.7 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.169 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.477 ' HA ' HD12 ' A' ' 66' ' ' ILE . 4.6 ttt-85 -63.62 -41.03 98.33 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.949 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -38.27 86.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.711 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 tp -60.75 -43.4 98.03 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.903 HD11 HD22 ' B' ' 102' ' ' LEU . 5.6 mt -67.21 -38.01 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.681 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -67.65 -49.51 62.56 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -64.31 -23.28 67.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.257 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 t -75.7 73.03 2.67 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.123 0.487 . . . . 0.0 110.821 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.15 100.63 13.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.552 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.08 -95.33 0.19 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.943 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.18 135.84 49.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.591 0.234 . . . . 0.0 110.439 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.707 HD11 HD21 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -128.12 141.83 51.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.093 0.473 . . . . 0.0 111.309 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -101.87 128.36 48.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.112 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.707 HD21 HD11 ' A' ' 73' ' ' LEU . 1.7 mp -126.53 129.18 48.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.664 0.269 . . . . 0.0 111.383 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.408 ' HA ' ' HA2' ' B' ' 86' ' ' GLY . 8.3 m -119.57 114.8 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.685 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -107.9 157.57 8.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.541 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.004 HD21 HD13 ' A' ' 47' ' ' LEU . 4.4 mt . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.831 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.728 0.299 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -105.43 155.87 16.83 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.632 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.616 HG11 ' CB ' ' A' ' 39' ' ' ASN . 17.4 t -131.49 135.11 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.725 0.297 . . . . 0.0 111.118 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 4.7 tt -103.65 107.12 17.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.612 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 21.3 tp -99.88 129.27 45.95 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.332 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.4 ttt -109.37 164.64 12.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.984 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.991 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 . . . . . 0 N--CA 1.471 0.581 0 CA-C-O 121.314 0.578 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.498 ' CE2' HD22 ' A' ' 73' ' ' LEU . 69.0 m-85 -71.49 -32.03 67.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.417 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.01 26.74 47.94 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.467 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 34' ' ' ALA . 4.2 mp -104.73 116.64 32.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.665 0.269 . . . . 0.0 110.846 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -92.74 113.52 25.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.231 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.903 HD22 HD11 ' A' ' 66' ' ' ILE . 5.0 mp -94.79 125.01 39.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.288 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . 0.443 ' HA2' HD11 ' A' ' 59' ' ' LEU . . . -110.27 178.36 20.02 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.581 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.496 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -136.12 146.45 46.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.094 0.447 . . . . 0.0 111.017 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -134.1 141.79 47.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.43 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.703 HD11 ' HB3' ' B' ' 140' ' ' MET . 5.6 mt -88.14 122.05 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.597 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -122.25 171.47 9.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.047 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 0.735 HG21 ' CD2' ' B' ' 123' ' ' LEU . 38.8 t -83.78 93.59 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.059 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . 0.413 ' HG3' ' HA3' ' A' ' 20' ' ' GLY . 7.1 mtpt -61.94 -51.55 67.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.64 121.44 3.72 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.102 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.402 ' HG2' ' HG3' ' B' ' 125' ' ' GLU . 1.0 OUTLIER -116.92 143.89 45.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.025 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 36.1 p -65.65 137.17 57.15 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.628 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . 0.643 ' HA ' HG21 ' B' ' 118' ' ' THR . 0.0 OUTLIER -79.07 162.87 25.58 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.997 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.4 m 59.73 23.07 11.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.286 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.6 -154.99 27.36 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.095 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.611 HD13 ' O ' ' A' ' 7' ' ' MET . 2.2 mt -82.86 -33.38 27.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.529 0.204 . . . . 0.0 111.374 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.521 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -73.12 -35.43 66.53 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.165 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.643 HG21 ' HA ' ' B' ' 113' ' ' ARG . 1.3 p -78.63 -33.88 46.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.277 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -60.83 -38.35 85.15 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.311 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -100.19 -36.05 9.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.42 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.06 44.03 7.28 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.907 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.624 ' HA ' HG21 ' A' ' 4' ' ' VAL . 7.0 p30 -55.38 -54.1 47.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.383 0.135 . . . . 0.0 111.261 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.735 ' CD2' HG21 ' B' ' 108' ' ' VAL . 0.0 OUTLIER -142.4 156.66 45.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 111.296 179.169 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.81 150.8 20.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.591 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' B' ' 111' ' ' MET . 5.3 mt-10 -59.83 109.44 0.94 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.092 0.472 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 111.04 0.08 28.49 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.98 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -78.42 138.66 38.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 117.347 0.573 . . . . 0.0 110.719 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -76.1 124.38 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.327 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.855 ' HB ' HG21 ' B' ' 137' ' ' THR . 19.8 mt -91.99 144.05 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.173 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 tp -98.39 -41.89 7.61 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.356 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -145.83 148.06 32.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 111.195 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 32.2 mt -138.35 118.42 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.809 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . 0.556 ' HB3' HD11 ' B' ' 148' ' ' LEU . 2.3 t-20 53.87 48.09 22.09 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.317 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 65.58 18.02 65.3 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.993 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.21 144.8 47.54 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.667 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.0 t -63.52 146.88 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.855 HG21 ' HB ' ' B' ' 129' ' ' ILE . 18.2 m -115.32 1.42 13.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.865 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.667 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.5 tt0 -100.39 131.63 46.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.67 0.271 . . . . 0.0 110.357 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 71.85 -7.65 1.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.435 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.703 ' HB3' HD11 ' B' ' 106' ' ' ILE . 36.7 ttm -65.51 155.42 35.69 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.012 0.434 . . . . 0.0 111.377 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 28.6 t -79.58 149.56 31.33 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.387 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 tt -60.8 -48.13 83.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.893 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 39.1 p -58.47 -38.22 77.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.882 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.21 -43.21 95.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.841 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.655 ' HB1' HG21 ' B' ' 106' ' ' ILE . . . -59.71 -42.88 94.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.173 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -67.67 -38.3 83.57 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.654 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -67.63 -38.35 83.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.485 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . 0.556 HD11 ' HB3' ' B' ' 133' ' ' ASN . 0.1 OUTLIER -60.3 -44.09 95.71 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.844 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.68 HD11 HD22 ' A' ' 19' ' ' LEU . 15.7 mt -68.13 -37.7 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.915 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -69.16 -48.39 62.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.773 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -71.22 -23.62 62.05 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.992 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 80.1 p -77.25 66.97 3.12 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.147 0.498 . . . . 0.0 110.628 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -74.51 127.94 34.31 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.564 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . 0.421 ' HA2' ' HE3' ' A' ' 8' ' ' LYS . . . 109.39 -91.64 0.66 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.274 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -124.17 138.36 54.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.692 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -129.71 135.19 48.19 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.035 0.445 . . . . 0.0 111.14 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -97.86 136.93 37.46 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.643 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.483 HD13 HD11 ' B' ' 123' ' ' LEU . 1.2 mt -134.03 128.77 35.0 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.803 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.408 ' O ' HG23 ' B' ' 129' ' ' ILE . 21.1 t -113.69 136.6 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.893 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' B' ' 123' ' ' LEU . 21.9 t -128.84 149.67 33.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.266 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 N--CA 1.462 0.142 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.548 179.603 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 2' ' ' ILE . 13.5 tt . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.781 0.324 . . . . 0.0 110.968 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.12 156.1 15.74 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.669 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' B' ' 122' ' ' ASN . 21.6 t -132.47 133.03 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.377 . . . . 0.0 111.058 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.35 114.81 29.14 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.492 HD11 HD21 ' B' ' 122' ' ' ASN . 1.1 mp -98.42 144.53 27.69 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.604 ' O ' HD13 ' B' ' 116' ' ' LEU . 30.8 ttm -113.24 164.05 14.02 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.893 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.405 ' N ' ' HG2' ' A' ' 7' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.109 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.952 0.406 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.811 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 57.2 m-85 -71.82 -22.25 61.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.817 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.48 20.38 38.12 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.704 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.9 mp -102.48 115.95 31.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.821 0.31 . . . . 0.0 110.786 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.99 114.58 24.74 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.911 HD22 HD11 ' B' ' 149' ' ' ILE . 2.1 mp -97.9 124.81 42.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 111.776 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -114.73 174.93 15.71 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 p -130.17 151.04 51.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.608 0.704 . . . . 0.0 111.84 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -136.75 135.83 38.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.176 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.565 ' HB ' HG22 ' A' ' 54' ' ' THR . 21.5 mt -88.14 121.47 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.931 0.396 . . . . 0.0 110.125 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' ' HG2' ' A' ' 26' ' ' LYS . 41.7 p90 -125.42 172.92 9.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.314 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.886 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.8 t -82.29 97.53 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.745 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.415 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -67.65 -57.01 7.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.282 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.39 141.33 17.17 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.953 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -126.66 144.31 50.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.17 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.5 m -73.73 127.83 33.87 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.583 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -63.29 168.25 4.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.73 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.63 29.8 15.03 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.445 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.87 -174.09 17.58 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.194 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.39 -28.19 61.88 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' N ' HD21 ' B' ' 89' ' ' LEU . . . -74.38 -36.49 63.55 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.502 0.191 . . . . 0.0 111.203 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.9 -34.05 45.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.062 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -62.77 -37.14 85.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.339 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.62 -33.41 10.31 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.493 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.48 44.74 32.26 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.165 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.836 ' HB3' HG11 ' B' ' 87' ' ' VAL . 10.4 p-10 -81.65 -49.04 10.95 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.886 ' HB3' HG21 ' A' ' 25' ' ' VAL . 13.2 mt -95.64 113.18 24.8 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.904 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.47 130.29 34.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.552 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -54.39 111.62 0.83 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.125 0.488 . . . . 0.0 110.868 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.95 -14.1 37.66 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.865 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.33 138.64 58.6 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.038 0.447 . . . . 0.0 111.31 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 45' ' ' ILE . 24.3 pt -79.96 119.49 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.674 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.701 HG21 HD11 ' A' ' 49' ' ' ILE . 7.8 mt -83.33 144.11 10.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.343 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.425 HD23 ' HB2' ' A' ' 48' ' ' LYS . 3.5 tt -105.23 -42.56 5.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.438 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HB2' HD23 ' A' ' 47' ' ' LEU . 3.1 mttm -152.38 147.97 26.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.68 0.276 . . . . 0.0 111.368 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.994 HD12 HD23 ' A' ' 75' ' ' LEU . 27.8 mm -137.47 118.97 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.431 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.91 40.14 31.85 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.217 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.27 14.58 80.59 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.32 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 m -120.23 139.64 52.38 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.028 0.414 . . . . 0.0 110.51 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.3 t -59.69 145.63 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.203 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.565 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -124.18 20.13 9.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.433 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.517 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -116.79 132.13 56.77 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 71.1 -7.57 1.11 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.65 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.5 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -68.38 172.13 6.41 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 111.125 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.81 146.16 24.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.308 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' B' ' 139' ' ' ASN . 0.9 OUTLIER -60.9 -38.62 86.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.27 -46.94 84.47 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -44.2 93.94 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.796 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.96 93.61 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.951 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -39.66 88.57 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.695 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.97 -38.39 86.01 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 2.2 tp -60.32 -43.35 96.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.026 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.775 HD11 HD22 ' B' ' 102' ' ' LEU . 24.5 mt -68.33 -37.48 78.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.78 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.0 -49.44 57.75 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.078 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 65' ' ' LEU . 1.8 ptpt -64.89 -30.5 71.5 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.212 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 m -81.95 62.01 5.52 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.201 0.524 . . . . 0.0 110.791 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 147.26 41.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.785 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.0 -86.59 0.59 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.224 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -134.95 126.87 29.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.663 0.268 . . . . 0.0 110.568 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.781 HD23 ' CE2' ' B' ' 98' ' ' TYR . 2.3 pp -125.87 143.84 50.91 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.45 141.46 34.29 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.994 HD23 HD12 ' A' ' 49' ' ' ILE . 0.8 OUTLIER -133.4 128.08 34.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.965 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 t -107.97 134.62 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.248 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.98 164.58 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.518 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tp . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.594 179.658 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.89 166.96 20.34 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.924 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.836 HG11 ' HB3' ' A' ' 39' ' ' ASN . 21.4 t -129.69 134.86 62.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.641 0.258 . . . . 0.0 111.086 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tt -96.99 121.91 39.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.516 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.551 HD21 ' N ' ' A' ' 34' ' ' ALA . 7.6 tp -115.3 144.62 43.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.581 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.7 ttt -107.1 163.61 12.85 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.144 0.497 . . . . 0.0 110.922 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' B' ' 97' ' ' GLU . 4.1 tttt . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.914 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . 0.405 ' HA ' ' HE3' ' B' ' 91' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.827 0.346 . . . . 0.0 110.818 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.781 ' CE2' HD23 ' A' ' 73' ' ' LEU . 47.0 m-85 -49.74 -31.14 10.72 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.685 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.25 15.36 74.52 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.521 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.429 HD11 ' CB ' ' A' ' 34' ' ' ALA . 2.6 mp -101.3 119.82 39.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.659 0.266 . . . . 0.0 110.668 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -96.13 113.43 25.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.211 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.775 HD22 HD11 ' A' ' 66' ' ' ILE . 7.9 mp -97.41 124.78 41.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.625 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.44 177.13 17.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.978 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.37 145.76 50.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.847 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -130.05 140.16 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.413 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 1.046 HD13 ' HB2' ' B' ' 145' ' ' ALA . 9.1 mt -88.37 120.46 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.176 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -119.68 170.48 9.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.714 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' B' ' 126' ' ' GLY . 41.2 t -81.07 89.5 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.038 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -53.77 -42.46 68.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.816 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.03 132.17 0.51 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -114.24 146.31 40.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.079 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 25.2 p -77.13 126.57 31.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.704 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . 0.687 ' HA ' HG21 ' B' ' 118' ' ' THR . 0.0 OUTLIER -65.78 165.87 12.04 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.289 -179.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.3 m 64.95 22.85 12.52 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.183 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -105.19 -171.7 24.11 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.172 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.604 HD13 ' O ' ' A' ' 7' ' ' MET . 0.2 OUTLIER -71.15 -30.81 66.93 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.405 ' CA ' HD21 ' A' ' 6' ' ' LEU . . . -74.25 -35.03 63.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.489 0.185 . . . . 0.0 110.941 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.687 HG21 ' HA ' ' B' ' 113' ' ' ARG . 2.1 p -78.95 -34.1 44.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.184 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -59.15 -38.85 80.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.424 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.58 -29.9 10.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.539 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.16 58.44 5.59 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.2 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.608 ' HB2' HG21 ' A' ' 4' ' ' VAL . 0.9 OUTLIER -95.95 -32.68 12.49 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.569 HD11 ' CB ' ' B' ' 158' ' ' LEU . 39.4 mt -131.34 133.02 44.91 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.641 0.258 . . . . 0.0 111.195 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.79 161.86 13.4 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' B' ' 125' ' ' GLU . 2.1 pt-20 -73.64 120.55 19.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.518 0.675 . . . . 0.0 110.178 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 108' ' ' VAL . . . 106.89 -15.77 40.25 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.587 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . 0.4 ' OD2' HG11 ' B' ' 160' ' ' VAL . 50.2 t0 -63.97 135.31 56.37 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 111.082 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 13.7 pt -78.25 121.32 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.825 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.434 HD13 HD21 ' A' ' 19' ' ' LEU . 15.6 mt -91.2 143.7 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.149 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.77 -35.47 6.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.902 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.83 148.04 31.47 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.541 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 45.4 mt -140.93 118.68 9.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.616 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 55.7 44.14 26.84 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.931 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.83 17.43 73.29 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.051 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.84 137.71 54.42 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 116.948 0.374 . . . . 0.0 110.478 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.56 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.3 t -59.87 145.04 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.838 0.351 . . . . 0.0 110.872 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.633 ' CG2' HD12 ' B' ' 106' ' ' ILE . 1.8 m -119.03 9.9 11.98 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.788 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.56 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.3 OUTLIER -102.28 131.13 49.06 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . 0.509 ' HA ' HD12 ' A' ' 59' ' ' LEU . 4.9 m-80 70.85 -4.33 1.75 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.548 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.2 OUTLIER -65.65 169.52 6.2 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 111.285 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.69 141.72 28.28 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.168 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.404 HD22 ' NE ' ' B' ' 146' ' ' ARG . 0.8 OUTLIER -58.14 -44.38 87.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.555 179.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 7.2 t -61.46 -39.29 90.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.693 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -64.81 -46.73 80.77 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 1.046 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.54 -42.56 88.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . 0.404 ' NE ' HD22 ' B' ' 142' ' ' LEU . 91.0 mtt180 -65.72 -40.27 92.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.502 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -66.39 -38.63 87.93 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.886 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . 0.524 ' O ' HD23 ' B' ' 148' ' ' LEU . 5.3 tt -59.94 -44.78 94.16 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.713 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.911 HD11 HD22 ' A' ' 19' ' ' LEU . 4.9 mt -68.5 -37.35 77.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.773 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.85 -47.57 65.63 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.055 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -66.33 -27.77 68.16 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 3.6 m -79.24 63.23 3.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.006 0.431 . . . . 0.0 110.747 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 18.2 mmm-85 -83.93 74.78 10.18 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.422 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 167.54 -73.32 0.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.251 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.41 127.49 27.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.712 0.291 . . . . 0.0 110.875 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.811 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -129.84 139.51 51.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 4.4 tt0 -103.57 141.01 36.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.195 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.569 ' CB ' HD11 ' B' ' 123' ' ' LEU . 1.0 OUTLIER -134.72 128.13 32.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 111.001 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.24 135.27 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.47 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.4 HG11 ' OD2' ' B' ' 127' ' ' ASP . 16.9 m -128.46 152.82 37.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.854 0.359 . . . . 0.0 111.711 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 15.0 tp . . . . . 0 C--O 1.232 0.173 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 -179.844 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.1 pt . . . . . 0 C--O 1.235 0.307 0 CA-C-O 120.625 0.25 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.74 158.6 22.64 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.865 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' B' ' 122' ' ' ASN . 23.0 t -130.01 132.73 65.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.758 0.313 . . . . 0.0 110.94 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.756 HD22 ' HD2' ' B' ' 155' ' ' LYS . 0.4 OUTLIER -96.88 113.68 25.25 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.023 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.995 HD13 HD12 ' B' ' 158' ' ' LEU . 8.0 mp -91.23 131.56 36.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.656 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.0 ttt -107.62 162.21 14.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.228 0.537 . . . . 0.0 111.143 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.738 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.711 0.291 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.934 ' CE2' HD23 ' B' ' 156' ' ' LEU . 50.6 m-85 -61.56 -29.76 70.23 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.95 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.48 27.25 57.71 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.196 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' B' ' 117' ' ' ALA . 2.4 mp -113.75 117.86 32.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.71 0.29 . . . . 0.0 110.66 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.38 113.33 25.27 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.596 HD22 HD11 ' B' ' 149' ' ' ILE . 7.1 mp -98.01 124.86 42.69 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.193 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -105.27 -167.46 23.88 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.8 OUTLIER -146.02 149.24 33.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.258 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' B' ' 104' ' ' SER . 1.9 pt20 -132.1 133.47 44.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.964 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.761 ' HB ' HG22 ' A' ' 54' ' ' THR . 68.8 mt -87.75 120.23 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.115 0.483 . . . . 0.0 110.29 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.409 ' CE2' ' HG2' ' A' ' 26' ' ' LYS . 46.4 p90 -122.86 172.92 8.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.297 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.1 t -82.54 99.78 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.767 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -70.93 -58.69 3.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.216 -179.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -156.42 147.56 22.22 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.631 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.32 163.15 30.65 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.894 0.378 . . . . 0.0 111.428 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.8 m -65.38 139.89 58.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -76.51 156.92 32.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.977 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 50.35 30.9 4.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.918 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.17 -170.55 30.84 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.152 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.37 -31.09 68.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -75.02 -36.94 61.9 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.236 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -33.85 45.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.175 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -60.86 -39.21 88.29 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.149 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.14 -30.83 11.71 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.789 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.38 47.92 20.64 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.226 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.724 ' HB3' HG11 ' B' ' 87' ' ' VAL . 21.7 p-10 -65.24 -47.34 77.13 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.721 HD11 HD22 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -129.44 136.57 50.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.812 0.339 . . . . 0.0 111.386 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.96 148.48 22.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.489 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -59.53 109.49 0.91 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.27 0.557 . . . . 0.0 111.08 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.23 -13.6 16.27 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.286 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -62.86 135.43 57.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.232 0.516 . . . . 0.0 110.391 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.55 112.43 18.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.085 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.432 HG21 ' CG1' ' A' ' 49' ' ' ILE . 5.9 mt -77.49 130.43 36.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.176 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.2 tp -92.21 -40.96 10.7 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.322 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -151.36 148.66 28.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.852 0.358 . . . . 0.0 111.833 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.432 ' CG1' HG21 ' A' ' 46' ' ' ILE . 29.7 mt -138.33 119.66 17.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.344 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HB2' HD21 ' A' ' 65' ' ' LEU . 6.5 m120 55.23 39.99 31.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.124 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.77 11.65 84.41 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.424 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 m -119.82 135.3 54.92 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 117.113 0.456 . . . . 0.0 110.203 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.686 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.3 t -61.69 147.79 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.843 0.354 . . . . 0.0 111.146 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.761 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -118.42 6.55 11.81 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.751 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.686 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -91.01 135.73 33.55 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 p30 52.59 11.79 0.21 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.649 0.593 . . . . 0.0 112.198 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.41 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -73.32 171.92 12.16 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.003 0.43 . . . . 0.0 111.357 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.6 130.66 35.22 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.883 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.97 -35.69 59.27 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.9 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.9 -46.75 80.44 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.063 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.67 -46.06 89.92 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.684 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.701 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -58.04 -42.12 84.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -70.31 -37.46 74.75 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.466 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -67.85 -38.17 82.81 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.568 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.568 HD21 ' HB2' ' A' ' 50' ' ' ASN . 9.1 tt -59.69 -44.77 93.51 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.706 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.497 ' CD1' HD22 ' B' ' 102' ' ' LEU . 37.5 mt -68.22 -37.66 78.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.763 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.03 -49.61 56.05 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.791 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -65.19 -27.24 68.55 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.207 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.5 t -80.55 63.13 4.89 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.002 0.43 . . . . 0.0 110.557 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -77.76 94.83 4.54 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.537 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.06 -84.1 0.18 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.521 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.8 ' CG ' HD21 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -129.6 131.08 46.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.641 0.257 . . . . 0.0 110.761 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.749 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -129.83 140.71 50.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 111.323 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -106.37 140.64 38.98 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.553 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.721 HD22 HD11 ' A' ' 40' ' ' LEU . 1.7 mp -136.11 134.64 38.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.102 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.4 t -118.87 140.69 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.93 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.17 134.97 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.321 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 tt . . . . . 0 CA--C 1.53 0.182 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.774 179.461 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.912 0.387 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.49 157.03 15.59 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.409 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.724 HG11 ' HB3' ' A' ' 39' ' ' ASN . 13.8 t -131.09 134.28 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.895 0.378 . . . . 0.0 111.328 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.8 HD21 ' CG ' ' A' ' 72' ' ' LYS . 7.9 tt -106.19 108.1 19.44 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.573 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.8 tp -99.04 144.69 27.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.831 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 9.2 ttm -117.81 163.13 16.99 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.133 0.492 . . . . 0.0 111.051 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.102 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 121.006 0.432 . . . . 0.0 111.386 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.749 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 69.3 m-85 -79.33 -26.26 42.18 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.377 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.39 28.57 43.53 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.395 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.556 HD13 ' HB3' ' B' ' 98' ' ' TYR . 5.9 mp -105.07 123.49 47.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.722 0.296 . . . . 0.0 110.702 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.47 113.65 27.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.371 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.701 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.9 pt? -109.3 124.86 51.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.459 . . . . 0.0 111.453 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -106.8 -170.2 22.55 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.258 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.6 OUTLIER -134.71 147.54 50.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.882 0.373 . . . . 0.0 111.375 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 21' ' ' SER . 3.3 pt20 -125.34 139.04 54.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.225 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.819 HD13 ' HB2' ' B' ' 145' ' ' ALA . 33.7 mt -88.15 120.42 37.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.963 0.411 . . . . 0.0 111.034 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -124.2 171.58 9.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.083 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' B' ' 123' ' ' LEU . 39.3 t -80.27 95.22 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.92 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -53.18 50.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.112 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -156.21 141.35 17.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.688 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.12 151.04 49.38 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.867 0.365 . . . . 0.0 111.463 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -65.73 143.34 57.59 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.165 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -73.15 148.71 43.62 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.148 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 54.85 32.84 18.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.61 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' B' ' 119' ' ' LYS . . . -96.47 -164.98 33.34 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.323 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 8.6 mt -66.36 -37.12 84.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.567 ' HB2' HD21 ' A' ' 17' ' ' LEU . . . -75.1 -33.73 61.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.273 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -33.72 44.47 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.286 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' B' ' 115' ' ' GLY . 12.1 ttmt -64.17 -37.07 86.14 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 111.266 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.99 -30.8 12.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.467 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.82 45.69 63.55 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.2 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.693 ' HB3' HG11 ' A' ' 4' ' ' VAL . 3.3 p30 -81.83 -53.4 6.21 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.695 ' HB3' HG21 ' B' ' 108' ' ' VAL . 10.2 mp -118.5 119.41 34.47 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.68 0.276 . . . . 0.0 110.944 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.17 152.84 22.5 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.619 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -60.5 110.65 1.32 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.169 0.509 . . . . 0.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.55 -15.16 24.69 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.894 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -62.85 135.75 57.49 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 117.245 0.522 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -81.05 108.86 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.103 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.476 ' CD1' HD21 ' A' ' 19' ' ' LEU . 29.3 mt -76.41 152.49 5.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.322 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.548 HD22 ' CD1' ' B' ' 161' ' ' LEU . 13.7 tp -110.7 -31.28 7.26 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.538 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -152.44 147.42 26.23 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.711 0.291 . . . . 0.0 111.066 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 13.5 mt -137.18 117.73 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.452 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' B' ' 156' ' ' LEU . 0.1 OUTLIER 49.4 43.34 23.35 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.515 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.98 18.73 79.32 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.344 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 93.1 m -120.77 144.11 48.46 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.997 0.398 . . . . 0.0 110.28 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 t -74.14 140.07 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.457 . . . . 0.0 111.609 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.545 ' HA ' HD12 ' B' ' 106' ' ' ILE . 52.8 p -93.01 -22.08 19.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.129 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.09 142.35 38.17 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.925 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.5 p30 53.13 10.74 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.811 0.694 . . . . 0.0 112.467 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.656 ' HG2' HD11 ' B' ' 106' ' ' ILE . 0.5 OUTLIER -86.52 144.18 27.36 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.902 0.382 . . . . 0.0 110.808 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.11 144.76 46.87 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.515 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.528 ' O ' HD23 ' B' ' 142' ' ' LEU . 6.2 tt -60.75 -46.0 92.12 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.925 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 9.7 t -55.28 -42.64 73.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -40.9 84.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.617 0.246 . . . . 0.0 110.769 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -61.87 -43.15 99.44 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.037 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -38.13 79.34 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -38.08 82.37 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.779 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . 0.514 HD23 ' C ' ' B' ' 148' ' ' LEU . 7.7 tt -59.98 -44.82 94.24 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.649 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.596 HD11 HD22 ' A' ' 19' ' ' LEU . 8.2 mt -67.79 -37.31 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.03 -48.76 62.14 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.0 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -67.44 -24.95 65.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.683 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 22.9 m -75.58 70.39 2.41 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.212 0.53 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -86.5 78.38 9.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.667 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 164.55 -81.89 0.11 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.62 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . 0.756 ' HD2' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -137.0 128.96 29.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.534 0.206 . . . . 0.0 110.628 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.934 HD23 ' CE2' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -127.86 131.78 49.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.948 0.404 . . . . 0.0 111.2 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -91.1 142.56 27.62 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.083 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.995 HD12 HD13 ' A' ' 6' ' ' LEU . 2.3 mt -132.55 134.51 45.05 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.809 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.09 134.0 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.636 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 6.1 m -127.99 152.9 36.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 111.719 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . 0.548 ' CD1' HD22 ' B' ' 130' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.826 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.98 0.419 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.74 156.6 22.89 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.774 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.586 HG21 ' CB ' ' B' ' 122' ' ' ASN . 22.8 t -132.77 133.39 59.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.702 0.287 . . . . 0.0 111.093 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.5 HD22 ' HD3' ' B' ' 155' ' ' LYS . 0.2 OUTLIER -101.46 111.44 23.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.815 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.648 HD11 ' ND2' ' B' ' 122' ' ' ASN . 10.4 mp -90.6 141.88 28.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.25 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 37.2 ttm -120.05 165.3 14.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.988 0.423 . . . . 0.0 110.9 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 pttp . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.937 179.844 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 120.817 0.342 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.456 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 70.4 m-85 -78.26 -30.89 48.84 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.728 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.453 ' O ' HG23 ' B' ' 112' ' ' THR . . . 80.88 28.34 46.62 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.464 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' B' ' 117' ' ' ALA . 0.3 OUTLIER -101.85 121.39 42.02 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.646 0.26 . . . . 0.0 110.668 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.38 114.04 27.88 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.03 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.997 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.8 pt? -111.44 124.82 53.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.192 0.52 . . . . 0.0 111.763 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.91 -177.56 22.24 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.556 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.26 149.3 47.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.155 0.478 . . . . 0.0 111.058 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -132.87 140.2 47.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.231 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.863 ' HB ' HG22 ' A' ' 54' ' ' THR . 49.4 mt -88.05 120.54 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.003 0.43 . . . . 0.0 110.433 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -119.88 172.91 7.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.912 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.919 HG21 HD13 ' A' ' 40' ' ' LEU . 45.6 t -79.5 92.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.118 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.94 -51.85 59.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.217 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.13 162.6 39.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 36.0 mtp -138.4 156.46 47.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.107 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.622 HG23 ' HA3' ' A' ' 32' ' ' GLY . 3.7 t -69.33 145.32 53.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.693 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -75.52 130.13 38.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.674 0.273 . . . . 0.0 110.944 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.23 28.25 5.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.141 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.622 ' HA3' HG23 ' A' ' 29' ' ' THR . . . -84.5 -163.38 36.2 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.369 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.494 ' C ' HD21 ' B' ' 89' ' ' LEU . 1.6 mt -73.93 -30.19 62.43 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.98 -37.17 61.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.467 0.175 . . . . 0.0 111.409 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.52 -34.05 47.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.153 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -63.97 -36.49 84.12 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.428 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.84 -32.58 11.27 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.362 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.48 47.78 20.63 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.238 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -57.51 -35.15 69.89 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.919 HD13 HG21 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -163.49 163.83 24.61 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.727 0.299 . . . . 0.0 111.025 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.39 150.39 22.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.706 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -61.68 114.4 3.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.12 0.486 . . . . 0.0 111.233 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.93 9.86 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.755 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -60.6 135.85 57.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.919 0.359 . . . . 0.0 110.368 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 pt -75.06 121.82 27.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.895 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.994 HG21 HD11 ' A' ' 49' ' ' ILE . 16.5 mt -88.95 138.14 19.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.118 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.883 HD13 HD22 ' A' ' 78' ' ' LEU . 10.0 tp -97.43 -45.55 6.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.484 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.74 147.93 33.55 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.873 0.368 . . . . 0.0 111.59 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.994 HD11 HG21 ' A' ' 46' ' ' ILE . 22.4 mm -138.61 120.77 17.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.432 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 53.47 41.55 32.09 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.242 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.48 13.0 80.29 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.436 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m -120.97 137.52 54.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.038 0.419 . . . . 0.0 110.431 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.647 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.1 t -57.58 146.11 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.274 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.863 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -123.32 17.74 9.82 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.416 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.647 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -121.59 127.85 51.34 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 70.88 -4.07 1.83 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.288 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.11 174.63 3.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 111.27 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.92 147.8 25.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.418 HD11 ' OG ' ' B' ' 104' ' ' SER . 2.1 mp -61.9 -48.95 78.16 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.85 -37.98 80.81 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.221 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.19 -47.89 69.55 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.946 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.602 ' CB ' HD13 ' A' ' 23' ' ' ILE . . . -61.94 -40.15 94.54 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.204 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -70.24 -38.41 75.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -38.16 83.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.677 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.44 HD21 HG22 ' A' ' 49' ' ' ILE . 1.2 tp -60.49 -44.36 96.05 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.735 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.708 HD11 HD22 ' B' ' 102' ' ' LEU . 12.3 mt -68.33 -37.57 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.604 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.94 -41.42 78.1 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.641 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -6.7 57.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.72 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.94 56.64 4.02 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 110.862 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.68 78.86 7.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.381 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' B' ' 91' ' ' LYS . . . 162.29 -78.77 0.15 Allowed Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.295 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -136.2 129.87 32.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.774 -0.213 . . . . 0.0 110.787 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.729 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.6 OUTLIER -128.05 126.98 42.32 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.108 0.48 . . . . 0.0 110.871 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 37.4 tt0 -97.83 142.62 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.279 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.74 ' HA ' HD13 ' A' ' 49' ' ' ILE . 0.8 OUTLIER -133.76 124.02 25.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.772 0.32 . . . . 0.0 110.75 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.6 t -109.57 134.6 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.747 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 t -116.29 135.21 57.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.048 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.883 HD22 HD13 ' A' ' 47' ' ' LEU . 5.4 tp . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.521 ' C ' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.288 0 CA-C-O 120.765 0.317 . . . . 0.0 110.953 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.478 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -114.03 155.48 16.29 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.75 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 25.9 t -129.6 134.33 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 111.088 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.432 ' O ' HD12 ' B' ' 88' ' ' LEU . 0.3 OUTLIER -103.64 122.42 44.98 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.6 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.494 HD21 ' C ' ' A' ' 33' ' ' LEU . 1.3 tp -109.09 124.63 51.09 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.542 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . 0.487 ' HG3' ' N ' ' B' ' 91' ' ' LYS . 3.7 tpp -100.12 162.85 12.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.072 0.463 . . . . 0.0 110.772 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . 0.487 ' N ' ' HG3' ' B' ' 90' ' ' MET . 6.6 pttm . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.349 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.465 0.295 0 CA-C-O 121.053 0.454 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.729 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 67.4 m-85 -76.26 -25.55 55.07 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.517 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . 0.436 ' HA3' ' HB ' ' A' ' 29' ' ' THR . . . 93.62 20.2 32.53 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.458 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.625 ' CD2' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -101.78 118.21 36.46 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.651 0.262 . . . . 0.0 110.708 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -92.07 113.26 25.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.949 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.708 HD22 HD11 ' A' ' 66' ' ' ILE . 5.2 mp -96.34 124.93 40.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 110.922 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.91 171.9 13.94 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.822 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.418 ' OG ' HD11 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -136.71 145.07 44.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.835 0.35 . . . . 0.0 110.891 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -130.44 139.71 50.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.274 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.845 HD13 ' HB2' ' B' ' 145' ' ' ALA . 1.9 mt -88.3 120.64 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.069 0.461 . . . . 0.0 110.238 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.419 ' CE2' ' HD3' ' B' ' 109' ' ' LYS . 40.1 p90 -119.62 172.58 7.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.928 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 0.601 HG21 ' HB3' ' B' ' 123' ' ' LEU . 27.7 t -81.36 97.62 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.013 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . 0.419 ' HD3' ' CE2' ' B' ' 107' ' ' PHE . 0.5 OUTLIER -67.57 -50.58 57.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.717 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -167.48 143.61 4.17 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.805 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.463 ' SD ' HG11 ' B' ' 108' ' ' VAL . 0.0 OUTLIER -127.68 159.53 34.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.795 0.331 . . . . 0.0 111.119 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 16' ' ' GLY . 64.2 p -75.75 124.63 27.61 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.435 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.64 156.77 15.92 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.967 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.68 34.79 17.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.299 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.11 -175.54 20.26 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.913 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.84 -35.6 80.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.57 0.224 . . . . 0.0 111.559 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.499 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -74.95 -34.82 62.1 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.26 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -34.1 44.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.13 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.47 -35.41 80.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.199 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -100.07 -27.95 13.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.648 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 65.8 57.39 11.09 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.094 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.648 ' ND2' HD11 ' A' ' 6' ' ' LEU . 1.5 p30 -94.82 -33.63 12.79 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.705 HD11 HD13 ' B' ' 158' ' ' LEU . 47.9 mt -122.36 135.96 54.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.636 0.255 . . . . 0.0 111.55 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 142.93 34.22 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.581 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -56.68 111.39 1.0 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 111.249 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.32 -16.47 24.6 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.266 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -60.47 135.8 57.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.332 0.566 . . . . 0.0 110.64 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 pt -79.82 111.01 16.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.751 ' HB ' HG21 ' B' ' 137' ' ' THR . 59.4 mt -72.48 140.96 17.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.108 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.416 HD13 ' CD1' ' B' ' 161' ' ' LEU . 1.1 tp -98.0 -45.14 6.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.114 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -148.84 147.8 29.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.911 0.386 . . . . 0.0 111.477 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.633 HG22 HD22 ' B' ' 133' ' ' ASN . 13.9 mt -134.01 123.87 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.264 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . 0.633 HD22 HG22 ' B' ' 132' ' ' ILE . 3.7 m-80 54.86 33.49 19.97 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.687 0.279 . . . . 0.0 111.182 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.65 17.55 77.28 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.92 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 6.8 m -120.66 143.85 48.49 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.8 0.3 . . . . 0.0 110.341 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.432 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.2 t -59.46 144.26 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.199 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.751 HG21 ' HB ' ' B' ' 129' ' ' ILE . 2.9 m -117.23 21.56 13.07 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.603 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.432 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.8 OUTLIER -115.87 129.38 56.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 71.42 -5.23 1.65 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.361 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.739 ' HB3' HD11 ' B' ' 106' ' ' ILE . 4.8 ttt -68.37 150.72 47.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.812 0.339 . . . . 0.0 110.826 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 51.1 m -71.78 144.22 49.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.307 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.75 -46.03 92.01 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.06 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 4.4 t -58.04 -38.89 77.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.107 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.03 -42.85 84.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.803 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.997 ' HB1' HD11 ' A' ' 19' ' ' LEU . . . -60.47 -42.42 96.18 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.086 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -67.94 -39.46 83.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.318 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -37.86 86.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' B' ' 133' ' ' ASN . 6.9 tt -59.85 -45.27 92.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.735 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.6 HD12 HD22 ' A' ' 19' ' ' LEU . 46.3 mt -68.42 -37.01 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.773 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.41 -46.3 70.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -65.49 -26.91 68.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.292 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 20.7 p -87.17 74.89 9.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.194 0.521 . . . . 0.0 111.052 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.93 51.98 2.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.708 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -164.39 -83.36 0.05 OUTLIER Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.465 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . 0.5 ' HD3' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -124.54 126.88 46.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.685 0.278 . . . . 0.0 110.424 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.772 HD21 HD11 ' B' ' 158' ' ' LEU . 0.0 OUTLIER -129.81 143.07 50.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.46 -179.176 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -109.09 138.61 45.16 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.487 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.772 HD11 HD21 ' B' ' 156' ' ' LEU . 0.6 OUTLIER -133.36 127.31 33.21 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.762 0.315 . . . . 0.0 111.04 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.93 139.93 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.578 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.442 HG21 ' CD2' ' B' ' 123' ' ' LEU . 22.3 t -135.74 154.9 35.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.35 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . 0.416 ' CD1' HD13 ' B' ' 130' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.254 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.759 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.235 0.336 0 CA-C-O 120.648 0.261 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -109.97 161.75 12.88 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.575 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.725 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.6 t -127.33 134.62 65.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.818 0.342 . . . . 0.0 111.277 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 mt -98.03 123.47 42.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.979 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.73 137.42 51.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.503 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.683 ' O ' HD13 ' B' ' 116' ' ' LEU . 3.9 ttt -109.67 164.87 12.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.53 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.116 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.748 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 57.5 m-85 -60.37 -27.26 67.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.865 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.87 18.58 43.41 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.707 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.677 HD21 ' CB ' ' B' ' 117' ' ' ALA . 8.7 mp -108.02 119.07 38.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.723 0.297 . . . . 0.0 110.73 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.2 113.44 25.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.192 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.854 HD22 HD11 ' B' ' 149' ' ' ILE . 1.5 mp -92.94 124.9 37.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.262 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.6 -169.59 21.85 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.615 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.6 148.54 32.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.934 0.367 . . . . 0.0 111.367 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.26 133.13 45.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.878 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.768 ' HB ' HG22 ' A' ' 54' ' ' THR . 53.9 mt -87.76 120.28 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 0.0 110.542 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -124.83 173.22 8.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.207 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 40' ' ' LEU . 39.8 t -83.33 100.5 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.659 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -47.71 53.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.613 0.244 . . . . 0.0 111.044 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -161.69 144.64 12.11 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.592 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -130.35 155.75 45.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 111.333 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.0 t -65.35 144.71 56.92 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.975 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.0 tpt85 -79.72 148.6 31.47 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.2 30.57 19.98 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.486 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.58 -170.98 27.93 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.108 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.562 HD22 ' O ' ' B' ' 90' ' ' MET . 0.1 OUTLIER -68.52 -32.66 72.77 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.642 0.221 . . . . 0.0 111.585 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.994 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -73.99 -35.42 64.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.07 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.29 -33.99 42.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.241 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.59 -37.55 86.69 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.165 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.94 -26.61 13.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.452 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.7 38.75 93.41 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.986 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.701 ' HB3' HG11 ' B' ' 87' ' ' VAL . 3.6 p30 -68.87 -46.85 67.4 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.459 0.17 . . . . 0.0 111.459 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.692 ' CD1' HD22 ' A' ' 75' ' ' LEU . 57.8 mt -116.62 129.3 56.08 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.717 0.294 . . . . 0.0 111.125 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.78 150.49 21.78 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.426 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -60.37 110.88 1.36 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.095 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.5 -15.43 17.47 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.153 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -64.19 132.79 51.39 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 117.268 0.534 . . . . 0.0 110.425 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.5 pt -79.9 112.74 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.83 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.452 ' HA ' HG12 ' A' ' 77' ' ' VAL . 19.6 mt -78.01 134.28 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.98 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 tp -91.72 -45.49 8.41 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.706 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -148.92 149.84 31.9 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.801 0.334 . . . . 0.0 111.68 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 23.0 mt -138.02 119.99 18.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.621 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 55.7 36.48 27.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.314 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.33 2.46 90.6 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.6 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -111.91 134.89 53.19 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.295 0.547 . . . . 0.0 110.411 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.2 t -57.88 146.81 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.268 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.768 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -120.39 23.6 10.79 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.373 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.56 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -116.81 139.18 50.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.438 ' HB2' ' CD1' ' B' ' 142' ' ' LEU . 11.9 p30 53.68 9.22 0.18 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.614 0.571 . . . . 0.0 112.22 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.513 ' HB3' HD11 ' A' ' 23' ' ' ILE . 14.2 tpp -82.95 159.82 22.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.779 0.323 . . . . 0.0 110.734 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.506 ' N ' ' HG3' ' A' ' 57' ' ' MET . 0.1 OUTLIER -72.77 138.1 46.26 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.194 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.0 -47.23 81.34 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.097 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.0 p -58.1 -41.28 83.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.189 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.25 -47.78 84.46 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.019 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.6 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -59.64 -40.81 88.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.981 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.19 -40.5 94.31 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.709 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -65.32 -38.74 91.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.905 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.3 tt -60.06 -43.92 95.06 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.942 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.487 ' CD1' HD22 ' B' ' 102' ' ' LEU . 57.0 mt -68.46 -37.11 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.809 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.7 -49.28 69.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.902 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.0 pttt -64.1 -23.5 67.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.27 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.7 m -81.36 66.99 7.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.098 0.475 . . . . 0.0 110.431 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.95 64.27 8.03 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.008 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.91 -76.29 0.07 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.588 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.82 129.61 32.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.274 . . . . 0.0 110.629 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.849 HD23 ' CE1' ' B' ' 98' ' ' TYR . 0.4 OUTLIER -129.82 136.82 50.02 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 26.6 mt-30 -98.32 143.08 29.17 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.719 HD13 HD13 ' B' ' 89' ' ' LEU . 1.9 mp -135.75 128.79 31.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.043 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.84 144.21 25.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.695 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 46' ' ' ILE . 10.6 m -141.57 167.67 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.957 0.408 . . . . 0.0 111.595 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.174 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.916 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.595 0.236 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.4 159.6 25.3 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.929 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.701 HG11 ' HB3' ' A' ' 39' ' ' ASN . 9.1 t -130.06 135.16 61.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.681 0.276 . . . . 0.0 111.078 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.51 114.08 25.81 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.792 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.719 HD13 HD13 ' A' ' 75' ' ' LEU . 10.9 mp -100.35 137.85 38.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.642 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . 0.562 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -110.21 170.42 8.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.379 0.609 . . . . 0.0 111.47 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 27.8 tttm . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.375 -179.876 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 120.865 0.364 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.849 ' CE1' HD23 ' A' ' 73' ' ' LEU . 52.1 m-85 -88.1 -26.74 22.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.955 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.42 14.05 72.03 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.618 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.994 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -97.55 122.22 40.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 110.522 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.85 113.72 27.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.267 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.6 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.8 pt? -107.84 125.01 50.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.082 0.468 . . . . 0.0 111.329 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -104.33 -163.05 24.54 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.067 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.32 146.51 30.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.696 0.248 . . . . 0.0 111.162 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.475 ' NE2' HG21 ' B' ' 128' ' ' ILE . 6.1 pt20 -127.14 137.14 52.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.026 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 1.081 HD13 ' HB2' ' B' ' 145' ' ' ALA . 28.4 mt -88.18 120.42 37.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.591 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.466 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 47.4 p90 -123.88 172.55 8.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.988 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 0.602 HG21 ' HB3' ' B' ' 123' ' ' LEU . 96.6 t -85.16 98.55 6.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.924 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . 0.466 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -68.3 -57.57 5.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.416 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.08 139.84 23.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.743 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 6.1 ptt? -131.07 152.84 49.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 111.626 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 p -72.82 142.28 48.02 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.261 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -78.24 154.92 30.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.963 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.1 m 62.9 34.6 14.09 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.68 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.11 -175.28 20.23 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.96 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.683 HD13 ' O ' ' A' ' 7' ' ' MET . 0.2 OUTLIER -67.24 -32.54 73.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.669 0.234 . . . . 0.0 111.625 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.677 ' CB ' HD21 ' A' ' 17' ' ' LEU . . . -74.93 -37.92 61.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.657 0.265 . . . . 0.0 111.021 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.0 -33.71 44.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.246 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -58.68 -39.79 81.7 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.315 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.38 -31.71 9.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.544 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 49.28 11.01 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.434 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.725 ' HB3' HG11 ' A' ' 4' ' ' VAL . 14.4 p-10 -78.73 -44.05 24.34 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.764 ' CD1' HD13 ' B' ' 158' ' ' LEU . 85.1 mt -111.62 118.57 36.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.609 0.242 . . . . 0.0 110.993 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 131.44 34.64 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.252 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -48.14 109.49 0.24 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.083 0.468 . . . . 0.0 111.382 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 108.15 -1.99 33.25 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.344 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -70.83 135.61 48.2 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.456 0.628 . . . . 0.0 111.468 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.475 HG21 ' NE2' ' B' ' 105' ' ' GLN . 1.5 pt -79.95 107.47 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.592 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.642 ' CD1' HD21 ' A' ' 19' ' ' LEU . 42.7 mt -75.76 147.56 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.342 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.702 HD13 HD13 ' B' ' 161' ' ' LEU . 2.3 tp -110.21 -42.45 4.16 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.607 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -144.0 148.19 34.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.747 0.308 . . . . 0.0 111.387 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 34.8 mt -138.81 118.23 14.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.765 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 4.0 m120 52.37 48.01 23.53 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.36 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.23 16.66 67.2 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.201 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 46.2 m -120.83 140.48 51.69 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.811 0.305 . . . . 0.0 110.293 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.612 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.3 t -62.36 147.53 11.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.001 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.701 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -125.84 19.51 7.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.464 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.612 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.4 tt0 -111.95 133.95 53.81 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 72.51 -9.2 1.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.514 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.677 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.1 OUTLIER -66.34 169.59 7.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.96 0.409 . . . . 0.0 111.228 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 30.7 t -90.77 148.71 22.38 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.994 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.438 ' CD1' ' HB2' ' A' ' 56' ' ' ASN . 5.2 tt -58.1 -48.95 78.61 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.369 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 64.6 p -58.62 -39.75 81.37 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.709 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -46.39 85.04 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 1.081 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.73 -43.19 90.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -66.46 -39.49 88.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.443 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -42.16 98.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.984 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 tp -61.56 -43.18 99.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.454 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.854 HD11 HD22 ' A' ' 19' ' ' LEU . 12.0 mt -68.73 -37.54 77.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.727 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.55 -49.51 73.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.003 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -64.83 -24.27 67.49 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.366 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.6 m -79.44 70.0 5.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.924 0.393 . . . . 0.0 110.956 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.42 60.19 6.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.547 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.19 -82.76 0.05 OUTLIER Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.498 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -132.77 131.54 41.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.569 0.224 . . . . 0.0 110.489 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.748 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -128.56 137.11 51.56 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.06 0.457 . . . . 0.0 111.275 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 24.8 tt0 -101.92 140.49 36.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.395 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.764 HD13 ' CD1' ' B' ' 123' ' ' LEU . 1.0 OUTLIER -135.78 129.42 32.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.874 0.368 . . . . 0.0 111.091 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.403 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 13.3 t -113.99 132.17 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.707 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -129.36 165.83 28.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.551 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . 0.702 HD13 HD13 ' B' ' 130' ' ' LEU . 1.1 mp . . . . . 0 C--O 1.232 0.165 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.983 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.463 0.22 0 CA-C-O 120.773 0.32 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -127.15 158.05 20.91 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.761 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.1 134.37 62.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.587 0.232 . . . . 0.0 111.029 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.93 107.35 18.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 tp -108.19 123.96 49.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.478 ' HB3' ' HB3' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -104.0 150.97 23.76 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.925 0.393 . . . . 0.0 111.341 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.54 ' HA ' HD13 ' B' ' 116' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.224 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.248 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.465 0.325 0 CA-C-O 120.725 0.298 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.712 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 59.3 m-85 -72.27 -15.83 61.91 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.468 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.66 25.97 48.09 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.511 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.807 HD21 HD11 ' B' ' 123' ' ' LEU . 0.4 OUTLIER -106.05 117.69 34.68 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.579 0.228 . . . . 0.0 110.9 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.413 ' HB2' ' HG2' ' B' ' 110' ' ' GLU . 6.3 mtt85 -97.02 113.34 24.87 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.411 HD21 HG13 ' B' ' 129' ' ' ILE . 7.7 mp -102.06 124.93 48.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.183 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -103.42 -164.68 25.45 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.752 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.9 OUTLIER -147.0 147.96 31.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.023 0.411 . . . . 0.0 111.281 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -131.82 137.38 48.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.124 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.85 HD13 ' HB2' ' A' ' 62' ' ' ALA . 64.3 mt -87.89 120.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.619 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.471 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 45.2 p90 -124.91 172.11 9.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.339 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.756 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.3 t -83.0 100.21 6.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.89 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.471 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 1.2 tptp -68.05 -57.5 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.235 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -159.59 134.37 7.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.651 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -114.15 156.75 23.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.01 0.434 . . . . 0.0 111.299 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -65.55 138.21 57.9 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 148.64 47.93 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.917 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.87 31.82 21.07 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.53 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.08 -154.84 30.16 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.411 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.564 HD22 ' O ' ' B' ' 90' ' ' MET . 1.2 mt -85.54 -31.75 22.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.547 0.213 . . . . 0.0 111.455 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.819 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -75.21 -34.93 61.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.118 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.99 -33.81 44.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.988 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -38.6 83.93 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.358 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -103.16 -32.73 9.5 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.513 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.58 49.88 13.29 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.395 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.619 ' HB3' HG11 ' B' ' 87' ' ' VAL . 7.9 p-10 -82.82 -47.68 11.63 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.756 ' HB3' HG21 ' A' ' 25' ' ' VAL . 17.6 mt -105.95 128.45 53.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 111.147 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.41 133.36 38.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.543 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -54.96 110.44 0.66 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.191 0.519 . . . . 0.0 111.168 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.43 -7.91 28.45 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.816 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -73.37 135.67 44.31 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.244 0.545 . . . . 0.0 111.047 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.4 pt -74.38 114.59 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.543 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.0 mt -80.63 138.84 19.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.212 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.582 HD12 HD13 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -95.79 -46.99 6.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.535 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.4 OUTLIER -150.5 148.19 28.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.8 0.333 . . . . 0.0 111.567 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 43.5 mt -137.04 118.36 18.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.78 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 55.95 45.06 24.62 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.152 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.41 15.26 70.22 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.355 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.9 m -120.81 137.08 54.72 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.935 0.368 . . . . 0.0 110.474 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.603 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.2 t -60.42 147.18 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.294 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.806 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -125.2 21.76 7.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.534 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.603 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -117.45 129.73 56.01 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 70.5 -3.84 1.79 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.354 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.712 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -68.69 173.15 5.42 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.831 0.348 . . . . 0.0 111.162 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.74 139.72 30.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.99 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' B' ' 139' ' ' ASN . 5.6 tt -56.35 -42.24 77.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.527 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.4 m -65.15 -37.21 86.7 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.004 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -44.81 78.67 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.637 0.256 . . . . 0.0 110.839 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 1.001 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -59.72 -41.8 91.66 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.496 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.0 ptt85 -71.65 -35.85 70.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.714 0.292 . . . . 0.0 110.711 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.2 -38.62 82.15 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.664 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -44.96 93.5 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.773 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.584 HD12 HD22 ' B' ' 102' ' ' LEU . 59.3 mt -68.32 -36.8 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.08 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -48.78 63.78 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.742 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -29.16 70.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.146 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.2 m -84.31 85.39 7.38 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.842 0.353 . . . . 0.0 111.035 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.81 113.12 25.1 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.61 -89.07 0.24 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.593 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.84 131.85 53.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.662 0.268 . . . . 0.0 110.655 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.758 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.4 OUTLIER -129.53 138.5 51.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.961 0.41 . . . . 0.0 111.323 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.7 tt0 -101.65 138.95 37.96 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.673 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.71 HD13 HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -133.64 125.12 28.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.949 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.66 146.55 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.52 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.443 HG22 ' O ' ' B' ' 85' ' ' ILE . 32.7 m -121.21 140.51 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.278 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.582 HD13 HD12 ' A' ' 47' ' ' LEU . 21.2 tp . . . . . 0 N--CA 1.465 0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.911 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.443 ' O ' HG22 ' A' ' 77' ' ' VAL . 10.3 tt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.669 0.271 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.17 157.37 25.47 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.732 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 39' ' ' ASN . 21.5 t -131.08 132.65 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.79 0.328 . . . . 0.0 111.096 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.426 HD12 ' HG3' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -97.84 107.07 19.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.417 HD21 ' N ' ' A' ' 34' ' ' ALA . 2.2 tp -91.26 141.55 28.67 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.513 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . 0.564 ' O ' HD22 ' A' ' 33' ' ' LEU . 9.4 tpp -118.44 163.15 17.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.695 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . 0.498 ' N ' ' HG3' ' B' ' 90' ' ' MET . 7.2 pttt . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.144 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 120.916 0.388 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.758 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 60.2 m-85 -68.28 -23.74 64.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.455 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.09 20.28 73.16 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.46 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -98.06 117.05 31.54 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.664 0.268 . . . . 0.0 110.605 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.23 113.4 25.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.101 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 1.001 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.8 pt? -110.6 124.84 52.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.125 0.488 . . . . 0.0 111.07 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -111.05 -164.04 18.33 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.243 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.58 148.91 40.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.706 0.288 . . . . 0.0 111.078 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 21' ' ' SER . 1.8 pt20 -127.65 136.73 52.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.135 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.783 HD13 ' HB2' ' B' ' 145' ' ' ALA . 42.1 mt -87.78 120.2 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.345 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -122.97 172.98 8.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.121 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 0.964 HG21 HD13 ' B' ' 123' ' ' LEU . 33.2 t -81.59 95.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.044 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -43.97 88.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.143 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -168.93 140.43 2.52 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.839 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.578 ' SD ' HG23 ' B' ' 118' ' ' THR . 0.2 OUTLIER -126.46 161.09 28.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.891 0.377 . . . . 0.0 111.434 -179.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 18.8 p -77.09 122.77 25.44 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.208 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -64.64 150.33 47.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.963 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m 62.63 32.76 16.17 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.31 -166.48 24.73 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.128 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.54 HD13 ' HA ' ' A' ' 8' ' ' LYS . 4.4 mt -75.45 -30.99 60.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.647 0.224 . . . . 0.0 111.417 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.72 -34.4 62.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.17 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.578 HG23 ' SD ' ' B' ' 111' ' ' MET . 0.1 OUTLIER -78.77 -33.96 45.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.084 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.84 -37.71 87.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.336 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.08 -31.66 12.02 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.663 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.61 51.37 7.28 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.345 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -66.56 -35.58 80.57 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.964 HD13 HG21 ' B' ' 108' ' ' VAL . 0.5 OUTLIER -154.27 164.19 38.95 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.804 0.335 . . . . 0.0 111.11 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 148.33 30.79 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.882 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -56.16 112.3 1.18 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.103 0.478 . . . . 0.0 110.981 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.2 -16.67 22.33 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.965 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -61.79 138.81 58.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.071 0.462 . . . . 0.0 111.222 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.424 ' O ' HG13 ' B' ' 128' ' ' ILE . 44.3 pt -78.56 124.9 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.794 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.418 HD11 HD22 ' B' ' 123' ' ' LEU . 33.2 mm -90.91 131.69 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.543 HD13 HD13 ' B' ' 161' ' ' LEU . 15.9 tp -94.89 -44.01 7.93 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.563 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -148.62 152.69 37.18 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.424 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 35.5 mt -141.11 118.24 8.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.573 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 55.79 38.74 30.43 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.15 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.04 2.08 88.37 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.517 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 47.8 m -109.69 131.65 54.86 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 117.054 0.427 . . . . 0.0 110.349 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.625 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.2 t -58.47 146.95 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.696 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -120.93 18.91 11.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.675 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.625 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.1 OUTLIER -109.42 130.2 55.51 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.224 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . 0.473 ' HB3' HD13 ' A' ' 59' ' ' LEU . 5.1 m-80 71.6 -6.11 1.49 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.375 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.606 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -65.61 168.5 7.44 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.909 0.385 . . . . 0.0 111.1 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 14.5 t -89.37 149.44 22.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.167 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -47.11 87.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.633 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 12.0 p -60.21 -37.22 79.61 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.17 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.1 -41.47 67.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.606 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.783 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -63.5 -41.82 98.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.256 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . 0.468 ' HA ' HD12 ' B' ' 149' ' ' ILE . 0.0 OUTLIER -71.3 -36.47 71.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.661 0.267 . . . . 0.0 110.482 179.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -68.02 -38.35 82.46 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.526 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . 0.428 HD13 ' O ' ' B' ' 148' ' ' LEU . 0.4 OUTLIER -59.79 -44.38 93.96 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' B' ' 146' ' ' ARG . 7.9 mt -65.95 -38.34 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.713 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -68.71 -49.62 57.39 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.777 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -25.64 68.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.2 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 6.0 m -81.28 63.74 5.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.907 0.385 . . . . 0.0 110.502 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -76.71 121.99 24.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.95 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 120.1 -83.7 0.36 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.31 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 7' ' ' MET . 0.0 OUTLIER -132.75 130.35 39.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.722 0.296 . . . . 0.0 110.687 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.712 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.94 134.14 48.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.111 0.481 . . . . 0.0 111.156 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.6 tm0? -93.21 141.21 28.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.258 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.33 123.73 24.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.704 0.288 . . . . 0.0 110.678 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.453 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 32.6 t -107.88 135.85 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.291 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.28 141.51 43.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.771 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . 0.543 HD13 HD13 ' B' ' 130' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.198 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.967 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.234 0.273 0 CA-C-O 120.659 0.266 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.3 158.85 23.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.728 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.3 t -129.85 134.89 62.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 110.848 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.99 113.09 26.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.754 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.2 tp -99.69 144.88 28.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.77 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.656 ' O ' HD22 ' B' ' 116' ' ' LEU . 3.0 ttt -112.78 164.08 13.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.147 0.499 . . . . 0.0 110.793 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.195 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 N--CA 1.463 0.213 0 CA-C-O 120.963 0.411 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.781 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 72.8 m-85 -104.54 -30.94 9.69 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.355 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.24 25.39 44.14 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.527 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' B' ' 117' ' ' ALA . 1.0 OUTLIER -104.78 122.01 44.83 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -102.44 113.42 26.74 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.15 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.798 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.7 pt? -108.96 124.98 51.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.111 0.481 . . . . 0.0 111.646 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -106.66 -162.48 22.32 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.855 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.66 149.33 35.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.484 ' NE2' HG21 ' A' ' 45' ' ' ILE . 3.1 pt20 -129.67 136.15 49.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.011 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.667 ' HB ' HG22 ' A' ' 54' ' ' THR . 38.8 mt -88.01 120.69 37.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.0 110.631 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -121.97 173.38 7.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.177 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.43 HG21 HD22 ' A' ' 40' ' ' LEU . 40.4 t -79.93 98.18 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.611 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -55.68 10.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.121 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -162.4 145.0 11.15 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 32.0 mtm -119.57 149.54 41.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.955 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 p -65.55 148.98 50.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -75.13 151.66 38.56 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.817 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.47 34.47 20.46 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.633 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.94 172.59 18.29 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.753 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -29.65 69.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.598 ' N ' HD21 ' B' ' 89' ' ' LEU . . . -74.76 -39.55 61.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.205 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.97 -33.71 44.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.115 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -39.77 79.26 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.386 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -106.9 -27.54 10.64 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.558 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.87 59.03 7.99 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.418 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.881 ' CB ' HG11 ' B' ' 87' ' ' VAL . 5.7 m-80 -88.62 -33.82 17.5 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.6 0.2 . . . . 0.0 111.328 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.578 ' CD1' HD22 ' A' ' 75' ' ' LEU . 4.4 mt -111.82 134.78 53.17 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.144 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.1 132.71 43.4 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.751 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -57.18 113.48 1.74 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.11 0.481 . . . . 0.0 111.27 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.22 -18.93 13.64 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.793 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -62.37 137.2 58.21 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.879 0.371 . . . . 0.0 110.512 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.484 HG21 ' NE2' ' A' ' 22' ' ' GLN . 33.4 pt -76.39 128.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.916 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.467 HG22 ' OG1' ' A' ' 54' ' ' THR . 17.0 mt -95.45 137.39 23.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.872 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.4 tp -103.72 -36.67 7.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.444 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -148.25 147.85 29.82 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.896 0.379 . . . . 0.0 111.547 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 35.8 mt -142.27 117.58 5.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.957 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 51.3 29.47 5.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.369 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.84 -10.83 64.4 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.615 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -103.67 124.79 49.5 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 117.329 0.565 . . . . 0.0 110.845 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.747 HG22 ' H ' ' A' ' 55' ' ' GLU . 2.4 p -56.97 149.61 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.147 0.499 . . . . 0.0 110.941 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -118.59 31.15 6.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.511 -178.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.747 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -127.6 128.52 45.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 71.02 -5.82 1.43 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.299 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ttt -78.14 156.06 30.13 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.837 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -71.94 138.72 48.3 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.459 HD11 ' HA2' ' B' ' 103' ' ' GLY . 0.7 OUTLIER -58.08 -45.04 87.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.195 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.9 p -59.31 -44.92 92.5 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.141 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.16 -47.19 87.35 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.07 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.714 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -61.6 -40.38 94.59 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.87 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.459 ' HA ' HD12 ' A' ' 66' ' ' ILE . 51.6 mtp85 -64.4 -40.57 96.04 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.948 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -65.76 -38.53 89.32 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.813 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 65' ' ' LEU . 1.3 tm? -59.93 -44.23 94.47 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.751 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 63' ' ' ARG . 4.8 mt -68.18 -37.02 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -63.19 -49.33 74.68 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.829 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -69.59 -26.84 64.65 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.352 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -76.13 68.82 2.62 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.056 0.455 . . . . 0.0 110.879 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -87.42 99.47 12.03 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.546 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.13 -82.87 0.17 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.631 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.25 130.65 37.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.627 0.251 . . . . 0.0 110.566 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.746 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.7 OUTLIER -129.59 140.7 51.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.423 . . . . 0.0 111.219 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.9 tt0 -109.87 140.24 44.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.597 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.578 HD22 ' CD1' ' A' ' 40' ' ' LEU . 1.5 mp -130.24 126.44 37.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.605 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.4 t -115.51 133.59 61.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.05 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -122.78 165.8 18.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.249 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 C--O 1.232 0.173 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.675 179.761 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.668 HD13 ' N ' ' B' ' 86' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.73 0.3 . . . . 0.0 111.026 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.668 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -142.79 157.6 26.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.835 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.881 HG11 ' CB ' ' A' ' 39' ' ' ASN . 16.9 t -122.92 135.24 63.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.659 0.266 . . . . 0.0 111.096 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.431 ' O ' HD12 ' B' ' 88' ' ' LEU . 0.4 OUTLIER -104.87 127.47 52.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.511 179.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.598 HD21 ' N ' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -111.52 144.57 40.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.775 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 4.1 ttt -111.28 163.68 13.7 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.855 -179.926 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.682 0.277 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.746 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 43.0 m-85 -55.75 -30.52 61.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.548 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.5 19.51 77.99 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.554 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -93.2 118.48 31.29 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.57 113.36 26.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.211 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.714 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.7 pt? -105.12 124.94 50.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . 0.459 ' HA2' HD11 ' A' ' 59' ' ' LEU . . . -108.46 -177.36 21.89 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.972 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.438 ' OG ' HD12 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -139.06 148.62 43.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.857 0.361 . . . . 0.0 111.193 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -129.1 139.91 51.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.78 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.943 HD13 ' HB2' ' B' ' 145' ' ' ALA . 35.6 mt -88.13 121.66 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 110.828 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.485 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 44.7 p90 -124.29 170.57 10.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.204 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.74 98.28 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.139 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . 0.485 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -66.24 -56.36 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.259 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -153.48 142.0 20.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.654 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -130.7 158.61 39.61 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.832 0.348 . . . . 0.0 111.308 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 89.9 m -65.28 134.87 54.55 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.974 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.93 149.7 44.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.8 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.78 30.39 18.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.461 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.83 -171.61 32.89 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.1 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.656 HD22 ' O ' ' A' ' 7' ' ' MET . 1.3 mp -68.11 -32.51 72.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.499 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -74.94 -38.65 61.69 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.547 0.213 . . . . 0.0 111.349 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -33.52 45.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.18 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -60.81 -39.04 87.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.026 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.08 -31.63 11.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.375 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.57 45.79 21.64 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.45 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.65 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.4 p-10 -77.68 -39.5 44.59 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.449 ' CD1' HD13 ' B' ' 158' ' ' LEU . 78.6 mt -122.59 127.2 49.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.778 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.99 131.28 38.12 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -48.11 110.77 0.36 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.009 0.433 . . . . 0.0 111.255 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.95 -5.71 30.73 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.452 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -68.3 136.47 53.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.264 0.532 . . . . 0.0 111.396 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -79.0 101.28 4.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.271 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.748 HG21 HD11 ' B' ' 132' ' ' ILE . 7.7 mt -64.68 148.38 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.02 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 tt -111.12 -44.53 3.56 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.616 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -151.6 148.05 27.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.79 0.329 . . . . 0.0 111.687 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 1.105 HD12 HD23 ' B' ' 158' ' ' LEU . 36.5 mm -132.83 118.53 34.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.526 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 56.81 42.92 25.89 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.31 15.35 74.81 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.216 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 7.5 m -120.89 140.27 52.04 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.957 0.378 . . . . 0.0 110.219 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.627 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.6 t -61.46 148.36 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.825 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.755 HG22 HD12 ' B' ' 106' ' ' ILE . 0.2 OUTLIER -129.12 22.78 5.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.135 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.627 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.0 OUTLIER -112.17 135.27 53.04 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.379 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 72.11 -9.53 0.99 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.484 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.629 ' HB3' HD11 ' B' ' 106' ' ' ILE . 4.0 tpp -66.55 170.65 5.93 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.02 148.62 22.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.987 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.04 -35.76 71.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.759 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' B' ' 146' ' ' ARG . 3.8 m -65.68 -37.24 85.95 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.159 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.38 -38.68 65.57 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 110.607 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.943 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -64.03 -42.57 97.06 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.089 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' B' ' 143' ' ' THR . 7.0 ppt_? -72.63 -35.53 67.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.65 0.262 . . . . 0.0 110.59 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -39.23 82.83 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.773 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.85 -45.15 93.35 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.602 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.505 HD12 HD22 ' A' ' 19' ' ' LEU . 47.7 mt -68.56 -36.79 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.772 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.57 -48.77 71.26 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.985 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -70.35 -24.94 63.07 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.61 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 96.9 p -78.06 67.35 3.88 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.064 0.459 . . . . 0.0 110.751 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 6.7 mtm-85 -76.62 128.31 34.46 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.587 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.57 -91.47 0.59 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.506 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.42 134.57 50.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.783 0.325 . . . . 0.0 110.723 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.781 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -129.76 141.68 50.83 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.331 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 7.8 tt0 -100.37 139.57 35.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.676 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 1.105 HD23 HD12 ' B' ' 132' ' ' ILE . 0.7 OUTLIER -134.0 128.79 35.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.91 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.56 137.11 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -125.01 143.83 37.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.248 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 5.9 tt . . . . . 0 C--N 1.332 -0.177 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.486 179.786 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.739 0.304 . . . . 0.0 111.469 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.97 158.77 23.48 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.564 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.713 HG11 ' HB3' ' B' ' 122' ' ' ASN . 25.8 t -132.07 133.34 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.68 0.276 . . . . 0.0 110.963 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.497 HD23 ' OE1' ' B' ' 157' ' ' GLN . 0.3 OUTLIER -107.01 107.62 18.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.104 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.487 HD21 ' N ' ' B' ' 117' ' ' ALA . 5.9 tp -91.03 128.5 36.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.118 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.497 ' O ' HD13 ' B' ' 116' ' ' LEU . 21.2 ttt -114.97 162.27 17.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.295 0.569 . . . . 0.0 111.274 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 tttm . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.798 -179.755 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.524 0.202 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.716 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 86.9 m-85 -58.2 -27.44 63.9 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.42 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.36 29.02 58.86 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.666 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.67 118.84 37.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.278 . . . . 0.0 110.727 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.18 113.43 25.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.928 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.704 HD21 HD13 ' B' ' 129' ' ' ILE . 5.9 mp -97.06 124.88 41.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 111.342 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -110.33 179.85 20.48 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -132.61 150.18 52.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.194 0.497 . . . . 0.0 111.354 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' B' ' 104' ' ' SER . 7.9 pt20 -134.42 141.56 46.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.794 ' HB ' HG22 ' A' ' 54' ' ' THR . 2.9 mm -87.84 121.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.401 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -126.41 171.54 10.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.205 0.526 . . . . 0.0 111.392 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.76 100.46 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.853 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -55.76 5.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.082 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -156.58 133.8 10.58 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.559 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.06 145.12 48.82 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.896 0.379 . . . . 0.0 111.28 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.5 m -65.31 120.07 12.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.588 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.82 164.59 7.75 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.003 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.63 27.77 14.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.34 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.52 -175.18 20.55 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.182 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.648 HD22 ' O ' ' B' ' 90' ' ' MET . 0.6 OUTLIER -69.01 -31.1 69.69 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.5 ' N ' HD21 ' B' ' 89' ' ' LEU . . . -75.17 -34.88 61.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.52 0.2 . . . . 0.0 111.138 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.84 -34.09 45.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.216 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -37.75 85.5 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.49 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -102.41 -32.7 9.86 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.349 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.56 53.92 8.07 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.141 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.67 ' OD1' HG11 ' B' ' 87' ' ' VAL . 5.1 m-80 -70.03 -47.68 61.08 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.523 0.202 . . . . 0.0 111.296 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.638 HD13 ' C ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -116.49 136.17 53.22 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.902 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.81 141.79 28.32 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.207 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -56.99 109.66 0.68 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.186 0.517 . . . . 0.0 110.856 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.8 -7.77 38.95 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.708 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -67.16 138.58 57.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.078 0.466 . . . . 0.0 110.955 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 pt -77.33 120.93 28.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.811 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.915 HG21 HD11 ' A' ' 49' ' ' ILE . 24.1 mt -90.38 152.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.877 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.859 HD13 HD11 ' A' ' 78' ' ' LEU . 2.5 tp -111.7 -52.2 2.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.831 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.14 147.9 40.86 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 111.568 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 46' ' ' ILE . 37.4 mm -132.78 118.35 33.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 m120 53.28 36.71 23.44 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.754 0.311 . . . . 0.0 111.264 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.55 16.74 77.2 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.162 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.615 HG21 HD11 ' A' ' 65' ' ' LEU . 1.6 m -120.54 143.68 48.46 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.905 0.353 . . . . 0.0 110.094 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.449 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.3 t -63.79 143.93 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 111.295 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.794 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -127.72 27.86 5.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.945 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.449 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -123.99 126.76 46.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.013 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 72.0 -5.71 1.66 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.403 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.427 ' CE ' ' HB ' ' A' ' 53' ' ' VAL . 2.3 tpp -67.97 172.59 5.37 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.96 0.409 . . . . 0.0 111.439 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.7 t -90.81 150.96 21.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.244 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -42.01 82.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.793 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.7 t -57.66 -41.94 82.52 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.9 -46.11 86.31 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.95 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' B' ' 102' ' ' LEU . . . -60.22 -41.06 92.28 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.29 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -71.38 -37.33 71.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.435 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -67.92 -38.24 82.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.63 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 52' ' ' THR . 0.1 OUTLIER -59.72 -45.39 92.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.81 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.547 ' CD1' HD22 ' B' ' 102' ' ' LEU . 48.5 mt -68.73 -36.82 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.872 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -48.71 62.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.879 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.9 -24.52 62.49 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.775 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.4 p -79.38 65.37 4.53 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.116 0.484 . . . . 0.0 110.973 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -78.07 119.92 22.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.69 -89.45 0.46 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.29 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -126.35 130.22 50.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.625 0.25 . . . . 0.0 110.681 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.663 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.6 OUTLIER -122.78 143.47 49.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.947 0.404 . . . . 0.0 111.233 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.2 tm0? -105.85 142.14 36.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.867 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' HA ' HD13 ' A' ' 49' ' ' ILE . 1.4 mp -137.71 125.78 22.89 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.914 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.5 t -112.65 133.46 58.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.775 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.53 161.53 41.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.312 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.859 HD11 HD13 ' A' ' 47' ' ' LEU . 6.7 mp . . . . . 0 C--N 1.332 -0.168 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.257 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 120.663 0.268 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.13 158.84 22.16 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.88 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.67 HG11 ' OD1' ' A' ' 39' ' ' ASN . 15.3 t -129.67 135.05 62.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.691 0.282 . . . . 0.0 111.028 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 7.4 tt -105.35 109.31 21.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.464 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.5 HD21 ' N ' ' A' ' 34' ' ' ALA . 10.6 tp -94.04 141.34 28.64 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . 0.648 ' O ' HD22 ' A' ' 33' ' ' LEU . 13.2 ttt -115.09 165.73 12.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.096 0.474 . . . . 0.0 111.167 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.623 179.84 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 120.756 0.312 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.663 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 53.1 m-85 -80.34 -29.52 38.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.756 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.89 20.04 38.06 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.552 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.415 HD21 ' CB ' ' A' ' 34' ' ' ALA . 4.8 mp -100.1 120.17 39.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.701 0.286 . . . . 0.0 110.804 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.35 113.57 26.77 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.973 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.547 HD22 ' CD1' ' A' ' 66' ' ' ILE . 1.7 pt? -113.51 125.02 53.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.151 0.501 . . . . 0.0 111.339 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -108.16 -162.11 20.85 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.003 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -141.72 146.51 36.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -126.66 143.19 51.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.222 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 1.063 HD13 ' HB2' ' B' ' 145' ' ' ALA . 30.2 mt -88.4 120.71 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -122.15 172.3 8.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.805 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 57.9 t -84.06 94.14 3.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.174 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -64.17 -51.66 62.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.264 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -155.42 133.24 11.32 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.742 0.306 . . . . 0.0 110.784 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -121.45 144.26 48.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 89.3 m -66.51 123.43 20.02 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.01 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -65.53 162.07 18.85 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.127 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 62.03 35.31 16.05 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.122 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -117.94 -175.75 16.93 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.175 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 7' ' ' MET . 4.0 mt -65.43 -33.54 76.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.519 0.199 . . . . 0.0 111.48 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.487 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -74.95 -35.06 62.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.306 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.86 -33.9 45.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.186 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -62.65 -37.52 86.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.303 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.16 -29.93 11.84 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.563 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.75 48.27 43.27 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.289 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.713 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.2 p30 -72.26 -41.64 66.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.447 HD13 HD13 ' B' ' 158' ' ' LEU . 2.9 mp -125.48 127.49 46.56 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.665 0.269 . . . . 0.0 110.827 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.08 136.35 33.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.0 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -49.71 107.0 0.13 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.051 0.453 . . . . 0.0 111.666 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.68 -2.95 24.65 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.411 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -76.17 139.96 41.5 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 117.654 0.727 . . . . 0.0 111.275 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.72 113.07 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.068 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 1.028 HG21 HD11 ' B' ' 132' ' ' ILE . 6.8 mt -82.52 137.22 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.294 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 tp -96.82 -40.24 9.03 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -148.61 148.23 29.89 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 111.909 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 1.028 HD11 HG21 ' B' ' 129' ' ' ILE . 18.4 mm -135.02 118.22 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.087 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . 0.471 ' HB2' HD21 ' B' ' 148' ' ' LEU . 3.0 t-20 54.88 42.58 30.99 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.988 0.423 . . . . 0.0 111.074 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.14 16.09 76.79 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.139 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 13.2 m -120.74 137.47 54.48 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.934 0.367 . . . . 0.0 110.586 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.513 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.3 t -59.4 145.16 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.034 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.826 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -118.5 18.35 13.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.428 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.513 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.3 OUTLIER -105.67 140.6 38.48 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.3 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 52.64 9.91 0.13 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.705 0.628 . . . . 0.0 112.349 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.73 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -73.89 173.68 9.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 111.264 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.19 137.22 32.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.956 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.62 -40.73 69.22 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.388 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 1.2 p -64.16 -38.03 89.59 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.218 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.78 -48.22 72.54 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.756 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 1.063 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.49 -42.26 87.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.942 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -69.45 -37.49 77.38 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.576 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -67.81 -38.64 83.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.551 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . 0.51 ' O ' HD23 ' B' ' 148' ' ' LEU . 6.7 tt -60.02 -44.85 94.33 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.586 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.547 HD11 HD22 ' A' ' 19' ' ' LEU . 11.8 mt -68.34 -36.64 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.92 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -69.14 -41.75 76.89 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.714 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.1 0.07 52.83 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 97.1 p -91.51 54.8 2.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.263 0.554 . . . . 0.0 110.945 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.32 83.94 1.42 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.377 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 159.58 -90.27 0.11 Allowed Glycine 0 C--O 1.226 -0.375 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.302 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.24 133.71 41.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.501 0.191 . . . . 0.0 110.804 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.716 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.64 125.61 38.46 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 111.297 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.497 ' OE1' HD23 ' A' ' 5' ' ' LEU . 2.7 mt-30 -92.33 119.13 31.6 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.447 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.69 HD23 HD12 ' B' ' 132' ' ' ILE . 0.4 OUTLIER -111.41 129.84 55.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.699 0.285 . . . . 0.0 110.988 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 27.0 t -116.48 140.29 39.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.431 HG21 ' HG ' ' B' ' 123' ' ' LEU . 27.0 t -132.19 138.01 53.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.092 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.861 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.829 0.347 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.22 158.69 24.45 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.57 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.672 HG11 ' HB3' ' B' ' 122' ' ' ASN . 23.3 t -131.87 134.44 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.68 0.276 . . . . 0.0 110.829 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.15 115.95 30.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.622 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.45 HD21 ' N ' ' B' ' 117' ' ' ALA . 1.6 tp -102.79 142.53 33.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.444 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.634 ' O ' HD22 ' B' ' 116' ' ' LEU . 0.7 OUTLIER -107.47 162.21 14.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.218 0.533 . . . . 0.0 110.589 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.487 ' N ' ' HG3' ' A' ' 7' ' ' MET . 11.2 ttpt . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.008 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.883 ' CE2' HD23 ' B' ' 156' ' ' LEU . 52.9 m-85 -58.79 -32.97 69.82 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.325 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' O ' HG23 ' B' ' 112' ' ' THR . . . 85.76 20.54 55.8 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.383 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -105.31 123.32 47.66 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.872 0.336 . . . . 0.0 110.556 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.413 ' HB2' ' HG2' ' B' ' 110' ' ' GLU . 0.0 OUTLIER -100.73 113.57 26.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.337 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.865 HD22 HD11 ' B' ' 149' ' ' ILE . 1.2 mp -92.39 124.87 36.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.108 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.38 -173.84 22.43 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.52 147.34 31.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.291 . . . . 0.0 110.836 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -130.84 133.85 46.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.193 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.969 HD13 ' HB2' ' A' ' 62' ' ' ALA . 46.1 mt -87.94 120.32 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.958 0.408 . . . . 0.0 110.327 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -126.72 173.19 9.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.191 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.816 ' CG2' HD12 ' A' ' 40' ' ' LEU . 60.3 t -85.5 97.71 5.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.018 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -55.4 21.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.266 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -147.19 144.64 29.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.922 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.426 ' SD ' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -138.24 148.76 45.08 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.948 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.4 t -65.83 132.86 49.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.056 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -74.72 148.33 40.59 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.566 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.7 31.4 21.11 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.24 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.46 -144.11 16.19 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.355 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 -38.45 17.61 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.71 0.29 . . . . 0.0 111.154 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.487 ' CB ' HD21 ' B' ' 100' ' ' LEU . . . -74.91 -30.17 61.19 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.251 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.426 HG23 ' SD ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -79.14 -35.48 42.05 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.93 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -36.69 84.76 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.991 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.0 -28.14 13.92 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.102 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.34 49.19 53.72 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.507 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.846 ' HB3' HG11 ' B' ' 87' ' ' VAL . 11.8 p-10 -94.12 -32.16 13.87 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.816 HD12 ' CG2' ' A' ' 25' ' ' VAL . 3.3 mm? -114.64 131.08 56.84 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.674 0.273 . . . . 0.0 110.997 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.16 117.91 35.37 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -43.9 108.53 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.133 0.492 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.51 -5.37 31.35 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.346 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.401 ' OD2' HD13 ' A' ' 40' ' ' LEU . 50.3 p-10 -75.85 139.99 42.0 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.854 0.827 . . . . 0.0 111.751 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.4 pt -80.13 118.45 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.175 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.645 HD11 HD11 ' B' ' 102' ' ' LEU . 26.4 mt -85.0 134.43 27.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.801 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 tp -99.42 -29.9 12.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.677 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -157.59 148.47 21.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.775 0.321 . . . . 0.0 111.425 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.558 HD11 HD21 ' B' ' 102' ' ' LEU . 37.5 mt -140.73 118.12 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.563 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.444 ' HB2' HD21 ' A' ' 65' ' ' LEU . 0.6 OUTLIER 56.52 35.89 26.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.275 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 12.33 83.87 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.176 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.9 m -120.15 135.88 54.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.864 0.332 . . . . 0.0 110.398 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.3 t -59.83 147.46 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.826 0.346 . . . . 0.0 111.037 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -122.17 19.02 10.75 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.396 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -106.27 144.4 33.02 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 p30 52.58 7.82 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 123.644 0.59 . . . . 0.0 112.376 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.713 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -76.15 176.58 7.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 111.123 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 t -92.12 146.72 23.5 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.756 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.52 -43.93 96.59 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.599 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.4 p -62.47 -38.22 89.0 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.069 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -48.01 75.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.905 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.969 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -62.22 -40.55 96.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.994 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -67.6 -39.28 84.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.77 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -66.59 -38.49 87.12 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.545 ' O ' HD23 ' A' ' 65' ' ' LEU . 6.2 tt -59.91 -45.38 92.73 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.529 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.886 HD11 HD22 ' B' ' 102' ' ' LEU . 5.7 mt -68.5 -37.05 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.94 -49.46 57.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.108 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.48 -19.43 63.75 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.253 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 t -79.33 63.99 4.11 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.196 0.522 . . . . 0.0 110.574 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 mtm105 -79.08 97.72 6.24 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.413 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.67 -93.99 0.18 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.214 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.38 125.96 45.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.581 0.229 . . . . 0.0 110.66 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.843 HD23 ' CE1' ' B' ' 98' ' ' TYR . 2.3 pp -124.73 143.85 50.55 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.896 0.379 . . . . 0.0 111.188 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -105.14 142.65 34.54 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.779 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.755 HD11 HD11 ' A' ' 73' ' ' LEU . 1.0 OUTLIER -135.34 132.28 37.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.819 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.53 135.0 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.292 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.5 m -122.98 146.59 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.196 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.9 tp . . . . . 0 C--O 1.231 0.112 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.552 179.658 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.603 HD13 ' N ' ' B' ' 86' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.903 0.382 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.603 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -117.84 157.21 15.27 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.447 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.846 HG11 ' HB3' ' A' ' 39' ' ' ASN . 17.3 t -130.82 134.54 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 0.0 111.063 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 73' ' ' LEU . 0.6 OUTLIER -102.92 107.35 18.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.619 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 9.4 tp -95.19 139.54 31.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.392 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 8.2 ttt -114.52 164.4 14.04 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.993 0.425 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.172 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.25 0 CA-C-O 120.76 0.314 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.843 ' CE1' HD23 ' A' ' 73' ' ' LEU . 71.0 m-85 -59.48 -30.6 68.66 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.377 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.44 24.74 32.74 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.512 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.487 HD21 ' CB ' ' A' ' 34' ' ' ALA . 11.2 mp -108.48 120.5 42.6 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.757 0.313 . . . . 0.0 110.699 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -92.91 117.05 29.62 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.761 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.886 HD22 HD11 ' A' ' 66' ' ' ILE . 1.1 tp -94.7 125.2 39.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -116.46 177.09 16.7 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.658 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.22 146.59 46.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.904 0.352 . . . . 0.0 110.922 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -128.14 137.01 51.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.219 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.966 HD13 ' HB2' ' B' ' 145' ' ' ALA . 42.3 mt -88.27 120.48 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.908 0.385 . . . . 0.0 110.457 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -124.73 172.59 9.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.079 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' B' ' 123' ' ' LEU . 40.2 t -82.74 96.03 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.146 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -57.6 6.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.689 0.28 . . . . 0.0 111.178 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -149.28 138.46 21.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.615 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -132.25 140.12 48.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.017 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 16' ' ' GLY . 38.6 p -69.37 120.48 15.24 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.788 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . 0.676 ' HA ' HG21 ' B' ' 118' ' ' THR . 8.0 ptt180 -63.04 169.24 3.49 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.738 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m 62.01 23.66 13.97 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.946 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.16 -164.51 24.77 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.255 -0.497 . . . . 0.0 112.326 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.634 HD22 ' O ' ' A' ' 7' ' ' MET . 0.0 OUTLIER -77.58 -31.41 53.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.579 0.228 . . . . 0.0 111.295 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.45 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -74.45 -34.96 63.3 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.186 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.676 HG21 ' HA ' ' B' ' 113' ' ' ARG . 2.1 p -79.0 -34.05 44.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.085 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -58.81 -39.53 81.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.264 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -103.92 -29.14 11.15 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.465 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.7 46.26 47.75 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.251 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.672 ' HB3' HG11 ' A' ' 4' ' ' VAL . 12.0 p-10 -73.37 -38.44 65.69 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.514 0.197 . . . . 0.0 111.355 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' B' ' 158' ' ' LEU . 1.5 mp -127.61 139.37 52.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.763 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.2 148.35 27.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.43 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -60.31 113.32 2.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.086 0.469 . . . . 0.0 110.962 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.48 -16.12 24.38 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.009 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -60.6 136.09 57.95 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.317 0.559 . . . . 0.0 111.295 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.92 99.15 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.377 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.84 HD13 HD21 ' A' ' 19' ' ' LEU . 4.7 mt -63.52 147.42 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.681 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 18.2 tp -110.28 -35.46 6.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.617 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -157.32 148.26 21.54 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.783 0.325 . . . . 0.0 111.19 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.555 HD11 HD21 ' A' ' 19' ' ' LEU . 43.8 mt -141.04 118.25 8.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.752 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 3.9 m120 53.83 50.52 16.73 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.065 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.15 18.71 60.73 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.031 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 2.9 m -120.57 139.09 53.45 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.702 0.251 . . . . 0.0 110.33 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.611 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.4 t -65.73 145.11 14.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 111.293 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.879 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -113.96 -1.79 13.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.196 179.38 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.611 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.2 OUTLIER -99.6 150.36 22.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 p30 52.41 8.57 0.08 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.571 0.544 . . . . 0.0 112.242 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.455 ' HB3' HD11 ' B' ' 106' ' ' ILE . 2.9 ttm -90.98 151.0 21.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.722 0.296 . . . . 0.0 110.764 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 30.0 t -71.8 145.78 48.45 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.014 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.489 ' O ' HD23 ' B' ' 142' ' ' LEU . 6.1 tt -60.19 -47.97 83.7 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.705 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 3.2 p -55.52 -38.38 69.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.023 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.02 -47.93 69.94 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.69 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.966 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -60.54 -40.81 92.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.048 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -67.24 -39.23 86.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.664 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -66.85 -38.39 86.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.788 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.05 -44.45 94.68 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.772 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.865 HD11 HD22 ' A' ' 19' ' ' LEU . 29.6 mt -68.18 -37.46 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.967 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -68.95 -49.36 58.64 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.811 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -67.83 -25.46 65.57 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.02 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 43.8 t -76.39 65.69 2.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.039 0.447 . . . . 0.0 110.632 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -78.7 100.49 7.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.348 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 144.21 -94.78 0.18 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.962 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.9 126.25 46.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.636 0.255 . . . . 0.0 110.898 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.883 HD23 ' CE2' ' A' ' 15' ' ' TYR . 2.1 pp -123.76 132.71 53.86 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.837 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 0.0 OUTLIER -93.08 142.79 26.9 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.495 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.765 HD21 HD11 ' B' ' 156' ' ' LEU . 0.3 OUTLIER -133.26 128.22 35.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.022 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.43 140.2 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.589 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.57 160.69 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.836 0.351 . . . . 0.0 111.184 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.654 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.5 HD13 ' C ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.714 0.292 . . . . 0.0 111.335 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.403 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -120.93 157.03 16.03 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.781 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.528 HG11 ' CB ' ' B' ' 122' ' ' ASN . 21.8 t -130.41 135.21 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 0.0 111.352 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' B' ' 157' ' ' GLN . 0.9 OUTLIER -103.12 108.99 20.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.639 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.521 HD23 ' CD2' ' A' ' 15' ' ' TYR . 15.4 tp -98.78 141.93 30.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.736 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.3 ttt -118.7 163.51 16.74 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.097 0.475 . . . . 0.0 110.904 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.072 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.275 0 CA-C-O 121.275 0.559 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.584 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 62.0 m-85 -77.29 -9.62 58.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.85 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.55 24.12 71.23 Favored Glycine 0 C--N 1.341 0.851 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.483 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.625 HD11 ' HB2' ' B' ' 117' ' ' ALA . 6.8 mp -105.93 123.52 48.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.657 0.265 . . . . 0.0 110.508 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.19 113.04 24.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.013 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.795 HD22 HD11 ' B' ' 149' ' ' ILE . 9.4 mp -96.79 124.79 40.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' B' ' 109' ' ' LYS . . . -106.57 -168.43 22.69 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.45 ' OG ' HD12 ' B' ' 142' ' ' LEU . 0.1 OUTLIER -144.74 155.45 43.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.281 0.541 . . . . 0.0 110.687 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' B' ' 104' ' ' SER . 2.3 pt20 -136.81 131.35 33.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.799 HD13 ' HB2' ' A' ' 62' ' ' ALA . 40.5 mt -87.72 120.28 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.012 0.434 . . . . 0.0 109.903 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.484 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 42.8 p90 -121.79 173.15 7.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.193 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.793 HG21 ' HB3' ' A' ' 40' ' ' LEU . 32.0 t -83.99 96.58 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.972 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -64.09 -52.57 58.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.932 -179.276 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -163.95 142.89 7.71 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.695 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -134.45 139.01 45.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.046 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.0 t -65.72 126.1 27.38 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.699 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 ptt85 -63.9 172.78 2.1 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.028 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.65 27.42 13.2 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.198 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.98 -174.17 18.58 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.243 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.631 HD22 ' O ' ' B' ' 90' ' ' MET . 2.8 mp -74.78 -26.92 60.09 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.52 -36.87 63.19 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.186 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.99 -33.8 44.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -65.71 -36.22 83.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.157 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.31 -29.79 12.96 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.406 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.1 42.1 85.26 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.112 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.707 ' HB3' HG11 ' B' ' 87' ' ' VAL . 11.8 p-10 -70.72 -46.24 63.43 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.39 0.138 . . . . 0.0 111.291 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.793 ' HB3' HG21 ' A' ' 25' ' ' VAL . 8.5 mt -114.56 127.11 55.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.813 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 142.49 29.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.502 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -59.22 109.59 0.89 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.108 0.48 . . . . 0.0 110.465 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.83 -9.65 55.34 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.731 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -60.79 139.64 57.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.103 0.478 . . . . 0.0 111.172 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.19 118.4 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.765 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.463 ' CD1' HD21 ' B' ' 102' ' ' LEU . 34.7 mt -89.09 152.04 3.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.786 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.922 HD13 HD13 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -117.35 -43.12 2.84 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.083 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 148.85 31.79 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.023 0.439 . . . . 0.0 111.958 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.51 ' CD1' HG21 ' A' ' 54' ' ' THR . 66.8 mt -141.27 121.29 12.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.462 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 m120 55.34 34.2 22.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.398 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.92 9.58 84.22 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.663 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.2 m -119.86 138.16 53.57 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.155 0.478 . . . . 0.0 110.333 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.2 t -57.12 145.82 7.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.124 0.488 . . . . 0.0 111.006 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.661 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -130.54 28.88 4.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.972 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.523 ' H ' HG12 ' A' ' 53' ' ' VAL . 8.5 tt0 -98.3 -102.0 0.21 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.428 ' HB2' ' CD1' ' B' ' 142' ' ' LEU . 6.7 p30 -66.37 -2.86 4.96 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.513 ' HB3' HD11 ' A' ' 23' ' ' ILE . 1.2 tpt -52.77 164.18 0.39 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.167 0.508 . . . . 0.0 111.7 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 m -79.01 147.35 32.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.592 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' B' ' 139' ' ' ASN . 0.5 OUTLIER -61.99 -46.54 88.77 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.781 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 t -59.56 -41.77 90.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.83 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -66.85 -43.13 84.46 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.702 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.799 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.055 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -68.59 -38.59 80.79 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.463 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -38.4 82.78 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.816 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -43.5 98.44 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.75 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.816 HD11 HD22 ' B' ' 102' ' ' LEU . 11.4 mt -68.55 -38.08 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.709 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -68.49 -49.49 59.37 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.651 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -23.11 66.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.343 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.0 m -76.1 68.27 2.53 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.962 0.411 . . . . 0.0 110.67 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.0 119.29 20.53 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.505 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.84 -94.03 0.56 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.278 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.69 127.25 43.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.705 0.288 . . . . 0.0 110.804 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.872 HD23 ' CE2' ' B' ' 98' ' ' TYR . 2.2 pp -119.49 133.69 55.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 4.9 mm-40 -93.56 142.69 27.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.91 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.698 HD21 HD11 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -133.82 123.82 25.46 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.53 134.42 53.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.032 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 46' ' ' ILE . 35.0 m -128.62 150.13 34.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.785 0.326 . . . . 0.0 111.549 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.922 HD13 HD13 ' A' ' 47' ' ' LEU . 3.8 tp . . . . . 0 C--O 1.233 0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.281 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.649 0.261 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.27 157.75 15.63 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.56 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.707 HG11 ' HB3' ' A' ' 39' ' ' ASN . 17.7 t -130.53 135.22 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.618 0.246 . . . . 0.0 111.206 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.51 113.99 27.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.81 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.463 HD23 ' CD1' ' B' ' 98' ' ' TYR . 2.2 tp -105.02 144.67 31.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . 0.631 ' O ' HD22 ' A' ' 33' ' ' LEU . 4.0 ttt -109.74 163.9 13.06 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.202 0.525 . . . . 0.0 110.848 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.089 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . 0.61 ' OE2' HG22 ' A' ' 66' ' ' ILE . 0.7 OUTLIER . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.646 0.26 . . . . 0.0 110.729 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.872 ' CE2' HD23 ' A' ' 73' ' ' LEU . 72.2 m-85 -51.51 -31.5 24.18 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.49 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.14 26.62 65.92 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.579 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.14 119.47 38.8 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.682 0.277 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.01 113.37 25.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.294 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.816 HD22 HD11 ' A' ' 66' ' ' ILE . 1.1 mp -97.01 125.11 41.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -108.91 -179.0 21.52 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.427 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.411 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -146.62 144.74 29.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.018 0.409 . . . . 0.0 111.101 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.413 ' NE2' HG21 ' B' ' 128' ' ' ILE . 5.7 pt20 -130.65 137.91 49.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.164 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.927 HD13 ' HB2' ' B' ' 145' ' ' ALA . 18.8 mt -87.93 120.6 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.337 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -122.13 172.11 8.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.231 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' B' ' 123' ' ' LEU . 40.9 t -80.97 96.71 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.772 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . 0.427 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 0.4 OUTLIER -67.07 -57.06 7.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.103 -179.167 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -155.13 147.68 24.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.657 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -138.13 147.9 44.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 111.007 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -65.28 121.86 15.79 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.849 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . 0.642 ' HA ' HG21 ' B' ' 118' ' ' THR . 20.0 ttt180 -69.04 157.03 37.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.556 HG22 ' O ' ' B' ' 113' ' ' ARG . 0.5 OUTLIER 68.68 14.16 8.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.484 -179.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.59 -158.26 33.79 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.302 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp -81.85 -30.43 32.09 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.528 0.204 . . . . 0.0 111.543 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.625 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -75.06 -34.23 61.8 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.362 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.642 HG21 ' HA ' ' B' ' 113' ' ' ARG . 0.8 OUTLIER -79.12 -33.96 43.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -37.8 85.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.353 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.89 -26.43 12.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.729 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.57 44.64 89.46 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.085 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.528 ' CB ' HG11 ' A' ' 4' ' ' VAL . 9.5 p30 -58.75 -44.64 90.59 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.553 ' HB3' HG21 ' B' ' 108' ' ' VAL . 4.7 mp -133.14 142.51 48.71 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.692 0.282 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.05 144.47 25.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.432 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -59.6 111.15 1.31 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 111.185 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.69 -9.0 23.84 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.186 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -68.1 135.55 52.35 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 117.307 0.553 . . . . 0.0 110.558 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.413 HG21 ' NE2' ' B' ' 105' ' ' GLN . 1.9 pt -77.63 113.7 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.754 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.434 ' HA ' HG12 ' B' ' 160' ' ' VAL . 16.3 mt -81.6 133.98 28.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.268 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.424 HD13 HD13 ' B' ' 161' ' ' LEU . 5.0 tp -95.17 -38.81 10.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.241 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -147.32 148.03 30.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 111.694 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 26.0 mt -136.35 119.43 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.414 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 57.11 40.66 28.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.841 0.353 . . . . 0.0 111.024 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.5 15.4 77.42 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.142 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.84 141.56 50.45 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.0 0.4 . . . . 0.0 110.389 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.573 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.2 t -60.17 147.87 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.051 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.684 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -121.69 20.31 11.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.807 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.573 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.5 tt0 -105.75 138.53 41.79 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.473 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 59' ' ' LEU . 11.4 p30 52.98 9.95 0.14 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.618 0.574 . . . . 0.0 112.295 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.415 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.3 OUTLIER -71.77 172.08 10.44 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.771 0.319 . . . . 0.0 111.483 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 44.8 t -91.38 142.64 27.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.45 HD12 ' OG ' ' A' ' 21' ' ' SER . 2.7 tt -59.18 -42.52 91.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.643 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.1 p -60.37 -39.67 88.06 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.771 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -48.21 74.83 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.957 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.927 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -60.81 -41.01 94.82 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.88 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -66.3 -39.92 89.67 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.437 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -38.23 82.33 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.398 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . 0.407 ' HA ' ' HG2' ' B' ' 151' ' ' LYS . 0.8 OUTLIER -59.97 -44.78 94.24 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.687 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.795 HD11 HD22 ' A' ' 19' ' ' LEU . 11.3 mt -68.49 -36.69 75.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.885 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.05 -48.85 61.78 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.81 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' B' ' 148' ' ' LEU . 0.5 OUTLIER -66.01 -26.23 67.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.487 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.0 m -74.18 69.32 1.52 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.729 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.45 80.27 6.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.524 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 160.46 -81.94 0.14 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.025 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.1 125.89 25.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.544 0.211 . . . . 0.0 110.906 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.584 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -123.41 141.09 52.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.958 0.408 . . . . 0.0 111.226 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.401 ' HB2' HD21 ' A' ' 5' ' ' LEU . 29.3 tt0 -102.77 136.86 41.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.727 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mt -131.85 129.87 40.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.971 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 34.2 t -115.0 136.26 52.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.786 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' B' ' 129' ' ' ILE . 10.0 m -141.19 161.91 22.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.912 0.386 . . . . 0.0 111.39 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . 0.424 HD13 HD13 ' B' ' 130' ' ' LEU . 6.7 mp . . . . . 0 C--N 1.332 -0.167 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.687 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.627 HD13 ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.764 0.316 . . . . 0.0 111.199 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.627 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -138.57 156.78 24.31 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.867 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.825 HG11 ' HB3' ' B' ' 122' ' ' ASN . 19.5 t -129.06 134.27 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.868 0.366 . . . . 0.0 111.208 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.68 107.31 18.19 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.517 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.479 HD21 ' N ' ' B' ' 117' ' ' ALA . 5.5 tp -94.47 137.47 33.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.501 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.478 ' O ' HD13 ' B' ' 116' ' ' LEU . 17.5 ttt -113.65 163.81 14.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.991 0.424 . . . . 0.0 110.639 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.802 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 120.768 0.318 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.866 ' CE1' HD23 ' B' ' 156' ' ' LEU . 64.6 m-85 -67.21 -27.69 67.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.526 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.69 23.18 70.57 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.384 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.672 ' CD2' HD13 ' B' ' 123' ' ' LEU . 0.2 OUTLIER -98.77 120.23 38.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.593 0.235 . . . . 0.0 110.761 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.96 113.4 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.076 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.541 HD22 HD11 ' B' ' 149' ' ' ILE . 5.1 mp -99.12 124.85 44.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.163 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.85 -169.17 20.81 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.37 152.72 39.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.167 0.483 . . . . 0.0 110.582 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.466 ' NE2' HG21 ' A' ' 45' ' ' ILE . 6.9 pt20 -136.37 137.25 40.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.38 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.805 ' HB ' HG22 ' A' ' 54' ' ' THR . 41.0 mt -88.03 120.37 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.131 0.491 . . . . 0.0 110.204 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.416 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 45.5 p90 -121.0 172.33 8.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.109 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.685 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.7 t -82.19 94.51 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.015 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -62.7 -52.33 63.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.042 -179.379 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.09 144.03 20.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.807 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.422 ' HE1' ' HB1' ' A' ' 34' ' ' ALA . 10.1 ptp -132.26 145.49 51.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.153 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -66.95 119.89 12.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.958 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.01 154.8 9.06 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.056 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.1 m 63.62 30.28 14.97 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.918 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.49 -173.16 25.94 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.158 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.569 HD22 ' O ' ' B' ' 90' ' ' MET . 0.3 OUTLIER -67.49 -32.26 72.96 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HB1' ' HE1' ' A' ' 28' ' ' MET . . . -74.37 -35.81 63.54 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.024 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -34.07 44.29 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.046 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -39.94 77.54 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.563 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.35 -33.81 8.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.513 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.2 56.77 3.61 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.105 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.701 ' HB3' HG11 ' B' ' 87' ' ' VAL . 0.4 OUTLIER -93.45 -52.76 4.35 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.543 0.211 . . . . 0.0 110.942 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.685 ' HB3' HG21 ' A' ' 25' ' ' VAL . 5.9 mp -103.34 116.43 32.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.579 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.52 138.1 31.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.371 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.29 110.14 0.58 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.209 0.528 . . . . 0.0 110.875 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.99 -9.95 29.46 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.693 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -65.97 137.5 57.17 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 121.036 0.446 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.466 HG21 ' NE2' ' A' ' 22' ' ' GLN . 3.3 pt -78.47 110.79 14.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.671 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.699 HD13 HD21 ' B' ' 102' ' ' LEU . 8.3 mt -77.76 133.95 29.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.921 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.401 HD13 ' HB2' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -91.11 -46.16 8.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.547 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HB2' ' CG2' ' A' ' 76' ' ' VAL . 7.5 mttt -154.21 152.23 30.11 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.953 0.406 . . . . 0.0 111.48 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.501 HD11 HD21 ' B' ' 102' ' ' LEU . 48.7 mt -137.33 118.18 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.58 39.66 30.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.426 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.48 14.63 82.28 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.489 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.1 m -119.95 137.57 53.97 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 117.042 0.421 . . . . 0.0 110.279 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.3 t -60.63 144.32 13.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.092 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.805 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -128.4 26.71 5.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.365 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 9.8 tt0 -97.29 -109.92 0.16 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -63.45 -5.32 3.53 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.2 tpt -49.33 164.09 0.09 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.231 0.538 . . . . 0.0 111.895 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.7 147.26 45.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.587 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.453 HD11 ' OG ' ' B' ' 104' ' ' SER . 1.4 mp -62.92 -51.53 66.55 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.261 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.0 t -57.64 -38.69 75.47 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.301 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -64.17 -47.82 78.38 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.632 0.253 . . . . 0.0 110.766 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.804 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -58.81 -42.01 88.13 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.239 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 51.4 mtt-85 -69.65 -38.23 77.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -38.45 84.51 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.828 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.51 -43.75 96.76 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.89 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.872 HD11 HD22 ' B' ' 102' ' ' LEU . 10.1 mt -68.25 -37.3 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 110.692 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -49.75 59.53 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.769 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -68.32 -23.42 64.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.163 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.6 t -82.17 61.95 5.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 110.711 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -78.99 118.76 21.29 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.447 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.11 -99.77 0.59 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.966 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -118.03 131.58 56.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.754 0.311 . . . . 0.0 110.873 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.797 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -128.16 144.24 51.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.039 -179.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.12 128.47 54.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.39 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.544 HD11 HD21 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -125.7 128.6 48.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.446 -179.261 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.549 HG12 ' HA3' ' B' ' 86' ' ' GLY . 4.5 m -120.08 120.1 62.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.468 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -109.42 156.82 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.612 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.401 ' HB2' HD13 ' A' ' 47' ' ' LEU . 10.3 tt . . . . . 0 C--O 1.232 0.178 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.732 0.301 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.549 ' HA3' HG12 ' A' ' 76' ' ' VAL . . . -129.83 160.59 22.85 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.831 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.701 HG11 ' HB3' ' A' ' 39' ' ' ASN . 21.1 t -130.71 131.75 64.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.781 0.324 . . . . 0.0 111.0 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -95.35 113.1 24.74 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.626 HD23 ' CD1' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -102.82 144.68 30.83 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.881 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . 0.569 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -117.86 171.52 8.01 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.462 0.648 . . . . 0.0 111.125 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 tttp . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.26 -179.636 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 . . . . . 0 CA--C 1.533 0.325 0 CA-C-O 120.68 0.276 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.797 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 70.0 m-85 -67.31 -26.56 66.58 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.306 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.98 25.68 68.58 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.472 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.613 HD13 ' HB3' ' B' ' 98' ' ' TYR . 7.8 mp -105.51 116.01 31.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.716 0.293 . . . . 0.0 110.385 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 125.7 34.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.528 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.872 HD22 HD11 ' A' ' 66' ' ' ILE . 2.2 mp -104.95 124.86 50.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.493 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -116.2 172.18 14.1 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.391 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.453 ' OG ' HD11 ' A' ' 59' ' ' LEU . 2.1 p -128.77 151.09 49.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.419 0.609 . . . . 0.0 111.763 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -133.41 136.97 45.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.162 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.756 ' HB ' HG22 ' B' ' 137' ' ' THR . 50.8 mt -87.98 120.16 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.963 0.411 . . . . 0.0 110.36 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -122.51 173.11 7.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.266 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 0.679 HG21 ' HB3' ' B' ' 123' ' ' LEU . 35.2 t -82.72 97.82 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.845 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.39 -47.76 63.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.048 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -162.56 145.2 10.99 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.473 ' HB2' HD12 ' A' ' 17' ' ' LEU . 11.3 ptt? -134.84 155.6 50.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.854 0.359 . . . . 0.0 111.166 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.36 120.07 12.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.702 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 145.36 47.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.135 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.7 27.89 14.84 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.156 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.33 -150.76 27.33 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.559 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 7' ' ' MET . 3.6 mt -84.38 -34.1 23.65 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.592 ' CB ' HD12 ' B' ' 123' ' ' LEU . . . -72.88 -32.26 65.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.176 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.81 -34.9 44.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.046 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -63.7 -36.41 83.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.162 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -98.21 -33.96 10.91 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.297 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.38 40.1 41.15 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.401 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.825 ' HB3' HG11 ' A' ' 4' ' ' VAL . 14.6 p-10 -92.4 -36.64 13.02 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.469 0.176 . . . . 0.0 111.399 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.679 ' HB3' HG21 ' B' ' 108' ' ' VAL . 1.6 mt -98.73 74.99 2.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.03 130.73 47.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.561 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -56.63 108.08 0.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.271 0.558 . . . . 0.0 110.85 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.69 -13.05 46.59 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.785 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -58.53 137.17 57.59 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.2 0.524 . . . . 0.0 111.087 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pt -81.57 114.21 22.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.661 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.54 ' CD1' HD21 ' A' ' 19' ' ' LEU . 36.6 mt -84.85 149.51 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.072 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.693 HD13 HD12 ' B' ' 161' ' ' LEU . 8.3 tp -113.63 -41.54 3.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.751 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -147.23 148.31 31.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.894 0.378 . . . . 0.0 111.769 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.456 HD11 HG21 ' B' ' 137' ' ' THR . 23.2 mt -138.92 119.77 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.391 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.44 38.16 29.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.47 15.2 81.68 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.211 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . 0.451 ' CB ' HD11 ' B' ' 148' ' ' LEU . 39.3 m -120.61 141.21 50.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.965 0.382 . . . . 0.0 110.347 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.49 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.1 t -62.56 144.16 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.256 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.756 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -122.37 19.67 10.53 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.296 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.49 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.2 OUTLIER -116.8 128.52 55.37 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 70.24 -3.51 1.8 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.188 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.459 ' HG3' ' N ' ' B' ' 141' ' ' SER . 0.1 OUTLIER -73.3 149.87 42.36 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.79 0.328 . . . . 0.0 110.496 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . 0.459 ' N ' ' HG3' ' B' ' 140' ' ' MET . 33.4 t -71.49 150.08 45.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.372 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.08 -45.14 87.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.261 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 34.9 p -56.31 -40.22 74.02 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.08 -46.42 71.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.763 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.74 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -62.3 -39.83 94.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.338 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -70.23 -37.36 74.98 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.82 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.13 -38.79 82.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.634 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . 0.451 HD11 ' CB ' ' B' ' 135' ' ' THR . 0.2 OUTLIER -60.19 -44.03 95.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.032 179.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.541 HD11 HD22 ' A' ' 19' ' ' LEU . 12.3 mt -68.38 -37.01 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.864 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.13 -49.69 54.72 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.067 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.21 -28.04 69.1 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.168 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 30.2 t -75.35 79.73 2.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 110.773 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -88.67 121.64 31.25 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.599 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 115.32 -92.22 0.58 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.308 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.46 135.05 53.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.639 0.257 . . . . 0.0 110.983 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.866 HD23 ' CE1' ' A' ' 15' ' ' TYR . 2.5 pp -122.59 133.3 54.55 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -99.35 139.09 35.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.148 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.617 HD13 ' CD2' ' B' ' 123' ' ' LEU . 3.9 tt -137.29 142.08 41.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.839 0.352 . . . . 0.0 111.368 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 6.9 t -122.04 130.44 74.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.297 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.527 HG13 ' CD2' ' B' ' 158' ' ' LEU . 31.9 m -121.2 146.41 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . 0.693 HD12 HD13 ' B' ' 130' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.73 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.234 0.239 0 CA-C-O 120.759 0.314 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.42 168.46 23.09 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.978 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.758 HG21 ' HB2' ' B' ' 122' ' ' ASN . 23.5 t -128.51 132.94 67.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.658 0.266 . . . . 0.0 110.978 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.63 HD23 ' CD ' ' B' ' 155' ' ' LYS . 1.8 mp -95.79 124.28 39.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.8 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' B' ' 117' ' ' ALA . 1.1 mp -108.31 134.25 51.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.623 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.3 ttm -109.11 163.83 12.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.239 0.543 . . . . 0.0 111.06 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.9 tttm . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.064 -179.759 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 121.333 0.587 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.859 ' CE1' HD23 ' B' ' 156' ' ' LEU . 62.8 m-85 -77.81 -32.72 52.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.499 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.09 22.93 28.69 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.576 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.487 HD11 ' CB ' ' B' ' 117' ' ' ALA . 3.6 mp -102.76 119.09 38.23 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.647 0.26 . . . . 0.0 110.738 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.432 ' HB3' ' HG3' ' B' ' 110' ' ' GLU . 0.0 OUTLIER -98.73 124.25 43.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.88 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.863 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.7 pt? -122.42 124.96 44.84 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.204 0.526 . . . . 0.0 111.741 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.24 -169.56 21.33 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.584 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.7 OUTLIER -146.75 148.76 32.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.162 0.481 . . . . 0.0 111.167 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -131.19 146.54 52.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.37 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.978 HD13 ' HB2' ' A' ' 62' ' ' ALA . 5.6 mt -88.8 121.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.995 0.426 . . . . 0.0 111.045 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.41 ' CD1' ' HG2' ' B' ' 105' ' ' GLN . 39.7 p90 -121.5 172.83 7.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.017 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.653 HG21 ' HG ' ' A' ' 40' ' ' LEU . 38.7 t -86.3 96.65 5.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.126 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -63.11 -57.26 11.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.92 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -151.57 135.43 16.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.94 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.419 ' HB3' HD23 ' B' ' 100' ' ' LEU . 0.0 OUTLIER -116.8 148.28 41.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.6 t -65.28 142.05 58.4 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.074 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 154.72 26.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 55.37 29.23 12.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.466 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.24 -165.72 25.67 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.097 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.606 HD13 ' O ' ' B' ' 90' ' ' MET . 0.3 OUTLIER -77.19 -30.32 54.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.614 0.207 . . . . 0.0 111.429 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.861 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -73.78 -35.85 64.98 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.216 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.64 -33.75 46.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.096 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -38.67 87.09 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.376 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -101.22 -31.81 10.82 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.641 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.1 43.21 27.06 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.177 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.479 ' CG ' HD13 ' A' ' 40' ' ' LEU . 1.7 p30 -51.42 -49.57 61.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.155 0.182 . . . . 0.0 111.328 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.653 ' HG ' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -138.93 157.76 45.44 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.869 0.366 . . . . 0.0 111.13 179.01 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 147.29 25.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.598 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.25 109.97 0.86 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.302 0.573 . . . . 0.0 110.935 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.93 -4.28 28.86 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.745 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -70.55 135.44 48.52 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.201 0.524 . . . . 0.0 111.099 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 pt -78.87 111.49 15.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.493 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.741 ' HB ' HG21 ' A' ' 54' ' ' THR . 53.8 mt -79.77 146.1 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.302 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.534 HD22 ' CD1' ' A' ' 78' ' ' LEU . 19.3 tp -107.46 -37.58 6.17 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.73 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.04 147.76 31.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.874 0.369 . . . . 0.0 111.591 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 23.8 mt -137.7 118.34 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.514 ' HB2' HD21 ' A' ' 65' ' ' LEU . 5.5 m120 52.92 35.69 19.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.874 0.368 . . . . 0.0 111.383 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.68 15.89 74.52 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.146 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -120.89 141.05 50.98 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 117.061 0.43 . . . . 0.0 110.383 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.4 t -59.86 144.44 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 111.078 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.741 HG21 ' HB ' ' A' ' 46' ' ' ILE . 2.7 m -116.42 13.69 15.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.891 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.573 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -116.94 133.22 56.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.838 ' HA ' HD21 ' B' ' 142' ' ' LEU . 5.2 m-80 71.36 -6.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.391 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.506 ' HB3' HD11 ' A' ' 23' ' ' ILE . 1.1 tpt -69.75 170.89 10.06 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.846 0.355 . . . . 0.0 110.987 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -89.94 139.73 30.32 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.051 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.527 HD12 ' OG ' ' B' ' 104' ' ' SER . 6.1 tt -55.89 -44.57 78.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.605 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -58.9 -40.14 83.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.821 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.2 -46.78 76.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.784 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.978 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -59.83 -42.1 92.82 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.951 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.35 -37.9 80.95 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.581 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -68.05 -38.56 82.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.719 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.527 ' C ' HD23 ' A' ' 65' ' ' LEU . 9.2 tt -61.13 -43.92 98.13 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.724 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.666 HD11 HD22 ' B' ' 102' ' ' LEU . 8.0 mt -68.6 -37.03 77.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.023 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.16 -49.12 59.69 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.749 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.36 -25.06 67.87 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.372 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 t -77.51 68.12 3.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.083 0.468 . . . . 0.0 110.723 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.1 mtt85 -84.06 66.46 9.24 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.397 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.89 -75.61 0.07 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.659 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.94 128.94 29.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.711 -0.245 . . . . 0.0 111.242 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.79 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.9 OUTLIER -125.7 132.34 52.41 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.958 0.408 . . . . 0.0 111.077 179.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.589 ' O ' HD13 ' A' ' 75' ' ' LEU . 4.2 tt0 -102.15 136.41 42.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.621 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.603 HD22 ' N ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -127.12 130.71 50.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.28 133.93 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.254 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.07 165.68 30.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.811 0.339 . . . . 0.0 111.443 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.534 ' CD1' HD22 ' A' ' 47' ' ' LEU . 1.3 mp . . . . . 0 C--O 1.232 0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.089 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.507 ' C ' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.259 0 CA-C-O 120.787 0.327 . . . . 0.0 110.904 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.454 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -118.57 157.99 14.98 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 39' ' ' ASN . 18.8 t -125.46 134.78 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.698 0.285 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.42 125.6 50.76 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.713 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.531 HD11 ' O ' ' A' ' 33' ' ' LEU . 11.0 tp -119.02 138.6 52.72 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.243 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . 0.606 ' O ' HD13 ' A' ' 33' ' ' LEU . 3.0 ttt -100.45 163.87 12.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.119 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.595 0.236 . . . . 0.0 110.672 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.79 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 52.3 m-85 -57.97 -25.37 60.92 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.388 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.24 17.76 66.14 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.319 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.861 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -100.63 114.93 29.03 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 113.38 24.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.27 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.666 HD22 HD11 ' A' ' 66' ' ' ILE . 0.9 OUTLIER -100.14 124.92 46.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.107 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.45 172.99 15.51 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.5 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.527 ' OG ' HD12 ' A' ' 59' ' ' LEU . 1.1 p -124.43 153.6 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.996 0.398 . . . . 0.0 111.167 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 21' ' ' SER . 2.4 pt20 -134.23 134.29 41.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.164 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.983 HD13 ' HB2' ' B' ' 145' ' ' ALA . 19.9 mt -87.76 120.52 36.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.034 0.445 . . . . 0.0 109.866 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.462 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 47.8 p90 -121.8 173.72 7.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.218 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 0.82 HG21 ' HB3' ' B' ' 123' ' ' LEU . 39.8 t -84.68 101.49 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . 0.462 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 5.6 mmtt -70.35 -53.23 17.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.732 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.432 ' HG3' ' HB3' ' A' ' 18' ' ' ARG . 5.1 pt-20 -161.72 145.08 12.31 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.798 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -138.37 139.32 38.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 10.0 t -65.39 125.7 25.92 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.473 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . 0.726 ' HA ' HG21 ' B' ' 118' ' ' THR . 0.0 OUTLIER -75.6 61.38 1.32 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.333 0.587 . . . . 0.0 111.3 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.41 27.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.955 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -130.11 -173.65 13.46 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.598 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.34 -32.17 72.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.595 0.236 . . . . 0.0 111.273 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.514 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -65.8 -41.19 92.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.325 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.726 HG21 ' HA ' ' B' ' 113' ' ' ARG . 11.0 m -78.91 -33.01 45.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.821 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -39.37 84.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.269 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.74 -32.76 9.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.618 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.89 40.12 26.55 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.275 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.758 ' HB2' HG21 ' A' ' 4' ' ' VAL . 7.1 p-10 -71.04 -47.05 60.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.389 0.138 . . . . 0.0 111.207 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.82 ' HB3' HG21 ' B' ' 108' ' ' VAL . 21.0 mt -92.8 119.74 32.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.676 0.274 . . . . 0.0 110.717 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.6 136.87 34.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.459 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -58.45 107.76 0.54 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.164 0.507 . . . . 0.0 110.534 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 102.49 -7.84 54.27 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.64 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -63.02 138.92 58.7 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.154 0.502 . . . . 0.0 111.252 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' B' ' 161' ' ' LEU . 1.3 pt -76.41 121.73 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.707 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.562 HG21 HD11 ' B' ' 132' ' ' ILE . 12.7 mt -89.66 135.02 27.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 tp -97.1 -41.94 8.1 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.579 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -148.5 147.92 29.65 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.792 0.33 . . . . 0.0 111.487 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.661 HG22 HD22 ' B' ' 133' ' ' ASN . 20.1 mt -141.41 119.65 9.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.662 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . 0.661 HD22 HG22 ' B' ' 132' ' ' ILE . 67.4 m-80 58.3 40.55 24.44 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.243 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.54 10.11 79.01 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.396 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.44 138.79 52.23 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 117.138 0.469 . . . . 0.0 110.204 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.602 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.3 t -59.45 147.93 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.163 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.807 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.3 OUTLIER -121.64 20.48 11.03 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.709 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.602 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.3 OUTLIER -110.8 130.71 55.5 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 73.01 -10.49 0.99 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.499 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.703 ' HB3' HD11 ' B' ' 106' ' ' ILE . 1.2 tpt -65.49 169.21 6.3 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 121.016 0.436 . . . . 0.0 111.052 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 25.0 t -92.54 150.18 20.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.838 HD21 ' HA ' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -58.56 -44.15 89.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.89 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 8.9 t -59.25 -40.19 85.16 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.631 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.28 -44.98 82.04 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.716 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.983 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -60.79 -41.77 96.25 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.019 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.7 -37.82 76.75 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.37 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -67.86 -38.42 83.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.526 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -44.76 93.15 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.651 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.506 HD12 HD22 ' A' ' 19' ' ' LEU . 59.1 mt -68.3 -36.95 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.685 0.278 . . . . 0.0 110.763 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -69.18 -49.08 59.91 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.882 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -70.2 -23.3 62.93 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.613 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 80.1 p -79.06 66.29 4.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.122 0.486 . . . . 0.0 110.625 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -74.55 126.6 31.12 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.544 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 115.12 -90.36 0.53 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.452 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . 0.63 ' CD ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -128.18 133.94 48.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 0.0 110.617 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.859 HD23 ' CE1' ' A' ' 15' ' ' TYR . 2.0 pp -124.59 144.26 50.25 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.412 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 55.5 tt0 -109.51 141.6 41.74 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.79 HD11 HD11 ' B' ' 156' ' ' LEU . 1.1 mt -135.02 132.5 38.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.972 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.02 137.78 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.297 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 7.8 m -135.21 161.77 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.818 0.342 . . . . 0.0 111.403 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . 0.549 ' HB3' HD11 ' B' ' 128' ' ' ILE . 4.9 tt . . . . . 0 CA--C 1.529 0.159 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.017 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.684 HD13 ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.247 0 CA-C-O 120.846 0.355 . . . . 0.0 110.944 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.684 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -139.45 156.81 24.82 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.835 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.551 HG11 ' CB ' ' B' ' 122' ' ' ASN . 18.1 t -131.34 134.63 60.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.777 0.322 . . . . 0.0 111.041 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.24 107.12 17.81 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.732 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.444 HD21 ' C ' ' B' ' 116' ' ' LEU . 6.4 tp -92.7 134.79 34.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.289 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.97 171.37 7.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.387 0.613 . . . . 0.0 111.354 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.8 pttt . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.564 -179.477 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.712 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 77.7 m-85 -100.28 -24.99 14.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.809 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.59 30.9 65.87 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.546 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' B' ' 117' ' ' ALA . 0.0 OUTLIER -104.94 123.84 48.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.658 0.266 . . . . 0.0 110.942 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.423 ' HB2' ' HG3' ' B' ' 110' ' ' GLU . 0.0 OUTLIER -100.19 113.22 25.73 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.08 179.487 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.746 HD22 HD11 ' B' ' 149' ' ' ILE . 8.0 mp -94.15 124.84 38.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.024 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.18 172.09 14.85 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.531 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.558 ' OG ' HD11 ' B' ' 142' ' ' LEU . 0.3 OUTLIER -132.47 149.02 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.006 0.403 . . . . 0.0 111.223 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' B' ' 104' ' ' SER . 7.0 pt20 -131.94 141.53 49.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.181 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.767 ' HB ' HG22 ' A' ' 54' ' ' THR . 4.1 mm -87.81 121.69 38.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.304 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -125.93 171.5 10.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.413 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.771 HG21 ' HB3' ' A' ' 40' ' ' LEU . 44.7 t -84.36 100.18 7.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.04 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -56.12 8.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.893 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -157.15 145.84 19.74 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.992 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.627 ' SD ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -137.53 143.8 41.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.274 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.8 p -65.71 121.08 14.18 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.616 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.68 163.85 6.76 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.204 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 62.88 25.09 14.9 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.278 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.37 -169.09 25.76 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.391 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.549 HD13 ' O ' ' B' ' 90' ' ' MET . 0.3 OUTLIER -73.75 -30.17 62.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.81 -35.09 62.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.642 0.258 . . . . 0.0 111.025 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.627 HG23 ' SD ' ' A' ' 28' ' ' MET . 1.2 p -78.68 -34.18 46.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.133 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -61.73 -38.15 86.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.197 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -98.98 -30.69 12.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.273 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.05 47.02 25.92 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.037 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.808 ' HB3' HG11 ' B' ' 87' ' ' VAL . 12.4 p-10 -85.31 -40.0 17.04 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.771 ' HB3' HG21 ' A' ' 25' ' ' VAL . 3.3 mm? -106.34 125.46 51.02 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.652 0.263 . . . . 0.0 111.07 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 132.12 41.25 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.236 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.02 107.07 0.43 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.225 0.536 . . . . 0.0 111.012 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.87 -9.07 43.4 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.917 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -69.56 144.07 53.19 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.26 0.553 . . . . 0.0 111.294 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 77' ' ' VAL . 20.2 pt -81.65 116.59 26.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.666 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.571 HG21 HD11 ' A' ' 49' ' ' ILE . 6.0 mt -83.03 137.72 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.947 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.442 HD12 HD12 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -91.71 -51.5 5.21 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.5 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -150.52 152.19 33.8 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.71 0.29 . . . . 0.0 111.2 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.571 HD11 HG21 ' A' ' 46' ' ' ILE . 29.7 mt -140.67 118.11 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.86 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.53 39.85 30.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.177 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.56 3.95 87.08 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.207 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.2 m -107.71 129.76 55.0 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.0 t -61.64 146.15 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.979 0.418 . . . . 0.0 111.079 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.767 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -120.41 22.76 11.18 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.354 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.574 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -127.24 124.62 39.32 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.147 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 72.35 -9.23 1.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.444 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -69.94 174.48 5.26 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.868 0.366 . . . . 0.0 111.146 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.62 132.31 34.19 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.007 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.577 HD12 ' OG ' ' B' ' 104' ' ' SER . 7.9 tt -54.25 -42.83 70.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.751 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -63.6 -38.48 91.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.085 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.2 -48.13 74.46 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.075 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -59.33 -40.52 86.59 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.227 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.69 -37.62 76.68 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.792 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -38.68 82.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.776 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.513 ' O ' HD13 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -59.71 -44.21 93.81 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.787 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 73' ' ' LEU . 8.2 mt -67.97 -37.47 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.825 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.86 -49.56 67.71 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.806 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -65.94 -26.74 67.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.423 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 86.0 p -84.85 60.69 6.35 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.114 0.483 . . . . 0.0 110.791 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -73.46 96.67 2.42 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.839 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.36 -92.19 0.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.249 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.28 130.45 52.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.709 0.29 . . . . 0.0 110.353 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.839 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.7 OUTLIER -129.51 139.69 51.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.21 0.528 . . . . 0.0 111.528 -179.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.471 ' OE1' HG23 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -98.12 138.59 35.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.999 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.515 HD11 HD21 ' A' ' 73' ' ' LEU . 1.6 mp -136.6 127.62 27.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 111.316 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.471 HG23 ' OE1' ' A' ' 74' ' ' GLN . 25.4 t -113.53 134.45 56.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.372 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 45' ' ' ILE . 18.7 t -129.26 140.81 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.073 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.442 HD12 HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.749 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.774 0.321 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -129.63 160.96 22.84 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.744 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.808 HG11 ' HB3' ' A' ' 39' ' ' ASN . 26.3 t -130.77 135.1 60.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.72 0.295 . . . . 0.0 111.289 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tt -97.87 109.07 21.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.536 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.486 HD23 ' CD1' ' B' ' 98' ' ' TYR . 1.1 tp -104.44 144.84 31.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.075 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . 0.549 ' O ' HD13 ' A' ' 33' ' ' LEU . 38.9 ttm -113.13 164.19 13.81 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.117 0.484 . . . . 0.0 110.657 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . 0.404 ' HG3' ' CE2' ' B' ' 98' ' ' TYR . 10.6 mtpt . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.141 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.191 0.519 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.839 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 52.0 m-85 -72.86 -31.57 64.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.274 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.98 17.39 72.46 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.563 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -97.96 118.41 34.49 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -99.41 113.36 25.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.188 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.466 HD23 ' H ' ' B' ' 102' ' ' LEU . 1.7 pt? -110.95 125.08 53.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.165 0.507 . . . . 0.0 111.16 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -107.4 -162.66 21.67 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.278 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.577 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.3 OUTLIER -144.77 145.75 31.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 110.856 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 21' ' ' SER . 7.7 pt20 -128.12 140.35 51.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.496 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.848 ' HB ' HG22 ' B' ' 137' ' ' THR . 45.3 mt -88.14 120.38 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -121.62 172.94 7.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.874 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 1.039 HG21 HD13 ' B' ' 123' ' ' LEU . 42.9 t -81.66 93.51 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.31 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -63.51 -50.48 69.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.013 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.423 ' HG3' ' HB2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -165.21 149.03 8.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.651 ' SD ' HD11 ' B' ' 123' ' ' LEU . 9.1 mtm -128.4 161.4 29.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.061 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.423 HG23 ' HA3' ' B' ' 115' ' ' GLY . 10.1 t -65.62 125.36 25.0 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.708 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -57.85 136.52 57.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.21 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m 60.86 30.28 19.55 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.05 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . 0.423 ' HA3' HG23 ' B' ' 112' ' ' THR . . . -87.6 -156.43 30.02 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.447 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.444 ' C ' HD21 ' A' ' 6' ' ' LEU . 13.4 mt -82.44 -30.12 30.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.511 0.196 . . . . 0.0 111.349 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.497 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -75.23 -34.69 61.46 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.285 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.9 -33.85 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.074 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -38.69 84.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.374 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -103.04 -29.88 11.1 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.673 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.68 44.21 57.74 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.151 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.551 ' CB ' HG11 ' A' ' 4' ' ' VAL . 8.5 p30 -63.31 -39.89 95.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.464 0.173 . . . . 0.0 111.341 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 1.039 HD13 HG21 ' B' ' 108' ' ' VAL . 4.1 pp -133.26 163.88 28.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.923 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.5 135.16 52.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.62 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -53.77 113.09 1.07 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.188 0.518 . . . . 0.0 111.076 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.08 -14.5 23.65 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.527 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -66.22 136.64 56.17 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.129 0.49 . . . . 0.0 110.887 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 5.8 pt -74.75 117.49 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.663 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.941 HG21 HD11 ' B' ' 132' ' ' ILE . 27.3 mm -83.19 137.55 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.909 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 13.4 tp -98.67 -40.94 7.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.001 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -150.03 150.83 32.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.969 0.414 . . . . 0.0 111.806 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.996 HD12 HD23 ' B' ' 158' ' ' LEU . 34.4 mm -137.01 118.82 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.89 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . 0.528 ' HB2' HD11 ' B' ' 148' ' ' LEU . 4.5 m-80 56.2 31.54 18.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.682 0.277 . . . . 0.0 111.228 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.89 -2.3 85.65 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.178 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 13.4 m -104.66 131.98 51.45 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.075 0.437 . . . . 0.0 110.227 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.588 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.1 t -56.44 147.16 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.937 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.848 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -118.55 19.54 13.25 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.588 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.4 OUTLIER -106.6 134.43 49.75 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 52.18 12.24 0.2 Allowed 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.636 0.585 . . . . 0.0 112.175 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.22 173.38 5.72 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.413 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.3 141.36 30.13 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.558 HD11 ' OG ' ' A' ' 21' ' ' SER . 2.9 mp -58.41 -47.93 82.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.028 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 4.5 t -63.04 -37.06 85.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.776 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -65.61 -48.12 73.36 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.815 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.635 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -59.77 -41.15 90.45 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.397 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 17.8 mtt85 -68.27 -38.66 81.95 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.629 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -67.5 -38.35 84.17 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' B' ' 133' ' ' ASN . 0.2 OUTLIER -59.97 -44.17 94.63 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.915 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.746 HD11 HD22 ' A' ' 19' ' ' LEU . 5.3 mt -68.17 -38.09 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.832 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.01 -48.47 62.94 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.922 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -69.53 -19.07 63.71 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.266 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 3.2 m -74.33 69.77 1.63 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.772 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -82.97 120.3 25.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.716 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.69 -88.94 0.51 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.515 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.04 130.65 51.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.683 0.278 . . . . 0.0 110.809 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.712 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -120.04 130.97 54.95 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.095 0.474 . . . . 0.0 111.394 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 9.4 tt0 -93.75 135.43 35.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.68 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.996 HD23 HD12 ' B' ' 132' ' ' ILE . 0.5 OUTLIER -131.4 127.99 38.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 20.9 t -114.15 145.64 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.437 HG12 HD13 ' B' ' 129' ' ' ILE . 27.1 m -136.74 161.26 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.178 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' B' ' 161' ' ' LEU . 9.0 tp . . . . . 0 C--O 1.233 0.185 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.38 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.9 tt . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.838 0.352 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.8 156.87 21.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.711 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' B' ' 122' ' ' ASN . 24.9 t -132.67 134.18 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.777 0.322 . . . . 0.0 110.872 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.86 107.04 18.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.691 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.523 HD21 ' N ' ' B' ' 117' ' ' ALA . 2.8 tp -91.87 134.01 35.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.312 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 ttt -123.09 163.18 21.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.127 0.489 . . . . 0.0 110.911 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.537 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.771 0.32 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.77 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 78.6 m-85 -73.76 -27.95 61.43 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.67 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' HG23 ' B' ' 112' ' ' THR . . . 77.97 27.59 58.08 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.653 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mp -108.04 121.07 44.07 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.748 0.308 . . . . 0.0 110.737 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -102.42 113.73 27.31 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.06 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.9 pt? -105.46 125.18 50.69 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.211 0.529 . . . . 0.0 112.098 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.36 -178.53 21.89 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.611 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.403 ' OG ' HD12 ' B' ' 142' ' ' LEU . 1.2 p -132.4 148.59 52.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.296 0.548 . . . . 0.0 111.565 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.465 ' NE2' HG21 ' A' ' 45' ' ' ILE . 9.9 pt20 -135.37 145.73 47.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.593 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.699 HD12 HG23 ' A' ' 54' ' ' THR . 4.8 mt -88.42 121.34 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.036 0.446 . . . . 0.0 111.051 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -122.28 172.32 8.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.957 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.597 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.3 t -84.01 97.5 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.92 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -58.5 4.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.306 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -149.2 136.46 20.01 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.34 134.61 36.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.072 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.1 p -73.23 127.64 33.19 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.518 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.806 ' HA ' HG21 ' A' ' 35' ' ' THR . 14.7 ptt-85 -72.91 65.69 0.75 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.254 0.55 . . . . 0.0 111.219 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.41 25.38 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.023 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.22 -172.63 13.39 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.714 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.676 HD22 ' H ' ' B' ' 90' ' ' MET . 1.6 mp -69.97 -30.5 67.87 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.639 0.22 . . . . 0.0 111.567 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.593 ' CB ' HD21 ' B' ' 100' ' ' LEU . . . -68.62 -41.3 79.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.544 0.212 . . . . 0.0 111.133 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.806 HG21 ' HA ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -78.78 -33.4 46.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.827 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -65.49 -36.42 83.81 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.188 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.58 -32.33 11.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.483 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.0 40.15 57.5 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.268 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.717 ' ND2' HD11 ' B' ' 89' ' ' LEU . 4.4 p30 -83.01 -31.06 27.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.425 0.155 . . . . 0.0 111.311 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.9 HD11 HD22 ' A' ' 75' ' ' LEU . 4.6 mt -115.28 123.67 49.39 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.699 0.285 . . . . 0.0 110.96 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.06 139.71 30.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.443 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.88 110.24 0.77 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 110.664 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.82 -11.25 45.53 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.705 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.84 138.13 57.42 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 121.05 0.452 . . . . 0.0 111.201 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.465 HG21 ' NE2' ' A' ' 22' ' ' GLN . 1.1 pt -84.13 99.15 6.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.248 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.598 HD13 HD21 ' B' ' 102' ' ' LEU . 5.7 mt -64.82 139.33 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.689 ' CD1' HD12 ' A' ' 78' ' ' LEU . 1.1 tp -92.62 -38.98 11.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.416 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -149.95 150.7 32.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.745 0.307 . . . . 0.0 111.388 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.7 mt -138.1 118.1 15.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.402 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.641 ' HB2' HD11 ' A' ' 65' ' ' LEU . 4.2 m120 53.14 41.95 32.16 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.277 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.73 6.13 76.54 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.972 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -104.98 131.59 52.3 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.2 144.88 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.791 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.699 HG23 HD12 ' A' ' 23' ' ' ILE . 20.7 m -109.95 23.1 14.81 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.419 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -126.2 130.6 51.28 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.344 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.0 p30 51.53 11.63 0.13 Allowed 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.762 0.664 . . . . 0.0 112.718 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.519 ' SD ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -69.23 -174.77 0.68 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.899 0.38 . . . . 0.0 111.114 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.8 124.6 35.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tt -58.39 -44.19 88.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.784 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.455 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 7.1 t -63.5 -37.33 86.9 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.01 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -34.72 62.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.653 0.264 . . . . 0.0 110.593 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.577 ' HB1' HD13 ' A' ' 23' ' ' ILE . . . -65.37 -43.34 91.08 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.24 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 60' ' ' THR . 1.4 ptt180 -71.97 -36.81 69.92 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.52 -37.85 83.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.239 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.641 HD11 ' HB2' ' A' ' 50' ' ' ASN . 2.9 tm? -59.41 -45.25 92.05 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.794 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.513 HD13 ' HB2' ' B' ' 102' ' ' LEU . 7.2 mt -68.77 -37.58 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.947 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -49.34 56.61 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -23.36 67.2 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.258 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.5 m -76.03 67.81 2.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 110.805 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 -90.85 53.16 2.32 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.705 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -171.83 -82.46 0.05 OUTLIER Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.294 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.83 126.38 36.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.637 0.256 . . . . 0.0 110.742 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.748 HD23 ' CE1' ' B' ' 98' ' ' TYR . 0.2 OUTLIER -129.9 134.55 47.57 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.289 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -92.01 140.68 29.41 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.939 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.9 HD22 HD11 ' A' ' 40' ' ' LEU . 1.2 mp -134.07 128.14 33.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.962 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 46' ' ' ILE . 19.8 t -115.78 142.95 26.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.851 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.468 HG22 ' O ' ' B' ' 85' ' ' ILE . 35.9 m -129.62 155.43 41.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.798 0.332 . . . . 0.0 111.39 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.689 HD12 ' CD1' ' A' ' 47' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.093 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 77' ' ' VAL . 18.1 tt . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.805 0.336 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -123.62 158.63 18.23 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.671 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.621 HG21 ' HB2' ' A' ' 39' ' ' ASN . 21.3 t -131.5 134.0 61.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.856 0.36 . . . . 0.0 111.255 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.63 107.92 19.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.408 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.717 HD11 ' ND2' ' A' ' 39' ' ' ASN . 7.1 mp -96.37 144.73 26.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . 0.676 ' H ' HD22 ' A' ' 33' ' ' LEU . 9.8 ttt -116.35 163.57 15.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.814 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.155 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.748 ' CE1' HD23 ' A' ' 73' ' ' LEU . 38.1 m-85 -93.86 -6.95 44.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.844 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.98 9.99 86.46 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.648 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.593 HD21 ' CB ' ' A' ' 34' ' ' ALA . 3.7 mp -105.7 115.06 29.6 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.659 0.266 . . . . 0.0 110.518 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.45 113.27 21.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.979 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.598 HD21 HD13 ' A' ' 46' ' ' ILE . 1.6 mp -96.77 124.75 40.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.064 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.28 174.84 15.55 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.558 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -133.17 144.73 50.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.983 0.391 . . . . 0.0 111.083 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -131.43 144.77 51.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.324 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.776 HG13 HG22 ' B' ' 137' ' ' THR . 0.9 OUTLIER -88.31 121.35 38.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.006 0.431 . . . . 0.0 110.803 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.418 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 32.1 p90 -119.26 171.82 8.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 0.665 HG21 ' HB3' ' B' ' 123' ' ' LEU . 35.5 t -79.69 91.91 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.97 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . 0.418 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -63.39 -45.54 90.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.971 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -163.49 132.14 3.84 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.718 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.92 146.88 50.15 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.826 0.346 . . . . 0.0 111.31 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 16' ' ' GLY . 74.4 p -65.29 123.56 19.89 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.885 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 18.9 ttm105 -63.72 155.26 30.63 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.28 30.53 19.92 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.262 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.35 -168.74 26.81 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.24 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 mt -65.24 -36.74 85.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.538 0.208 . . . . 0.0 111.168 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.523 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -74.87 -33.14 62.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.387 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.77 -34.26 45.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.122 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -37.94 86.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.222 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.16 -30.57 12.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.484 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.15 51.5 10.07 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.314 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.554 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.0 p-10 -87.12 -44.73 11.3 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.665 ' HB3' HG21 ' B' ' 108' ' ' VAL . 7.9 mp -123.46 124.84 43.77 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.741 0.305 . . . . 0.0 111.1 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.65 151.77 19.03 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.493 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -60.42 111.29 1.51 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.176 0.513 . . . . 0.0 111.048 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.28 -18.49 20.85 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.96 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -61.13 135.12 57.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.162 0.481 . . . . 0.0 110.523 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.63 120.76 30.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.264 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.401 HG21 HG12 ' B' ' 132' ' ' ILE . 29.0 mt -87.95 137.92 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.772 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 tp -100.14 -35.65 9.59 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.546 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . 0.448 ' HE3' HG22 ' B' ' 136' ' ' VAL . 14.4 mttp -150.44 147.97 28.18 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 111.4 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.696 HG23 HD23 ' B' ' 158' ' ' LEU . 14.9 mt -140.66 118.42 9.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.541 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 5.8 m120 57.03 47.5 17.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.969 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 66.2 17.28 65.75 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.236 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 75.6 m -120.91 137.13 54.74 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.753 0.276 . . . . 0.0 110.286 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.594 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.6 t -69.71 145.24 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.875 0.369 . . . . 0.0 110.851 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.776 HG22 HG13 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -114.8 0.65 13.87 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.815 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.594 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.0 OUTLIER -84.77 129.14 34.86 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.206 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 69.95 -4.12 1.57 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.633 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.02 171.12 10.02 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.965 0.412 . . . . 0.0 111.156 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 3.6 m -91.91 146.97 23.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.28 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.403 HD12 ' OG ' ' A' ' 21' ' ' SER . 2.8 tt -61.55 -44.91 96.18 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.887 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 23.3 p -57.5 -46.29 83.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.115 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.87 -46.31 89.98 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.003 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 1.06 ' HB1' HD11 ' A' ' 19' ' ' LEU . . . -59.27 -41.69 89.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.119 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 13.7 ttt180 -70.36 -37.24 74.56 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.411 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -38.41 82.81 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.745 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 7.2 tt -59.67 -45.19 92.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.697 HD12 HD22 ' A' ' 19' ' ' LEU . 35.0 mt -68.37 -36.89 76.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.807 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -61.79 -48.25 81.48 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.786 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -25.23 66.46 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.383 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 70.7 m -74.59 78.36 1.99 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.536 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -94.21 46.94 1.18 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.185 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -165.85 -83.34 0.05 OUTLIER Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.378 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -128.03 131.36 49.16 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.291 0.236 . . . . 0.0 110.521 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.77 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -129.9 136.48 49.56 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.001 0.429 . . . . 0.0 111.285 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 12.8 tt0 -97.39 140.95 31.09 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.551 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.696 HD23 HG23 ' B' ' 132' ' ' ILE . 5.0 mt -135.92 125.09 24.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.154 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 18.8 t -114.64 133.03 62.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.458 HG11 ' HG ' ' B' ' 123' ' ' LEU . 30.0 m -129.05 162.42 36.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.846 0.355 . . . . 0.0 111.284 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 9.6 tp . . . . . 0 C--O 1.232 0.182 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 179.811 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.487 HD13 ' C ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.863 0.363 . . . . 0.0 110.904 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.455 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -117.45 159.09 14.25 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.924 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.769 HG11 ' HB3' ' B' ' 122' ' ' ASN . 21.0 t -123.92 134.57 66.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.789 0.328 . . . . 0.0 111.154 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.96 116.5 30.32 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.738 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.482 HD21 ' N ' ' B' ' 117' ' ' ALA . 8.4 tp -109.79 144.53 38.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.731 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.7 ttt -112.39 163.2 14.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.188 0.518 . . . . 0.0 110.837 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.079 -179.904 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.808 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 43.8 m-85 -86.48 -28.19 23.6 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.089 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.34 20.42 32.57 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.625 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.78 119.35 38.65 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.666 0.233 . . . . 0.0 110.678 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -96.25 113.52 25.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.81 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.98 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.5 pt? -108.13 124.76 50.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.18 0.514 . . . . 0.0 111.48 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.24 -166.25 21.24 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.922 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.3 OUTLIER -146.12 145.04 30.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.836 0.318 . . . . 0.0 111.254 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.581 ' NE2' HG21 ' A' ' 45' ' ' ILE . 5.4 pt20 -125.24 138.88 54.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.885 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.781 ' HB ' HG22 ' A' ' 54' ' ' THR . 34.9 mt -88.0 120.49 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.649 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 46.6 p90 -123.55 171.15 9.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.15 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.6 t -81.47 98.68 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.775 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 1.6 tptp -70.46 -55.53 8.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.049 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -157.06 135.97 11.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.859 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.3 ptt? -120.55 150.74 40.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 111.244 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.6 m -66.36 122.31 17.24 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.96 162.68 18.73 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.925 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.24 30.84 20.19 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.358 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.74 -161.29 16.39 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.116 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.11 -31.43 39.18 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.868 0.334 . . . . 0.0 111.809 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.592 ' CB ' HD11 ' B' ' 100' ' ' LEU . . . -74.88 -37.41 62.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.521 0.2 . . . . 0.0 111.117 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.89 -33.62 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.225 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -59.52 -39.37 83.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.565 0.221 . . . . 0.0 111.491 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -102.63 -34.43 9.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.38 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.77 53.81 7.0 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.743 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.696 ' ND2' HD11 ' B' ' 89' ' ' LEU . 13.0 m-80 -75.74 -36.99 59.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.421 0.153 . . . . 0.0 111.369 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.757 HD11 HD13 ' A' ' 75' ' ' LEU . 2.8 mp -129.16 138.44 51.77 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.775 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.98 145.71 25.2 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.694 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -61.38 112.36 2.15 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.208 0.528 . . . . 0.0 111.188 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.77 -10.76 18.54 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.015 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -67.53 134.66 51.7 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 117.291 0.546 . . . . 0.0 110.215 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.581 HG21 ' NE2' ' A' ' 22' ' ' GLN . 1.2 pt -77.54 111.7 14.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.835 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.9 mt -77.4 138.72 19.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.051 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.7 tp -101.05 -38.05 8.34 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.24 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -149.81 148.06 28.74 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 120.943 0.401 . . . . 0.0 111.763 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.639 HG22 HD22 ' A' ' 50' ' ' ASN . 14.2 mt -139.58 118.6 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.155 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.639 HD22 HG22 ' A' ' 49' ' ' ILE . 67.8 m-80 56.86 37.08 28.57 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.31 6.66 88.85 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.594 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.6 m -114.12 138.97 49.73 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.166 0.483 . . . . 0.0 110.381 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.596 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.1 t -59.45 147.69 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.781 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -123.39 19.85 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.808 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.596 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -116.51 128.48 55.48 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 70.09 -4.38 1.54 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.606 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.5 173.89 5.49 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.937 0.399 . . . . 0.0 111.238 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.9 143.17 27.53 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.265 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -41.49 86.87 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.692 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -63.63 -39.39 94.24 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.011 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.67 -48.59 71.59 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.837 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.804 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -61.37 -39.43 90.59 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.461 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -72.46 -37.52 68.5 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.452 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -67.89 -38.27 82.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -45.28 92.54 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.552 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.5 mt -68.58 -36.78 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.912 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -68.94 -49.48 57.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.776 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -67.07 -24.42 65.97 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.314 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 t -75.49 71.33 2.42 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.03 0.443 . . . . 0.0 110.781 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.07 91.32 8.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.39 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.84 -83.02 0.15 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.082 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.504 ' HB3' HD21 ' B' ' 88' ' ' LEU . 5.0 mttp -136.93 122.88 20.17 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.465 0.306 . . . . 0.0 110.455 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.584 HD23 ' CE1' ' B' ' 98' ' ' TYR . 0.4 OUTLIER -108.62 141.46 40.53 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 111.315 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.502 ' HB2' HD12 ' B' ' 88' ' ' LEU . 1.3 tt0 -107.98 141.68 39.26 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.848 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.757 HD13 HD11 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -135.29 125.3 25.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.982 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.6 132.12 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.373 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.36 168.35 23.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.187 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.235 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.8 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.531 ' C ' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.925 0.393 . . . . 0.0 111.048 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.498 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -132.24 158.04 22.76 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.666 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.589 HG11 ' CG ' ' A' ' 39' ' ' ASN . 15.2 t -131.47 135.17 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.73 0.3 . . . . 0.0 111.391 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 72' ' ' LYS . 1.1 tt -102.58 124.12 47.55 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.572 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.696 HD11 ' ND2' ' A' ' 39' ' ' ASN . 8.8 mp -106.08 124.49 49.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.758 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . 0.46 ' HB3' ' CG ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -96.97 155.74 16.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.042 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 3.8 tttm . . . . . 0 C--O 1.234 0.273 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.375 -179.714 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.584 ' CE1' HD23 ' A' ' 73' ' ' LEU . 76.0 m-85 -60.31 -26.27 66.41 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.21 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.88 21.14 54.09 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.866 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.592 HD11 ' CB ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -95.76 122.84 38.97 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.733 0.301 . . . . 0.0 110.691 179.791 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.17 113.24 26.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.929 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.804 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.7 pt? -109.32 124.8 51.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.247 0.546 . . . . 0.0 111.074 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -105.09 -164.76 23.93 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.898 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.31 150.07 37.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.909 0.385 . . . . 0.0 110.831 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.429 HE22 HG22 ' B' ' 128' ' ' ILE . 0.0 OUTLIER -130.02 135.98 48.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.819 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.931 HD13 ' HB2' ' B' ' 145' ' ' ALA . 83.2 mt -87.91 120.89 37.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.369 . . . . 0.0 110.51 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.424 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 42.5 p90 -123.16 172.11 8.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.129 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 0.751 ' CG2' HD23 ' B' ' 123' ' ' LEU . 35.6 t -83.47 97.32 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.136 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . 0.424 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -65.31 -52.11 56.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.033 -179.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -162.31 138.49 7.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.879 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -121.66 152.48 39.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.907 0.384 . . . . 0.0 111.311 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 23.4 m -78.84 127.62 32.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.798 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 165.39 12.07 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.065 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.24 28.72 15.88 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.52 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.54 -174.94 19.97 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.318 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.04 -28.9 63.66 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.482 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -75.0 -35.09 62.02 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.181 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.14 -34.08 43.59 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.989 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -60.82 -38.44 85.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.563 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.25 -29.86 11.01 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.708 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.81 49.62 34.76 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.245 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.769 ' HB3' HG11 ' A' ' 4' ' ' VAL . 2.1 p-10 -71.88 -40.3 69.02 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.751 HD23 ' CG2' ' B' ' 108' ' ' VAL . 3.0 mp -122.78 146.33 47.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.626 0.251 . . . . 0.0 111.045 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -104.53 139.61 39.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.584 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -55.0 112.76 1.12 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.2 0.524 . . . . 0.0 110.67 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.58 -13.44 39.09 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.391 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -62.16 138.1 58.35 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.974 0.416 . . . . 0.0 110.809 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.782 HD11 ' HB2' ' B' ' 161' ' ' LEU . 1.4 pp -76.77 125.65 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.641 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.579 HD12 HG22 ' B' ' 106' ' ' ILE . 20.8 mt -93.26 147.8 5.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.714 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.46 HD22 HD11 ' B' ' 161' ' ' LEU . 32.3 tp -114.9 -40.76 3.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.777 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -147.19 148.04 31.1 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.394 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.676 HG23 HD23 ' B' ' 158' ' ' LEU . 38.7 mt -141.45 118.85 8.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.215 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . 0.558 ' HB2' HD21 ' B' ' 148' ' ' LEU . 8.6 m120 58.35 35.53 24.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.987 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.51 9.3 86.63 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.412 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -119.12 130.16 55.42 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 117.098 0.449 . . . . 0.0 110.395 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.681 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.4 t -59.22 147.03 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.101 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.869 HG22 HD12 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -115.55 4.8 14.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.998 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.681 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.2 OUTLIER -92.98 131.23 38.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.187 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 71.44 -4.84 1.74 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.458 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.467 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.5 OUTLIER -69.78 171.04 9.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.997 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 38.5 t -87.01 144.4 26.92 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.11 -46.2 88.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.512 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.01 -37.16 83.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.774 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.8 -47.56 80.37 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.98 ' HB1' HD11 ' A' ' 19' ' ' LEU . . . -58.7 -41.84 87.23 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.935 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 76.9 ttt-85 -66.63 -39.97 88.52 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.299 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -38.15 86.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.805 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' B' ' 133' ' ' ASN . 8.3 tt -59.73 -44.31 93.83 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.532 HD12 HD22 ' A' ' 19' ' ' LEU . 39.1 mt -68.35 -37.19 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.611 0.244 . . . . 0.0 110.76 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -49.36 59.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.932 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -25.47 62.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.408 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 29.1 t -80.39 79.74 6.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.995 0.426 . . . . 0.0 110.597 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.82 126.64 35.77 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.542 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.16 -92.99 0.57 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.119 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -122.95 135.14 54.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.629 0.252 . . . . 0.0 110.717 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.808 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -129.58 132.31 46.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.119 0.485 . . . . 0.0 111.139 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.1 tm0? -94.58 139.09 31.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.316 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.676 HD23 HG23 ' B' ' 132' ' ' ILE . 5.5 mt -134.07 123.4 24.42 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.712 0.291 . . . . 0.0 111.009 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 21.4 t -110.91 135.71 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.465 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' B' ' 129' ' ' ILE . 18.4 m -136.13 158.57 38.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.175 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . 0.782 ' HB2' HD11 ' B' ' 128' ' ' ILE . 18.9 mt . . . . . 0 CA--C 1.531 0.229 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.253 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.4 tt . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.717 0.294 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.48 157.8 22.21 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.74 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.759 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.5 t -131.12 134.48 61.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.981 0.42 . . . . 0.0 111.351 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.568 HD23 ' NZ ' ' B' ' 155' ' ' LYS . 9.0 mp -101.39 108.59 20.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.874 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.691 HD23 ' CD2' ' A' ' 15' ' ' TYR . 3.1 tp -94.7 141.91 28.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.619 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.423 ' O ' HD13 ' B' ' 116' ' ' LEU . 2.9 ttt -126.19 164.27 21.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.116 0.484 . . . . 0.0 111.122 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.076 -179.668 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.621 0.248 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.881 ' CE1' HD23 ' B' ' 156' ' ' LEU . 52.2 m-85 -66.75 -28.69 68.61 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.972 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.4 19.8 37.28 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.694 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.797 HD22 HD22 ' B' ' 123' ' ' LEU . 1.3 mt -98.49 116.57 31.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.572 0.225 . . . . 0.0 110.708 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.459 ' HB2' ' HG2' ' B' ' 110' ' ' GLU . 55.8 mtt85 -91.2 113.49 25.76 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.744 HD22 HD11 ' B' ' 149' ' ' ILE . 6.6 mp -95.4 124.97 39.7 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.451 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.67 175.2 20.0 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.3 OUTLIER -137.08 144.41 43.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.033 0.416 . . . . 0.0 111.136 -179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' B' ' 104' ' ' SER . 9.8 pt20 -128.31 140.81 51.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.338 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.981 HD13 ' HB2' ' A' ' 62' ' ' ALA . 15.8 mt -88.17 120.49 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.411 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 43.7 p90 -123.9 171.71 9.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.639 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.806 HG21 ' HB3' ' A' ' 40' ' ' LEU . 95.8 t -81.19 98.47 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.577 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 3.0 tptp -69.27 -57.76 4.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.356 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -156.13 139.77 16.01 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.786 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -124.83 156.42 37.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.289 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.403 HG23 ' O ' ' B' ' 99' ' ' GLY . 32.8 p -65.26 121.54 15.02 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -58.84 145.99 38.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.064 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.2 m 64.32 32.92 11.86 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.312 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.25 -171.66 29.68 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.205 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.597 HD13 ' O ' ' B' ' 90' ' ' MET . 2.6 mt -69.25 -32.4 71.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.515 0.198 . . . . 0.0 111.332 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.02 -33.58 61.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.006 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.83 -34.67 45.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.044 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -63.48 -36.96 85.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.078 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -97.72 -31.6 12.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.422 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.81 50.59 10.8 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.729 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.885 ' HB3' HG11 ' B' ' 87' ' ' VAL . 13.3 p30 -89.32 -39.68 13.3 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.806 ' HB3' HG21 ' A' ' 25' ' ' VAL . 26.8 mt -111.72 121.18 44.41 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.668 0.27 . . . . 0.0 110.978 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 119.42 34.17 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.245 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -42.52 107.26 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.984 0.421 . . . . 0.0 111.818 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 117.02 -11.43 14.9 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.712 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -69.72 131.79 45.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.532 0.666 . . . . 0.0 111.286 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.6 pt -75.86 104.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.263 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 25' ' ' VAL . 39.7 mm -66.0 141.65 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.394 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.555 HD13 ' CD1' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -100.72 -43.02 6.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.249 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -152.8 148.16 26.88 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.884 0.373 . . . . 0.0 111.588 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.506 HG23 ' CD1' ' A' ' 75' ' ' LEU . 41.6 mt -135.17 121.61 33.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.211 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.477 HD22 HG22 ' A' ' 49' ' ' ILE . 4.6 m-80 52.7 40.27 30.02 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.759 0.314 . . . . 0.0 111.11 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.15 17.61 78.81 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.062 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.5 m -120.37 141.64 49.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.861 0.331 . . . . 0.0 110.204 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.502 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.0 t -64.44 143.95 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.165 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.766 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -117.87 15.43 14.33 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.457 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.502 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -115.75 133.38 56.09 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.498 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 73.29 -11.57 0.89 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.328 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.47 ' HG3' ' N ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -73.8 152.92 40.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.671 0.272 . . . . 0.0 110.532 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.47 ' N ' ' HG3' ' A' ' 57' ' ' MET . 48.0 t -71.3 144.7 49.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.005 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tt -54.7 -42.32 71.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.753 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.24 -38.27 76.54 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.023 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.66 -47.83 77.01 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.839 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.981 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -59.36 -42.15 90.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.908 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.17 -40.09 90.22 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.66 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -64.88 -39.71 93.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -43.29 97.97 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.595 HD11 HD22 ' B' ' 102' ' ' LEU . 7.8 mt -68.61 -37.71 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.797 0.332 . . . . 0.0 110.656 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -69.05 -49.15 60.01 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -20.09 65.62 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.456 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -75.74 68.96 2.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.955 0.407 . . . . 0.0 110.915 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.28 109.14 14.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.49 -82.93 0.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.068 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 141.89 49.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.615 0.245 . . . . 0.0 110.673 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.714 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 1.2 pt? -130.36 132.42 45.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.879 0.371 . . . . 0.0 111.475 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.587 ' O ' HD13 ' A' ' 75' ' ' LEU . 52.9 tt0 -98.67 127.93 44.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.607 HD21 ' HG ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -125.34 129.44 49.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.822 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.95 131.94 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.532 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.47 138.87 48.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.492 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.555 ' CD1' HD13 ' A' ' 47' ' ' LEU . 3.5 tt . . . . . 0 C--O 1.233 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.416 ' O ' HG23 ' B' ' 85' ' ' ILE . 10.8 tt . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.798 0.332 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.22 156.46 17.33 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.577 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.885 HG11 ' HB3' ' A' ' 39' ' ' ASN . 17.7 t -132.62 134.52 58.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.718 0.294 . . . . 0.0 111.103 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 107.03 17.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.536 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 73' ' ' LEU . 16.9 tp -99.89 140.52 33.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.451 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . 0.597 ' O ' HD13 ' A' ' 33' ' ' LEU . 51.1 ttm -120.96 161.77 21.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.201 0.524 . . . . 0.0 110.783 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.824 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.961 0.41 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.714 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 69.2 m-85 -73.56 -30.18 62.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.228 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 29' ' ' THR . . . 89.06 23.44 35.01 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.68 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 mp -103.61 122.27 44.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.758 0.279 . . . . 0.0 110.522 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -102.66 113.56 27.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.303 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.595 HD22 HD11 ' A' ' 66' ' ' ILE . 9.4 mp -98.16 124.78 42.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.949 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.48 -176.36 24.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.772 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -136.09 146.19 46.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.823 0.344 . . . . 0.0 111.0 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 21' ' ' SER . 8.9 pt20 -126.82 139.71 52.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.324 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 1.149 HD13 ' HB2' ' B' ' 145' ' ' ALA . 50.2 mt -88.19 120.5 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.407 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -121.41 172.44 8.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.954 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 0.694 HG22 HD23 ' B' ' 123' ' ' LEU . 38.3 t -81.73 96.24 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.117 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -58.05 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.884 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 18' ' ' ARG . 1.7 pt-20 -157.24 137.74 13.01 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.576 ' CB ' HD23 ' A' ' 17' ' ' LEU . 1.2 ptt? -119.79 161.44 20.76 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 111.68 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 51.9 m -78.46 140.31 38.64 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . 0.496 ' O ' HG22 ' B' ' 114' ' ' THR . 0.0 OUTLIER -76.33 152.24 36.44 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.103 179.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.563 HG23 ' O ' ' B' ' 114' ' ' THR . 0.5 OUTLIER 64.88 16.59 10.58 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.168 179.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.31 -168.46 41.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.224 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 7' ' ' MET . 0.1 OUTLIER -75.69 -27.32 58.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.673 ' CB ' HD21 ' A' ' 17' ' ' LEU . . . -74.8 -37.98 62.23 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.587 0.232 . . . . 0.0 111.213 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -33.74 43.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.827 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.0 -38.49 86.24 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.333 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.32 -37.6 9.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.222 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.08 55.7 3.46 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.309 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.759 ' HB3' HG11 ' A' ' 4' ' ' VAL . 0.5 OUTLIER -101.98 -45.52 5.16 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.409 0.147 . . . . 0.0 111.377 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.797 HD22 HD22 ' A' ' 17' ' ' LEU . 4.4 mp -85.25 119.92 26.17 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.79 0.328 . . . . 0.0 110.672 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.44 125.54 42.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.43 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -56.42 107.69 0.4 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.065 0.46 . . . . 0.0 110.916 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.13 -14.15 44.33 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.024 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.78 137.34 58.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.042 0.449 . . . . 0.0 110.983 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.75 105.19 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.288 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.503 HG12 HD11 ' B' ' 158' ' ' LEU . 7.8 mt -71.78 143.98 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.82 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 19.3 tp -105.81 -33.68 7.91 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.878 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -155.73 148.09 23.73 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.79 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 24.2 mt -137.95 117.73 15.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.146 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . 0.762 ' HB2' HD21 ' B' ' 148' ' ' LEU . 6.3 m120 56.73 36.81 28.22 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.043 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.5 13.74 82.21 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.305 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.5 m -120.45 128.46 53.19 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.922 0.361 . . . . 0.0 110.4 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.535 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.2 t -59.37 144.46 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 111.208 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.805 HG22 HD12 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -109.16 11.28 25.65 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.595 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.535 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.4 OUTLIER -99.79 132.98 44.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 72.47 -11.62 0.8 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.657 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.627 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.5 OUTLIER -64.07 168.45 5.33 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 111.141 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.38 148.22 22.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.257 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.22 -42.88 82.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.861 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 69.4 p -63.03 -39.81 95.86 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.176 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -41.53 97.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.035 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 1.149 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.91 -44.57 91.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.868 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -69.91 -36.6 75.49 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.506 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -67.85 -39.28 83.83 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.766 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . 0.762 HD21 ' HB2' ' B' ' 133' ' ' ASN . 5.6 tt -61.81 -42.42 98.99 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.785 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.744 HD11 HD22 ' A' ' 19' ' ' LEU . 14.7 mt -68.3 -38.16 79.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.589 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.16 -49.36 57.54 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.709 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -65.42 -25.86 67.72 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.236 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 10.7 t -84.44 63.41 7.81 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.015 0.436 . . . . 0.0 110.575 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.81 103.91 8.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.274 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 141.69 -93.11 0.18 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.088 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . 0.568 ' NZ ' HD23 ' A' ' 5' ' ' LEU . 14.0 ttpp -123.8 126.98 47.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.543 0.211 . . . . 0.0 110.963 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.881 HD23 ' CE1' ' A' ' 15' ' ' TYR . 1.2 pp -124.18 126.89 46.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.999 0.428 . . . . 0.0 111.353 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.8 mt-30 -94.45 141.49 28.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.219 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.503 HD11 HG12 ' B' ' 129' ' ' ILE . 3.7 tt -137.33 140.51 41.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.034 0.445 . . . . 0.0 111.536 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 25.3 t -120.08 134.59 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.278 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.484 HG13 ' CD2' ' B' ' 158' ' ' LEU . 27.6 m -124.71 159.34 31.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.753 0.311 . . . . 0.0 111.309 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.433 HG23 HG23 ' B' ' 160' ' ' VAL . 11.8 tt . . . . . 0 C--O 1.234 0.241 0 CA-C-O 120.725 0.298 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -128.86 157.28 21.49 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.906 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.66 HG11 ' HB3' ' B' ' 122' ' ' ASN . 21.9 t -132.12 133.66 60.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.743 0.306 . . . . 0.0 111.193 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 mt -98.19 111.67 23.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.784 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 tp -102.16 134.11 45.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.394 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.551 ' O ' HD13 ' B' ' 116' ' ' LEU . 7.4 ttm -109.11 164.16 12.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.643 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.729 -179.905 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.614 0.245 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.746 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 62.7 m-85 -52.2 -27.4 14.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.776 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.71 18.16 62.27 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.431 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.646 HD23 HG13 ' B' ' 108' ' ' VAL . 0.1 OUTLIER -97.75 115.14 27.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.715 0.293 . . . . 0.0 110.287 179.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -93.32 113.47 25.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.849 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.559 HD12 HG21 ' B' ' 106' ' ' ILE . 1.9 pt? -105.97 124.92 50.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 111.565 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -109.42 -176.81 21.33 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.55 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.423 ' OG ' HD12 ' B' ' 142' ' ' LEU . 0.3 OUTLIER -142.34 146.46 35.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.905 0.353 . . . . 0.0 111.067 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.428 ' NE2' HG21 ' A' ' 45' ' ' ILE . 6.5 pt20 -127.27 135.52 50.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.848 ' HB ' HG22 ' A' ' 54' ' ' THR . 42.2 mt -87.91 120.56 37.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.002 0.43 . . . . 0.0 110.557 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -123.71 172.57 8.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.062 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.467 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.0 t -82.37 100.15 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.795 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -70.66 -59.68 2.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.399 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.7 136.05 20.3 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.753 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 13.0 ptp -122.1 151.4 40.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.892 0.377 . . . . 0.0 111.211 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -65.53 134.34 53.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -71.86 146.95 47.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.773 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.27 33.58 14.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.258 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.78 -171.75 26.57 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.272 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.632 HD13 ' O ' ' B' ' 90' ' ' MET . 0.1 OUTLIER -70.45 -31.6 68.83 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.646 0.223 . . . . 0.0 111.423 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.594 ' HB3' HD11 ' B' ' 100' ' ' LEU . . . -74.93 -34.26 62.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.261 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.09 -34.0 43.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.079 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -64.06 -36.63 84.62 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.336 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.48 -30.5 11.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.421 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.36 45.26 61.39 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.281 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.722 ' HB3' HG11 ' B' ' 87' ' ' VAL . 14.7 p-10 -74.61 -38.55 62.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.508 0.194 . . . . 0.0 111.391 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.669 ' CD1' HD13 ' A' ' 75' ' ' LEU . 5.6 mt -128.43 133.86 48.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.924 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.88 148.32 24.58 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.593 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -59.33 112.23 1.66 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.097 0.475 . . . . 0.0 111.001 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.26 -15.84 20.25 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.394 -0.821 . . . . 0.0 113.177 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -63.04 133.69 54.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.242 0.521 . . . . 0.0 110.285 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.428 HG21 ' NE2' ' A' ' 22' ' ' GLN . 4.3 pt -81.8 104.69 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.434 ' CG2' HG21 ' A' ' 54' ' ' THR . 64.4 mt -65.35 148.63 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.031 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.583 HD12 HD12 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -106.85 -45.81 4.1 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.6 -179.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -149.27 148.16 29.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 111.768 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.671 HD13 HD11 ' A' ' 66' ' ' ILE . 26.6 mt -129.74 118.06 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.496 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 m120 49.99 32.19 5.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.642 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.51 16.46 58.63 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.199 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.6 m -120.79 135.83 55.05 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.869 0.334 . . . . 0.0 110.355 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.1 t -57.83 142.38 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.848 0.356 . . . . 0.0 111.295 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.848 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -119.39 16.79 13.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.401 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.525 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -121.87 129.33 52.5 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 71.56 -6.6 1.37 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.255 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.03 173.95 4.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.937 0.399 . . . . 0.0 111.043 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.77 135.89 33.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.669 HD12 ' OG ' ' B' ' 104' ' ' SER . 0.2 OUTLIER -56.63 -43.08 79.9 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.889 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 43.4 p -64.72 -39.07 93.01 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.064 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.32 -47.99 68.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.816 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.572 ' O ' HD12 ' A' ' 66' ' ' ILE . . . -62.37 -40.17 95.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.756 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -62.78 -39.79 95.3 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.447 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -65.35 -38.35 89.82 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.981 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -46.33 89.45 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.668 0.271 . . . . 0.0 110.745 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.671 HD11 HD13 ' A' ' 49' ' ' ILE . 3.1 mp -69.04 -36.49 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.841 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.6 -46.36 69.53 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.155 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -64.05 -28.22 69.64 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.0 t -78.53 88.8 4.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.959 0.409 . . . . 0.0 110.76 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -99.16 40.45 1.21 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' HD2' ' B' ' 91' ' ' LYS . . . -151.37 -88.17 0.07 OUTLIER Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.284 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -129.46 122.16 28.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.619 0.247 . . . . 0.0 110.474 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.598 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -114.97 136.37 53.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.031 0.443 . . . . 0.0 111.116 -179.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -100.96 134.41 44.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.506 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.669 HD13 ' CD1' ' A' ' 40' ' ' LEU . 1.3 mt -127.4 137.94 52.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.015 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.3 t -120.16 139.55 47.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.425 ' CG2' HD23 ' A' ' 40' ' ' LEU . 19.7 t -115.34 142.49 28.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.183 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.583 HD12 HD12 ' A' ' 47' ' ' LEU . 8.6 tt . . . . . 0 C--O 1.233 0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.233 0.236 0 CA-C-O 120.53 0.205 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.22 158.63 27.3 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.923 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.722 HG11 ' HB3' ' A' ' 39' ' ' ASN . 21.4 t -131.43 135.18 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 111.021 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.77 107.46 18.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.432 HD23 ' CD2' ' B' ' 98' ' ' TYR . 1.3 tp -90.71 136.49 33.03 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.871 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . 0.632 ' O ' HD13 ' A' ' 33' ' ' LEU . 9.9 ttm -104.32 164.85 11.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 111.005 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.128 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 120.696 0.284 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.598 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 50.0 m-85 -58.41 -27.62 64.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.652 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.87 14.39 55.08 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.525 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.594 HD11 ' HB3' ' A' ' 34' ' ' ALA . 8.4 mp -101.55 119.94 39.55 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.746 0.308 . . . . 0.0 110.655 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -101.79 113.56 26.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.156 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.451 HD23 ' H ' ' B' ' 102' ' ' LEU . 1.9 pt? -102.93 125.02 49.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 111.301 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.67 -170.81 20.31 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.377 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.669 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -146.59 152.16 38.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.979 0.389 . . . . 0.0 110.887 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -128.88 138.64 52.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.13 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.714 ' HB ' HG22 ' B' ' 137' ' ' THR . 26.8 mt -88.08 120.49 37.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.447 . . . . 0.0 110.492 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -121.69 173.23 7.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.044 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 0.678 HG21 ' HB3' ' B' ' 123' ' ' LEU . 46.1 t -82.51 98.03 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.046 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -44.98 71.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.039 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -155.0 160.91 41.43 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.947 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 18.1 mtp -138.13 162.13 35.02 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 111.136 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 5.7 p -95.9 124.39 39.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.643 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . 0.573 ' HA ' HG21 ' B' ' 118' ' ' THR . 0.0 OUTLIER -64.72 160.51 19.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.03 0.443 . . . . 0.0 110.866 179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 58.13 22.84 9.49 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.02 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -103.31 -172.04 26.02 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.203 -0.523 . . . . 0.0 111.961 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 7' ' ' MET . 0.2 OUTLIER -72.24 -29.59 64.07 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.39 63.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.559 0.218 . . . . 0.0 111.077 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . 0.573 HG21 ' HA ' ' B' ' 113' ' ' ARG . 1.0 OUTLIER -79.23 -34.03 43.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.246 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -57.81 -39.76 78.37 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.444 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -104.14 -36.16 7.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.028 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.2 53.34 5.7 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.756 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.66 ' HB3' HG11 ' A' ' 4' ' ' VAL . 8.5 p-10 -84.49 -36.5 22.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.777 HD11 HD22 ' B' ' 158' ' ' LEU . 3.7 mt -115.44 128.02 55.74 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.735 0.302 . . . . 0.0 111.218 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.77 140.37 34.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.351 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -57.27 110.43 0.84 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.068 0.461 . . . . 0.0 111.33 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 115.47 -16.44 16.98 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.264 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.09 132.68 54.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.389 0.594 . . . . 0.0 110.499 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 pt -79.15 106.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.854 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.688 HD13 HG12 ' B' ' 160' ' ' VAL . 36.8 mm -71.15 146.5 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.247 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 9.7 tp -109.5 -43.09 4.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.323 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.31 147.91 34.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.785 0.326 . . . . 0.0 111.461 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.433 HD11 HG21 ' B' ' 137' ' ' THR . 24.6 mt -137.86 118.14 16.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.39 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . 0.577 ' HB2' HD21 ' B' ' 148' ' ' LEU . 1.1 m120 56.79 37.34 28.74 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.102 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.17 16.36 80.76 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.985 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -120.73 142.72 49.26 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.82 0.31 . . . . 0.0 110.21 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.511 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.3 t -61.75 144.47 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.003 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.714 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -122.64 19.64 10.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.313 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.511 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.6 OUTLIER -112.0 142.15 44.77 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.365 179.608 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 53.15 9.08 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.218 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.23 176.12 9.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 111.268 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 47.2 t -91.93 142.74 27.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.423 HD12 ' OG ' ' A' ' 21' ' ' SER . 2.1 tt -61.09 -45.14 95.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.896 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 10.0 t -65.29 -37.14 86.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.845 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.2 -47.89 66.67 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.82 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.523 ' CB ' HD13 ' B' ' 106' ' ' ILE . . . -62.83 -40.42 97.36 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.843 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -61.68 -41.13 97.15 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.274 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -38.31 90.58 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.943 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' B' ' 133' ' ' ASN . 9.3 tt -59.6 -45.87 90.65 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.556 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.63 -36.72 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.795 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.94 -49.06 61.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.819 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -26.9 67.54 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.419 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 32.4 t -75.1 71.83 2.18 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.138 0.494 . . . . 0.0 110.634 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -86.57 97.9 10.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.328 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 147.46 -85.01 0.17 Allowed Glycine 0 C--O 1.228 -0.275 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.244 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 131.1 37.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.646 0.26 . . . . 0.0 110.682 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.746 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.59 143.64 51.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.002 0.429 . . . . 0.0 111.545 -179.565 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 32.7 tt0 -103.16 142.44 34.14 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.403 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.777 HD22 HD11 ' B' ' 123' ' ' LEU . 1.7 mp -136.24 128.34 29.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 110.951 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.402 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 18.7 t -117.09 134.01 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.688 HG12 HD13 ' B' ' 129' ' ' ILE . 22.6 m -124.44 156.32 32.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.195 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.914 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.719 0.295 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.12 157.79 22.84 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.507 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.812 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.5 t -131.55 134.99 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.302 . . . . 0.0 111.368 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.702 HD22 ' HE3' ' B' ' 155' ' ' LYS . 0.8 OUTLIER -100.5 107.24 18.9 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.512 179.535 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 tp -95.27 127.79 41.6 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.692 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.737 ' O ' HD22 ' B' ' 116' ' ' LEU . 3.2 ttt -106.99 165.67 11.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.954 0.407 . . . . 0.0 110.945 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.1 pttt . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.016 179.843 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.586 0.231 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.868 ' CE1' HD23 ' B' ' 156' ' ' LEU . 76.0 m-85 -60.13 -30.17 69.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.557 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.88 28.09 39.26 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.338 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.561 HD11 ' CB ' ' B' ' 117' ' ' ALA . 0.2 OUTLIER -106.59 120.54 42.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.673 0.273 . . . . 0.0 110.62 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.68 114.82 27.47 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.399 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.704 HD22 HD11 ' B' ' 149' ' ' ILE . 5.7 mp -98.09 124.92 42.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.153 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -110.23 177.88 19.83 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.764 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.5 OUTLIER -135.11 146.66 49.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.067 0.434 . . . . 0.0 111.321 -179.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -129.59 139.18 51.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.109 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.862 HD13 ' HB2' ' A' ' 62' ' ' ALA . 55.9 mt -88.11 120.41 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.036 0.446 . . . . 0.0 110.71 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -121.18 172.44 7.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.912 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.575 ' CG2' HD22 ' A' ' 40' ' ' LEU . 42.6 t -79.92 93.76 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.967 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -50.68 63.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.928 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.408 ' HB3' ' CG ' ' B' ' 101' ' ' ARG . 6.3 tt0 -158.47 151.82 23.01 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.985 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.48 146.01 41.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.122 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.455 HG23 ' O ' ' B' ' 99' ' ' GLY . 26.5 p -65.56 121.41 14.85 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.959 0.409 . . . . 0.0 110.767 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 151.08 22.1 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.101 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.05 31.74 13.34 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.281 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.76 -168.07 26.32 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.43 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 mt -70.32 -34.33 72.56 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 110.686 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.66 ' HA ' HD21 ' B' ' 89' ' ' LEU . . . -75.02 -33.7 61.81 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.896 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.1 -34.43 43.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.019 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.73 -38.76 82.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.406 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.9 -26.27 12.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.709 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.56 50.53 54.18 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.051 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.685 ' CG ' HG11 ' B' ' 87' ' ' VAL . 16.6 m-80 -78.19 -34.19 49.65 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.575 HD22 ' CG2' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -129.07 137.41 51.25 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.672 0.272 . . . . 0.0 110.897 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 143.0 32.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.74 113.44 1.65 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 111.344 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.4 -17.44 14.2 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.845 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.464 ' HB3' HD23 ' A' ' 40' ' ' LEU . 9.8 t70 -59.57 136.98 58.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.094 0.473 . . . . 0.0 110.999 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -81.19 109.86 15.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.575 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.688 HD13 HD21 ' B' ' 102' ' ' LEU . 9.3 mt -79.93 145.2 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.217 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -110.87 -27.29 8.89 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.007 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.619 ' HE3' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -158.25 147.97 19.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.263 179.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 28.8 mt -142.32 117.9 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.739 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 51.09 33.41 9.18 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.306 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.43 83.17 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.609 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -105.16 129.02 53.65 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 117.141 0.47 . . . . 0.0 110.443 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.666 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.8 t -64.42 146.81 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.392 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.567 ' HA ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -105.35 -10.52 16.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.487 179.518 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.666 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -87.84 142.33 27.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 p30 53.39 9.44 0.16 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.668 0.605 . . . . 0.0 112.271 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 ttm -90.43 149.66 22.15 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.675 0.274 . . . . 0.0 110.596 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 m -71.71 139.22 49.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.762 0.315 . . . . 0.0 111.14 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.683 HD11 ' O ' ' B' ' 102' ' ' LEU . 12.1 tp -57.93 -42.68 85.34 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.396 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.8 m -56.98 -38.27 72.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.756 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -68.46 -47.93 65.86 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.533 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.862 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -61.04 -40.5 93.86 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.423 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -69.8 -38.44 76.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.5 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -38.34 85.47 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.52 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -44.5 94.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.873 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.724 HD11 HD22 ' B' ' 102' ' ' LEU . 10.6 mt -68.26 -37.49 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.72 0.295 . . . . 0.0 110.698 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.06 -37.96 78.8 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.946 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -89.8 1.42 56.17 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.1 p -90.94 56.52 3.23 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.196 0.522 . . . . 0.0 110.842 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.82 100.23 1.5 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.829 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.24 -91.52 0.17 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.273 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.65 135.44 47.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.571 0.224 . . . . 0.0 110.719 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.862 HD23 ' CE2' ' B' ' 98' ' ' TYR . 0.8 OUTLIER -129.31 130.31 45.97 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.949 0.404 . . . . 0.0 111.009 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 15.8 mt-30 -98.05 142.44 29.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.785 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.443 ' HG ' HD12 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -130.38 127.93 40.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.908 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.02 142.77 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.6 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.408 HG23 HG23 ' B' ' 85' ' ' ILE . 34.1 m -136.12 158.55 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.178 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 tp . . . . . 0 C--O 1.233 0.228 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.952 -179.94 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . 0.629 HD13 ' N ' ' B' ' 86' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.651 0.262 . . . . 0.0 110.844 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . 0.629 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -151.55 159.92 28.49 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.938 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.685 HG11 ' CG ' ' A' ' 39' ' ' ASN . 7.1 t -129.17 134.7 63.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.707 0.289 . . . . 0.0 111.262 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.494 ' C ' HD23 ' B' ' 88' ' ' LEU . 9.7 tt -101.95 125.54 48.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.05 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.66 HD21 ' HA ' ' A' ' 34' ' ' ALA . 9.1 mp -112.35 124.72 53.1 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.966 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.3 ttt -116.07 159.26 21.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.632 0.73 . . . . 0.0 112.005 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.522 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 121.388 0.613 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.862 ' CE2' HD23 ' A' ' 73' ' ' LEU . 85.2 m-85 -94.11 -29.39 15.19 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.468 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 29' ' ' THR . . . 75.94 29.72 58.6 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.884 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.73 125.5 51.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.646 0.26 . . . . 0.0 110.756 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . 0.408 ' CG ' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -108.09 114.61 28.63 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.012 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.724 HD22 HD11 ' A' ' 66' ' ' ILE . 3.6 mp -89.38 128.5 35.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.264 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.16 168.48 13.36 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.601 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 2.4 p -127.66 149.93 49.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.036 0.446 . . . . 0.0 111.196 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 21' ' ' SER . 6.9 pt20 -132.72 137.02 46.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.97 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.763 HD12 HG22 ' B' ' 137' ' ' THR . 69.4 mt -88.0 120.55 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 121.112 0.482 . . . . 0.0 110.482 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -122.82 172.79 8.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.972 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 0.844 HG21 ' HB3' ' B' ' 123' ' ' LEU . 39.3 t -80.42 95.96 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.778 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -65.69 -55.96 14.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.918 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.19 144.8 17.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.003 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -136.15 155.44 50.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.936 0.398 . . . . 0.0 111.394 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 11.8 p -78.62 124.59 28.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 ttp-105 -65.06 166.0 10.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.82 31.86 18.24 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.19 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -112.23 -158.05 13.91 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.259 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.737 HD22 ' O ' ' A' ' 7' ' ' MET . 2.0 mp -84.99 -29.96 24.59 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.526 0.203 . . . . 0.0 111.451 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . 0.561 ' CB ' HD11 ' A' ' 17' ' ' LEU . . . -75.15 -37.49 61.33 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.634 0.254 . . . . 0.0 111.33 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -33.64 44.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.089 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -57.27 -40.86 78.59 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.198 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -102.09 -28.61 12.23 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.661 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.22 24.24 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.152 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.812 ' HB3' HG11 ' A' ' 4' ' ' VAL . 12.3 p-10 -74.22 -47.25 36.62 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.844 ' HB3' HG21 ' B' ' 108' ' ' VAL . 6.6 mp -123.68 123.41 40.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.673 0.273 . . . . 0.0 110.842 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.41 150.52 21.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.769 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -59.46 111.09 1.26 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.08 0.467 . . . . 0.0 111.082 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.83 -18.76 19.18 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 115.41 -0.813 . . . . 0.0 113.26 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . 0.476 ' HB3' HG11 ' B' ' 160' ' ' VAL . 23.0 m-20 -59.14 135.41 57.63 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.236 0.518 . . . . 0.0 110.701 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.417 ' O ' HG13 ' B' ' 160' ' ' VAL . 4.0 pt -81.77 113.7 21.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.196 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.756 HG21 HD11 ' B' ' 132' ' ' ILE . 5.7 mt -81.95 147.23 6.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.522 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.667 HD13 HD13 ' B' ' 161' ' ' LEU . 6.8 tt -110.25 -40.83 4.57 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.582 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -147.57 148.9 31.64 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.836 0.35 . . . . 0.0 111.937 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.756 HD11 HG21 ' B' ' 129' ' ' ILE . 32.6 mm -133.78 117.97 28.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 52.28 33.71 13.23 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.547 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.56 4.79 79.6 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.57 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 91.3 m -113.57 133.72 55.1 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 117.076 0.438 . . . . 0.0 110.464 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.456 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.6 t -59.1 146.16 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.763 HG22 HD12 ' B' ' 106' ' ' ILE . 0.2 OUTLIER -125.78 25.09 6.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.47 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.456 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.3 OUTLIER -113.03 130.88 55.99 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.073 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 70.8 -4.44 1.71 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.425 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.475 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -67.22 172.05 5.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.79 0.328 . . . . 0.0 111.007 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 43.4 t -88.34 145.33 25.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.375 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -40.84 83.24 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.848 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -39.21 86.62 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.81 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -65.57 -47.18 76.66 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.835 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.724 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -60.69 -40.94 94.05 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -69.52 -38.0 77.39 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.637 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -65.85 -40.1 91.39 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.947 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.03 -43.84 98.29 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.678 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.704 HD11 HD22 ' A' ' 19' ' ' LEU . 14.0 mt -68.32 -37.4 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.762 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -68.22 -49.58 59.77 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.044 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -68.39 -22.86 64.61 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.466 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.8 m -76.28 68.15 2.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.018 0.437 . . . . 0.0 110.771 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.13 91.31 7.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.467 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 155.85 -94.7 0.14 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.298 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . 0.702 ' HE3' HD22 ' A' ' 5' ' ' LEU . 21.8 tttp -126.42 132.31 51.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.624 0.25 . . . . 0.0 110.406 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.868 HD23 ' CE1' ' A' ' 15' ' ' TYR . 1.3 pp -128.69 144.14 51.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 21.9 tt0 -111.05 143.05 42.37 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.633 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.749 HD23 HD12 ' B' ' 132' ' ' ILE . 0.5 OUTLIER -133.82 128.2 34.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.679 0.276 . . . . 0.0 110.969 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 12.9 t -112.2 131.89 62.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.519 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' B' ' 127' ' ' ASP . 21.3 t -130.0 143.46 40.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.889 0.376 . . . . 0.0 111.496 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . 0.667 HD13 HD13 ' B' ' 130' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.203 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.775 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.865 0.364 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.37 165.13 12.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.667 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.683 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.6 t -129.97 134.71 62.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 120.653 0.264 . . . . 0.0 111.116 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.439 HD22 ' HE2' ' B' ' 155' ' ' LYS . 1.7 mt -99.86 106.85 18.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.751 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.438 ' O ' HD23 ' B' ' 156' ' ' LEU . 4.4 tp -100.94 127.52 47.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.452 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.67 159.53 14.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.823 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.832 0.349 . . . . 0.0 110.971 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 121.028 0.442 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.684 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 70.0 m-85 -63.58 -30.45 71.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.158 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.75 22.59 33.1 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.667 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 15' ' ' TYR . 6.0 mp -101.71 118.31 36.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.827 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.16 113.54 25.33 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.274 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.848 HD22 HD11 ' B' ' 149' ' ' ILE . 1.0 OUTLIER -97.71 124.95 42.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.152 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -115.21 -172.77 17.37 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.778 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.592 ' OG ' HD12 ' B' ' 142' ' ' LEU . 0.2 OUTLIER -144.09 151.36 39.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.813 0.34 . . . . 0.0 110.935 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -133.11 134.47 44.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.963 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.779 ' HB ' HG22 ' A' ' 54' ' ' THR . 50.0 mt -87.82 120.18 36.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.061 0.458 . . . . 0.0 110.15 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -123.31 171.2 9.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.913 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.9 t -84.6 97.04 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.087 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -40.17 96.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.916 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -170.22 156.42 5.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.02 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -138.37 157.24 46.62 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.862 0.363 . . . . 0.0 111.159 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.43 126.53 28.54 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -62.07 145.03 54.4 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.77 33.26 22.69 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.472 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.59 -167.71 31.08 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.321 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 mt -67.23 -35.59 79.88 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.581 0.229 . . . . 0.0 111.211 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -75.08 -35.19 61.82 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.163 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.84 -33.87 45.62 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.022 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -40.23 81.83 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.245 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.1 -27.62 12.81 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.73 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.61 43.75 51.46 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.035 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.602 ' HB3' HG11 ' B' ' 87' ' ' VAL . 24.7 p-10 -59.71 -48.91 79.8 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -138.43 147.28 43.14 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.697 0.284 . . . . 0.0 110.91 179.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 156.68 16.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.519 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 1.2 pt-20 -71.46 121.95 19.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.492 0.663 . . . . 0.0 109.898 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.41 3.24 35.38 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.948 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -85.94 135.14 33.79 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.419 0.609 . . . . 0.0 110.485 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.429 HD13 ' H ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -73.88 112.21 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.022 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.421 HD13 HD11 ' A' ' 49' ' ' ILE . 30.7 mt -79.04 146.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.502 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 78' ' ' LEU . 10.4 tp -102.57 -43.95 5.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.394 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -151.93 150.98 30.65 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 111.372 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 28.3 mt -140.91 118.09 8.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.726 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.486 ' HB2' HD13 ' A' ' 65' ' ' LEU . 1.9 m120 54.44 33.72 19.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.125 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.0 -2.39 87.05 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.123 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.1 m -104.64 126.46 51.75 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.985 0.393 . . . . 0.0 110.385 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.9 t -59.37 146.19 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.881 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.779 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.96 14.05 18.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.566 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.617 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -106.91 132.92 52.32 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.343 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.538 ' HB2' HD13 ' B' ' 142' ' ' LEU . 10.1 p30 53.18 8.89 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 123.672 0.608 . . . . 0.0 112.579 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 31.2 tpp -82.69 161.06 22.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.686 0.279 . . . . 0.0 110.831 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.91 128.21 35.03 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.987 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.464 HD12 ' OG ' ' B' ' 104' ' ' SER . 9.9 tt -53.15 -42.57 66.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -61.65 -38.49 87.93 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.221 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.04 -48.05 77.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.939 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.683 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -61.42 -39.34 90.39 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.061 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -71.03 -35.47 72.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.654 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.1 tpmp? -66.5 -40.73 89.38 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.026 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.595 HD23 ' HA ' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -62.66 -41.79 99.26 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.868 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.8 mt -68.3 -38.06 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.033 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -48.99 62.44 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -64.19 -26.59 68.59 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.062 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.4 t -83.97 93.34 8.04 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.797 0.332 . . . . 0.0 110.707 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.48 40.38 1.27 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -143.71 -87.68 0.09 OUTLIER Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.273 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.65 133.52 50.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.758 -0.221 . . . . 0.0 110.558 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.788 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.8 OUTLIER -125.03 134.02 52.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.044 0.45 . . . . 0.0 111.369 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -97.65 141.08 31.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.464 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.631 ' HB2' HD11 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -137.12 124.6 22.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.73 0.3 . . . . 0.0 110.856 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.5 143.51 30.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.218 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.534 HG13 HD22 ' A' ' 40' ' ' LEU . 3.3 m -127.47 154.75 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.056 0.455 . . . . 0.0 111.705 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 47' ' ' LEU . 5.6 tp . . . . . 0 C--O 1.233 0.209 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.534 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.733 0.301 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.4 158.63 22.18 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.618 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 39' ' ' ASN . 20.9 t -129.76 134.52 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.652 0.263 . . . . 0.0 111.292 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 8.8 tt -99.82 110.06 22.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.344 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.462 HD21 ' N ' ' A' ' 34' ' ' ALA . 2.8 tp -99.37 143.14 29.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.66 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 21.8 ttt -117.72 162.75 17.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.206 0.527 . . . . 0.0 111.316 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.001 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' B' ' 98' ' ' TYR . 33.0 tt0 . . . . . 0 CA--C 1.533 0.305 0 CA-C-O 120.823 0.344 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' TYR . . . . . 0.788 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 58.8 m-85 -63.82 -27.06 68.92 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.207 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.76 22.17 37.35 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.727 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 34' ' ' ALA . 3.5 mp -104.22 125.55 50.59 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.747 0.308 . . . . 0.0 110.552 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -105.97 113.82 27.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.21 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.683 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.8 pt? -106.66 124.96 50.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.192 0.52 . . . . 0.0 111.642 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' A' ' 59' ' ' LEU . . . -105.71 -165.15 23.39 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.978 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' SER . . . . . 0.464 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -145.67 148.86 33.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.825 0.345 . . . . 0.0 111.17 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -132.45 139.03 47.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.153 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' ILE . . . . . 0.941 HD13 ' HB2' ' B' ' 145' ' ' ALA . 10.8 mt -88.19 120.62 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 110.588 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -122.42 171.98 8.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.181 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' VAL . . . . . 0.894 HG21 ' HB3' ' B' ' 123' ' ' LEU . 29.7 t -82.08 98.04 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.806 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.03 -53.26 40.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.195 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.43 ' HA ' ' HG2' ' B' ' 125' ' ' GLU . 2.6 pt-20 -162.06 138.67 8.04 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.927 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.2 161.35 19.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 111.31 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.5 p -78.03 120.26 22.61 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.65 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -61.34 149.28 38.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.157 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.2 m 67.67 25.51 8.14 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.377 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.18 -171.18 27.24 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.42 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -29.32 62.88 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.07 -34.42 61.78 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.124 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 1.2 p -78.94 -34.15 44.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.95 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -38.63 83.76 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.358 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -102.02 -31.2 10.77 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.401 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.26 45.96 28.83 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.251 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' ASN . . . . . 0.683 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.0 p-10 -75.68 -39.28 57.81 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.539 0.17 . . . . 0.0 111.4 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' LEU . . . . . 0.894 ' HB3' HG21 ' B' ' 108' ' ' VAL . 16.2 mt -121.82 121.86 38.16 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.994 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.48 147.31 23.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' B' ' 110' ' ' GLU . 4.8 mt-10 -59.45 111.22 1.31 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.955 0.407 . . . . 0.0 111.17 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.31 -16.33 24.68 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.46 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -58.13 134.35 56.39 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.408 0.604 . . . . 0.0 110.777 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 8.5 pt -83.74 99.79 6.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.601 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.618 ' HB ' HG21 ' B' ' 137' ' ' THR . 9.9 mt -66.78 136.74 26.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.246 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 tp -96.09 -42.13 8.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.619 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -146.23 147.79 31.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.764 0.316 . . . . 0.0 111.548 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 34.2 mt -134.9 117.93 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.757 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 50.9 44.18 28.35 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.494 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.22 18.42 78.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.008 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 30.6 m -120.72 142.22 49.71 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.597 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.9 t -62.81 146.08 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.982 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 137' ' ' THR . . . . . 0.807 HG22 ' HB ' ' B' ' 106' ' ' ILE . 1.4 m -120.98 16.94 11.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.917 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 138' ' ' GLU . . . . . 0.597 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.3 tt0 -117.45 131.34 56.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 71.12 -6.55 1.29 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.554 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 140' ' ' MET . . . . . 0.637 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.9 OUTLIER -67.2 171.49 5.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.002 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 20.8 m -87.35 139.6 30.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.218 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 142' ' ' LEU . . . . . 0.592 HD12 ' OG ' ' A' ' 21' ' ' SER . 9.0 tt -56.01 -44.87 79.11 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 58.1 p -61.91 -40.2 94.64 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.805 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -62.97 -48.08 80.42 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.941 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.19 -42.03 85.23 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.071 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -69.49 -37.46 77.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.746 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -68.11 -39.4 82.81 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.661 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.92 -43.8 94.69 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.675 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.848 HD11 HD22 ' A' ' 19' ' ' LEU . 11.7 mt -68.27 -37.58 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.837 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.78 -49.68 56.65 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -21.64 63.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.294 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 37.8 t -82.2 66.48 7.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.13 0.491 . . . . 0.0 110.532 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -77.24 122.78 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 126.01 -92.09 0.4 Allowed Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.158 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . 0.439 ' HE2' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -128.59 133.72 48.4 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.591 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 156' ' ' LEU . . . . . 0.684 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -124.3 143.01 50.81 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.925 0.393 . . . . 0.0 111.357 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.648 ' O ' HD13 ' B' ' 158' ' ' LEU . 2.6 tt0 -105.23 131.67 52.4 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.849 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 158' ' ' LEU . . . . . 0.648 HD13 ' O ' ' B' ' 157' ' ' GLN . 0.4 OUTLIER -127.78 133.47 49.46 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.82 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.29 140.1 44.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.669 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 9.0 m -133.24 152.02 34.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.421 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--O 1.233 0.216 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 179.727 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.4 mtm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.714 0.292 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.55 124.38 7.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.343 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -96.28 157.48 21.47 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.402 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' B' ' 122' ' ' ASN . 21.4 t -131.35 134.03 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.708 0.29 . . . . 0.0 111.288 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.76 HD23 ' HD3' ' B' ' 155' ' ' LYS . 4.0 mp -103.13 115.02 29.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.508 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.505 HD21 ' N ' ' B' ' 117' ' ' ALA . 3.5 tp -104.98 126.28 51.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.709 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.71 ' O ' HD13 ' B' ' 116' ' ' LEU . 0.0 OUTLIER -98.16 161.41 13.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.743 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -98.27 132.16 43.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.983 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.423 ' H ' HD11 ' B' ' 116' ' ' LEU . 71.3 m -126.55 34.81 4.74 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.936 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -159.15 120.75 3.37 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.527 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.1 43.26 1.09 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.96 0.41 . . . . 0.0 111.241 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -111.8 -39.93 4.43 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.011 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -157.53 -178.15 7.12 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.911 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -74.04 -175.7 2.28 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.535 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.709 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 78.7 m-85 -58.24 -23.15 54.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.346 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 72.93 27.53 68.6 Favored Glycine 0 C--N 1.337 0.627 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.432 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.495 HD11 ' CB ' ' B' ' 117' ' ' ALA . 0.2 OUTLIER -103.06 120.84 41.39 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.631 0.253 . . . . 0.0 110.782 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.406 ' HB2' ' HG3' ' B' ' 110' ' ' GLU . 0.2 OUTLIER -98.48 113.36 25.35 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.463 HD22 HD11 ' B' ' 149' ' ' ILE . 10.1 mp -105.99 124.95 50.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 111.215 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.19 178.31 19.49 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.637 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.562 ' OG ' HD12 ' B' ' 142' ' ' LEU . 0.6 OUTLIER -139.99 142.92 36.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.152 0.476 . . . . 0.0 111.205 -179.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' B' ' 104' ' ' SER . 11.0 pt20 -129.31 154.42 46.88 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.673 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.593 HD11 ' HB3' ' A' ' 57' ' ' MET . 3.2 mt -90.32 120.77 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.378 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.406 ' CE1' ' CG ' ' B' ' 105' ' ' GLN . 39.9 p90 -118.31 173.02 7.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.558 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.871 HG21 ' HB3' ' A' ' 40' ' ' LEU . 21.5 t -79.16 94.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.102 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -48.94 71.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.423 ' HG2' ' HB3' ' B' ' 101' ' ' ARG . 5.1 pt-20 -167.01 153.74 8.54 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.907 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.37 161.47 34.43 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.834 0.35 . . . . 0.0 111.063 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -70.55 135.66 48.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.002 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -68.91 144.75 54.11 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.707 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 58.06 31.02 20.13 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.337 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.78 -174.35 29.37 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.165 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.591 HD13 ' O ' ' B' ' 90' ' ' MET . 0.2 OUTLIER -67.22 -31.06 71.17 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.45 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -75.15 -39.06 60.7 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.568 0.223 . . . . 0.0 111.452 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.03 -33.71 44.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.167 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -63.28 -37.06 85.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.382 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -100.3 -30.91 11.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.684 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.25 47.14 24.25 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.341 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.665 ' CB ' HG11 ' B' ' 87' ' ' VAL . 10.4 p-10 -63.07 -48.33 79.12 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.46 0.171 . . . . 0.0 111.319 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.871 ' HB3' HG21 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -134.06 144.29 48.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.723 0.296 . . . . 0.0 111.21 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.99 148.24 22.35 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.629 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HG2' ' HA ' ' A' ' 27' ' ' GLU . 4.5 mt-10 -59.01 110.91 1.13 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 111.234 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.75 -16.4 21.15 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.191 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -60.39 134.71 57.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 117.244 0.522 . . . . 0.0 110.704 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.8 pt -79.86 119.86 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.961 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.709 ' HB ' HG21 ' A' ' 54' ' ' THR . 38.0 mt -88.97 137.54 21.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.961 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.82 -41.82 8.27 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.329 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.68 147.67 34.62 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.744 0.306 . . . . 0.0 111.069 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.418 HG13 ' OG1' ' A' ' 54' ' ' THR . 14.7 mt -136.65 117.94 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.676 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 52.25 44.54 29.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 111.224 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.17 17.86 76.15 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.042 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.3 m -120.74 139.39 53.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.759 0.28 . . . . 0.0 110.374 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.5 t -59.8 145.86 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.149 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.709 HG21 ' HB ' ' A' ' 46' ' ' ILE . 2.5 m -120.69 20.89 11.66 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.686 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.512 ' H ' HG12 ' A' ' 53' ' ' VAL . 2.7 tt0 -119.33 129.65 54.96 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 70.66 -7.67 1.02 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.57 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.593 ' HB3' HD11 ' A' ' 23' ' ' ILE . 10.5 ttt -66.07 150.66 48.36 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.808 0.337 . . . . 0.0 110.622 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.9 t -71.8 143.47 49.49 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.079 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' B' ' 139' ' ' ASN . 1.1 tt -57.73 -46.19 84.78 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -40.43 82.37 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.055 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -64.08 -47.64 79.31 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.006 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.501 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -59.25 -41.55 89.02 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.003 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -37.96 81.74 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.635 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -38.68 83.18 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.733 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.417 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -59.87 -43.32 94.79 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.923 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.668 HD11 HD22 ' B' ' 102' ' ' LEU . 14.3 mt -68.18 -37.84 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.546 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -66.83 -49.56 65.38 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.781 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 65' ' ' LEU . 14.6 pttp -68.77 -22.22 64.3 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.437 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.9 t -74.87 73.15 2.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.034 0.445 . . . . 0.0 110.704 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.26 105.84 16.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.474 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.1 -91.19 0.21 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.239 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 pttp -129.34 134.11 47.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.735 0.302 . . . . 0.0 110.652 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.881 HD23 ' CE2' ' B' ' 98' ' ' TYR . 2.1 pp -123.47 143.96 49.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.109 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.488 ' OE1' HD11 ' B' ' 88' ' ' LEU . 31.9 tt0 -112.22 140.48 46.88 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.867 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.774 HD11 HD11 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -135.42 128.64 31.92 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.861 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.0 t -109.74 138.84 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.939 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.781 HG22 HD21 ' A' ' 40' ' ' LEU . 4.2 t -121.13 154.31 24.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.288 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.0 tt -108.76 116.33 31.78 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.511 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 60.27 173.04 0.09 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.187 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t70 65.58 113.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.39 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.3 -63.11 0.91 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.502 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.06 -72.58 0.66 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.747 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 C--O 1.252 1.204 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.497 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 5.9 mtt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.523 ' C ' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -122.6 121.54 63.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.876 0.369 . . . . 0.0 111.007 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.48 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -120.02 157.69 15.55 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.791 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.665 HG11 ' CB ' ' A' ' 39' ' ' ASN . 16.8 t -131.58 135.31 59.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.769 0.318 . . . . 0.0 111.313 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.488 HD11 ' OE1' ' A' ' 74' ' ' GLN . 2.7 mp -104.47 114.94 29.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.62 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 tp -102.16 133.36 47.13 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.978 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . 0.591 ' O ' HD13 ' A' ' 33' ' ' LEU . 5.7 ttm -105.06 164.47 11.78 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.036 0.446 . . . . 0.0 110.95 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -87.93 148.01 24.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.908 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 3.0 p -79.53 171.05 15.68 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.642 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -77.31 70.24 3.68 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.218 0.532 . . . . 0.0 110.556 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -174.93 132.76 0.33 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.323 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -63.44 95.9 0.1 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.787 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.32 177.52 6.77 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.229 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -98.96 -179.79 4.38 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.89 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.881 ' CE2' HD23 ' A' ' 73' ' ' LEU . 70.6 m-85 -77.0 -32.12 56.96 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.394 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 79.73 26.83 55.57 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.394 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.672 HD13 ' HB3' ' B' ' 98' ' ' TYR . 6.2 mp -104.83 123.12 47.13 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 110.812 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . 0.423 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -98.03 113.68 25.62 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.245 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.668 HD22 HD11 ' A' ' 66' ' ' ILE . 1.9 mp -98.26 124.69 43.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.983 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.88 166.21 12.14 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.918 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 1.6 p -121.07 150.71 40.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.028 0.414 . . . . 0.0 111.244 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.473 ' O ' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -137.49 145.38 42.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.459 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.633 HD12 HG23 ' B' ' 137' ' ' THR . 2.6 mt -88.86 121.14 38.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.175 0.512 . . . . 0.0 111.324 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -118.78 174.54 6.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.568 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.919 HG21 ' HB3' ' B' ' 123' ' ' LEU . 39.0 t -83.37 95.57 3.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.135 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -63.32 -56.33 17.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 110.573 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.406 ' HG3' ' HB2' ' A' ' 18' ' ' ARG . 14.0 pt-20 -163.99 146.26 9.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.909 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -133.37 156.02 48.4 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.804 0.335 . . . . 0.0 111.349 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.26 132.49 49.2 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -67.57 147.82 52.25 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.929 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 5.2 m 61.85 33.78 17.45 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.243 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -101.38 -170.31 28.08 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.146 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.71 HD13 ' O ' ' A' ' 7' ' ' MET . 7.4 mt -72.84 -30.06 63.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.676 0.238 . . . . 0.0 111.477 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.505 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -75.18 -36.73 61.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.173 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.79 -33.86 52.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.084 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -61.57 -38.43 87.49 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.217 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.88 -28.29 13.18 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.763 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.55 39.07 50.67 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.266 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.464 ' HB3' HG11 ' A' ' 4' ' ' VAL . 26.2 p-10 -59.51 -42.4 92.12 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.919 ' HB3' HG21 ' B' ' 108' ' ' VAL . 1.1 mt -133.05 143.87 49.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.766 0.317 . . . . 0.0 111.171 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -94.04 141.39 28.59 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.56 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -58.19 109.71 0.81 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.104 0.478 . . . . 0.0 110.789 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 108' ' ' VAL . . . 104.99 -15.75 47.47 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.592 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . 0.593 ' OD1' HG13 ' B' ' 160' ' ' VAL . 10.1 t70 -62.54 141.97 58.19 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.172 0.511 . . . . 0.0 111.459 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.438 HG22 ' NE2' ' B' ' 105' ' ' GLN . 29.6 pt -79.8 127.96 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.898 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.865 ' HB ' HG21 ' B' ' 137' ' ' THR . 26.8 mt -94.91 143.79 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.425 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.404 ' CD1' HD12 ' B' ' 161' ' ' LEU . 0.8 OUTLIER -97.46 -36.63 10.28 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.629 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -154.81 152.43 29.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.627 0.251 . . . . 0.0 111.28 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.539 HG23 ' CD1' ' B' ' 158' ' ' LEU . 10.0 mt -132.4 117.5 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.324 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . 0.412 ' HB2' ' CD1' ' B' ' 148' ' ' LEU . 2.4 m120 51.16 34.7 11.65 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.373 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.63 85.7 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.178 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 58.6 m -102.47 132.48 48.48 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.955 0.377 . . . . 0.0 110.201 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.454 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.4 t -54.19 145.32 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.075 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.865 HG21 ' HB ' ' B' ' 129' ' ' ILE . 27.8 m -113.59 20.19 16.18 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.662 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.454 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.6 OUTLIER -119.44 127.7 53.33 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.417 ' HA ' HD12 ' A' ' 59' ' ' LEU . 2.4 m-80 70.56 -5.55 1.39 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.755 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.484 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.1 OUTLIER -65.25 169.75 5.37 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.858 0.361 . . . . 0.0 111.131 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.38 146.77 23.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.481 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.562 HD12 ' OG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -61.71 -42.22 98.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.004 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 44.2 p -64.12 -39.44 94.04 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.982 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -63.74 -47.92 79.11 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.931 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.37 90.26 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -69.33 -38.86 78.39 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.546 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -67.43 -38.06 83.97 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.631 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' B' ' 133' ' ' ASN . 0.2 OUTLIER -60.04 -44.57 94.58 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.63 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.618 HG23 HD13 ' B' ' 156' ' ' LEU . 37.9 mt -68.4 -37.57 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.928 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -69.48 -49.22 56.85 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.787 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -24.92 66.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.628 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 99.6 p -83.53 61.17 6.08 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.053 0.454 . . . . 0.0 110.746 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -69.65 110.96 5.13 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.568 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.62 -84.08 0.3 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.76 ' HD3' HD23 ' A' ' 5' ' ' LEU . 2.9 ttmm -132.24 135.14 46.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.657 0.265 . . . . 0.0 110.792 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.709 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -128.64 143.49 50.96 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.939 0.4 . . . . 0.0 111.11 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.633 ' C ' HD22 ' B' ' 158' ' ' LEU . 50.3 tt0 -105.61 142.76 34.79 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.213 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.633 HD22 ' C ' ' B' ' 157' ' ' GLN . 3.6 mm? -134.98 146.84 49.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.314 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 6.2 t -120.67 128.93 76.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.299 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.593 HG13 ' OD1' ' B' ' 127' ' ' ASP . 53.9 t -122.31 146.63 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.617 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.404 HD12 ' CD1' ' B' ' 130' ' ' LEU . 0.5 OUTLIER -112.21 116.12 29.93 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.524 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -177.65 42.76 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.861 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 2.9 t70 69.46 135.48 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.997 0.427 . . . . 0.0 111.206 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.51 121.07 21.81 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.023 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 mt -142.61 141.06 31.88 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.052 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.062 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.806 0.336 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.8 pp -143.68 154.58 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.394 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.96 159.93 23.43 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.654 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' B' ' 122' ' ' ASN . 27.3 t -123.56 131.76 72.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.696 0.284 . . . . 0.0 110.977 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 tt -100.28 108.57 20.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.706 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.521 HD21 ' N ' ' B' ' 117' ' ' ALA . 4.1 tp -95.88 136.58 36.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.718 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.611 ' O ' HD13 ' B' ' 116' ' ' LEU . 24.4 ttm -110.75 165.09 12.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.013 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.421 ' HE3' ' HA2' ' B' ' 154' ' ' GLY . 10.7 pttp -79.0 137.63 37.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.977 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.89 137.63 1.67 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.213 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 65.58 101.26 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 69.84 126.83 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.474 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.12 50.18 1.74 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.31 70.66 0.89 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.303 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 49.07 -173.3 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.211 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.692 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 64.9 m-85 -88.26 -32.24 18.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.312 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.13 23.32 35.18 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.733 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 15' ' ' TYR . 3.4 mp -104.98 115.46 30.32 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.786 0.293 . . . . 0.0 110.794 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.99 113.53 22.83 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.68 HD22 HD11 ' B' ' 149' ' ' ILE . 1.7 mp -102.02 124.8 48.26 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.596 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -114.82 -167.51 15.57 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.77 147.92 31.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.241 0.521 . . . . 0.0 111.136 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -133.47 140.57 47.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.414 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.895 HD13 ' HB2' ' A' ' 62' ' ' ALA . 27.5 mt -88.22 120.55 37.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.41 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.414 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 40.1 p90 -122.26 173.95 7.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.01 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.762 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.1 t -80.16 94.12 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.778 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.42 ' HE2' ' HG2' ' B' ' 138' ' ' GLU . 0.0 OUTLIER -65.12 -56.25 14.06 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.039 -179.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -147.53 151.18 35.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.98 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.77 ' SD ' HG23 ' A' ' 35' ' ' THR . 3.2 tmm? -138.26 142.72 39.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.82 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.76 120.06 12.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.623 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.75 153.68 23.63 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.083 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.98 22.46 12.69 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.327 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.87 -168.77 36.55 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.568 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.507 ' H ' HD12 ' A' ' 33' ' ' LEU . 1.1 mp -71.34 -30.8 66.62 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -74.97 -33.39 61.88 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.77 HG23 ' SD ' ' A' ' 28' ' ' MET . 0.7 OUTLIER -79.14 -34.7 43.05 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.176 179.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.27 -36.88 85.12 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.21 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -98.39 -37.56 9.57 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.424 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.35 45.7 9.67 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.789 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.616 ' CB ' HG11 ' B' ' 87' ' ' VAL . 13.3 p-10 -71.93 -49.45 37.48 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.762 ' HB3' HG21 ' A' ' 25' ' ' VAL . 4.8 mp -129.82 132.01 46.35 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.661 0.267 . . . . 0.0 111.107 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.25 145.95 24.06 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.651 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -58.05 111.84 1.32 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.077 0.465 . . . . 0.0 111.075 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.68 -19.4 12.55 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.856 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -62.9 134.27 55.95 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.105 0.452 . . . . 0.0 110.587 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 pt -78.65 130.25 36.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.058 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.635 HD13 HD21 ' B' ' 102' ' ' LEU . 5.1 mt -96.07 138.06 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.503 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.004 HD13 HD21 ' A' ' 78' ' ' LEU . 2.8 tp -98.93 -40.61 7.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.984 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.403 ' N ' HG23 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -152.49 148.21 27.14 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.832 0.349 . . . . 0.0 111.409 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.472 ' CG1' HG21 ' A' ' 46' ' ' ILE . 42.1 mt -138.74 118.83 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.66 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 53.23 44.64 29.93 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.9 0.381 . . . . 0.0 111.182 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.47 15.37 72.88 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.172 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 m -120.84 135.45 55.17 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.855 0.328 . . . . 0.0 110.389 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.662 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.2 t -62.67 146.98 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.927 0.394 . . . . 0.0 111.266 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.671 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -126.71 16.32 7.5 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.334 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.662 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -112.7 131.61 55.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 71.46 -6.18 1.44 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.281 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.478 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -72.85 175.03 6.9 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 69.9 m -90.14 143.81 26.44 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.496 HD12 ' OG ' ' B' ' 104' ' ' SER . 2.2 tt -58.41 -40.48 82.57 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.788 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.5 m -63.17 -42.06 99.34 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.88 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -63.99 -48.05 77.92 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.768 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.895 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -60.47 -40.57 91.7 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.169 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.477 ' HA ' HD12 ' A' ' 66' ' ' ILE . 4.6 ttt-85 -63.62 -41.03 98.33 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.949 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.64 -38.27 86.55 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.711 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.4 tp -60.75 -43.4 98.03 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.903 HD11 HD22 ' B' ' 102' ' ' LEU . 5.6 mt -67.21 -38.01 80.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.681 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -67.65 -49.51 62.56 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.825 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -64.31 -23.28 67.24 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.257 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.4 t -75.7 73.03 2.67 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.123 0.487 . . . . 0.0 110.821 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -88.15 100.63 13.11 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.552 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.08 -95.33 0.19 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.092 -0.575 . . . . 0.0 111.943 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.18 135.84 49.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.591 0.234 . . . . 0.0 110.439 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.707 HD11 HD21 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -128.12 141.83 51.37 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.093 0.473 . . . . 0.0 111.309 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -101.87 128.36 48.29 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.112 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.707 HD21 HD11 ' A' ' 73' ' ' LEU . 1.7 mp -126.53 129.18 48.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.664 0.269 . . . . 0.0 111.383 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.408 ' HA ' ' HA2' ' B' ' 86' ' ' GLY . 8.3 m -119.57 114.8 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.685 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.7 m -107.9 157.57 8.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.541 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.004 HD21 HD13 ' A' ' 47' ' ' LEU . 4.4 mt -102.05 137.18 40.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.831 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -138.89 -176.1 4.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.602 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 37.3 t70 62.8 66.65 0.74 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.101 0.477 . . . . 0.0 110.557 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 63.8 p -76.87 122.75 25.26 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.029 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.9 mp 66.15 177.14 0.22 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.57 -0.729 . . . . 0.0 111.251 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.909 0.385 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.26 133.89 68.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.163 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -105.43 155.87 16.83 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.632 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.616 HG11 ' CB ' ' A' ' 39' ' ' ASN . 17.4 t -131.49 135.11 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.725 0.297 . . . . 0.0 111.118 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 4.7 tt -103.65 107.12 17.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.612 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 21.3 tp -99.88 129.27 45.95 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.332 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.4 ttt -109.37 164.64 12.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.984 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 129.59 38.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.991 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 10.6 t -161.47 59.53 0.27 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.305 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.39 132.64 0.79 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.108 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -68.82 81.93 0.29 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.713 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -148.94 -178.69 6.5 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.081 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.5 111.66 23.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.793 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 47.95 -172.36 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.314 0.578 . . . . 0.0 112.225 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.498 ' CE2' HD22 ' A' ' 73' ' ' LEU . 69.0 m-85 -71.49 -32.03 67.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.417 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.01 26.74 47.94 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.467 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 34' ' ' ALA . 4.2 mp -104.73 116.64 32.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.665 0.269 . . . . 0.0 110.846 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -92.74 113.52 25.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.231 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.903 HD22 HD11 ' A' ' 66' ' ' ILE . 5.0 mp -94.79 125.01 39.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.288 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . 0.443 ' HA2' HD11 ' A' ' 59' ' ' LEU . . . -110.27 178.36 20.02 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.581 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.496 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -136.12 146.45 46.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.094 0.447 . . . . 0.0 111.017 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -134.1 141.79 47.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.43 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.703 HD11 ' HB3' ' B' ' 140' ' ' MET . 5.6 mt -88.14 122.05 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.597 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -122.25 171.47 9.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.047 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.735 HG21 ' CD2' ' B' ' 123' ' ' LEU . 38.8 t -83.78 93.59 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.059 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . 0.413 ' HG3' ' HA3' ' A' ' 20' ' ' GLY . 7.1 mtpt -61.94 -51.55 67.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.099 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.64 121.44 3.72 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.102 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.402 ' HG2' ' HG3' ' B' ' 125' ' ' GLU . 1.0 OUTLIER -116.92 143.89 45.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.025 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 36.1 p -65.65 137.17 57.15 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.628 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.643 ' HA ' HG21 ' B' ' 118' ' ' THR . 0.0 OUTLIER -79.07 162.87 25.58 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.997 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.4 m 59.73 23.07 11.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.286 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.6 -154.99 27.36 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.095 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.611 HD13 ' O ' ' A' ' 7' ' ' MET . 2.2 mt -82.86 -33.38 27.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.529 0.204 . . . . 0.0 111.374 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.521 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -73.12 -35.43 66.53 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.165 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.643 HG21 ' HA ' ' B' ' 113' ' ' ARG . 1.3 p -78.63 -33.88 46.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.277 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -60.83 -38.35 85.15 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.311 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -100.19 -36.05 9.44 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.42 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.06 44.03 7.28 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.907 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.624 ' HA ' HG21 ' A' ' 4' ' ' VAL . 7.0 p30 -55.38 -54.1 47.92 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.383 0.135 . . . . 0.0 111.261 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.735 ' CD2' HG21 ' B' ' 108' ' ' VAL . 0.0 OUTLIER -142.4 156.66 45.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 111.296 179.169 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.81 150.8 20.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.591 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' B' ' 111' ' ' MET . 5.3 mt-10 -59.83 109.44 0.94 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.092 0.472 . . . . 0.0 110.874 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 111.04 0.08 28.49 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.98 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -78.42 138.66 38.61 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 117.347 0.573 . . . . 0.0 110.719 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 pt -76.1 124.38 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.327 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.855 ' HB ' HG21 ' B' ' 137' ' ' THR . 19.8 mt -91.99 144.05 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.173 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 5.7 tp -98.39 -41.89 7.61 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.356 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -145.83 148.06 32.49 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.747 0.308 . . . . 0.0 111.195 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 32.2 mt -138.35 118.42 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.809 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . 0.556 ' HB3' HD11 ' B' ' 148' ' ' LEU . 2.3 t-20 53.87 48.09 22.09 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.317 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 65.58 18.02 65.3 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.993 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.21 144.8 47.54 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.667 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.0 t -63.52 146.88 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.855 HG21 ' HB ' ' B' ' 129' ' ' ILE . 18.2 m -115.32 1.42 13.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.865 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.667 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.5 tt0 -100.39 131.63 46.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.67 0.271 . . . . 0.0 110.357 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 71.85 -7.65 1.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.435 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.703 ' HB3' HD11 ' B' ' 106' ' ' ILE . 36.7 ttm -65.51 155.42 35.69 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.012 0.434 . . . . 0.0 111.377 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 28.6 t -79.58 149.56 31.33 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.387 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 8.2 tt -60.8 -48.13 83.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.893 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 39.1 p -58.47 -38.22 77.12 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.882 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.21 -43.21 95.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.841 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.655 ' HB1' HG21 ' B' ' 106' ' ' ILE . . . -59.71 -42.88 94.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.173 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -67.67 -38.3 83.57 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.654 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -67.63 -38.35 83.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.485 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . 0.556 HD11 ' HB3' ' B' ' 133' ' ' ASN . 0.1 OUTLIER -60.3 -44.09 95.71 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.844 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.68 HD11 HD22 ' A' ' 19' ' ' LEU . 15.7 mt -68.13 -37.7 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.915 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -69.16 -48.39 62.41 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.773 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -71.22 -23.62 62.05 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.992 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 80.1 p -77.25 66.97 3.12 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.147 0.498 . . . . 0.0 110.628 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -74.51 127.94 34.31 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.564 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . 0.421 ' HA2' ' HE3' ' A' ' 8' ' ' LYS . . . 109.39 -91.64 0.66 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.274 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -124.17 138.36 54.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.692 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -129.71 135.19 48.19 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.035 0.445 . . . . 0.0 111.14 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -97.86 136.93 37.46 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.643 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.483 HD13 HD11 ' B' ' 123' ' ' LEU . 1.2 mt -134.03 128.77 35.0 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.803 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.408 ' O ' HG23 ' B' ' 129' ' ' ILE . 21.1 t -113.69 136.6 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.893 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' B' ' 123' ' ' LEU . 21.9 t -128.84 149.67 33.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.266 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 6.9 tp -84.2 123.29 29.95 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.548 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' B' ' 163' ' ' ASP . 21.6 ttp180 -83.66 65.2 8.38 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.596 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' B' ' 162' ' ' ARG . 19.9 t0 174.8 124.28 0.02 OUTLIER 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.917 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 74.6 m -156.19 -47.07 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . 0.437 ' H ' HD23 ' B' ' 165' ' ' LEU . 0.4 OUTLIER -88.13 115.8 25.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.916 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.252 1.217 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.127 179.905 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.6 0.238 . . . . 0.0 111.377 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 2' ' ' ILE . 13.5 tt -147.03 119.79 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.781 0.324 . . . . 0.0 110.968 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -111.12 156.1 15.74 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.669 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' B' ' 122' ' ' ASN . 21.6 t -132.47 133.03 60.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.377 . . . . 0.0 111.058 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.35 114.81 29.14 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.492 HD11 HD21 ' B' ' 122' ' ' ASN . 1.1 mp -98.42 144.53 27.69 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.013 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.604 ' O ' HD13 ' B' ' 116' ' ' LEU . 30.8 ttm -113.24 164.05 14.02 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.893 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.405 ' N ' ' HG2' ' A' ' 7' ' ' MET . 0.0 OUTLIER -88.32 142.67 27.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.109 -179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 t -165.29 106.94 0.79 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.603 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.13 34.8 21.2 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.203 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.33 107.4 7.15 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -94.14 -34.53 12.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.51 53.77 2.91 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.938 0.399 . . . . 0.0 111.161 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 64.65 -177.06 0.17 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.426 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.811 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 57.2 m-85 -71.82 -22.25 61.58 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.817 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.48 20.38 38.12 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.704 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.9 mp -102.48 115.95 31.63 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.821 0.31 . . . . 0.0 110.786 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.99 114.58 24.74 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.911 HD22 HD11 ' B' ' 149' ' ' ILE . 2.1 mp -97.9 124.81 42.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 111.776 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -114.73 174.93 15.71 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 p -130.17 151.04 51.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.608 0.704 . . . . 0.0 111.84 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -136.75 135.83 38.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.176 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.565 ' HB ' HG22 ' A' ' 54' ' ' THR . 21.5 mt -88.14 121.47 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.931 0.396 . . . . 0.0 110.125 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.415 ' CE2' ' HG2' ' A' ' 26' ' ' LYS . 41.7 p90 -125.42 172.92 9.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.314 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.886 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.8 t -82.29 97.53 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.745 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.415 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -67.65 -57.01 7.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.282 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -156.39 141.33 17.17 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.953 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -126.66 144.31 50.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.17 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.5 m -73.73 127.83 33.87 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.583 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -63.29 168.25 4.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.73 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.63 29.8 15.03 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.445 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -115.87 -174.09 17.58 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.194 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.39 -28.19 61.88 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' N ' HD21 ' B' ' 89' ' ' LEU . . . -74.38 -36.49 63.55 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.502 0.191 . . . . 0.0 111.203 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.9 -34.05 45.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.062 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -62.77 -37.14 85.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.339 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.62 -33.41 10.31 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.493 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.48 44.74 32.26 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.165 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.836 ' HB3' HG11 ' B' ' 87' ' ' VAL . 10.4 p-10 -81.65 -49.04 10.95 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.886 ' HB3' HG21 ' A' ' 25' ' ' VAL . 13.2 mt -95.64 113.18 24.8 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.904 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.47 130.29 34.62 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.552 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -54.39 111.62 0.83 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.125 0.488 . . . . 0.0 110.868 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.95 -14.1 37.66 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.865 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -63.33 138.64 58.6 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.038 0.447 . . . . 0.0 111.31 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.414 ' O ' HG13 ' A' ' 45' ' ' ILE . 24.3 pt -79.96 119.49 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.674 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.701 HG21 HD11 ' A' ' 49' ' ' ILE . 7.8 mt -83.33 144.11 10.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.343 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.425 HD23 ' HB2' ' A' ' 48' ' ' LYS . 3.5 tt -105.23 -42.56 5.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.438 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HB2' HD23 ' A' ' 47' ' ' LEU . 3.1 mttm -152.38 147.97 26.92 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.68 0.276 . . . . 0.0 111.368 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.994 HD12 HD23 ' A' ' 75' ' ' LEU . 27.8 mm -137.47 118.97 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.431 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.91 40.14 31.85 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.217 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.27 14.58 80.59 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.32 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 m -120.23 139.64 52.38 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 117.028 0.414 . . . . 0.0 110.51 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.3 t -59.69 145.63 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.203 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.565 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -124.18 20.13 9.01 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.433 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.517 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -116.79 132.13 56.77 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 71.1 -7.57 1.11 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.65 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.5 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -68.38 172.13 6.41 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 111.125 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.81 146.16 24.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.308 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' B' ' 139' ' ' ASN . 0.9 OUTLIER -60.9 -38.62 86.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.828 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.27 -46.94 84.47 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -44.2 93.94 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.796 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.09 -41.96 93.61 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.951 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.57 -39.66 88.57 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.695 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.97 -38.39 86.01 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 2.2 tp -60.32 -43.35 96.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.026 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.775 HD11 HD22 ' B' ' 102' ' ' LEU . 24.5 mt -68.33 -37.48 78.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.78 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.0 -49.44 57.75 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.078 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 65' ' ' LEU . 1.8 ptpt -64.89 -30.5 71.5 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.212 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 m -81.95 62.01 5.52 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.201 0.524 . . . . 0.0 110.791 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.71 147.26 41.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.785 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.0 -86.59 0.59 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.224 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -134.95 126.87 29.49 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.663 0.268 . . . . 0.0 110.568 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.781 HD23 ' CE2' ' B' ' 98' ' ' TYR . 2.3 pp -125.87 143.84 50.91 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.45 141.46 34.29 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.994 HD23 HD12 ' A' ' 49' ' ' ILE . 0.8 OUTLIER -133.4 128.08 34.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.965 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 t -107.97 134.62 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.248 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.98 164.58 27.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.518 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tp -89.55 135.91 33.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.594 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -91.91 42.66 1.11 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.229 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.16 111.19 0.64 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.691 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.23 95.27 0.09 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.946 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.0 mt -149.87 161.62 41.92 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.009 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.038 179.789 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 pp -117.03 143.06 28.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.738 0.304 . . . . 0.0 111.218 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -127.89 166.96 20.34 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.924 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.836 HG11 ' HB3' ' A' ' 39' ' ' ASN . 21.4 t -129.69 134.86 62.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.641 0.258 . . . . 0.0 111.086 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 5.8 tt -96.99 121.91 39.4 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.516 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.551 HD21 ' N ' ' A' ' 34' ' ' ALA . 7.6 tp -115.3 144.62 43.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.581 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.7 ttt -107.1 163.61 12.85 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.144 0.497 . . . . 0.0 110.922 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' B' ' 97' ' ' GLU . 4.1 tttt -93.54 146.39 23.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.914 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.3 m -136.83 146.95 46.24 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.041 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 68.62 104.23 0.05 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.766 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.16 80.46 1.27 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.173 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -165.18 -48.03 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.733 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -119.84 178.79 4.46 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.099 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . 0.405 ' HA ' ' HE3' ' B' ' 91' ' ' LYS . 0.8 OUTLIER -95.77 -174.03 3.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.818 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.781 ' CE2' HD23 ' A' ' 73' ' ' LEU . 47.0 m-85 -49.74 -31.14 10.72 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.685 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 82.25 15.36 74.52 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.521 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.429 HD11 ' CB ' ' A' ' 34' ' ' ALA . 2.6 mp -101.3 119.82 39.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.659 0.266 . . . . 0.0 110.668 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -96.13 113.43 25.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.211 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.775 HD22 HD11 ' A' ' 66' ' ' ILE . 7.9 mp -97.41 124.78 41.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.625 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.44 177.13 17.42 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.978 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.37 145.76 50.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.847 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -130.05 140.16 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.413 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 1.046 HD13 ' HB2' ' B' ' 145' ' ' ALA . 9.1 mt -88.37 120.46 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.176 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -119.68 170.48 9.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.714 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' B' ' 126' ' ' GLY . 41.2 t -81.07 89.5 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.038 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -53.77 -42.46 68.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.816 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.03 132.17 0.51 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -114.24 146.31 40.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.079 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 25.2 p -77.13 126.57 31.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.704 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.687 ' HA ' HG21 ' B' ' 118' ' ' THR . 0.0 OUTLIER -65.78 165.87 12.04 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.289 -179.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.3 m 64.95 22.85 12.52 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.183 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -105.19 -171.7 24.11 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.413 -0.422 . . . . 0.0 112.172 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.604 HD13 ' O ' ' A' ' 7' ' ' MET . 0.2 OUTLIER -71.15 -30.81 66.93 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.405 ' CA ' HD21 ' A' ' 6' ' ' LEU . . . -74.25 -35.03 63.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.489 0.185 . . . . 0.0 110.941 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.687 HG21 ' HA ' ' B' ' 113' ' ' ARG . 2.1 p -78.95 -34.1 44.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.184 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -59.15 -38.85 80.69 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.424 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.58 -29.9 10.83 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.539 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.16 58.44 5.59 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.2 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.608 ' HB2' HG21 ' A' ' 4' ' ' VAL . 0.9 OUTLIER -95.95 -32.68 12.49 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.569 HD11 ' CB ' ' B' ' 158' ' ' LEU . 39.4 mt -131.34 133.02 44.91 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.641 0.258 . . . . 0.0 111.195 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.79 161.86 13.4 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' B' ' 125' ' ' GLU . 2.1 pt-20 -73.64 120.55 19.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.518 0.675 . . . . 0.0 110.178 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 108' ' ' VAL . . . 106.89 -15.77 40.25 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.587 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . 0.4 ' OD2' HG11 ' B' ' 160' ' ' VAL . 50.2 t0 -63.97 135.31 56.37 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.266 0.555 . . . . 0.0 111.082 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 13.7 pt -78.25 121.32 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.825 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.434 HD13 HD21 ' A' ' 19' ' ' LEU . 15.6 mt -91.2 143.7 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.149 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.77 -35.47 6.17 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.902 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.83 148.04 31.47 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.775 0.321 . . . . 0.0 111.541 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 45.4 mt -140.93 118.68 9.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.616 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 55.7 44.14 26.84 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.931 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.83 17.43 73.29 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.051 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.84 137.71 54.42 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 116.948 0.374 . . . . 0.0 110.478 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.56 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.3 t -59.87 145.04 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.838 0.351 . . . . 0.0 110.872 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.633 ' CG2' HD12 ' B' ' 106' ' ' ILE . 1.8 m -119.03 9.9 11.98 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.788 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.56 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.3 OUTLIER -102.28 131.13 49.06 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.509 ' HA ' HD12 ' A' ' 59' ' ' LEU . 4.9 m-80 70.85 -4.33 1.75 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.601 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.548 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.2 OUTLIER -65.65 169.52 6.2 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 111.285 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.69 141.72 28.28 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.168 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.404 HD22 ' NE ' ' B' ' 146' ' ' ARG . 0.8 OUTLIER -58.14 -44.38 87.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.555 179.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 7.2 t -61.46 -39.29 90.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.693 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -64.81 -46.73 80.77 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 1.046 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.54 -42.56 88.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . 0.404 ' NE ' HD22 ' B' ' 142' ' ' LEU . 91.0 mtt180 -65.72 -40.27 92.05 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.502 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -66.39 -38.63 87.93 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.886 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . 0.524 ' O ' HD23 ' B' ' 148' ' ' LEU . 5.3 tt -59.94 -44.78 94.16 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.713 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.911 HD11 HD22 ' A' ' 19' ' ' LEU . 4.9 mt -68.5 -37.35 77.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.773 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.85 -47.57 65.63 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.055 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 17.4 mmtt -66.33 -27.77 68.16 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 3.6 m -79.24 63.23 3.82 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.006 0.431 . . . . 0.0 110.747 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 18.2 mmm-85 -83.93 74.78 10.18 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.422 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 167.54 -73.32 0.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.251 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.41 127.49 27.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.712 0.291 . . . . 0.0 110.875 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.811 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -129.84 139.51 51.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 4.4 tt0 -103.57 141.01 36.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.195 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.569 ' CB ' HD11 ' B' ' 123' ' ' LEU . 1.0 OUTLIER -134.72 128.13 32.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 111.001 -179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.24 135.27 60.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.47 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.4 HG11 ' OD2' ' B' ' 127' ' ' ASP . 16.9 m -128.46 152.82 37.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.854 0.359 . . . . 0.0 111.711 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 15.0 tp -115.73 122.26 44.97 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 1.7 tpp180 69.73 141.4 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.171 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 175.81 142.63 0.06 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.162 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 21.5 m -72.75 170.35 14.78 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.979 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 1.3 tp -138.56 103.18 4.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.908 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.085 -179.86 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.509 HD11 ' NH1' ' B' ' 162' ' ' ARG . 14.1 pt -126.87 155.2 37.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.625 0.25 . . . . 0.0 111.255 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.74 158.6 22.64 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.865 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' B' ' 122' ' ' ASN . 23.0 t -130.01 132.73 65.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 120.758 0.313 . . . . 0.0 110.94 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.756 HD22 ' HD2' ' B' ' 155' ' ' LYS . 0.4 OUTLIER -96.88 113.68 25.25 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.023 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.995 HD13 HD12 ' B' ' 158' ' ' LEU . 8.0 mp -91.23 131.56 36.68 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.656 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.0 ttt -107.62 162.21 14.16 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.228 0.537 . . . . 0.0 111.143 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.65 119.63 37.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.738 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.491 ' OG ' HD21 ' B' ' 116' ' ' LEU . 2.0 p -114.42 36.07 3.93 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.256 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.49 114.35 1.18 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.734 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.55 49.49 1.8 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 121.07 0.462 . . . . 0.0 111.419 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -171.84 35.18 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.119 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -175.43 -178.92 1.2 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 111.558 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -113.71 175.66 5.36 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.866 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.934 ' CE2' HD23 ' B' ' 156' ' ' LEU . 50.6 m-85 -61.56 -29.76 70.23 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.95 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.48 27.25 57.71 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.196 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' B' ' 117' ' ' ALA . 2.4 mp -113.75 117.86 32.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.71 0.29 . . . . 0.0 110.66 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.38 113.33 25.27 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.173 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.596 HD22 HD11 ' B' ' 149' ' ' ILE . 7.1 mp -98.01 124.86 42.69 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.193 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -105.27 -167.46 23.88 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.8 OUTLIER -146.02 149.24 33.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.258 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' B' ' 104' ' ' SER . 1.9 pt20 -132.1 133.47 44.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.964 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.761 ' HB ' HG22 ' A' ' 54' ' ' THR . 68.8 mt -87.75 120.23 36.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.115 0.483 . . . . 0.0 110.29 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.409 ' CE2' ' HG2' ' A' ' 26' ' ' LYS . 46.4 p90 -122.86 172.92 8.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.297 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.1 t -82.54 99.78 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.767 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 0.0 OUTLIER -70.93 -58.69 3.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.216 -179.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -156.42 147.56 22.22 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.631 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.32 163.15 30.65 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.894 0.378 . . . . 0.0 111.428 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.8 m -65.38 139.89 58.6 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -76.51 156.92 32.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.977 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 50.35 30.9 4.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.918 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.17 -170.55 30.84 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.152 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' B' ' 93' ' ' ARG . 0.2 OUTLIER -70.37 -31.09 68.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -75.02 -36.94 61.9 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.236 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.91 -33.85 45.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.175 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -60.86 -39.21 88.29 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.149 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -100.14 -30.83 11.71 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.789 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.38 47.92 20.64 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.226 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.724 ' HB3' HG11 ' B' ' 87' ' ' VAL . 21.7 p-10 -65.24 -47.34 77.13 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.721 HD11 HD22 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -129.44 136.57 50.09 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.812 0.339 . . . . 0.0 111.386 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.96 148.48 22.17 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.489 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -59.53 109.49 0.91 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.27 0.557 . . . . 0.0 111.08 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.23 -13.6 16.27 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.286 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -62.86 135.43 57.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.232 0.516 . . . . 0.0 110.391 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -80.55 112.43 18.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.085 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.432 HG21 ' CG1' ' A' ' 49' ' ' ILE . 5.9 mt -77.49 130.43 36.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.176 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.2 tp -92.21 -40.96 10.7 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.322 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -151.36 148.66 28.4 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.852 0.358 . . . . 0.0 111.833 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.432 ' CG1' HG21 ' A' ' 46' ' ' ILE . 29.7 mt -138.33 119.66 17.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.344 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HB2' HD21 ' A' ' 65' ' ' LEU . 6.5 m120 55.23 39.99 31.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.124 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.77 11.65 84.41 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.424 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 m -119.82 135.3 54.92 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 117.113 0.456 . . . . 0.0 110.203 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.686 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.3 t -61.69 147.79 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.843 0.354 . . . . 0.0 111.146 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.761 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -118.42 6.55 11.81 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.751 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.686 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -91.01 135.73 33.55 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.225 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 p30 52.59 11.79 0.21 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.649 0.593 . . . . 0.0 112.198 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.41 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -73.32 171.92 12.16 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.003 0.43 . . . . 0.0 111.357 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.6 130.66 35.22 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.883 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.97 -35.69 59.27 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.9 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.9 -46.75 80.44 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.063 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.67 -46.06 89.92 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.684 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.701 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -58.04 -42.12 84.68 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.4 mtp180 -70.31 -37.46 74.75 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.466 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -67.85 -38.17 82.81 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.568 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.568 HD21 ' HB2' ' A' ' 50' ' ' ASN . 9.1 tt -59.69 -44.77 93.51 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.706 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.497 ' CD1' HD22 ' B' ' 102' ' ' LEU . 37.5 mt -68.22 -37.66 78.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.763 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.03 -49.61 56.05 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.791 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -65.19 -27.24 68.55 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.207 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.5 t -80.55 63.13 4.89 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.002 0.43 . . . . 0.0 110.557 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.0 mtt-85 -77.76 94.83 4.54 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.537 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 148.06 -84.1 0.18 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.521 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.8 ' CG ' HD21 ' B' ' 88' ' ' LEU . 0.0 OUTLIER -129.6 131.08 46.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.641 0.257 . . . . 0.0 110.761 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.749 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -129.83 140.71 50.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 111.323 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -106.37 140.64 38.98 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.553 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.721 HD22 HD11 ' A' ' 40' ' ' LEU . 1.7 mp -136.11 134.64 38.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.102 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.4 t -118.87 140.69 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.93 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.17 134.97 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.321 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 tt -99.76 135.03 41.8 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.774 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 65.38 105.58 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.945 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.02 103.36 0.03 OUTLIER 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.63 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.9 t -95.0 83.84 4.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.28 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.24 -41.71 69.78 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.784 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.488 -0.768 . . . . 0.0 111.14 179.65 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 5.2 ttt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 111.522 0.194 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.0 pp -132.55 135.57 57.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.912 0.387 . . . . 0.0 111.614 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.49 157.03 15.59 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.409 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.724 HG11 ' HB3' ' A' ' 39' ' ' ASN . 13.8 t -131.09 134.28 61.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.895 0.378 . . . . 0.0 111.328 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.8 HD21 ' CG ' ' A' ' 72' ' ' LYS . 7.9 tt -106.19 108.1 19.44 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.573 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 1.8 tp -99.04 144.69 27.91 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.831 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 9.2 ttm -117.81 163.13 16.99 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.133 0.492 . . . . 0.0 111.051 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.33 118.49 30.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.102 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.36 42.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.866 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . 0.424 ' HB2' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -111.37 24.71 12.5 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.187 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 49.27 38.55 13.85 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 120.924 0.393 . . . . 0.0 111.371 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -151.7 -173.22 4.45 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.989 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -104.98 131.2 52.79 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.765 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 68.36 166.17 0.25 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.386 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.749 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 69.3 m-85 -79.33 -26.26 42.18 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.377 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 81.39 28.57 43.53 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.395 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.556 HD13 ' HB3' ' B' ' 98' ' ' TYR . 5.9 mp -105.07 123.49 47.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.722 0.296 . . . . 0.0 110.702 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.47 113.65 27.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.371 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.701 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.9 pt? -109.3 124.86 51.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.063 0.459 . . . . 0.0 111.453 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -106.8 -170.2 22.55 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.258 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.6 OUTLIER -134.71 147.54 50.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.882 0.373 . . . . 0.0 111.375 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 21' ' ' SER . 3.3 pt20 -125.34 139.04 54.03 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.225 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.819 HD13 ' HB2' ' B' ' 145' ' ' ALA . 33.7 mt -88.15 120.42 37.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.963 0.411 . . . . 0.0 111.034 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -124.2 171.58 9.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.083 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.695 HG21 ' HB3' ' B' ' 123' ' ' LEU . 39.3 t -80.27 95.22 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.92 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -53.18 50.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.112 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -156.21 141.35 17.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.688 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.12 151.04 49.38 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.867 0.365 . . . . 0.0 111.463 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -65.73 143.34 57.59 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.165 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -73.15 148.71 43.62 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.148 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 54.85 32.84 18.55 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.61 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' B' ' 119' ' ' LYS . . . -96.47 -164.98 33.34 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.323 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.491 HD21 ' OG ' ' A' ' 9' ' ' SER . 8.6 mt -66.36 -37.12 84.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.567 ' HB2' HD21 ' A' ' 17' ' ' LEU . . . -75.1 -33.73 61.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.273 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -33.72 44.47 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.286 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' B' ' 115' ' ' GLY . 12.1 ttmt -64.17 -37.07 86.14 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.734 0.302 . . . . 0.0 111.266 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -98.99 -30.8 12.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.467 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 68.82 45.69 63.55 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.2 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.693 ' HB3' HG11 ' A' ' 4' ' ' VAL . 3.3 p30 -81.83 -53.4 6.21 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.695 ' HB3' HG21 ' B' ' 108' ' ' VAL . 10.2 mp -118.5 119.41 34.47 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.68 0.276 . . . . 0.0 110.944 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.17 152.84 22.5 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.619 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -60.5 110.65 1.32 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.169 0.509 . . . . 0.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.55 -15.16 24.69 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.894 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -62.85 135.75 57.49 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 117.245 0.522 . . . . 0.0 110.316 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -81.05 108.86 14.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.103 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.476 ' CD1' HD21 ' A' ' 19' ' ' LEU . 29.3 mt -76.41 152.49 5.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.322 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.548 HD22 ' CD1' ' B' ' 161' ' ' LEU . 13.7 tp -110.7 -31.28 7.26 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.691 -0.231 . . . . 0.0 111.538 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -152.44 147.42 26.23 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.711 0.291 . . . . 0.0 111.066 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 13.5 mt -137.18 117.73 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.452 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' B' ' 156' ' ' LEU . 0.1 OUTLIER 49.4 43.34 23.35 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.515 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.98 18.73 79.32 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.344 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 93.1 m -120.77 144.11 48.46 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.997 0.398 . . . . 0.0 110.28 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 t -74.14 140.07 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.059 0.457 . . . . 0.0 111.609 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.545 ' HA ' HD12 ' B' ' 106' ' ' ILE . 52.8 p -93.01 -22.08 19.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.129 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.09 142.35 38.17 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.925 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.5 p30 53.13 10.74 0.19 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.811 0.694 . . . . 0.0 112.467 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.656 ' HG2' HD11 ' B' ' 106' ' ' ILE . 0.5 OUTLIER -86.52 144.18 27.36 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.902 0.382 . . . . 0.0 110.808 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.11 144.76 46.87 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.515 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.528 ' O ' HD23 ' B' ' 142' ' ' LEU . 6.2 tt -60.75 -46.0 92.12 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.925 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 9.7 t -55.28 -42.64 73.85 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -40.9 84.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.617 0.246 . . . . 0.0 110.769 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -61.87 -43.15 99.44 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.037 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -38.13 79.34 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.671 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -38.08 82.37 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.779 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . 0.514 HD23 ' C ' ' B' ' 148' ' ' LEU . 7.7 tt -59.98 -44.82 94.24 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.649 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.596 HD11 HD22 ' A' ' 19' ' ' LEU . 8.2 mt -67.79 -37.31 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.655 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.03 -48.76 62.14 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.0 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -67.44 -24.95 65.69 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.683 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 22.9 m -75.58 70.39 2.41 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.212 0.53 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -86.5 78.38 9.23 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.667 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 164.55 -81.89 0.11 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.62 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.756 ' HD2' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -137.0 128.96 29.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.534 0.206 . . . . 0.0 110.628 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.934 HD23 ' CE2' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -127.86 131.78 49.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.948 0.404 . . . . 0.0 111.2 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -91.1 142.56 27.62 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.083 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.995 HD12 HD13 ' A' ' 6' ' ' LEU . 2.3 mt -132.55 134.51 45.05 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.809 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.09 134.0 65.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.636 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 6.1 m -127.99 152.9 36.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 120.859 0.361 . . . . 0.0 111.719 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.548 ' CD1' HD22 ' B' ' 130' ' ' LEU . 0.3 OUTLIER -107.58 119.13 38.56 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.826 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.509 ' NH1' HD11 ' A' ' 2' ' ' ILE . 0.4 OUTLIER -99.85 55.13 0.94 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.738 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 2.0 t70 70.35 151.88 0.1 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.263 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 23.1 t -77.56 164.37 25.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.316 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.29 89.84 3.2 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.223 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 C--O 1.252 1.204 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.014 -179.964 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 120.644 0.259 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.8 tp -140.91 121.98 13.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.98 0.419 . . . . 0.0 111.282 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.74 156.6 22.89 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.774 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.586 HG21 ' CB ' ' B' ' 122' ' ' ASN . 22.8 t -132.77 133.39 59.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.702 0.287 . . . . 0.0 111.093 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.5 HD22 ' HD3' ' B' ' 155' ' ' LYS . 0.2 OUTLIER -101.46 111.44 23.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.815 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.648 HD11 ' ND2' ' B' ' 122' ' ' ASN . 10.4 mp -90.6 141.88 28.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.25 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 37.2 ttm -120.05 165.3 14.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.988 0.423 . . . . 0.0 110.9 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -93.33 141.31 28.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.937 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 m -146.43 51.18 1.13 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -155.89 32.32 0.35 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.452 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 52.9 72.14 0.44 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.92 0.39 . . . . 0.0 111.759 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.8 t30 63.24 90.96 0.07 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.347 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -152.95 151.73 30.65 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.246 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -73.81 157.35 36.56 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.456 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 70.4 m-85 -78.26 -30.89 48.84 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.728 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.453 ' O ' HG23 ' B' ' 112' ' ' THR . . . 80.88 28.34 46.62 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.464 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' B' ' 117' ' ' ALA . 0.3 OUTLIER -101.85 121.39 42.02 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.646 0.26 . . . . 0.0 110.668 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.38 114.04 27.88 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.03 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.997 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.8 pt? -111.44 124.82 53.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.192 0.52 . . . . 0.0 111.763 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.91 -177.56 22.24 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.556 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.26 149.3 47.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.155 0.478 . . . . 0.0 111.058 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -132.87 140.2 47.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.231 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.863 ' HB ' HG22 ' A' ' 54' ' ' THR . 49.4 mt -88.05 120.54 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.003 0.43 . . . . 0.0 110.433 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -119.88 172.91 7.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.912 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.919 HG21 HD13 ' A' ' 40' ' ' LEU . 45.6 t -79.5 92.88 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.118 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.94 -51.85 59.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.217 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.13 162.6 39.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 36.0 mtp -138.4 156.46 47.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.107 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.622 HG23 ' HA3' ' A' ' 32' ' ' GLY . 3.7 t -69.33 145.32 53.08 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.693 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -75.52 130.13 38.36 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.674 0.273 . . . . 0.0 110.944 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.23 28.25 5.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.141 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.622 ' HA3' HG23 ' A' ' 29' ' ' THR . . . -84.5 -163.38 36.2 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.369 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.494 ' C ' HD21 ' B' ' 89' ' ' LEU . 1.6 mt -73.93 -30.19 62.43 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.98 -37.17 61.97 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.467 0.175 . . . . 0.0 111.409 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.52 -34.05 47.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.153 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.6 mttm -63.97 -36.49 84.12 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.428 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.84 -32.58 11.27 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.362 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.48 47.78 20.63 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.238 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -57.51 -35.15 69.89 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.919 HD13 HG21 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -163.49 163.83 24.61 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.727 0.299 . . . . 0.0 111.025 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.39 150.39 22.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.706 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -61.68 114.4 3.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.12 0.486 . . . . 0.0 111.233 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.93 9.86 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.755 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -60.6 135.85 57.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.919 0.359 . . . . 0.0 110.368 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 pt -75.06 121.82 27.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.895 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.994 HG21 HD11 ' A' ' 49' ' ' ILE . 16.5 mt -88.95 138.14 19.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.118 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.883 HD13 HD22 ' A' ' 78' ' ' LEU . 10.0 tp -97.43 -45.55 6.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.484 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.74 147.93 33.55 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.873 0.368 . . . . 0.0 111.59 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.994 HD11 HG21 ' A' ' 46' ' ' ILE . 22.4 mm -138.61 120.77 17.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.432 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 53.47 41.55 32.09 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.242 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.48 13.0 80.29 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.436 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.9 m -120.97 137.52 54.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.038 0.419 . . . . 0.0 110.431 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.647 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.1 t -57.58 146.11 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.274 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.863 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -123.32 17.74 9.82 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.416 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.647 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -121.59 127.85 51.34 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 70.88 -4.07 1.83 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.288 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.11 174.63 3.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 111.27 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.92 147.8 25.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.143 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.418 HD11 ' OG ' ' B' ' 104' ' ' SER . 2.1 mp -61.9 -48.95 78.16 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.665 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.85 -37.98 80.81 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.221 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.19 -47.89 69.55 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.946 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.602 ' CB ' HD13 ' A' ' 23' ' ' ILE . . . -61.94 -40.15 94.54 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.204 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.8 mtt-85 -70.24 -38.41 75.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.65 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -38.16 83.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.677 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.44 HD21 HG22 ' A' ' 49' ' ' ILE . 1.2 tp -60.49 -44.36 96.05 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.735 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.708 HD11 HD22 ' B' ' 102' ' ' LEU . 12.3 mt -68.33 -37.57 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.604 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.94 -41.42 78.1 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.641 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -6.7 57.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.72 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.94 56.64 4.02 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.963 0.411 . . . . 0.0 110.862 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.68 78.86 7.4 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.381 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' B' ' 91' ' ' LYS . . . 162.29 -78.77 0.15 Allowed Glycine 0 C--N 1.332 0.343 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.295 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -136.2 129.87 32.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.774 -0.213 . . . . 0.0 110.787 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.729 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.6 OUTLIER -128.05 126.98 42.32 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.108 0.48 . . . . 0.0 110.871 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 37.4 tt0 -97.83 142.62 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.279 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.74 ' HA ' HD13 ' A' ' 49' ' ' ILE . 0.8 OUTLIER -133.76 124.02 25.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.772 0.32 . . . . 0.0 110.75 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.6 t -109.57 134.6 51.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.747 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 t -116.29 135.21 57.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.048 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.883 HD22 HD13 ' A' ' 47' ' ' LEU . 5.4 tp -115.32 134.74 54.84 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.812 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.25 116.02 28.69 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.465 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.11 155.94 1.18 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.015 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.02 -45.78 89.84 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.121 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.7 mp -73.92 168.81 18.72 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.85 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.451 179.827 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.521 ' C ' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -138.32 122.39 21.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.765 0.317 . . . . 0.0 110.953 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.478 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -114.03 155.48 16.29 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.75 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 25.9 t -129.6 134.33 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.703 0.287 . . . . 0.0 111.088 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.432 ' O ' HD12 ' B' ' 88' ' ' LEU . 0.3 OUTLIER -103.64 122.42 44.98 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.6 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.494 HD21 ' C ' ' A' ' 33' ' ' LEU . 1.3 tp -109.09 124.63 51.09 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.542 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . 0.487 ' HG3' ' N ' ' B' ' 91' ' ' LYS . 3.7 tpp -100.12 162.85 12.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.072 0.463 . . . . 0.0 110.772 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . 0.487 ' N ' ' HG3' ' B' ' 90' ' ' MET . 6.6 pttm -85.81 126.06 33.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.349 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.31 35.61 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.472 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 175.84 114.11 0.02 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.708 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 66.52 113.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.737 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -78.01 -168.78 1.36 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.754 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.8 68.27 0.59 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.615 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 63.38 173.76 0.16 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.517 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.729 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 67.4 m-85 -76.26 -25.55 55.07 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.517 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.436 ' HA3' ' HB ' ' A' ' 29' ' ' THR . . . 93.62 20.2 32.53 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.458 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.625 ' CD2' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -101.78 118.21 36.46 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.651 0.262 . . . . 0.0 110.708 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -92.07 113.26 25.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.949 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.708 HD22 HD11 ' A' ' 66' ' ' ILE . 5.2 mp -96.34 124.93 40.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.91 0.386 . . . . 0.0 110.922 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.91 171.9 13.94 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.822 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.418 ' OG ' HD11 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -136.71 145.07 44.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.835 0.35 . . . . 0.0 110.891 -179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -130.44 139.71 50.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.274 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.845 HD13 ' HB2' ' B' ' 145' ' ' ALA . 1.9 mt -88.3 120.64 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.069 0.461 . . . . 0.0 110.238 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.419 ' CE2' ' HD3' ' B' ' 109' ' ' LYS . 40.1 p90 -119.62 172.58 7.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.928 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.601 HG21 ' HB3' ' B' ' 123' ' ' LEU . 27.7 t -81.36 97.62 3.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.013 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . 0.419 ' HD3' ' CE2' ' B' ' 107' ' ' PHE . 0.5 OUTLIER -67.57 -50.58 57.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.717 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -167.48 143.61 4.17 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.805 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.463 ' SD ' HG11 ' B' ' 108' ' ' VAL . 0.0 OUTLIER -127.68 159.53 34.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.795 0.331 . . . . 0.0 111.119 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 16' ' ' GLY . 64.2 p -75.75 124.63 27.61 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.435 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.64 156.77 15.92 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.967 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.68 34.79 17.33 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.299 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.11 -175.54 20.26 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.913 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.84 -35.6 80.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.57 0.224 . . . . 0.0 111.559 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.499 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -74.95 -34.82 62.1 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.26 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -34.1 44.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.13 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.47 -35.41 80.2 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.199 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -100.07 -27.95 13.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.648 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 65.8 57.39 11.09 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.094 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.648 ' ND2' HD11 ' A' ' 6' ' ' LEU . 1.5 p30 -94.82 -33.63 12.79 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.705 HD11 HD13 ' B' ' 158' ' ' LEU . 47.9 mt -122.36 135.96 54.81 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.636 0.255 . . . . 0.0 111.55 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 142.93 34.22 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.581 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -56.68 111.39 1.0 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 111.249 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.32 -16.47 24.6 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.266 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -60.47 135.8 57.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.332 0.566 . . . . 0.0 110.64 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 pt -79.82 111.01 16.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.841 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.751 ' HB ' HG21 ' B' ' 137' ' ' THR . 59.4 mt -72.48 140.96 17.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.108 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.416 HD13 ' CD1' ' B' ' 161' ' ' LEU . 1.1 tp -98.0 -45.14 6.38 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.114 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -148.84 147.8 29.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.911 0.386 . . . . 0.0 111.477 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.633 HG22 HD22 ' B' ' 133' ' ' ASN . 13.9 mt -134.01 123.87 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.264 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . 0.633 HD22 HG22 ' B' ' 132' ' ' ILE . 3.7 m-80 54.86 33.49 19.97 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.687 0.279 . . . . 0.0 111.182 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.65 17.55 77.28 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.92 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 6.8 m -120.66 143.85 48.49 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.8 0.3 . . . . 0.0 110.341 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.432 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.2 t -59.46 144.26 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.199 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.751 HG21 ' HB ' ' B' ' 129' ' ' ILE . 2.9 m -117.23 21.56 13.07 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.603 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.432 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.8 OUTLIER -115.87 129.38 56.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 71.42 -5.23 1.65 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.361 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.739 ' HB3' HD11 ' B' ' 106' ' ' ILE . 4.8 ttt -68.37 150.72 47.84 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.812 0.339 . . . . 0.0 110.826 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 51.1 m -71.78 144.22 49.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.307 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.75 -46.03 92.01 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.06 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 4.4 t -58.04 -38.89 77.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.107 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.03 -42.85 84.15 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.803 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.997 ' HB1' HD11 ' A' ' 19' ' ' LEU . . . -60.47 -42.42 96.18 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.086 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -67.94 -39.46 83.46 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.318 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -37.86 86.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' B' ' 133' ' ' ASN . 6.9 tt -59.85 -45.27 92.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.735 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.6 HD12 HD22 ' A' ' 19' ' ' LEU . 46.3 mt -68.42 -37.01 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.773 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.41 -46.3 70.29 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -65.49 -26.91 68.13 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.292 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 20.7 p -87.17 74.89 9.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.194 0.521 . . . . 0.0 111.052 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.93 51.98 2.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.708 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -164.39 -83.36 0.05 OUTLIER Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.465 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.5 ' HD3' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -124.54 126.88 46.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.685 0.278 . . . . 0.0 110.424 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.772 HD21 HD11 ' B' ' 158' ' ' LEU . 0.0 OUTLIER -129.81 143.07 50.63 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.46 -179.176 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -109.09 138.61 45.16 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.487 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.772 HD11 HD21 ' B' ' 156' ' ' LEU . 0.6 OUTLIER -133.36 127.31 33.21 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.762 0.315 . . . . 0.0 111.04 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.93 139.93 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.578 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.442 HG21 ' CD2' ' B' ' 123' ' ' LEU . 22.3 t -135.74 154.9 35.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.35 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.416 ' CD1' HD13 ' B' ' 130' ' ' LEU . 0.2 OUTLIER -121.69 116.56 24.77 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.759 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 45.6 ptt85 -122.59 131.77 53.98 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.65 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -47.96 133.15 14.87 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.408 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.54 158.33 34.1 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.092 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.06 110.23 13.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.32 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.007 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 mtt . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp -144.55 141.69 23.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 120.648 0.261 . . . . 0.0 111.147 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -109.97 161.75 12.88 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.575 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.725 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.6 t -127.33 134.62 65.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.818 0.342 . . . . 0.0 111.277 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.7 mt -98.03 123.47 42.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.979 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.73 137.42 51.65 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.503 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.683 ' O ' HD13 ' B' ' 116' ' ' LEU . 3.9 ttt -109.67 164.87 12.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.917 0.389 . . . . 0.0 110.53 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.81 119.1 25.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.116 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.696 ' HB2' HD11 ' B' ' 116' ' ' LEU . 5.0 m -151.28 115.92 5.15 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.48 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 59.72 51.67 6.07 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.071 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 14' ' ' GLU . . . -119.49 99.29 6.59 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.77 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -60.66 -35.19 75.63 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.233 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.47 90.69 1.74 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.813 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.484 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 30.5 tt0 66.77 174.59 0.25 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.053 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.748 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 57.5 m-85 -60.37 -27.26 67.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.865 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.87 18.58 43.41 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.707 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.677 HD21 ' CB ' ' B' ' 117' ' ' ALA . 8.7 mp -108.02 119.07 38.42 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.723 0.297 . . . . 0.0 110.73 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.2 113.44 25.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.192 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.854 HD22 HD11 ' B' ' 149' ' ' ILE . 1.5 mp -92.94 124.9 37.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.262 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.6 -169.59 21.85 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.615 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.6 148.54 32.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.934 0.367 . . . . 0.0 111.367 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.26 133.13 45.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.878 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.768 ' HB ' HG22 ' A' ' 54' ' ' THR . 53.9 mt -87.76 120.28 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.043 0.449 . . . . 0.0 110.542 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -124.83 173.22 8.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.207 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 40' ' ' LEU . 39.8 t -83.33 100.5 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.659 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -47.71 53.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.613 0.244 . . . . 0.0 111.044 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -161.69 144.64 12.11 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.592 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -130.35 155.75 45.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.887 0.375 . . . . 0.0 111.333 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.0 t -65.35 144.71 56.92 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.975 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 29.0 tpt85 -79.72 148.6 31.47 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.2 30.57 19.98 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.486 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -101.58 -170.98 27.93 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.108 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.562 HD22 ' O ' ' B' ' 90' ' ' MET . 0.1 OUTLIER -68.52 -32.66 72.77 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.642 0.221 . . . . 0.0 111.585 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.994 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -73.99 -35.42 64.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.07 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.29 -33.99 42.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.241 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.59 -37.55 86.69 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.165 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -101.94 -26.61 13.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.452 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.7 38.75 93.41 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.986 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.701 ' HB3' HG11 ' B' ' 87' ' ' VAL . 3.6 p30 -68.87 -46.85 67.4 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.459 0.17 . . . . 0.0 111.459 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.692 ' CD1' HD22 ' A' ' 75' ' ' LEU . 57.8 mt -116.62 129.3 56.08 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.717 0.294 . . . . 0.0 111.125 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.78 150.49 21.78 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.426 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -60.37 110.88 1.36 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.095 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.5 -15.43 17.47 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.153 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -64.19 132.79 51.39 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 117.268 0.534 . . . . 0.0 110.425 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.5 pt -79.9 112.74 18.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.83 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.452 ' HA ' HG12 ' A' ' 77' ' ' VAL . 19.6 mt -78.01 134.28 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.98 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 tp -91.72 -45.49 8.41 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.706 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -148.92 149.84 31.9 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.801 0.334 . . . . 0.0 111.68 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 23.0 mt -138.02 119.99 18.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.621 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 55.7 36.48 27.31 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.314 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.33 2.46 90.6 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.6 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -111.91 134.89 53.19 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 117.295 0.547 . . . . 0.0 110.411 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.2 t -57.88 146.81 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.268 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.768 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -120.39 23.6 10.79 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.373 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.56 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -116.81 139.18 50.9 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.438 ' HB2' ' CD1' ' B' ' 142' ' ' LEU . 11.9 p30 53.68 9.22 0.18 Allowed 'General case' 0 CA--C 1.535 0.392 0 O-C-N 123.614 0.571 . . . . 0.0 112.22 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.513 ' HB3' HD11 ' A' ' 23' ' ' ILE . 14.2 tpp -82.95 159.82 22.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.779 0.323 . . . . 0.0 110.734 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.506 ' N ' ' HG3' ' A' ' 57' ' ' MET . 0.1 OUTLIER -72.77 138.1 46.26 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.194 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.0 -47.23 81.34 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.097 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.0 p -58.1 -41.28 83.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.189 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.25 -47.78 84.46 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.019 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.6 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -59.64 -40.81 88.9 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.981 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.19 -40.5 94.31 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.709 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -65.32 -38.74 91.11 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.905 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.3 tt -60.06 -43.92 95.06 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.942 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.487 ' CD1' HD22 ' B' ' 102' ' ' LEU . 57.0 mt -68.46 -37.11 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.809 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.7 -49.28 69.11 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.902 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.0 pttt -64.1 -23.5 67.35 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.27 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.7 m -81.36 66.99 7.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.098 0.475 . . . . 0.0 110.431 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.95 64.27 8.03 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.008 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 177.91 -76.29 0.07 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.588 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.82 129.61 32.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.653 -0.274 . . . . 0.0 110.629 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.849 HD23 ' CE1' ' B' ' 98' ' ' TYR . 0.4 OUTLIER -129.82 136.82 50.02 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.089 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 26.6 mt-30 -98.32 143.08 29.17 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.719 HD13 HD13 ' B' ' 89' ' ' LEU . 1.9 mp -135.75 128.79 31.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 111.043 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.84 144.21 25.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.695 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 46' ' ' ILE . 10.6 m -141.57 167.67 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.957 0.408 . . . . 0.0 111.595 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.58 122.94 33.83 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.916 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.31 115.67 4.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.591 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 58.72 88.48 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.403 0.439 . . . . 0.0 111.206 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.2 p -76.78 -72.07 0.36 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.408 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.52 -61.84 1.64 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.95 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.872 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.84 148.52 31.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-O 120.595 0.236 . . . . 0.0 111.008 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.4 159.6 25.3 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.929 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.701 HG11 ' HB3' ' A' ' 39' ' ' ASN . 9.1 t -130.06 135.16 61.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.681 0.276 . . . . 0.0 111.078 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.51 114.08 25.81 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.792 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.719 HD13 HD13 ' A' ' 75' ' ' LEU . 10.9 mp -100.35 137.85 38.22 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.642 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . 0.562 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -110.21 170.42 8.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.379 0.609 . . . . 0.0 111.47 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -87.28 144.88 26.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.375 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 94.9 p -141.63 27.91 1.83 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.841 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.69 84.88 0.14 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.96 0.409 . . . . 0.0 111.202 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.76 85.01 1.68 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.989 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 57.82 29.16 17.05 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.248 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.84 48.65 10.91 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.091 0.472 . . . . 0.0 111.232 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -179.27 176.64 0.83 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.187 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.849 ' CE1' HD23 ' A' ' 73' ' ' LEU . 52.1 m-85 -88.1 -26.74 22.35 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.955 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.42 14.05 72.03 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.618 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.994 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.3 OUTLIER -97.55 122.22 40.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.683 0.278 . . . . 0.0 110.522 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.85 113.72 27.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.267 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.6 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.8 pt? -107.84 125.01 50.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.082 0.468 . . . . 0.0 111.329 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -104.33 -163.05 24.54 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.067 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.32 146.51 30.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.696 0.248 . . . . 0.0 111.162 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.475 ' NE2' HG21 ' B' ' 128' ' ' ILE . 6.1 pt20 -127.14 137.14 52.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.026 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 1.081 HD13 ' HB2' ' B' ' 145' ' ' ALA . 28.4 mt -88.18 120.42 37.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.591 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.466 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 47.4 p90 -123.88 172.55 8.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.988 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.602 HG21 ' HB3' ' B' ' 123' ' ' LEU . 96.6 t -85.16 98.55 6.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.924 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . 0.466 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -68.3 -57.57 5.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.416 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.08 139.84 23.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.743 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 6.1 ptt? -131.07 152.84 49.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.936 0.398 . . . . 0.0 111.626 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 3.0 p -72.82 142.28 48.02 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.261 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -78.24 154.92 30.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.963 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.1 m 62.9 34.6 14.09 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.68 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.11 -175.28 20.23 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.96 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.696 HD11 ' HB2' ' A' ' 9' ' ' SER . 0.2 OUTLIER -67.24 -32.54 73.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.669 0.234 . . . . 0.0 111.625 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.677 ' CB ' HD21 ' A' ' 17' ' ' LEU . . . -74.93 -37.92 61.9 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.657 0.265 . . . . 0.0 111.021 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.0 -33.71 44.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.246 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 18.3 mttm -58.68 -39.79 81.7 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.315 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.38 -31.71 9.89 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.544 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.69 49.28 11.01 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.434 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.725 ' HB3' HG11 ' A' ' 4' ' ' VAL . 14.4 p-10 -78.73 -44.05 24.34 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.764 ' CD1' HD13 ' B' ' 158' ' ' LEU . 85.1 mt -111.62 118.57 36.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.609 0.242 . . . . 0.0 110.993 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 131.44 34.64 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.252 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -48.14 109.49 0.24 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.083 0.468 . . . . 0.0 111.382 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 108.15 -1.99 33.25 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.344 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -70.83 135.61 48.2 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.456 0.628 . . . . 0.0 111.468 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.475 HG21 ' NE2' ' B' ' 105' ' ' GLN . 1.5 pt -79.95 107.47 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.592 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.642 ' CD1' HD21 ' A' ' 19' ' ' LEU . 42.7 mt -75.76 147.56 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.342 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.702 HD13 HD13 ' B' ' 161' ' ' LEU . 2.3 tp -110.21 -42.45 4.16 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.607 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -144.0 148.19 34.92 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.747 0.308 . . . . 0.0 111.387 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 34.8 mt -138.81 118.23 14.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.765 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 4.0 m120 52.37 48.01 23.53 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.36 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.23 16.66 67.2 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.201 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 46.2 m -120.83 140.48 51.69 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.811 0.305 . . . . 0.0 110.293 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.612 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.3 t -62.36 147.53 11.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.001 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.701 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -125.84 19.51 7.83 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.464 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.612 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.4 tt0 -111.95 133.95 53.81 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 72.51 -9.2 1.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.514 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.677 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.1 OUTLIER -66.34 169.59 7.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.96 0.409 . . . . 0.0 111.228 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 30.7 t -90.77 148.71 22.38 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.994 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.438 ' CD1' ' HB2' ' A' ' 56' ' ' ASN . 5.2 tt -58.1 -48.95 78.61 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.369 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 64.6 p -58.62 -39.75 81.37 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.709 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -46.39 85.04 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.71 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 1.081 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.73 -43.19 90.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -66.46 -39.49 88.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.443 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -42.16 98.8 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.984 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 1.2 tp -61.56 -43.18 99.34 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.454 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.854 HD11 HD22 ' A' ' 19' ' ' LEU . 12.0 mt -68.73 -37.54 77.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.727 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -63.55 -49.51 73.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.003 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -64.83 -24.27 67.49 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.366 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.6 m -79.44 70.0 5.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.924 0.393 . . . . 0.0 110.956 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.42 60.19 6.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.547 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.19 -82.76 0.05 OUTLIER Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.498 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -132.77 131.54 41.26 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.569 0.224 . . . . 0.0 110.489 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.748 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -128.56 137.11 51.56 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.06 0.457 . . . . 0.0 111.275 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 24.8 tt0 -101.92 140.49 36.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.395 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.764 HD13 ' CD1' ' B' ' 123' ' ' LEU . 1.0 OUTLIER -135.78 129.42 32.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.874 0.368 . . . . 0.0 111.091 -179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.403 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 13.3 t -113.99 132.17 63.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.707 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -129.36 165.83 28.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.551 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.702 HD13 HD13 ' B' ' 130' ' ' LEU . 1.1 mp -116.71 131.66 56.89 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.983 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.44 40.08 2.06 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.016 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 23.9 t70 67.54 153.58 0.09 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.236 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 23.2 t -94.49 -66.37 0.92 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.811 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 5.6 mt -153.73 -55.03 0.11 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.756 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.773 179.944 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mmt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.635 0.255 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.6 pp -132.6 158.39 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.773 0.32 . . . . 0.0 111.17 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -127.15 158.05 20.91 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.761 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.6 t -130.1 134.37 62.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.587 0.232 . . . . 0.0 111.029 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.93 107.35 18.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.427 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 tp -108.19 123.96 49.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.478 ' HB3' ' HB3' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -104.0 150.97 23.76 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 120.925 0.393 . . . . 0.0 111.341 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.54 ' HA ' HD13 ' B' ' 116' ' ' LEU . 0.1 OUTLIER -99.37 136.31 39.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.248 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -160.58 62.78 0.31 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.182 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.36 27.75 0.35 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 48.92 71.87 0.34 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -145.62 161.13 40.54 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.311 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -94.68 110.0 21.88 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.444 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 67.54 161.22 0.17 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.094 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.712 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 59.3 m-85 -72.27 -15.83 61.91 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.468 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.66 25.97 48.09 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.511 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.807 HD21 HD11 ' B' ' 123' ' ' LEU . 0.4 OUTLIER -106.05 117.69 34.68 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.579 0.228 . . . . 0.0 110.9 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.413 ' HB2' ' HG2' ' B' ' 110' ' ' GLU . 6.3 mtt85 -97.02 113.34 24.87 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.411 HD21 HG13 ' B' ' 129' ' ' ILE . 7.7 mp -102.06 124.93 48.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.183 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -103.42 -164.68 25.45 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.752 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.9 OUTLIER -147.0 147.96 31.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.023 0.411 . . . . 0.0 111.281 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -131.82 137.38 48.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.124 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.85 HD13 ' HB2' ' A' ' 62' ' ' ALA . 64.3 mt -87.89 120.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.619 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.471 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 45.2 p90 -124.91 172.11 9.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.339 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.756 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.3 t -83.0 100.21 6.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.89 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.471 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 1.2 tptp -68.05 -57.5 6.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.235 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -159.59 134.37 7.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.651 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -114.15 156.75 23.65 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.01 0.434 . . . . 0.0 111.299 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.8 t -65.55 138.21 57.9 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 148.64 47.93 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.917 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.87 31.82 21.07 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.53 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.08 -154.84 30.16 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.411 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.564 HD22 ' O ' ' B' ' 90' ' ' MET . 1.2 mt -85.54 -31.75 22.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.547 0.213 . . . . 0.0 111.455 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.819 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -75.21 -34.93 61.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.118 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.99 -33.81 44.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.988 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -38.6 83.93 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.358 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -103.16 -32.73 9.5 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.513 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.58 49.88 13.29 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.395 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.619 ' HB3' HG11 ' B' ' 87' ' ' VAL . 7.9 p-10 -82.82 -47.68 11.63 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.756 ' HB3' HG21 ' A' ' 25' ' ' VAL . 17.6 mt -105.95 128.45 53.81 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 111.147 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.41 133.36 38.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.543 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -54.96 110.44 0.66 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.191 0.519 . . . . 0.0 111.168 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.43 -7.91 28.45 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.816 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -73.37 135.67 44.31 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 121.244 0.545 . . . . 0.0 111.047 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.4 pt -74.38 114.59 14.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.543 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.0 mt -80.63 138.84 19.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.212 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.582 HD12 HD13 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -95.79 -46.99 6.35 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.535 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.4 OUTLIER -150.5 148.19 28.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.8 0.333 . . . . 0.0 111.567 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 43.5 mt -137.04 118.36 18.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.78 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 55.95 45.06 24.62 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.152 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.41 15.26 70.22 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.355 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.9 m -120.81 137.08 54.72 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.935 0.368 . . . . 0.0 110.474 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.603 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.2 t -60.42 147.18 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.294 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.806 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -125.2 21.76 7.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.534 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.603 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -117.45 129.73 56.01 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 70.5 -3.84 1.79 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.354 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.712 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -68.69 173.15 5.42 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.831 0.348 . . . . 0.0 111.162 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.74 139.72 30.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.99 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' B' ' 139' ' ' ASN . 5.6 tt -56.35 -42.24 77.43 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.527 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.4 m -65.15 -37.21 86.7 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.004 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -44.81 78.67 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.637 0.256 . . . . 0.0 110.839 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 1.001 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -59.72 -41.8 91.66 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.496 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.0 ptt85 -71.65 -35.85 70.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.714 0.292 . . . . 0.0 110.711 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.2 -38.62 82.15 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.664 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.71 -44.96 93.5 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.773 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.584 HD12 HD22 ' B' ' 102' ' ' LEU . 59.3 mt -68.32 -36.8 76.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.08 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -48.78 63.78 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.742 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -29.16 70.31 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.146 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.2 m -84.31 85.39 7.38 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.842 0.353 . . . . 0.0 111.035 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.81 113.12 25.1 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.61 -89.07 0.24 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.593 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.84 131.85 53.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.662 0.268 . . . . 0.0 110.655 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.758 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.4 OUTLIER -129.53 138.5 51.37 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.961 0.41 . . . . 0.0 111.323 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.7 tt0 -101.65 138.95 37.96 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.673 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.71 HD13 HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -133.64 125.12 28.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.949 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t -116.66 146.55 20.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.52 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.443 HG22 ' O ' ' B' ' 85' ' ' ILE . 32.7 m -121.21 140.51 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.278 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.582 HD13 HD12 ' A' ' 47' ' ' LEU . 21.2 tp -84.15 131.96 34.72 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.911 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 63.09 -174.25 0.15 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.873 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.39 76.44 0.32 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.933 0.397 . . . . 0.0 111.328 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.9 t -168.05 121.02 0.88 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.86 -64.01 0.68 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.93 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.49 -0.767 . . . . 0.0 111.186 -179.941 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 1.9 tmt? . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 120.724 0.297 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.443 ' O ' HG22 ' A' ' 77' ' ' VAL . 10.3 tt -147.52 147.82 17.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.006 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.17 157.37 25.47 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.732 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 39' ' ' ASN . 21.5 t -131.08 132.65 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.79 0.328 . . . . 0.0 111.096 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.426 HD12 ' HG3' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -97.84 107.07 19.48 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.417 HD21 ' N ' ' A' ' 34' ' ' ALA . 2.2 tp -91.26 141.55 28.67 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.513 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . 0.564 ' O ' HD22 ' A' ' 33' ' ' LEU . 9.4 tpp -118.44 163.15 17.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.695 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . 0.498 ' N ' ' HG3' ' B' ' 90' ' ' MET . 7.2 pttt -83.16 134.26 34.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.144 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 7.9 m -150.3 112.53 4.64 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.177 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 68.18 119.76 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.517 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 66.5 104.63 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.489 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -87.28 51.89 2.36 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 111.477 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -109.71 53.64 0.68 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.229 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 65.43 162.98 0.15 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.519 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.758 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 60.2 m-85 -68.28 -23.74 64.79 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.455 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.09 20.28 73.16 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.46 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.819 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -98.06 117.05 31.54 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.664 0.268 . . . . 0.0 110.605 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.23 113.4 25.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.101 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 1.001 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.8 pt? -110.6 124.84 52.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.125 0.488 . . . . 0.0 111.07 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -111.05 -164.04 18.33 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.243 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.58 148.91 40.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.706 0.288 . . . . 0.0 111.078 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 21' ' ' SER . 1.8 pt20 -127.65 136.73 52.01 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.135 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.783 HD13 ' HB2' ' B' ' 145' ' ' ALA . 42.1 mt -87.78 120.2 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.345 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -122.97 172.98 8.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.121 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.964 HG21 HD13 ' B' ' 123' ' ' LEU . 33.2 t -81.59 95.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.044 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -43.97 88.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.143 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -168.93 140.43 2.52 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.839 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.578 ' SD ' HG23 ' B' ' 118' ' ' THR . 0.2 OUTLIER -126.46 161.09 28.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.891 0.377 . . . . 0.0 111.434 -179.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 18.8 p -77.09 122.77 25.44 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.208 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -64.64 150.33 47.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.963 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 3.2 m 62.63 32.76 16.17 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.31 -166.48 24.73 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.128 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.54 HD13 ' HA ' ' A' ' 8' ' ' LYS . 4.4 mt -75.45 -30.99 60.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.647 0.224 . . . . 0.0 111.417 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.72 -34.4 62.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.17 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.578 HG23 ' SD ' ' B' ' 111' ' ' MET . 0.1 OUTLIER -78.77 -33.96 45.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.084 179.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.84 -37.71 87.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.336 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.08 -31.66 12.02 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.663 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.61 51.37 7.28 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.345 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -66.56 -35.58 80.57 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 111.601 0.222 . . . . 0.0 111.601 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.964 HD13 HG21 ' B' ' 108' ' ' VAL . 0.5 OUTLIER -154.27 164.19 38.95 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.804 0.335 . . . . 0.0 111.11 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 148.33 30.79 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.882 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -56.16 112.3 1.18 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.103 0.478 . . . . 0.0 110.981 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.2 -16.67 22.33 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.965 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -61.79 138.81 58.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.071 0.462 . . . . 0.0 111.222 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.424 ' O ' HG13 ' B' ' 128' ' ' ILE . 44.3 pt -78.56 124.9 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.794 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.418 HD11 HD22 ' B' ' 123' ' ' LEU . 33.2 mm -90.91 131.69 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.935 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.543 HD13 HD13 ' B' ' 161' ' ' LEU . 15.9 tp -94.89 -44.01 7.93 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.563 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 mttp -148.62 152.69 37.18 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.424 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 35.5 mt -141.11 118.24 8.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.573 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 55.79 38.74 30.43 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.15 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.04 2.08 88.37 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.517 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 47.8 m -109.69 131.65 54.86 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 117.054 0.427 . . . . 0.0 110.349 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.625 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.2 t -58.47 146.95 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.696 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -120.93 18.91 11.75 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.675 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.625 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.1 OUTLIER -109.42 130.2 55.51 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.224 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.473 ' HB3' HD13 ' A' ' 59' ' ' LEU . 5.1 m-80 71.6 -6.11 1.49 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.375 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.606 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -65.61 168.5 7.44 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.909 0.385 . . . . 0.0 111.1 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 14.5 t -89.37 149.44 22.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.167 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.94 -47.11 87.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.633 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 12.0 p -60.21 -37.22 79.61 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.17 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.1 -41.47 67.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.606 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.783 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -63.5 -41.82 98.53 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.256 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . 0.468 ' HA ' HD12 ' B' ' 149' ' ' ILE . 0.0 OUTLIER -71.3 -36.47 71.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.661 0.267 . . . . 0.0 110.482 179.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -68.02 -38.35 82.46 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.526 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . 0.428 HD13 ' O ' ' B' ' 148' ' ' LEU . 0.4 OUTLIER -59.79 -44.38 93.96 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.633 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' B' ' 146' ' ' ARG . 7.9 mt -65.95 -38.34 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.713 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -68.71 -49.62 57.39 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.777 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.11 -25.64 68.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.2 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 6.0 m -81.28 63.74 5.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.907 0.385 . . . . 0.0 110.502 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -76.71 121.99 24.07 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.95 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 120.1 -83.7 0.36 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.31 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 7' ' ' MET . 0.0 OUTLIER -132.75 130.35 39.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.722 0.296 . . . . 0.0 110.687 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.712 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.94 134.14 48.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.111 0.481 . . . . 0.0 111.156 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.6 tm0? -93.21 141.21 28.68 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.258 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.33 123.73 24.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.704 0.288 . . . . 0.0 110.678 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.453 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 32.6 t -107.88 135.85 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.291 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.28 141.51 43.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.771 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.543 HD13 HD13 ' B' ' 130' ' ' LEU . 0.7 OUTLIER -106.66 116.7 32.38 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.967 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -162.0 127.96 3.6 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.715 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.0 167.63 0.18 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.436 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.04 -62.9 1.28 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.754 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 2.1 mt 64.47 106.86 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.566 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.388 -0.815 . . . . 0.0 110.86 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 mmt . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.479 0.181 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.37 148.15 33.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.959 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.3 158.85 23.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.728 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.3 t -129.85 134.89 62.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.749 0.309 . . . . 0.0 110.848 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.99 113.09 26.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.754 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.2 tp -99.69 144.88 28.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.77 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.656 ' O ' HD22 ' B' ' 116' ' ' LEU . 3.0 ttt -112.78 164.08 13.81 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.147 0.499 . . . . 0.0 110.793 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -99.41 129.93 45.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.195 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.44 179.93 5.24 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.991 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.2 mtt-85 -76.03 72.07 2.84 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.897 0.38 . . . . 0.0 111.05 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -172.81 96.05 0.13 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.029 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 67.16 133.89 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.316 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.42 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 2.2 mt-10 -77.34 59.67 1.87 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.092 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -170.45 175.36 4.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.11 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.781 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 72.8 m-85 -104.54 -30.94 9.69 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.355 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.24 25.39 44.14 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.527 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' B' ' 117' ' ' ALA . 1.0 OUTLIER -104.78 122.01 44.83 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.715 0.293 . . . . 0.0 110.612 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -102.44 113.42 26.74 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.15 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.798 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.7 pt? -108.96 124.98 51.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.111 0.481 . . . . 0.0 111.646 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -106.66 -162.48 22.32 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.855 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.66 149.33 35.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.802 0.334 . . . . 0.0 111.069 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.484 ' NE2' HG21 ' A' ' 45' ' ' ILE . 3.1 pt20 -129.67 136.15 49.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.011 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.667 ' HB ' HG22 ' A' ' 54' ' ' THR . 38.8 mt -88.01 120.69 37.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.982 0.42 . . . . 0.0 110.631 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -121.97 173.38 7.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.177 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.43 HG21 HD22 ' A' ' 40' ' ' LEU . 40.4 t -79.93 98.18 3.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.611 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -55.68 10.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.121 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -162.4 145.0 11.15 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 32.0 mtm -119.57 149.54 41.77 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.955 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 p -65.55 148.98 50.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -75.13 151.66 38.56 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.817 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.47 34.47 20.46 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.633 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.94 172.59 18.29 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.753 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -29.65 69.87 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.598 ' N ' HD21 ' B' ' 89' ' ' LEU . . . -74.76 -39.55 61.73 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.205 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.97 -33.71 44.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.115 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -39.77 79.26 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.386 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -106.9 -27.54 10.64 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.558 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.87 59.03 7.99 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.418 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.881 ' CB ' HG11 ' B' ' 87' ' ' VAL . 5.7 m-80 -88.62 -33.82 17.5 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.6 0.2 . . . . 0.0 111.328 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.578 ' CD1' HD22 ' A' ' 75' ' ' LEU . 4.4 mt -111.82 134.78 53.17 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.144 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -98.1 132.71 43.4 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.751 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -57.18 113.48 1.74 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.11 0.481 . . . . 0.0 111.27 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.22 -18.93 13.64 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.793 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -62.37 137.2 58.21 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.879 0.371 . . . . 0.0 110.512 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.484 HG21 ' NE2' ' A' ' 22' ' ' GLN . 33.4 pt -76.39 128.4 37.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.916 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.467 HG22 ' OG1' ' A' ' 54' ' ' THR . 17.0 mt -95.45 137.39 23.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.872 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.4 tp -103.72 -36.67 7.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.444 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -148.25 147.85 29.82 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.896 0.379 . . . . 0.0 111.547 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 35.8 mt -142.27 117.58 5.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.957 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 51.3 29.47 5.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.369 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.84 -10.83 64.4 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.615 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -103.67 124.79 49.5 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 117.329 0.565 . . . . 0.0 110.845 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.747 HG22 ' H ' ' A' ' 55' ' ' GLU . 2.4 p -56.97 149.61 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.147 0.499 . . . . 0.0 110.941 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.667 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -118.59 31.15 6.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.511 -178.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.747 ' H ' HG22 ' A' ' 53' ' ' VAL . 0.8 OUTLIER -127.6 128.52 45.69 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 71.02 -5.82 1.43 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.299 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.5 ttt -78.14 156.06 30.13 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.837 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.6 m -71.94 138.72 48.3 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.459 HD11 ' HA2' ' B' ' 103' ' ' GLY . 0.7 OUTLIER -58.08 -45.04 87.82 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.195 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.9 p -59.31 -44.92 92.5 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.141 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.16 -47.19 87.35 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.07 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.714 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -61.6 -40.38 94.59 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.87 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.459 ' HA ' HD12 ' A' ' 66' ' ' ILE . 51.6 mtp85 -64.4 -40.57 96.04 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.948 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -65.76 -38.53 89.32 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.813 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.518 ' O ' HD13 ' A' ' 65' ' ' LEU . 1.3 tm? -59.93 -44.23 94.47 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.751 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.459 HD12 ' HA ' ' A' ' 63' ' ' ARG . 4.8 mt -68.18 -37.02 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.833 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -63.19 -49.33 74.68 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.829 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -69.59 -26.84 64.65 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.352 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.4 m -76.13 68.82 2.62 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.056 0.455 . . . . 0.0 110.879 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -87.42 99.47 12.03 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.546 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.13 -82.87 0.17 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.631 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.25 130.65 37.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.627 0.251 . . . . 0.0 110.566 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.746 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.7 OUTLIER -129.59 140.7 51.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.989 0.423 . . . . 0.0 111.219 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.9 tt0 -109.87 140.24 44.05 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.597 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.578 HD22 ' CD1' ' A' ' 40' ' ' LEU . 1.5 mp -130.24 126.44 37.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.605 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.4 t -115.51 133.59 61.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.05 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -122.78 165.8 18.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.249 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 tt -104.82 124.08 48.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.675 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.86 -173.81 0.14 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.789 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 66.04 107.4 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.153 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.63 -60.02 0.89 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.028 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.12 -55.66 2.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.757 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 C--O 1.253 1.237 0 CA-C-O 118.608 -0.711 . . . . 0.0 111.145 179.789 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.478 0.18 . . . . 0.0 111.393 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.668 HD13 ' N ' ' B' ' 86' ' ' GLY . 0.0 OUTLIER -117.06 140.72 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.026 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.668 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -142.79 157.6 26.83 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.835 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.881 HG11 ' CB ' ' A' ' 39' ' ' ASN . 16.9 t -122.92 135.24 63.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.659 0.266 . . . . 0.0 111.096 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.431 ' O ' HD12 ' B' ' 88' ' ' LEU . 0.4 OUTLIER -104.87 127.47 52.7 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.511 179.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.598 HD21 ' N ' ' A' ' 34' ' ' ALA . 0.9 OUTLIER -111.52 144.57 40.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.775 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 4.1 ttt -111.28 163.68 13.7 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -98.72 130.47 45.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.855 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 7.5 t -107.56 111.89 24.37 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.839 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 45.8 ttt-85 70.24 134.33 0.03 OUTLIER 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.474 0.484 . . . . 0.0 110.63 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.97 72.34 0.57 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.36 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.72 120.33 3.08 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.475 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 67.33 148.8 0.05 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.534 0.521 . . . . 0.0 111.719 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.36 -178.54 7.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.658 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.746 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 43.0 m-85 -55.75 -30.52 61.36 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.548 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.5 19.51 77.99 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.554 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -93.2 118.48 31.29 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.57 113.36 26.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.211 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.714 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.7 pt? -105.12 124.94 50.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . 0.459 ' HA2' HD11 ' A' ' 59' ' ' LEU . . . -108.46 -177.36 21.89 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.972 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.438 ' OG ' HD12 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -139.06 148.62 43.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.857 0.361 . . . . 0.0 111.193 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -129.1 139.91 51.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.78 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.943 HD13 ' HB2' ' B' ' 145' ' ' ALA . 35.6 mt -88.13 121.66 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.865 0.364 . . . . 0.0 110.828 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.485 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 44.7 p90 -124.29 170.57 10.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.204 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.74 98.28 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.139 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . 0.485 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -66.24 -56.36 11.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.259 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -153.48 142.0 20.78 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.654 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -130.7 158.61 39.61 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.832 0.348 . . . . 0.0 111.308 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 89.9 m -65.28 134.87 54.55 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.974 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.93 149.7 44.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.8 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.78 30.39 18.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.461 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -97.83 -171.61 32.89 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.1 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.656 HD22 ' O ' ' A' ' 7' ' ' MET . 1.3 mp -68.11 -32.51 72.87 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.499 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -74.94 -38.65 61.69 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.547 0.213 . . . . 0.0 111.349 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.87 -33.52 45.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.18 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -60.81 -39.04 87.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.026 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.08 -31.63 11.67 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.375 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.57 45.79 21.64 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.45 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.65 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.4 p-10 -77.68 -39.5 44.59 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 111.562 0.208 . . . . 0.0 111.562 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.449 ' CD1' HD13 ' B' ' 158' ' ' LEU . 78.6 mt -122.59 127.2 49.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.778 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.99 131.28 38.12 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -48.11 110.77 0.36 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.009 0.433 . . . . 0.0 111.255 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.95 -5.71 30.73 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.452 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -68.3 136.47 53.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.264 0.532 . . . . 0.0 111.396 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 3.2 pt -79.0 101.28 4.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.271 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.748 HG21 HD11 ' B' ' 132' ' ' ILE . 7.7 mt -64.68 148.38 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.02 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 tt -111.12 -44.53 3.56 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.616 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 11.2 mttp -151.6 148.05 27.51 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.79 0.329 . . . . 0.0 111.687 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 1.105 HD12 HD23 ' B' ' 158' ' ' LEU . 36.5 mm -132.83 118.53 34.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.526 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 56.81 42.92 25.89 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.31 15.35 74.81 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.216 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 7.5 m -120.89 140.27 52.04 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-N 116.957 0.378 . . . . 0.0 110.219 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.627 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.6 t -61.46 148.36 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.825 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.755 HG22 HD12 ' B' ' 106' ' ' ILE . 0.2 OUTLIER -129.12 22.78 5.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.135 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.627 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.0 OUTLIER -112.17 135.27 53.04 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.379 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 72.11 -9.53 0.99 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.484 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.629 ' HB3' HD11 ' B' ' 106' ' ' ILE . 4.0 tpp -66.55 170.65 5.93 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.925 0.393 . . . . 0.0 111.25 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.02 148.62 22.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.987 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.04 -35.76 71.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.759 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' B' ' 146' ' ' ARG . 3.8 m -65.68 -37.24 85.95 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.159 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.38 -38.68 65.57 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 110.607 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.943 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -64.03 -42.57 97.06 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.089 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' B' ' 143' ' ' THR . 7.0 ppt_? -72.63 -35.53 67.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.65 0.262 . . . . 0.0 110.59 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -39.23 82.83 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.773 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.85 -45.15 93.35 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.602 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.505 HD12 HD22 ' A' ' 19' ' ' LEU . 47.7 mt -68.56 -36.79 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.772 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -65.57 -48.77 71.26 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.985 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 5.7 mttp -70.35 -24.94 63.07 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.61 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 96.9 p -78.06 67.35 3.88 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.064 0.459 . . . . 0.0 110.751 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 6.7 mtm-85 -76.62 128.31 34.46 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.587 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.57 -91.47 0.59 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.506 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.42 134.57 50.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.783 0.325 . . . . 0.0 110.723 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.781 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -129.76 141.68 50.83 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.331 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 7.8 tt0 -100.37 139.57 35.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.676 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 1.105 HD23 HD12 ' B' ' 132' ' ' ILE . 0.7 OUTLIER -134.0 128.79 35.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.91 -179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 31.5 t -114.56 137.11 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -125.01 143.83 37.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.248 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 5.9 tt -125.03 130.64 52.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.486 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.96 61.28 0.19 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.061 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 11.8 t70 66.76 169.26 0.24 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.179 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 5.9 p -97.46 152.75 18.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.384 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' B' ' 165' ' ' LEU . 0.3 OUTLIER 71.33 108.11 0.06 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.703 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.978 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.609 0.243 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 pp -137.84 147.79 25.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.469 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.97 158.77 23.48 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.564 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.713 HG11 ' HB3' ' B' ' 122' ' ' ASN . 25.8 t -132.07 133.34 60.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.68 0.276 . . . . 0.0 110.963 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.497 HD23 ' OE1' ' B' ' 157' ' ' GLN . 0.3 OUTLIER -107.01 107.62 18.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.104 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.487 HD21 ' N ' ' B' ' 117' ' ' ALA . 5.9 tp -91.03 128.5 36.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.118 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.497 ' O ' HD13 ' B' ' 116' ' ' LEU . 21.2 ttt -114.97 162.27 17.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.295 0.569 . . . . 0.0 111.274 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -99.48 123.48 43.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.798 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 t -159.32 126.34 4.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.784 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.04 33.79 23.56 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.326 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.81 120.73 3.11 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.206 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 13' ' ' GLU . 9.1 t30 -85.53 -176.0 5.9 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.539 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 12' ' ' ASN . 29.9 tt0 68.7 159.96 0.18 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.79 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.66 171.69 6.08 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.684 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.716 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 86.9 m-85 -58.2 -27.44 63.9 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.42 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.36 29.02 58.86 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.666 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.67 118.84 37.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.278 . . . . 0.0 110.727 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.18 113.43 25.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.928 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.704 HD21 HD13 ' B' ' 129' ' ' ILE . 5.9 mp -97.06 124.88 41.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.957 0.408 . . . . 0.0 111.342 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -110.33 179.85 20.48 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -132.61 150.18 52.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.194 0.497 . . . . 0.0 111.354 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' B' ' 104' ' ' SER . 7.9 pt20 -134.42 141.56 46.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.794 ' HB ' HG22 ' A' ' 54' ' ' THR . 2.9 mm -87.84 121.63 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.401 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -126.41 171.54 10.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.205 0.526 . . . . 0.0 111.392 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.76 100.46 7.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.853 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -55.76 5.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.082 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -156.58 133.8 10.58 Favored 'General case' 0 N--CA 1.46 0.075 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.559 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.06 145.12 48.82 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.896 0.379 . . . . 0.0 111.28 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.5 m -65.31 120.07 12.1 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.588 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.82 164.59 7.75 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.003 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.63 27.77 14.95 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.34 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.52 -175.18 20.55 Favored Glycine 0 C--N 1.339 0.701 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.182 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.648 HD22 ' O ' ' B' ' 90' ' ' MET . 0.6 OUTLIER -69.01 -31.1 69.69 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.5 ' N ' HD21 ' B' ' 89' ' ' LEU . . . -75.17 -34.88 61.61 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.52 0.2 . . . . 0.0 111.138 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.84 -34.09 45.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.216 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -37.75 85.5 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.49 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -102.41 -32.7 9.86 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.349 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.56 53.92 8.07 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.141 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.67 ' OD1' HG11 ' B' ' 87' ' ' VAL . 5.1 m-80 -70.03 -47.68 61.08 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.523 0.202 . . . . 0.0 111.296 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.638 HD13 ' C ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -116.49 136.17 53.22 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.902 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.81 141.79 28.32 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.207 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -56.99 109.66 0.68 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.186 0.517 . . . . 0.0 110.856 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.8 -7.77 38.95 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.708 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -67.16 138.58 57.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.078 0.466 . . . . 0.0 110.955 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 pt -77.33 120.93 28.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.811 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.915 HG21 HD11 ' A' ' 49' ' ' ILE . 24.1 mt -90.38 152.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.877 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.859 HD13 HD11 ' A' ' 78' ' ' LEU . 2.5 tp -111.7 -52.2 2.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.831 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.14 147.9 40.86 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.838 0.351 . . . . 0.0 111.568 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 46' ' ' ILE . 37.4 mm -132.78 118.35 33.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.456 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.3 m120 53.28 36.71 23.44 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.754 0.311 . . . . 0.0 111.264 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.55 16.74 77.2 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.162 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.615 HG21 HD11 ' A' ' 65' ' ' LEU . 1.6 m -120.54 143.68 48.46 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.905 0.353 . . . . 0.0 110.094 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.449 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.3 t -63.79 143.93 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 111.295 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.794 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -127.72 27.86 5.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.945 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.449 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -123.99 126.76 46.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.013 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 72.0 -5.71 1.66 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.403 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.427 ' CE ' ' HB ' ' A' ' 53' ' ' VAL . 2.3 tpp -67.97 172.59 5.37 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.96 0.409 . . . . 0.0 111.439 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.7 t -90.81 150.96 21.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.244 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -42.01 82.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.793 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.7 t -57.66 -41.94 82.52 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.9 -46.11 86.31 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.95 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' B' ' 102' ' ' LEU . . . -60.22 -41.06 92.28 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.29 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -71.38 -37.33 71.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.435 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -67.92 -38.24 82.66 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.63 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 52' ' ' THR . 0.1 OUTLIER -59.72 -45.39 92.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.81 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.547 ' CD1' HD22 ' B' ' 102' ' ' LEU . 48.5 mt -68.73 -36.82 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.872 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -48.71 62.49 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.879 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.9 -24.52 62.49 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.775 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.4 p -79.38 65.37 4.53 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.116 0.484 . . . . 0.0 110.973 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -78.07 119.92 22.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.696 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.69 -89.45 0.46 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.29 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 ptpp? -126.35 130.22 50.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.625 0.25 . . . . 0.0 110.681 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.663 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.6 OUTLIER -122.78 143.47 49.81 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.947 0.404 . . . . 0.0 111.233 -179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 1.2 tm0? -105.85 142.14 36.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.867 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.484 ' HA ' HD13 ' A' ' 49' ' ' ILE . 1.4 mp -137.71 125.78 22.89 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.914 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.5 t -112.65 133.46 58.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.775 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.53 161.53 41.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.312 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.859 HD11 HD13 ' A' ' 47' ' ' LEU . 6.7 mp -101.42 131.28 47.6 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.257 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -144.14 63.8 1.32 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.538 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -48.81 102.91 0.04 OUTLIER 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.636 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.9 t -73.03 -29.59 63.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.087 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 82' ' ' LEU . 1.9 mp -60.17 135.18 57.64 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.925 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.982 -179.923 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.659 0.266 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp -133.45 140.05 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.273 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.13 158.84 22.16 Favored Glycine 0 C--N 1.333 0.361 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.88 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.67 HG11 ' OD1' ' A' ' 39' ' ' ASN . 15.3 t -129.67 135.05 62.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.691 0.282 . . . . 0.0 111.028 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 7.4 tt -105.35 109.31 21.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.464 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.5 HD21 ' N ' ' A' ' 34' ' ' ALA . 10.6 tp -94.04 141.34 28.64 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . 0.648 ' O ' HD22 ' A' ' 33' ' ' LEU . 13.2 ttt -115.09 165.73 12.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.096 0.474 . . . . 0.0 111.167 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 tppt? -89.74 140.69 29.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.623 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -97.05 102.99 14.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.435 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 56.06 35.56 25.82 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.923 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 67.36 125.33 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.963 0.411 . . . . 0.0 111.478 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -149.81 149.12 30.04 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.195 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -68.5 86.23 0.3 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.675 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 67.13 164.69 0.21 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.155 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.663 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 53.1 m-85 -80.34 -29.52 38.02 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.756 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 91.89 20.04 38.06 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.552 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.415 HD21 ' CB ' ' A' ' 34' ' ' ALA . 4.8 mp -100.1 120.17 39.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.701 0.286 . . . . 0.0 110.804 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.35 113.57 26.77 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.973 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.547 HD22 ' CD1' ' A' ' 66' ' ' ILE . 1.7 pt? -113.51 125.02 53.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.151 0.501 . . . . 0.0 111.339 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -108.16 -162.11 20.85 Favored Glycine 0 C--N 1.332 0.352 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.003 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -141.72 146.51 36.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -126.66 143.19 51.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.222 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 1.063 HD13 ' HB2' ' B' ' 145' ' ' ALA . 30.2 mt -88.4 120.71 37.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -122.15 172.3 8.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.805 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 57.9 t -84.06 94.14 3.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.174 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -64.17 -51.66 62.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.264 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -155.42 133.24 11.32 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.742 0.306 . . . . 0.0 110.784 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -121.45 144.26 48.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 89.3 m -66.51 123.43 20.02 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.01 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -65.53 162.07 18.85 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.127 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 62.03 35.31 16.05 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.122 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -117.94 -175.75 16.93 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.175 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 7' ' ' MET . 4.0 mt -65.43 -33.54 76.19 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.519 0.199 . . . . 0.0 111.48 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.487 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -74.95 -35.06 62.13 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.306 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.86 -33.9 45.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.186 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -62.65 -37.52 86.68 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.303 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.16 -29.93 11.84 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.563 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.75 48.27 43.27 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.289 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.713 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.2 p30 -72.26 -41.64 66.52 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.447 HD13 HD13 ' B' ' 158' ' ' LEU . 2.9 mp -125.48 127.49 46.56 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.665 0.269 . . . . 0.0 110.827 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -89.08 136.35 33.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.0 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -49.71 107.0 0.13 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.051 0.453 . . . . 0.0 111.666 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.68 -2.95 24.65 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.411 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -76.17 139.96 41.5 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 117.654 0.727 . . . . 0.0 111.275 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pt -75.72 113.07 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.068 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 1.028 HG21 HD11 ' B' ' 132' ' ' ILE . 6.8 mt -82.52 137.22 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.294 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 5.8 tp -96.82 -40.24 9.03 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.531 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -148.61 148.23 29.89 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.972 0.415 . . . . 0.0 111.909 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 1.028 HD11 HG21 ' B' ' 129' ' ' ILE . 18.4 mm -135.02 118.22 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.087 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . 0.471 ' HB2' HD21 ' B' ' 148' ' ' LEU . 3.0 t-20 54.88 42.58 30.99 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.988 0.423 . . . . 0.0 111.074 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.14 16.09 76.79 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.139 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 13.2 m -120.74 137.47 54.48 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.934 0.367 . . . . 0.0 110.586 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.513 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.3 t -59.4 145.16 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.034 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.826 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -118.5 18.35 13.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.428 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.513 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.3 OUTLIER -105.67 140.6 38.48 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.3 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 52.64 9.91 0.13 Allowed 'General case' 0 CA--C 1.533 0.304 0 O-C-N 123.705 0.628 . . . . 0.0 112.349 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.73 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -73.89 173.68 9.59 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.946 0.403 . . . . 0.0 111.264 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.19 137.22 32.52 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.956 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.62 -40.73 69.22 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.388 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 1.2 p -64.16 -38.03 89.59 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.218 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.78 -48.22 72.54 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.756 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 1.063 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.49 -42.26 87.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.942 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -69.45 -37.49 77.38 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.576 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 7.0 ttmm -67.81 -38.64 83.53 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.551 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . 0.51 ' O ' HD23 ' B' ' 148' ' ' LEU . 6.7 tt -60.02 -44.85 94.33 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.586 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.547 HD11 HD22 ' A' ' 19' ' ' LEU . 11.8 mt -68.34 -36.64 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.92 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -69.14 -41.75 76.89 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.714 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.1 0.07 52.83 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 97.1 p -91.51 54.8 2.6 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.263 0.554 . . . . 0.0 110.945 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.32 83.94 1.42 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.377 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 159.58 -90.27 0.11 Allowed Glycine 0 C--O 1.226 -0.375 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.302 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.24 133.71 41.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.501 0.191 . . . . 0.0 110.804 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.716 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.64 125.61 38.46 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.146 0.498 . . . . 0.0 111.297 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.497 ' OE1' HD23 ' A' ' 5' ' ' LEU . 2.7 mt-30 -92.33 119.13 31.6 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.447 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.69 HD23 HD12 ' B' ' 132' ' ' ILE . 0.4 OUTLIER -111.41 129.84 55.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.699 0.285 . . . . 0.0 110.988 -179.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 27.0 t -116.48 140.29 39.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.929 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.431 HG21 ' HG ' ' B' ' 123' ' ' LEU . 27.0 t -132.19 138.01 53.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.092 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.18 117.94 27.42 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.861 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -97.43 166.26 11.62 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.922 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -46.85 128.36 10.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.639 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 28.3 m -140.27 172.9 12.09 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.463 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 pp -163.01 172.62 14.73 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.203 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.584 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptm . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.008 0.432 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 pp -130.99 155.61 42.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.253 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.22 158.69 24.45 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.57 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.672 HG11 ' HB3' ' B' ' 122' ' ' ASN . 23.3 t -131.87 134.44 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.68 0.276 . . . . 0.0 110.829 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.15 115.95 30.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.622 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.45 HD21 ' N ' ' B' ' 117' ' ' ALA . 1.6 tp -102.79 142.53 33.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.444 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.634 ' O ' HD22 ' B' ' 116' ' ' LEU . 0.7 OUTLIER -107.47 162.21 14.14 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.218 0.533 . . . . 0.0 110.589 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.487 ' N ' ' HG3' ' A' ' 7' ' ' MET . 11.2 ttpt -97.32 137.79 35.77 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.008 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -128.04 178.94 5.86 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.361 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 71.28 136.83 0.04 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.577 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.88 84.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.044 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 71.43 101.72 0.06 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.932 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -174.21 124.3 0.32 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.993 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -61.11 160.31 10.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.927 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.883 ' CE2' HD23 ' B' ' 156' ' ' LEU . 52.9 m-85 -58.79 -32.97 69.82 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.325 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' O ' HG23 ' B' ' 112' ' ' THR . . . 85.76 20.54 55.8 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.383 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.5 mp -105.31 123.32 47.66 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.872 0.336 . . . . 0.0 110.556 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.413 ' HB2' ' HG2' ' B' ' 110' ' ' GLU . 0.0 OUTLIER -100.73 113.57 26.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.337 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.865 HD22 HD11 ' B' ' 149' ' ' ILE . 1.2 mp -92.39 124.87 36.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.108 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -107.38 -173.84 22.43 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.52 147.34 31.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.291 . . . . 0.0 110.836 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -130.84 133.85 46.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.193 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.969 HD13 ' HB2' ' A' ' 62' ' ' ALA . 46.1 mt -87.94 120.32 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.958 0.408 . . . . 0.0 110.327 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -126.72 173.19 9.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.191 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.816 ' CG2' HD12 ' A' ' 40' ' ' LEU . 60.3 t -85.5 97.71 5.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.018 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -55.4 21.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.266 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -147.19 144.64 29.08 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.922 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.426 ' SD ' HG23 ' A' ' 35' ' ' THR . 0.0 OUTLIER -138.24 148.76 45.08 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.948 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.4 t -65.83 132.86 49.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.056 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -74.72 148.33 40.59 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.566 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.7 31.4 21.11 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.24 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.46 -144.11 16.19 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.355 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 -38.45 17.61 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.71 0.29 . . . . 0.0 111.154 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.487 ' CB ' HD21 ' B' ' 100' ' ' LEU . . . -74.91 -30.17 61.19 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.251 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.426 HG23 ' SD ' ' A' ' 28' ' ' MET . 0.0 OUTLIER -79.14 -35.48 42.05 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.93 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -36.69 84.76 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.991 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.0 -28.14 13.92 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.102 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.34 49.19 53.72 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.081 -0.58 . . . . 0.0 112.507 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.846 ' HB3' HG11 ' B' ' 87' ' ' VAL . 11.8 p-10 -94.12 -32.16 13.87 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.816 HD12 ' CG2' ' A' ' 25' ' ' VAL . 3.3 mm? -114.64 131.08 56.84 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.674 0.273 . . . . 0.0 110.997 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.16 117.91 35.37 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -43.9 108.53 0.11 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.133 0.492 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 109.51 -5.37 31.35 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.346 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.401 ' OD2' HD13 ' A' ' 40' ' ' LEU . 50.3 p-10 -75.85 139.99 42.0 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.854 0.827 . . . . 0.0 111.751 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.4 pt -80.13 118.45 27.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.175 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.645 HD11 HD11 ' B' ' 102' ' ' LEU . 26.4 mt -85.0 134.43 27.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.801 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 tp -99.42 -29.9 12.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.677 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -157.59 148.47 21.27 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.775 0.321 . . . . 0.0 111.425 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.558 HD11 HD21 ' B' ' 102' ' ' LEU . 37.5 mt -140.73 118.12 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.563 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.444 ' HB2' HD21 ' A' ' 65' ' ' LEU . 0.6 OUTLIER 56.52 35.89 26.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.275 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 12.33 83.87 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.176 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.9 m -120.15 135.88 54.81 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.864 0.332 . . . . 0.0 110.398 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.614 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.3 t -59.83 147.46 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.826 0.346 . . . . 0.0 111.037 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.759 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -122.17 19.02 10.75 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.396 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.614 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -106.27 144.4 33.02 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.3 p30 52.58 7.82 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 123.644 0.59 . . . . 0.0 112.376 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.713 ' HB3' HD11 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -76.15 176.58 7.9 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 111.123 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 t -92.12 146.72 23.5 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.756 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.52 -43.93 96.59 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.599 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.4 p -62.47 -38.22 89.0 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.069 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -48.01 75.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.905 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.969 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -62.22 -40.55 96.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.994 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -67.6 -39.28 84.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.77 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -66.59 -38.49 87.12 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.545 ' O ' HD23 ' A' ' 65' ' ' LEU . 6.2 tt -59.91 -45.38 92.73 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.529 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.886 HD11 HD22 ' B' ' 102' ' ' LEU . 5.7 mt -68.5 -37.05 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.94 -49.46 57.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.108 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.48 -19.43 63.75 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.253 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 t -79.33 63.99 4.11 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.196 0.522 . . . . 0.0 110.574 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 mtm105 -79.08 97.72 6.24 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.413 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.67 -93.99 0.18 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.214 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.38 125.96 45.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.581 0.229 . . . . 0.0 110.66 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.843 HD23 ' CE1' ' B' ' 98' ' ' TYR . 2.3 pp -124.73 143.85 50.55 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.896 0.379 . . . . 0.0 111.188 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -105.14 142.65 34.54 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.779 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.755 HD11 HD11 ' A' ' 73' ' ' LEU . 1.0 OUTLIER -135.34 132.28 37.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.819 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.53 135.0 54.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.292 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.5 m -122.98 146.59 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.196 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.9 tp -92.86 116.38 28.99 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.552 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.39 155.89 18.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.476 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 168.34 80.19 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.465 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 t -70.91 104.41 2.94 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.069 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.2 mt 64.42 162.75 0.13 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.597 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.603 HD13 ' N ' ' B' ' 86' ' ' GLY . 0.0 OUTLIER -139.8 124.16 19.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 120.903 0.382 . . . . 0.0 110.751 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.603 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -117.84 157.21 15.27 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.447 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.846 HG11 ' HB3' ' A' ' 39' ' ' ASN . 17.3 t -130.82 134.54 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 0.0 111.063 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 73' ' ' LEU . 0.6 OUTLIER -102.92 107.35 18.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.619 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 9.4 tp -95.19 139.54 31.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.392 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 8.2 ttt -114.52 164.4 14.04 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.993 0.425 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.02 119.15 36.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.172 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 12.8 m -155.4 34.89 0.37 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.917 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.77 115.61 1.63 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.238 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 65.78 123.04 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.864 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -70.04 79.09 0.49 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.71 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -169.92 179.6 3.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.796 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.2 167.18 4.23 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.843 ' CE1' HD23 ' A' ' 73' ' ' LEU . 71.0 m-85 -59.48 -30.6 68.66 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.377 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.44 24.74 32.74 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.512 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.487 HD21 ' CB ' ' A' ' 34' ' ' ALA . 11.2 mp -108.48 120.5 42.6 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.757 0.313 . . . . 0.0 110.699 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -92.91 117.05 29.62 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.761 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.886 HD22 HD11 ' A' ' 66' ' ' ILE . 1.1 tp -94.7 125.2 39.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.116 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -116.46 177.09 16.7 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.658 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.22 146.59 46.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.904 0.352 . . . . 0.0 110.922 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -128.14 137.01 51.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.219 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.966 HD13 ' HB2' ' B' ' 145' ' ' ALA . 42.3 mt -88.27 120.48 37.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.908 0.385 . . . . 0.0 110.457 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -124.73 172.59 9.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.079 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' B' ' 123' ' ' LEU . 40.2 t -82.74 96.03 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.146 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -57.6 6.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.689 0.28 . . . . 0.0 111.178 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -149.28 138.46 21.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.615 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -132.25 140.12 48.52 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.017 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 16' ' ' GLY . 38.6 p -69.37 120.48 15.24 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.788 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.676 ' HA ' HG21 ' B' ' 118' ' ' THR . 8.0 ptt180 -63.04 169.24 3.49 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.738 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m 62.01 23.66 13.97 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.946 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -104.16 -164.51 24.77 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.255 -0.497 . . . . 0.0 112.326 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.634 HD22 ' O ' ' A' ' 7' ' ' MET . 0.0 OUTLIER -77.58 -31.41 53.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.579 0.228 . . . . 0.0 111.295 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.45 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -74.45 -34.96 63.3 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.186 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.676 HG21 ' HA ' ' B' ' 113' ' ' ARG . 2.1 p -79.0 -34.05 44.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.085 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -58.81 -39.53 81.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.264 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -103.92 -29.14 11.15 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.465 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.7 46.26 47.75 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.251 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.672 ' HB3' HG11 ' A' ' 4' ' ' VAL . 12.0 p-10 -73.37 -38.44 65.69 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.514 0.197 . . . . 0.0 111.355 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' B' ' 158' ' ' LEU . 1.5 mp -127.61 139.37 52.78 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.763 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -105.2 148.35 27.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.43 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -60.31 113.32 2.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.086 0.469 . . . . 0.0 110.962 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.48 -16.12 24.38 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.009 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -60.6 136.09 57.95 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 117.317 0.559 . . . . 0.0 111.295 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -80.92 99.15 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.377 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.84 HD13 HD21 ' A' ' 19' ' ' LEU . 4.7 mt -63.52 147.42 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.681 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 18.2 tp -110.28 -35.46 6.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.617 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -157.32 148.26 21.54 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.783 0.325 . . . . 0.0 111.19 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.555 HD11 HD21 ' A' ' 19' ' ' LEU . 43.8 mt -141.04 118.25 8.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.752 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 3.9 m120 53.83 50.52 16.73 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.065 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.15 18.71 60.73 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.031 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 2.9 m -120.57 139.09 53.45 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.702 0.251 . . . . 0.0 110.33 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.611 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.4 t -65.73 145.11 14.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.357 . . . . 0.0 111.293 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.879 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -113.96 -1.79 13.72 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.196 179.38 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.611 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.2 OUTLIER -99.6 150.36 22.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 p30 52.41 8.57 0.08 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.571 0.544 . . . . 0.0 112.242 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.455 ' HB3' HD11 ' B' ' 106' ' ' ILE . 2.9 ttm -90.98 151.0 21.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.722 0.296 . . . . 0.0 110.764 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 30.0 t -71.8 145.78 48.45 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.014 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.489 ' O ' HD23 ' B' ' 142' ' ' LEU . 6.1 tt -60.19 -47.97 83.7 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.705 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 3.2 p -55.52 -38.38 69.15 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.023 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.02 -47.93 69.94 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.69 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.966 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -60.54 -40.81 92.91 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.048 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -67.24 -39.23 86.14 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.664 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -66.85 -38.39 86.3 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.788 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.05 -44.45 94.68 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.772 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.865 HD11 HD22 ' A' ' 19' ' ' LEU . 29.6 mt -68.18 -37.46 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.967 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -68.95 -49.36 58.64 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.811 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -67.83 -25.46 65.57 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.02 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 43.8 t -76.39 65.69 2.32 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.039 0.447 . . . . 0.0 110.632 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -78.7 100.49 7.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.348 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 144.21 -94.78 0.18 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.962 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.9 126.25 46.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.636 0.255 . . . . 0.0 110.898 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.883 HD23 ' CE2' ' A' ' 15' ' ' TYR . 2.1 pp -123.76 132.71 53.86 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.837 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.468 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 0.0 OUTLIER -93.08 142.79 26.9 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.495 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.765 HD21 HD11 ' B' ' 156' ' ' LEU . 0.3 OUTLIER -133.26 128.22 35.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.022 -179.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.43 140.2 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.589 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 14.4 m -130.57 160.69 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.836 0.351 . . . . 0.0 111.184 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.7 123.53 44.02 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.654 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 64.01 169.45 0.17 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.2 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 167.6 144.21 0.02 OUTLIER 'General case' 0 C--O 1.233 0.209 0 C-N-CA 122.828 0.451 . . . . 0.0 110.45 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 1.5 m 61.72 -176.23 0.13 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.404 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.04 171.19 7.48 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.982 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.193 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 tpt . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 120.757 0.313 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.5 HD13 ' C ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -146.95 133.48 13.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.335 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.403 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -120.93 157.03 16.03 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.781 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.528 HG11 ' CB ' ' B' ' 122' ' ' ASN . 21.8 t -130.41 135.21 61.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 0.0 111.352 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' B' ' 157' ' ' GLN . 0.9 OUTLIER -103.12 108.99 20.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.639 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.521 HD23 ' CD2' ' A' ' 15' ' ' TYR . 15.4 tp -98.78 141.93 30.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.736 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 27.3 ttt -118.7 163.51 16.74 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.097 0.475 . . . . 0.0 110.904 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.24 134.69 37.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.072 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -168.63 125.38 1.0 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.695 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.43 35.59 23.0 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.342 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.536 ' HB3' HD11 ' B' ' 116' ' ' LEU . . . -165.48 124.01 1.64 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.276 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -104.42 -174.74 2.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.69 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 58.87 57.65 3.53 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.061 0.457 . . . . 0.0 110.443 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.48 -171.9 0.13 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.275 0.559 . . . . 0.0 110.844 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.584 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 62.0 m-85 -77.29 -9.62 58.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.85 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.55 24.12 71.23 Favored Glycine 0 C--N 1.341 0.851 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.483 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.625 HD11 ' HB2' ' B' ' 117' ' ' ALA . 6.8 mp -105.93 123.52 48.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.657 0.265 . . . . 0.0 110.508 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.19 113.04 24.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.013 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.795 HD22 HD11 ' B' ' 149' ' ' ILE . 9.4 mp -96.79 124.79 40.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' B' ' 109' ' ' LYS . . . -106.57 -168.43 22.69 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.45 ' OG ' HD12 ' B' ' 142' ' ' LEU . 0.1 OUTLIER -144.74 155.45 43.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.281 0.541 . . . . 0.0 110.687 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' B' ' 104' ' ' SER . 2.3 pt20 -136.81 131.35 33.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.799 HD13 ' HB2' ' A' ' 62' ' ' ALA . 40.5 mt -87.72 120.28 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.012 0.434 . . . . 0.0 109.903 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.484 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 42.8 p90 -121.79 173.15 7.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.193 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.793 HG21 ' HB3' ' A' ' 40' ' ' LEU . 32.0 t -83.99 96.58 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.972 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -64.09 -52.57 58.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.932 -179.276 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -163.95 142.89 7.71 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.695 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -134.45 139.01 45.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.046 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.0 t -65.72 126.1 27.38 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.699 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.6 ptt85 -63.9 172.78 2.1 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.028 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.65 27.42 13.2 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.198 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -113.98 -174.17 18.58 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.194 -0.527 . . . . 0.0 112.243 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' B' ' 92' ' ' SER . 2.8 mp -74.78 -26.92 60.09 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.52 -36.87 63.19 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.755 -0.202 . . . . 0.0 111.186 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.99 -33.8 44.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.008 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -65.71 -36.22 83.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.157 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.31 -29.79 12.96 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.406 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.1 42.1 85.26 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.112 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.707 ' HB3' HG11 ' B' ' 87' ' ' VAL . 11.8 p-10 -70.72 -46.24 63.43 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.39 0.138 . . . . 0.0 111.291 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.793 ' HB3' HG21 ' A' ' 25' ' ' VAL . 8.5 mt -114.56 127.11 55.62 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.813 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.75 142.49 29.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.502 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -59.22 109.59 0.89 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.108 0.48 . . . . 0.0 110.465 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.83 -9.65 55.34 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.731 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -60.79 139.64 57.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.103 0.478 . . . . 0.0 111.172 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.19 118.4 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.765 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.463 ' CD1' HD21 ' B' ' 102' ' ' LEU . 34.7 mt -89.09 152.04 3.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.786 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.922 HD13 HD13 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -117.35 -43.12 2.84 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.083 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 148.85 31.79 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.023 0.439 . . . . 0.0 111.958 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.51 ' CD1' HG21 ' A' ' 54' ' ' THR . 66.8 mt -141.27 121.29 12.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.462 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 m120 55.34 34.2 22.37 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.398 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.92 9.58 84.22 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.663 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.2 m -119.86 138.16 53.57 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.155 0.478 . . . . 0.0 110.333 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.2 t -57.12 145.82 7.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.124 0.488 . . . . 0.0 111.006 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.661 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -130.54 28.88 4.88 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.972 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.523 ' H ' HG12 ' A' ' 53' ' ' VAL . 8.5 tt0 -98.3 -102.0 0.21 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.428 ' HB2' ' CD1' ' B' ' 142' ' ' LEU . 6.7 p30 -66.37 -2.86 4.96 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.513 ' HB3' HD11 ' A' ' 23' ' ' ILE . 1.2 tpt -52.77 164.18 0.39 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.167 0.508 . . . . 0.0 111.7 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.9 m -79.01 147.35 32.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.592 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.42 ' CD1' ' HB2' ' B' ' 139' ' ' ASN . 0.5 OUTLIER -61.99 -46.54 88.77 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.781 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.1 t -59.56 -41.77 90.9 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.83 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -66.85 -43.13 84.46 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.702 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.799 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -61.21 -42.46 98.63 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.055 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -68.59 -38.59 80.79 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.463 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -38.4 82.78 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.816 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -43.5 98.44 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.75 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.816 HD11 HD22 ' B' ' 102' ' ' LEU . 11.4 mt -68.55 -38.08 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.709 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -68.49 -49.49 59.37 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.651 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -23.11 66.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.343 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.0 m -76.1 68.27 2.53 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.962 0.411 . . . . 0.0 110.67 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -77.0 119.29 20.53 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.505 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 119.84 -94.03 0.56 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.278 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.69 127.25 43.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.705 0.288 . . . . 0.0 110.804 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.872 HD23 ' CE2' ' B' ' 98' ' ' TYR . 2.2 pp -119.49 133.69 55.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 4.9 mm-40 -93.56 142.69 27.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.91 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.698 HD21 HD11 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -133.82 123.82 25.46 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.756 0.312 . . . . 0.0 110.919 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.53 134.42 53.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.032 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 46' ' ' ILE . 35.0 m -128.62 150.13 34.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.785 0.326 . . . . 0.0 111.549 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.922 HD13 HD13 ' A' ' 47' ' ' LEU . 3.8 tp -91.18 136.1 33.32 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.281 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.87 -169.09 1.97 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.63 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.07 136.27 0.03 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.782 0.325 . . . . 0.0 110.827 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.1 t -80.42 164.34 23.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.182 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.19 175.13 10.3 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.199 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.089 -0.958 . . . . 0.0 111.165 179.89 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.543 0.211 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pp -126.98 143.31 40.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.204 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.27 157.75 15.63 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.56 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.707 HG11 ' HB3' ' A' ' 39' ' ' ASN . 17.7 t -130.53 135.22 60.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.618 0.246 . . . . 0.0 111.206 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.51 113.99 27.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.81 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.463 HD23 ' CD1' ' B' ' 98' ' ' TYR . 2.2 tp -105.02 144.67 31.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . 0.631 ' O ' HD22 ' A' ' 33' ' ' LEU . 4.0 ttt -109.74 163.9 13.06 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.202 0.525 . . . . 0.0 110.848 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.45 138.39 34.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.089 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . 0.708 ' HB3' HD11 ' A' ' 33' ' ' LEU . 60.4 p -117.47 141.99 47.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.743 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 65.41 106.95 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.759 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.98 70.63 1.04 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.072 0.463 . . . . 0.0 110.801 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -138.46 -49.79 0.55 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.579 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -127.24 178.84 5.78 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.132 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . 0.61 ' OE2' HG22 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -94.1 -179.78 5.06 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.729 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.872 ' CE2' HD23 ' A' ' 73' ' ' LEU . 72.2 m-85 -51.51 -31.5 24.18 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.49 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.14 26.62 65.92 Favored Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.579 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 5.0 mp -101.14 119.47 38.8 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.682 0.277 . . . . 0.0 110.664 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.01 113.37 25.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.294 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.816 HD22 HD11 ' A' ' 66' ' ' ILE . 1.1 mp -97.01 125.11 41.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.203 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -108.91 -179.0 21.52 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.427 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.411 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -146.62 144.74 29.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.018 0.409 . . . . 0.0 111.101 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.413 ' NE2' HG21 ' B' ' 128' ' ' ILE . 5.7 pt20 -130.65 137.91 49.82 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.164 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.927 HD13 ' HB2' ' B' ' 145' ' ' ALA . 18.8 mt -87.93 120.6 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.337 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -122.13 172.11 8.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.231 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' B' ' 123' ' ' LEU . 40.9 t -80.97 96.71 3.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.772 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . 0.427 ' HD3' ' HA3' ' A' ' 20' ' ' GLY . 0.4 OUTLIER -67.07 -57.06 7.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.103 -179.167 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -155.13 147.68 24.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.657 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -138.13 147.9 44.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 111.007 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -65.28 121.86 15.79 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.849 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.642 ' HA ' HG21 ' B' ' 118' ' ' THR . 20.0 ttt180 -69.04 157.03 37.61 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.556 HG22 ' O ' ' B' ' 113' ' ' ARG . 0.5 OUTLIER 68.68 14.16 8.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.484 -179.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -93.59 -158.26 33.79 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.302 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 11' ' ' ALA . 1.2 mp -81.85 -30.43 32.09 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.528 0.204 . . . . 0.0 111.543 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.625 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -75.06 -34.23 61.8 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.362 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.642 HG21 ' HA ' ' B' ' 113' ' ' ARG . 0.8 OUTLIER -79.12 -33.96 43.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -37.8 85.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.353 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.89 -26.43 12.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.729 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 66.57 44.64 89.46 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.085 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.528 ' CB ' HG11 ' A' ' 4' ' ' VAL . 9.5 p30 -58.75 -44.64 90.59 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.553 ' HB3' HG21 ' B' ' 108' ' ' VAL . 4.7 mp -133.14 142.51 48.71 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.692 0.282 . . . . 0.0 111.048 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.05 144.47 25.45 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.432 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -59.6 111.15 1.31 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.18 0.514 . . . . 0.0 111.185 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.69 -9.0 23.84 Favored Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.411 -0.813 . . . . 0.0 113.186 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -68.1 135.55 52.35 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 117.307 0.553 . . . . 0.0 110.558 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.413 HG21 ' NE2' ' B' ' 105' ' ' GLN . 1.9 pt -77.63 113.7 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.754 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.434 ' HA ' HG12 ' B' ' 160' ' ' VAL . 16.3 mt -81.6 133.98 28.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.268 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.424 HD13 HD13 ' B' ' 161' ' ' LEU . 5.0 tp -95.17 -38.81 10.42 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.241 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -147.32 148.03 30.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.883 0.373 . . . . 0.0 111.694 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . . . . . . . . . 26.0 mt -136.35 119.43 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.414 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 57.11 40.66 28.18 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.841 0.353 . . . . 0.0 111.024 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.5 15.4 77.42 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.142 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.84 141.56 50.45 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 117.0 0.4 . . . . 0.0 110.389 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.573 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.2 t -60.17 147.87 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.051 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.684 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -121.69 20.31 11.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.807 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.573 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.5 tt0 -105.75 138.53 41.79 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.473 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 59' ' ' LEU . 11.4 p30 52.98 9.95 0.14 Allowed 'General case' 0 CA--C 1.536 0.418 0 O-C-N 123.618 0.574 . . . . 0.0 112.295 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.415 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.3 OUTLIER -71.77 172.08 10.44 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.771 0.319 . . . . 0.0 111.483 179.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 44.8 t -91.38 142.64 27.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.059 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.45 HD12 ' OG ' ' A' ' 21' ' ' SER . 2.7 tt -59.18 -42.52 91.05 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.643 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 27.1 p -60.37 -39.67 88.06 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.771 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -48.21 74.83 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.957 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.927 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -60.81 -41.01 94.82 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.88 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -66.3 -39.92 89.67 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.437 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -38.23 82.33 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.398 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . 0.407 ' HA ' ' HG2' ' B' ' 151' ' ' LYS . 0.8 OUTLIER -59.97 -44.78 94.24 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.687 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.795 HD11 HD22 ' A' ' 19' ' ' LEU . 11.3 mt -68.49 -36.69 75.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.885 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.05 -48.85 61.78 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.81 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' B' ' 148' ' ' LEU . 0.5 OUTLIER -66.01 -26.23 67.44 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.487 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.0 m -74.18 69.32 1.52 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.126 0.489 . . . . 0.0 110.729 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.45 80.27 6.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.524 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 160.46 -81.94 0.14 Allowed Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.025 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.1 125.89 25.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.544 0.211 . . . . 0.0 110.906 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.584 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -123.41 141.09 52.35 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.958 0.408 . . . . 0.0 111.226 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.401 ' HB2' HD21 ' A' ' 5' ' ' LEU . 29.3 tt0 -102.77 136.86 41.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.727 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mt -131.85 129.87 40.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.971 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 34.2 t -115.0 136.26 52.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.786 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' B' ' 129' ' ' ILE . 10.0 m -141.19 161.91 22.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.912 0.386 . . . . 0.0 111.39 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.424 HD13 HD13 ' B' ' 130' ' ' LEU . 6.7 mp -120.73 122.94 41.48 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.687 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -82.05 67.78 8.19 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.193 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 61.42 102.44 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.578 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.13 -60.29 2.39 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.749 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 mp -141.68 34.26 1.62 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.177 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.67 179.768 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpp? . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.655 0.264 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.627 HD13 ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -127.59 142.36 43.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.199 -179.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.627 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -138.57 156.78 24.31 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.867 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.825 HG11 ' HB3' ' B' ' 122' ' ' ASN . 19.5 t -129.06 134.27 64.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.868 0.366 . . . . 0.0 111.208 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.68 107.31 18.19 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.517 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.479 HD21 ' N ' ' B' ' 117' ' ' ALA . 5.5 tp -94.47 137.47 33.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.501 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.478 ' O ' HD13 ' B' ' 116' ' ' LEU . 17.5 ttt -113.65 163.81 14.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.991 0.424 . . . . 0.0 110.639 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.96 132.84 36.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.802 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.7 t -73.52 -171.55 1.02 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.047 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -74.79 69.24 1.81 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.052 0.454 . . . . 0.0 110.996 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.55 111.2 0.67 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.618 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -64.95 86.28 0.05 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.789 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -160.84 164.34 31.41 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.842 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -71.79 167.51 19.79 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.794 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.866 ' CE1' HD23 ' B' ' 156' ' ' LEU . 64.6 m-85 -67.21 -27.69 67.46 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.526 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 76.69 23.18 70.57 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.384 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.672 ' CD2' HD13 ' B' ' 123' ' ' LEU . 0.2 OUTLIER -98.77 120.23 38.86 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.593 0.235 . . . . 0.0 110.761 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.96 113.4 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.076 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.541 HD22 HD11 ' B' ' 149' ' ' ILE . 5.1 mp -99.12 124.85 44.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.163 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -108.85 -169.17 20.81 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.37 152.72 39.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.167 0.483 . . . . 0.0 110.582 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.466 ' NE2' HG21 ' A' ' 45' ' ' ILE . 6.9 pt20 -136.37 137.25 40.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.38 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.805 ' HB ' HG22 ' A' ' 54' ' ' THR . 41.0 mt -88.03 120.37 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.131 0.491 . . . . 0.0 110.204 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.416 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 45.5 p90 -121.0 172.33 8.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.109 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.685 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.7 t -82.19 94.51 2.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.015 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 0.2 OUTLIER -62.7 -52.33 63.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.042 -179.379 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.09 144.03 20.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.807 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.422 ' HE1' ' HB1' ' A' ' 34' ' ' ALA . 10.1 ptp -132.26 145.49 51.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.153 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -66.95 119.89 12.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.958 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.01 154.8 9.06 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.056 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.1 m 63.62 30.28 14.97 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.918 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.49 -173.16 25.94 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.158 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.569 HD22 ' O ' ' B' ' 90' ' ' MET . 0.3 OUTLIER -67.49 -32.26 72.96 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HB1' ' HE1' ' A' ' 28' ' ' MET . . . -74.37 -35.81 63.54 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.024 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -34.07 44.29 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.046 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -39.94 77.54 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.563 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.35 -33.81 8.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.513 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.2 56.77 3.61 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.105 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.701 ' HB3' HG11 ' B' ' 87' ' ' VAL . 0.4 OUTLIER -93.45 -52.76 4.35 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.543 0.211 . . . . 0.0 110.942 -179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.685 ' HB3' HG21 ' A' ' 25' ' ' VAL . 5.9 mp -103.34 116.43 32.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.579 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.52 138.1 31.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.371 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.29 110.14 0.58 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.209 0.528 . . . . 0.0 110.875 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.99 -9.95 29.46 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.693 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -65.97 137.5 57.17 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-O 121.036 0.446 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.466 HG21 ' NE2' ' A' ' 22' ' ' GLN . 3.3 pt -78.47 110.79 14.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.671 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.699 HD13 HD21 ' B' ' 102' ' ' LEU . 8.3 mt -77.76 133.95 29.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.921 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.401 HD13 ' HB2' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -91.11 -46.16 8.27 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.547 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HB2' ' CG2' ' A' ' 76' ' ' VAL . 7.5 mttt -154.21 152.23 30.11 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.953 0.406 . . . . 0.0 111.48 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.501 HD11 HD21 ' B' ' 102' ' ' LEU . 48.7 mt -137.33 118.18 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.3 m120 53.58 39.66 30.38 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.426 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.48 14.63 82.28 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.489 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.1 m -119.95 137.57 53.97 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 117.042 0.421 . . . . 0.0 110.279 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.3 t -60.63 144.32 13.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.092 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.805 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -128.4 26.71 5.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.365 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 9.8 tt0 -97.29 -109.92 0.16 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -63.45 -5.32 3.53 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.2 tpt -49.33 164.09 0.09 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.231 0.538 . . . . 0.0 111.895 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.7 147.26 45.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.587 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.453 HD11 ' OG ' ' B' ' 104' ' ' SER . 1.4 mp -62.92 -51.53 66.55 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.261 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.0 t -57.64 -38.69 75.47 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.301 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -64.17 -47.82 78.38 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.632 0.253 . . . . 0.0 110.766 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.804 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -58.81 -42.01 88.13 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.239 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 51.4 mtt-85 -69.65 -38.23 77.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.771 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -38.45 84.51 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.828 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.9 tp -60.51 -43.75 96.76 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.89 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.872 HD11 HD22 ' B' ' 102' ' ' LEU . 10.1 mt -68.25 -37.3 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 110.692 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -49.75 59.53 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.769 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -68.32 -23.42 64.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.163 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.6 t -82.17 61.95 5.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 110.711 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -78.99 118.76 21.29 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.447 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.11 -99.77 0.59 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.966 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -118.03 131.58 56.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.754 0.311 . . . . 0.0 110.873 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.797 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -128.16 144.24 51.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.039 -179.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.12 128.47 54.42 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.39 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.544 HD11 HD21 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -125.7 128.6 48.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.446 -179.261 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.549 HG12 ' HA3' ' B' ' 86' ' ' GLY . 4.5 m -120.08 120.1 62.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.468 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -109.42 156.82 10.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.612 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.401 ' HB2' HD13 ' A' ' 47' ' ' LEU . 10.3 tt -111.2 125.25 53.6 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.87 -176.39 4.97 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.606 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 65.4 93.0 0.07 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.902 0.382 . . . . 0.0 111.042 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.5 p -95.49 29.41 2.58 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.544 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mt -159.24 -64.09 0.08 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.819 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.148 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 2.6 ptt? . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.532 0.206 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.3 pp -131.73 146.61 33.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.354 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.549 ' HA3' HG12 ' A' ' 76' ' ' VAL . . . -129.83 160.59 22.85 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.831 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.701 HG11 ' HB3' ' A' ' 39' ' ' ASN . 21.1 t -130.71 131.75 64.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.781 0.324 . . . . 0.0 111.0 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 9.3 mp -95.35 113.1 24.74 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.671 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.626 HD23 ' CD1' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -102.82 144.68 30.83 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.881 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . 0.569 ' O ' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -117.86 171.52 8.01 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.462 0.648 . . . . 0.0 111.125 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -89.65 135.98 33.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.26 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . 0.532 ' CB ' HD11 ' A' ' 33' ' ' LEU . 3.8 m -118.88 179.22 4.21 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.009 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -85.05 82.52 8.4 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.955 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.1 -146.25 0.34 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.442 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 35.7 t-20 -72.9 -69.08 0.43 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.678 0.275 . . . . 0.0 110.529 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.07 134.28 0.33 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.796 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 64.61 174.08 0.2 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.797 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 70.0 m-85 -67.31 -26.56 66.58 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.306 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.98 25.68 68.58 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.472 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.613 HD13 ' HB3' ' B' ' 98' ' ' TYR . 7.8 mp -105.51 116.01 31.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.716 0.293 . . . . 0.0 110.385 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 125.7 34.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.528 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.872 HD22 HD11 ' A' ' 66' ' ' ILE . 2.2 mp -104.95 124.86 50.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.493 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -116.2 172.18 14.1 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.391 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.453 ' OG ' HD11 ' A' ' 59' ' ' LEU . 2.1 p -128.77 151.09 49.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 117.419 0.609 . . . . 0.0 111.763 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -133.41 136.97 45.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.162 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.756 ' HB ' HG22 ' B' ' 137' ' ' THR . 50.8 mt -87.98 120.16 36.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.963 0.411 . . . . 0.0 110.36 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -122.51 173.11 7.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.266 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.679 HG21 ' HB3' ' B' ' 123' ' ' LEU . 35.2 t -82.72 97.82 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.845 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.39 -47.76 63.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.048 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -162.56 145.2 10.99 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.473 ' HB2' HD12 ' A' ' 17' ' ' LEU . 11.3 ptt? -134.84 155.6 50.37 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.854 0.359 . . . . 0.0 111.166 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.36 120.07 12.14 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.702 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 145.36 47.71 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.135 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.7 27.89 14.84 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.156 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -96.33 -150.76 27.33 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.559 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 7' ' ' MET . 3.6 mt -84.38 -34.1 23.65 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.592 ' CB ' HD12 ' B' ' 123' ' ' LEU . . . -72.88 -32.26 65.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.176 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.81 -34.9 44.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.046 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -63.7 -36.41 83.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.162 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -98.21 -33.96 10.91 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.297 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.38 40.1 41.15 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.401 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.825 ' HB3' HG11 ' A' ' 4' ' ' VAL . 14.6 p-10 -92.4 -36.64 13.02 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.469 0.176 . . . . 0.0 111.399 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.679 ' HB3' HG21 ' B' ' 108' ' ' VAL . 1.6 mt -98.73 74.99 2.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.913 0.387 . . . . 0.0 111.115 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.03 130.73 47.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.561 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -56.63 108.08 0.45 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.271 0.558 . . . . 0.0 110.85 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.69 -13.05 46.59 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.785 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -58.53 137.17 57.59 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 121.2 0.524 . . . . 0.0 111.087 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pt -81.57 114.21 22.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.661 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.54 ' CD1' HD21 ' A' ' 19' ' ' LEU . 36.6 mt -84.85 149.51 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.072 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.693 HD13 HD12 ' B' ' 161' ' ' LEU . 8.3 tp -113.63 -41.54 3.6 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.751 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -147.23 148.31 31.35 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.894 0.378 . . . . 0.0 111.769 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.456 HD11 HG21 ' B' ' 137' ' ' THR . 23.2 mt -138.92 119.77 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.391 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.44 38.16 29.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.47 15.2 81.68 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.211 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . 0.451 ' CB ' HD11 ' B' ' 148' ' ' LEU . 39.3 m -120.61 141.21 50.53 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.965 0.382 . . . . 0.0 110.347 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.49 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.1 t -62.56 144.16 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.256 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.756 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -122.37 19.67 10.53 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.296 179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.49 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.2 OUTLIER -116.8 128.52 55.37 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 70.24 -3.51 1.8 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.188 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.459 ' HG3' ' N ' ' B' ' 141' ' ' SER . 0.1 OUTLIER -73.3 149.87 42.36 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.79 0.328 . . . . 0.0 110.496 179.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . 0.459 ' N ' ' HG3' ' B' ' 140' ' ' MET . 33.4 t -71.49 150.08 45.19 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.372 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.08 -45.14 87.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.261 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 34.9 p -56.31 -40.22 74.02 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.08 -46.42 71.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.763 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.74 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -62.3 -39.83 94.29 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.338 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -70.23 -37.36 74.98 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.82 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.13 -38.79 82.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.634 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . 0.451 HD11 ' CB ' ' B' ' 135' ' ' THR . 0.2 OUTLIER -60.19 -44.03 95.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.032 179.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.541 HD11 HD22 ' A' ' 19' ' ' LEU . 12.3 mt -68.38 -37.01 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.864 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.13 -49.69 54.72 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.067 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.21 -28.04 69.1 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.168 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 30.2 t -75.35 79.73 2.42 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 110.773 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -88.67 121.64 31.25 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.599 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 115.32 -92.22 0.58 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.308 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.46 135.05 53.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.639 0.257 . . . . 0.0 110.983 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.866 HD23 ' CE1' ' A' ' 15' ' ' TYR . 2.5 pp -122.59 133.3 54.55 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 38.7 tt0 -99.35 139.09 35.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.148 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.617 HD13 ' CD2' ' B' ' 123' ' ' LEU . 3.9 tt -137.29 142.08 41.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.839 0.352 . . . . 0.0 111.368 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 6.9 t -122.04 130.44 74.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.297 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.527 HG13 ' CD2' ' B' ' 158' ' ' LEU . 31.9 m -121.2 146.41 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.693 HD12 HD13 ' B' ' 130' ' ' LEU . 0.6 OUTLIER -88.75 128.46 35.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.73 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 63.01 -176.75 0.15 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.889 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 65.0 105.03 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.461 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 2.6 m -162.29 155.03 19.77 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.47 152.86 23.65 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.755 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.518 -0.754 . . . . 0.0 111.477 -179.912 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 120.55 0.214 . . . . 0.0 111.459 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.9 pp -143.14 156.66 17.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.421 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.42 168.46 23.09 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.978 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.758 HG21 ' HB2' ' B' ' 122' ' ' ASN . 23.5 t -128.51 132.94 67.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.658 0.266 . . . . 0.0 110.978 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.63 HD23 ' CD ' ' B' ' 155' ' ' LYS . 1.8 mp -95.79 124.28 39.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.8 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' B' ' 117' ' ' ALA . 1.1 mp -108.31 134.25 51.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.623 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 51.3 ttm -109.11 163.83 12.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.239 0.543 . . . . 0.0 111.06 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.9 tttm -86.38 141.19 29.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.064 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 1.4 m -150.96 129.87 12.49 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.59 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 9' ' ' SER . 20.3 mtm180 72.25 138.51 0.05 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.527 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.78 82.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.005 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -128.59 148.16 50.76 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.481 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.84 108.27 2.09 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.673 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 49.05 -172.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.333 0.587 . . . . 0.0 112.243 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.859 ' CE1' HD23 ' B' ' 156' ' ' LEU . 62.8 m-85 -77.81 -32.72 52.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.499 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.09 22.93 28.69 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.576 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.487 HD11 ' CB ' ' B' ' 117' ' ' ALA . 3.6 mp -102.76 119.09 38.23 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.647 0.26 . . . . 0.0 110.738 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.432 ' HB3' ' HG3' ' B' ' 110' ' ' GLU . 0.0 OUTLIER -98.73 124.25 43.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.88 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.863 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.7 pt? -122.42 124.96 44.84 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.204 0.526 . . . . 0.0 111.741 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.24 -169.56 21.33 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.584 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.7 OUTLIER -146.75 148.76 32.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.162 0.481 . . . . 0.0 111.167 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -131.19 146.54 52.37 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.37 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.978 HD13 ' HB2' ' A' ' 62' ' ' ALA . 5.6 mt -88.8 121.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.995 0.426 . . . . 0.0 111.045 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.41 ' CD1' ' HG2' ' B' ' 105' ' ' GLN . 39.7 p90 -121.5 172.83 7.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.017 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.653 HG21 ' HG ' ' A' ' 40' ' ' LEU . 38.7 t -86.3 96.65 5.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.126 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -63.11 -57.26 11.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.92 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -151.57 135.43 16.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.94 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.419 ' HB3' HD23 ' B' ' 100' ' ' LEU . 0.0 OUTLIER -116.8 148.28 41.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.6 t -65.28 142.05 58.4 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.074 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.09 154.72 26.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 55.37 29.23 12.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.466 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.24 -165.72 25.67 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.097 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.606 HD13 ' O ' ' B' ' 90' ' ' MET . 0.3 OUTLIER -77.19 -30.32 54.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.614 0.207 . . . . 0.0 111.429 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.861 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -73.78 -35.85 64.98 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.216 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.64 -33.75 46.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.096 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -38.67 87.09 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.376 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -101.22 -31.81 10.82 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.641 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.1 43.21 27.06 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.177 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.479 ' CG ' HD13 ' A' ' 40' ' ' LEU . 1.7 p30 -51.42 -49.57 61.37 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.155 0.182 . . . . 0.0 111.328 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.653 ' HG ' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -138.93 157.76 45.44 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.869 0.366 . . . . 0.0 111.13 179.01 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.24 147.29 25.3 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.598 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -58.25 109.97 0.86 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.302 0.573 . . . . 0.0 110.935 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.93 -4.28 28.86 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.745 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -70.55 135.44 48.52 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.201 0.524 . . . . 0.0 111.099 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 pt -78.87 111.49 15.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.493 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.741 ' HB ' HG21 ' A' ' 54' ' ' THR . 53.8 mt -79.77 146.1 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.302 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.534 HD22 ' CD1' ' A' ' 78' ' ' LEU . 19.3 tp -107.46 -37.58 6.17 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.73 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -146.04 147.76 31.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.874 0.369 . . . . 0.0 111.591 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 23.8 mt -137.7 118.34 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.69 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.514 ' HB2' HD21 ' A' ' 65' ' ' LEU . 5.5 m120 52.92 35.69 19.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.874 0.368 . . . . 0.0 111.383 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.68 15.89 74.52 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.146 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -120.89 141.05 50.98 Favored 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 117.061 0.43 . . . . 0.0 110.383 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.573 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.4 t -59.86 144.44 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.876 0.37 . . . . 0.0 111.078 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.741 HG21 ' HB ' ' A' ' 46' ' ' ILE . 2.7 m -116.42 13.69 15.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.891 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.573 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -116.94 133.22 56.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.838 ' HA ' HD21 ' B' ' 142' ' ' LEU . 5.2 m-80 71.36 -6.18 1.42 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.391 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.506 ' HB3' HD11 ' A' ' 23' ' ' ILE . 1.1 tpt -69.75 170.89 10.06 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.846 0.355 . . . . 0.0 110.987 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -89.94 139.73 30.32 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.051 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.527 HD12 ' OG ' ' B' ' 104' ' ' SER . 6.1 tt -55.89 -44.57 78.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.605 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -58.9 -40.14 83.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.821 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.2 -46.78 76.07 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.784 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.978 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -59.83 -42.1 92.82 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.951 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.35 -37.9 80.95 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.581 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -68.05 -38.56 82.62 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.719 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.527 ' C ' HD23 ' A' ' 65' ' ' LEU . 9.2 tt -61.13 -43.92 98.13 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.724 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.666 HD11 HD22 ' B' ' 102' ' ' LEU . 8.0 mt -68.6 -37.03 77.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.023 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -69.16 -49.12 59.69 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.749 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.36 -25.06 67.87 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.372 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.3 t -77.51 68.12 3.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.083 0.468 . . . . 0.0 110.723 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.1 mtt85 -84.06 66.46 9.24 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.397 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 176.89 -75.61 0.07 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.659 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.94 128.94 29.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.711 -0.245 . . . . 0.0 111.242 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.79 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.9 OUTLIER -125.7 132.34 52.41 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.958 0.408 . . . . 0.0 111.077 179.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.589 ' O ' HD13 ' A' ' 75' ' ' LEU . 4.2 tt0 -102.15 136.41 42.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.621 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.603 HD22 ' N ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -127.12 130.71 50.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.9 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.28 133.93 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.254 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.2 m -131.07 165.68 30.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.811 0.339 . . . . 0.0 111.443 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.534 ' CD1' HD22 ' A' ' 47' ' ' LEU . 1.3 mp -115.44 116.86 28.93 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.089 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.05 115.61 17.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.707 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.36 116.01 1.05 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.453 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 91.2 p -66.93 116.81 8.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.048 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.2 -51.71 0.09 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.883 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.244 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.01 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 1.9 mtt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.861 0.363 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.507 ' C ' HD13 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -145.96 124.65 5.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.904 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.454 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -118.57 157.99 14.98 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.835 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 39' ' ' ASN . 18.8 t -125.46 134.78 65.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.698 0.285 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.42 125.6 50.76 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.713 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.531 HD11 ' O ' ' A' ' 33' ' ' LEU . 11.0 tp -119.02 138.6 52.72 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.243 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . 0.606 ' O ' HD13 ' A' ' 33' ' ' LEU . 3.0 ttt -100.45 163.87 12.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 139.82 32.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.119 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' B' ' 93' ' ' ARG . 0.5 OUTLIER -104.67 124.75 49.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.788 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' B' ' 92' ' ' SER . 3.1 mmm180 69.18 134.26 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.808 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -73.64 67.48 1.13 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.074 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -174.16 145.3 1.04 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.281 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 65.73 160.4 0.13 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.98 0.419 . . . . 0.0 111.535 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.95 178.35 5.69 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.672 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.79 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 52.3 m-85 -57.97 -25.37 60.92 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.388 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 83.24 17.76 66.14 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.319 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.861 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -100.63 114.93 29.03 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 113.38 24.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.27 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.666 HD22 HD11 ' A' ' 66' ' ' ILE . 0.9 OUTLIER -100.14 124.92 46.11 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.107 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.45 172.99 15.51 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.5 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.527 ' OG ' HD12 ' A' ' 59' ' ' LEU . 1.1 p -124.43 153.6 41.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.996 0.398 . . . . 0.0 111.167 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 21' ' ' SER . 2.4 pt20 -134.23 134.29 41.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.164 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.983 HD13 ' HB2' ' B' ' 145' ' ' ALA . 19.9 mt -87.76 120.52 36.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.034 0.445 . . . . 0.0 109.866 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.462 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 47.8 p90 -121.8 173.72 7.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.218 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.82 HG21 ' HB3' ' B' ' 123' ' ' LEU . 39.8 t -84.68 101.49 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.107 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . 0.462 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 5.6 mmtt -70.35 -53.23 17.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.732 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.432 ' HG3' ' HB3' ' A' ' 18' ' ' ARG . 5.1 pt-20 -161.72 145.08 12.31 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.798 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -138.37 139.32 38.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.878 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 10.0 t -65.39 125.7 25.92 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.473 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.726 ' HA ' HG21 ' B' ' 118' ' ' THR . 0.0 OUTLIER -75.6 61.38 1.32 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.333 0.587 . . . . 0.0 111.3 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.41 27.17 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.955 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -130.11 -173.65 13.46 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.598 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.34 -32.17 72.08 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.595 0.236 . . . . 0.0 111.273 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.514 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -65.8 -41.19 92.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.325 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.726 HG21 ' HA ' ' B' ' 113' ' ' ARG . 11.0 m -78.91 -33.01 45.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.821 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.67 -39.37 84.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.269 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.74 -32.76 9.68 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.618 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.89 40.12 26.55 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.275 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.758 ' HB2' HG21 ' A' ' 4' ' ' VAL . 7.1 p-10 -71.04 -47.05 60.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.389 0.138 . . . . 0.0 111.207 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.82 ' HB3' HG21 ' B' ' 108' ' ' VAL . 21.0 mt -92.8 119.74 32.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.676 0.274 . . . . 0.0 110.717 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.6 136.87 34.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.459 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -58.45 107.76 0.54 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.164 0.507 . . . . 0.0 110.534 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 102.49 -7.84 54.27 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.64 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -63.02 138.92 58.7 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 121.154 0.502 . . . . 0.0 111.252 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' B' ' 161' ' ' LEU . 1.3 pt -76.41 121.73 29.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.707 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.562 HG21 HD11 ' B' ' 132' ' ' ILE . 12.7 mt -89.66 135.02 27.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 tp -97.1 -41.94 8.1 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.579 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -148.5 147.92 29.65 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.792 0.33 . . . . 0.0 111.487 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.661 HG22 HD22 ' B' ' 133' ' ' ASN . 20.1 mt -141.41 119.65 9.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.662 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . 0.661 HD22 HG22 ' B' ' 132' ' ' ILE . 67.4 m-80 58.3 40.55 24.44 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.243 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.54 10.11 79.01 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.396 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.44 138.79 52.23 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 117.138 0.469 . . . . 0.0 110.204 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.602 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.3 t -59.45 147.93 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.163 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.807 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.3 OUTLIER -121.64 20.48 11.03 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.709 -179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.602 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.3 OUTLIER -110.8 130.71 55.5 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 73.01 -10.49 0.99 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.499 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.703 ' HB3' HD11 ' B' ' 106' ' ' ILE . 1.2 tpt -65.49 169.21 6.3 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 121.016 0.436 . . . . 0.0 111.052 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 25.0 t -92.54 150.18 20.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.288 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.838 HD21 ' HA ' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -58.56 -44.15 89.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.89 179.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 8.9 t -59.25 -40.19 85.16 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.631 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.28 -44.98 82.04 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.716 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.983 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -60.79 -41.77 96.25 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.019 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.7 -37.82 76.75 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.37 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -67.86 -38.42 83.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.526 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -44.76 93.15 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.651 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.506 HD12 HD22 ' A' ' 19' ' ' LEU . 59.1 mt -68.3 -36.95 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 120.685 0.278 . . . . 0.0 110.763 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -69.18 -49.08 59.91 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.882 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -70.2 -23.3 62.93 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.613 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 80.1 p -79.06 66.29 4.47 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.122 0.486 . . . . 0.0 110.625 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -74.55 126.6 31.12 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.544 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 115.12 -90.36 0.53 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.452 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.63 ' CD ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -128.18 133.94 48.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.69 0.281 . . . . 0.0 110.617 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.859 HD23 ' CE1' ' A' ' 15' ' ' TYR . 2.0 pp -124.59 144.26 50.25 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.412 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 55.5 tt0 -109.51 141.6 41.74 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.79 HD11 HD11 ' B' ' 156' ' ' LEU . 1.1 mt -135.02 132.5 38.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.972 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.02 137.78 49.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.297 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 7.8 m -135.21 161.77 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.818 0.342 . . . . 0.0 111.403 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.549 ' HB3' HD11 ' B' ' 128' ' ' ILE . 4.9 tt -119.72 125.82 49.57 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.017 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.459 ' O ' HD23 ' B' ' 161' ' ' LEU . 30.5 mtt180 -99.5 168.54 9.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.897 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -46.24 146.69 1.29 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.933 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.47 157.54 26.33 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.304 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 3.8 tt -160.71 -59.79 0.06 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.162 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.612 -0.709 . . . . 0.0 111.296 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.566 0.222 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.684 HD13 ' N ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -145.46 131.91 14.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.944 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.684 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -139.45 156.81 24.82 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.835 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.551 HG11 ' CB ' ' B' ' 122' ' ' ASN . 18.1 t -131.34 134.63 60.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.777 0.322 . . . . 0.0 111.041 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.24 107.12 17.81 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.732 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.444 HD21 ' C ' ' B' ' 116' ' ' LEU . 6.4 tp -92.7 134.79 34.68 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.289 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.97 171.37 7.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.387 0.613 . . . . 0.0 111.354 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.8 pttt -87.12 128.77 35.11 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.564 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.402 ' H ' HD11 ' B' ' 116' ' ' LEU . 2.6 m -162.86 47.69 0.15 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.837 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -143.93 63.35 1.34 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.746 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 57.17 25.37 10.88 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.967 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.0 79.87 0.1 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.018 0.437 . . . . 0.0 111.725 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -158.12 70.49 0.55 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.757 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 47.91 -173.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.712 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 77.7 m-85 -100.28 -24.99 14.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.809 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.59 30.9 65.87 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.546 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' B' ' 117' ' ' ALA . 0.0 OUTLIER -104.94 123.84 48.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.658 0.266 . . . . 0.0 110.942 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.423 ' HB2' ' HG3' ' B' ' 110' ' ' GLU . 0.0 OUTLIER -100.19 113.22 25.73 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.08 179.487 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.746 HD22 HD11 ' B' ' 149' ' ' ILE . 8.0 mp -94.15 124.84 38.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.024 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -111.18 172.09 14.85 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.531 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.558 ' OG ' HD11 ' B' ' 142' ' ' LEU . 0.3 OUTLIER -132.47 149.02 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.006 0.403 . . . . 0.0 111.223 -179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' B' ' 104' ' ' SER . 7.0 pt20 -131.94 141.53 49.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.181 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.767 ' HB ' HG22 ' A' ' 54' ' ' THR . 4.1 mm -87.81 121.69 38.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.304 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -125.93 171.5 10.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.413 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.771 HG21 ' HB3' ' A' ' 40' ' ' LEU . 44.7 t -84.36 100.18 7.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.04 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -56.12 8.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.893 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -157.15 145.84 19.74 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.992 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.627 ' SD ' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER -137.53 143.8 41.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.274 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.8 p -65.71 121.08 14.18 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.616 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.68 163.85 6.76 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.204 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 62.88 25.09 14.9 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.278 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.37 -169.09 25.76 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.391 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.549 HD13 ' O ' ' B' ' 90' ' ' MET . 0.3 OUTLIER -73.75 -30.17 62.64 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.81 -35.09 62.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.642 0.258 . . . . 0.0 111.025 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.627 HG23 ' SD ' ' A' ' 28' ' ' MET . 1.2 p -78.68 -34.18 46.39 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.133 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -61.73 -38.15 86.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.197 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -98.98 -30.69 12.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.273 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.05 47.02 25.92 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.037 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.808 ' HB3' HG11 ' B' ' 87' ' ' VAL . 12.4 p-10 -85.31 -40.0 17.04 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.771 ' HB3' HG21 ' A' ' 25' ' ' VAL . 3.3 mm? -106.34 125.46 51.02 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.652 0.263 . . . . 0.0 111.07 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 132.12 41.25 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.236 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.02 107.07 0.43 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.225 0.536 . . . . 0.0 111.012 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.87 -9.07 43.4 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.917 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -69.56 144.07 53.19 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.26 0.553 . . . . 0.0 111.294 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.411 ' O ' HG13 ' A' ' 77' ' ' VAL . 20.2 pt -81.65 116.59 26.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.666 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.571 HG21 HD11 ' A' ' 49' ' ' ILE . 6.0 mt -83.03 137.72 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.947 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.442 HD12 HD12 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -91.71 -51.5 5.21 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.5 -179.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -150.52 152.19 33.8 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.71 0.29 . . . . 0.0 111.2 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.571 HD11 HG21 ' A' ' 46' ' ' ILE . 29.7 mt -140.67 118.11 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.86 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.53 39.85 30.6 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.177 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.56 3.95 87.08 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.728 -0.749 . . . . 0.0 113.207 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.2 m -107.71 129.76 55.0 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.0 t -61.64 146.15 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.979 0.418 . . . . 0.0 111.079 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.767 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -120.41 22.76 11.18 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.354 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.574 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -127.24 124.62 39.32 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.147 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 72.35 -9.23 1.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.444 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -69.94 174.48 5.26 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.868 0.366 . . . . 0.0 111.146 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.62 132.31 34.19 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.007 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.577 HD12 ' OG ' ' B' ' 104' ' ' SER . 7.9 tt -54.25 -42.83 70.36 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.751 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.8 p -63.6 -38.48 91.27 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.085 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.2 -48.13 74.46 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.075 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.401 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -59.33 -40.52 86.59 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.227 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.69 -37.62 76.68 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.792 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.15 -38.68 82.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.776 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.513 ' O ' HD13 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -59.71 -44.21 93.81 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.787 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 73' ' ' LEU . 8.2 mt -67.97 -37.47 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.825 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.86 -49.56 67.71 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.806 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -65.94 -26.74 67.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.423 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 86.0 p -84.85 60.69 6.35 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.114 0.483 . . . . 0.0 110.791 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -73.46 96.67 2.42 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.839 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 153.36 -92.19 0.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.249 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.28 130.45 52.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.709 0.29 . . . . 0.0 110.353 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.839 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.7 OUTLIER -129.51 139.69 51.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.21 0.528 . . . . 0.0 111.528 -179.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.471 ' OE1' HG23 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -98.12 138.59 35.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.999 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.515 HD11 HD21 ' A' ' 73' ' ' LEU . 1.6 mp -136.6 127.62 27.75 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.741 0.305 . . . . 0.0 111.316 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.471 HG23 ' OE1' ' A' ' 74' ' ' GLN . 25.4 t -113.53 134.45 56.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.372 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 45' ' ' ILE . 18.7 t -129.26 140.81 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.073 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.442 HD12 HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -86.69 137.62 32.31 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.749 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -87.75 54.93 3.28 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.037 0.446 . . . . 0.0 110.883 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.83 163.99 4.12 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.735 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.6 p -113.21 156.37 23.39 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.428 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.8 tp -135.35 121.75 20.49 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.026 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 117.917 -1.04 . . . . 0.0 110.885 -179.893 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 3.3 ttp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 120.794 0.33 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.06 132.75 39.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.013 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -129.63 160.96 22.84 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.744 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.808 HG11 ' HB3' ' A' ' 39' ' ' ASN . 26.3 t -130.77 135.1 60.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 120.72 0.295 . . . . 0.0 111.289 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tt -97.87 109.07 21.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.536 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.486 HD23 ' CD1' ' B' ' 98' ' ' TYR . 1.1 tp -104.44 144.84 31.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.075 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . 0.549 ' O ' HD13 ' A' ' 33' ' ' LEU . 38.9 ttm -113.13 164.19 13.81 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.117 0.484 . . . . 0.0 110.657 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . 0.404 ' HG3' ' CE2' ' B' ' 98' ' ' TYR . 10.6 mtpt -92.19 148.59 22.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.141 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -77.37 -174.25 3.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.83 26.4 9.11 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.571 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -166.03 37.4 0.05 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.641 0.258 . . . . 0.0 111.692 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.87 154.08 34.36 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.976 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -84.87 114.15 21.9 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.313 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 49.3 -173.23 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.686 0.616 . . . . 0.0 112.185 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.839 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 52.0 m-85 -72.86 -31.57 64.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.274 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.98 17.39 72.46 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.563 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 mp -97.96 118.41 34.49 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -99.41 113.36 25.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.188 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.466 HD23 ' H ' ' B' ' 102' ' ' LEU . 1.7 pt? -110.95 125.08 53.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.165 0.507 . . . . 0.0 111.16 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -107.4 -162.66 21.67 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.278 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.577 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.3 OUTLIER -144.77 145.75 31.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.732 0.301 . . . . 0.0 110.856 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 21' ' ' SER . 7.7 pt20 -128.12 140.35 51.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.496 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.848 ' HB ' HG22 ' B' ' 137' ' ' THR . 45.3 mt -88.14 120.38 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.495 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -121.62 172.94 7.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.874 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 1.039 HG21 HD13 ' B' ' 123' ' ' LEU . 42.9 t -81.66 93.51 2.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.31 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -63.51 -50.48 69.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.013 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.423 ' HG3' ' HB2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -165.21 149.03 8.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.651 ' SD ' HD11 ' B' ' 123' ' ' LEU . 9.1 mtm -128.4 161.4 29.56 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.061 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.423 HG23 ' HA3' ' B' ' 115' ' ' GLY . 10.1 t -65.62 125.36 25.0 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.708 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -57.85 136.52 57.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.21 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.9 m 60.86 30.28 19.55 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.05 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . 0.423 ' HA3' HG23 ' B' ' 112' ' ' THR . . . -87.6 -156.43 30.02 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.447 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.444 ' C ' HD21 ' A' ' 6' ' ' LEU . 13.4 mt -82.44 -30.12 30.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.511 0.196 . . . . 0.0 111.349 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.497 ' HB2' HD11 ' A' ' 17' ' ' LEU . . . -75.23 -34.69 61.46 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.285 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.9 -33.85 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.074 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -38.69 84.54 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.374 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -103.04 -29.88 11.1 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.673 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 70.68 44.21 57.74 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.151 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.551 ' CB ' HG11 ' A' ' 4' ' ' VAL . 8.5 p30 -63.31 -39.89 95.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.464 0.173 . . . . 0.0 111.341 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 1.039 HD13 HG21 ' B' ' 108' ' ' VAL . 4.1 pp -133.26 163.88 28.31 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.923 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.5 135.16 52.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.62 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -53.77 113.09 1.07 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.188 0.518 . . . . 0.0 111.076 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.08 -14.5 23.65 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.527 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -66.22 136.64 56.17 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.129 0.49 . . . . 0.0 110.887 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 5.8 pt -74.75 117.49 19.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.663 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.941 HG21 HD11 ' B' ' 132' ' ' ILE . 27.3 mm -83.19 137.55 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.909 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 13.4 tp -98.67 -40.94 7.93 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.001 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -150.03 150.83 32.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.969 0.414 . . . . 0.0 111.806 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.996 HD12 HD23 ' B' ' 158' ' ' LEU . 34.4 mm -137.01 118.82 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.89 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . 0.528 ' HB2' HD11 ' B' ' 148' ' ' LEU . 4.5 m-80 56.2 31.54 18.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.682 0.277 . . . . 0.0 111.228 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.89 -2.3 85.65 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.178 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 13.4 m -104.66 131.98 51.45 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.075 0.437 . . . . 0.0 110.227 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.588 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.1 t -56.44 147.16 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.937 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.848 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -118.55 19.54 13.25 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.588 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.4 OUTLIER -106.6 134.43 49.75 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 52.18 12.24 0.2 Allowed 'General case' 0 CA--C 1.535 0.376 0 O-C-N 123.636 0.585 . . . . 0.0 112.175 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.22 173.38 5.72 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.413 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.3 141.36 30.13 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.166 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.558 HD11 ' OG ' ' A' ' 21' ' ' SER . 2.9 mp -58.41 -47.93 82.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.028 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 4.5 t -63.04 -37.06 85.7 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.776 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -65.61 -48.12 73.36 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.815 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.635 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -59.77 -41.15 90.45 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.397 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 17.8 mtt85 -68.27 -38.66 81.95 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.629 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -67.5 -38.35 84.17 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.698 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' B' ' 133' ' ' ASN . 0.2 OUTLIER -59.97 -44.17 94.63 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.915 179.595 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.746 HD11 HD22 ' A' ' 19' ' ' LEU . 5.3 mt -68.17 -38.09 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.832 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.01 -48.47 62.94 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.922 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -69.53 -19.07 63.71 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.266 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 3.2 m -74.33 69.77 1.63 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.922 0.391 . . . . 0.0 110.772 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -82.97 120.3 25.53 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.716 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.69 -88.94 0.51 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.515 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.04 130.65 51.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.683 0.278 . . . . 0.0 110.809 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.712 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -120.04 130.97 54.95 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.095 0.474 . . . . 0.0 111.394 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 9.4 tt0 -93.75 135.43 35.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.68 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.996 HD23 HD12 ' B' ' 132' ' ' ILE . 0.5 OUTLIER -131.4 127.99 38.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.934 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 20.9 t -114.15 145.64 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.491 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.437 HG12 HD13 ' B' ' 129' ' ' ILE . 27.1 m -136.74 161.26 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.178 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' B' ' 161' ' ' LEU . 9.0 tp -89.19 118.63 29.03 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.38 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.41 139.31 1.66 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.646 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 21.6 t0 59.37 87.18 0.08 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.032 0.444 . . . . 0.0 111.174 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.15 112.4 17.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.738 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.16 154.96 32.47 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.091 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.152 179.928 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.602 ' CE ' HD22 ' B' ' 130' ' ' LEU . 4.0 tpt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.571 0.224 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.9 tt -145.8 123.18 4.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.113 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.8 156.87 21.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.711 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' B' ' 122' ' ' ASN . 24.9 t -132.67 134.18 58.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.777 0.322 . . . . 0.0 110.872 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.86 107.04 18.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.691 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.523 HD21 ' N ' ' B' ' 117' ' ' ALA . 2.8 tp -91.87 134.01 35.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.312 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.9 ttt -123.09 163.18 21.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.127 0.489 . . . . 0.0 110.911 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.44 115.99 30.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.537 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.1 m -140.65 36.94 1.82 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.184 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.99 107.05 0.13 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.723 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 65.38 121.65 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.425 0.453 . . . . 0.0 111.447 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -69.64 83.48 0.44 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.939 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -145.78 165.34 29.11 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.795 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -66.53 169.91 6.95 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.206 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.77 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 78.6 m-85 -73.76 -27.95 61.43 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.67 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' HG23 ' B' ' 112' ' ' THR . . . 77.97 27.59 58.08 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.653 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mp -108.04 121.07 44.07 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.748 0.308 . . . . 0.0 110.737 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -102.42 113.73 27.31 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.06 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.9 pt? -105.46 125.18 50.69 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.211 0.529 . . . . 0.0 112.098 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.36 -178.53 21.89 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.611 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.403 ' OG ' HD12 ' B' ' 142' ' ' LEU . 1.2 p -132.4 148.59 52.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.296 0.548 . . . . 0.0 111.565 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.465 ' NE2' HG21 ' A' ' 45' ' ' ILE . 9.9 pt20 -135.37 145.73 47.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.593 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.699 HD12 HG23 ' A' ' 54' ' ' THR . 4.8 mt -88.42 121.34 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.036 0.446 . . . . 0.0 111.051 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -122.28 172.32 8.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.957 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.597 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.3 t -84.01 97.5 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.92 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.77 -58.5 4.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.306 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -149.2 136.46 20.01 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.34 134.61 36.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.072 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.1 p -73.23 127.64 33.19 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.518 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.806 ' HA ' HG21 ' A' ' 35' ' ' THR . 14.7 ptt-85 -72.91 65.69 0.75 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.254 0.55 . . . . 0.0 111.219 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.41 25.38 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.023 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.22 -172.63 13.39 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.714 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.676 HD22 ' H ' ' B' ' 90' ' ' MET . 1.6 mp -69.97 -30.5 67.87 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.639 0.22 . . . . 0.0 111.567 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.593 ' CB ' HD21 ' B' ' 100' ' ' LEU . . . -68.62 -41.3 79.69 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.544 0.212 . . . . 0.0 111.133 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.806 HG21 ' HA ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -78.78 -33.4 46.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.827 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -65.49 -36.42 83.81 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.188 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.58 -32.33 11.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.483 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.0 40.15 57.5 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.268 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.717 ' ND2' HD11 ' B' ' 89' ' ' LEU . 4.4 p30 -83.01 -31.06 27.65 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.425 0.155 . . . . 0.0 111.311 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.9 HD11 HD22 ' A' ' 75' ' ' LEU . 4.6 mt -115.28 123.67 49.39 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.699 0.285 . . . . 0.0 110.96 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.06 139.71 30.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.443 179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.88 110.24 0.77 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 110.664 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.82 -11.25 45.53 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.705 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -58.84 138.13 57.42 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 121.05 0.452 . . . . 0.0 111.201 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.465 HG21 ' NE2' ' A' ' 22' ' ' GLN . 1.1 pt -84.13 99.15 6.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.248 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.598 HD13 HD21 ' B' ' 102' ' ' LEU . 5.7 mt -64.82 139.33 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.552 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.689 ' CD1' HD12 ' A' ' 78' ' ' LEU . 1.1 tp -92.62 -38.98 11.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.416 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -149.95 150.7 32.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.745 0.307 . . . . 0.0 111.388 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.7 mt -138.1 118.1 15.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.402 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.641 ' HB2' HD11 ' A' ' 65' ' ' LEU . 4.2 m120 53.14 41.95 32.16 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.277 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.73 6.13 76.54 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.972 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.3 m -104.98 131.59 52.3 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.2 144.88 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.791 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.699 HG23 HD12 ' A' ' 23' ' ' ILE . 20.7 m -109.95 23.1 14.81 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.419 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -126.2 130.6 51.28 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.344 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.0 p30 51.53 11.63 0.13 Allowed 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.762 0.664 . . . . 0.0 112.718 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.519 ' SD ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -69.23 -174.77 0.68 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.899 0.38 . . . . 0.0 111.114 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.8 124.6 35.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.993 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tt -58.39 -44.19 88.85 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.784 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.455 ' O ' ' HG3' ' A' ' 63' ' ' ARG . 7.1 t -63.5 -37.33 86.9 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.01 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -34.72 62.84 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.653 0.264 . . . . 0.0 110.593 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.577 ' HB1' HD13 ' A' ' 23' ' ' ILE . . . -65.37 -43.34 91.08 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.24 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 60' ' ' THR . 1.4 ptt180 -71.97 -36.81 69.92 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.52 -37.85 83.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.239 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.641 HD11 ' HB2' ' A' ' 50' ' ' ASN . 2.9 tm? -59.41 -45.25 92.05 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.794 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.513 HD13 ' HB2' ' B' ' 102' ' ' LEU . 7.2 mt -68.77 -37.58 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.947 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -49.34 56.61 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.931 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -23.36 67.2 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.258 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.5 m -76.03 67.81 2.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.986 0.422 . . . . 0.0 110.805 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 -90.85 53.16 2.32 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.705 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -171.83 -82.46 0.05 OUTLIER Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.294 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.83 126.38 36.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.637 0.256 . . . . 0.0 110.742 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.748 HD23 ' CE1' ' B' ' 98' ' ' TYR . 0.2 OUTLIER -129.9 134.55 47.57 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.289 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -92.01 140.68 29.41 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.939 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.9 HD22 HD11 ' A' ' 40' ' ' LEU . 1.2 mp -134.07 128.14 33.63 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.962 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 46' ' ' ILE . 19.8 t -115.78 142.95 26.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.851 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.468 HG22 ' O ' ' B' ' 85' ' ' ILE . 35.9 m -129.62 155.43 41.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 120.798 0.332 . . . . 0.0 111.39 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.689 HD12 ' CD1' ' A' ' 47' ' ' LEU . 0.9 OUTLIER -109.34 121.04 44.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.093 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.421 ' HB2' HD12 ' A' ' 82' ' ' LEU . 0.0 OUTLIER -99.34 41.45 1.15 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.152 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 46.43 66.23 1.01 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.819 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.19 104.38 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.204 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 83' ' ' GLU . 0.5 OUTLIER -115.95 142.47 46.74 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.537 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.463 ' H ' HD23 ' A' ' 82' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.548 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 4.3 mtm . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.767 0.318 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 77' ' ' VAL . 18.1 tt -132.2 134.27 59.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.055 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 76' ' ' VAL . . . -123.62 158.63 18.23 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.671 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.621 HG21 ' HB2' ' A' ' 39' ' ' ASN . 21.3 t -131.5 134.0 61.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.856 0.36 . . . . 0.0 111.255 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.63 107.92 19.48 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.408 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.717 HD11 ' ND2' ' A' ' 39' ' ' ASN . 7.1 mp -96.37 144.73 26.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . 0.676 ' H ' HD22 ' A' ' 33' ' ' LEU . 9.8 ttt -116.35 163.57 15.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.814 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.89 133.67 36.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.155 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.91 175.46 10.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.091 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 40.5 mtt85 -94.23 57.69 2.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -173.42 101.21 0.12 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.365 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 1.1 t30 69.24 160.76 0.2 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.32 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -83.16 175.26 10.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.197 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 68.39 167.61 0.26 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.611 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.748 ' CE1' HD23 ' A' ' 73' ' ' LEU . 38.1 m-85 -93.86 -6.95 44.6 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.844 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.98 9.99 86.46 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.648 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.593 HD21 ' CB ' ' A' ' 34' ' ' ALA . 3.7 mp -105.7 115.06 29.6 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.659 0.266 . . . . 0.0 110.518 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.45 113.27 21.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.979 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.598 HD21 HD13 ' A' ' 46' ' ' ILE . 1.6 mp -96.77 124.75 40.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.064 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.28 174.84 15.55 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.558 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -133.17 144.73 50.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.983 0.391 . . . . 0.0 111.083 -179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -131.43 144.77 51.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.324 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.776 HG13 HG22 ' B' ' 137' ' ' THR . 0.9 OUTLIER -88.31 121.35 38.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.006 0.431 . . . . 0.0 110.803 -179.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.418 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 32.1 p90 -119.26 171.82 8.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.665 HG21 ' HB3' ' B' ' 123' ' ' LEU . 35.5 t -79.69 91.91 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.97 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . 0.418 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -63.39 -45.54 90.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.971 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -163.49 132.14 3.84 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.718 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.92 146.88 50.15 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.826 0.346 . . . . 0.0 111.31 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 16' ' ' GLY . 74.4 p -65.29 123.56 19.89 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.885 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 18.9 ttm105 -63.72 155.26 30.63 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.854 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.28 30.53 19.92 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.262 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.35 -168.74 26.81 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.24 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 2.6 mt -65.24 -36.74 85.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.538 0.208 . . . . 0.0 111.168 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.523 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -74.87 -33.14 62.05 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.387 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.77 -34.26 45.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.122 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -37.94 86.67 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.222 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.16 -30.57 12.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.484 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.15 51.5 10.07 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.314 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.554 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.0 p-10 -87.12 -44.73 11.3 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.665 ' HB3' HG21 ' B' ' 108' ' ' VAL . 7.9 mp -123.46 124.84 43.77 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.741 0.305 . . . . 0.0 111.1 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -94.65 151.77 19.03 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.493 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -60.42 111.29 1.51 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.176 0.513 . . . . 0.0 111.048 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.28 -18.49 20.85 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.96 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -61.13 135.12 57.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 117.162 0.481 . . . . 0.0 110.523 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.63 120.76 30.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.264 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.401 HG21 HG12 ' B' ' 132' ' ' ILE . 29.0 mt -87.95 137.92 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.772 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.602 HD22 ' CE ' ' A' ' 1' ' ' MET . 2.8 tp -100.14 -35.65 9.59 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.546 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . 0.448 ' HE3' HG22 ' B' ' 136' ' ' VAL . 14.4 mttp -150.44 147.97 28.18 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 111.4 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.696 HG23 HD23 ' B' ' 158' ' ' LEU . 14.9 mt -140.66 118.42 9.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.541 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 5.8 m120 57.03 47.5 17.37 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.969 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 66.2 17.28 65.75 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.236 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 75.6 m -120.91 137.13 54.74 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 116.753 0.276 . . . . 0.0 110.286 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.594 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.6 t -69.71 145.24 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.875 0.369 . . . . 0.0 110.851 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.776 HG22 HG13 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -114.8 0.65 13.87 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.815 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.594 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.0 OUTLIER -84.77 129.14 34.86 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.206 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 69.95 -4.12 1.57 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.633 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -70.02 171.12 10.02 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.965 0.412 . . . . 0.0 111.156 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 3.6 m -91.91 146.97 23.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.28 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.403 HD12 ' OG ' ' A' ' 21' ' ' SER . 2.8 tt -61.55 -44.91 96.18 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.887 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 23.3 p -57.5 -46.29 83.93 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.115 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.87 -46.31 89.98 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.003 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 1.06 ' HB1' HD11 ' A' ' 19' ' ' LEU . . . -59.27 -41.69 89.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.119 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 13.7 ttt180 -70.36 -37.24 74.56 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.411 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -38.41 82.81 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.745 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 7.2 tt -59.67 -45.19 92.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.697 HD12 HD22 ' A' ' 19' ' ' LEU . 35.0 mt -68.37 -36.89 76.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.807 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -61.79 -48.25 81.48 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.786 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 -25.23 66.46 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.383 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 70.7 m -74.59 78.36 1.99 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.886 0.374 . . . . 0.0 110.536 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -94.21 46.94 1.18 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.185 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -165.85 -83.34 0.05 OUTLIER Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.378 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -128.03 131.36 49.16 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 122.291 0.236 . . . . 0.0 110.521 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.77 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.5 OUTLIER -129.9 136.48 49.56 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.001 0.429 . . . . 0.0 111.285 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 12.8 tt0 -97.39 140.95 31.09 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.551 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.696 HD23 HG23 ' B' ' 132' ' ' ILE . 5.0 mt -135.92 125.09 24.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.154 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 18.8 t -114.64 133.03 62.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.698 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.458 HG11 ' HG ' ' B' ' 123' ' ' LEU . 30.0 m -129.05 162.42 36.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.846 0.355 . . . . 0.0 111.284 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.531 HD13 ' HE1' ' A' ' 1' ' ' MET . 9.6 tp -124.13 127.05 47.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -93.36 95.14 9.13 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.382 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.86 162.81 1.65 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.787 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 1.7 m 72.07 179.18 0.24 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.432 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . 0.422 HD22 ' N ' ' B' ' 165' ' ' LEU . 3.6 mm? -103.0 112.25 24.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.747 0.308 . . . . 0.0 110.672 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.318 -179.737 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.737 0.303 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.487 HD13 ' C ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -127.66 123.3 60.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.904 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.455 ' N ' HD13 ' A' ' 2' ' ' ILE . . . -117.45 159.09 14.25 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.924 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.769 HG11 ' HB3' ' B' ' 122' ' ' ASN . 21.0 t -123.92 134.57 66.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.789 0.328 . . . . 0.0 111.154 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.96 116.5 30.32 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.738 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.482 HD21 ' N ' ' B' ' 117' ' ' ALA . 8.4 tp -109.79 144.53 38.09 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.731 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 22.7 ttt -112.39 163.2 14.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.188 0.518 . . . . 0.0 110.837 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -81.43 144.82 31.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.079 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.424 ' HB2' HD12 ' B' ' 116' ' ' LEU . 0.2 OUTLIER -113.87 -169.08 1.44 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.866 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -78.57 64.06 3.52 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.899 0.38 . . . . 0.0 110.758 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.62 43.91 2.93 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 65.36 -81.87 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.092 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 11.8 pt-20 -158.21 163.89 37.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.52 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 13' ' ' GLU . 19.5 tt0 69.48 151.08 0.09 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.034 0.445 . . . . 0.0 111.507 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.808 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 43.8 m-85 -86.48 -28.19 23.6 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.089 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.34 20.42 32.57 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.625 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.0 mp -101.78 119.35 38.65 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.666 0.233 . . . . 0.0 110.678 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -96.25 113.52 25.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.81 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.98 HD11 ' HB1' ' B' ' 145' ' ' ALA . 1.5 pt? -108.13 124.76 50.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.18 0.514 . . . . 0.0 111.48 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -108.24 -166.25 21.24 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.922 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.3 OUTLIER -146.12 145.04 30.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.836 0.318 . . . . 0.0 111.254 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.581 ' NE2' HG21 ' A' ' 45' ' ' ILE . 5.4 pt20 -125.24 138.88 54.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.885 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.781 ' HB ' HG22 ' A' ' 54' ' ' THR . 34.9 mt -88.0 120.49 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.649 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CE2' ' HD2' ' A' ' 26' ' ' LYS . 46.6 p90 -123.55 171.15 9.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.15 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.6 t -81.47 98.68 4.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.775 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HD2' ' CE2' ' A' ' 24' ' ' PHE . 1.6 tptp -70.46 -55.53 8.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.049 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -157.06 135.97 11.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.859 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.3 ptt? -120.55 150.74 40.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 111.244 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.6 m -66.36 122.31 17.24 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.96 162.68 18.73 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.925 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.24 30.84 20.19 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.358 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.74 -161.29 16.39 Favored Glycine 0 C--N 1.338 0.694 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.116 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.11 -31.43 39.18 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.868 0.334 . . . . 0.0 111.809 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.592 ' CB ' HD11 ' B' ' 100' ' ' LEU . . . -74.88 -37.41 62.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.521 0.2 . . . . 0.0 111.117 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.89 -33.62 45.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.225 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -59.52 -39.37 83.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.565 0.221 . . . . 0.0 111.491 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -102.63 -34.43 9.08 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.38 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.77 53.81 7.0 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.743 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.696 ' ND2' HD11 ' B' ' 89' ' ' LEU . 13.0 m-80 -75.74 -36.99 59.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.421 0.153 . . . . 0.0 111.369 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.757 HD11 HD13 ' A' ' 75' ' ' LEU . 2.8 mp -129.16 138.44 51.77 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.775 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.98 145.71 25.2 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.694 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -61.38 112.36 2.15 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.208 0.528 . . . . 0.0 111.188 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.77 -10.76 18.54 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.015 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -67.53 134.66 51.7 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 117.291 0.546 . . . . 0.0 110.215 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.581 HG21 ' NE2' ' A' ' 22' ' ' GLN . 1.2 pt -77.54 111.7 14.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.835 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.9 mt -77.4 138.72 19.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.051 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.7 tp -101.05 -38.05 8.34 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.24 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -149.81 148.06 28.74 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 120.943 0.401 . . . . 0.0 111.763 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.639 HG22 HD22 ' A' ' 50' ' ' ASN . 14.2 mt -139.58 118.6 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.155 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.639 HD22 HG22 ' A' ' 49' ' ' ILE . 67.8 m-80 56.86 37.08 28.57 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.31 6.66 88.85 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.594 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.6 m -114.12 138.97 49.73 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 117.166 0.483 . . . . 0.0 110.381 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.596 HG12 ' H ' ' A' ' 55' ' ' GLU . 3.1 t -59.45 147.69 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.781 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -123.39 19.85 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.808 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.596 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -116.51 128.48 55.48 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 70.09 -4.38 1.54 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.606 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.5 173.89 5.49 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.937 0.399 . . . . 0.0 111.238 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.9 143.17 27.53 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.265 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -41.49 86.87 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.692 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.6 p -63.63 -39.39 94.24 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.011 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -65.67 -48.59 71.59 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.837 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.804 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -61.37 -39.43 90.59 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.461 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -72.46 -37.52 68.5 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.452 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -67.89 -38.27 82.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.715 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -45.28 92.54 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.552 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 57.5 mt -68.58 -36.78 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.912 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -68.94 -49.48 57.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.776 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -67.07 -24.42 65.97 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.314 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.6 t -75.49 71.33 2.42 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.03 0.443 . . . . 0.0 110.781 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.07 91.32 8.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.39 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.84 -83.02 0.15 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.082 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.504 ' HB3' HD21 ' B' ' 88' ' ' LEU . 5.0 mttp -136.93 122.88 20.17 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.465 0.306 . . . . 0.0 110.455 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.584 HD23 ' CE1' ' B' ' 98' ' ' TYR . 0.4 OUTLIER -108.62 141.46 40.53 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 111.315 -179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.502 ' HB2' HD12 ' B' ' 88' ' ' LEU . 1.3 tt0 -107.98 141.68 39.26 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.848 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.757 HD13 HD11 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -135.29 125.3 25.87 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.982 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.8 t -111.6 132.12 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.373 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.36 168.35 23.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.187 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.49 116.89 31.64 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.8 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.558 ' HG3' HG21 ' B' ' 85' ' ' ILE . 0.0 OUTLIER -85.62 111.93 20.52 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.707 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -53.54 155.73 2.88 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.34 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.7 35.31 4.84 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.436 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.5 mt -89.81 155.57 19.08 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.718 0.294 . . . . 0.0 110.599 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.142 -0.933 . . . . 0.0 110.807 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.621 0.248 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.558 HG21 ' HG3' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -134.13 119.11 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.925 0.393 . . . . 0.0 111.048 179.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.498 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -132.24 158.04 22.76 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.666 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.589 HG11 ' CG ' ' A' ' 39' ' ' ASN . 15.2 t -131.47 135.17 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.73 0.3 . . . . 0.0 111.391 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 72' ' ' LYS . 1.1 tt -102.58 124.12 47.55 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.572 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.696 HD11 ' ND2' ' A' ' 39' ' ' ASN . 8.8 mp -106.08 124.49 49.66 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.758 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . 0.46 ' HB3' ' CG ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -96.97 155.74 16.65 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.042 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -88.67 119.4 29.11 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.375 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.41 144.45 22.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.761 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 58.54 33.32 23.01 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.499 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -169.31 125.26 0.88 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.056 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.66 29.52 3.68 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.164 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.26 -179.64 5.91 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.6 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -55.83 159.75 2.98 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 110.827 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.584 ' CE1' HD23 ' A' ' 73' ' ' LEU . 76.0 m-85 -60.31 -26.27 66.41 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.21 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.88 21.14 54.09 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.866 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.592 HD11 ' CB ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -95.76 122.84 38.97 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.733 0.301 . . . . 0.0 110.691 179.791 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.17 113.24 26.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.929 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.804 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.7 pt? -109.32 124.8 51.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.247 0.546 . . . . 0.0 111.074 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 23' ' ' ILE . . . -105.09 -164.76 23.93 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.898 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.31 150.07 37.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.909 0.385 . . . . 0.0 110.831 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.429 HE22 HG22 ' B' ' 128' ' ' ILE . 0.0 OUTLIER -130.02 135.98 48.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.819 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.931 HD13 ' HB2' ' B' ' 145' ' ' ALA . 83.2 mt -87.91 120.89 37.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.874 0.369 . . . . 0.0 110.51 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.424 ' CE2' ' HG2' ' B' ' 109' ' ' LYS . 42.5 p90 -123.16 172.11 8.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.129 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.751 ' CG2' HD23 ' B' ' 123' ' ' LEU . 35.6 t -83.47 97.32 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.136 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . 0.424 ' HG2' ' CE2' ' B' ' 107' ' ' PHE . 0.0 OUTLIER -65.31 -52.11 56.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.033 -179.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -162.31 138.49 7.63 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.879 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -121.66 152.48 39.3 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.907 0.384 . . . . 0.0 111.311 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 23.4 m -78.84 127.62 32.28 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.798 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 165.39 12.07 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.065 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.24 28.72 15.88 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.52 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.54 -174.94 19.97 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.318 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 9' ' ' SER . 0.0 OUTLIER -72.04 -28.9 63.66 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.482 ' N ' HD21 ' A' ' 6' ' ' LEU . . . -75.0 -35.09 62.02 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.181 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.14 -34.08 43.59 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.989 179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -60.82 -38.44 85.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.563 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.25 -29.86 11.01 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.708 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.81 49.62 34.76 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.245 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.769 ' HB3' HG11 ' A' ' 4' ' ' VAL . 2.1 p-10 -71.88 -40.3 69.02 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.751 HD23 ' CG2' ' B' ' 108' ' ' VAL . 3.0 mp -122.78 146.33 47.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.626 0.251 . . . . 0.0 111.045 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -104.53 139.61 39.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.584 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -55.0 112.76 1.12 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.2 0.524 . . . . 0.0 110.67 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.58 -13.44 39.09 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.391 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -62.16 138.1 58.35 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.974 0.416 . . . . 0.0 110.809 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.782 HD11 ' HB2' ' B' ' 161' ' ' LEU . 1.4 pp -76.77 125.65 36.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.641 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.579 HD12 HG22 ' B' ' 106' ' ' ILE . 20.8 mt -93.26 147.8 5.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.714 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.46 HD22 HD11 ' B' ' 161' ' ' LEU . 32.3 tp -114.9 -40.76 3.46 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.777 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -147.19 148.04 31.1 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.394 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.676 HG23 HD23 ' B' ' 158' ' ' LEU . 38.7 mt -141.45 118.85 8.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.215 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . 0.558 ' HB2' HD21 ' B' ' 148' ' ' LEU . 8.6 m120 58.35 35.53 24.89 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.987 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.51 9.3 86.63 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.412 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -119.12 130.16 55.42 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 117.098 0.449 . . . . 0.0 110.395 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.681 HG12 ' H ' ' B' ' 138' ' ' GLU . 3.4 t -59.22 147.03 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.101 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.869 HG22 HD12 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -115.55 4.8 14.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.998 -179.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.681 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.2 OUTLIER -92.98 131.23 38.17 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.187 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 71.44 -4.84 1.74 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.458 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.467 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.5 OUTLIER -69.78 171.04 9.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.997 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 38.5 t -87.01 144.4 26.92 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.212 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.11 -46.2 88.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.512 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.01 -37.16 83.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.774 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.8 -47.56 80.37 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.754 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.98 ' HB1' HD11 ' A' ' 19' ' ' LEU . . . -58.7 -41.84 87.23 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.935 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 76.9 ttt-85 -66.63 -39.97 88.52 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.299 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -38.15 86.9 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.805 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' B' ' 133' ' ' ASN . 8.3 tt -59.73 -44.31 93.83 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.927 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.532 HD12 HD22 ' A' ' 19' ' ' LEU . 39.1 mt -68.35 -37.19 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.611 0.244 . . . . 0.0 110.76 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -49.36 59.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.932 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -25.47 62.98 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.408 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 29.1 t -80.39 79.74 6.94 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.995 0.426 . . . . 0.0 110.597 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.82 126.64 35.77 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.542 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.16 -92.99 0.57 Allowed Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.119 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -122.95 135.14 54.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.629 0.252 . . . . 0.0 110.717 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.808 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -129.58 132.31 46.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.119 0.485 . . . . 0.0 111.139 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.1 tm0? -94.58 139.09 31.65 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.316 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.676 HD23 HG23 ' B' ' 132' ' ' ILE . 5.5 mt -134.07 123.4 24.42 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.712 0.291 . . . . 0.0 111.009 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 21.4 t -110.91 135.71 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.465 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' B' ' 129' ' ' ILE . 18.4 m -136.13 158.57 38.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.175 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.782 ' HB2' HD11 ' B' ' 128' ' ' ILE . 18.9 mt -117.56 117.57 29.77 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.253 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -97.71 172.95 7.37 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.073 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.51 84.09 0.01 OUTLIER 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.805 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 28.3 p -170.81 -64.5 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.399 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.62 169.19 10.94 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.012 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.969 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.46 ' HG2' ' HB2' ' B' ' 162' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 120.415 0.15 . . . . 0.0 111.361 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.4 tt -141.43 139.27 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.717 0.294 . . . . 0.0 111.348 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.48 157.8 22.21 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.74 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.759 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.5 t -131.12 134.48 61.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.981 0.42 . . . . 0.0 111.351 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.568 HD23 ' NZ ' ' B' ' 155' ' ' LYS . 9.0 mp -101.39 108.59 20.24 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.874 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.691 HD23 ' CD2' ' A' ' 15' ' ' TYR . 3.1 tp -94.7 141.91 28.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.619 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.423 ' O ' HD13 ' B' ' 116' ' ' LEU . 2.9 ttt -126.19 164.27 21.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.116 0.484 . . . . 0.0 111.122 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -99.28 139.3 35.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.076 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 p -152.5 39.29 0.56 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.952 0.406 . . . . 0.0 111.456 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -138.44 -149.16 0.29 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.68 36.95 4.52 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.815 0.34 . . . . 0.0 111.48 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -133.66 145.38 49.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.605 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -98.0 51.4 1.04 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.027 0.442 . . . . 0.0 110.73 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -175.01 127.46 0.28 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.746 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.881 ' CE1' HD23 ' B' ' 156' ' ' LEU . 52.2 m-85 -66.75 -28.69 68.61 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.972 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.4 19.8 37.28 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.694 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.797 HD22 HD22 ' B' ' 123' ' ' LEU . 1.3 mt -98.49 116.57 31.01 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.572 0.225 . . . . 0.0 110.708 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.459 ' HB2' ' HG2' ' B' ' 110' ' ' GLU . 55.8 mtt85 -91.2 113.49 25.76 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.744 HD22 HD11 ' B' ' 149' ' ' ILE . 6.6 mp -95.4 124.97 39.7 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.451 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -107.67 175.2 20.0 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.3 OUTLIER -137.08 144.41 43.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.033 0.416 . . . . 0.0 111.136 -179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' B' ' 104' ' ' SER . 9.8 pt20 -128.31 140.81 51.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.338 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.981 HD13 ' HB2' ' A' ' 62' ' ' ALA . 15.8 mt -88.17 120.49 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.411 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 43.7 p90 -123.9 171.71 9.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.639 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.806 HG21 ' HB3' ' A' ' 40' ' ' LEU . 95.8 t -81.19 98.47 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.577 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 3.0 tptp -69.27 -57.76 4.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.356 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -156.13 139.77 16.01 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.786 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -124.83 156.42 37.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.289 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.403 HG23 ' O ' ' B' ' 99' ' ' GLY . 32.8 p -65.26 121.54 15.02 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -58.84 145.99 38.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.064 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.2 m 64.32 32.92 11.86 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.312 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.25 -171.66 29.68 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.205 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.597 HD13 ' O ' ' B' ' 90' ' ' MET . 2.6 mt -69.25 -32.4 71.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.515 0.198 . . . . 0.0 111.332 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.02 -33.58 61.82 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.006 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.83 -34.67 45.02 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.044 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -63.48 -36.96 85.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.078 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -97.72 -31.6 12.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.422 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.81 50.59 10.8 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.729 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.885 ' HB3' HG11 ' B' ' 87' ' ' VAL . 13.3 p30 -89.32 -39.68 13.3 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.806 ' HB3' HG21 ' A' ' 25' ' ' VAL . 26.8 mt -111.72 121.18 44.41 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.668 0.27 . . . . 0.0 110.978 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 119.42 34.17 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.245 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -42.52 107.26 0.08 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.984 0.421 . . . . 0.0 111.818 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 117.02 -11.43 14.9 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 115.777 -0.647 . . . . 0.0 113.712 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 41.2 p-10 -69.72 131.79 45.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 117.532 0.666 . . . . 0.0 111.286 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.6 pt -75.86 104.51 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.263 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 25' ' ' VAL . 39.7 mm -66.0 141.65 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.394 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.555 HD13 ' CD1' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -100.72 -43.02 6.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.249 179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -152.8 148.16 26.88 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.884 0.373 . . . . 0.0 111.588 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.506 HG23 ' CD1' ' A' ' 75' ' ' LEU . 41.6 mt -135.17 121.61 33.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.211 179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.477 HD22 HG22 ' A' ' 49' ' ' ILE . 4.6 m-80 52.7 40.27 30.02 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.759 0.314 . . . . 0.0 111.11 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.15 17.61 78.81 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.062 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.5 m -120.37 141.64 49.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.861 0.331 . . . . 0.0 110.204 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.502 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.0 t -64.44 143.95 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.165 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.766 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -117.87 15.43 14.33 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.457 179.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.502 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -115.75 133.38 56.09 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.498 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 73.29 -11.57 0.89 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.328 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.47 ' HG3' ' N ' ' A' ' 58' ' ' SER . 0.1 OUTLIER -73.8 152.92 40.17 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.671 0.272 . . . . 0.0 110.532 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.47 ' N ' ' HG3' ' A' ' 57' ' ' MET . 48.0 t -71.3 144.7 49.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.005 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tt -54.7 -42.32 71.34 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.753 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.24 -38.27 76.54 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.023 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.66 -47.83 77.01 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.839 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.981 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -59.36 -42.15 90.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.908 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.17 -40.09 90.22 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.66 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -64.88 -39.71 93.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.824 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.7 -43.29 97.97 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.595 HD11 HD22 ' B' ' 102' ' ' LEU . 7.8 mt -68.61 -37.71 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.797 0.332 . . . . 0.0 110.656 179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -69.05 -49.15 60.01 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.24 -20.09 65.62 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.456 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -75.74 68.96 2.38 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.955 0.407 . . . . 0.0 110.915 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.28 109.14 14.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.26 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 126.49 -82.93 0.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.068 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 141.89 49.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.615 0.245 . . . . 0.0 110.673 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.714 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 1.2 pt? -130.36 132.42 45.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.879 0.371 . . . . 0.0 111.475 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.587 ' O ' HD13 ' A' ' 75' ' ' LEU . 52.9 tt0 -98.67 127.93 44.77 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.607 HD21 ' HG ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -125.34 129.44 49.95 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.822 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.0 t -109.95 131.94 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.532 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.47 138.87 48.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.492 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.555 ' CD1' HD13 ' A' ' 47' ' ' LEU . 3.5 tt -121.62 117.53 26.94 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.934 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -100.73 77.07 1.85 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.02 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.9 t0 58.76 91.83 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.415 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.413 ' HB2' HD21 ' A' ' 78' ' ' LEU . 1.5 m -151.31 134.88 16.27 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.142 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.4 mt -78.73 176.41 9.54 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.298 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.093 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.881 0.372 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.416 ' O ' HG23 ' B' ' 85' ' ' ILE . 10.8 tt -144.55 120.66 4.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.95 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -104.22 156.46 17.33 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.577 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.885 HG11 ' HB3' ' A' ' 39' ' ' ASN . 17.7 t -132.62 134.52 58.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.718 0.294 . . . . 0.0 111.103 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 107.03 17.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.536 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 73' ' ' LEU . 16.9 tp -99.89 140.52 33.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.451 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . 0.597 ' O ' HD13 ' A' ' 33' ' ' LEU . 51.1 ttm -120.96 161.77 21.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.201 0.524 . . . . 0.0 110.783 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.59 144.79 28.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.824 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.45 22.46 7.88 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.72 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 178.76 124.76 0.05 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.733 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -84.7 83.76 7.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.88 0.372 . . . . 0.0 110.851 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -148.56 -49.55 0.16 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.491 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -120.64 -179.9 4.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.018 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -90.06 -178.82 5.53 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.064 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.714 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 69.2 m-85 -73.56 -30.18 62.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.228 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 29' ' ' THR . . . 89.06 23.44 35.01 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.68 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 mp -103.61 122.27 44.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.758 0.279 . . . . 0.0 110.522 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -102.66 113.56 27.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.303 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.595 HD22 HD11 ' A' ' 66' ' ' ILE . 9.4 mp -98.16 124.78 42.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.949 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.48 -176.36 24.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.772 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -136.09 146.19 46.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.823 0.344 . . . . 0.0 111.0 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 21' ' ' SER . 8.9 pt20 -126.82 139.71 52.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.324 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 1.149 HD13 ' HB2' ' B' ' 145' ' ' ALA . 50.2 mt -88.19 120.5 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.407 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -121.41 172.44 8.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.954 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.694 HG22 HD23 ' B' ' 123' ' ' LEU . 38.3 t -81.73 96.24 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.117 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 -58.05 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.884 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 18' ' ' ARG . 1.7 pt-20 -157.24 137.74 13.01 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.976 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.576 ' CB ' HD23 ' A' ' 17' ' ' LEU . 1.2 ptt? -119.79 161.44 20.76 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.917 0.389 . . . . 0.0 111.68 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 51.9 m -78.46 140.31 38.64 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.143 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.496 ' O ' HG22 ' B' ' 114' ' ' THR . 0.0 OUTLIER -76.33 152.24 36.44 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.103 179.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.563 HG23 ' O ' ' B' ' 114' ' ' THR . 0.5 OUTLIER 64.88 16.59 10.58 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.168 179.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -91.31 -168.46 41.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.224 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 7' ' ' MET . 0.1 OUTLIER -75.69 -27.32 58.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.673 ' CB ' HD21 ' A' ' 17' ' ' LEU . . . -74.8 -37.98 62.23 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.587 0.232 . . . . 0.0 111.213 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -33.74 43.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.827 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.0 -38.49 86.24 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.333 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -99.32 -37.6 9.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.222 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.08 55.7 3.46 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.309 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.759 ' HB3' HG11 ' A' ' 4' ' ' VAL . 0.5 OUTLIER -101.98 -45.52 5.16 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.409 0.147 . . . . 0.0 111.377 -179.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.797 HD22 HD22 ' A' ' 17' ' ' LEU . 4.4 mp -85.25 119.92 26.17 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.79 0.328 . . . . 0.0 110.672 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.44 125.54 42.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.43 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -56.42 107.69 0.4 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.065 0.46 . . . . 0.0 110.916 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 106.13 -14.15 44.33 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.38 -0.827 . . . . 0.0 113.024 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.78 137.34 58.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.042 0.449 . . . . 0.0 110.983 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.75 105.19 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.288 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.503 HG12 HD11 ' B' ' 158' ' ' LEU . 7.8 mt -71.78 143.98 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.82 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 19.3 tp -105.81 -33.68 7.91 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.878 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -155.73 148.09 23.73 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.79 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 24.2 mt -137.95 117.73 15.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.146 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . 0.762 ' HB2' HD21 ' B' ' 148' ' ' LEU . 6.3 m120 56.73 36.81 28.22 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.043 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.5 13.74 82.21 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.305 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.5 m -120.45 128.46 53.19 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.922 0.361 . . . . 0.0 110.4 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.535 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.2 t -59.37 144.46 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 111.208 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.805 HG22 HD12 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -109.16 11.28 25.65 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.595 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.535 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.4 OUTLIER -99.79 132.98 44.79 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 72.47 -11.62 0.8 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.657 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.627 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.5 OUTLIER -64.07 168.45 5.33 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.837 0.351 . . . . 0.0 111.141 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.38 148.22 22.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.257 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.22 -42.88 82.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.861 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 69.4 p -63.03 -39.81 95.86 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.176 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -41.53 97.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.035 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 1.149 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.91 -44.57 91.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.868 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -69.91 -36.6 75.49 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.506 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -67.85 -39.28 83.83 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.766 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . 0.762 HD21 ' HB2' ' B' ' 133' ' ' ASN . 5.6 tt -61.81 -42.42 98.99 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.785 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.744 HD11 HD22 ' A' ' 19' ' ' LEU . 14.7 mt -68.3 -38.16 79.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.589 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.16 -49.36 57.54 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.709 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -65.42 -25.86 67.72 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.236 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 10.7 t -84.44 63.41 7.81 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.015 0.436 . . . . 0.0 110.575 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.81 103.91 8.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.274 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 141.69 -93.11 0.18 Allowed Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.088 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.568 ' NZ ' HD23 ' A' ' 5' ' ' LEU . 14.0 ttpp -123.8 126.98 47.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.543 0.211 . . . . 0.0 110.963 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.881 HD23 ' CE1' ' A' ' 15' ' ' TYR . 1.2 pp -124.18 126.89 46.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.999 0.428 . . . . 0.0 111.353 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 1.8 mt-30 -94.45 141.49 28.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.219 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.503 HD11 HG12 ' B' ' 129' ' ' ILE . 3.7 tt -137.33 140.51 41.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.034 0.445 . . . . 0.0 111.536 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 25.3 t -120.08 134.59 63.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.278 179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.484 HG13 ' CD2' ' B' ' 158' ' ' LEU . 27.6 m -124.71 159.34 31.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.753 0.311 . . . . 0.0 111.309 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.41 128.99 54.46 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.46 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 0.1 OUTLIER -100.45 164.06 12.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.174 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 66.43 175.31 0.24 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.298 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 1.3 m -142.14 36.95 1.55 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.184 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 62.1 83.9 0.15 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.843 0.354 . . . . 0.0 110.954 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.459 -0.781 . . . . 0.0 111.176 179.91 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.433 HG23 HG23 ' B' ' 160' ' ' VAL . 11.8 tt -142.79 123.17 10.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.725 0.298 . . . . 0.0 111.108 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' B' ' 159' ' ' VAL . . . -128.86 157.28 21.49 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.906 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.66 HG11 ' HB3' ' B' ' 122' ' ' ASN . 21.9 t -132.12 133.66 60.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.743 0.306 . . . . 0.0 111.193 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 mt -98.19 111.67 23.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.784 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 tp -102.16 134.11 45.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.394 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.551 ' O ' HD13 ' B' ' 116' ' ' LEU . 7.4 ttm -109.11 164.16 12.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.091 0.472 . . . . 0.0 110.643 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -98.03 116.34 30.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.729 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.8 t -104.26 30.92 4.92 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.126 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.05 125.27 3.48 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.391 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.1 56.32 3.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.025 0.441 . . . . 0.0 111.198 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 178.9 138.05 0.09 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 67.9 135.79 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.935 0.398 . . . . 0.0 110.985 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.54 177.88 1.82 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.746 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 62.7 m-85 -52.2 -27.4 14.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.776 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.71 18.16 62.27 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.431 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.646 HD23 HG13 ' B' ' 108' ' ' VAL . 0.1 OUTLIER -97.75 115.14 27.42 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.715 0.293 . . . . 0.0 110.287 179.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -93.32 113.47 25.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.849 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.559 HD12 HG21 ' B' ' 106' ' ' ILE . 1.9 pt? -105.97 124.92 50.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 111.565 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -109.42 -176.81 21.33 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.55 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.423 ' OG ' HD12 ' B' ' 142' ' ' LEU . 0.3 OUTLIER -142.34 146.46 35.01 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.905 0.353 . . . . 0.0 111.067 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.428 ' NE2' HG21 ' A' ' 45' ' ' ILE . 6.5 pt20 -127.27 135.52 50.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.848 ' HB ' HG22 ' A' ' 54' ' ' THR . 42.2 mt -87.91 120.56 37.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.002 0.43 . . . . 0.0 110.557 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -123.71 172.57 8.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.062 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.467 HG21 ' HB3' ' A' ' 40' ' ' LEU . 40.0 t -82.37 100.15 5.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.795 179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -70.66 -59.68 2.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.399 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.7 136.05 20.3 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.753 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 13.0 ptp -122.1 151.4 40.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.892 0.377 . . . . 0.0 111.211 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 t -65.53 134.34 53.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -71.86 146.95 47.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.773 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.27 33.58 14.0 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.258 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.78 -171.75 26.57 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.272 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.632 HD13 ' O ' ' B' ' 90' ' ' MET . 0.1 OUTLIER -70.45 -31.6 68.83 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.646 0.223 . . . . 0.0 111.423 179.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.594 ' HB3' HD11 ' B' ' 100' ' ' LEU . . . -74.93 -34.26 62.09 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.261 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.09 -34.0 43.97 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.079 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -64.06 -36.63 84.62 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.336 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.48 -30.5 11.78 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.421 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.36 45.26 61.39 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.281 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.722 ' HB3' HG11 ' B' ' 87' ' ' VAL . 14.7 p-10 -74.61 -38.55 62.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.508 0.194 . . . . 0.0 111.391 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.669 ' CD1' HD13 ' A' ' 75' ' ' LEU . 5.6 mt -128.43 133.86 48.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.924 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.88 148.32 24.58 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.593 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -59.33 112.23 1.66 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.097 0.475 . . . . 0.0 111.001 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 114.26 -15.84 20.25 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.394 -0.821 . . . . 0.0 113.177 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -63.04 133.69 54.93 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.242 0.521 . . . . 0.0 110.285 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.428 HG21 ' NE2' ' A' ' 22' ' ' GLN . 4.3 pt -81.8 104.69 10.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.908 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.434 ' CG2' HG21 ' A' ' 54' ' ' THR . 64.4 mt -65.35 148.63 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.031 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.583 HD12 HD12 ' A' ' 78' ' ' LEU . 0.6 OUTLIER -106.85 -45.81 4.1 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.6 -179.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -149.27 148.16 29.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 111.768 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.671 HD13 HD11 ' A' ' 66' ' ' ILE . 26.6 mt -129.74 118.06 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.496 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.6 m120 49.99 32.19 5.46 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.642 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.51 16.46 58.63 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.199 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.6 m -120.79 135.83 55.05 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.869 0.334 . . . . 0.0 110.355 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.1 t -57.83 142.38 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.848 0.356 . . . . 0.0 111.295 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.848 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -119.39 16.79 13.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.401 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.525 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -121.87 129.33 52.5 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 71.56 -6.6 1.37 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.255 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.03 173.95 4.99 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.937 0.399 . . . . 0.0 111.043 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.77 135.89 33.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.669 HD12 ' OG ' ' B' ' 104' ' ' SER . 0.2 OUTLIER -56.63 -43.08 79.9 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.889 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 43.4 p -64.72 -39.07 93.01 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.064 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.32 -47.99 68.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.816 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.572 ' O ' HD12 ' A' ' 66' ' ' ILE . . . -62.37 -40.17 95.57 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.756 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -62.78 -39.79 95.3 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.447 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -65.35 -38.35 89.82 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.981 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.73 -46.33 89.45 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.668 0.271 . . . . 0.0 110.745 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.671 HD11 HD13 ' A' ' 49' ' ' ILE . 3.1 mp -69.04 -36.49 73.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.841 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -68.6 -46.36 69.53 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.155 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -64.05 -28.22 69.64 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.936 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.0 t -78.53 88.8 4.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.959 0.409 . . . . 0.0 110.76 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.7 mtt85 -99.16 40.45 1.21 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.805 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' HD2' ' B' ' 91' ' ' LYS . . . -151.37 -88.17 0.07 OUTLIER Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.284 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -129.46 122.16 28.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.619 0.247 . . . . 0.0 110.474 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.598 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.5 OUTLIER -114.97 136.37 53.2 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.031 0.443 . . . . 0.0 111.116 -179.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -100.96 134.41 44.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.506 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.669 HD13 ' CD1' ' A' ' 40' ' ' LEU . 1.3 mt -127.4 137.94 52.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.015 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.3 t -120.16 139.55 47.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.425 ' CG2' HD23 ' A' ' 40' ' ' LEU . 19.7 t -115.34 142.49 28.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.183 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.583 HD12 HD12 ' A' ' 47' ' ' LEU . 8.6 tt -84.87 122.63 29.44 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -156.63 101.11 1.98 Allowed 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.856 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.9 t70 176.47 108.81 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.633 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.9 m -143.69 127.81 17.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.043 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.479 HD13 ' H ' ' A' ' 83' ' ' GLU . 0.2 OUTLIER 69.93 150.96 0.09 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.808 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.479 ' H ' HD13 ' A' ' 82' ' ' LEU . 7.3 tp10 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.395 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 120.602 0.239 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.5 pp -130.17 153.71 39.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.09 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.22 158.63 27.3 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.923 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.722 HG11 ' HB3' ' A' ' 39' ' ' ASN . 21.4 t -131.43 135.18 59.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.811 0.338 . . . . 0.0 111.021 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.77 107.46 18.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.432 HD23 ' CD2' ' B' ' 98' ' ' TYR . 1.3 tp -90.71 136.49 33.03 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.871 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . 0.632 ' O ' HD13 ' A' ' 33' ' ' LEU . 9.9 ttm -104.32 164.85 11.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.081 0.467 . . . . 0.0 111.005 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -81.52 146.0 30.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.128 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 1.7 t -163.09 97.84 0.93 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.413 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 59.02 32.29 22.12 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.079 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.94 82.12 6.08 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.925 0.393 . . . . 0.0 110.794 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -59.01 -32.94 70.17 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.369 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -141.63 74.71 1.47 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.798 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 65.98 173.8 0.23 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.598 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 50.0 m-85 -58.41 -27.62 64.46 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.652 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.87 14.39 55.08 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 116.009 -0.542 . . . . 0.0 112.525 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.594 HD11 ' HB3' ' A' ' 34' ' ' ALA . 8.4 mp -101.55 119.94 39.55 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.746 0.308 . . . . 0.0 110.655 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -101.79 113.56 26.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.156 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.451 HD23 ' H ' ' B' ' 102' ' ' LEU . 1.9 pt? -102.93 125.02 49.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 111.301 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.67 -170.81 20.31 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.377 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.669 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -146.59 152.16 38.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.979 0.389 . . . . 0.0 110.887 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -128.88 138.64 52.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.13 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.714 ' HB ' HG22 ' B' ' 137' ' ' THR . 26.8 mt -88.08 120.49 37.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.038 0.447 . . . . 0.0 110.492 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -121.69 173.23 7.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.044 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.678 HG21 ' HB3' ' B' ' 123' ' ' LEU . 46.1 t -82.51 98.03 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.046 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.14 -44.98 71.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.039 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -155.0 160.91 41.43 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.947 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 18.1 mtp -138.13 162.13 35.02 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 111.136 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 5.7 p -95.9 124.39 39.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.643 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.573 ' HA ' HG21 ' B' ' 118' ' ' THR . 0.0 OUTLIER -64.72 160.51 19.84 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.03 0.443 . . . . 0.0 110.866 179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 58.13 22.84 9.49 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.02 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -103.31 -172.04 26.02 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.203 -0.523 . . . . 0.0 111.961 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.551 HD13 ' O ' ' A' ' 7' ' ' MET . 0.2 OUTLIER -72.24 -29.59 64.07 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.39 63.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.559 0.218 . . . . 0.0 111.077 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . 0.573 HG21 ' HA ' ' B' ' 113' ' ' ARG . 1.0 OUTLIER -79.23 -34.03 43.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.246 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -57.81 -39.76 78.37 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.444 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -104.14 -36.16 7.79 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.028 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.2 53.34 5.7 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.756 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.66 ' HB3' HG11 ' A' ' 4' ' ' VAL . 8.5 p-10 -84.49 -36.5 22.21 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.777 HD11 HD22 ' B' ' 158' ' ' LEU . 3.7 mt -115.44 128.02 55.74 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.735 0.302 . . . . 0.0 111.218 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.77 140.37 34.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.351 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -57.27 110.43 0.84 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.068 0.461 . . . . 0.0 111.33 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 115.47 -16.44 16.98 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.397 -0.82 . . . . 0.0 113.264 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.09 132.68 54.7 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.389 0.594 . . . . 0.0 110.499 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 pt -79.15 106.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.854 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.688 HD13 HG12 ' B' ' 160' ' ' VAL . 36.8 mm -71.15 146.5 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.247 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 9.7 tp -109.5 -43.09 4.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.323 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.31 147.91 34.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.785 0.326 . . . . 0.0 111.461 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.433 HD11 HG21 ' B' ' 137' ' ' THR . 24.6 mt -137.86 118.14 16.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.39 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . 0.577 ' HB2' HD21 ' B' ' 148' ' ' LEU . 1.1 m120 56.79 37.34 28.74 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.102 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 76.17 16.36 80.76 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.985 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -120.73 142.72 49.26 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.82 0.31 . . . . 0.0 110.21 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.511 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.3 t -61.75 144.47 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.003 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.714 HG22 ' HB ' ' B' ' 106' ' ' ILE . 0.2 OUTLIER -122.64 19.64 10.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.313 179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.511 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.6 OUTLIER -112.0 142.15 44.77 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.365 179.608 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 53.15 9.08 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.218 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.23 176.12 9.05 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.821 0.343 . . . . 0.0 111.268 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 47.2 t -91.93 142.74 27.23 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.423 HD12 ' OG ' ' A' ' 21' ' ' SER . 2.1 tt -61.09 -45.14 95.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.896 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 10.0 t -65.29 -37.14 86.25 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.845 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -68.2 -47.89 66.67 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.82 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.523 ' CB ' HD13 ' B' ' 106' ' ' ILE . . . -62.83 -40.42 97.36 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.843 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 ttm180 -61.68 -41.13 97.15 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.274 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -38.31 90.58 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.943 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' B' ' 133' ' ' ASN . 9.3 tt -59.6 -45.87 90.65 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.556 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.63 -36.72 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.795 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.94 -49.06 61.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.819 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -26.9 67.54 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.419 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 32.4 t -75.1 71.83 2.18 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.138 0.494 . . . . 0.0 110.634 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 12.5 ttm105 -86.57 97.9 10.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.328 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 147.46 -85.01 0.17 Allowed Glycine 0 C--O 1.228 -0.275 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.244 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.5 131.1 37.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.646 0.26 . . . . 0.0 110.682 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.746 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -128.59 143.64 51.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.002 0.429 . . . . 0.0 111.545 -179.565 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 32.7 tt0 -103.16 142.44 34.14 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.403 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.777 HD22 HD11 ' B' ' 123' ' ' LEU . 1.7 mp -136.24 128.34 29.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 110.951 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.402 ' HA ' ' HA2' ' A' ' 3' ' ' GLY . 18.7 t -117.09 134.01 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.688 HG12 HD13 ' B' ' 129' ' ' ILE . 22.6 m -124.44 156.32 32.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.195 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 1.4 tt -124.58 123.08 39.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 13.5 ttm180 -104.6 137.98 41.63 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.147 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 68.74 117.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.474 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.22 -24.08 63.04 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.356 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' B' ' 165' ' ' LEU . 0.2 OUTLIER -61.94 -29.77 70.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.669 0.271 . . . . 0.0 111.096 179.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.373 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.441 ' CE ' HD11 ' B' ' 161' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 pp -138.62 140.62 38.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.719 0.295 . . . . 0.0 111.081 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.12 157.79 22.84 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.507 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.812 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.5 t -131.55 134.99 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.735 0.302 . . . . 0.0 111.368 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.702 HD22 ' HE3' ' B' ' 155' ' ' LYS . 0.8 OUTLIER -100.5 107.24 18.9 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.512 179.535 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 tp -95.27 127.79 41.6 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.692 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.737 ' O ' HD22 ' B' ' 116' ' ' LEU . 3.2 ttt -106.99 165.67 11.17 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.954 0.407 . . . . 0.0 110.945 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -93.31 145.96 24.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.016 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -147.99 47.93 1.07 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.986 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.27 -147.14 0.25 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.211 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.58 79.43 1.91 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.893 0.378 . . . . 0.0 111.301 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.54 78.13 0.3 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.328 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -151.38 177.82 9.89 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.156 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.51 155.83 18.22 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.501 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.868 ' CE1' HD23 ' B' ' 156' ' ' LEU . 76.0 m-85 -60.13 -30.17 69.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.557 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.88 28.09 39.26 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.338 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.561 HD11 ' CB ' ' B' ' 117' ' ' ALA . 0.2 OUTLIER -106.59 120.54 42.23 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.673 0.273 . . . . 0.0 110.62 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.68 114.82 27.47 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.399 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.704 HD22 HD11 ' B' ' 149' ' ' ILE . 5.7 mp -98.09 124.92 42.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.153 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -110.23 177.88 19.83 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.764 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' B' ' 105' ' ' GLN . 0.5 OUTLIER -135.11 146.66 49.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.067 0.434 . . . . 0.0 111.321 -179.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -129.59 139.18 51.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.109 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.862 HD13 ' HB2' ' A' ' 62' ' ' ALA . 55.9 mt -88.11 120.41 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.036 0.446 . . . . 0.0 110.71 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -121.18 172.44 7.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.912 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.575 ' CG2' HD22 ' A' ' 40' ' ' LEU . 42.6 t -79.92 93.76 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.967 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -50.68 63.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.928 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.408 ' HB3' ' CG ' ' B' ' 101' ' ' ARG . 6.3 tt0 -158.47 151.82 23.01 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.985 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.48 146.01 41.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.122 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.455 HG23 ' O ' ' B' ' 99' ' ' GLY . 26.5 p -65.56 121.41 14.85 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.959 0.409 . . . . 0.0 110.767 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.79 151.08 22.1 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.101 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.05 31.74 13.34 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.281 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.76 -168.07 26.32 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.43 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 mt -70.32 -34.33 72.56 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 110.686 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.66 ' HA ' HD21 ' B' ' 89' ' ' LEU . . . -75.02 -33.7 61.81 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.896 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.1 -34.43 43.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.019 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.73 -38.76 82.61 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.406 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.9 -26.27 12.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.709 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.56 50.53 54.18 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.051 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.685 ' CG ' HG11 ' B' ' 87' ' ' VAL . 16.6 m-80 -78.19 -34.19 49.65 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.575 HD22 ' CG2' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -129.07 137.41 51.25 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.672 0.272 . . . . 0.0 110.897 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.47 143.0 32.01 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.725 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.74 113.44 1.65 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 111.344 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.4 -17.44 14.2 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.845 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.464 ' HB3' HD23 ' A' ' 40' ' ' LEU . 9.8 t70 -59.57 136.98 58.15 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.094 0.473 . . . . 0.0 110.999 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -81.19 109.86 15.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.575 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.688 HD13 HD21 ' B' ' 102' ' ' LEU . 9.3 mt -79.93 145.2 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.217 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -110.87 -27.29 8.89 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.007 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.619 ' HE3' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -158.25 147.97 19.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.263 179.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 28.8 mt -142.32 117.9 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.739 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 51.09 33.41 9.18 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.306 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.43 83.17 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.609 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -105.16 129.02 53.65 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 117.141 0.47 . . . . 0.0 110.443 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.666 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.8 t -64.42 146.81 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.392 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.567 ' HA ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -105.35 -10.52 16.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.487 179.518 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.666 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -87.84 142.33 27.9 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.5 p30 53.39 9.44 0.16 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.668 0.605 . . . . 0.0 112.271 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 ttm -90.43 149.66 22.15 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.675 0.274 . . . . 0.0 110.596 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 m -71.71 139.22 49.06 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.762 0.315 . . . . 0.0 111.14 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.683 HD11 ' O ' ' B' ' 102' ' ' LEU . 12.1 tp -57.93 -42.68 85.34 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.396 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.8 m -56.98 -38.27 72.79 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.756 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -68.46 -47.93 65.86 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.533 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.862 ' HB2' HD13 ' A' ' 23' ' ' ILE . . . -61.04 -40.5 93.86 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.423 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -69.8 -38.44 76.65 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.5 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -38.34 85.47 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.52 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.82 -44.5 94.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.873 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.724 HD11 HD22 ' B' ' 102' ' ' LEU . 10.6 mt -68.26 -37.49 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.72 0.295 . . . . 0.0 110.698 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -69.06 -37.96 78.8 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.946 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -89.8 1.42 56.17 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.1 p -90.94 56.52 3.23 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.196 0.522 . . . . 0.0 110.842 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.82 100.23 1.5 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.829 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 143.24 -91.52 0.17 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.273 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.65 135.44 47.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.571 0.224 . . . . 0.0 110.719 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.862 HD23 ' CE2' ' B' ' 98' ' ' TYR . 0.8 OUTLIER -129.31 130.31 45.97 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.949 0.404 . . . . 0.0 111.009 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 15.8 mt-30 -98.05 142.44 29.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.785 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.443 ' HG ' HD12 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -130.38 127.93 40.36 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.908 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.02 142.77 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.6 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.408 HG23 HG23 ' B' ' 85' ' ' ILE . 34.1 m -136.12 158.55 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.178 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.1 tp -88.68 122.17 31.82 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.952 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.2 138.97 34.69 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.932 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 67.36 166.17 0.23 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.104 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.0 m -121.55 84.96 2.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.889 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.7 mp -75.63 -55.98 5.14 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.753 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.879 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 3.9 mmt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.432 0.158 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . 0.629 HD13 ' N ' ' B' ' 86' ' ' GLY . 0.0 OUTLIER -122.8 133.12 69.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.844 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . 0.629 ' N ' HD13 ' B' ' 85' ' ' ILE . . . -151.55 159.92 28.49 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.938 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.685 HG11 ' CG ' ' A' ' 39' ' ' ASN . 7.1 t -129.17 134.7 63.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.707 0.289 . . . . 0.0 111.262 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.494 ' C ' HD23 ' B' ' 88' ' ' LEU . 9.7 tt -101.95 125.54 48.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.05 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.66 HD21 ' HA ' ' A' ' 34' ' ' ALA . 9.1 mp -112.35 124.72 53.1 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.966 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 3.3 ttt -116.07 159.26 21.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.632 0.73 . . . . 0.0 112.005 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.81 128.92 45.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.522 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.45 76.35 0.1 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.754 0.312 . . . . 0.0 111.11 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 177.41 36.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.022 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . 41.31 75.01 0.09 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.863 0.363 . . . . 0.0 111.444 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -136.93 -176.78 4.48 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.996 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -118.45 113.0 20.68 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.899 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 46.89 -172.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.388 0.613 . . . . 0.0 112.444 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.862 ' CE2' HD23 ' A' ' 73' ' ' LEU . 85.2 m-85 -94.11 -29.39 15.19 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.468 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 29' ' ' THR . . . 75.94 29.72 58.6 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.884 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.73 125.5 51.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.646 0.26 . . . . 0.0 110.756 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . 0.408 ' CG ' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -108.09 114.61 28.63 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.012 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.724 HD22 HD11 ' A' ' 66' ' ' ILE . 3.6 mp -89.38 128.5 35.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.264 -179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.16 168.48 13.36 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.601 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 2.4 p -127.66 149.93 49.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.036 0.446 . . . . 0.0 111.196 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 21' ' ' SER . 6.9 pt20 -132.72 137.02 46.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.97 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.763 HD12 HG22 ' B' ' 137' ' ' THR . 69.4 mt -88.0 120.55 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 121.112 0.482 . . . . 0.0 110.482 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -122.82 172.79 8.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.972 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.844 HG21 ' HB3' ' B' ' 123' ' ' LEU . 39.3 t -80.42 95.96 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.778 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -65.69 -55.96 14.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.918 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.19 144.8 17.56 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.003 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -136.15 155.44 50.16 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.936 0.398 . . . . 0.0 111.394 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 11.8 p -78.62 124.59 28.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.905 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 ttp-105 -65.06 166.0 10.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.923 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.82 31.86 18.24 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.19 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -112.23 -158.05 13.91 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.259 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.737 HD22 ' O ' ' A' ' 7' ' ' MET . 2.0 mp -84.99 -29.96 24.59 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.526 0.203 . . . . 0.0 111.451 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.561 ' CB ' HD11 ' A' ' 17' ' ' LEU . . . -75.15 -37.49 61.33 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 120.634 0.254 . . . . 0.0 111.33 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -33.64 44.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.089 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -57.27 -40.86 78.59 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.198 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -102.09 -28.61 12.23 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.661 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.2 47.22 24.24 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.152 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.812 ' HB3' HG11 ' A' ' 4' ' ' VAL . 12.3 p-10 -74.22 -47.25 36.62 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.844 ' HB3' HG21 ' B' ' 108' ' ' VAL . 6.6 mp -123.68 123.41 40.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.673 0.273 . . . . 0.0 110.842 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.41 150.52 21.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.769 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -59.46 111.09 1.26 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.08 0.467 . . . . 0.0 111.082 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 113.83 -18.76 19.18 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 115.41 -0.813 . . . . 0.0 113.26 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . 0.476 ' HB3' HG11 ' B' ' 160' ' ' VAL . 23.0 m-20 -59.14 135.41 57.63 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 117.236 0.518 . . . . 0.0 110.701 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.417 ' O ' HG13 ' B' ' 160' ' ' VAL . 4.0 pt -81.77 113.7 21.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.196 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.756 HG21 HD11 ' B' ' 132' ' ' ILE . 5.7 mt -81.95 147.23 6.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.522 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.667 HD13 HD13 ' B' ' 161' ' ' LEU . 6.8 tt -110.25 -40.83 4.57 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.582 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -147.57 148.9 31.64 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.836 0.35 . . . . 0.0 111.937 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.756 HD11 HG21 ' B' ' 129' ' ' ILE . 32.6 mm -133.78 117.97 28.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.458 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 52.28 33.71 13.23 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.547 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.56 4.79 79.6 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.57 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 91.3 m -113.57 133.72 55.1 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-N 117.076 0.438 . . . . 0.0 110.464 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.456 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.6 t -59.1 146.16 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.938 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.763 HG22 HD12 ' B' ' 106' ' ' ILE . 0.2 OUTLIER -125.78 25.09 6.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.47 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.456 ' H ' HG12 ' B' ' 136' ' ' VAL . 0.3 OUTLIER -113.03 130.88 55.99 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.073 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 70.8 -4.44 1.71 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.425 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.475 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.0 OUTLIER -67.22 172.05 5.15 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.79 0.328 . . . . 0.0 111.007 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 43.4 t -88.34 145.33 25.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.375 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -40.84 83.24 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.848 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.12 -39.21 86.62 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.81 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -65.57 -47.18 76.66 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.835 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.724 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -60.69 -40.94 94.05 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.15 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -69.52 -38.0 77.39 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.637 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -65.85 -40.1 91.39 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.947 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.03 -43.84 98.29 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.678 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.704 HD11 HD22 ' A' ' 19' ' ' LEU . 14.0 mt -68.32 -37.4 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.762 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -68.22 -49.58 59.77 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.044 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -68.39 -22.86 64.61 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.466 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 4.8 m -76.28 68.15 2.63 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.018 0.437 . . . . 0.0 110.771 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.13 91.31 7.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.467 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 155.85 -94.7 0.14 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.298 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.702 ' HE3' HD22 ' A' ' 5' ' ' LEU . 21.8 tttp -126.42 132.31 51.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.624 0.25 . . . . 0.0 110.406 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.868 HD23 ' CE1' ' A' ' 15' ' ' TYR . 1.3 pp -128.69 144.14 51.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.053 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' B' ' 132' ' ' ILE . 21.9 tt0 -111.05 143.05 42.37 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.633 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.749 HD23 HD12 ' B' ' 132' ' ' ILE . 0.5 OUTLIER -133.82 128.2 34.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.679 0.276 . . . . 0.0 110.969 -179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 12.9 t -112.2 131.89 62.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.519 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . 0.476 HG11 ' HB3' ' B' ' 127' ' ' ASP . 21.3 t -130.0 143.46 40.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.889 0.376 . . . . 0.0 111.496 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.667 HD13 HD13 ' B' ' 130' ' ' LEU . 0.3 OUTLIER -107.36 123.26 48.1 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.775 179.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' B' ' 163' ' ' ASP . 0.2 OUTLIER 65.95 176.69 0.22 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.956 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' B' ' 162' ' ' ARG . 36.0 t70 177.31 156.93 0.33 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.676 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.8 t 60.39 33.84 20.7 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.961 0.41 . . . . 0.0 110.831 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.36 -178.86 5.95 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.827 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.169 -179.964 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttm . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 120.381 0.134 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.0 pp -117.3 126.55 74.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.865 0.364 . . . . 0.0 111.069 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.37 165.13 12.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.667 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.683 HG11 ' HB3' ' B' ' 122' ' ' ASN . 20.6 t -129.97 134.71 62.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 120.653 0.264 . . . . 0.0 111.116 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.439 HD22 ' HE2' ' B' ' 155' ' ' LYS . 1.7 mt -99.86 106.85 18.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.751 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.438 ' O ' HD23 ' B' ' 156' ' ' LEU . 4.4 tp -100.94 127.52 47.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.452 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -99.67 159.53 14.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.823 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.98 116.2 28.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.832 0.349 . . . . 0.0 110.971 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.3 t -147.84 113.7 5.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.24 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.74 58.77 2.72 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.119 0.485 . . . . 0.0 110.633 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.78 111.07 7.03 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.846 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.28 124.3 31.08 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.688 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 74.66 65.58 0.08 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.996 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 59.66 -172.52 0.12 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.552 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.684 ' CZ ' HD22 ' B' ' 156' ' ' LEU . 70.0 m-85 -63.58 -30.45 71.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.158 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.75 22.59 33.1 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.667 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 15' ' ' TYR . 6.0 mp -101.71 118.31 36.67 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.827 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.16 113.54 25.33 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.274 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.848 HD22 HD11 ' B' ' 149' ' ' ILE . 1.0 OUTLIER -97.71 124.95 42.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.152 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' B' ' 106' ' ' ILE . . . -115.21 -172.77 17.37 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.778 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.592 ' OG ' HD12 ' B' ' 142' ' ' LEU . 0.2 OUTLIER -144.09 151.36 39.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.813 0.34 . . . . 0.0 110.935 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -133.11 134.47 44.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.963 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.779 ' HB ' HG22 ' A' ' 54' ' ' THR . 50.0 mt -87.82 120.18 36.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.061 0.458 . . . . 0.0 110.15 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -123.31 171.2 9.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.913 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.9 t -84.6 97.04 4.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.087 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -40.17 96.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.916 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -170.22 156.42 5.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.02 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -138.37 157.24 46.62 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.862 0.363 . . . . 0.0 111.159 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.43 126.53 28.54 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.866 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -62.07 145.03 54.4 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.77 33.26 22.69 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.472 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -98.59 -167.71 31.08 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.321 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 mt -67.23 -35.59 79.88 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.581 0.229 . . . . 0.0 111.211 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' B' ' 100' ' ' LEU . . . -75.08 -35.19 61.82 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.163 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.84 -33.87 45.62 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.022 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -40.23 81.83 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.245 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.1 -27.62 12.81 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.73 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.61 43.75 51.46 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.035 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.602 ' HB3' HG11 ' B' ' 87' ' ' VAL . 24.7 p-10 -59.71 -48.91 79.8 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -138.43 147.28 43.14 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.697 0.284 . . . . 0.0 110.91 179.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 156.68 16.34 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.519 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 1.2 pt-20 -71.46 121.95 19.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.492 0.663 . . . . 0.0 109.898 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.41 3.24 35.38 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.948 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -85.94 135.14 33.79 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.419 0.609 . . . . 0.0 110.485 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.429 HD13 ' H ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -73.88 112.21 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.022 -179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.421 HD13 HD11 ' A' ' 49' ' ' ILE . 30.7 mt -79.04 146.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.502 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 78' ' ' LEU . 10.4 tp -102.57 -43.95 5.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.394 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -151.93 150.98 30.65 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.765 0.317 . . . . 0.0 111.372 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.488 ' HA ' ' O ' ' A' ' 74' ' ' GLN . 28.3 mt -140.91 118.09 8.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.726 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.486 ' HB2' HD13 ' A' ' 65' ' ' LEU . 1.9 m120 54.44 33.72 19.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.125 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.0 -2.39 87.05 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.123 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.1 m -104.64 126.46 51.75 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.985 0.393 . . . . 0.0 110.385 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 55' ' ' GLU . 2.9 t -59.37 146.19 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.881 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.779 HG22 ' HB ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.96 14.05 18.38 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.566 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.617 ' H ' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -106.91 132.92 52.32 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.343 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.538 ' HB2' HD13 ' B' ' 142' ' ' LEU . 10.1 p30 53.18 8.89 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 123.672 0.608 . . . . 0.0 112.579 -178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 31.2 tpp -82.69 161.06 22.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.686 0.279 . . . . 0.0 110.831 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.91 128.21 35.03 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.987 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.464 HD12 ' OG ' ' B' ' 104' ' ' SER . 9.9 tt -53.15 -42.57 66.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -61.65 -38.49 87.93 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.221 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.04 -48.05 77.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.939 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.683 ' HB1' HD11 ' B' ' 102' ' ' LEU . . . -61.42 -39.34 90.39 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.061 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -71.03 -35.47 72.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.654 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.1 tpmp? -66.5 -40.73 89.38 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.026 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.595 HD23 ' HA ' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -62.66 -41.79 99.26 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.868 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 54.8 mt -68.3 -38.06 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.033 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -48.99 62.44 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.874 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -64.19 -26.59 68.59 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.062 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.4 t -83.97 93.34 8.04 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.797 0.332 . . . . 0.0 110.707 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.48 40.38 1.27 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -143.71 -87.68 0.09 OUTLIER Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.273 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.65 133.52 50.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.758 -0.221 . . . . 0.0 110.558 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.788 HD22 ' CZ ' ' B' ' 98' ' ' TYR . 0.8 OUTLIER -125.03 134.02 52.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.044 0.45 . . . . 0.0 111.369 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -97.65 141.08 31.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.464 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.631 ' HB2' HD11 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -137.12 124.6 22.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.73 0.3 . . . . 0.0 110.856 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.5 143.51 30.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.218 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.534 HG13 HD22 ' A' ' 40' ' ' LEU . 3.3 m -127.47 154.75 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 121.056 0.455 . . . . 0.0 111.705 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.626 HD13 HD13 ' A' ' 47' ' ' LEU . 5.6 tp -109.82 137.77 47.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.534 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 63.93 -174.6 0.16 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.576 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 67.38 125.97 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.744 0.307 . . . . 0.0 111.438 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 p 67.36 144.23 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.111 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 mt 68.38 154.25 0.1 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.048 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.969 -179.977 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.65 0.262 . . . . 0.0 111.706 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.59 152.62 23.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.733 0.301 . . . . 0.0 111.239 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.4 158.63 22.18 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.618 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 39' ' ' ASN . 20.9 t -129.76 134.52 63.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.652 0.263 . . . . 0.0 111.292 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 8.8 tt -99.82 110.06 22.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.344 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.462 HD21 ' N ' ' A' ' 34' ' ' ALA . 2.8 tp -99.37 143.14 29.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.66 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' MET . . . . . . . . . . . . . 21.8 ttt -117.72 162.75 17.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.206 0.527 . . . . 0.0 111.316 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.28 145.53 28.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.001 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.33 70.38 0.19 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.017 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 41.2 mtt-85 61.07 92.79 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.612 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.1 29.84 1.45 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.979 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 69.06 -69.37 0.16 Allowed 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.367 0.267 . . . . 0.0 111.523 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -160.12 118.66 2.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.74 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' B' ' 98' ' ' TYR . 33.0 tt0 66.14 165.34 0.19 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' TYR . . . . . 0.788 ' CZ ' HD22 ' A' ' 73' ' ' LEU . 58.8 m-85 -63.82 -27.06 68.92 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.207 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.76 22.17 37.35 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.727 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 34' ' ' ALA . 3.5 mp -104.22 125.55 50.59 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.747 0.308 . . . . 0.0 110.552 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 11.9 mtm180 -105.97 113.82 27.59 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.21 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.683 HD11 ' HB1' ' A' ' 62' ' ' ALA . 1.8 pt? -106.66 124.96 50.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.192 0.52 . . . . 0.0 111.642 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' A' ' 59' ' ' LEU . . . -105.71 -165.15 23.39 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.978 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . 0.464 ' OG ' HD12 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -145.67 148.86 33.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.825 0.345 . . . . 0.0 111.17 -179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -132.45 139.03 47.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.153 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' ILE . . . . . 0.941 HD13 ' HB2' ' B' ' 145' ' ' ALA . 10.8 mt -88.19 120.62 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.975 0.417 . . . . 0.0 110.588 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -122.42 171.98 8.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.181 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.894 HG21 ' HB3' ' B' ' 123' ' ' LEU . 29.7 t -82.08 98.04 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.806 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.03 -53.26 40.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.195 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.43 ' HA ' ' HG2' ' B' ' 125' ' ' GLU . 2.6 pt-20 -162.06 138.67 8.04 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.927 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.2 161.35 19.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.913 0.387 . . . . 0.0 111.31 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.5 p -78.03 120.26 22.61 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.65 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -61.34 149.28 38.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.157 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.2 m 67.67 25.51 8.14 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.377 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -102.18 -171.18 27.24 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.42 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -29.32 62.88 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.07 -34.42 61.78 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.124 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' THR . . . . . . . . . . . . . 1.2 p -78.94 -34.15 44.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.95 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -38.63 83.76 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.358 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -102.02 -31.2 10.77 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.401 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.26 45.96 28.83 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.251 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' ASN . . . . . 0.683 ' HB3' HG11 ' A' ' 4' ' ' VAL . 13.0 p-10 -75.68 -39.28 57.81 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.539 0.17 . . . . 0.0 111.4 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.894 ' HB3' HG21 ' B' ' 108' ' ' VAL . 16.2 mt -121.82 121.86 38.16 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.994 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.48 147.31 23.38 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.541 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' B' ' 110' ' ' GLU . 4.8 mt-10 -59.45 111.22 1.31 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.955 0.407 . . . . 0.0 111.17 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' GLY . . . . . . . . . . . . . . . 112.31 -16.33 24.68 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 113.46 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -58.13 134.35 56.39 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.408 0.604 . . . . 0.0 110.777 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 8.5 pt -83.74 99.79 6.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.601 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.618 ' HB ' HG21 ' B' ' 137' ' ' THR . 9.9 mt -66.78 136.74 26.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.246 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 tp -96.09 -42.13 8.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.619 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -146.23 147.79 31.8 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.764 0.316 . . . . 0.0 111.548 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' B' ' 157' ' ' GLN . 34.2 mt -134.9 117.93 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.757 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 50.9 44.18 28.35 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.494 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' GLY . . . . . . . . . . . . . . . 72.22 18.42 78.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.008 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' THR . . . . . . . . . . . . . 30.6 m -120.72 142.22 49.71 Favored 'General case' 0 C--N 1.334 -0.078 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.597 HG12 ' H ' ' B' ' 138' ' ' GLU . 2.9 t -62.81 146.08 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.982 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' THR . . . . . 0.807 HG22 ' HB ' ' B' ' 106' ' ' ILE . 1.4 m -120.98 16.94 11.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.917 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' GLU . . . . . 0.597 ' H ' HG12 ' B' ' 136' ' ' VAL . 1.3 tt0 -117.45 131.34 56.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 71.12 -6.55 1.29 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.554 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 140' ' ' MET . . . . . 0.637 ' HB3' HD11 ' B' ' 106' ' ' ILE . 0.9 OUTLIER -67.2 171.49 5.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.002 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' SER . . . . . . . . . . . . . 20.8 m -87.35 139.6 30.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.218 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' LEU . . . . . 0.592 HD12 ' OG ' ' A' ' 21' ' ' SER . 9.0 tt -56.01 -44.87 79.11 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . . . . . . . . . 58.1 p -61.91 -40.2 94.64 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.805 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -62.97 -48.08 80.42 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.941 ' HB2' HD13 ' B' ' 106' ' ' ILE . . . -58.19 -42.03 85.23 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.071 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' ARG . . . . . . . . . . . . . 10.7 ttt180 -69.49 -37.46 77.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.746 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -68.11 -39.4 82.81 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.661 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' LEU . . . . . . . . . . . . . 1.3 tp -59.92 -43.8 94.69 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.675 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.848 HD11 HD22 ' A' ' 19' ' ' LEU . 11.7 mt -68.27 -37.58 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.837 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -68.78 -49.68 56.65 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.885 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.16 -21.64 63.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.294 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 37.8 t -82.2 66.48 7.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.13 0.491 . . . . 0.0 110.532 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -77.24 122.78 25.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.476 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . 126.01 -92.09 0.4 Allowed Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.158 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.439 ' HE2' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -128.59 133.72 48.4 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.591 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 156' ' ' LEU . . . . . 0.684 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -124.3 143.01 50.81 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.925 0.393 . . . . 0.0 111.357 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.648 ' O ' HD13 ' B' ' 158' ' ' LEU . 2.6 tt0 -105.23 131.67 52.4 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.849 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' LEU . . . . . 0.648 HD13 ' O ' ' B' ' 157' ' ' GLN . 0.4 OUTLIER -127.78 133.47 49.46 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.82 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 21.3 t -119.29 140.1 44.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.669 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' VAL . . . . . . . . . . . . . 9.0 m -133.24 152.02 34.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.421 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 4.3 mt -103.72 123.68 47.49 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -132.16 159.98 37.38 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.969 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' ASP . . . . . . . . . . . . . 1.3 t0 63.0 87.27 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.909 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 18.8 m -81.44 115.56 20.83 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.009 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' LEU . . . . . . . . . . . . . 4.8 mt -135.78 90.64 2.62 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.834 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.443 -179.901 . . . . . . . . 1 1 . 1 stop_ save_